Citrus Sinensis ID: 012191
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.480 | 0.393 | 0.646 | 6e-88 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.891 | 0.584 | 0.436 | 7e-88 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.504 | 0.460 | 0.504 | 4e-63 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.452 | 0.419 | 0.549 | 4e-61 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.508 | 0.458 | 0.483 | 3e-60 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.455 | 0.415 | 0.533 | 6e-60 | |
| E1BB52 | 1512 | Cyclin-dependent kinase 1 | no | no | 0.547 | 0.169 | 0.403 | 6e-50 | |
| Q14004 | 1512 | Cyclin-dependent kinase 1 | yes | no | 0.482 | 0.149 | 0.432 | 6e-50 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.482 | 0.149 | 0.432 | 1e-49 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | no | no | 0.384 | 0.145 | 0.486 | 2e-49 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 325 bits (832), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 146/226 (64%), Positives = 182/226 (80%), Gaps = 1/226 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QL+ GLEHCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA + H++P+TSRVVTL
Sbjct: 223 MRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTL 282
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELLLGATDYG +DLWS GC+ AELL G+PI+ GRTEVEQLHKI+KLCGSP +DY
Sbjct: 283 WYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDY 342
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WKK K H ++KP++PY S+RETFKD P +++ LI+ LLS+EP R TASAAL SE+F
Sbjct: 343 WKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFF 402
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHR-EDARRKKVGGRVRGAETRK 225
+++PYAC+ + LP YPPSKEIDAK R E+ RR++ + +G RK
Sbjct: 403 TSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARK 448
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 7e-88, Method: Compositional matrix adjust.
Identities = 203/465 (43%), Positives = 278/465 (59%), Gaps = 48/465 (10%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLLHGLEHCHSRGVLHRDIKGSNLL+++ LK+ DFGLANF +QPLTSRVVTL
Sbjct: 268 MKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTL 327
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+TDYG +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP ++Y
Sbjct: 328 WYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEY 387
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WK SKLPHAT+FKPQQPY + ETFK LP++A+ L+E LL+VEP R T ++AL SE+F
Sbjct: 388 WKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFF 447
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
+T P A D SSLP Y P KEID K +E+ ++K + ++++ +R+S K P
Sbjct: 448 TTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQVSRES----KAVPAP 503
Query: 241 DVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQV 300
D N SL ++ R+ Q V N ++ + ++A+ I PL+
Sbjct: 504 DS----------NAESLTSIQK-----RQGQHNQVSNSDKFNPGEDAASFRIE---PLKS 545
Query: 301 STSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGS 360
T AK + S R+ + ++ P L T+ ++ R G+
Sbjct: 546 GT------AKDGHTRYGVSSVNRNGENVMMGSSRSPRKELRTQRSFVQR---------GT 590
Query: 361 RTDSRGHDSLEA---VKIAMLN-QWSQLERPDSFDASDGYHSQEL---SLALYQREEMAT 413
SR +S+ A A+ N +W + DS++ ++G + L + +E
Sbjct: 591 AQLSRFSNSVAARDGSHFAIANPRWFE----DSYNNNNGRQNGGAWSQRLVVKHKEFTKH 646
Query: 414 KRNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKS 458
K + ++ E++ SGPL+S +DE+L+ HERQI+ AVRK+
Sbjct: 647 KESITVNGEKKERMHCSGPLVSAGGNLDEMLKEHERQIQLAVRKA 691
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 122/242 (50%), Positives = 162/242 (66%), Gaps = 6/242 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA ++ H LT+RV+TL
Sbjct: 145 MRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNGNLTNRVITL 204
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+T YGP+VD+WSVGC+FAELL GKPIL G+ E EQL KIF+LCG+P +
Sbjct: 205 WYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFELCGTPDELI 264
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W +K+P FKPQ+P ++E+FK A++L+E +L+++P +R +A AL +EY
Sbjct: 265 WPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRISAKDALDAEY 324
Query: 180 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 239
F T P CD SLP Y S E K + +R+ A R+ + S+L P+
Sbjct: 325 FWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQ-----AEEAAKRQKLQHPPPHSRLPPI 379
Query: 240 ED 241
++
Sbjct: 380 QN 381
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 117/213 (54%), Positives = 146/213 (68%), Gaps = 1/213 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H LT+RV+TL
Sbjct: 145 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITL 204
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLGAT YGP++D+WSVGC+FAELL KPIL G+ E EQL+KIF+LCGSP +
Sbjct: 205 WYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKL 264
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W SK+P FKP +P +RE F+ A+ L+E +L ++P +R +A AL +EY
Sbjct: 265 WPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEY 324
Query: 180 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRK 212
F T P CD SLP Y S E K + +R+
Sbjct: 325 FWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQ 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (593), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 118/244 (48%), Positives = 155/244 (63%), Gaps = 6/244 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H LT+RV+TL
Sbjct: 145 MKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGNLTNRVITL 204
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+T YGP+VD+WSVGC+FAELL GKPIL G+ E EQL KIF +CG+P +
Sbjct: 205 WYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFDVCGTPDESN 264
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W +K+P FKP + ++E FK A++L+E +L+++P +R +A AL +EY
Sbjct: 265 WPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRISAQDALDAEY 324
Query: 180 FSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPV 239
F + P CD SLP Y S E K + R+ A R+ T+ +L P+
Sbjct: 325 FWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQ-----ADEAAKRQKTQHPQPHGRLPPI 379
Query: 240 EDVA 243
+
Sbjct: 380 QQTG 383
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 6e-60, Method: Compositional matrix adjust.
Identities = 118/221 (53%), Positives = 148/221 (66%), Gaps = 8/221 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL +CH VLHRDIKGSNLL++NEG LKLADFGLA + H LT+RV+TL
Sbjct: 145 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITL 204
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLGAT YGP++D+WSVGC+FAELL GKPIL G+TE EQL+KI++LCGSP +
Sbjct: 205 WYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESN 264
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W SK+P K +P +RE ++ A+ L+E +L ++P +R A AL +EY
Sbjct: 265 WPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEY 324
Query: 180 FSTKPYACDLSSLPIYPPSKEIDAK-------HREDARRKK 213
F T P CD SLP Y S E K H E+A +K+
Sbjct: 325 FWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRHNEEAAKKQ 365
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|E1BB52|CDK13_BOVIN Cyclin-dependent kinase 13 OS=Bos taurus GN=CDK13 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (505), Expect = 6e-50, Method: Compositional matrix adjust.
Identities = 107/265 (40%), Positives = 153/265 (57%), Gaps = 9/265 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+TL
Sbjct: 819 MRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITL 878
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 879 WYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAV 938
Query: 121 WKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL E+
Sbjct: 939 WPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEF 998
Query: 180 F-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK--SHGM--S 234
+P LP++ E+ +K R RR+K G T K RK S GM S
Sbjct: 999 LRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTVKAPRKDLSLGMDDS 1055
Query: 235 KLAPVEDVAVRTQFAKKINGHSLHI 259
+ + + V +Q + N ++ +
Sbjct: 1056 RTSTPQSVLPSSQLKPQGNSNAAPV 1080
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14004|CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 199 bits (505), Expect = 6e-50, Method: Compositional matrix adjust.
Identities = 100/231 (43%), Positives = 138/231 (59%), Gaps = 5/231 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+TL
Sbjct: 818 MRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITL 877
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 878 WYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAV 937
Query: 121 WKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL E+
Sbjct: 938 WPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEF 997
Query: 180 F-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 229
+P LP++ E+ +K R RR+K G T K RK
Sbjct: 998 LRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDVSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 100/231 (43%), Positives = 138/231 (59%), Gaps = 5/231 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QL+ GL++CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+TL
Sbjct: 818 MRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITL 877
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I ++CGSP
Sbjct: 878 WYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAV 937
Query: 121 WKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W KLP+ KP++ Y LRE F +P A++L + +L+++P KR TA AL E+
Sbjct: 938 WPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEF 997
Query: 180 F-STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRK 229
+P LP++ E+ +K R RR+K G T K RK
Sbjct: 998 LRDVEPSKMPPPDLPLWQDCHELWSKKR---RRQKQMGMTDDLSTIKAPRK 1045
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 88/181 (48%), Positives = 120/181 (66%), Gaps = 1/181 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QL+ GLE+CH + LHRDIK SN+L+NN G +KLADFGLA ++ +P T++V+TL
Sbjct: 823 MKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVITL 882
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG Y P++D+WS GC+ EL KPI Q E+ QL I +LCGSP
Sbjct: 883 WYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 942
Query: 121 WKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W KLP+ KP++ Y LRE F +PT A++L++ +L+++P KR TA L S++
Sbjct: 943 WPDVIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQSDF 1002
Query: 180 F 180
Sbjct: 1003 L 1003
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| 255547313 | 661 | ATP binding protein, putative [Ricinus c | 1.0 | 0.708 | 0.778 | 0.0 | |
| 356516828 | 677 | PREDICTED: probable serine/threonine-pro | 0.993 | 0.686 | 0.735 | 0.0 | |
| 297733936 | 686 | unnamed protein product [Vitis vinifera] | 0.980 | 0.669 | 0.769 | 0.0 | |
| 359491675 | 663 | PREDICTED: probable serine/threonine-pro | 0.980 | 0.692 | 0.769 | 0.0 | |
| 356508521 | 674 | PREDICTED: probable serine/threonine-pro | 0.993 | 0.689 | 0.733 | 0.0 | |
| 224119046 | 685 | predicted protein [Populus trichocarpa] | 0.993 | 0.678 | 0.765 | 0.0 | |
| 356565121 | 671 | PREDICTED: probable serine/threonine-pro | 0.989 | 0.690 | 0.706 | 0.0 | |
| 449439293 | 697 | PREDICTED: probable serine/threonine-pro | 0.991 | 0.665 | 0.706 | 0.0 | |
| 356511986 | 670 | PREDICTED: probable serine/threonine-pro | 0.989 | 0.691 | 0.693 | 0.0 | |
| 79346260 | 709 | protein kinase domain-containing protein | 0.993 | 0.655 | 0.679 | 0.0 |
| >gi|255547313|ref|XP_002514714.1| ATP binding protein, putative [Ricinus communis] gi|223546318|gb|EEF47820.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/469 (77%), Positives = 404/469 (86%), Gaps = 1/469 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCHS+GV+HRDIKGSNLLVNNEG+LK+ DFGLANF +TGHRQPLTSRVVTL
Sbjct: 193 MRQLLFGLEHCHSKGVMHRDIKGSNLLVNNEGMLKVGDFGLANFCHTGHRQPLTSRVVTL 252
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+T+YG SVDLWSVGCVFAELL+GKP+LQGRTEVEQLHKIFKLCGSPPD+Y
Sbjct: 253 WYRPPELLLGSTEYGASVDLWSVGCVFAELLLGKPVLQGRTEVEQLHKIFKLCGSPPDEY 312
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WKKS+LPHATLFKPQQPYDSSLRE FKDLPTTAVNLIETLLSVEPYKR TAS+ALASEYF
Sbjct: 313 WKKSRLPHATLFKPQQPYDSSLREIFKDLPTTAVNLIETLLSVEPYKRGTASSALASEYF 372
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
TKPYACD SSLP YPPSKEIDAK+RE+ARRKK GR RGAETRK RK G++KLAP E
Sbjct: 373 MTKPYACDPSSLPKYPPSKEIDAKNREEARRKKTSGRSRGAETRKPARKPGGINKLAPAE 432
Query: 241 DVAVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 299
D R Q ++ ++ + K D SG E +K +D EE HVKNAS GDIPFSGPLQ
Sbjct: 433 DATARIQGSQNSITTNVCLPKGVDAKSGGEARKASLDKLEEIFHVKNASQGDIPFSGPLQ 492
Query: 300 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 359
VS+SSGFAWA+RRKDDAS+RSH+RSTSR + N LE S AL ++N+DSR+ ENGD I G
Sbjct: 493 VSSSSGFAWARRRKDDASVRSHSRSTSRSLINNGLENSTALQEKSNFDSRRRENGDAIYG 552
Query: 360 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 419
RT+SRGHDS E K A+ QWSQLERPDSFDAS+GYHSQELSLALYQREEM +RNNLG
Sbjct: 553 IRTNSRGHDSNEISKRALQKQWSQLERPDSFDASEGYHSQELSLALYQREEMEARRNNLG 612
Query: 420 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 468
FQDQG+KV+FSGPLLSQSHR+DELLERHERQIRQAVRKSWFQRGKK K
Sbjct: 613 FQDQGDKVDFSGPLLSQSHRVDELLERHERQIRQAVRKSWFQRGKKHGK 661
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516828|ref|XP_003527095.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1860), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/469 (73%), Positives = 395/469 (84%), Gaps = 4/469 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCH RGV+HRDIKGSNLLVNNEGVLK+ADFGLANF N GHRQPLTSRVVTL
Sbjct: 212 MKQLLVGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANFVNPGHRQPLTSRVVTL 271
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+TDYGP+VDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+Y
Sbjct: 272 WYRPPELLLGSTDYGPAVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEY 331
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WKKS+LPHATLFKPQQPYDS LR++FKDLP T+V+L++TLLS+EPYKR TA++AL+SEYF
Sbjct: 332 WKKSRLPHATLFKPQQPYDSCLRQSFKDLPVTSVHLLQTLLSIEPYKRGTATSALSSEYF 391
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
TKPYACD SSLP+YPPSKEIDAKHRE++ RKK+ GRVRG ETRK +RK G +KLAP E
Sbjct: 392 KTKPYACDPSSLPVYPPSKEIDAKHREES-RKKISGRVRGTETRKPSRKPLGFNKLAPAE 450
Query: 241 DVAVRTQFAKKINGHSLHILKDDELS-GREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 299
D+A +TQ + K+N S +L+++ G + QKP E+ASHVKNAS GDIP SGPLQ
Sbjct: 451 DLASQTQTSHKVNARSFRVLEEERTKIGDKAQKPSSGKPEDASHVKNASQGDIPLSGPLQ 510
Query: 300 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 359
VSTSSGFAWAK RKDD S RSH R+ SRG N LEP L++RNN D+R EN + G
Sbjct: 511 VSTSSGFAWAKSRKDDTSFRSHCRTISRGHTFNPLEP-CTLNSRNNLDTRNQENKEFSGG 569
Query: 360 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 419
T+SRGHD LE K++M NQWS+ +RPDSFDASD YHSQELS+ALY RE+ A+KR+NL
Sbjct: 570 C-TNSRGHDLLEISKLSMQNQWSKFDRPDSFDASDEYHSQELSIALYHREDSASKRSNLS 628
Query: 420 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 468
FQDQGEKVEFSGPLLSQ H +DELLERHER IR+ VR+SWFQRGKK K
Sbjct: 629 FQDQGEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQRGKKLGK 677
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733936|emb|CBI15183.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1852), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/464 (76%), Positives = 401/464 (86%), Gaps = 5/464 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL GLEHCHSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVTLWY
Sbjct: 224 QLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWY 283
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
RPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+YWK
Sbjct: 284 RPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWK 343
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182
KSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEYF T
Sbjct: 344 KSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKT 403
Query: 183 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 242
KPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P E+
Sbjct: 404 KPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPAENF 461
Query: 243 AVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVS 301
+TQ K+NG+ HI K+ D G E KP +D EASH+KNAS GDIPFSGPLQVS
Sbjct: 462 TAQTQGPHKLNGNGFHIFKEGDGKLGGEPPKPSIDVLTEASHMKNASQGDIPFSGPLQVS 521
Query: 302 TSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSR 361
TSSGFAWAKRRKDDAS RSH+RS+SRG NALEP+AALH RNN S + EN D+ NG R
Sbjct: 522 TSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNN--SNRLENSDVSNGGR 579
Query: 362 TDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQ 421
TDSRG+DS E K ML QW Q ERPDSFDASD YHSQELSL +Y+REEMA KRN+L +Q
Sbjct: 580 TDSRGYDSSEIAKRVMLKQWGQFERPDSFDASDMYHSQELSLPMYRREEMAAKRNHLSYQ 639
Query: 422 DQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 465
DQGEKVEFSGPLLSQSHR+DELLERHER IRQAVR+SWFQRGKK
Sbjct: 640 DQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQRGKK 683
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491675|ref|XP_003634302.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1852), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/464 (76%), Positives = 401/464 (86%), Gaps = 5/464 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL GLEHCHSRGV+HRDIKG+NLLVNNEG+LK+ADFGLANF ++ +RQPLTSRVVTLWY
Sbjct: 201 QLLSGLEHCHSRGVMHRDIKGANLLVNNEGILKIADFGLANFCSSVYRQPLTSRVVTLWY 260
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
RPPELLLG+TDYG SVDLWSVGCVFAELL+G+PIL+GRTEVEQLHKIFKLCGSPPD+YWK
Sbjct: 261 RPPELLLGSTDYGASVDLWSVGCVFAELLVGRPILKGRTEVEQLHKIFKLCGSPPDEYWK 320
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182
KSKLPHATLFKPQQPY+S LRE+FKDLPT +V+LIETLLSVEPYKR TAS+ALASEYF T
Sbjct: 321 KSKLPHATLFKPQQPYESCLRESFKDLPTISVDLIETLLSVEPYKRGTASSALASEYFKT 380
Query: 183 KPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVEDV 242
KPYACD SSLP Y P+KEIDAK+RE++RRKKVGGRVRG+E K TRK +G++KL P E+
Sbjct: 381 KPYACDPSSLPKYSPNKEIDAKNREESRRKKVGGRVRGSE--KPTRKPNGINKLVPAENF 438
Query: 243 AVRTQFAKKINGHSLHILKD-DELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQVS 301
+TQ K+NG+ HI K+ D G E KP +D EASH+KNAS GDIPFSGPLQVS
Sbjct: 439 TAQTQGPHKLNGNGFHIFKEGDGKLGGEPPKPSIDVLTEASHMKNASQGDIPFSGPLQVS 498
Query: 302 TSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGSR 361
TSSGFAWAKRRKDDAS RSH+RS+SRG NALEP+AALH RNN S + EN D+ NG R
Sbjct: 499 TSSGFAWAKRRKDDASTRSHSRSSSRGLGCNALEPNAALHARNN--SNRLENSDVSNGGR 556
Query: 362 TDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGFQ 421
TDSRG+DS E K ML QW Q ERPDSFDASD YHSQELSL +Y+REEMA KRN+L +Q
Sbjct: 557 TDSRGYDSSEIAKRVMLKQWGQFERPDSFDASDMYHSQELSLPMYRREEMAAKRNHLSYQ 616
Query: 422 DQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 465
DQGEKVEFSGPLLSQSHR+DELLERHER IRQAVR+SWFQRGKK
Sbjct: 617 DQGEKVEFSGPLLSQSHRVDELLERHERHIRQAVRRSWFQRGKK 660
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508521|ref|XP_003523004.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/469 (73%), Positives = 394/469 (84%), Gaps = 4/469 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCH RGV+HRDIKGSNLLVNNEGVLK+ADFGLAN+ N+GHRQPLTSRVVTL
Sbjct: 209 MKQLLAGLEHCHLRGVMHRDIKGSNLLVNNEGVLKVADFGLANYVNSGHRQPLTSRVVTL 268
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+TDY PSVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+Y
Sbjct: 269 WYRPPELLLGSTDYDPSVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEY 328
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WKKSKLPHATLFKP+QPYDS LR++FKDLPTT+V+L++TLLSVEPYKR TA++AL+SEYF
Sbjct: 329 WKKSKLPHATLFKPEQPYDSCLRQSFKDLPTTSVHLLQTLLSVEPYKRGTATSALSSEYF 388
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
TKPYACD SSLP+YPPSKEIDAKHR D RKK+ GRVRG TRK +RK G +KLAP E
Sbjct: 389 KTKPYACDPSSLPVYPPSKEIDAKHR-DESRKKISGRVRGTATRKPSRKPLGFNKLAPAE 447
Query: 241 DVAVRTQFAKKINGHSLHILKDDELS-GREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 299
+A +TQ ++K+NG S HIL+++++ G + QK E+A H+KNAS GDIP SGPLQ
Sbjct: 448 GLASQTQTSQKVNGRSFHILEEEKIKIGDKAQKSSSGKPEDAFHMKNASQGDIPLSGPLQ 507
Query: 300 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 359
VSTSSGFAWAK RKDD S RSH R+ SRG + NALEPS L+TRNN D+ EN + G
Sbjct: 508 VSTSSGFAWAKSRKDDTSFRSHCRTISRGHIFNALEPS-TLNTRNNLDTTNQENKEFC-G 565
Query: 360 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 419
+SRGHD LE K++M NQWS+ +RPDSFDASD YHSQELS ALY RE+ +KR+NL
Sbjct: 566 RYPNSRGHDLLEISKLSMQNQWSKFDRPDSFDASDEYHSQELSTALYHREDSVSKRSNLT 625
Query: 420 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 468
FQDQGEKVEFSGPLLSQ H +DELLERHER IR+ VR+SWFQRGKK K
Sbjct: 626 FQDQGEKVEFSGPLLSQMHTVDELLERHERHIRRTVRRSWFQRGKKLGK 674
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119046|ref|XP_002317972.1| predicted protein [Populus trichocarpa] gi|222858645|gb|EEE96192.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 710 bits (1832), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/469 (76%), Positives = 396/469 (84%), Gaps = 4/469 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL+HCHS+GV+HRDIKGSNLLVNNEG+LK+ DFGLANF +GHRQPLTSRVVTL
Sbjct: 220 MRQLLSGLDHCHSKGVMHRDIKGSNLLVNNEGILKVGDFGLANFCTSGHRQPLTSRVVTL 279
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+TDYG SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+Y
Sbjct: 280 WYRPPELLLGSTDYGASVDLWSVGCVFAELLLGKPILQGRTEVEQLHKIFKLCGSPPDEY 339
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WKKSKLPHATLFKPQQPYDS LRETFKDLPTTAVNLIETLLSVEPY R TA +ALASEYF
Sbjct: 340 WKKSKLPHATLFKPQQPYDSCLRETFKDLPTTAVNLIETLLSVEPYNRGTAFSALASEYF 399
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
STKPYACD SSLP YPPSKEIDAK E+A RKK+ GR RG ETRK TRK +G+SKLAP E
Sbjct: 400 STKPYACDPSSLPKYPPSKEIDAKKHEEAGRKKISGRGRGTETRKCTRKPYGISKLAPAE 459
Query: 241 DVAVRTQFAKKINGHSLHILK-DDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQ 299
D+A R Q +IN ++ I K D SG E +KP +D EE H+KNAS GDIPFSGPLQ
Sbjct: 460 DLAARIQ-CGQINTSNMRIPKVRDGKSGGEARKPSLDKLEEIFHIKNASQGDIPFSGPLQ 518
Query: 300 VSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIING 359
VS+SSGFAWAKRR DASIRSH+RS SRG N LEPS+ +NN DS++H NGD+I G
Sbjct: 519 VSSSSGFAWAKRRNGDASIRSHSRSISRGHSNNGLEPSS--EEKNNSDSKQHNNGDLIYG 576
Query: 360 SRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLG 419
RT+SRGH+S E K A+ QWSQ ERPDSFDAS+ YHSQELSLALYQRE M +KR+NL
Sbjct: 577 VRTNSRGHNSYEISKFALQKQWSQFERPDSFDASEEYHSQELSLALYQREGMESKRSNLV 636
Query: 420 FQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKKFRK 468
FQDQ +KV+FSGPLLSQSHR+DELLERHER IRQAVRKSWF RGKK K
Sbjct: 637 FQDQMDKVDFSGPLLSQSHRVDELLERHERHIRQAVRKSWFHRGKKHGK 685
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565121|ref|XP_003550793.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/467 (70%), Positives = 387/467 (82%), Gaps = 4/467 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCHSRGV+HRDIKGSNLLVNNEG+LK+ADFGLANFSN+G++QPLTSRVVTL
Sbjct: 204 MKQLLSGLEHCHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVTL 263
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+T YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP++Y
Sbjct: 264 WYRPPELLLGSTAYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEEY 323
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WKK++LPHATLFKPQQPYDSSLRETFKD + VNL++TLLSVEP KR TAS+AL+ EYF
Sbjct: 324 WKKTRLPHATLFKPQQPYDSSLRETFKDFHASTVNLLQTLLSVEPSKRGTASSALSLEYF 383
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
KPYAC+ SSLPIYPPSKEIDAKH E++RRKK+GGR E+RK +RK +SKLAP E
Sbjct: 384 KIKPYACEPSSLPIYPPSKEIDAKHEEESRRKKIGGRACKPESRKPSRKPLALSKLAPAE 443
Query: 241 DVAVRTQFAKKINGHSLHILK-DDELSGREVQKPLVDNREEA-SHVKNASHGDIPFSGPL 298
D+ +TQ + K+N S HI+K +D + E K E+A S++KNAS DIPF GPL
Sbjct: 444 DLTSQTQTSHKMNDRSAHIIKQEDTNTCEEAPKQSSGKPEDASSYMKNASQVDIPFPGPL 503
Query: 299 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIIN 358
QVS SSGFAWAKRR+DD S+RSH+RS SRG + N+LE S L++R+N +SR HEN +
Sbjct: 504 QVSKSSGFAWAKRRRDDTSVRSHSRSISRGFIFNSLETS-TLNSRDNSESRNHENKEFF- 561
Query: 359 GSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNL 418
G+RT+SRG+ LE K+AM NQWS+ +RPDSFD D YHSQELSLA+Y R++ +KR+NL
Sbjct: 562 GARTNSRGNHLLEISKLAMQNQWSKFDRPDSFDTCDEYHSQELSLAIYNRQDSLSKRSNL 621
Query: 419 GFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 465
+QDQ EKVEFSGPLLSQ H +DELLERHER IR VR+SWFQRGKK
Sbjct: 622 SYQDQEEKVEFSGPLLSQMHTVDELLERHERHIRHTVRRSWFQRGKK 668
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439293|ref|XP_004137420.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] gi|449486990|ref|XP_004157463.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/464 (70%), Positives = 382/464 (82%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCHSRGV+HRDIKGSNLLVNNEGVLK+ADFGLANF NTGHRQPLTSRVVTL
Sbjct: 233 MKQLLSGLEHCHSRGVMHRDIKGSNLLVNNEGVLKVADFGLANFCNTGHRQPLTSRVVTL 292
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+TDY SVDLWSVGCVFAELL+GKPILQGRTEVEQLHKIFKLCGSPPD+Y
Sbjct: 293 WYRPPELLLGSTDYNASVDLWSVGCVFAELLVGKPILQGRTEVEQLHKIFKLCGSPPDEY 352
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WKKSKLPHATLFKPQ PY++ LR+TFKD P+T VNL+ETLLSVEPYKR AS+AL SEYF
Sbjct: 353 WKKSKLPHATLFKPQHPYNNCLRQTFKDHPSTTVNLLETLLSVEPYKRGVASSALISEYF 412
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
STKPYACD SS+PIYPP+KEIDAK RE+ RRKK GR RG + R+ TRK G+SKLAP E
Sbjct: 413 STKPYACDPSSMPIYPPNKEIDAKQREETRRKKGSGRSRGLDNRRLTRKHLGISKLAPAE 472
Query: 241 DVAVRTQFAKKINGHSLHILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFSGPLQV 300
D++V + KI+ ++ ++ ++ + G E +K +D EE HVKN+S GDIPFSGPLQV
Sbjct: 473 DLSVSARDLHKISINAQNLKEEKVIKGVEAEKMSMDKLEETIHVKNSSQGDIPFSGPLQV 532
Query: 301 STSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIINGS 360
STSSGFAWA+RR+DDASIR ++RS SRG +IN LE S LH+ +N DS+ HE D+ + S
Sbjct: 533 STSSGFAWARRRRDDASIRCYSRSISRGHLINGLEDSTTLHSISNLDSKIHEKSDMSSIS 592
Query: 361 RTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNLGF 420
R+ S+GH+S E K+ M N W + ERPDSFD SD YHSQE + ALY R+E KR L +
Sbjct: 593 RSSSKGHESNERSKVVMRNPWGKFERPDSFDTSDEYHSQEFAAALYLRDEKEAKRKQLSY 652
Query: 421 QDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGK 464
QDQ +KVE+SGPLLSQS R+DELL+RHER IRQ VR+SWFQRGK
Sbjct: 653 QDQVDKVEYSGPLLSQSSRVDELLDRHERHIRQTVRRSWFQRGK 696
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511986|ref|XP_003524702.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1738), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/467 (69%), Positives = 386/467 (82%), Gaps = 4/467 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL G+EHCHSRGV+HRDIKGSNLLVNNEG+LK+ADFGLANFSN+G++QPLTSRVVTL
Sbjct: 203 MKQLLSGIEHCHSRGVMHRDIKGSNLLVNNEGILKVADFGLANFSNSGNKQPLTSRVVTL 262
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+T YG SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP++Y
Sbjct: 263 WYRPPELLLGSTAYGASVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPEEY 322
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WKK++LPHATLFKPQQPYDS LRETFKD ++VNL++TLLSVEP KR TAS+AL+ EYF
Sbjct: 323 WKKTRLPHATLFKPQQPYDSCLRETFKDFHASSVNLLQTLLSVEPSKRGTASSALSLEYF 382
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
TKPYACD SSLPIYPPSKEIDAK+ E++RRKK+GGR AE+RK +R +SKLAP E
Sbjct: 383 KTKPYACDPSSLPIYPPSKEIDAKNEEESRRKKIGGRACRAESRKPSRNPLALSKLAPAE 442
Query: 241 DVAVRTQFAKKINGHSLHILKDDEL-SGREVQKPLVDNREEA-SHVKNASHGDIPFSGPL 298
D++ +TQ ++K++ S+HI+K++ + E K E+A S++KNAS DIPF GPL
Sbjct: 443 DLSSQTQTSQKMDDRSVHIIKEENTNTCEEAPKQSSGKPEDASSYMKNASQVDIPFPGPL 502
Query: 299 QVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENGDIIN 358
QVS SSGFAWAKRR+DD S+RSH+RS SRG + N+ E S L++RNN +SR HEN
Sbjct: 503 QVSKSSGFAWAKRRRDDTSVRSHSRSISRGYIFNSSETS-TLNSRNNSESRNHENKKFF- 560
Query: 359 GSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATKRNNL 418
G+ +SRGHD LE K+AM NQWS+ +R DSFD D YHSQELS+ALY R++ +KR+NL
Sbjct: 561 GAHANSRGHDLLEISKLAMQNQWSKFDRLDSFDTCDEYHSQELSVALYNRQDSLSKRSNL 620
Query: 419 GFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 465
+QDQ EKVEFSGPLLSQ H +DELLERHE IR+ VR+SWFQRGKK
Sbjct: 621 SYQDQAEKVEFSGPLLSQMHTVDELLERHESHIRRTVRRSWFQRGKK 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79346260|ref|NP_173302.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|332191623|gb|AEE29744.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/471 (67%), Positives = 373/471 (79%), Gaps = 6/471 (1%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLTSRVVT 59
M QLL GL+HCH+RGV+HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLTSRVVT
Sbjct: 236 MKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSRVVT 295
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYRPPELLLGAT+YG SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCGSPP+D
Sbjct: 296 LWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPPED 355
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRET--FKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
YWKKSKLPHA LFKPQQ YD LRET K L +NLIETLLS++P+KR TAS AL S
Sbjct: 356 YWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTALVS 415
Query: 178 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGR-VRGAETRKTTRKSHGMSKL 236
+YF++KP+ACD SSLP+Y PSKEIDAKHRED RKK+ G RG E+RK TRK +KL
Sbjct: 416 QYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPPAFAKL 475
Query: 237 APVEDVAVRTQFAKKINGHSLH-ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFS 295
AP EDV +Q +K NGHS+H + D ++QKP ++EASHVKNAS GD+PFS
Sbjct: 476 APAEDVRHHSQKFQKRNGHSVHNSIDSDSTLFEKMQKPSNHEKDEASHVKNASQGDVPFS 535
Query: 296 GPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDS-RKHENG 354
GPLQVS SSGFAWAKRRKDD +RSH RS SRG + N L PS A + DS +
Sbjct: 536 GPLQVSVSSGFAWAKRRKDDICVRSHNRSLSRGHIPNLLGPSPAFSENTDVDSKNNEKEK 595
Query: 355 DIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATK 414
+ +G RTDS+ ++ E +K++ML +W QLERPDSF SD YHSQELSL LYQREE A K
Sbjct: 596 EEKHGERTDSQDREAYEMLKLSMLKKWRQLERPDSFGGSDEYHSQELSLELYQREEKAAK 655
Query: 415 RNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 465
+LG++D EK+EFSGPLLS+S+ +DELLERHERQIRQ VRKSWFQ+GKK
Sbjct: 656 LGHLGYEDNDEKIEFSGPLLSKSYGVDELLERHERQIRQLVRKSWFQKGKK 706
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.993 | 0.655 | 0.668 | 3.7e-167 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.961 | 0.643 | 0.660 | 2.5e-159 | |
| TAIR|locus:2175743 | 644 | cdc2cAt "CDC2C" [Arabidopsis t | 0.444 | 0.322 | 0.721 | 2.9e-97 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.568 | 0.372 | 0.572 | 2.4e-87 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.739 | 0.537 | 0.473 | 1e-86 | |
| TAIR|locus:2140543 | 469 | AT4G10010 [Arabidopsis thalian | 0.444 | 0.443 | 0.692 | 3.5e-86 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.444 | 0.338 | 0.663 | 4.5e-84 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.632 | 0.4 | 0.526 | 4e-83 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.660 | 0.445 | 0.534 | 9.4e-82 | |
| TAIR|locus:504955609 | 629 | AT3G01085 [Arabidopsis thalian | 0.668 | 0.497 | 0.486 | 2.8e-80 |
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1626 (577.4 bits), Expect = 3.7e-167, P = 3.7e-167
Identities = 315/471 (66%), Positives = 368/471 (78%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-TGHRQPLTSRVVT 59
M QLL GL+HCH+RGV+HRDIKGSNLLVNNEG+LK+ADFGLANF N +G++QPLTSRVVT
Sbjct: 236 MKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNKQPLTSRVVT 295
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYRPPELLLGAT+YG SVDLWSVGCVFAELLIGKP+LQGRTEVEQLHKIFKLCGSPP+D
Sbjct: 296 LWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPPED 355
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALAS 177
YWKKSKLPHA LFKPQQ YD LRET K L +NLIETLLS++P+KR TAS AL S
Sbjct: 356 YWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKRGTASTALVS 415
Query: 178 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHGMSKL 236
+YF++KP+ACD SSLP+Y PSKEIDAKHRED E+RK TRK +KL
Sbjct: 416 QYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGRRGTESRKPTRKPPAFAKL 475
Query: 237 APVEDVAVRTQFAKKINGHSLH-ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPFS 295
AP EDV +Q +K NGHS+H + D ++QKP ++EASHVKNAS GD+PFS
Sbjct: 476 APAEDVRHHSQKFQKRNGHSVHNSIDSDSTLFEKMQKPSNHEKDEASHVKNASQGDVPFS 535
Query: 296 GPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSRKHENG- 354
GPLQVS SSGFAWAKRRKDD +RSH RS SRG + N L PS A + DS+ +E
Sbjct: 536 GPLQVSVSSGFAWAKRRKDDICVRSHNRSLSRGHIPNLLGPSPAFSENTDVDSKNNEKEK 595
Query: 355 DIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMATK 414
+ +G RTDS+ ++ E +K++ML +W QLERPDSF SD YHSQELSL LYQREE A K
Sbjct: 596 EEKHGERTDSQDREAYEMLKLSMLKKWRQLERPDSFGGSDEYHSQELSLELYQREEKAAK 655
Query: 415 RNNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQRGKK 465
+LG++D EK+EFSGPLLS+S+ +DELLERHERQIRQ VRKSWFQ+GKK
Sbjct: 656 LGHLGYEDNDEKIEFSGPLLSKSYGVDELLERHERQIRQLVRKSWFQKGKK 706
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1552 (551.4 bits), Expect = 2.5e-159, P = 2.5e-159
Identities = 311/471 (66%), Positives = 369/471 (78%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQ-PLTSRVV 58
M QLL GL+HCHSRGV+HRDIKGSNLL++NEG+LK+ADFGLANFSN+ GH++ PLTSRVV
Sbjct: 226 MKQLLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVV 285
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
TLWYRPPELLLGATDYG SVDLWSVGCVFAELL+GKPIL+GRTEVEQLHKIFKLCGSPP+
Sbjct: 286 TLWYRPPELLLGATDYGASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPE 345
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
DYWKKSKLPHA LFKPQQ YDS LRET KDL T +NLIETLLS++P+KR TAS+AL S+
Sbjct: 346 DYWKKSKLPHAMLFKPQQTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQ 405
Query: 179 YFSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXA-ETRKTTRKSHGMSKLA 237
YF+TKP+ACD SSLPIYPPSKEID KHR++A + RK +RK+H ++LA
Sbjct: 406 YFTTKPFACDPSSLPIYPPSKEIDTKHRDEAARKKISGNGRRGIDPRKPSRKAHSFNRLA 465
Query: 238 PVEDVAVRTQ-FAKKINGHSLH--ILKDDELSGREVQKPLVDNREEASHVKNASHGDIPF 294
P DV +T+ F K+I GH +H I D L G+ +Q PL ++EASHVK+AS GD+PF
Sbjct: 466 P--DVRHQTETFQKRI-GHLVHSSIESDARLCGK-LQNPLDHKKDEASHVKHASQGDVPF 521
Query: 295 SGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNYDSR--KHE 352
SGPLQVS S+ FAWAKR KDD +R H RS SRG + + S A + +++ +S+ K E
Sbjct: 522 SGPLQVSKSNSFAWAKREKDDVCVRVHNRSLSRGYIPSLSGHSPAFNGKSDVESKINKDE 581
Query: 353 NGDIINGSRTDSRGHDSLEAVKIAMLNQWSQLERPDSFDASDGYHSQELSLALYQREEMA 412
D +TDSRG +S E VK +ML QW QLERPDSF ASD YHSQELSL LYQR+EMA
Sbjct: 582 KED-----KTDSRGEESYEMVKRSMLKQWRQLERPDSFGASDEYHSQELSLGLYQRDEMA 636
Query: 413 TKR-NNLGFQDQGEKVEFSGPLLSQSHRIDELLERHERQIRQAVRKSWFQR 462
K NNLG G+K+EFSGPLLSQS+ +DELLERHER IR+ +RK WFQ+
Sbjct: 637 KKMGNNLG---DGDKIEFSGPLLSQSYGVDELLERHERNIRKLIRKPWFQK 684
|
|
| TAIR|locus:2175743 cdc2cAt "CDC2C" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
Identities = 150/208 (72%), Positives = 176/208 (84%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCH RGV+HRDIK SN+LVNN+GVLKL DFGLAN ++ LTSRVVTL
Sbjct: 210 MKQLLWGLEHCHMRGVIHRDIKASNILVNNKGVLKLGDFGLANVVTPSNKNQLTSRVVTL 269
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELL+G+T YG SVDLWSVGCVFAE+L+GKPIL+GRTE+EQLHKI+KLCGSP D +
Sbjct: 270 WYRAPELLMGSTSYGVSVDLWSVGCVFAEILMGKPILKGRTEIEQLHKIYKLCGSPQDSF 329
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WK++KLPHAT FKPQ Y+++LRE KDL T V L+ETLLS+EP KR TAS+AL SEYF
Sbjct: 330 WKRTKLPHATSFKPQHTYEATLRERCKDLSATGVYLLETLLSMEPDKRGTASSALNSEYF 389
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHRED 208
T+PYACD SSLP YPP+KE+DAK+R+D
Sbjct: 390 LTRPYACDPSSLPKYPPNKEMDAKYRDD 417
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 2.4e-87, Sum P(2) = 2.4e-87
Identities = 154/269 (57%), Positives = 191/269 (71%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLLHGLEHCHSRGVLHRDIKGSNLL+++ LK+ DFGLANF +QPLTSRVVTL
Sbjct: 268 MKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTL 327
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG+TDYG +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP ++Y
Sbjct: 328 WYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEY 387
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
WK SKLPHAT+FKPQQPY + ETFK LP++A+ L+E LL+VEP R T ++AL SE+F
Sbjct: 388 WKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFF 447
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPVE 240
+T P A D SSLP Y P KEID K +E+ ++++ +R+S + AP
Sbjct: 448 TTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDSKQVSRESKAVP--APDS 505
Query: 241 DVAVRTQFAKKINGHSLHILKDDELSGRE 269
+ T K+ H+ + D+ + E
Sbjct: 506 NAESLTSIQKRQGQHN-QVSNSDKFNPGE 533
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 1.0e-86, Sum P(2) = 1.0e-86
Identities = 172/363 (47%), Positives = 225/363 (61%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL HCHSRGVLHRDIKGSNLL+++ GVLK+ADFGLA F + + PLTSRVVTL
Sbjct: 242 MQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVTL 301
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLGA YG VDLWS GC+ EL GKPIL G+TEVEQLHKIFKLCGSP +DY
Sbjct: 302 WYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLHKIFKLCGSPTEDY 361
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
W+K KLP + F+P PY + E FKDLPT ++L+E LLS++P +R +A+ AL SEYF
Sbjct: 362 WRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSAARALESEYF 421
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPVE 240
T+P+ACD SSLP YPPSKEIDAK R+DA + +T R+SH + PV+
Sbjct: 422 RTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQRPTQEKHERQDSQT-RRSHERKLIPPVK 480
Query: 241 ------DVAVRTQFAKK-INGHSLHILKD----DELSGREVQK-PLVDNRE--EASHVKN 286
AV + + + G+S ++D + SGR P++ NR ++VK+
Sbjct: 481 ANNPSLSTAVENPYLRSCVPGNSQRQMQDMTCNNPTSGRVSHSGPMMKNRNLSRLTYVKD 540
Query: 287 ASHGDIPFSGPLQVSTSSGFAWAKRRKDDASIRSHTRSTSRGQVI-NALEPSAALHTRNN 345
+ IP G+ + ++ D R R+ +R + N+ + + +
Sbjct: 541 NAAPRIPSYRANSAGQGGGYVGSDQQMMDQQ-RKELRTFNRADTMDNSKRQTKIPNDPSW 599
Query: 346 YDS 348
YDS
Sbjct: 600 YDS 602
|
|
| TAIR|locus:2140543 AT4G10010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 793 (284.2 bits), Expect = 3.5e-86, Sum P(2) = 3.5e-86
Identities = 144/208 (69%), Positives = 173/208 (83%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCHSRG+LHRDIKG NLLVNN+GVLK+ DFGLAN + QPLTSRVVTL
Sbjct: 81 MKQLLSGLEHCHSRGILHRDIKGPNLLVNNDGVLKIGDFGLANIYHPEQDQPLTSRVVTL 140
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELLLGAT+YGP +DLWSVGC+ EL +GKPI+ GRTEVEQ+HKIFK CGSP DDY
Sbjct: 141 WYRAPELLLGATEYGPGIDLWSVGCILTELFLGKPIMPGRTEVEQMHKIFKFCGSPSDDY 200
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
W+K+KLP AT FKPQQPY L ETFK+LP +A+ L++ LLS+EP KR TAS+ L+S++F
Sbjct: 201 WQKTKLPLATSFKPQQPYKRVLLETFKNLPPSALALVDKLLSLEPAKRGTASSTLSSKFF 260
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHRED 208
+ +P C++SSLP YPPSKE+DAK R++
Sbjct: 261 TMEPLPCNVSSLPKYPPSKELDAKVRDE 288
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 4.5e-84, Sum P(2) = 4.5e-84
Identities = 138/208 (66%), Positives = 172/208 (82%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCHSRG+LHRDIKGSNLLVNN+GVLK+ DFGLA+F QPLTSRVVTL
Sbjct: 246 MKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVTL 305
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELLLG+T+YGP++DLWSVGC+ AEL + KPI+ GRTEVEQ+HKIFKLCGSP +++
Sbjct: 306 WYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEEF 365
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
W +K P AT +KPQ PY L ETFK+L +++++L++ LLSVEP KR +AS+ L SE+F
Sbjct: 366 WNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSEFF 425
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHRED 208
+T+P C +SSLP YPPSKE+DAK R++
Sbjct: 426 TTEPLPCHISSLPKYPPSKELDAKVRDE 453
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 4.0e-83, Sum P(2) = 4.0e-83
Identities = 159/302 (52%), Positives = 196/302 (64%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GLEHCHSRGVLHRDIKGSNLL++++GVLK+ADFGLA F + LTS VVTL
Sbjct: 318 MRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFGLATFFDPAKSVSLTSHVVTL 377
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLGA+ YG VDLWS GC+ EL GKPIL G+TEVEQLHKIFKLCGSP ++Y
Sbjct: 378 WYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGKTEVEQLHKIFKLCGSPTENY 437
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
W+K KLP + FK PY + E FKD P + ++L+ETLLS++P R++A AL SEYF
Sbjct: 438 WRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETLLSIDPDHRSSADRALESEYF 497
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPVE 240
TKP+ACD S+LP YPPSKEIDAK R++A TR SH + PV+
Sbjct: 498 KTKPFACDPSNLPKYPPSKEIDAKMRDEAKRQQPMRAEKQERQDSMTRISHERKFVPPVK 557
Query: 241 -DVAVRTQFAKKINGHSLHILKDDELSGREVQKPL--VDNREEASHVKNASHG-DIPFSG 296
+ ++ K+ L D S +E + P V + + H +N G I SG
Sbjct: 558 ANNSLSMTMEKQYK--DLRSRNDSFKSFKEERTPHGPVPDYQNMQHNRNNQTGVRISHSG 615
Query: 297 PL 298
PL
Sbjct: 616 PL 617
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
Identities = 177/331 (53%), Positives = 218/331 (65%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ QLLHGL+HCHSRGVLHRDIKGSNLL++N GVLK+ADFGLA+F + QPLTSRVVTL
Sbjct: 239 LQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTSRVVTL 298
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLGAT YG +VDLWS GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP +DY
Sbjct: 299 WYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPTEDY 358
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
W KS+LPHAT+FKP QPY + ETFK+ P A+ L+ETLLSV P R TA+AAL SE+F
Sbjct: 359 WVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTATAALKSEFF 418
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHR-EDAXXXXXXXXXXXAETRKTTRKSHGM-SKLAP 238
ST+P CD SSLP YPPSKE+DA+ R E++ + R+ T++S + + A
Sbjct: 419 STRPLPCDPSSLPKYPPSKELDARMRDEESRRQVGGNRDQRHQERRGTKESRAIPAPDAN 478
Query: 239 VEDVAV----RTQFAKKINGHSLHILKDDELSGREVQKP------LVDNREEASHV---K 285
E VA ++Q + + ++ SG + P NRE ++ K
Sbjct: 479 AELVASMQKRQSQSTNRSRSEKFNPHPEEVASGFPIDPPRPSSQAFEPNRESQGNIIPHK 538
Query: 286 NASHGDIPFSGPLQVSTSSGFAWAKRRKDDA 316
ASH SGPL S S A +R D+
Sbjct: 539 RASH-----SGPL--SRRSASAKGRRNYQDS 562
|
|
| TAIR|locus:504955609 AT3G01085 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 2.8e-80, Sum P(2) = 2.8e-80
Identities = 164/337 (48%), Positives = 223/337 (66%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL G+EHCH RG++HRDIK +N+LVNN+GVLKLADFGLAN ++ LTSRVVTL
Sbjct: 220 MKQLLWGVEHCHLRGIMHRDIKAANILVNNKGVLKLADFGLANIVTPRNKNQLTSRVVTL 279
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELL+G+T Y SVDLWSVGCVFAE+L G+P+L+GRTE+EQLHKI+KL GSP +++
Sbjct: 280 WYRAPELLMGSTSYSVSVDLWSVGCVFAEILTGRPLLKGRTEIEQLHKIYKLSGSPDEEF 339
Query: 121 WKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W+K+KL P +F+PQ Y+ LRE F + P TA+NL+E LLS++P KR TAS+AL SEY
Sbjct: 340 WEKNKLHPQTKMFRPQHQYEGCLRERFDEFPKTAINLLENLLSIDPEKRGTASSALMSEY 399
Query: 180 FSTKPYACDLSSLPIYPPSKEIDAKHREDAXXXXXXXXXXXAETRKTTRKSHGMSKLAPV 239
F+T+PYACD S+LP YPP+KE+DAK+RE+ T+K G S+ A V
Sbjct: 400 FNTQPYACDPSTLPKYPPNKEMDAKYREELQRRRRVSIKK--RDNLATKKL-GKSRRATV 456
Query: 240 EDVAVRTQFAKKINGHSLHILKDDELSGREVQKPLV-DNREEASHVKNASHGDIPFSGPL 298
++ +L+ L + + +E + +V E S S + P++
Sbjct: 457 KEPT------------NLNRLPTHQETKKEAETEIVVQTPSETSQATTRS--EFPYNSLS 502
Query: 299 QVST-SSGFAWA--KRRKDD--ASIRSHTRSTSRGQV 330
Q + +SGFAWA K+RK++ AS ++ + S V
Sbjct: 503 QTTAPASGFAWAGTKKRKENDVASTLTYIQPGSASHV 539
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00120612 | hypothetical protein (686 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 468 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-97 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-79 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-76 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-70 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-69 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-69 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-67 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-62 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-58 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-58 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-54 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-54 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-54 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-50 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-50 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-50 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-49 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-49 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-49 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-49 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-48 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-48 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-47 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-46 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-45 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-45 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-44 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-43 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-43 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-42 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-42 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-42 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-42 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-41 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-41 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-41 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-40 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-40 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-39 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-39 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-38 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-38 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-38 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-37 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-37 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-37 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-35 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-34 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-33 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-33 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-31 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-29 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-28 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-27 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-27 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-08 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 9e-07 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 0.001 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.001 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.003 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.003 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.003 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 294 bits (756), Expect = 1e-97
Identities = 110/182 (60%), Positives = 136/182 (74%), Gaps = 2/182 (1%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL++ HS G+LHRDIKGSN+L+NN+GVLKLADFGLA + T+RV+TL
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL 165
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLGAT YGP VD+WSVGC+ AEL +GKPI QG TE+EQL KIF+LCGSP D+
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPT-TAVNLIETLLSVEPYKRATASAALASE 178
W SKLP KP++PY LRE FK L +A++L++ LL+++P KR +A AL E
Sbjct: 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285
Query: 179 YF 180
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 247 bits (634), Expect = 4e-79
Identities = 91/194 (46%), Positives = 122/194 (62%), Gaps = 4/194 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M L GLE+ HS +LHRD+K +NLL+ ++GVLKLADFGLA + +R +T +VVT
Sbjct: 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTR 166
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELL GA YG VD+WSVGC+FAELL+ P L G ++++QL KIF+ G+P ++
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W + LP FKP P L++ F A++L++ LL++ P KR TA AL Y
Sbjct: 227 WPGVTSLPDYVEFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
Query: 180 FSTKPYACDLSSLP 193
FS P S LP
Sbjct: 285 FSNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (616), Expect = 1e-76
Identities = 83/182 (45%), Positives = 113/182 (62%), Gaps = 5/182 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
M QLL GL +CHS +LHRD+K N+L+N +GVLKLADFGLA F T VVT
Sbjct: 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVT 161
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR PE+LLG+ Y +VD+WSVGC+FAE++ GKP+ G +E++QL KIF++ G+P ++
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE 221
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
W +KLP P+ P L + L ++L+ +L P KR +A AL
Sbjct: 222 SWPGVTKLPDYKPTFPKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280
Query: 179 YF 180
YF
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 1e-70
Identities = 87/184 (47%), Positives = 117/184 (63%), Gaps = 6/184 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
M QLL G+ H H +LHRD+K SNLL+NN G+LK+ DFGLA + +P T VVT
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLVVT 169
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR PELLLGA +Y ++D+WSVGC+FAELL KP+ G++E++QL+KIFKL G+P +
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATASAALA 176
W S+LP A + + LR+ F L +L+ LL+ +P KR +A AL
Sbjct: 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289
Query: 177 SEYF 180
YF
Sbjct: 290 HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 4e-69
Identities = 91/180 (50%), Positives = 121/180 (67%), Gaps = 1/180 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL +CH + LHRDIK SN+L+NN+G +KLADFGLA N+ +P T++V+TL
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPPELLLG YGP++D+WS GC+ EL KPI Q E+ QL I +LCGSP
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W KLP+ KP++ Y LRE F +PT A++L++ +L+++P KR TA AL S +
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 4e-69
Identities = 94/199 (47%), Positives = 128/199 (64%), Gaps = 6/199 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVT 59
M QLL GL++ H ++HRD+K SNLL+ ++G LK+ADFGLA G +P+T +VVT
Sbjct: 114 MLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA--RTYGLPAKPMTPKVVT 171
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR PELLLG T Y ++D+W+VGC+ AELL KP+L G++E+EQL I +L G+P +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231
Query: 120 YWKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
W S LP F P+QPY ++L+ F L + L+ LL +P KRATA AL S
Sbjct: 232 IWPGFSDLPLVGKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290
Query: 178 EYFSTKPYACDLSSLPIYP 196
YF KP C+ +P +P
Sbjct: 291 SYFKEKPLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 1e-67
Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 11/191 (5%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFSNTGHR 50
M QLL G+ + H +LHRDIK +N+L++N+G+LK+ADFGLA G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 51 QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 110
+ T+ VVT WYRPPELLLG Y +VD+W +GCVFAE+ +PILQG+++++QLH IF
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
Query: 111 KLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 169
KLCG+P ++ W LP Y +L E F L ++L+ LLS++PYKR
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300
Query: 170 TASAALASEYF 180
TAS AL YF
Sbjct: 301 TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 7e-62
Identities = 89/207 (42%), Positives = 129/207 (62%), Gaps = 16/207 (7%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNT 47
+ Q+L+GL H +HRD+ +N+ +N++G+ K+ADFGLA
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 48 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 107
R+ +TS+VVTLWYR PELL+GA Y +VD+WSVGC+FAELL GKP+ G E++QL
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
Query: 108 KIFKLCGSPPDDYW-KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 166
+IF+L G+P +D W + KLP T F P++P D L+ F + A++L+++LL + P
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKD--LKTIFPNASDDAIDLLQSLLKLNPL 302
Query: 167 KRATASAALASEYFSTKPYACDLSSLP 193
+R +A AL EYF + P CD S LP
Sbjct: 303 ERISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-58
Identities = 87/181 (48%), Positives = 113/181 (62%), Gaps = 2/181 (1%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ QLL GL CHS G+LHRD+K NLL+N EGVLKLADFGLA + R P T VVT
Sbjct: 104 LYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTR 162
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELLLG Y VD+WSVGC+FAELL +P+ G++E++QL KIF+ G+P +
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV 222
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W K + L F + L + F + A++L+ +L +P+KR TA ALA Y
Sbjct: 223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282
Query: 180 F 180
F
Sbjct: 283 F 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 3e-58
Identities = 78/183 (42%), Positives = 112/183 (61%), Gaps = 5/183 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M LL G+ + H+ G++HRD+K +NLL++ +GVLK+ADFGLA + + + +V T
Sbjct: 105 MRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELL GA Y P VDLW+VGC+FAELL G P+ G ++EQL +F+ G+P ++
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET 224
Query: 121 WKK-SKLPHAT--LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
W + LP F +P L E F D A++L++ LL +P KR +A+ AL
Sbjct: 225 WPGLTSLPDYNKITFPESKP--IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282
Query: 178 EYF 180
YF
Sbjct: 283 PYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-54
Identities = 80/183 (43%), Positives = 112/183 (61%), Gaps = 7/183 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ QLL G+ +CHS VLHRD+K NLL++ EG LKLADFGLA R T VVTL
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTL 163
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PE+LLG+ Y VD+WS+GC+FAE++ +P+ G +E++QL +IF+ G+P +D
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223
Query: 121 WKK-SKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
W + LP +KP P L + +L ++L+ +L +P KR +A AAL
Sbjct: 224 WPGVTSLPD---YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280
Query: 178 EYF 180
YF
Sbjct: 281 PYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-54
Identities = 79/209 (37%), Positives = 115/209 (55%), Gaps = 15/209 (7%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVV 58
+ Q+L GL++ HS V+HRD+K SN+LVN+ LK+ DFGLA + + LT VV
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T WYR PELLL ++ Y ++D+WSVGC+FAELL KP+ GR ++QL+ I ++ G+P +
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 119 DYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
+ K A + P L + F A++L+E +L +P KR TA ALA
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 177 SEYFSTKPYACDLSSLPIYPPSKEIDAKH 205
Y + ++ P E AK
Sbjct: 289 HPYLA-----------QLHDPEDEPVAKP 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-54
Identities = 75/182 (41%), Positives = 113/182 (62%), Gaps = 9/182 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVT 59
M QLL G++ HS ++HRD+K N+LV ++G +K+ADFGLA +S LTS VVT
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVT 169
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR PE+LL ++ Y VD+WSVGC+FAEL +P+ +G +E +QL KIF + G P ++
Sbjct: 170 LWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228
Query: 120 YW-KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
W + LP ++ F P S + ++ ++L++ +L+ P+KR +A AL
Sbjct: 229 EWPRNVSLPRSS-FPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285
Query: 179 YF 180
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 7e-54
Identities = 86/191 (45%), Positives = 112/191 (58%), Gaps = 16/191 (8%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHRQPLTSRV 57
M LL+GL + H +LHRD+K +N+L+ +G+LKLADFGLA + S T+RV
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
VTLWYRPPELLLG DYGP +D+W GC+ AE+ PI+QG TE QL I +LCGS
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 118 DDYWKK-SKLPHATLFK----PQQPYD---SSLRETFKDLPTTAVNLIETLLSVEPYKRA 169
+ W KL LFK PQ L+ KD A++LI+ LL ++P KR
Sbjct: 245 PEVWPGVDKLE---LFKKMELPQGQKRKVKERLKPYVKDP--HALDLIDKLLVLDPAKRI 299
Query: 170 TASAALASEYF 180
A AL ++F
Sbjct: 300 DADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-50
Identities = 70/181 (38%), Positives = 92/181 (50%), Gaps = 25/181 (13%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
Q+L GLE+ HS G++HRD+K N+L++ GV+K+ADFGLA LT+ V T
Sbjct: 104 ALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK-SSSSLTTFVGTP 162
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK-LCGSPPDD 119
WY PE+LLG YGP VD+WS+G + ELL GKP G ++QL I + L D
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFD 222
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
K SS E KD LI+ L+ +P KR TA L +
Sbjct: 223 EPKW----------------SSGSEEAKD-------LIKKCLNKDPSKRPTAEEILQHPW 259
Query: 180 F 180
F
Sbjct: 260 F 260
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 5e-50
Identities = 67/178 (37%), Positives = 94/178 (52%), Gaps = 28/178 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L LE+ HS+G++HRD+K N+L++ +G +KLADFGLA + G + LT+ V T Y
Sbjct: 105 QILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEY 162
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE+LLG YG +VD+WS+G + ELL GKP G +QL ++FK G P +
Sbjct: 163 MAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPP 218
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
D+ A +LI LL +P KR TA AL +F
Sbjct: 219 P----------------------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 5e-50
Identities = 79/188 (42%), Positives = 107/188 (56%), Gaps = 13/188 (6%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF----SNTGHRQPLTSR 56
+ QLL GL +CH R VLHRD+K NLL++ G LKLADFGLA S T ++
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-----YSNE 163
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGS 115
VVTLWYRPP++LLG+T+Y S+D+W VGC+F E+ G+P+ G T+V +QLHKIF++ G+
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT 223
Query: 116 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFK--DLPTTAVNLIETLLSVEPYKRATAS 172
P ++ W S P + L D L L EP KR +A+
Sbjct: 224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA 283
Query: 173 AALASEYF 180
A+ YF
Sbjct: 284 EAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 6e-50
Identities = 70/182 (38%), Positives = 103/182 (56%), Gaps = 5/182 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL + +CHS ++HRDIK N+LV+ GVLKL DFG A PLT V T WY
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWY 167
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP----D 118
R PELL+G T+YG VD+W++GC+ AELL G+P+ G ++++QL+ I K G P +
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
+ + +P QP +S R + + A++ ++ L ++P +R T L
Sbjct: 228 LFSSNPRFAGVAFPEPSQP-ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286
Query: 179 YF 180
YF
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 84/182 (46%), Positives = 109/182 (59%), Gaps = 4/182 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL CHS VLHRD+K NLL+N G LKLADFGLA R ++ VVTL
Sbjct: 105 MFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTL 163
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 119
WYRPP++L GA Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P ++
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
W SKLP + P P +SL L +T +L++ LL P +R +A AL
Sbjct: 224 SWPGVSKLPDYKPY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282
Query: 179 YF 180
YF
Sbjct: 283 YF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 82/181 (45%), Positives = 113/181 (62%), Gaps = 7/181 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G+ CHSR VLHRD+K NLL++N+GV+KLADFGLA R T VVTLWY
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWY 167
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE+LLG+ Y VD+WS+G +FAE+ KP+ G +E++QL +IF++ G+P +D W
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227
Query: 123 K-SKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
+ LP +K P SLR K+L ++L+E +L +P KR +A AL Y
Sbjct: 228 GVTSLPD---YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
Query: 180 F 180
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-49
Identities = 80/200 (40%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL GL++ HS VLHRD+K SNLL+N LK+ DFGLA ++ +T VVT WY
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWY 174
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PELLL ++Y ++D+WSVGC+FAELL KP+ G+ V QL I +L GSP ++
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 123 KSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+ A + PY S F A++L+E +L +P KR T ALA Y
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
Query: 181 STKPYACDLSSLPIYPPSKE 200
+ ++ PS E
Sbjct: 295 A-----------SLHDPSDE 303
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 6e-49
Identities = 77/189 (40%), Positives = 105/189 (55%), Gaps = 19/189 (10%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--------NFSNTGHRQP 52
QLL G+ CH VLHRD+K NLL+N G LKLADFGLA FSN
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN------ 159
Query: 53 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 112
VVTLWYR P++LLG+ Y S+D+WSVGC+ AE++ G+P+ G +QL KIF++
Sbjct: 160 ---EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216
Query: 113 CGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 171
G+P + W S+LP P+ P L++ F ++L+ LL + P R +A
Sbjct: 217 MGTPTESTWPGISQLPEYKPTFPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275
Query: 172 SAALASEYF 180
AL +F
Sbjct: 276 HDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 84/186 (45%), Positives = 113/186 (60%), Gaps = 13/186 (6%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLA-NFSNTGHRQPL---TS 55
M QLL G+ HCH GV+HRD+K NLLV+ + G+LK+AD GL FS P+ T
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTH 170
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
+VTLWYR PE+LLG+T Y VD+WSVGC+FAE+ +P+ G +E++QL IFKL G+
Sbjct: 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230
Query: 116 PPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
P + W SKL F +P D L DL ++L++ +L +P KR +A AA
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288
Query: 175 LASEYF 180
L YF
Sbjct: 289 LTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 75/181 (41%), Positives = 105/181 (58%), Gaps = 3/181 (1%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ Q+L GL H H G HRD+K NLLV+ V+K+ADFGLA R P T V T
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR 162
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PE+LL +T Y VD+W++GC+ AEL +P+ G +E++QL+KI + G+P
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222
Query: 121 WKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W + KL F+ Q +SL + + A++LI+ +L +P KR TAS AL Y
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
Query: 180 F 180
F
Sbjct: 283 F 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 77/211 (36%), Positives = 106/211 (50%), Gaps = 17/211 (8%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSR 56
M QLL L++ HS V+HRD+K SN+L+N++ +KLADFGLA LT
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
V T WYR PE+LLG+T Y VD+WSVGC+ E+L+GKP+ G + + QL KI ++ G P
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232
Query: 117 PDDYWK--KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
+ + KS L L E A++L++ LL P KR TA A
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292
Query: 175 LASEYFSTKPYACDLSSLPIYPPSKEIDAKH 205
L Y + + PS E +
Sbjct: 293 LEHPYVA-----------QFHNPSDEPVLPY 312
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 6e-46
Identities = 77/203 (37%), Positives = 110/203 (54%), Gaps = 23/203 (11%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSR 56
+ Q+L+G+ + HS VLHRD+K +N+LV E GV+K+ D GLA N +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 57 --VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQ 105
VVT+WYR PELLLGA Y ++D+W++GC+FAELL +PI +GR +Q
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233
Query: 106 LHKIFKLCGSPPDDYWKK-SKLPH----ATLFKPQQPYDSSLR---ETFKDLPTTAVNLI 157
L +IF++ G+P + W K+P FK + +SL E K + +L+
Sbjct: 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLL 293
Query: 158 ETLLSVEPYKRATASAALASEYF 180
LL +P KR TA AL YF
Sbjct: 294 RKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 78/181 (43%), Positives = 106/181 (58%), Gaps = 7/181 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL GL CHS VLHRD+K NLL+N EG +KLADFGLA R T VVTLWY
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWY 166
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE+LLG Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P + W
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226
Query: 123 K-SKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
+ LP +KP P + L +L+ +L +P KR +A AALA +
Sbjct: 227 GVTSLPD---YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
Query: 180 F 180
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 81/183 (44%), Positives = 112/183 (61%), Gaps = 6/183 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVT 59
+ Q+L G+ +CHS VLHRD+K NLL++ LKLADFGLA R T VVT
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVT 166
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR PE+LLG+ Y VD+WSVGC+FAE++ KP+ G +E+++L KIF++ G+P ++
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 120 YWKK-SKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
W + LP + + F P D L L V+L+ +L ++P KR TA AAL
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKD--LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284
Query: 178 EYF 180
EYF
Sbjct: 285 EYF 287
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 64/187 (34%), Positives = 98/187 (52%), Gaps = 17/187 (9%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q L + CH +HRD+K N+L+ +G +KL DFG A T V T WY
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWY 166
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS------- 115
R PELL+G T YGP VD+W++GCVFAELL G+P+ G+++V+QL+ I K G
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226
Query: 116 --PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 173
+ ++K +P +P L F ++ + A++ ++ L ++P +R +
Sbjct: 227 IFSTNQFFKGLSIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEE 279
Query: 174 ALASEYF 180
L YF
Sbjct: 280 LLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 154 bits (389), Expect = 3e-43
Identities = 78/186 (41%), Positives = 110/186 (59%), Gaps = 12/186 (6%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL +CH R +LHRD+K NLL+N +G LKLADFGLA + + + ++ VVTL
Sbjct: 109 MFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTL 167
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYRPP++LLG+T+Y +D+W VGC+ E+ G+P+ G T E+LH IF+L G+P ++
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227
Query: 121 WKKSKLPHATLFKPQQPYD------SSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
W P T + + Y L L T ++L+ +LL E R +A AA
Sbjct: 228 W-----PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282
Query: 175 LASEYF 180
L YF
Sbjct: 283 LRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 7e-43
Identities = 73/191 (38%), Positives = 111/191 (58%), Gaps = 19/191 (9%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSR 56
Q+L GL++ HS VLHRD+K NLLVN + LK+ DFGLA N G +T
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF---MTEY 169
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
V T WYR PE++L Y ++D+WSVGC+ AELL KP+ +G+ V+QL++I ++ G+P
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229
Query: 117 PDDYWKKSKLPHA-----TL-FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
++ + P A +L P++P++S F + A++L+E LL+ +P KR +
Sbjct: 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESI----FPNANPLALDLLEKLLAFDPTKRIS 285
Query: 171 ASAALASEYFS 181
AL Y +
Sbjct: 286 VEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 75/199 (37%), Positives = 114/199 (57%), Gaps = 13/199 (6%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL++ HS G++HRD+K SN+ VN + LK+ DFGLA ++ +T V T WY
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWY 181
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AELL GK + G ++QL +I L G+P ++ +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTT----AVNLIETLLSVEPYKRATASAALASE 178
K A + P ++ FK++ + A++L+E +L ++P KR TA+ ALA
Sbjct: 242 KISSESARNYIQSLPQMP--KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299
Query: 179 YFSTKPYACDLSSLPIYPP 197
Y Y D P+ PP
Sbjct: 300 YL--AEYH-DPEDEPVAPP 315
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 67/180 (37%), Positives = 100/180 (55%), Gaps = 3/180 (1%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL L+H H G+ HRDIK N+L+ ++ +LKLADFG + + P T + T
Sbjct: 106 MYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS--KPPYTEYISTR 162
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PE LL YGP +D+W+VGCVF E+L P+ G E++Q+ KI + G+P +
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
KK + + + LR+ + ++L++ LL+ +P +R TA AL YF
Sbjct: 223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 77/180 (42%), Positives = 106/180 (58%), Gaps = 4/180 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL GL +CH R VLHRD+K NLL+N G LKLADFGLA + + + ++ VVTLWY
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWY 170
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
RPP++LLG+TDY +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P ++ W
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230
Query: 123 K--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
S + P+ D + L + L+ LL E KR +A A+ YF
Sbjct: 231 GILSNEEFKSYNYPKYRADCLHNHAPR-LDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-42
Identities = 85/186 (45%), Positives = 114/186 (61%), Gaps = 9/186 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL + H + +LHRD+K NLL++ G LKLADFGLA + + Q +S VVTL
Sbjct: 109 MFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTL 167
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDD 119
WYRPP++LLGATDY ++D+W GC+F E+L G+P G ++V EQL KI+ + G P +D
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227
Query: 120 YWKK-SKLPH--ATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAA 174
W SKLP+ F P +P LR +K L P A +L +L + P R +A A
Sbjct: 228 TWPGVSKLPNYKPEWFLPCKP--QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285
Query: 175 LASEYF 180
L YF
Sbjct: 286 LLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 67/189 (35%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRV 57
+ QLL GL++ HS V+HRD+K SNLLVN + L++ DFG+A S T H+ +T V
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T WYR PELLL +Y ++D+WSVGC+FAE+L + + G+ V QL I + GSP
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232
Query: 118 DDYWKKSKLPHA----TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 173
++ + +QP + F A++L+ +L +P +R T
Sbjct: 233 EEVLNRIGSDRVRKYIQNLPRKQPVP--WSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290
Query: 174 ALASEYFST 182
AL + +
Sbjct: 291 ALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 79/200 (39%), Positives = 114/200 (57%), Gaps = 20/200 (10%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL +CH R VLHRD+K NLL+N G LKLADFGLA + + + ++ VVTLWY
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWY 170
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW- 121
RPP++LLG+++Y +D+W VGC+F E+ G+P+ G T ++LH IF+L G+P ++ W
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 122 --------KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 173
K P +KPQ + + R L T + L+ L E KR +A
Sbjct: 231 GISSNDEFKNYNFPK---YKPQPLINHAPR-----LDTEGIELLTKFLQYESKKRISAEE 282
Query: 174 ALASEYFSTKPYACDLSSLP 193
A+ YF + + SLP
Sbjct: 283 AMKHAYF--RSLGTRIHSLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 5e-41
Identities = 76/181 (41%), Positives = 108/181 (59%), Gaps = 7/181 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M Q L GL+ H+ ++HRD+K N+LV + G +KLADFGLA + + LT VVTL
Sbjct: 114 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTL 171
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PE+LL +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G PP+D
Sbjct: 172 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230
Query: 121 WKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W + LP F P+ P ++ ++ + L+ +L+ P+KR +A AL +
Sbjct: 231 WPRDVTLPRGA-FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
Query: 180 F 180
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 71/180 (39%), Positives = 103/180 (57%), Gaps = 3/180 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL++ HS G+LHRDIK NLLVN+ VLK+ DFGLA + +T VVT +Y
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE+L+G+ Y +VD+WSVGC+FAELL + + Q ++ ++QL I L G+P + +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230
Query: 123 KS---KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
+ H + P L AV+L+ +L +P KR +A+ ALA Y
Sbjct: 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 75/195 (38%), Positives = 106/195 (54%), Gaps = 24/195 (12%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ Q+L GL++ HS GV+HRD+K SN+L+N LK+ DFGLA + + +T V T
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQ--MTGYVSTR 169
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
+YR PE++L Y VD+WS GC+FAE+L GKP+ G+ V Q I L G+PPDD
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 121 WKK----------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
LP + P E FK+ +A++L+E +L +P KR +
Sbjct: 230 INTICSENTLRFVQSLPK----REPVP----FSEKFKNADPSAIDLLEKMLVFDPQKRIS 281
Query: 171 ASAALASEYFSTKPY 185
A+ ALA Y PY
Sbjct: 282 AAEALAHPYL--APY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-39
Identities = 81/189 (42%), Positives = 115/189 (60%), Gaps = 11/189 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL GL + H R +LHRD+K NLL+++ G LKLADFGLA + + ++ VVTLWY
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWY 169
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYW 121
RPP++LLG+T+Y +D+W VGC+F E++ G G +++ QL +IF + G+P +D W
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 122 KK-SKLPHATLFKPQQ--PYDS-SLRETFKDLPTT--AVNLIETLLSVEPYKRATASAAL 175
LPH FKP++ Y +LR+ + L A +L LL P R +A AAL
Sbjct: 230 PGVHSLPH---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286
Query: 176 ASEYFSTKP 184
+ EYFS P
Sbjct: 287 SHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 71/198 (35%), Positives = 101/198 (51%), Gaps = 32/198 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTL 60
Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA H LT V T
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD- 119
WYR PE++L + Y ++D+WSVGC+ AE+L +P+ G+ + QL+ I + G+P +
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233
Query: 120 -----------YWK----KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 164
Y K K K+P LF P A++L++ +L+
Sbjct: 234 LNCIISLRARNYIKSLPFKPKVPWNKLF----PNADPK----------ALDLLDKMLTFN 279
Query: 165 PYKRATASAALASEYFST 182
P+KR T ALA Y
Sbjct: 280 PHKRITVEEALAHPYLEQ 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 2e-38
Identities = 69/181 (38%), Positives = 108/181 (59%), Gaps = 6/181 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL++ H+ G++HRD+K NL VN + LK+ DFGLA +++ +T VVT WY
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS----EMTGYVVTRWY 181
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AE+L GKP+ +G ++QL +I K+ G+P ++ +
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241
Query: 123 KSKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
K + A + + P R + AVN++E +L ++ R TA+ ALA YF
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
Query: 181 S 181
Sbjct: 302 E 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 74/198 (37%), Positives = 109/198 (55%), Gaps = 20/198 (10%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA-----NFSNTGHRQPLT 54
M QLL GL++ HS VLHRD+K +N+ +N E VLK+ DFGLA ++S+ G+ L+
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY---LS 176
Query: 55 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 114
+VT WYR P LLL +Y ++D+W+ GC+FAE+L GKP+ G E+EQ+ I +
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE--- 233
Query: 115 SPP-----DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 169
S P D + +P +P LR+ + A++ +E +L+ P R
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPR-RPLRDLLPGVNPEALDFLEQILTFNPMDRL 292
Query: 170 TASAALASEYFSTKPYAC 187
TA AL Y S Y+C
Sbjct: 293 TAEEALMHPYMS--CYSC 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 68/183 (37%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ Q+L G+E CHS ++HRDIK N+LV+ GV+KL DFG A + T V T
Sbjct: 106 LFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATR 164
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELL+G T YG +VD+W+VGC+ E+L G+P+ G ++++QL+ I K G+ +
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224
Query: 121 ---WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
++K+ L A + P+ L + F L ++L + L ++P R ++S L
Sbjct: 225 QEIFQKNPL-FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283
Query: 178 EYF 180
E+F
Sbjct: 284 EFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 76/200 (38%), Positives = 113/200 (56%), Gaps = 6/200 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL GL++ HS G++HRD+K SN+ VN + L++ DFGLA ++ +T V T WY
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWY 181
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AELL GK + G ++QL +I ++ G+P + K
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 123 KSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
K HA + P+ L++ F+ A++L+E +L ++ KR +AS ALA YF
Sbjct: 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
Query: 181 STKPYACDLSSLPIYPPSKE 200
S D Y S E
Sbjct: 302 SQYHDPEDEPEAEPYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 78/182 (42%), Positives = 109/182 (59%), Gaps = 9/182 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA + + LTS VVTL
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTL 173
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP-PDD 119
WYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P +D
Sbjct: 174 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232
Query: 120 YWKKSKLPHATLF-KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
+ + LP K QP + + D+ +L+ L+ P KR +A +AL+
Sbjct: 233 WPRDVALPRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288
Query: 179 YF 180
YF
Sbjct: 289 YF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 8e-37
Identities = 80/225 (35%), Positives = 117/225 (52%), Gaps = 17/225 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 60
QLL L++ H+ V HRD+K N+L N + LK+ DFGLA F++T T V T
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 61 WYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
WYR PEL G+ + Y P++D+WS+GC+FAE+L GKP+ G+ V QL I L G+P
Sbjct: 171 WYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 119 DYWKKSKLPHATLF----KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
+ + + A + + +QP + F + A+ L+E LL+ +P R TA A
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287
Query: 175 LASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR 219
LA YF L+ + P ++ I E RR+ VR
Sbjct: 288 LADPYFK------GLAKVEREPSAQPITKLEFEFERRRLTKEDVR 326
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 2e-35
Identities = 69/181 (38%), Positives = 101/181 (55%), Gaps = 6/181 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGLA ++ +T V T WY
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWY 183
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + K
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243
Query: 123 KSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
K A + + F AV+L+E +L ++ KR TA+ ALA YF
Sbjct: 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
Query: 181 S 181
+
Sbjct: 304 A 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 70/181 (38%), Positives = 106/181 (58%), Gaps = 8/181 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL++ HS G++HRD+K NL VN + LK+ DFGLA ++ +T VVT WY
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWY 180
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P ++ +
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 123 KSKLPHATLF---KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
K + A + P+ P F AV+L+E +L ++ KR TA+ AL Y
Sbjct: 241 KLEDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299
Query: 180 F 180
F
Sbjct: 300 F 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 73/181 (40%), Positives = 106/181 (58%), Gaps = 7/181 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
QL L + HS+ + HRD+K NLL++ N LKL DFG A G R S + + +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRF 235
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
YR PEL+LGAT+Y +DLWS+GC+ AE+++G PI G++ V+QL +I ++ G+P +D
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 122 KKSKLPHATL-FKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
K+ +A + F +P D L++ F K P A+N I L EP KR ALA +
Sbjct: 296 KEMNPNYADIKFPDVKPKD--LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353
Query: 180 F 180
F
Sbjct: 354 F 354
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 29/197 (14%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 183
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++LG Y +VD+WSVGC+ E++ G + G ++Q +KI + G+P D++
Sbjct: 184 RAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242
Query: 123 K--------------------SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 162
+ +L LF P + L+ + A +L+ +L
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK------ASQARDLLSKMLV 296
Query: 163 VEPYKRATASAALASEY 179
++P KR + AL Y
Sbjct: 297 IDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 79/202 (39%), Positives = 114/202 (56%), Gaps = 24/202 (11%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR--QPLTSR 56
Q+L G+ + H+ VLHRD+K +N+LV EG +K+AD G A N+ + L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLH 107
VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E +QL
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235
Query: 108 KIFKLCGSPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLP-TTAVNLIE 158
+IF + G P D W+ K+P H+TL F+ + SL E K P + A +L++
Sbjct: 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295
Query: 159 TLLSVEPYKRATASAALASEYF 180
LL+++P KR T+ A+ YF
Sbjct: 296 KLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 4e-30
Identities = 80/202 (39%), Positives = 113/202 (55%), Gaps = 24/202 (11%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHR--QPLTSR 56
Q+L G+ + H+ VLHRD+K +N+LV EG +K+AD G A N+ + L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLH 107
VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E +QL
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235
Query: 108 KIFKLCGSPPDDYWKK-SKLP-HATL---FKPQQPYDSSL---RETFKDLPTTAVN-LIE 158
+IF + G P D W+ K+P + TL F+ +SSL E K P + V L++
Sbjct: 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295
Query: 159 TLLSVEPYKRATASAALASEYF 180
LL+++P KR T+ AL YF
Sbjct: 296 KLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 69/181 (38%), Positives = 94/181 (51%), Gaps = 4/181 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QL+ + CH ++HRDIK NLL+++ VLKL DFG A + G T V T WY
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PELLLGA YG +VD+WSVGC+ EL G+P+ G +E++QL I K+ G P + K
Sbjct: 168 RSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226
Query: 123 --KSKLPHATLFKPQQPYDSSLRETFKD-LPTTAVNLIETLLSVEPYKRATASAALASEY 179
S L P + SL + L ++L++ LL + P R L
Sbjct: 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286
Query: 180 F 180
F
Sbjct: 287 F 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 39/91 (42%), Positives = 57/91 (62%), Gaps = 2/91 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVT 59
+ Q+L GLE+ HS G++HRD+K N+L+++ G +KLADFGL+ T + L + V T
Sbjct: 98 LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGT 156
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAEL 90
Y PE+LLG Y D+WS+G + EL
Sbjct: 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 56/180 (31%), Positives = 84/180 (46%), Gaps = 42/180 (23%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
Q+L GL + HS G++HRDIKG+N+LV+++GV+KLADFG A + + S T
Sbjct: 107 TRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
++ PE++ G +YG + D+WS+GC E+ GKP
Sbjct: 167 PYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPP----------------------- 202
Query: 120 YWKKSKLPHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
W + P A L+K P+ P + L A + + L +P KR TA
Sbjct: 203 -WSELGNPMAALYKIGSSGEPPEIP---------EHLSEEAKDFLRKCLRRDPKKRPTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 16/215 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 191
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++LG Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P ++ K
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 123 KSKLPHATLFKPQQPYDS-SLRETFKDL------------PTTAVNLIETLLSVEPYKRA 169
K + T + + Y S + F D+ + A +L+ +L ++ KR
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 170 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK 204
+ AL Y + + + P P K++D +
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDER 345
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 67/193 (34%), Positives = 107/193 (55%), Gaps = 18/193 (9%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYY 188
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++LG Y +VD+WSVGC+ EL+ G I QG ++Q +K+ + G+P ++
Sbjct: 189 RAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247
Query: 123 K--SKLPHATLFKPQQPYDSSLRETFKD--LP----------TTAVNLIETLLSVEPYKR 168
+ + + +PQ P S E F D P + A +L+ +L ++P KR
Sbjct: 248 RLQPTVRNYVENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306
Query: 169 ATASAALASEYFS 181
+ AL Y +
Sbjct: 307 ISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANF-----SNTGHRQPLT 54
+ Q+L LE+ HS+G++HRDIK N+L++ + V+KL DFGLA S + +
Sbjct: 107 LAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166
Query: 55 SRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKI 109
+ V T Y PE+LLG + S D+WS+G ELL G P +G Q KI
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226
Query: 110 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 169
+P P + A +L++ LL+ +P R
Sbjct: 227 ILELPTPSLASPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRL 267
Query: 170 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKV 214
++S+ L+ + + S + P + +
Sbjct: 268 SSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALI 312
|
Length = 384 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 16/215 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 184
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++ K
Sbjct: 185 RAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 123 K----------SKLPHATLFKPQQPYDSSL---RETFKDLPTTAVNLIETLLSVEPYKRA 169
K ++ +A L P+ DS E K + A +L+ +L ++P KR
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 170 TASAALASEYFSTKPYACDLSSLPIYPPSKEIDAK 204
+ AL Y + ++ + P K++D +
Sbjct: 304 SVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDER 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 35/173 (20%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF------SNTGHRQPLTSR 56
+++ LE+ HS G++HRD+K N+L+++ G LKL DFGL+ N + R
Sbjct: 101 EIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 57 VV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
+V T Y PE++LG + +VD WS+GC+ E L+G P G T E I
Sbjct: 161 IVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219
Query: 116 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
P+D ++ A++LI LL +P KR
Sbjct: 220 WPED---------------------------VEVSDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 59/180 (32%), Positives = 83/180 (46%), Gaps = 34/180 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV-TL 60
QL L++ HSR +LHRDIK N+ + + G++KL DFG++ S+T L VV T
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVVGTP 167
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
+Y PEL Y D+WS+GCV EL K +G +E KI K G P
Sbjct: 168 YYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYP--- 221
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+P Y S LR NL+ +LL +P +R + + L S +
Sbjct: 222 ----PIP--------SQYSSELR-----------NLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 40/94 (42%), Positives = 59/94 (62%), Gaps = 5/94 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLW 61
+LL GLE+ HS G++HRDIK +N+L+ ++G +KL DFGL+ S+T R + V T +
Sbjct: 106 ELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPY 162
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
+ PE++ G Y D+WS+G EL GKP
Sbjct: 163 WMAPEVING-KPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 54/188 (28%), Positives = 79/188 (42%), Gaps = 49/188 (26%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH------------- 49
++L LE+ HS+G++HRD+K N+L++ + +K+ DFG A +
Sbjct: 110 EILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 50 ------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 103
R+ S V T Y PELL G S DLW++GC+ ++L GKP +G E
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228
Query: 104 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 163
KI KL S P + P A +LIE LL +
Sbjct: 229 LTFQKILKLEYSFP-----------------------------PNFPPDAKDLIEKLLVL 259
Query: 164 EPYKRATA 171
+P R
Sbjct: 260 DPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 7e-23
Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 33/167 (19%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLW 61
+++ LE+ HS G+++RD+K N+L++ +G +KL DFGLA S+ G R + T
Sbjct: 101 EIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPE 158
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
Y PE+LLG YG +VD WS+G + E+L GKP E KI K
Sbjct: 159 YLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK---------- 207
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
+ P + L A +LI LL +P KR
Sbjct: 208 DPLRFP-------------------EFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GLE+ H R +HRDIKG+N+LV+ GV+KLADFG+A S + ++
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYW 167
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ YG + D+WS+GC E+ GKP +++E + +FK+ G +
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKI-GRSKE---- 219
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
P P L A + I L +P R TA+ L
Sbjct: 220 ----------LPPIP---------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 42/111 (37%), Positives = 63/111 (56%), Gaps = 6/111 (5%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ Q+L GL + H +GV+HRDIK +N+L +GV+KLADFG+A N + + V T
Sbjct: 105 VYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTP 163
Query: 61 WYRPPELLLGATDYGPSV--DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
++ PE++ + G S D+WS+GC ELL G P + L +I
Sbjct: 164 YWMAPEVIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 57/193 (29%), Positives = 84/193 (43%), Gaps = 31/193 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
++L GLE+ HS+ V+HRDIK N+L++ +G +KLADFG A S V T
Sbjct: 122 CREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTP 180
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
++ PE++ DYGP VD+WS+G + E+ G+P + L I G PP
Sbjct: 181 YWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--- 235
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
L + + P+ FKD + L +P KR +A L +
Sbjct: 236 -----LKNPEKWSPE----------FKD-------FLNKCLVKDPEKRPSAEELLQHPFL 273
Query: 181 STKPYACDLSSLP 193
AC
Sbjct: 274 KK---ACPKEEFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-21
Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 17/156 (10%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQPLTSRV 57
Q+L GL + H+RG++HRDIKG+N+LV+N+G +K++DFG+ AN +T S
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG--- 114
++++ PE ++ T Y D+WS+GC+ E+L GK + QL IFK+
Sbjct: 174 GSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGK---HPFPDCTQLQAIFKIGENAS 229
Query: 115 -SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149
P + ++ F+ D + R T +L
Sbjct: 230 PEIPSNISSEAIDFLEKTFEI----DHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 56/178 (31%), Positives = 83/178 (46%), Gaps = 34/178 (19%)
Query: 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG----LANFSNTGHRQPLTSRV 57
QLL GL + HS G++HRDIK +N+ +++ GV+KL DFG L N + T + + S
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE-VQSLA 164
Query: 58 VTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI-FKLCG 114
T Y PE++ G +G + D+WS+GCV E+ GK +E++ +I F +
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA 221
Query: 115 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
KP P L KD ++ L +P KR TAS
Sbjct: 222 GH----------------KPPIPDSLQLSPEGKD-------FLDRCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 3 QLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV 57
QLL L CH+R VLHRD+K +N+ ++ +KL DFGLA + V
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYV 171
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
T +Y PE L + Y D+WS+GC+ EL P R +++ KI
Sbjct: 172 GTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-19
Identities = 44/118 (37%), Positives = 65/118 (55%), Gaps = 6/118 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 60
Q+L G+E+ HS ++HRDIKG+N+L ++ G +KL DFG + T + V T
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
++ PE++ G YG D+WSVGC E+L KP E E + IFK+ P +
Sbjct: 172 YWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 38/118 (32%), Positives = 65/118 (55%), Gaps = 2/118 (1%)
Query: 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT--GHRQPLTSRVVT 59
Q+L GL + HS+G+LHRD+K NLLV+ +G+ K++DFG++ S+ + Q ++ +
Sbjct: 115 EQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
W P + + Y VD+WS+GCV E+ G+ + + K+ +PP
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 56/174 (32%), Positives = 78/174 (44%), Gaps = 35/174 (20%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR--VVTL 60
+++ G+E H RG++HRDIK NLL++ G LKL DFGL+ R L ++ V T
Sbjct: 105 EVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS-------RNGLENKKFVGTP 157
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE +LG D D WS+GCV E L G P T PD
Sbjct: 158 DYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAV 201
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
+ + + P+ E + AV+LI LL ++P KR A+
Sbjct: 202 FD--NILSRRINWPE--------EVKEFCSPEAVDLINRLLCMDPAKRLGANGY 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 36/93 (38%), Positives = 57/93 (61%), Gaps = 3/93 (3%)
Query: 3 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
Q+L GL++ H+ R ++HRDIK SNLL+N++G +K+ADFG++ + V T+
Sbjct: 107 QILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT-LDQCNTFVGTVT 165
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
Y PE + G + Y + D+WS+G E +GK
Sbjct: 166 YMSPERIQGES-YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 46/122 (37%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA---NFSNTGHRQPLTSRVV 58
QLL GL + H ++HRD+KG+NLL+++ G L++ADFG A TG + +
Sbjct: 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS--P 116
T+ + PE+L G YG S D+WSVGCV E+ KP L IFK+ +
Sbjct: 171 TIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229
Query: 117 PD 118
P
Sbjct: 230 PS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 60/191 (31%), Positives = 80/191 (41%), Gaps = 53/191 (27%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR----QPLTSRV 57
Q+L GL++ H ++HRDIKG N+LVN GV+K++DFG T R P T
Sbjct: 116 QILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG------TSKRLAGINPCTETF 169
Query: 58 V-TLWYRPPELL-LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
TL Y PE++ G YG D+WS+GC E+ GKP F G
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP-------------PFIELGE 216
Query: 116 PPDDYWKKSKLPHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
P A +FK P+ P + L A N I +P KR
Sbjct: 217 -----------PQAAMFKVGMFKIHPEIP---------ESLSAEAKNFILRCFEPDPDKR 256
Query: 169 ATASAALASEY 179
A+A L +
Sbjct: 257 ASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 26/181 (14%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVV--T 59
++L GLE+ HS G +HRDIK N+L+ +G +K+ADFG+ A+ ++ G R + T
Sbjct: 110 EVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ PE++ Y D+WS G EL G ++ L L PP
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQNDPPS- 226
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
L +K Y S R+ +I L +P KR TA L ++
Sbjct: 227 ------LETGADYK---KYSKSFRK-----------MISLCLQKDPSKRPTAEELLKHKF 266
Query: 180 F 180
F
Sbjct: 267 F 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 49/176 (27%), Positives = 74/176 (42%), Gaps = 30/176 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ Q++ + + H G+LHRDIK N+ + G++KL DFG++ + + T V T
Sbjct: 107 LFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTP 165
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
+Y PEL G Y D+W++GCV ELL K + + KI + +P
Sbjct: 166 YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS- 223
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
Y S L L+ +LL +P KR TA L
Sbjct: 224 ----------------VYSSELIS-----------LVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 29/162 (17%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
LE+ HS+G++HRDIK N+L++ +G + + DF +A TS T Y PE
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPE 169
Query: 67 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 126
+L Y +VD WS+G E L GK +G + D + +
Sbjct: 170 VLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAKQE 215
Query: 127 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
L+ + A++ I LL +P KR
Sbjct: 216 TADVLYPATWSTE-------------AIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 10/103 (9%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR---- 56
+ ++L GLE+ H G +HRDIK +N+L++ EG +KLADFG++ G S+
Sbjct: 104 LREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTF 158
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 99
V T ++ PE++ + Y D+WS+G EL G+P L
Sbjct: 159 VGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 40/107 (37%), Positives = 62/107 (57%), Gaps = 2/107 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ + G + T T Y
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-CGTPDY 162
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE+LLG Y SVD WS G + E+LIG+ G E E I
Sbjct: 163 IAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 24/159 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSR 56
Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG + S
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG----IKSV 169
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
T ++ PE++ G YG D+WSV C E+L KP E E + IFK+ P
Sbjct: 170 TGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQP 225
Query: 117 PDDYWKKSKLPHATL-----FKPQQPYDSSLRETFKDLP 150
K LP F Q + R T + L
Sbjct: 226 -----TKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 51/173 (29%), Positives = 73/173 (42%), Gaps = 33/173 (19%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVVTL 60
QL LEH HS+ ++HRDIK +N+ + GV+KL D GL F S T S V T
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTP 170
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+Y PE + Y D+WS+GC+ E+ + P + + L K + C PP
Sbjct: 171 YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP-- 227
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
P Y LR+ L+ ++ +P KR S
Sbjct: 228 -------------LPADHYSEELRD-----------LVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 40/130 (30%), Positives = 59/130 (45%), Gaps = 28/130 (21%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
M ++ ++ H G +HRD+K N L++ G +KL DFGL+ + S V +
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGS 161
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
Y PE+L G Y +VD WS+GC+ E L G P GS P++
Sbjct: 162 PDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFP---------------PFSGSTPNE 205
Query: 120 ------YWKK 123
YWK+
Sbjct: 206 TWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLW 61
Q L GLE+ HS +HRDIK N+L+N EG KLADFG++ + V+ T +
Sbjct: 107 QTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPF 164
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
+ PE++ Y D+WS+G E+ GKP
Sbjct: 165 WMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 45/120 (37%), Positives = 65/120 (54%), Gaps = 14/120 (11%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSR 56
Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG + S
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG----MKSV 169
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
T ++ PE++ G YG D+WSVGC E+L KP E E + IFK+ P
Sbjct: 170 TGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-15
Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 42/180 (23%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLTSRV 57
QLL GL+ H + +LHRD+K +N+L+ ++K+ D G++ N + T P
Sbjct: 111 QLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH---- 166
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
Y PE+ G Y D+WS+GC+ E+ P + R+ ++ L +K+
Sbjct: 167 ----YMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLR--YKVQRG-- 216
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
K +P Y L+ N I ++L V+P R LAS
Sbjct: 217 ----KYPPIPPI--------YSQDLQ-----------NFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 34/201 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+ L LE HS V+HRDIK N+L+ +G +KL DFG T + ++ V T ++
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYW 181
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ YGP VD+WS+G + E++ G+P + L+ I
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------- 227
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS- 181
AT P+ L F+D + L ++ KR +A L +
Sbjct: 228 ------ATNGTPELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLKI 274
Query: 182 TKPYACDLSSL-PIYPPSKEI 201
KP LSSL P+ +KE
Sbjct: 275 AKP----LSSLTPLIAAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
GL+ H RG+++RD+K N+L+++EG +K+ADFG+ ++ T Y PE
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPE 166
Query: 67 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
+L YGP+VD W++G + E+L G+ +G E E I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 45/122 (36%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSR 56
Q+L G+ + HS ++HRDIKG+N+L ++ G +KL DFG + S TG R S
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR----SV 169
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
T ++ PE++ G YG D+WS+GC E+L KP E E + IFK+ P
Sbjct: 170 TGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQP 225
Query: 117 PD 118
+
Sbjct: 226 TN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 50/181 (27%), Positives = 74/181 (40%), Gaps = 32/181 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 58
+ ++L L++ H GV+HRDIK +N+LV N G +KL DFG+A N+ R
Sbjct: 107 IREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG--- 163
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T ++ PE++ Y D+WS+G E+ G P + L
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMMLIP---- 215
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
KSK P Y LRE + L EP +R +A L S+
Sbjct: 216 ----KSKPPRL----EDNGYSKLLRE-----------FVAACLDEEPKERLSAEELLKSK 256
Query: 179 Y 179
+
Sbjct: 257 W 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 39/113 (34%), Positives = 63/113 (55%), Gaps = 9/113 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLTSRV 57
Q+L G+ + H+ V+HRDIKG+N+++ G++KL DFG A + H L S
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 110
T ++ PE ++ + YG D+WS+GC E+ GKP L +++L +F
Sbjct: 170 GTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 36/89 (40%), Positives = 53/89 (59%), Gaps = 5/89 (5%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPPE 66
E+ H+RG+++RD+K NLL+++ G +KL DFG A +G + T T Y PE
Sbjct: 106 FEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPE 162
Query: 67 LLLGATDYGPSVDLWSVGCVFAELLIGKP 95
++L Y SVD WS+G + ELL G+P
Sbjct: 163 IILN-KGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 35/118 (29%), Positives = 64/118 (54%), Gaps = 3/118 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q++ GLEH H R +++RD+K N+L+++ G ++++D GLA + + R T Y
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGY 160
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
PE+L G Y SVD +++GC E++ G+ + R E + ++ + +Y
Sbjct: 161 MAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 45/147 (30%), Positives = 60/147 (40%), Gaps = 32/147 (21%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----------NFSNTGHRQPLTSRV 57
L+ H G +HRDIK N+L++ +G +KLADFGL + N H V
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 58 VTLW------------------YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQG 99
+ Y PE+L G T YG D WS+G + E+L G P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYS 232
Query: 100 RTEVEQLHKI--FKLC-GSPPDDYWKK 123
T E +KI +K PPD
Sbjct: 233 DTLQETYNKIINWKESLRFPPDPPVSP 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 61
+ L GL + H G +HRDIKG+N+L+ +G +KLADFG+ A + T ++ S + T +
Sbjct: 109 ETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSFIGTPY 166
Query: 62 YRPPELLL--GATDYGPSVDLWSVGCVFAELLIGKP 95
+ PE+ Y D+W++G EL +P
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 40/122 (32%), Positives = 68/122 (55%), Gaps = 10/122 (8%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVT 59
+++ L GL+H H +HRD+KG+N+L+ EG +KL DFG+ A ++T R+ + V T
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGT 187
Query: 60 LWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
++ PE++ + Y D+WS+G EL G P L ++ + +FK+ +
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRN 244
Query: 116 PP 117
PP
Sbjct: 245 PP 246
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 3/116 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QL LEH HSR V+HRDIK +N+ + GV+KL D GL F ++ S V T +Y
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHKIFKLCGSPP 117
PE + Y D+WS+GC+ E+ + P + + L K + C PP
Sbjct: 173 MSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 37/107 (34%), Positives = 61/107 (57%), Gaps = 2/107 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ GL+ H +G+++RD+K N+L++ +G +K+ADFG+ + G + ++ T Y
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA-STFCGTPDY 162
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE+L G Y SVD WS G + E+LIG+ G E E I
Sbjct: 163 IAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 42/130 (32%), Positives = 56/130 (43%), Gaps = 28/130 (21%)
Query: 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNTGHRQP 52
+L GL + H ++HRD+K SN+LVN+ G +KL DFG LA + G
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVG---- 161
Query: 53 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK----PILQGRTEV-EQLH 107
T Y PE + G DY D+WS+G EL G+ P + E L
Sbjct: 162 ------TSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214
Query: 108 KIFKLCGSPP 117
I PP
Sbjct: 215 YIVN--EPPP 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 32/100 (32%), Positives = 56/100 (56%), Gaps = 3/100 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
++ GLE H +++RD+K N+L+++ G ++++D GLA G + + RV T+ Y
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGY 167
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 102
PE ++ Y S D W +GC+ E++ GK + R E
Sbjct: 168 MAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 33/191 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 61
+L L H++GV+HRDIK ++L+ ++G +KL+DFG A S R+ S V T +
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPY 180
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
+ PE ++ YG VD+WS+G + E++ G+P ++ + +I PP
Sbjct: 181 WMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPP---- 233
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 181
K K H LR ++ +L +P +RATA+ L + +
Sbjct: 234 -KLKNLHKV--------SPRLRS-----------FLDRMLVRDPAQRATAAELLNHPFLA 273
Query: 182 TKPYACDLSSL 192
A SS+
Sbjct: 274 K---AGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 22/198 (11%)
Query: 4 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYR 63
+L +++ H ++HRDIK N+ +N+ G + L DFG A F + T+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250
Query: 64 PPELLLGATD-YGPSVDLWSVGCVFAEL------LIGKPILQGRTEVE-QLHKIFKLCGS 115
PELL A D YGP+VD+WS G V E+ L K L G + + Q+ I + G+
Sbjct: 251 APELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308
Query: 116 PPDDYWKKSKLPHATLFK---------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPY 166
P+++ A L + ++P L +LP LI +L+ + +
Sbjct: 309 HPNEFPID---AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365
Query: 167 KRATASAALASEYFSTKP 184
R +A A L F P
Sbjct: 366 HRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 40/98 (40%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
L GL + HS +HRDIK N+L+ G +KLADFG A+ + P S V T ++
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYW 177
Query: 63 RPPELLLGATD---YGPSVDLWSVGCVFAELLIGKPIL 97
PE++L A D Y VD+WS+G EL KP L
Sbjct: 178 MAPEVIL-AMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 42/119 (35%), Positives = 67/119 (56%), Gaps = 6/119 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ LEH H G+++RDIK N+L+++EG + L DFGL+ + ++ S T+ Y
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP--ILQGR--TEVEQLHKIFKLCGSPP 117
PE++ G +G +VD WS+G + ELL G L+G T+ E +I K PP
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--DPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 3/116 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QL +EH HSR V+HRDIK +N+ + GV+KL D GL F ++ S V T +Y
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAEL-LIGKPILQGRTEVEQLHKIFKLCGSPP 117
PE + Y D+WS+GC+ E+ + P + + L + + C PP
Sbjct: 173 MSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 1/87 (1%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 67
L+H H G+++RDIK N+L+++EG + L DFGL+ + S T+ Y PE+
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 68 LLGATD-YGPSVDLWSVGCVFAELLIG 93
+ G + + +VD WS+G + ELL G
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 64
L GL + HS ++HRDIK N+L+ G +KLADFG A+ S+ P S V T ++
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMA 185
Query: 65 PELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE++L + Y VD+WS+G EL KP L + L+ I
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 11/116 (9%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVT 59
+ + L GL + H V+HRDIKG N+L+ +KL DFG+ A +T R+ + + T
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGT 176
Query: 60 LWYRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
++ PE++ A D P D+WS+G EL GKP L + L KI
Sbjct: 177 PYWMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
GL++ H +++RD+K NLL++ EG +K+ADFGL G ++ T + PE
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPE 171
Query: 67 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 104
+L T Y +VD W +G + E+L+G+ G E E
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 37/107 (34%), Positives = 62/107 (57%), Gaps = 2/107 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ GL+ HS+G+++RD+K N++++ +G +K+ADFG+ + G + ++ T Y
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGTPDY 162
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE+L G Y SVD WS G + E+LIG+ G E E I
Sbjct: 163 IAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW----YR 63
LE+ HS+ +++RD+K N+L++ EG +KL DFG A + L R TL Y
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEYL 165
Query: 64 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE ++ + + +VD W++G + E+L+G P KI
Sbjct: 166 APE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 41/118 (34%), Positives = 67/118 (56%), Gaps = 10/118 (8%)
Query: 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWYR 63
L GL+H H+ ++HRD+KG+N+L+ EG +KL DFG+ A ++T R+ + V T ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWM 195
Query: 64 PPELLLGATDYGPS----VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
PE++ Y S D+WS+G EL G P L ++ + +FK+ +PP
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIPRNPP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 30/173 (17%)
Query: 4 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWY 62
+L L + HS+GV+HRDIK ++L+ +G +KL+DFG A S ++ S V T ++
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYW 183
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE ++ T YG VD+WS+G + E++ G+P + V+ + +L SPP
Sbjct: 184 MAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP----- 234
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
P P LR+ +E +L+ EP +RATA L
Sbjct: 235 ----PKLKNAHKISPV---LRD-----------FLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
Q+L L HS V+HRD+K N+L+ +G +KLADFG++ N Q + + T
Sbjct: 109 CRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTFIGTP 167
Query: 61 WYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
++ PE++ T Y D+WS+G EL +P E+ + + K+ S
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKILKSE 224
Query: 117 P 117
P
Sbjct: 225 P 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 40/102 (39%), Positives = 65/102 (63%), Gaps = 6/102 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
+++ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS ++P S V T
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHAS-VGTHG 160
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 102
Y PE+L T Y S D +S+GC+ +LL G P Q +T+
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 39/102 (38%), Positives = 64/102 (62%), Gaps = 6/102 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
+++ GLEH H+R V++RD+K +N+L++ G ++++D GLA +FS ++P S V T
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHAS-VGTHG 160
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTE 102
Y PE+L Y S D +S+GC+ +LL G P Q +T+
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 37/93 (39%), Positives = 58/93 (62%), Gaps = 4/93 (4%)
Query: 4 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLWY 62
+L L H++GV+HRDIK ++L+ ++G +KL+DFG A S R+ S V T ++
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYW 182
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
PE L+ YGP VD+WS+G + E++ G+P
Sbjct: 183 MAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 3/100 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
++L GLE H ++RD+K N+L+++ G ++++D GLA G + + RV T+ Y
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGY 167
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 102
PE +L Y S D W +GC+ E++ G+ +GR E
Sbjct: 168 MAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 43/112 (38%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLW 61
Q+ GL+H H R +LHRDIK N+ ++ G V KL DFG+A N T V T +
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPY 167
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 113
Y PE+ Y D+WS+GCV EL K +G + QL + K+C
Sbjct: 168 YLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 2/92 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+ L+H H R +LHRDIK N+ + +G +KL DFG+A N+ T + T +Y
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYY 167
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
PE+ Y D+W++GCV E+ K
Sbjct: 168 LSPEICENRP-YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 9e-12
Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 34/200 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+ L LE HS V+HRDIK N+L+ +G +KL DFG T + ++ V T ++
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYW 182
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ YGP VD+WS+G + E++ G+P + L+ I
Sbjct: 183 MAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------- 228
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS- 181
AT P+ L F+D + L ++ KR +A L ++
Sbjct: 229 ------ATNGTPELQNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 182 TKPYACDLSSL-PIYPPSKE 200
KP LSSL P+ +KE
Sbjct: 276 AKP----LSSLTPLIAAAKE 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 6/105 (5%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRP 64
GL HS+G+++RD+K N++++ EG +K+ADFG+ + G T+R T Y
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFCGTPDYIA 169
Query: 65 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE++ YG SVD W+ G + E+L G+P G E E I
Sbjct: 170 PEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 2/93 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+ L LE H+ V+HRDIK N+L+ +G +KL DFG T + ++ V T ++
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYW 181
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
PE++ YGP VD+WS+G + E++ G+P
Sbjct: 182 MAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 34/97 (35%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW- 61
Q++ LE+ HS +++RD+K NLL++++G +K+ DFG A + R TL
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCG 160
Query: 62 ---YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
Y PE++L YG +VD W++G + E+L G P
Sbjct: 161 TPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 49/179 (27%), Positives = 67/179 (37%), Gaps = 56/179 (31%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR----------------- 50
++ H G +HRDIK NLL++ +G +KL+DFGL HR
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 51 ---QPLTS-RVVTLW----------------YRPPELLLGATDYGPSVDLWSVGCVFAEL 90
+P++S R W Y PE+ L T Y D WS+G + E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEM 232
Query: 91 LIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149
L+G P E KI WK+ TL P + L KDL
Sbjct: 233 LVGYPPFCSDNPQETYRKIIN---------WKE------TLQFPD---EVPLSPEAKDL 273
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 42/111 (37%), Positives = 59/111 (53%), Gaps = 15/111 (13%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN---FSNT-----GH-----RQPLT 54
LE+ H+ G++HRD+K NLL+ + G +KL DFGL+ S T GH R+ L
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 55 SRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE 104
+V T Y PE++L YG VD W++G + E L+G G T E
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 40/120 (33%), Positives = 59/120 (49%), Gaps = 5/120 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLW 61
Q+ G++H H + VLHRDIK N+ + G +KL DFG A ++ G + V T +
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--CTYVGTPY 165
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP-PDDY 120
Y PPE+ Y D+WS+GC+ EL K Q + + K+ + P P Y
Sbjct: 166 YVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHY 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 40/120 (33%), Positives = 63/120 (52%), Gaps = 6/120 (5%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRP 64
GL H RG+++RD+K N+++++EG +K+ADFG+ +T+R T Y
Sbjct: 113 GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIA 169
Query: 65 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS 124
PE ++ YG SVD W+ G + E+L G+P G E E I + S P K++
Sbjct: 170 PE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 64
L GL + HS ++HRDIK N+L+ G +KLADFG A+ ++ P S V T ++
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMA 189
Query: 65 PELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE++L + Y VD+WS+G EL KP L + L+ I
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 39/100 (39%), Positives = 54/100 (54%), Gaps = 13/100 (13%)
Query: 4 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS----RVVT 59
++ GL + S +LHRD+K SN+LVN G +KL DFG++ Q + S V T
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-------TQLVNSIAKTYVGT 156
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQ 98
Y PE + G YG D+WS+G F EL +G+ P Q
Sbjct: 157 NAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ 195
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
Q+L L H H++ +LHRD+K N+L++ ++ V+K+ DFG++ + + V T
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYTVVGTPC 166
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
Y PEL G Y D+W++GCV EL K + + KI +P D
Sbjct: 167 YISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR- 224
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
Y LR+ LI ++L+++P KR S +A
Sbjct: 225 ----------------YSPDLRQ-----------LILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 2/93 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+ L L+ HS V+HRDIK N+L+ +G +KL DFG T + ++ V T ++
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYW 181
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
PE++ YGP VD+WS+G + E++ G+P
Sbjct: 182 MAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 2/109 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+L L+H HS G+++RD+K N+L++ EG +KL DFGL+ S H + S T+ Y
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVEY 164
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 111
PE ++ + S D WS G + E+L G QG+ E + I K
Sbjct: 165 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 37/112 (33%), Positives = 64/112 (57%), Gaps = 4/112 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 59
++++ LEH H +G+++RD+K N+L++ +G +KL DFGL S H +T T
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCGT 163
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 111
+ Y PE+L+ + +G +VD WS+G + ++L G P + + KI K
Sbjct: 164 IEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 35/117 (29%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
GLE H +++RD+K N+L+++ G ++++D GLA G Q + RV T+ Y PE
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPE 171
Query: 67 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 123
++ Y S D W++GC+ E++ G+ Q R + + ++ +L ++Y +K
Sbjct: 172 VVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 35/91 (38%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 67
L+ HS G +HRD+K N+L++ G LKLADFG + + V T Y PE+
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214
Query: 68 LL---GATDYGPSVDLWSVGCVFAELLIGKP 95
L G YG D WSVG E+L+G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 19/164 (11%)
Query: 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 64
L GL + HS ++HRD+K N+L++ G++KL DFG A+ P V T ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMA 179
Query: 65 PELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP--PDDY 120
PE++L + Y VD+WS+G EL KP L + L+ I + SP +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGH 238
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 164
W + + DS L++ +D PT+ V L + E
Sbjct: 239 WSEYF---------RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 39/116 (33%), Positives = 55/116 (47%), Gaps = 16/116 (13%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPLTS 55
Q+L GL H HS+ +LHRDIK NL ++ +K+ D G+A NF+NT
Sbjct: 109 QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-------- 160
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 111
V T +Y PE L Y D+W++G V E GK + + KI +
Sbjct: 161 IVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 33/142 (23%)
Query: 7 GLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFG--------LANFSNTGHRQPLTSRV 57
LE+ HS+ V+HRD+K SN+L+N G +KL DFG +A + G +
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP------ 168
Query: 58 VTLWYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLC 113
Y PE + + Y D+WS+G EL G+ P +T +QL ++ +
Sbjct: 169 ----YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-- 222
Query: 114 GSPPDDYWKKSKLPHATLFKPQ 135
P +LP F P+
Sbjct: 223 EPSP-------QLPAEK-FSPE 236
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 55/193 (28%), Positives = 84/193 (43%), Gaps = 15/193 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQPLTSRVVTL 60
+LL LE+ H V++RD+K N+L++ +G + L DFGL N + T
Sbjct: 101 ELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG---TP 157
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PELLLG Y +VD W++G + E+L G P E KI + PD +
Sbjct: 158 EYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGF 216
Query: 121 WKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLS---VEPYKRATASAA- 174
+ +K L P + + + K+ P + + LL P+K A +SA
Sbjct: 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAID 276
Query: 175 ---LASEYFSTKP 184
E+ KP
Sbjct: 277 TSNFDEEFTREKP 289
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 41/104 (39%), Positives = 58/104 (55%), Gaps = 8/104 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G+ + H R ++HRDIK SNLL+N+ +K+ADFG++ P S V T+ Y
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSVGTIAY 234
Query: 63 RPPE-----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGR 100
PE L GA D G + D+WS+G E +G+ P GR
Sbjct: 235 MSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 9e-11
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 31/186 (16%)
Query: 4 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWY 62
+L L + H++GV+HRDIK ++L+ ++G +KL+DFG + P +V T ++
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYW 184
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE ++ YG VD+WS+G + E++ G+P ++ + +I D+
Sbjct: 185 MAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------RDNLPP 236
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS- 181
+ K H SS+ F DL +L EP +RATA L +
Sbjct: 237 RVKDSHKV---------SSVLRGFLDL----------MLVREPSQRATAQELLQHPFLKL 277
Query: 182 TKPYAC 187
P +C
Sbjct: 278 AGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 6/111 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 60
++ L H +G+++RD+K N+L+++EG KLADFG+ G T+ T
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC---KEGIFNGKTTSTFCGTP 160
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 111
Y PE +L YGPSVD W++G + E+L G + E + I
Sbjct: 161 DYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 51/203 (25%), Positives = 80/203 (39%), Gaps = 35/203 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVVTLW 61
+L+ + H G +HRDIK N+L++ G +KLADFG A + V T
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPD 168
Query: 62 YRPPELLL-----GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
Y PE+L G YG D WS+G + E++ G+ T + + I
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI------- 221
Query: 117 PDDYWKKSKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
+ K P+ P SS ++LI++LL +R
Sbjct: 222 ---------MNFQRFLKFPEDPKVSS----------DFLDLIQSLLC-GQKERLGYEGLC 261
Query: 176 ASEYFSTKPYACDLSSLPIYPPS 198
+FS + +SLP + P+
Sbjct: 262 CHPFFSKIDWNNIRNSLPPFVPT 284
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 2/102 (1%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPEL 67
L H GV++RD+K N+L++ EG KLADFG+ + T+ T Y PE
Sbjct: 109 LMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPE- 166
Query: 68 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
+L +YGPSVD W++G + E++ G+P + E + I
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
+L GL + HSR ++HRDIK SN+L+ +G +KL DFG++ T T +
Sbjct: 112 ESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSF 168
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAEL 90
Y PE + G Y + D+WS+G E+
Sbjct: 169 YMAPERIQGKP-YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 35/82 (42%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 16 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 75
++HRD+K SN+LVN+ G +KL DFG+ S S V T Y PE L G T Y
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQG-THYT 176
Query: 76 PSVDLWSVGCVFAELLIGK-PI 96
D+WS+G E+ IG+ PI
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 5/149 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ ++L GL++ HS +HRDIK +N+L++ +G +KLADFG+A + T
Sbjct: 107 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
W P + A D+ D+WS+G EL G+P + L I K SPP
Sbjct: 167 WMAPEVIKQSAYDF--KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSPPTLE 222
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDL 149
+ SK P + D R T K+L
Sbjct: 223 GQYSK-PFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 36/88 (40%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLW 61
QLL +++ H G++HRDIK N+LVN + L DFG A F+ P + T+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAE 89
PE+L G Y PSVD+WS G V E
Sbjct: 328 TNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+ G+ H HS +++RD+K N+L++++G +L+D GLA G + +T R T Y
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGTNGY 160
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
PE+L Y VD +++GC E++ G+
Sbjct: 161 MAPEILKEEP-YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 34/96 (35%), Positives = 60/96 (62%), Gaps = 4/96 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
+ ++L GL++ HS +HRDIK +N+L++ +G +KLADFG+A ++T ++ + V T
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGT 164
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
++ PE++ + Y D+WS+G EL G+P
Sbjct: 165 PFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 60
+++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL G T + T
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTP 159
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
Y PE +L DYG +VD W +G V E++ G+
Sbjct: 160 EYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 2/105 (1%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
GL HS+G+++RD+K N+++++EG +K+ADFG+ N + T Y PE
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPE 171
Query: 67 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 111
++ YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 172 -IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 8/127 (6%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L L++ HS ++HRD+K N+L+ +G +KLADFG++ N Q S + T ++
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYW 176
Query: 63 RPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
PE+++ T Y D+WS+G E+ +P E+ + + K+ S P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPP 233
Query: 119 DYWKKSK 125
+ SK
Sbjct: 234 TLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 1/92 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ LEH H G+++RDIK N+L+++ G + L DFGL+ + + S T+ Y
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 63 RPPELLLGA-TDYGPSVDLWSVGCVFAELLIG 93
P+++ G + +VD WS+G + ELL G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 30/179 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
Q++ L+ HSR ++HRD+K +N+ + G++KL DFG + +S++ +S T +
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
Y PE L Y D+WS+G + ELL LH+ FK P
Sbjct: 237 YLAPE-LWERKRYSKKADMWSLGVILYELL-------------TLHRPFK---GP----- 274
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+ ++ L+ P+ + K L++ LLS P R T L +E+
Sbjct: 275 SQREIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 43/150 (28%), Positives = 77/150 (51%), Gaps = 7/150 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
+ ++L GL++ HS +HRDIK +N+L++ G +KLADFG+A ++T ++ + V T
Sbjct: 107 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGT 164
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
++ PE ++ + Y D+WS+G EL G+P +E+ + +F + + P
Sbjct: 165 PFWMAPE-VIKQSAYDSKADIWSLGITAIELAKGEP---PHSELHPMKVLFLIPKNNPPT 220
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDL 149
P + + S R T K+L
Sbjct: 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 27/179 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+ L GL + HS+G +HRDIKG+N+L+ + G +KLADFG+A T S + T ++
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYW 172
Query: 63 RPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
PE+ + Y D+W+VG EL +P + + L + K PP
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK-- 230
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
K K ++ F N ++ L+ P KR TA L +
Sbjct: 231 -LKDKTKWSSTFH---------------------NFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 43/122 (35%), Positives = 58/122 (47%), Gaps = 5/122 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ L+ HS G +HRD+K N+L++ G LKLADFG N + V T Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 63 RPPELLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF--KLCGSPP 117
PE+L G YG D WSVG E+L+G + V KI K + P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269
Query: 118 DD 119
DD
Sbjct: 270 DD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 34/90 (37%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRP 64
L + H RG+++RD+K N+L+++EG +KL D+G+ G R T+ T Y
Sbjct: 108 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIA 164
Query: 65 PELLLGATDYGPSVDLWSVGCVFAELLIGK 94
PE+L G DYG SVD W++G + E++ G+
Sbjct: 165 PEILRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 39/122 (31%), Positives = 63/122 (51%), Gaps = 14/122 (11%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 61
++L GL H H+ V+HRDIKG N+L+ +KL DFG+ A T R+ + + T +
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 186
Query: 62 YRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
+ PE++ A D P D+WS+G E+ G P L ++ + +F + +
Sbjct: 187 WMAPEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRN 241
Query: 116 PP 117
PP
Sbjct: 242 PP 243
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVV 58
+++ L + HS V++RD+K NL+++ +G +K+ DFGL + T + +
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-----MKTFCG 157
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
T Y PE +L DYG +VD W +G V E++ G+
Sbjct: 158 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 33/100 (33%), Positives = 57/100 (57%), Gaps = 2/100 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q++ GLEH H R +++RD+K N+L++N+G ++++D GLA G + T +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGF 163
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 102
PELL G +Y SVD +++G E++ + + R E
Sbjct: 164 MAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 35/223 (15%)
Query: 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS---NTGHRQ------PLTS 55
L GL + H G +HR+IK S++L++ +G++ L+ GL++ G + P S
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
V W P L Y D++SVG EL G+ Q + L + K
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---G 225
Query: 116 PPDDYWKKSKLPH--ATLFKPQQPYDSSLRETF-------------------KDLPTTAV 154
PP + P + + Q DS + E+ K
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285
Query: 155 NLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 197
NL+E L +P KR +AS+ L+ +F S L + PP
Sbjct: 286 NLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 61
++L GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ + + T +
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 176
Query: 62 YRPPELLLGATDYGPSV------DLWSVGCVFAELLIGKPIL 97
+ PE++ A D P DLWS+G E+ G P L
Sbjct: 177 WMAPEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 3/88 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QLL G+ + H R +LHRD+K N+ + N +LK+ DFG++ G T+ T +Y
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYY 171
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAEL 90
PE L Y D+WS+GC+ E+
Sbjct: 172 MSPE-ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 1/91 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+L+ LEH H +++RD+K N+L++ G + L DFGL+ +N + + T Y
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEY 162
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIG 93
PE+LL Y VD WS+G + E+ G
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 38/95 (40%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
+++ L+ HS G++HRD+K N+L++ G LKLADFG TG + T+ V T
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPD 208
Query: 62 YRPPELLL---GATDYGPSVDLWSVGCVFAELLIG 93
Y PE+L G YG D WSVG E+L+G
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRV 57
Q+ G+++ S+ +HRD+ N+LV +E ++K++DFGLA ++P S +
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
WY PE L + S D+WS G EL
Sbjct: 177 --FWY-APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 38/117 (32%), Positives = 61/117 (52%), Gaps = 10/117 (8%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGH-----RQP 52
M Q+L L H++G++HRD+K N++V+ GV K+ DFG+
Sbjct: 85 MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 53 LTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 108
T+ V+ T Y PE L G P+ DL++ G +F E L G+ ++QG + E L++
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVTLW 61
Q+L + H HS+ ++HRDIK +N+L+ + G++KL DFG + ++ T + T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK 108
Y PE+ Y D++S+G + ELL K G E +HK
Sbjct: 211 YVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRV 57
Q+ G+ + HS+ +HRD+ N+L++N+ ++K+ DFGLA GH R+ S V
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
WY L + + D+WS G ELL
Sbjct: 175 --FWYAVE--CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 34/89 (38%), Positives = 52/89 (58%), Gaps = 6/89 (6%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPP 65
L H RG+++RD+K N+L++ EG +KL D+G+ G R T+ T Y P
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC---KEGIRPGDTTSTFCGTPNYIAP 165
Query: 66 ELLLGATDYGPSVDLWSVGCVFAELLIGK 94
E+L G DYG SVD W++G + E++ G+
Sbjct: 166 EILRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 32/121 (26%), Positives = 57/121 (47%), Gaps = 19/121 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 55
+ +E+ S G +HRD+ N LV + V+K++DFGLA + S+ G + P+
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK- 166
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTE---VEQLHKIFK 111
+ PPE+ + + D+WS G + E+ GK + + VE + ++
Sbjct: 167 ------WAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219
Query: 112 L 112
L
Sbjct: 220 L 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 47/155 (30%), Positives = 65/155 (41%), Gaps = 47/155 (30%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------------- 42
+L +E H G +HRDIK N+L++ +G +KL DFGL
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQ 168
Query: 43 ---NFSN---------TGHR-QPLTSR-------------VVTLWYRPPELLLGATDYGP 76
+FSN G R +PL R V T Y PE+LL T Y
Sbjct: 169 DSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQ 227
Query: 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 111
D WSVG + E+L+G+P +T +E K+
Sbjct: 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 39/118 (33%), Positives = 63/118 (53%), Gaps = 5/118 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 61
+ L GL + HS+G +HRDIKG+N+L+ + G +KLADFG+ A + T ++ S + T +
Sbjct: 114 ETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPY 171
Query: 62 YRPPEL--LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
+ PE+ + Y D+W+VG EL +P + + L + K PP
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 48/155 (30%), Positives = 66/155 (42%), Gaps = 25/155 (16%)
Query: 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRVVTLW 61
LH L+ H GV+HRD+K SN+L++ G +KL DFG++ S R +
Sbjct: 127 LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA----- 179
Query: 62 YRPPELLLGAT---DYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 117
Y PE + Y D+WS+G EL G+ P +TE E L KI + PP
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE--EPP 237
Query: 118 DDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLP 150
LP F P D L + + P
Sbjct: 238 -------SLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 45/149 (30%), Positives = 59/149 (39%), Gaps = 43/149 (28%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-----------SNTGHRQ 51
+L +E H G +HRDIK N+L++ +G +KL DFGL HRQ
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168
Query: 52 ------------------PLTSR-------------VVTLWYRPPELLLGATDYGPSVDL 80
PL R V T Y PE+LL T Y D
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDW 227
Query: 81 WSVGCVFAELLIGKPILQGRTEVEQLHKI 109
WSVG + E+L+G+P T E K+
Sbjct: 228 WSVGVILYEMLVGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 49/136 (36%), Positives = 69/136 (50%), Gaps = 13/136 (9%)
Query: 4 LLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+L GL + + ++HRD+K SN+LVN+ G +KL DFG+ S S V T Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSY 168
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYW 121
PE L G T Y D+WS+G EL IG+ PI + ++L IF G P D
Sbjct: 169 MSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVD-- 220
Query: 122 KKSKLPHATLFKPQQP 137
+ PH+ +P+ P
Sbjct: 221 GEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 2/110 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + N + + T+ + +
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 111
+ PE L Y D+WS G + E+ VE+L K+ K
Sbjct: 202 WMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 31/97 (31%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW- 61
+L+ E+ HS+ +++RD+K NLL++N+G +K+ DFG A + + R TL
Sbjct: 126 ELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRTFTLCG 177
Query: 62 ---YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
Y PE ++ + +G +VD W++G + E + G P
Sbjct: 178 TPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 8/127 (6%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q L L + H ++HRD+K N+L +G +KLADFG++ NT Q S + T ++
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYW 169
Query: 63 RPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
PE+++ T Y D+WS+G E+ +P E+ + + K+ S P
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPP 226
Query: 119 DYWKKSK 125
+ S+
Sbjct: 227 TLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 33/116 (28%), Positives = 58/116 (50%), Gaps = 11/116 (9%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
G+E+ S+ ++HRD+ N+LV+ +GV K++DFGLA G S++ W P
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEA 168
Query: 67 LLLGATDYGPSVDLWSVGCVFAELL-IGK---PILQGRTEVEQLHKIFKLCGSPPD 118
L + D+WS G + E+ G+ P + + E + K +++ PP+
Sbjct: 169 LKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 34/94 (36%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRV 57
Q+ G+++ SR +HRD+ N+LV +E +K+ DFGL T + L S V
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
WY PE L+ + Y S D+WS G ELL
Sbjct: 177 --FWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
L H RG+++RD+K N+L++ +G +KL D+G+ G ++ T Y PE
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPE 166
Query: 67 LLLGATDYGPSVDLWSVGCVFAELLIGK 94
+L G +YG SVD W++G + E++ G+
Sbjct: 167 ILRG-EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 13/97 (13%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q++ E+ S +++RD+K NLL++ +G +K+ DFG A +T R TL
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--------RTYTLCG 190
Query: 63 RP----PELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
P PE+LL +G + D W++G E+L+G P
Sbjct: 191 TPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 4/111 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ + H +HRDIK N+L++ G ++LADFG N + V T Y
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 63 RPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE+L D YGP D WS+G E+L G+ + VE KI
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 51/205 (24%), Positives = 77/205 (37%), Gaps = 52/205 (25%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS-NTGHRQPLTSRVVTLW 61
Q+L GL + H++ ++HRD+K N+ +N+ + + D G A F L V T
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET-- 222
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
PE+L Y D+WS G V E+L P IF+ S P++Y
Sbjct: 223 -NAPEVLARDK-YNSKADIWSAGIVLFEML-AYP-----------STIFEDPPSTPEEYV 268
Query: 122 KKSKLPHATLFK------------PQQPYDSSLRETF-------------------KDLP 150
K H+ L K P+ P S L F +LP
Sbjct: 269 KSC---HSHLLKIISTLKVHPEEFPRDP-GSRLVRGFIEYASLERQPYTRYPCFQRVNLP 324
Query: 151 TTAVNLIETLLSVEPYKRATASAAL 175
L+ +L+ + R +A L
Sbjct: 325 IDGEFLVHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 50/177 (28%), Positives = 71/177 (40%), Gaps = 53/177 (29%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGH------- 49
++ H G +HRDIK NLL++++G +KL+DFGL + N H
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 50 -----------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 92
RQ S V T Y PE+ + T Y D WS+G + E+LI
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLI 231
Query: 93 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149
G P T E K+ WK++ +F P+ P + E KDL
Sbjct: 232 GYPPFCSETPQETYKKVMN---------WKET-----LIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 49/185 (26%), Positives = 71/185 (38%), Gaps = 49/185 (26%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGH------- 49
++ H G +HRDIK NLL++ +G +KL+DFGL + N H
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 50 -----------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI 92
RQ S V T Y PE+ + T Y D WS+G + E+LI
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLI 231
Query: 93 GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152
G P T E K+ WK++ +F P+ P ++ T
Sbjct: 232 GYPPFCSETPQETYRKVMN---------WKET-----LVFPPEVPISEKAKDLILRFCTD 277
Query: 153 AVNLI 157
+ N I
Sbjct: 278 SENRI 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+L GLE +++RD+K N+L+++ G ++++D GLA G + RV T+ Y
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGY 167
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 102
PE++ Y S D W +GC+ E++ G+ + R E
Sbjct: 168 MAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 36/111 (32%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
Q+ G+E+ S+ +HRD+ N+LV V+K+ADFGLA + +N + + T+ + +
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK 204
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 111
+ PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 205 WMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 35/82 (42%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 16 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 75
++HRD+K SN+LVN+ G +KL DFG+ S S V T Y PE L G T Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQG-THYS 180
Query: 76 PSVDLWSVGCVFAELLIGK-PI 96
D+WS+G E+ IG+ PI
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 3 QLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
Q++ L + H + ++HRD+ +N+++ + + + DFGLA LTS V T+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTIL 178
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
Y PE++ YG D+W+ GC+ ++ +P
Sbjct: 179 YSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 2/108 (1%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
++ L + HS +++RD+K N+L++++G + L DFGL N H ++ T Y
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEY 162
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 110
PE +L Y +VD W +G V E+L G P R E I
Sbjct: 163 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 43/129 (33%), Positives = 56/129 (43%), Gaps = 27/129 (20%)
Query: 3 QLLHGLEHCHS-------RGVLHRDIKGSNLLV-----------------NNEGVLKLAD 38
QLLH L +CH+ VLHRD+K N+ + N + K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 39 FGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLWSVGCVFAELLIGKPIL 97
FGL+ N G S V T +Y PELLL T Y D+W++GC+ EL GK
Sbjct: 186 FGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 98 QGRTEVEQL 106
QL
Sbjct: 244 HKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 6/115 (5%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQPLTSRVVT 59
+ +++ ++ H +HRDIK N+L++ G ++LADFG G Q + V T
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-VGT 166
Query: 60 LWYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 110
Y PE+L D YGP D WS+G E+L G+ + VE KI
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 7e-08
Identities = 29/118 (24%), Positives = 45/118 (38%), Gaps = 22/118 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-W 61
Q+ G+E+ S+ +HRD+ N LV V+K++DFGL+ + + W
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
PE L + D+WS G + L +IF L P
Sbjct: 170 M-APESLKEGK-FTSKSDVWSFGVL-------------------LWEIFTLGEQPYPG 206
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 2/92 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ L++ HS +++RD+K NL+++ +G +K+ DFGL T + + T Y
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKTFCGTPEY 161
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
PE +L DYG +VD W +G V E++ G+
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 15/99 (15%)
Query: 2 NQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLA-----NFSNTGHRQPLTS 55
++ GL + ++ ++HRDIK SN+LVN+ G +KL DFG++ + ++T
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-------- 161
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
V T Y PE + G Y D+WS+G EL +GK
Sbjct: 162 FVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 37/113 (32%), Positives = 51/113 (45%), Gaps = 7/113 (6%)
Query: 4 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVTLWY 62
LL L + H RG++HRD+K N+ ++ L DFG A + P TL
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 63 RPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPIL---QGRTEVEQLHKIFK 111
PELL A D Y D+WS G V E+ + L Q ++ QL I +
Sbjct: 254 NSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 36/102 (35%), Positives = 47/102 (46%), Gaps = 4/102 (3%)
Query: 12 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 71
H G +HRDIK N+L++ G ++LADFG V T Y PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 72 TD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
D YGP D WS+G E+L G+ + VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLT-SRVV 58
M QLL +E+ H + ++HRDIK N+ +N +G + L DFG A F R+ V
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK--EREAFDYGWVG 330
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
T+ PE+L G Y D+WS G + ++L
Sbjct: 331 TVATNSPEILAGDG-YCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 19/103 (18%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------NFSNT 47
+ LL G+E+ S+ +HRD+ N LV + V+K++DFGL+ ++
Sbjct: 104 LKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK 163
Query: 48 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 90
L R W PE L + D+WS G + E+
Sbjct: 164 KTGGKLPIR----WM-APESLKDGI-FTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 2/98 (2%)
Query: 12 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 71
HS +++RD+K N+L++++G + L DFGL H + ++ T Y PE+L
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-K 170
Query: 72 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
Y +VD W +G V E+L G P R E I
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 29/118 (24%), Positives = 46/118 (38%), Gaps = 22/118 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-W 61
Q+ G+E+ S+ +HRD+ N LV V+K++DFGL+ + + + W
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRW 170
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
PE L + D+WS G + L +IF L P
Sbjct: 171 M-APESLKEGK-FTSKSDVWSFGVL-------------------LWEIFTLGEEPYPG 207
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 32/95 (33%), Positives = 55/95 (57%), Gaps = 7/95 (7%)
Query: 3 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--T 59
+++ L++ HS + V++RD+K NL+++ +G +K+ DFGL G + T + T
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGT 159
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
Y PE +L DYG +VD W +G V E++ G+
Sbjct: 160 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 4/111 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + + + + T+ + +
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFK 111
+ PE L Y D+WS G + E+ +G G VE+L K+ K
Sbjct: 208 WMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 28/96 (29%), Positives = 53/96 (55%), Gaps = 16/96 (16%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVT 59
G+ + S+ +HRD+ N LV+++G +K++DFGL+ + S+ G + P+
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR----- 166
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 94
+ PPE+LL + + D+W+ G + E+ +GK
Sbjct: 167 --WSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 13/108 (12%)
Query: 16 VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP---PELLLGAT 72
++HRD+K SN+L++ G +KL DFG++ G ++ RP PE + +
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 73 DYGPSV--DLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP 117
G V D+WS+G E+ GK P + + +QL ++ K G PP
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPP 229
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 48/204 (23%), Positives = 76/204 (37%), Gaps = 57/204 (27%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------------NFSNT 47
++L LE+ H G+++RD+K N+L++ G + L+DF L+ S
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 48 GHRQPLTSRVV-------------TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
+ S T Y PE++ G +G +VD W++G + E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGT 229
Query: 95 PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154
+G E I + P P SS +A
Sbjct: 230 TPFKGSNRDETFSNIL-----------------KKEVTFPGSPPVSS----------SAR 262
Query: 155 NLIETLLSVEPYKRATASAALASE 178
+LI LL +P KR S A+E
Sbjct: 263 DLIRKLLVKDPSKR-LGSKRGAAE 285
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 37/141 (26%), Positives = 63/141 (44%), Gaps = 28/141 (19%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 55
Q+ G+ + +HRD++ +N+LV + V K+ADFGLA + G + P+
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFK 111
W P L G + D+WS G + EL+ + P + R +EQ+ + ++
Sbjct: 169 -----WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
Query: 112 L-C--GSPPDDY------WKK 123
+ C P + WKK
Sbjct: 222 MPCPQDCPISLHELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 31/70 (44%), Positives = 41/70 (58%), Gaps = 2/70 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVT 59
M Q+L GL H G++HRDIK NLLV +G +K+ DFG A TG + PL ++
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG-MLD 373
Query: 60 LWYRPPELLL 69
Y PPE L+
Sbjct: 374 PRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 9e-07
Identities = 17/49 (34%), Positives = 27/49 (55%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ LL G+E+ S+ +HRD+ N LV V+K++DFGL+
Sbjct: 101 LKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 19/94 (20%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVT 59
G+E+ +HRD+ N LV++ GV+K++DFG+ + S++G + P+
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----- 166
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGC----VFAE 89
+ PPE+ + Y D+WS G VF E
Sbjct: 167 --WSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRV 57
Q+ G+E+ S+ +HRD+ N+LV +E +K+ DFGL R+P S +
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 58 VTLWYRPPELLLGATDYGPSV--DLWSVGCVFAEL 90
WY P L T+ SV D+WS G V EL
Sbjct: 176 --FWYAPESL----TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 20/156 (12%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN--TGHRQPLTSRVVTL 60
Q+ G+E+ SR +HRD+ N+LV + V+K+ADFGLA + +++ R+
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK 201
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLI-------GKPILQGRTEVEQLHKIFKLC 113
W P L Y D+WS G + E+ G P+ + + + H++ K
Sbjct: 202 WMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPS 259
Query: 114 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149
+ Y + HA P Q R TFK L
Sbjct: 260 NCTHELYMLMRECWHAV---PTQ------RPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 60
Q+ G+E+ S +HRD+ N LV +K++DFGL+ +S +R S +
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR 191
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAEL 90
W P +L G + D+WS G V E+
Sbjct: 192 WMPPEAILYGK--FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 38/155 (24%), Positives = 56/155 (36%), Gaps = 47/155 (30%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-----FSNTGHRQPLTS 55
M + + +E H G +HRDIK N+L++ G +KL+DFGL+ + +++ L
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 56 RVVT-------------------------LW----------------YRPPELLLGATDY 74
+ W Y PE+ L Y
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGY 225
Query: 75 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
G D WS+G + E LIG P E KI
Sbjct: 226 GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 30/177 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+ L++ H + +LHRD+K N+ + ++K+ D G+A ++ + T +Y
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYY 168
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE L Y D+W++GC E+ K + +++I
Sbjct: 169 MSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------------ 215
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
+ KL P P KD LI T+LS P KR + + L Y
Sbjct: 216 EGKL-------PPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
++ L + HS +++RD+K N+L++++G + L DFGL T+ T Y
Sbjct: 104 EIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEY 162
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ----LHK 108
PE++ Y +VD W +G V E+L G P R E LHK
Sbjct: 163 LAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 18/35 (51%), Positives = 28/35 (80%)
Query: 8 LEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
L++ H G++HRD+K N+L++NEG +KL DFGL+
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 32/121 (26%), Positives = 57/121 (47%), Gaps = 19/121 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 55
Q+ G+ + +HRD++ +N+LV + V K+ADFGLA + G + P+
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFK 111
W P L G + D+WS G + EL+ + P + R +EQ+ + ++
Sbjct: 169 -----WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR 221
Query: 112 L 112
+
Sbjct: 222 M 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 39/153 (25%), Positives = 56/153 (36%), Gaps = 47/153 (30%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN----------FSNTGHRQP 52
+L +E H G +HRDIK N+L++ +G +KL DFGL + H +
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168
Query: 53 LTSRVVTLW------------------------------------YRPPELLLGATDYGP 76
+ LW Y PE+LL Y
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQ 227
Query: 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
D WSVG + E+L+G+P T E K+
Sbjct: 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 25/120 (20%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTSRVVT 59
G+ + S V+HRD+ N LV V+K++DFG+ F S+TG + P+
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----- 166
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGC----VFAELLIGKPILQGRTE---VEQLHKIFKL 112
W P Y D+WS G VF+E GK + R+ VE ++ F+L
Sbjct: 167 -WSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSE---GKTPYENRSNSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 8/109 (7%)
Query: 12 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA 71
HS +++RD+K N+L++++G + L DFGL + ++ T Y PE +L
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE-VLRK 170
Query: 72 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ-----LHKIFKLCGS 115
Y +VD W +G V E+L G P R +V Q LHK +L G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 24/84 (28%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
G+E+ + +HRD+ N+LV+ + V K++DFGLA ++ G + ++ W P
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEA 170
Query: 67 LLLGATDYGPSVDLWSVGCVFAEL 90
L + D+WS G + E+
Sbjct: 171 LREK--KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 26/71 (36%), Positives = 38/71 (53%), Gaps = 1/71 (1%)
Query: 50 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
R T+ V T YR PE++LG + S D+WS+GC+ EL GK + +E LH +
Sbjct: 299 RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357
Query: 110 FKLCGSPPDDY 120
K G P ++
Sbjct: 358 EKTLGRLPSEW 368
|
Length = 467 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+ G+ R +HRD++ +N+LV+ V K+ADFGLA + +
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 63 RPPELLLGATDYGP---SVDLWSVGCVFAELL 91
PE A ++G D+WS G + E++
Sbjct: 170 TAPE----AINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 37/118 (31%), Positives = 52/118 (44%), Gaps = 27/118 (22%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 60
Q+ G+E S+ +HRD+ N+LV + V+K+ADFGLA +R+ R+
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK 199
Query: 61 WYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
W P L D Y D+WS G +L L +IF L GSP
Sbjct: 200 WMAPEALF----DRVYTHQSDVWSFG-----------VL--------LWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 20/90 (22%), Positives = 43/90 (47%), Gaps = 2/90 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
++ G+ + ++ +HRD+ N +V + +K+ DFG+ + T + + ++ +
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELL 91
+ PE L + D+WS G V E+
Sbjct: 187 WMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 19/128 (14%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTL 60
G+ + S+ +HRD+ N LV VLK++DFG++ +S++G +Q +
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-----IPIK 159
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAEL----LIGKPILQGRTEVEQLHKIFKLCGSP 116
W P L G Y D+WS G + E + P + + EQ+ K +++
Sbjct: 160 WTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQ 217
Query: 117 --PDDYWK 122
PDD +K
Sbjct: 218 KCPDDVYK 225
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 2/89 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
Q+ G+ + R +HRD+ N LV V+K+ADFGL+ N + + + + + +
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAEL 90
+ PPE + Y D+W+ G V E+
Sbjct: 198 WMPPESIFYNR-YTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 60
Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + ++R+
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W P + Y D+WS G + E+
Sbjct: 242 WMAPESIFDKV--YTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 33/127 (25%), Positives = 58/127 (45%), Gaps = 20/127 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 55
Q+ G+ + +HRD++ +N+LV V K+ADFGLA + G + P+
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 168
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----IGKPILQGRTEVEQLHKIFK 111
W P L G + D+WS G + EL + P + R ++Q+ + ++
Sbjct: 169 -----WTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
Query: 112 LCGSPPD 118
+ PP+
Sbjct: 222 M-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 27/108 (25%)
Query: 2 NQLLHGL-----EHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-----ANFSNTGHRQ 51
++ GL EH ++HRD+K +N+LVN G +KL DFG+ A+ + T
Sbjct: 109 YAVVKGLKFLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--- 161
Query: 52 PLTSRVVTLWYRPPELL--LGATD---YGPSVDLWSVGCVFAELLIGK 94
+ Y PE + G Y D+WS+G E+ +G+
Sbjct: 162 -----IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 21/102 (20%)
Query: 2 NQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-------FSNT 47
+LL G+E+ S+ +HRD+ N LV VLK++DFG++ +
Sbjct: 93 KKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152
Query: 48 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAE 89
G +Q + W P L G Y D+WS G + E
Sbjct: 153 GLKQ-----IPIKWTAPEALNYGR--YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 60
Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + +R+
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W P + Y D+WS G + E+
Sbjct: 247 WMAPETIF--DRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN------FSNTGHRQPLTSRVVTL 60
G+E+ S+ +HRD+ N LV + VLK++DFG++ +++TG + ++
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK----QIPVK 161
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAE 89
W P L G Y D+WS G + E
Sbjct: 162 WTAPEALNYGR--YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 16/115 (13%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 55
Q+ G+ + ++ +HRD+ N+LV + K+ADFGLA + G + P+
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK- 169
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 109
W P L + D+WS G + E++ G+ G T E L ++
Sbjct: 170 -----WTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 28/110 (25%), Positives = 52/110 (47%), Gaps = 16/110 (14%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 55
Q+ G+ + + +HRD++ +N+LV+ + K+ADFGLA + G + P+
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 169
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVE 104
W P + G+ + D+WS G + E++ GK G + +
Sbjct: 170 -----WTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 21/150 (14%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPE 66
+E+ + +HRD+ N+LV+ + V K++DFGL +++ T ++ W P
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEA 170
Query: 67 LLLGATDYGPSVDLWSVGCVFAELL-IGK------PILQGRTEVEQLHKIFKLCGSPPDD 119
L + D+WS G + E+ G+ P+ VE+ +K+ G PP
Sbjct: 171 LR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV 228
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDL 149
Y + K D++ R +F L
Sbjct: 229 Y---------DVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 8/111 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+ G+ + SR +HRD+ N+LV V K+ADFGLA + +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170
Query: 63 RPPELLLGATDYGP---SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 109
PE A +YG D+WS G + E++ G+ G T E L ++
Sbjct: 171 TAPE----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 18/102 (17%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN----------------TGHR 50
+E+ HS+GVLHRD+K N+L+ G + + D+G A F
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 51 QPLTSRVV-TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
+ ++V T Y PE LLG S D++++G + ++L
Sbjct: 185 MTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 60
Q+ G+E SR +HRD+ N+L++ V+K+ DFGLA + + + + +R+
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAEL 90
W P + Y D+WS G + E+
Sbjct: 241 WMAPESIFDKV--YTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-----SNTGHRQPLTSRVVTLW 61
G+++ +HRD+ N+LVN+ V K++DFGL+ F S+ + L ++ W
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELL 91
P + + + D+WS G V E++
Sbjct: 178 TAPEAIAY--RKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 17/98 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNT-----GHRQPLTSR 56
QL+ L H ++H DIK N+L + + + L D+GL T G
Sbjct: 117 QLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG-------- 168
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
TL Y PE + G +Y S D W+VG + ELL GK
Sbjct: 169 --TLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTL 60
Q+ G+E+ S +H+D+ N+L+ + +K++D GL+ +S +R S +
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W P ++ G + D+WS G V E+
Sbjct: 192 WMPPEAIMYG--KFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 17/94 (18%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQPLTSRV 57
G+++ G +HRD+ N+LVN+ V K++DFGL A ++ G + P+
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR--- 174
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W P + + + D+WS G V E++
Sbjct: 175 ---WTAPEA--IAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 31/113 (27%), Positives = 50/113 (44%), Gaps = 22/113 (19%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 55
Q+ G+ + +HRD++ +N+LV+ K+ADFGLA + G + P+
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK- 168
Query: 56 RVVTLWYRPPELLLGATDYGP---SVDLWSVGCVFAELLI-GKPILQGRTEVE 104
W P A +YG D+WS G + E++ G+ G T E
Sbjct: 169 -----WTAPE-----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 3/108 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+ G+ + + +HRD+ N+LV + V K+ADFGLA ++ W
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT 171
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKI 109
P G + D+WS G + E+ G+ G E +I
Sbjct: 172 APEAASHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 14/42 (33%), Positives = 24/42 (57%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 44
Q+ +E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ L+ H G++ RD+ +N+L+++ G ++L F +S V Y
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEV--EDSCDGEAVENMY 148
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ 98
PE + G ++ + D WS+G + ELL GK +++
Sbjct: 149 CAPE-VGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 14/95 (14%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHRQPLTS 55
Q+ G+ S+ +HRD+ N+L+ + ++K+ DFGLA N+ G +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG-----NA 203
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 90
R+ W P + Y D+WS G + E+
Sbjct: 204 RLPVKWMAPESIFNCV--YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 16/93 (17%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL--------ANFSNTGHRQPLTSRVV 58
G+++ +HRD+ N+LVN+ V K++DFGL A ++ G + P+
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI----- 172
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W P + + + D+WS G V E++
Sbjct: 173 -RWTAPEAIAYRK--FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 54/226 (23%), Positives = 83/226 (36%), Gaps = 49/226 (21%)
Query: 4 LLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQ--------PLT 54
+L L++ H G +HR +K S++L++ +G + L+ GL +N S H Q P
Sbjct: 110 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKY 167
Query: 55 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK------PILQGRTEVEQLHK 108
S V W P L Y D++SVG EL G P Q E
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE------ 221
Query: 109 IFKLCGS----------PPDDYWKK----------SKLPHATLFKPQQPYDSSLRETFKD 148
KL G+ P ++ K + + +P +SS +
Sbjct: 222 --KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNG-ESSSHPYNRT 278
Query: 149 LPTTAVNLIETLLSVEPYKRATASAALASEYF-STKPYACDLSSLP 193
+ +E L P R +AS L +F K A + +LP
Sbjct: 279 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE--ALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 23/100 (23%), Positives = 45/100 (45%), Gaps = 17/100 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL---------ANFSNTGHRQ 51
+ + G+++ +HRD+ N+LVN+ K++DFGL ++ +G +
Sbjct: 113 LRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 52 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
P+ W P + + + D+WS G V E++
Sbjct: 173 PIR------WTAPEA--IAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 16/96 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGH------RQPLT 54
Q+ G+ + H RGV+H+DI N +++ E +K+ D L+ F H +P+
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 55 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 90
W L+ +Y + D+WS G + EL
Sbjct: 185 ------WMALESLV--NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 60
Q+ G+++ S +HRD+ N LV N +K+ADFG++ +G + R V
Sbjct: 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 196
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLI 92
W +LLG + + D+W+ G E+
Sbjct: 197 WMAWESILLG--KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 17/40 (42%), Positives = 25/40 (62%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
QL L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVV 58
M + G+E+ S+ +HRD+ N ++N + +ADFGL+ +S +RQ S++
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W L Y D+W+ G E++
Sbjct: 179 VKWLALES--LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTL 60
Q+ G+ + + ++HRD+ N+LV +K+ DFGLA + ++ +V
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W +L Y D+WS G EL+
Sbjct: 177 WMALESILHR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 26/106 (24%), Positives = 46/106 (43%), Gaps = 19/106 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---------SNTGHRQ 51
M+Q+ G+++ + +HRD+ N+L+ N+ K++DFGL+ + + +
Sbjct: 101 MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160
Query: 52 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI--GKP 95
PL WY P + + D+WS G E KP
Sbjct: 161 PLK------WYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQ 51
++Q+LH G+ + S+ +HRD+ N LV ++K+ DFG++ +S +R
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 52 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GK-PILQ-GRTEV 103
+ + W PPE ++ + D+WS G + E+ GK P Q TEV
Sbjct: 182 GGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVV 58
Q+ G++ S+ +HRD+ N+L+ + V K+ DFGLA N SN + +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG--NARLP 277
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGK 94
W P + Y D+WS G + E+ +GK
Sbjct: 278 VKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGK 312
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 13/96 (13%)
Query: 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQ-----PLTSRVV 58
L+ L++ HS+G +HR +K S++L++ +G + L+ + + G RQ S V
Sbjct: 111 LNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 59 TLWYRPPELL----LGATDYGPSVDLWSVGCVFAEL 90
L + PE+L G Y D++SVG EL
Sbjct: 171 NLPWLSPEVLQQNLQG---YNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 24/92 (26%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVV 58
M + G+E+ S+ +HRD+ N ++N + +ADFGL+ ++ +RQ +++
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAEL 90
W L Y D+WS G E+
Sbjct: 178 VKWIAIES--LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTL 60
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA + +V
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W +L Y D+WS G EL+
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 23/90 (25%), Positives = 48/90 (53%), Gaps = 2/90 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
Q+ G+ + S+ +HRD+ N LV ++K+ DFG++ + +T + + ++ +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELL 91
+ PPE ++ + D+WS+G V E+
Sbjct: 188 WMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 67/223 (30%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVT 59
M Q+L L+ HS G++HRD+K N++ + G K+ D G A V
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA-----------ADLRVG 309
Query: 60 LWYRPPELLLG-----------------------ATDYGPSV---------DLWSVGCVF 87
+ Y P E LL AT P + D++S G +F
Sbjct: 310 INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369
Query: 88 AELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY----WKKSKLPHATLFKPQQPYDSSLR 143
++ P L+ + + Q ++ K DY W+K P A+ LR
Sbjct: 370 LQMAF--PNLRSDSNLIQFNRQLKRN-----DYDLVAWRKLVEPRAS---------PDLR 413
Query: 144 ETFK--DLPTTA-VNLIETLLSVEPYKRATASAALASEYFSTK 183
F+ DL A L+++++ + +R +A AALA YF +
Sbjct: 414 RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDRE 456
|
Length = 566 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA------NFSNTGHRQPLTSR 56
Q+ G+ + S +HRD+ N LV V+K+ DFG++ ++ G R L R
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
+ PPE +L + D+WS G V E+
Sbjct: 190 -----WMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 22/87 (25%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN--FSNTGHRQPLTSRVVTLWYRP 64
G+E+ +R +HRD+ N ++ + + +ADFGL+ +S +RQ +++ W
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184
Query: 65 PELLLGATDYGPSVDLWSVGCVFAELL 91
L Y D+W+ G E+
Sbjct: 185 ES--LADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 13/112 (11%)
Query: 6 HGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLAN--FSNTGHRQPLTSRVV 58
LE H +HRD+ N LV+ +G V+K+ DFGLA + + +R+ +
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKI 109
W P LL G + D+WS G + E+L +G+ E L +
Sbjct: 177 VRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TL 60
Q+ G+++ S +HRD+ N LV +K+ADFG++ +G + R V
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 197
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W +LLG + + D+W+ G E+L
Sbjct: 198 WMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 8/93 (8%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-- 60
Q+ G+E S+ +HRD+ N+L+ ++K+ DFGLA + H S+ T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR--DIMHDSNYVSKGSTFLP 302
Query: 61 --WYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W P + Y D+WS G + E+
Sbjct: 303 VKWMAPESIF--DNLYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 10/96 (10%)
Query: 3 QLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 55
QLLH G+++ + +HRD+ N+LV V K+ADFGL+ ++ +
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-G 183
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
R+ W L + Y + D+WS G + E++
Sbjct: 184 RLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.95 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.94 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.94 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.94 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.93 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.93 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.93 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.93 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.93 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.93 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.93 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.93 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.93 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.93 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.92 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.92 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.92 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.92 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.92 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.92 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.92 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.92 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.92 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.91 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.91 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.91 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.91 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.91 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.91 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.91 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.9 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.9 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.9 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.9 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.9 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.9 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.9 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.9 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.9 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.9 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.9 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.89 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.89 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.89 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.89 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.89 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.88 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.88 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.88 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.88 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.88 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.87 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.87 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.87 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.87 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.87 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.86 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.86 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.82 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.82 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.81 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.8 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.8 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.79 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.79 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.78 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.77 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.75 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.74 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.72 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.72 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.71 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.71 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.67 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.66 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.64 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.64 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.63 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.63 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.62 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.59 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.54 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.36 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.35 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.24 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.22 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.18 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.13 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.1 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.61 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.52 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.52 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.44 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.38 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.34 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.33 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.27 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.14 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.96 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.87 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 97.85 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.64 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.48 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.45 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.13 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.73 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 96.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 96.3 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 94.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 94.52 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 94.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 93.81 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.72 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 93.25 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.12 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.86 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.81 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 92.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 92.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 91.95 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 91.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 91.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 90.98 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 90.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 90.8 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 90.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 90.33 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 90.27 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 89.59 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 88.62 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 87.72 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 87.45 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 86.91 | |
| PLN02236 | 344 | choline kinase | 86.45 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 86.01 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 85.69 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 85.22 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 83.25 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 82.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 81.58 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 81.46 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=419.75 Aligned_cols=216 Identities=72% Similarity=1.236 Sum_probs=210.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|+|||.||+|||.+||+|||||.+|||||++|.+||+|||+|+++.......+|..+.|+||+|||+|+|...|+.++|+
T Consensus 224 mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDl 303 (560)
T KOG0600|consen 224 MKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDL 303 (560)
T ss_pred HHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceee
Confidence 78999999999999999999999999999999999999999999998888889999999999999999999999999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+||||.||+.|+|+|+|.++++|+++|+++||.|.+++|+..++++...|++..+|.+.+.+.+..+++.+++||..|
T Consensus 304 WS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~l 383 (560)
T KOG0600|consen 304 WSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKL 383 (560)
T ss_pred hhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCCCChhHHHhhHHHHHHhhhcC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGG 216 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~p~~e~~~k~~~~~~r~~~~~ 216 (468)
|.+||.+|+||.++|+|+||.+.|++|+++.+|.|++++|+++|.+.+.++...+.
T Consensus 384 L~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~ 439 (560)
T KOG0600|consen 384 LSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGG 439 (560)
T ss_pred hccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhccccc
Confidence 99999999999999999999999999999999999999999999999888766543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=331.79 Aligned_cols=198 Identities=47% Similarity=0.841 Sum_probs=175.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|.|||.||+|||.+.|+|||||++|+|++..|.+||+|||+|+.++.. ..+++..+.|+||+|||+|+|...|+.++|+
T Consensus 183 ~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDM 261 (419)
T KOG0663|consen 183 MLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDM 261 (419)
T ss_pred HHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhh
Confidence 579999999999999999999999999999999999999999988754 4578899999999999999999999999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCc-cccCC-CCCCCCchhhhhcCC--CcHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFK-PQQPYDSSLRETFKD--LPTTAVNL 156 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~~~~~--~s~~l~dL 156 (468)
||+|||+.||++++|.|+|..+.+|+.+|+..+|.|.+..|+...... ...+. +..+| ..+...|.. +++...+|
T Consensus 262 WSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~py-n~lr~kF~~~~lse~g~~L 340 (419)
T KOG0663|consen 262 WSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPY-NNLRKKFGALSLSEQGFDL 340 (419)
T ss_pred hhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCc-hhhhhhccccccchhHHHH
Confidence 999999999999999999999999999999999999999999855443 32222 33333 355666655 45999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCCCChh
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKE 200 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~p~~e 200 (468)
|..+|.+||.+|+||.++|+|+||...|.++++..+|.+|...+
T Consensus 341 ln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 341 LNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred HHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 99999999999999999999999999999999999999987443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=314.57 Aligned_cols=194 Identities=44% Similarity=0.797 Sum_probs=169.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|.|+|.||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+.+.. ...+..+.|.||+|||++.|...|+..+||
T Consensus 107 ~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~-~~~~~~V~TRWYRAPELLfGsr~Yg~~VDm 185 (318)
T KOG0659|consen 107 MLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN-RIQTHQVVTRWYRAPELLFGSRQYGTGVDM 185 (318)
T ss_pred HHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC-cccccceeeeeccChHHhccchhcCCcchh
Confidence 4689999999999999999999999999999999999999999887654 344555899999999999999999999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhcc-CCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||+|||++||+.|.|.|+|.++.+|+..|+..+|.|.++.|+.. .++....+. +.|. ..+...|...+.++.|||.+
T Consensus 186 WavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~-~~P~-~~~~~lf~aas~d~ldLl~~ 263 (318)
T KOG0659|consen 186 WAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-QFPK-PPLNNLFPAASSDALDLLSK 263 (318)
T ss_pred hhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh-cCCC-CccccccccccHHHHHHHHh
Confidence 99999999999999999999999999999999999999999874 455544433 1111 12334788899999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPP 197 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~p 197 (468)
||.+||.+|+|+.|+|+|+||++.|.+++++.+|....
T Consensus 264 m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 264 MLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred hhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 99999999999999999999999999999888776543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=319.73 Aligned_cols=188 Identities=39% Similarity=0.675 Sum_probs=162.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCC-CCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
|+|||.||.|+|+.||+||||||.|||++.++.+||||||+|+..... ....++.++.|.||+|||+++....|+.++|
T Consensus 131 ~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiD 210 (359)
T KOG0660|consen 131 LYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAID 210 (359)
T ss_pred HHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhh
Confidence 589999999999999999999999999999999999999999877532 2345689999999999999999899999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCC--CCchhhhhcCCCcHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~~~s~~l~dLL 157 (468)
|||+||||+||++|++.|+|.+...|+..|...+|.|+++......-..+..+....+ -...+...|+..++.+.+||
T Consensus 211 iWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLl 290 (359)
T KOG0660|consen 211 IWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLL 290 (359)
T ss_pred hhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999988776544333222222111 12346788899999999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCCCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPYACD 188 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~ 188 (468)
++||.+||.+|+|++|+|.||||.....+.+
T Consensus 291 ekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 291 EKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 9999999999999999999999998655543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=326.66 Aligned_cols=181 Identities=41% Similarity=0.725 Sum_probs=166.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|+||++||+|+|.+|+.||||||+|||+..+..|||+|||+|+..... .++|.++.|.||+|||+|+....|+.++||
T Consensus 116 m~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~ 193 (538)
T KOG0661|consen 116 MYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDM 193 (538)
T ss_pred HHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC--CCcchhhhcccccchHHhhhccccCCchHH
Confidence 689999999999999999999999999999999999999999877643 688999999999999999999999999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhc-cCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|++|||++|+++-+|+|+|.++.+++.+|...+|.|..+.|.. ..+.....|....-....+..+++..+.++.+||.+
T Consensus 194 wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ 273 (538)
T KOG0661|consen 194 WAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIER 273 (538)
T ss_pred HHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHH
Confidence 9999999999999999999999999999999999999999986 556666666655555667888888999999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||.|||.+||||.++|+||||+..
T Consensus 274 ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 274 LLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HhcCCCccCccHHHHhcCcccccc
Confidence 999999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=306.54 Aligned_cols=181 Identities=35% Similarity=0.649 Sum_probs=156.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++|++.|+.|||+++||||||||+||||+.+|.+||||||+|+.+.. ....++.++.|.||+|||++.|...|+.++||
T Consensus 107 l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDi 185 (396)
T KOG0593|consen 107 LYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDI 185 (396)
T ss_pred HHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccc
Confidence 47999999999999999999999999999999999999999998773 33678899999999999999999999999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhc--cCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|++||++.||++|.+.|+|..+.+++..|.+.+|........- ........-.|...-...+...++.++..+.||+.
T Consensus 186 WAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k 265 (396)
T KOG0593|consen 186 WAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLK 265 (396)
T ss_pred hhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHH
Confidence 9999999999999999999999999999999999876442211 11111122234445556788899999999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccC
Q 012191 159 TLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+||..||.+|++.+++|.|+||..
T Consensus 266 ~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 266 KCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred HHhcCCccccccHHHHhcChHHHH
Confidence 999999999999999999999943
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.86 Aligned_cols=185 Identities=45% Similarity=0.806 Sum_probs=160.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|+||+.||+|||+++|+||||||.||||+.+|.+||+|||+|..+.-.. ..++..++|.||+|||+++|...|+..+||
T Consensus 126 m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDi 204 (323)
T KOG0594|consen 126 MRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDI 204 (323)
T ss_pred HHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcch
Confidence 6899999999999999999999999999999999999999998665332 346788999999999999999899999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhcc-CCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||+|||++||+++++.|+|..+.+++..|+..+|.|.+..|+.. .++.....-+...-...+...++...++..+|+.+
T Consensus 205 Ws~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~ 284 (323)
T KOG0594|consen 205 WSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSK 284 (323)
T ss_pred HhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHH
Confidence 99999999999999999999999999999999999999999873 34433322222222345566667777899999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
||+++|.+|+||..+|.||||...+..
T Consensus 285 ~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 285 LLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred HhccCcccCcCHHHHhcChhhcccccc
Confidence 999999999999999999999986543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=299.57 Aligned_cols=182 Identities=42% Similarity=0.686 Sum_probs=156.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
++||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+....+ .+..++..|..|+|||++.|...|+.++|
T Consensus 131 t~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~--epniSYicSRyYRaPELifga~~Yt~~ID 208 (364)
T KOG0658|consen 131 TYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSID 208 (364)
T ss_pred HHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC--CCceeEEEeccccCHHHHcCccccCceeE
Confidence 4799999999999999999999999999987 89999999999988766 44578889999999999999999999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||.|||++||+.|++.|+|.+..+|+..|++.+|.|..+....++.......-++..-.....-.....++++.+|+.+
T Consensus 209 iWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~ 288 (364)
T KOG0658|consen 209 IWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSK 288 (364)
T ss_pred EhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999887766554432222222211111122456789999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
+|.++|.+|.|+.|+|.||||....
T Consensus 289 ~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 289 LLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred HhccChhhcCCHHHHhcchhhHHhh
Confidence 9999999999999999999998753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=301.55 Aligned_cols=158 Identities=34% Similarity=0.532 Sum_probs=132.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC---CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC--CCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~--~~~s 75 (468)
++|||.||.|||++||+||||||+|||++.+ ..+||+|||+|++.+.. ..+...|||+.|.|||++.+. ..|.
T Consensus 282 f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~ 359 (475)
T KOG0615|consen 282 FKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYP 359 (475)
T ss_pred HHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccc--eehhhhcCCccccChhheecCCeeccc
Confidence 5899999999999999999999999999876 67999999999988643 567889999999999999643 3455
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHH-HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e-~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
.++||||+|||||.+|+|.+||.+..... ...+|.+.-...-. ..|..++++++
T Consensus 360 ~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p-------------------------~~w~~Iseea~ 414 (475)
T KOG0615|consen 360 SKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP-------------------------LQWDRISEEAL 414 (475)
T ss_pred chheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC-------------------------hhhhhhhHHHH
Confidence 68999999999999999999998765544 55555442222211 23457899999
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+||.+||.+||++|||+.|+|+||||+..|.
T Consensus 415 dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 415 DLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred HHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 9999999999999999999999999997654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=274.65 Aligned_cols=180 Identities=32% Similarity=0.511 Sum_probs=148.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC---CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
|+|||.||.|||.+||||||+||+|+|+... .-+||+|||+|.....+ .....++|||.|+|||++.. ..|+..
T Consensus 116 ~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g--~~~~G~~GtP~fmaPEvvrk-dpy~kp 192 (355)
T KOG0033|consen 116 IQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG--EAWHGFAGTPGYLSPEVLKK-DPYSKP 192 (355)
T ss_pred HHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc--cccccccCCCcccCHHHhhc-CCCCCc
Confidence 5899999999999999999999999999543 35999999999877733 55678899999999999976 579999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||+.|+|||.||.|.+||.+.+....++.|++.-...+..+| +.+++++++||
T Consensus 193 vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w-------------------------~~is~~Ak~Lv 247 (355)
T KOG0033|consen 193 VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW-------------------------DTVTPEAKSLI 247 (355)
T ss_pred chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc-------------------------CcCCHHHHHHH
Confidence 99999999999999999999999999999999875544444333 57899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCCCChhHHHhhHHHHHHhh
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 213 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~p~~e~~~k~~~~~~r~~ 213 (468)
++||..||.+|+|+.|+|+|||+.+..--. -...-+..++...+.+++|+-
T Consensus 248 rrML~~dP~kRIta~EAL~HpWi~~r~~~A-----s~~H~~dtvd~lrkfNarRKL 298 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKHPWICNRERVA-----SAIHRQDTVDCLKKFNARRKL 298 (355)
T ss_pred HHHhccChhhhccHHHHhCCchhcchHHHH-----HHhhhHHHHHHHHHhhHHHHH
Confidence 999999999999999999999998742110 112334456666666766653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.20 Aligned_cols=152 Identities=34% Similarity=0.515 Sum_probs=135.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|+||+.||.|||+++|+|||||..|||++++.+|||+|||+|..+.... ......||||.|+|||++.+ ...+..+||
T Consensus 124 l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k-~gHsfEvDi 201 (592)
T KOG0575|consen 124 LRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNK-SGHSFEVDI 201 (592)
T ss_pred HHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cccceecCCCcccChhHhcc-CCCCCchhh
Confidence 5899999999999999999999999999999999999999999887543 33456799999999999985 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+|||||.||+|+|||...+-.+.+.+|...-...| ..++.++++||.+|
T Consensus 202 WSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P-----------------------------~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 202 WSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP-----------------------------SHLSAEAKDLIRKL 252 (592)
T ss_pred hhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-----------------------------cccCHHHHHHHHHH
Confidence 9999999999999999999999999999865432222 26889999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||++++|.|+||++.
T Consensus 253 L~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred hcCCcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999999553
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=278.13 Aligned_cols=186 Identities=43% Similarity=0.781 Sum_probs=151.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC----CcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDY 74 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~----g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~ 74 (468)
|+|||.||.|||++-|+||||||.|||+..+ |.|||+|||+++.+...-.. .....+.|.||+|||+++|...|
T Consensus 138 lwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hY 217 (438)
T KOG0666|consen 138 LWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHY 217 (438)
T ss_pred HHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccc
Confidence 5799999999999999999999999999877 89999999999987754332 23456789999999999999999
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCc---------hHHHHHHHHHHcCCCCchhhhcc-CCCcc-ccCC-CC-CCCCc-
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRT---------EVEQLHKIFKLCGSPPDDYWKKS-KLPHA-TLFK-PQ-QPYDS- 140 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~---------~~e~l~~i~~~~g~p~~~~~~~~-~~~~~-~~~~-~~-~~~~~- 140 (468)
+.++|||++|||+.|||+-.|+|.|.. ..+++.+|++++|.|.+..|+.. +.|+. .... .. ..+..
T Consensus 218 T~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~ 297 (438)
T KOG0666|consen 218 TKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNV 297 (438)
T ss_pred cchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcc
Confidence 999999999999999999999998753 36789999999999999999874 34443 1111 01 11111
Q ss_pred hh---hhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 141 SL---RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 141 ~l---~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
+| ....+.-++.+.+||.+||++||.+|+|++++|+|+||+..+.+
T Consensus 298 sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 298 SLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred hHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 12 22334456669999999999999999999999999999998665
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=272.64 Aligned_cols=157 Identities=33% Similarity=0.496 Sum_probs=139.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC-----CCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-----ATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g-----~~~~s 75 (468)
|+||+.|++|||.++||||||||+|||++++..++|+|||+++.+.++ ..+...|||+.|+|||.+.. ...|+
T Consensus 129 MrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs 206 (411)
T KOG0599|consen 129 MRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYS 206 (411)
T ss_pred HHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCcc
Confidence 789999999999999999999999999999999999999999988776 46788899999999999853 45689
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
..+|+|++|+|+|.||.|.+||..+...-.+..|+..-.....+. |.+++...+|
T Consensus 207 ~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe-------------------------Wadis~~~Kd 261 (411)
T KOG0599|consen 207 KEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE-------------------------WADISATVKD 261 (411)
T ss_pred chhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc-------------------------hhhccccHHH
Confidence 999999999999999999999999888888888877544443333 4688999999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||.+||+.||.+|+|+.|+|.||||....
T Consensus 262 LIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 262 LISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred HHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 99999999999999999999999997643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=287.80 Aligned_cols=156 Identities=34% Similarity=0.582 Sum_probs=138.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC------------CccccccCCcccChhhhc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ------------PLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~------------~~~~~~gt~~Y~APE~l~ 69 (468)
-||+.||+|||++|||||||||+||||+.++.++|+|||.|..+.+.... ...+.+||..|.+||+|.
T Consensus 181 AeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~ 260 (604)
T KOG0592|consen 181 AEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN 260 (604)
T ss_pred HHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence 48999999999999999999999999999999999999999876643221 114579999999999997
Q ss_pred CCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCC
Q 012191 70 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149 (468)
Q Consensus 70 g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (468)
. ...+..+|||+||||||.|+.|.|||.+.++.-.+++|+++....+ +.+
T Consensus 261 ~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp-----------------------------~~f 310 (604)
T KOG0592|consen 261 D-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP-----------------------------EGF 310 (604)
T ss_pred C-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC-----------------------------CCC
Confidence 6 4678999999999999999999999999999999999998765444 357
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
++.+.+||.++|..||.+|+|+.+|-+||||....|..
T Consensus 311 p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 311 PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred CHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 89999999999999999999999999999999876653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=265.60 Aligned_cols=185 Identities=43% Similarity=0.810 Sum_probs=153.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCC---CCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG---HRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
|++|+.||.|+|...|+|||+|+.|+||+.+|.+||+|||+++.+... ....++.++.|+||++||+++|...|+++
T Consensus 130 Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~ 209 (376)
T KOG0669|consen 130 MKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPP 209 (376)
T ss_pred HHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCc
Confidence 678999999999999999999999999999999999999999755432 23346788999999999999999999999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccC--CC--CCCCCchhhhhcC--CCc
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLF--KP--QQPYDSSLRETFK--DLP 150 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~--~~--~~~~~~~l~~~~~--~~s 150 (468)
.|||..|||+.||+++.++|+|+++..+++.|..+||....+.|+... ++..... .| ...+ +.+....+ .-.
T Consensus 210 iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~-rkv~n~~kp~~kd 288 (376)
T KOG0669|consen 210 IDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQK-RKVKNRLKPYVKD 288 (376)
T ss_pred chhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchh-hhhhhhcccccCC
Confidence 999999999999999999999999999999999999999999998743 3222111 11 1111 11222222 125
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
+++.+||++||.+||.+|++++++|+|.||...|.+
T Consensus 289 ~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 289 DEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred hhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 679999999999999999999999999999987765
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=291.74 Aligned_cols=181 Identities=28% Similarity=0.568 Sum_probs=143.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCC--cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g--~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+|||.||.+||+.||||+||||+||||...+ .|||+|||.+++.... ...++.+..|+|||+++| ..|+.++|
T Consensus 296 ~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~----vytYiQSRfYRAPEVILG-lpY~~~ID 370 (586)
T KOG0667|consen 296 QQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR----VYTYIQSRFYRAPEVILG-LPYDTAID 370 (586)
T ss_pred HHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc----ceeeeeccccccchhhcc-CCCCCccc
Confidence 7999999999999999999999999997554 6999999999876642 337788999999999999 57999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC--------------------------
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK-------------------------- 133 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~-------------------------- 133 (468)
|||||||++||++|.|+|+|.++.+++..|++.+|.|+..+....+-.+..+-.
T Consensus 371 mWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~ 450 (586)
T KOG0667|consen 371 MWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYY 450 (586)
T ss_pred eeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhh
Confidence 999999999999999999999999999999999999987754432211100000
Q ss_pred ------CCCC-CCchhhhhcC-CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 134 ------PQQP-YDSSLRETFK-DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 134 ------~~~~-~~~~l~~~~~-~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
...+ -...+...+. .-...+.|||.+||.+||.+|+|+.++|+||||+......
T Consensus 451 ~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~~~ 512 (586)
T KOG0667|consen 451 RKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSLER 512 (586)
T ss_pred hhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccccccc
Confidence 0011 1122222222 2335579999999999999999999999999999765543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-33 Score=250.75 Aligned_cols=180 Identities=47% Similarity=0.832 Sum_probs=157.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|.|++.||.|||+++++||||||.|+||+.+|.+||+|||+++.++-.. ..+...+.|+||++|.++.|..-|+.+.|+
T Consensus 107 mlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcysaevvtlwyrppdvlfgakly~tsidm 185 (292)
T KOG0662|consen 107 MLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_pred HHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-EeeeceeeeeeccCcceeeeeehhccchHh
Confidence 5799999999999999999999999999999999999999998776532 233455789999999999999999999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhcc-CCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||.|||+.|+.. |.|.|+|.+..+++.+|+..+|.|.++.|+.. +++....+ |..+...++....+.+...-++|++
T Consensus 186 wsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y-p~ypattswsqivp~lns~grdllq 264 (292)
T KOG0662|consen 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY-PIYPATTSWSQIVPKLNSTGRDLLQ 264 (292)
T ss_pred hhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc-CCccccchHHHHhhhhcchhHHHHH
Confidence 999999999986 89999999999999999999999999999864 44433222 3334445667777888999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccC
Q 012191 159 TLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
++|.-+|..|++|+++|+||||..
T Consensus 265 kll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 265 KLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred HHhccCcccccCHHHHhcCccccc
Confidence 999999999999999999999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=270.47 Aligned_cols=178 Identities=43% Similarity=0.797 Sum_probs=145.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......+++.|+|||++.+...++.++||
T Consensus 109 ~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 187 (288)
T cd07871 109 MFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187 (288)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccccCceecccccChHHhcCCcccCcHHHH
Confidence 3699999999999999999999999999999999999999987543221 223445779999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCc--cccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH--ATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||+||++|+|++|.+||.+.+..+.+..+....+.++.+.|+...... .....+... ...+......++.++++||.
T Consensus 188 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dll~ 266 (288)
T cd07871 188 WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYR-AQPLINHAPRLDTDGIDLLS 266 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccC-CCchHHhCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999998887633211 111111111 11222344568899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccc
Q 012191 159 TLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+||++||.+|||+.|+|+||||
T Consensus 267 ~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 267 SLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HhcCcCcccCCCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=270.77 Aligned_cols=152 Identities=32% Similarity=0.500 Sum_probs=128.1
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+|||+||.|||+ ++||||||||+|||++..|.|||||||.+...... ...+.+||..|||||.+.+ ..|+.++||
T Consensus 185 ~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g-~~Ys~~sDI 260 (364)
T KOG0581|consen 185 RAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISG-ESYSVKSDI 260 (364)
T ss_pred HHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcC-CcCCcccce
Confidence 689999999996 99999999999999999999999999999766543 5578899999999999988 579999999
Q ss_pred eeeehhhhhhhhcCCCCCCC-----chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGR-----TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~-----~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
||||++++||.+|+.||... ...+++..| +..++... | . ..+++++++
T Consensus 261 WSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~~ppP~l----------------P------~--~~fS~ef~~ 313 (364)
T KOG0581|consen 261 WSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VDEPPPRL----------------P------E--GEFSPEFRS 313 (364)
T ss_pred ecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hcCCCCCC----------------C------c--ccCCHHHHH
Confidence 99999999999999999774 334444444 33222211 0 0 148999999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||..||+.||.+|+|+.|+|+|||++...
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999999999999999999999998754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=264.39 Aligned_cols=175 Identities=42% Similarity=0.749 Sum_probs=142.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++||
T Consensus 116 ~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 192 (290)
T cd07862 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDL 192 (290)
T ss_pred HHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhC-CCCCCccch
Confidence 369999999999999999999999999999999999999999765433 23345578999999999876 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+...++.+....|+.........+.... ...+....+.++..+.+||.+|
T Consensus 193 wslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~ 270 (290)
T cd07862 193 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKC 270 (290)
T ss_pred HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCC--CCCHHHHccCCCHHHHHHHHHH
Confidence 99999999999999999999999999999998888776666542211111111111 1233445567899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|+.||.+|||+.++|+||||
T Consensus 271 l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 271 LTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hccCchhcCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=275.94 Aligned_cols=152 Identities=34% Similarity=0.528 Sum_probs=133.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC-CCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~-~~s~~s 78 (468)
|+||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... .....+...+||+.|+|||++.+.. .-+.++
T Consensus 126 F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~a 204 (370)
T KOG0583|consen 126 FRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAA 204 (370)
T ss_pred HHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchh
Confidence 6899999999999999999999999999999 999999999998774 2335677889999999999998865 446899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCC-cHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL-PTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-s~~l~dLL 157 (468)
||||+|||||.|++|..||...+....+.+|.+.....+ ..+ ++++.+||
T Consensus 205 DvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p-----------------------------~~~~S~~~~~Li 255 (370)
T KOG0583|consen 205 DVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP-----------------------------SYLLSPEARSLI 255 (370)
T ss_pred hhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC-----------------------------CCcCCHHHHHHH
Confidence 999999999999999999999888888887655322211 124 89999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccC
Q 012191 158 ETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+||..||.+|+|+.+++.||||+.
T Consensus 256 ~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 256 EKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999997
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=283.67 Aligned_cols=181 Identities=38% Similarity=0.647 Sum_probs=143.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......++|+.|+|||++.+...|+.++||
T Consensus 177 ~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 254 (440)
T PTZ00036 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDL 254 (440)
T ss_pred HHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHH
Confidence 5999999999999999999999999998665 7999999999765433 223456789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcC-CCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK-DLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~s~~l~dLL~~ 159 (468)
||||||+|+|++|.+||.+.+..+++..+...++.+..+.+............+. .....+...++ ..+.++++||.+
T Consensus 255 wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~ 333 (440)
T PTZ00036 255 WSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQ 333 (440)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCc-cCchhHHHHhccCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999887766543321111100011 01112222232 478899999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
||.+||.+|||+.++|.||||.....
T Consensus 334 ~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 334 FLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HCCCChhHCcCHHHHhCChhHHhhhc
Confidence 99999999999999999999987543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.76 Aligned_cols=155 Identities=29% Similarity=0.495 Sum_probs=137.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|+||+.||.|||..+|+||||||+|+|++..+.|||+|||+|....++ ..+...||.+.|.+||++.|..+.+.++||
T Consensus 118 f~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDV 195 (786)
T KOG0588|consen 118 FRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDV 195 (786)
T ss_pred HHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--ccccccCCCcccCCchhhcCCCCCCCcccc
Confidence 589999999999999999999999999999999999999999866554 456778999999999999998878999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+|||||.||+|..||.+++-...+.++.......| ..++.++++||.+|
T Consensus 196 WSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP-----------------------------s~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 196 WSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP-----------------------------SNISSEAQDLLRRM 246 (786)
T ss_pred chhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC-----------------------------CcCCHHHHHHHHHH
Confidence 9999999999999999998888888887755332222 46899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
|.+||.+|+|.++++.|||+....-+
T Consensus 247 l~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred hccCccccccHHHHhhCchhhcCCCC
Confidence 99999999999999999999876543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=264.34 Aligned_cols=195 Identities=45% Similarity=0.793 Sum_probs=158.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.+...++.++||
T Consensus 114 ~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 192 (309)
T cd07845 114 MLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDM 192 (309)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CCCCcccccccccChhhhcCCCCcCchHHH
Confidence 4699999999999999999999999999999999999999987665332 223344568889999998776678899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|.+||.+.+..+.+..+...++.+....|+.... +....+.........+...+..+++.+.+||.+
T Consensus 193 wslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 272 (309)
T cd07845 193 WAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNF 272 (309)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHH
Confidence 9999999999999999999999999999999999888887765322 222222111111123344455678999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYP 196 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~ 196 (468)
||++||.+|||+.++|.||||...+.+|.+..+|.+|
T Consensus 273 ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 273 LLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred HhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 9999999999999999999999999999887777664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=259.95 Aligned_cols=179 Identities=37% Similarity=0.648 Sum_probs=139.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...............+++.|+|||++.+ ..++.++||
T Consensus 106 ~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 184 (287)
T cd07848 106 IYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDM 184 (287)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcC-CCCCCchhH
Confidence 4799999999999999999999999999999999999999997665433333345578999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCC---ccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP---HATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||++|+|++|.+||.+.+..+.+..+....+..+.+.+...... ....+................++.++.+||
T Consensus 185 wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll 264 (287)
T cd07848 185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLM 264 (287)
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHH
Confidence 99999999999999999998888888888887777766554421110 000000000001111222345789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccc
Q 012191 158 ETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.+||++||.+|||+.++|+||||
T Consensus 265 ~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 265 KNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=265.43 Aligned_cols=155 Identities=30% Similarity=0.482 Sum_probs=133.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
-+|+.||.|||+.|||||||||+|||++.+|.++|+|||++....... ......+||+.|||||++.+. .|+.++|.|
T Consensus 132 aEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t~tfcGT~eYmAPEil~~~-gy~~~vDWW 209 (357)
T KOG0598|consen 132 AEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DATRTFCGTPEYMAPEILLGK-GYDKAVDWW 209 (357)
T ss_pred HHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-CccccccCCccccChHHHhcC-CCCcccchH
Confidence 479999999999999999999999999999999999999997543322 334457999999999999984 799999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+||+|.+||.+.+......+|.+.-...+. ..++.++++||.++|
T Consensus 210 sLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p----------------------------~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 210 SLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP----------------------------GYLSEEARDLLKKLL 261 (357)
T ss_pred hHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC----------------------------ccCCHHHHHHHHHHh
Confidence 9999999999999999999999988888663211111 237899999999999
Q ss_pred CCCCCCCc----CHHHHHhcccccCCCCC
Q 012191 162 SVEPYKRA----TASAALASEYFSTKPYA 186 (468)
Q Consensus 162 ~~DP~kRp----Ta~e~L~Hp~F~~~p~~ 186 (468)
..||.+|. .+.++-.||||....|.
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 99999995 68999999999988774
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=264.83 Aligned_cols=180 Identities=39% Similarity=0.735 Sum_probs=136.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE----CCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDY 74 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl----d~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~ 74 (468)
+.||+.||.|||++||+||||||+|||+ +..+.+||+|||++........ .......+|+.|+|||++.+...+
T Consensus 114 ~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 193 (317)
T cd07868 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY 193 (317)
T ss_pred HHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCc
Confidence 4799999999999999999999999999 4557899999999976653321 123456789999999999876678
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCch---------HHHHHHHHHHcCCCCchhhhccCC-Ccccc----CC----CCC
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYWKKSKL-PHATL----FK----PQQ 136 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~~---------~e~l~~i~~~~g~p~~~~~~~~~~-~~~~~----~~----~~~ 136 (468)
+.++||||+||++|+|++|.+||.+... ..++..++..+|.+....|..... +.... +. ...
T Consensus 194 ~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (317)
T cd07868 194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 273 (317)
T ss_pred CchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcc
Confidence 9999999999999999999999976442 467788888889888777765321 11100 00 000
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 137 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 137 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.....+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 274 ~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 274 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11111112222346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=258.21 Aligned_cols=175 Identities=41% Similarity=0.768 Sum_probs=142.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...... .......+|..|+|||++.+ ..++.++||
T Consensus 114 ~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 190 (288)
T cd07863 114 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDM 190 (288)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc--ccCCCccccccccCchHhhC-CCCCCcchh
Confidence 469999999999999999999999999999999999999998765432 22344577999999999976 458999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+......+.++....+.+....|..........+.+.. ...+....+.++..+.+||.+|
T Consensus 191 wslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~ 268 (288)
T cd07863 191 WSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRG--PRPVQSVVPEIEESGAQLLLEM 268 (288)
T ss_pred hhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCC--CCchHHhCcCcCHHHHHHHHHH
Confidence 99999999999999999999988899999888888776666532111111111111 1234455567889999999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|++||.+|||+.++|.||||
T Consensus 269 L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 269 LTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=262.42 Aligned_cols=183 Identities=41% Similarity=0.735 Sum_probs=139.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+...++.++||
T Consensus 109 ~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 187 (303)
T cd07869 109 LFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187 (303)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHH
Confidence 4799999999999999999999999999999999999999986543221 223445789999999999876678899999
Q ss_pred eeeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCCchhhhhcC--CCcHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFK--DLPTTAVNL 156 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~--~~s~~l~dL 156 (468)
|||||++|+|++|.+||.+..+ .+.+..+....+.+....|..... +..............+...+. .++..+.+|
T Consensus 188 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 267 (303)
T cd07869 188 WGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDL 267 (303)
T ss_pred HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHH
Confidence 9999999999999999987544 466777777778887777754221 110000000001111222222 356789999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|.+||+.||.+|||+.++|+||||+..+
T Consensus 268 i~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 268 ASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred HHHHhccCchhccCHHHHhcCcccccCC
Confidence 9999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=269.12 Aligned_cols=183 Identities=33% Similarity=0.594 Sum_probs=141.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|..|+|||++.+ ..++.++||
T Consensus 132 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di 208 (364)
T cd07875 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDI 208 (364)
T ss_pred HHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC--CcccCCcccCCcCCHHHHhC-CCCCchhhH
Confidence 469999999999999999999999999999999999999999765432 22345578999999999976 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCC-------------chhhhhcC
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-------------SSLRETFK 147 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~l~~~~~ 147 (468)
|||||++|+|++|..||.+.+..+.+..+....+.+..+++................+. ........
T Consensus 209 wSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (364)
T cd07875 209 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288 (364)
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccc
Confidence 99999999999999999999999999999988888776665442211100000000000 00011122
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
..+..+++||.+||..||.+|||+.++|+||||..+..+
T Consensus 289 ~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred cccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 345789999999999999999999999999999864333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.59 Aligned_cols=179 Identities=40% Similarity=0.701 Sum_probs=143.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....++|+.|+|||++.+...++.++||
T Consensus 124 ~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 199 (343)
T cd07878 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDI 199 (343)
T ss_pred HHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC----CcCCccccccccCchHhcCCccCCchhhh
Confidence 46999999999999999999999999999999999999999876543 23455789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC--CCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|..||.+....+.+..+....+.+....+..........+.... .....+...+...++.+.+||.
T Consensus 200 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 279 (343)
T cd07878 200 WSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLE 279 (343)
T ss_pred HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHH
Confidence 99999999999999999999888888888888887776654432211111110000 0112234455667888999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..||.+|||+.++|.||||...
T Consensus 280 ~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 280 KMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHcCCChhhCCCHHHHhcCcchhcc
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=264.85 Aligned_cols=185 Identities=36% Similarity=0.619 Sum_probs=144.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC--CCCccccccCCcccChhhhcCC-CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGA-TDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~g~-~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......++|++|+|||++.+. ..++.+
T Consensus 109 ~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 188 (338)
T cd07859 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPA 188 (338)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCch
Confidence 4699999999999999999999999999999999999999987543221 1122456789999999998652 468899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCcccc-CC-CCCCCCchhhhhcCCCcHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL-FK-PQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~~~~~~s~~l~d 155 (468)
+|||||||++|+|++|++||.+.+...++..+....+.++...+.......... +. ........+...++.+++.+.+
T Consensus 189 ~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
T cd07859 189 IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALR 268 (338)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHH
Confidence 999999999999999999999999888888888888888766554322111000 00 0001112234456678899999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
||.+||..||.+|||+.++|+||||+....
T Consensus 269 li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 269 LLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=269.89 Aligned_cols=185 Identities=38% Similarity=0.620 Sum_probs=145.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..............++++.|+|||++.+...++.++||
T Consensus 109 ~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 188 (372)
T cd07853 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDI 188 (372)
T ss_pred HHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHH
Confidence 46999999999999999999999999999999999999999976554333344556789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCcc-ccC--CCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLF--KPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~-~~~--~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
||||||+|+|++|++||.+.+...++..+...+|.++...+........ ... ....+....+.......++++.+||
T Consensus 189 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 268 (372)
T cd07853 189 WSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLL 268 (372)
T ss_pred HhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999887654432110000 000 0000111111223345688999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
.+||++||.+|||+.++|.||||....+
T Consensus 269 ~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 269 CRMLVFDPDKRISAADALAHPYLDEGRL 296 (372)
T ss_pred HHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence 9999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=260.78 Aligned_cols=183 Identities=39% Similarity=0.743 Sum_probs=146.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+...++.++||
T Consensus 110 ~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 188 (309)
T cd07872 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188 (309)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cccccccccccccCCHHHhCCCCCCcHHHH
Confidence 3699999999999999999999999999999999999999987543322 122344678999999999776678899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCcc-ccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-TLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|.+||.+.+..+.+..++..++.+....|+....... ..+.........+......++.++++||.+
T Consensus 189 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 268 (309)
T cd07872 189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTK 268 (309)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999998888865332111 000000001112223445788999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||..||.+|||+.++|.||||+..+
T Consensus 269 ~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 269 FLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.22 Aligned_cols=153 Identities=29% Similarity=0.548 Sum_probs=133.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
+++|+||+|||.+||+|||||.+|||+..+|.+||+|||++..+..... .-...+||++|||||++.. ..|++++|||
T Consensus 376 re~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtr-k~YG~KVDIW 453 (550)
T KOG0578|consen 376 REILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTR-KPYGPKVDIW 453 (550)
T ss_pred HHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhhh-cccCccccch
Confidence 6789999999999999999999999999999999999999987765543 4456799999999999976 5799999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
|||+|+.||+-|.|||-..+....+..|.. .|.|... ....+++.+++||.+||
T Consensus 454 SLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk-------------------------~~~klS~~~kdFL~~cL 507 (550)
T KOG0578|consen 454 SLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK-------------------------NPEKLSPELKDFLDRCL 507 (550)
T ss_pred hhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC-------------------------CccccCHHHHHHHHHHh
Confidence 999999999999999998888877777754 3443321 12468999999999999
Q ss_pred CCCCCCCcCHHHHHhcccccC
Q 012191 162 SVEPYKRATASAALASEYFST 182 (468)
Q Consensus 162 ~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+.|+.+|++|.|||+||||..
T Consensus 508 ~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 508 VVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred hcchhcCCCHHHHhcChhhhh
Confidence 999999999999999999954
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=268.83 Aligned_cols=169 Identities=34% Similarity=0.516 Sum_probs=136.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCC----------------------CCC---------
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT----------------------GHR--------- 50 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~----------------------~~~--------- 50 (468)
-+++.||+.||+.|+|||||||+|+|||..|.+||+|||++.-+.. ...
T Consensus 248 aE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (550)
T KOG0605|consen 248 AETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRST 327 (550)
T ss_pred HHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccch
Confidence 4788999999999999999999999999999999999999842211 000
Q ss_pred ---------------CCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCC
Q 012191 51 ---------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115 (468)
Q Consensus 51 ---------------~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~ 115 (468)
....+.+|||-|+|||++++ ..|+..+|+||||||+||||.|.|||.+.+..+.+.+|+.--..
T Consensus 328 ~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~ 406 (550)
T KOG0605|consen 328 MSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET 406 (550)
T ss_pred hhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh
Confidence 01134589999999999998 45999999999999999999999999999999999999752100
Q ss_pred CCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcC---HHHHHhcccccCCCCCCCCCCC
Q 012191 116 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYACDLSSL 192 (468)
Q Consensus 116 p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~e~L~Hp~F~~~p~~~~~~~~ 192 (468)
...|. -..++.+++|||.+||. ||.+|.. +.||-.||||+...|..--...
T Consensus 407 --------l~fP~-----------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 407 --------LKFPE-----------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP 460 (550)
T ss_pred --------ccCCC-----------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence 11111 12467999999999999 9999975 9999999999999887655544
Q ss_pred CCCCC
Q 012191 193 PIYPP 197 (468)
Q Consensus 193 p~~~p 197 (468)
|.+.|
T Consensus 461 apfvP 465 (550)
T KOG0605|consen 461 APFVP 465 (550)
T ss_pred CCCCC
Confidence 55554
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.70 Aligned_cols=185 Identities=26% Similarity=0.437 Sum_probs=135.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..............+||+.|+|||++.+ ..|+.++||
T Consensus 188 ~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 266 (391)
T PHA03212 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDI 266 (391)
T ss_pred HHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHH
Confidence 3699999999999999999999999999999999999999986543322223345678999999999876 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCC-------chHHHHHHHHHHcCCCCchhhhccCCCccccC------CCCCCCCchhhhhcC
Q 012191 81 WSVGCVFAELLIGKPILQGR-------TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF------KPQQPYDSSLRETFK 147 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~-------~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~------~~~~~~~~~l~~~~~ 147 (468)
||||||+|+|++|..||.+. ....++..+....|.++.++...........+ ....+..........
T Consensus 267 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (391)
T PHA03212 267 WSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLY 346 (391)
T ss_pred HHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHh
Confidence 99999999999999877543 23456777777777766544211000000000 000011111112223
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
.++.++.+||.+||++||.+||||.|+|+||||...+.+
T Consensus 347 ~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 347 ELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 467889999999999999999999999999999886543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.14 Aligned_cols=182 Identities=26% Similarity=0.386 Sum_probs=137.4
Q ss_pred CHHHHHHHHHHHh-CCCeeccCCCCceEECCCC----------------cEEEEecCCccccCCCCCCCccccccCCccc
Q 012191 1 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEG----------------VLKLADFGLANFSNTGHRQPLTSRVVTLWYR 63 (468)
Q Consensus 1 m~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g----------------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~ 63 (468)
+.||+.||+|||+ .|||||||||+|||++.++ .+||+|||++.... ...+..+||+.|+
T Consensus 237 ~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~ 312 (467)
T PTZ00284 237 IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYR 312 (467)
T ss_pred HHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc----cccccccCCcccc
Confidence 4699999999998 5999999999999998765 49999999875432 2234568899999
Q ss_pred ChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccc-cCCCCC----CC
Q 012191 64 PPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT-LFKPQQ----PY 138 (468)
Q Consensus 64 APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~-~~~~~~----~~ 138 (468)
|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..+.+.+|.++..++..+...... .+.... .+
T Consensus 313 APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (467)
T PTZ00284 313 SPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCT 391 (467)
T ss_pred CcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccC
Confidence 9999987 46899999999999999999999999999999999999999998887665432211100 000000 00
Q ss_pred Cc-hhhhh-----c--CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 139 DS-SLRET-----F--KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 139 ~~-~l~~~-----~--~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
.. .+... + ....+.+.+||.+||++||.+|||+.|+|+||||......|
T Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~ 448 (467)
T PTZ00284 392 DPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPEC 448 (467)
T ss_pred CHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCcc
Confidence 00 00000 0 01246688999999999999999999999999998754433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=259.97 Aligned_cols=155 Identities=33% Similarity=0.481 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCC--CCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNT--GHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~--~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+|||+||.|||++||||+||||+|||++. ++.+||+|||++..... ..........||+.|||||++........++
T Consensus 124 r~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~s 203 (313)
T KOG0198|consen 124 RQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRES 203 (313)
T ss_pred HHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccc
Confidence 79999999999999999999999999999 79999999999876653 1112344678999999999998522233599
Q ss_pred ceeeeehhhhhhhhcCCCCCCC-chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~-~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++.||+||.+||... ...+.+..+......| .....++.++++||
T Consensus 204 DiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P---------------------------~ip~~ls~~a~~Fl 256 (313)
T KOG0198|consen 204 DIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP---------------------------EIPDSLSDEAKDFL 256 (313)
T ss_pred hhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC---------------------------CCCcccCHHHHHHH
Confidence 9999999999999999999873 3333333332111001 11245899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||..||.+||||.++|.|||....
T Consensus 257 ~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 257 RKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHhhcCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=255.14 Aligned_cols=180 Identities=36% Similarity=0.651 Sum_probs=148.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++|++.|+.|||+.||+||||||+||++..++.+||.|||+++..... -.++.+++|..|+|||++.+.. |...+||
T Consensus 124 ~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~-~ke~vdi 200 (369)
T KOG0665|consen 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMG-YKENVDI 200 (369)
T ss_pred HHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccC-Ccccchh
Confidence 479999999999999999999999999999999999999999765543 4678889999999999999865 9999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCC-chhhhhcC------------
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-SSLRETFK------------ 147 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~------------ 147 (468)
||+|||+.||++|...|.|.+..+++.++...+|.|.+.|........+..+.....|. ..+.+.|+
T Consensus 201 wSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~ 280 (369)
T KOG0665|consen 201 WSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSK 280 (369)
T ss_pred hhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCc
Confidence 99999999999999999999999999999999999999987664332222222111110 11222222
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.-+..+.+|+.+||..||++|+++.++|.||||+-|
T Consensus 281 ~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 281 LDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred cchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 224558999999999999999999999999999944
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=264.39 Aligned_cols=181 Identities=35% Similarity=0.635 Sum_probs=139.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++||
T Consensus 129 ~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di 205 (359)
T cd07876 129 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILG-MGYKENVDI 205 (359)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC--ccCCCCcccCCCCCchhccC-CCCCcchhh
Confidence 369999999999999999999999999999999999999998754332 22345678999999999976 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccC--CC---CCCCCc--------hhhhhcC
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KP---QQPYDS--------SLRETFK 147 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~--~~---~~~~~~--------~l~~~~~ 147 (468)
|||||++|+|++|..||.+.+....+..+...++.+...++........... .+ ...+.. .......
T Consensus 206 wSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (359)
T cd07876 206 WSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDK 285 (359)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccccccccc
Confidence 9999999999999999999998888888888888877665433110000000 00 000000 0011112
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
..+..+++||.+||.+||.+|||+.|+|+||||..+.
T Consensus 286 ~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 286 LKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred ccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 3567899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=256.17 Aligned_cols=177 Identities=28% Similarity=0.497 Sum_probs=135.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC--------------------CCcEEEEecCCccccCCCCCCCccccccCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN--------------------EGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~--------------------~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~ 61 (468)
+||+.+|+|||+.+++|.||||+|||+.+ +..|+|+|||.|++..... ...+.|..
T Consensus 199 ~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRH 274 (415)
T KOG0671|consen 199 YQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRH 274 (415)
T ss_pred HHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccc
Confidence 69999999999999999999999999832 2348999999998765432 55677999
Q ss_pred ccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhcc---------CCCccccC
Q 012191 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS---------KLPHATLF 132 (468)
Q Consensus 62 Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~---------~~~~~~~~ 132 (468)
|+|||+++| ..|+..+||||+||||+||++|..+|++.++.+.+..+...+|++|....... ++......
T Consensus 275 YRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~ 353 (415)
T KOG0671|consen 275 YRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVS 353 (415)
T ss_pred cCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccc
Confidence 999999998 56999999999999999999999999999999999989899998776543322 11110000
Q ss_pred CCC-----CCCCchhhhhcC---CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 133 KPQ-----QPYDSSLRETFK---DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 133 ~~~-----~~~~~~l~~~~~---~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
... ......+..... .....+.|||++||.+||.+|+|+.|||.||||..-
T Consensus 354 ~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 354 SKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred ccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 000 000001111111 123458999999999999999999999999999863
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=262.23 Aligned_cols=181 Identities=34% Similarity=0.606 Sum_probs=139.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++||
T Consensus 125 ~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di 201 (355)
T cd07874 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDI 201 (355)
T ss_pred HHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc--cccCCccccCCccCHHHHcC-CCCCchhhH
Confidence 369999999999999999999999999999999999999999765432 22345678999999999976 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC---------C----chhhhhcC
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY---------D----SSLRETFK 147 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~---------~----~~l~~~~~ 147 (468)
|||||++|+|++|..||.+....+.+..+...++.+..+++................+ . ........
T Consensus 202 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (355)
T cd07874 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281 (355)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccccccccc
Confidence 9999999999999999999998888888888888776665543221100000000000 0 00011122
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
..+..+++||.+||..||.+|||+.|+|+||||...-
T Consensus 282 ~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 282 LKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred ccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 3567889999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=257.11 Aligned_cols=180 Identities=38% Similarity=0.694 Sum_probs=134.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE----CCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDY 74 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl----d~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~ 74 (468)
+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++........ .......+|+.|+|||++.+...+
T Consensus 114 ~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 193 (317)
T cd07867 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY 193 (317)
T ss_pred HHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCcc
Confidence 3699999999999999999999999999 4567899999999976653321 123345779999999999876668
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCch---------HHHHHHHHHHcCCCCchhhhccCCC-cc----ccCCCC----C
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYWKKSKLP-HA----TLFKPQ----Q 136 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~~---------~e~l~~i~~~~g~p~~~~~~~~~~~-~~----~~~~~~----~ 136 (468)
+.++|||||||++|+|++|.+||.+..+ ..++..++..++.+....|...... .. ..+... .
T Consensus 194 ~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (317)
T cd07867 194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANS 273 (317)
T ss_pred CcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCc
Confidence 9999999999999999999999976432 4567778888888887777653211 00 000000 0
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 137 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 137 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.....+.......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 274 SLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00001111112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=248.25 Aligned_cols=184 Identities=39% Similarity=0.646 Sum_probs=151.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++|||.||.|||+.||+||||||.|+|++.+..+||||||+++.........++..+.|.+|+|||++.|...|+.++||
T Consensus 162 lYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDi 241 (449)
T KOG0664|consen 162 VYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDI 241 (449)
T ss_pred HHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccce
Confidence 48999999999999999999999999999999999999999998877766778888999999999999999999999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhcc-CCCccccCCCCCCCCchhhhhcC-----CCcHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFK-----DLPTTAV 154 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~-----~~s~~l~ 154 (468)
||+|||+.|||..+.+|+.....+++..|..++|.|..+..... .-...-.++. .+...++...+. .-..+..
T Consensus 242 WSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~-~~k~Ps~~vLYtlsS~~~~~heav 320 (449)
T KOG0664|consen 242 WSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRA-GLRAPDTQRLYKIASPDDKNHEAV 320 (449)
T ss_pred ehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhcc-CCCCCCccceeeecCCcccchHHH
Confidence 99999999999999999999999999999999999988765532 1111111111 111111111111 2345688
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+++..||.+||.+|++.+++|.|+|.....+
T Consensus 321 ~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 321 DLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HHHHHHhCCCCcccccHhhhcccccccccce
Confidence 9999999999999999999999999876543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=249.56 Aligned_cols=179 Identities=43% Similarity=0.729 Sum_probs=141.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+...++.++||
T Consensus 105 ~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 183 (284)
T cd07839 105 MFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 183 (284)
T ss_pred HHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHH
Confidence 3699999999999999999999999999999999999999987554322 223345678999999999876668899999
Q ss_pred eeeehhhhhhhhcCCC-CCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~p-f~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|..| |.+.+..+.+..+++.++.+....|............+..+....+....+.++.++.+||.+
T Consensus 184 wslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 263 (284)
T cd07839 184 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQN 263 (284)
T ss_pred HHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHH
Confidence 9999999999998766 567777788888888888887776654221111111112222223344556789999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||..||.+|||+.++|.||||
T Consensus 264 ~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 264 LLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HhcCChhhcCCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=246.81 Aligned_cols=157 Identities=30% Similarity=0.454 Sum_probs=129.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
|+||..||.|||+.+|.||||||+|+|... +..+||+|||+|+..... ..+...+.|++|.|||++ |...|+..
T Consensus 167 ~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevl-g~eKydks 243 (400)
T KOG0604|consen 167 MKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVL-GPEKYDKS 243 (400)
T ss_pred HHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC--ccccCCcccccccCHHHh-CchhcCCC
Confidence 589999999999999999999999999965 457999999999765432 456667889999999988 44679999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCch----HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~----~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
+|+||+|||+|.||||.|||..... ...-.+|......+|++.| ..+|+++
T Consensus 244 cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW-------------------------s~VSe~a 298 (400)
T KOG0604|consen 244 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW-------------------------SCVSEAA 298 (400)
T ss_pred CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH-------------------------hHHHHHH
Confidence 9999999999999999999976543 2234445444444444444 4689999
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 154 VNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+++|+.||..+|.+|.|+.+++.|||++....
T Consensus 299 KdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 299 KDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 99999999999999999999999999987543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=249.87 Aligned_cols=177 Identities=44% Similarity=0.801 Sum_probs=141.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++....... .......+++.|+|||.+.+...++.++||
T Consensus 107 ~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 185 (285)
T cd07861 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDI 185 (285)
T ss_pred HHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHH
Confidence 4799999999999999999999999999999999999999987554321 222344668899999998776667889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC--CCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+.+....+..++...+.+....|........ +.... .....+......++.++.+||.
T Consensus 186 ~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 263 (285)
T cd07861 186 WSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD--YKNTFPKWKKGSLRSAVKNLDEDGLDLLE 263 (285)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH--HHhhccccCcchhHHhcCCCCHHHHHHHH
Confidence 9999999999999999999988888888888888887777754221111 11100 0111223344568999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccc
Q 012191 159 TLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+||..||.+|||+.++|.||||
T Consensus 264 ~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 264 KMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhcCChhhCCCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=251.84 Aligned_cols=180 Identities=42% Similarity=0.756 Sum_probs=143.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||+.||+|+||||+|||++.++.++|+|||++....... .......+++.|+|||++.+...++.++|||
T Consensus 111 ~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~ 189 (301)
T cd07873 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQIDMW 189 (301)
T ss_pred HHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-CcccccceeecccCcHHHhCCCCCccHHHHH
Confidence 689999999999999999999999999999999999999986543221 1223446688999999988766788899999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCC-ccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++|.+||.+.+..+++..+....+.+....|...... ....+.........+......++..+.+||.+|
T Consensus 190 slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 269 (301)
T cd07873 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKL 269 (301)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHH
Confidence 9999999999999999999988899999998888888877643111 000011000111222334457889999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|+.||.+|||+.++|+||||..
T Consensus 270 l~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 270 LQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred hcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=255.61 Aligned_cols=153 Identities=26% Similarity=0.433 Sum_probs=126.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++|||
T Consensus 102 ~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 179 (323)
T cd05571 102 AEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDWW 179 (323)
T ss_pred HHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCccccChhhhcC-CCCCccccCc
Confidence 699999999999999999999999999999999999999986532211 22344578999999999976 4689999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|..||.+.+.......+...... ....++.++.+||.+||
T Consensus 180 SlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----------------------------~p~~~~~~~~~li~~~L 230 (323)
T cd05571 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-----------------------------FPRTLSPEAKSLLAGLL 230 (323)
T ss_pred ccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCHHHHHHHHHHc
Confidence 9999999999999999887766655554321100 01347889999999999
Q ss_pred CCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 162 SVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 162 ~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
..||.+|| ++.++|+||||....|
T Consensus 231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 231 KKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred cCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999999 8999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=248.17 Aligned_cols=151 Identities=26% Similarity=0.425 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
-||+.||+|||+++|++|||||+|||||.+|.+||+|||+|..... .....|||+.|+|||++.. ..|+.++|.|
T Consensus 151 AeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----rT~TlCGTPeYLAPEii~s-k~ynkavDWW 225 (355)
T KOG0616|consen 151 AEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----RTWTLCGTPEYLAPEIIQS-KGYNKAVDWW 225 (355)
T ss_pred HHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----cEEEecCCccccChHHhhc-CCCCcchhHH
Confidence 4899999999999999999999999999999999999999987764 2456799999999999976 6799999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
+|||++|||+.|.+||...+....+++|...--..| ..++.++++||.++|
T Consensus 226 alGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP-----------------------------~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 226 ALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP-----------------------------SYFSSDAKDLLKKLL 276 (355)
T ss_pred HHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC-----------------------------cccCHHHHHHHHHHH
Confidence 999999999999999999999999999977433332 257899999999999
Q ss_pred CCCCCCCc-----CHHHHHhcccccCCCCC
Q 012191 162 SVEPYKRA-----TASAALASEYFSTKPYA 186 (468)
Q Consensus 162 ~~DP~kRp-----Ta~e~L~Hp~F~~~p~~ 186 (468)
+.|-.+|. ...++..||||+...|.
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccccHH
Confidence 99999993 46799999999987764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=256.16 Aligned_cols=160 Identities=28% Similarity=0.387 Sum_probs=124.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...........+||+.|+|||++.+...++.++||
T Consensus 111 ~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 190 (332)
T cd05614 111 SGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDW 190 (332)
T ss_pred HHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCcccc
Confidence 36999999999999999999999999999999999999999876544333333456789999999999875567889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|+|++|..||...........+......... .....++..+.+||.+|
T Consensus 191 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~ 245 (332)
T cd05614 191 WSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-------------------------PFPSFIGPEAQDLLHKL 245 (332)
T ss_pred ccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC-------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999999999999754322111111111000000 01134788899999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|| ++.++|+||||+...|
T Consensus 246 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 246 LRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred cCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999 8899999999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=246.05 Aligned_cols=181 Identities=41% Similarity=0.781 Sum_probs=145.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.||+|+||||+||+++.++.++|+|||++...............++.+|+|||.+.+...++.++||
T Consensus 105 ~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 184 (286)
T cd07832 105 MRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDL 184 (286)
T ss_pred HHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHH
Confidence 46899999999999999999999999999999999999999876654332233455789999999998766667899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||+||++|+|++|.++|.+.++...+..+...++.+....|+.... ...............+...++..+..+.+||.+
T Consensus 185 ~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 264 (286)
T cd07832 185 WAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKG 264 (286)
T ss_pred HHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHH
Confidence 9999999999999999999999999999998888887766654221 111111111111223455667788999999999
Q ss_pred hcCCCCCCCcCHHHHHhccccc
Q 012191 160 LLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
||..||.+|||+.++|.||||.
T Consensus 265 ~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 265 LLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HhccChhhCCCHHHHhhCcCcC
Confidence 9999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=250.06 Aligned_cols=156 Identities=25% Similarity=0.447 Sum_probs=126.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||+.||+||||||+|||++.++.++|+|||++...... .......||..|+|||++.+ ..++.++|||
T Consensus 109 ~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvw 185 (285)
T cd05631 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRVGTVGYMAPEVINN-EKYTFSPDWW 185 (285)
T ss_pred HHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--CeecCCCCCCCccCHhhhcC-CCCCcccCch
Confidence 68999999999999999999999999999999999999999765432 22345578999999999976 4689999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|.+||.+.........+...+..... .....++..+.+||.+||
T Consensus 186 slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~l 240 (285)
T cd05631 186 GLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE-------------------------EYSEKFSEDAKSICRMLL 240 (285)
T ss_pred hHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc-------------------------cCCccCCHHHHHHHHHHh
Confidence 9999999999999999887654433333322211111 111357889999999999
Q ss_pred CCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 162 SVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 162 ~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
+.||.+||| ++++++||||....+
T Consensus 241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 241 TKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred hcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 999999997 999999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=252.82 Aligned_cols=160 Identities=26% Similarity=0.391 Sum_probs=129.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC-----CCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-----ATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g-----~~~~s 75 (468)
+.||+.||.|||+.||+||||||+|||++.++.+||+|||++...............+|+.|+|||++.. ...++
T Consensus 108 ~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 187 (330)
T cd05601 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187 (330)
T ss_pred HHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCC
Confidence 3699999999999999999999999999999999999999997665433222334578999999999863 34578
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++||||||||+|+|++|..||.+.+....+..+........ ......++..+.+
T Consensus 188 ~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~ 242 (330)
T cd05601 188 VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK-------------------------FPEDPKVSSDFLD 242 (330)
T ss_pred CcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC-------------------------CCCCCCCCHHHHH
Confidence 899999999999999999999998887777666644211000 0011357889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
||.+||. ||.+|||+.+++.||||....|.
T Consensus 243 li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 243 LIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred HHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 9999998 99999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=258.49 Aligned_cols=159 Identities=38% Similarity=0.569 Sum_probs=137.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC----CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~----g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
++||+.|+.|||+.||+||||||+|||+... +.+|++|||++.+... .......+||+.|+|||++.. ..|+.
T Consensus 141 ~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~-~~y~~ 217 (382)
T KOG0032|consen 141 IRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGG-RPYGD 217 (382)
T ss_pred HHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcC-CCCCc
Confidence 4799999999999999999999999999543 4799999999988776 356778899999999999975 57999
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
.+||||+||++|.|++|.+||.+.+.......|...-..... +.|..++..+++|
T Consensus 218 ~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~-------------------------~~w~~is~~akd~ 272 (382)
T KOG0032|consen 218 EVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS-------------------------EPWDDISESAKDF 272 (382)
T ss_pred ccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC-------------------------CCccccCHHHHHH
Confidence 999999999999999999999999998888877654333333 3346789999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
|..||..||.+|+|+.++|+|||++.....+
T Consensus 273 i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred HHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 9999999999999999999999998764443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=249.19 Aligned_cols=152 Identities=31% Similarity=0.459 Sum_probs=125.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 99 ~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 176 (312)
T cd05585 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLG-HGYTKAVDW 176 (312)
T ss_pred HHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcC-CCCCCccce
Confidence 3699999999999999999999999999999999999999987543221 22344578999999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+..... .....++..+.+||.+|
T Consensus 177 wslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~ 227 (312)
T cd05585 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-----------------------------RFPDGFDRDAKDLLIGL 227 (312)
T ss_pred echhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----------------------------CCCCcCCHHHHHHHHHH
Confidence 9999999999999999998777666655532110 01135778899999999
Q ss_pred cCCCCCCCc---CHHHHHhcccccCC
Q 012191 161 LSVEPYKRA---TASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRp---Ta~e~L~Hp~F~~~ 183 (468)
|..||.+|| ++.++|.||||...
T Consensus 228 L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 228 LSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred cCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 999999997 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=257.03 Aligned_cols=156 Identities=30% Similarity=0.463 Sum_probs=132.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC----CCCccccccCCcccChhhhcC---CCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH----RQPLTSRVVTLWYRPPELLLG---ATD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~~~gt~~Y~APE~l~g---~~~ 73 (468)
++.++.||+|||.+|||||||||+|+||+.+|++||+|||.+..+..+. ...+...+||+.|+|||++.+ ...
T Consensus 216 lrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~ 295 (576)
T KOG0585|consen 216 LRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSY 295 (576)
T ss_pred HHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccc
Confidence 4678999999999999999999999999999999999999998663221 122344699999999999977 334
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
.+.+.||||+||+||.|+.|+.||.+....+.+.+|...-...| ..+++.+.+
T Consensus 296 ~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP---------------------------~~pe~~e~~ 348 (576)
T KOG0585|consen 296 SGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFP---------------------------ENPEINEDL 348 (576)
T ss_pred cchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCC---------------------------CcccccHHH
Confidence 57899999999999999999999999999999999976322221 123578899
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 154 VNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+|||.+||..||.+|+|+.++..|||....
T Consensus 349 kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 349 KDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHHhhcChhheeehhhheecceeccC
Confidence 999999999999999999999999999864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=242.18 Aligned_cols=177 Identities=38% Similarity=0.683 Sum_probs=139.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++. +.+||+|||++...... .......++..|+|||.+.+...++.++||
T Consensus 106 ~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 182 (282)
T cd07831 106 MYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYTEYISTRWYRAPECLLTDGYYGPKMDI 182 (282)
T ss_pred HHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcCCCCCCcccCChhHhhcCCCCCcchhH
Confidence 368999999999999999999999999999 99999999998765432 223345678999999987655567889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+....+.+...............+.........+......++..+.+||.+|
T Consensus 183 ~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (282)
T cd07831 183 WAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKL 262 (282)
T ss_pred HHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHH
Confidence 99999999999999999999988888888888887776543322211111111111112233444567899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|..||.+|||+.++|.||||
T Consensus 263 l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 263 LAYDPDERITAKQALRHPYF 282 (282)
T ss_pred hccCcccccCHHHHhhCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=251.77 Aligned_cols=159 Identities=33% Similarity=0.505 Sum_probs=129.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC----------------------------CCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH----------------------------RQP 52 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~----------------------------~~~ 52 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 107 ~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (350)
T cd05573 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186 (350)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccccccccc
Confidence 4699999999999999999999999999999999999999987654432 112
Q ss_pred ccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccC
Q 012191 53 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 132 (468)
Q Consensus 53 ~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 132 (468)
.....||+.|+|||++.+. .++.++||||||||||+|++|..||.+.+.......+........ +
T Consensus 187 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------~------ 251 (350)
T cd05573 187 ANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLR--------F------ 251 (350)
T ss_pred ccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCccc--------C------
Confidence 3345789999999999874 689999999999999999999999998887776666644111110 0
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcC-HHHHHhcccccCCCCC
Q 012191 133 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT-ASAALASEYFSTKPYA 186 (468)
Q Consensus 133 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT-a~e~L~Hp~F~~~p~~ 186 (468)
.....+++.+.+||.+||. ||.+|++ +.++|.||||....|.
T Consensus 252 -----------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 252 -----------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred -----------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence 0012378999999999997 9999999 9999999999876553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=251.70 Aligned_cols=155 Identities=26% Similarity=0.384 Sum_probs=126.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......+||+.|+|||++.+...++.++||
T Consensus 102 ~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv 180 (330)
T cd05586 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180 (330)
T ss_pred HHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccce
Confidence 4699999999999999999999999999999999999999986533221 223455789999999999876668999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+.+..+.......+ ...++.++.+||.+|
T Consensus 181 wslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~~~~li~~~ 232 (330)
T cd05586 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP----------------------------KNVLSDEGRQFVKGL 232 (330)
T ss_pred eccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CccCCHHHHHHHHHH
Confidence 9999999999999999988776666555532110000 023678899999999
Q ss_pred cCCCCCCCc----CHHHHHhcccccCCC
Q 012191 161 LSVEPYKRA----TASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRp----Ta~e~L~Hp~F~~~p 184 (468)
|..||.+|| ++.++++||||....
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 999999998 799999999998644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=244.68 Aligned_cols=180 Identities=48% Similarity=0.887 Sum_probs=143.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC----------CCccccccCCcccChhhhcC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR----------QPLTSRVVTLWYRPPELLLG 70 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~----------~~~~~~~gt~~Y~APE~l~g 70 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ ...+...+++.|+|||.+.+
T Consensus 121 ~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (311)
T cd07866 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200 (311)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC
Confidence 46999999999999999999999999999999999999999875443211 11233466888999999877
Q ss_pred CCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhcCCC
Q 012191 71 ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDL 149 (468)
Q Consensus 71 ~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~ 149 (468)
...++.++||||||||+|+|++|.+||.+.+.......+...++.+....|.... ++..............+...+..+
T Consensus 201 ~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (311)
T cd07866 201 ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKL 280 (311)
T ss_pred CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccC
Confidence 5668899999999999999999999999999999999999988888776665422 121111111122233455566778
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
...+.+||.+||..||.+|||+.++|.||||
T Consensus 281 ~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 281 GPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=251.38 Aligned_cols=164 Identities=27% Similarity=0.426 Sum_probs=130.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhh-cCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELL-LGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l-~g~~~~s~ 76 (468)
++++|.||.|||.+|.||||||+.||||+.+|.|||+|||..-.+..... ..+...+||++|+|||++ .....|+.
T Consensus 132 Lre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdf 211 (516)
T KOG0582|consen 132 LREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDF 211 (516)
T ss_pred HHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccc
Confidence 47899999999999999999999999999999999999998754443321 112456899999999994 44567999
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++||||||++..||.+|..||........+.. ++.+.||..... ..-.+....++..++.+
T Consensus 212 KaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn~pp~~~t~-----------------~~~~d~~k~~~ksf~e~ 272 (516)
T KOG0582|consen 212 KADIWSFGITACELAHGHAPFSKYPPMKVLLL--TLQNDPPTLLTS-----------------GLDKDEDKKFSKSFREM 272 (516)
T ss_pred hhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--HhcCCCCCcccc-----------------cCChHHhhhhcHHHHHH
Confidence 99999999999999999999988777665543 344555422100 00022335677899999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||..||.+||||+++|.|+||+..
T Consensus 273 i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 273 IALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 999999999999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=250.68 Aligned_cols=150 Identities=27% Similarity=0.399 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||
T Consensus 125 ~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 199 (329)
T PTZ00263 125 AELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQS-KGHGKAVDWW 199 (329)
T ss_pred HHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----cceecCChhhcCHHHHcC-CCCCCcceee
Confidence 68999999999999999999999999999999999999999765432 234578999999999976 4578999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|.+||.+.+....+..+... .+. ....++..+.+||.+||
T Consensus 200 slG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~---------------------------~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 200 TMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLK---------------------------FPNWFDGRARDLVKGLL 250 (329)
T ss_pred chHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcC---------------------------CCCCCCHHHHHHHHHHh
Confidence 9999999999999999988776666665431 110 00236788999999999
Q ss_pred CCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 162 SVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 162 ~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
+.||.+|++ +.+++.||||....|
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 999999997 799999999987544
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=253.94 Aligned_cols=160 Identities=28% Similarity=0.428 Sum_probs=130.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC---CCCCCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA---TDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~---~~~s~~s 78 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++..............+||+.|+|||++.+. ..++.++
T Consensus 149 ~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 228 (370)
T cd05596 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228 (370)
T ss_pred HHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCce
Confidence 6899999999999999999999999999999999999999976554322233456789999999998653 2478899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+.+....+..+........ + .....++.++.+||.
T Consensus 229 DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------~-----~~~~~~s~~~~~li~ 283 (370)
T cd05596 229 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT--------------------F-----PDDIEISKQAKDLIC 283 (370)
T ss_pred eeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC--------------------C-----CCcCCCCHHHHHHHH
Confidence 999999999999999999999887777766654211110 0 011247899999999
Q ss_pred HhcCCCCCC--CcCHHHHHhcccccCCCCC
Q 012191 159 TLLSVEPYK--RATASAALASEYFSTKPYA 186 (468)
Q Consensus 159 ~mL~~DP~k--RpTa~e~L~Hp~F~~~p~~ 186 (468)
+||..+|.+ |+|+.++|+||||+...|.
T Consensus 284 ~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 284 AFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 999999988 9999999999999986553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=243.06 Aligned_cols=185 Identities=45% Similarity=0.794 Sum_probs=147.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....... .......+++.|+|||.+.+...++.++||
T Consensus 108 ~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 186 (298)
T cd07841 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDM 186 (298)
T ss_pred HHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-ccccccccceeeeCHHHHhCCCCCCcHHHH
Confidence 3699999999999999999999999999999999999999987654332 222334567889999998765668899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|.++|.+....+.+.+++..++.+....|.... ......+ .......+...+..++..+.+||.+
T Consensus 187 ~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~ 264 (298)
T cd07841 187 WSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF--KPFPPTPLKQIFPAASDDALDLLQR 264 (298)
T ss_pred HHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc--cccCCcchhhhcccccHHHHHHHHH
Confidence 999999999999999999988888888888888877776665421 1111111 1111223344556778999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPYACD 188 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~ 188 (468)
||.+||.+|||+.++|.|+||...+.+..
T Consensus 265 ~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 265 LLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred HhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 99999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=246.55 Aligned_cols=151 Identities=27% Similarity=0.403 Sum_probs=126.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++||
T Consensus 107 ~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di 181 (291)
T cd05612 107 ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQS-KGHNKAVDW 181 (291)
T ss_pred HHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcC-CCCCchhhH
Confidence 368999999999999999999999999999999999999998765432 234578999999999876 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+....+....-. ....++..+++||.+|
T Consensus 182 wSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~li~~~ 232 (291)
T cd05612 182 WALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE-----------------------------FPRHLDLYAKDLIKKL 232 (291)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC-----------------------------CCccCCHHHHHHHHHH
Confidence 99999999999999999988877766666432100 0124578899999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
|+.||.+|++ +.+++.||||....|
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999999995 999999999987555
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=262.87 Aligned_cols=153 Identities=29% Similarity=0.472 Sum_probs=133.2
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceee
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 82 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWS 82 (468)
.|+.||+|||++||||||||.+|||+|.+|.+||+|||+++..... .......+||+.|+|||++.+ ..|+.++|.|+
T Consensus 476 ev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~ 553 (694)
T KOG0694|consen 476 EVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWG 553 (694)
T ss_pred HHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC-CCccccccCChhhcChhhhcc-CcccchhhHHH
Confidence 5889999999999999999999999999999999999999754322 234567899999999999988 56999999999
Q ss_pred eehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcC
Q 012191 83 VGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 162 (468)
Q Consensus 83 LG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~ 162 (468)
|||+|||||.|.+||.|+++.+....|...--..| ..++.++.++|++||.
T Consensus 554 lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP-----------------------------~~ls~ea~~il~~ll~ 604 (694)
T KOG0694|consen 554 LGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP-----------------------------RFLSKEAIAIMRRLLR 604 (694)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC-----------------------------CcccHHHHHHHHHHhc
Confidence 99999999999999999999999999865321111 2478999999999999
Q ss_pred CCCCCCcC-----HHHHHhcccccCCCCC
Q 012191 163 VEPYKRAT-----ASAALASEYFSTKPYA 186 (468)
Q Consensus 163 ~DP~kRpT-----a~e~L~Hp~F~~~p~~ 186 (468)
.||++|.. +.++..||||+...|.
T Consensus 605 k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 605 KNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred cCcccccCCCCCCchhhhhCCccccCCHH
Confidence 99999975 5889999999998774
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=251.11 Aligned_cols=183 Identities=32% Similarity=0.603 Sum_probs=140.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+|+||||+|||++.++.+||+|||++...... .......++..|+|||.+.+ ..++.++||
T Consensus 124 ~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 200 (353)
T cd07850 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDI 200 (353)
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC--CCCCCCcccccccCHHHHhC-CCCCCchhh
Confidence 469999999999999999999999999999999999999999765432 22334567889999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC--------------CCCchhhhhc
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ--------------PYDSSLRETF 146 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~--------------~~~~~l~~~~ 146 (468)
|||||++|+|++|..||.+.+....+..+...++.++.+++............... .+........
T Consensus 201 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
T cd07850 201 WSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHN 280 (353)
T ss_pred HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCccccccc
Confidence 99999999999999999999888889999988888877654432211110000000 0000001112
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 147 KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 147 ~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
...+..+++||.+||..||.+|||+.++|.||||..+-.+
T Consensus 281 ~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 281 KLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred ccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 2456778999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=248.78 Aligned_cols=159 Identities=28% Similarity=0.445 Sum_probs=129.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+. .++.++||
T Consensus 107 ~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv 181 (333)
T cd05600 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGK-GYDFTVDY 181 (333)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCC-CCCCccce
Confidence 36999999999999999999999999999999999999999875543 23456789999999999874 68999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+...........+ ......++.++.+||.+|
T Consensus 182 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------------------~~~~~~~s~~~~~li~~~ 240 (333)
T cd05600 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY---------------------DDPRFNLSDEAWDLITKL 240 (333)
T ss_pred ecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC---------------------CccccccCHHHHHHHHHH
Confidence 99999999999999999988877766665432111100000 000135788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|..+|.+|||+.+++.||||....+
T Consensus 241 l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 241 INDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred hhChhhhcCCHHHHHhCcccCCCCH
Confidence 9999999999999999999997655
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=249.13 Aligned_cols=154 Identities=27% Similarity=0.435 Sum_probs=127.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 102 ~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 179 (320)
T cd05590 102 AAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQE-MLYGPSVDW 179 (320)
T ss_pred HHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcC-CCCCCccch
Confidence 3699999999999999999999999999999999999999986533221 22344578999999999876 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+.+..+....... ...++.++.+||.+|
T Consensus 180 wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~li~~~ 230 (320)
T cd05590 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY-----------------------------PTWLSQDAVDILKAF 230 (320)
T ss_pred hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999988877776664311100 123678899999999
Q ss_pred cCCCCCCCcCH------HHHHhcccccCCCC
Q 012191 161 LSVEPYKRATA------SAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa------~e~L~Hp~F~~~p~ 185 (468)
|+.||.+|+++ .+++.||||....|
T Consensus 231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred cccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999999998 99999999987544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=256.40 Aligned_cols=183 Identities=25% Similarity=0.358 Sum_probs=135.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.++|+|||++......... .....+||+.|+|||++.+ ..|+.++|
T Consensus 191 ~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 269 (392)
T PHA03207 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTD 269 (392)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC-CCCCchhh
Confidence 369999999999999999999999999999999999999998765433221 2234578999999999876 45889999
Q ss_pred eeeeehhhhhhhhcCCCCCCCc---hHHHHHHHHHHcCCCCchhhhccCCCcc-----ccCCCCCCCCchhhhh--cCCC
Q 012191 80 LWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHA-----TLFKPQQPYDSSLRET--FKDL 149 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~---~~e~l~~i~~~~g~p~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~--~~~~ 149 (468)
||||||++|+|++|..||.+.. ....+..+.+.++..+.++......... .......++. +... -..+
T Consensus 270 vwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 347 (392)
T PHA03207 270 IWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT--IPPVIRKYGM 347 (392)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcc--ccchhhccCc
Confidence 9999999999999999997753 3566777777776655443221100000 0000000110 1111 1246
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
+.++.+||.+||.+||.+|||+.++|.||||...|+.
T Consensus 348 ~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 348 HMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred chhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 7789999999999999999999999999999987653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=249.29 Aligned_cols=154 Identities=27% Similarity=0.437 Sum_probs=125.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+||+.|+|||++.+ ..++.++||
T Consensus 101 ~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 178 (328)
T cd05593 101 GAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGTPEYLAPEVLED-NDYGRAVDW 178 (328)
T ss_pred HHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccCCcCccChhhhcC-CCCCccCCc
Confidence 368999999999999999999999999999999999999998653321 122334578999999999876 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+....+.... . .....++.++.+||.+|
T Consensus 179 wslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~---------------------------~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--I---------------------------KFPRTLSADAKSLLSGL 229 (328)
T ss_pred cccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--c---------------------------cCCCCCCHHHHHHHHHH
Confidence 999999999999999998877665555442210 0 00135788999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|+ ++.++|+|+||....|
T Consensus 230 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred cCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999997 8999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=247.56 Aligned_cols=154 Identities=29% Similarity=0.436 Sum_probs=127.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 179 (321)
T cd05591 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQE-LEYGPSVDW 179 (321)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHcC-CCCCCccce
Confidence 3689999999999999999999999999999999999999986543221 22344578999999999876 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+....... ...++.++.+||.+|
T Consensus 180 wslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~ll~~~ 230 (321)
T cd05591 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY-----------------------------PVWLSKEAVSILKAF 230 (321)
T ss_pred echhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999988877777664321000 013678899999999
Q ss_pred cCCCCCCCc-------CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-------TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-------Ta~e~L~Hp~F~~~p~ 185 (468)
|+.||.+|+ ++.+++.||||....|
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 999999999 9999999999976544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-29 Score=239.79 Aligned_cols=142 Identities=33% Similarity=0.528 Sum_probs=121.2
Q ss_pred CHHHHHHHHHHHh--CC--CeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHS--RG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs--~g--IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
|.||+.||.+||+ .. |+||||||.||+|+.+|.+||+|||+++++... .....+.+|||.||+||++.+ ..|+.
T Consensus 130 f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~ 207 (375)
T KOG0591|consen 130 FVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK-TTFAHSLVGTPYYMSPERIHE-SGYNF 207 (375)
T ss_pred HHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch-hHHHHhhcCCCcccCHHHHhc-CCCCc
Confidence 4699999999999 44 999999999999999999999999999988753 355678899999999999987 57999
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++||||+||++|||+.-++||.|++-.+.-.+|..+ ..++... ..+|.++..|
T Consensus 208 kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~--------------------------~~YS~~l~~l 260 (375)
T KOG0591|consen 208 KSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPD--------------------------EHYSTDLREL 260 (375)
T ss_pred chhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcH--------------------------HHhhhHHHHH
Confidence 999999999999999999999999777776676543 2221100 2468889999
Q ss_pred HHHhcCCCCCCCcCH
Q 012191 157 IETLLSVEPYKRATA 171 (468)
Q Consensus 157 L~~mL~~DP~kRpTa 171 (468)
|..|+..||..||+.
T Consensus 261 i~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 261 INMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHccCCcccCCCc
Confidence 999999999999986
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=240.88 Aligned_cols=180 Identities=60% Similarity=1.064 Sum_probs=148.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++...........+...++..|+|||.+.+...++.++||
T Consensus 106 ~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 185 (287)
T cd07840 106 MKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDM 185 (287)
T ss_pred HHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHH
Confidence 36899999999999999999999999999999999999999976654432233445678899999988765668899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhcCCC-cHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDL-PTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~-s~~l~dLL~ 158 (468)
|||||++|+|++|.+||...+....+..+...++.+....|.... +.....+.+.......+...+... +..+.++|.
T Consensus 186 ~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 265 (287)
T cd07840 186 WSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLD 265 (287)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHH
Confidence 999999999999999999999888999999988888877776432 222233333444444555556665 999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccc
Q 012191 159 TLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+||..||.+|||+.++|.||||
T Consensus 266 ~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 266 KLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHcCCChhhCcCHHHHhhCcCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=251.12 Aligned_cols=152 Identities=28% Similarity=0.389 Sum_probs=128.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++||
T Consensus 137 ~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di 211 (340)
T PTZ00426 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLN-VGHGKAADW 211 (340)
T ss_pred HHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhC-CCCCccccc
Confidence 369999999999999999999999999999999999999999765432 234578999999999976 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|+|++|.+||.+.+.......+....... ...++..+.+||.+|
T Consensus 212 wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~ 262 (340)
T PTZ00426 212 WTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF-----------------------------PKFLDNNCKHLMKKL 262 (340)
T ss_pred cchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999888776666664321111 124678899999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~~ 186 (468)
|+.||.+|+ |+.++++||||....|.
T Consensus 263 l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 263 LSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred cccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999995 89999999999976553
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=241.90 Aligned_cols=179 Identities=48% Similarity=0.838 Sum_probs=142.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.||+|+||||+|||++.++.++|+|||++....... .......+++.|+|||.+.+...++.++||
T Consensus 112 ~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 190 (293)
T cd07843 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDM 190 (293)
T ss_pred HHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cccccccccccccCchhhcCCccccchhhH
Confidence 3689999999999999999999999999999999999999987655432 223345678899999998775567889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhcc-CCCccccCCCCCCCCchhhhhcCC--CcHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKD--LPTTAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~--~s~~l~dLL 157 (468)
|||||++|+|++|.+||.+......+.+++..++.+....|... .++..............+...++. ++..+.+||
T Consensus 191 ~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 270 (293)
T cd07843 191 WSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLL 270 (293)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHH
Confidence 99999999999999999999999999999999998888777643 222211111111111223344444 488999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccc
Q 012191 158 ETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.+||+.||++|||+.|+|.||||
T Consensus 271 ~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 271 NRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHhccCccccCCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=246.63 Aligned_cols=191 Identities=46% Similarity=0.868 Sum_probs=151.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-------------CCCccccccCCcccChhh
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-------------RQPLTSRVVTLWYRPPEL 67 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~ 67 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ........++..|+|||.
T Consensus 125 ~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 204 (335)
T PTZ00024 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPEL 204 (335)
T ss_pred HHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChh
Confidence 3699999999999999999999999999999999999999987654110 112223456888999999
Q ss_pred hcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhc
Q 012191 68 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETF 146 (468)
Q Consensus 68 l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~ 146 (468)
+.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|.... ++....+... ....+...+
T Consensus 205 ~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 282 (335)
T PTZ00024 205 LMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIF 282 (335)
T ss_pred cccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcC--CcccHHHhC
Confidence 9776667899999999999999999999999999999999999988888776665421 1111111111 112334455
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCC
Q 012191 147 KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP 193 (468)
Q Consensus 147 ~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p 193 (468)
...+..+.+||.+||..||.+|||++++|.||||+..+..+++..+|
T Consensus 283 ~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~~~~~~~ 329 (335)
T PTZ00024 283 PNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQLP 329 (335)
T ss_pred cCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCCCcccCC
Confidence 67789999999999999999999999999999999988877755443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=241.39 Aligned_cols=178 Identities=42% Similarity=0.759 Sum_probs=140.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+...++.++||
T Consensus 106 ~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 184 (284)
T cd07860 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184 (284)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cccccccccccccCCeEEecCCCCCcHHHH
Confidence 3689999999999999999999999999999999999999987554321 223344568899999998775557889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCC-CccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL-PHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|..||.+.++...+.+++...+.+....|..... +.....-+.. ....+....+.++..+++||.+
T Consensus 185 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 263 (284)
T cd07860 185 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW-ARQDFSKVVPPLDEDGRDLLSQ 263 (284)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccc-cccCHHHHcccCCHHHHHHHHH
Confidence 9999999999999999999998888888888888887766643211 1000000000 1122334455688999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||+.||.+|||+.++|.||||
T Consensus 264 ~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 264 MLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcCCCcccCCCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=247.32 Aligned_cols=153 Identities=26% Similarity=0.443 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 102 ~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 179 (325)
T cd05594 102 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDW 179 (325)
T ss_pred HHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccccCCcccCCHHHHcc-CCCCCcccc
Confidence 699999999997 799999999999999999999999999986533221 22334578999999999976 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+.......+...... ....+++++.+||.+|
T Consensus 180 wslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~-----------------------------~p~~~~~~~~~li~~~ 230 (325)
T cd05594 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-----------------------------FPRTLSPEAKSLLSGL 230 (325)
T ss_pred ccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC-----------------------------CCCCCCHHHHHHHHHH
Confidence 99999999999999999887766555554321100 0124688899999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|+ ++.++|+||||....|
T Consensus 231 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred hhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999997 9999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=250.32 Aligned_cols=159 Identities=28% Similarity=0.407 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC---CCCCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT---DYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~---~~s~~s 78 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++..............+||+.|+|||++.+.. .++.++
T Consensus 149 ~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~ 228 (370)
T cd05621 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228 (370)
T ss_pred HHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCccc
Confidence 68999999999999999999999999999999999999999766543322334567899999999997532 378899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+.+....+..+......... .....++..+++||.
T Consensus 229 DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------p~~~~~s~~~~~li~ 283 (370)
T cd05621 229 DWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF-------------------------PEDVEISKHAKNLIC 283 (370)
T ss_pred CEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC-------------------------CCcccCCHHHHHHHH
Confidence 9999999999999999999998887777776542211110 001246888999999
Q ss_pred HhcCCCCCC--CcCHHHHHhcccccCCCC
Q 012191 159 TLLSVEPYK--RATASAALASEYFSTKPY 185 (468)
Q Consensus 159 ~mL~~DP~k--RpTa~e~L~Hp~F~~~p~ 185 (468)
.||..++.+ |+|+.++|+||||+...|
T Consensus 284 ~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 284 AFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 999865543 899999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=246.94 Aligned_cols=153 Identities=29% Similarity=0.498 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .......+||+.|+|||++.+ ..++.++|||
T Consensus 103 ~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 180 (316)
T cd05620 103 AEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGTPDYIAPEILQG-LKYTFSVDWW 180 (316)
T ss_pred HHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccCCCcCccCHHHHcC-CCCCcccchh
Confidence 69999999999999999999999999999999999999998643221 122345678999999999976 4689999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|..||.+.+..+.+..+.... +. ....++.++.+||.+||
T Consensus 181 slGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~~---------------------------~~~~~~~~~~~li~~~l 231 (316)
T cd05620 181 SFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PH---------------------------YPRWITKESKDILEKLF 231 (316)
T ss_pred hhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC---------------------------CCCCCCHHHHHHHHHHc
Confidence 99999999999999999887766665553211 10 00236788999999999
Q ss_pred CCCCCCCcCH-HHHHhcccccCCCC
Q 012191 162 SVEPYKRATA-SAALASEYFSTKPY 185 (468)
Q Consensus 162 ~~DP~kRpTa-~e~L~Hp~F~~~p~ 185 (468)
..||.+|+++ +++++||||....+
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCH
Confidence 9999999997 58889999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=245.95 Aligned_cols=154 Identities=29% Similarity=0.480 Sum_probs=126.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 106 ~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 183 (323)
T cd05584 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMR-SGHGKAVDW 183 (323)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccC-CCCCCccee
Confidence 3699999999999999999999999999999999999999986433221 22334578999999999876 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+....+..+...... ....++..+.+||.+|
T Consensus 184 wslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~ 234 (323)
T cd05584 184 WSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN-----------------------------LPPYLTPEARDLLKKL 234 (323)
T ss_pred cccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCHHHHHHHHHH
Confidence 99999999999999999988777666665431100 1134678899999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|| ++.+++.||||....|
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=246.34 Aligned_cols=154 Identities=29% Similarity=0.503 Sum_probs=126.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 179 (316)
T cd05592 102 AAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKG-QKYNESVDW 179 (316)
T ss_pred HHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcC-CCCCCcccc
Confidence 3699999999999999999999999999999999999999987543222 22344578999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+.+..+.... +. ....++.++.+||.+|
T Consensus 180 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~---------------------------~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--PH---------------------------FPRWISKEAKDCLSKL 230 (316)
T ss_pred hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC---------------------------CCCCCCHHHHHHHHHH
Confidence 999999999999999999888776666553211 00 0024678899999999
Q ss_pred cCCCCCCCcCH-HHHHhcccccCCCC
Q 012191 161 LSVEPYKRATA-SAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa-~e~L~Hp~F~~~p~ 185 (468)
|..||.+||++ .++++||||....|
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 231 FERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred ccCCHHHcCCChHHHHcCcccCCCCH
Confidence 99999999986 58889999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=246.52 Aligned_cols=154 Identities=27% Similarity=0.401 Sum_probs=126.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 179 (323)
T cd05575 102 AAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGTPEYLAPEVLRK-QPYDRTVDW 179 (323)
T ss_pred HHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccccCChhhcChhhhcC-CCCCccccc
Confidence 369999999999999999999999999999999999999998643221 122344578999999999876 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+..... .....++..+.+||.+|
T Consensus 180 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~li~~~ 230 (323)
T cd05575 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-----------------------------RLKPNISVSARHLLEGL 230 (323)
T ss_pred cccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCHHHHHHHHHH
Confidence 9999999999999999998877666666543110 01135688999999999
Q ss_pred cCCCCCCCcCH----HHHHhcccccCCCC
Q 012191 161 LSVEPYKRATA----SAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa----~e~L~Hp~F~~~p~ 185 (468)
|+.||.+||++ .+++.||||....|
T Consensus 231 l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 231 LQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred hhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999999997 69999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=249.58 Aligned_cols=158 Identities=30% Similarity=0.472 Sum_probs=125.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-----------------------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ----------------------------- 51 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~----------------------------- 51 (468)
+.||+.||+|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 107 ~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (364)
T cd05599 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186 (364)
T ss_pred HHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccccccccc
Confidence 469999999999999999999999999999999999999998654321100
Q ss_pred --------CccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhc
Q 012191 52 --------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKK 123 (468)
Q Consensus 52 --------~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~ 123 (468)
.....+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+.+..+.+..+........
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 259 (364)
T cd05599 187 TWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ------ 259 (364)
T ss_pred chhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC------
Confidence 1113468999999999876 5689999999999999999999999998887776666543111000
Q ss_pred cCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcC---HHHHHhcccccCCCC
Q 012191 124 SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 185 (468)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~e~L~Hp~F~~~p~ 185 (468)
+ .....+++.+.+||.+||. +|.+|++ +.++|.||||....|
T Consensus 260 --------------~-----~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 260 --------------F-----PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred --------------C-----CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 0 0001468899999999997 9999998 999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-29 Score=253.26 Aligned_cols=152 Identities=32% Similarity=0.598 Sum_probs=137.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE-CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV-NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl-d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
|.||+.|+.|||+..||||||||+|+++ ..-|.|||.|||++..+.++ ..++..+|.+.|-|||+|+|..+..+++|
T Consensus 124 F~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVD 201 (864)
T KOG4717|consen 124 FAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KKLTTSCGSLAYSAPEILLGDSYDAPAVD 201 (864)
T ss_pred HHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--chhhcccchhhccCchhhhcCccCCcchh
Confidence 5799999999999999999999999876 56699999999999988876 46788899999999999999877778999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||||||.|+||++||+..++.+.+..|+.+-...| ..++.++++||..
T Consensus 202 iWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP-----------------------------shvS~eCrdLI~s 252 (864)
T KOG4717|consen 202 IWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP-----------------------------SHVSKECRDLIQS 252 (864)
T ss_pred hhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc-----------------------------hhhhHHHHHHHHH
Confidence 99999999999999999999999999999987644333 3578999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||..||.+|.|.+++..|+|++..
T Consensus 253 MLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HHhcCchhhccHHHHhccccccCC
Confidence 999999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=245.70 Aligned_cols=185 Identities=36% Similarity=0.625 Sum_probs=142.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ .......++..|+|||.+.+...++.++
T Consensus 112 ~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 191 (336)
T cd07849 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAI 191 (336)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHH
Confidence 36899999999999999999999999999999999999999876543221 1223456789999999987656688999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCC--CCchhhhhcCCCcHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~~~s~~l~dL 156 (468)
||||+||++|+|++|++||.+.+....+..+...++.++.+.+..........+....+ ....+....+.++.++.+|
T Consensus 192 DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 271 (336)
T cd07849 192 DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDL 271 (336)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHH
Confidence 99999999999999999999988888888888888877666554322111111100001 1112233445678899999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|.+||+.||.+|||+.++|.||||.....
T Consensus 272 i~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 272 LDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 99999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=245.51 Aligned_cols=154 Identities=27% Similarity=0.430 Sum_probs=127.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 107 ~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 184 (323)
T cd05616 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDW 184 (323)
T ss_pred HHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcC-CCCCCccch
Confidence 3689999999999999999999999999999999999999986543221 22334578999999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+....+..+....... ...++.++.+||.+|
T Consensus 185 wSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~ 235 (323)
T cd05616 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-----------------------------PKSMSKEAVAICKGL 235 (323)
T ss_pred hchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------------------------CCcCCHHHHHHHHHH
Confidence 999999999999999999988777777665421111 124688899999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
|+.||.+|++ ..+++.|+||....|
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred cccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999999998 489999999987554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=246.09 Aligned_cols=154 Identities=31% Similarity=0.481 Sum_probs=126.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 107 ~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 184 (324)
T cd05587 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAY-QPYGKSVDW 184 (324)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcC-CCCCcccch
Confidence 3689999999999999999999999999999999999999986432211 22334578999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+....... ...++..+.+||.+|
T Consensus 185 wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~li~~~ 235 (324)
T cd05587 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----------------------------PKSLSKEAVSICKGL 235 (324)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999888777776664321110 124678899999999
Q ss_pred cCCCCCCCcCH-----HHHHhcccccCCCC
Q 012191 161 LSVEPYKRATA-----SAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa-----~e~L~Hp~F~~~p~ 185 (468)
|..||.+|+++ .++++||||....|
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999986 89999999987543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=239.45 Aligned_cols=180 Identities=50% Similarity=0.933 Sum_probs=144.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++...............++..|+|||.+.+...++.++||
T Consensus 122 ~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 201 (302)
T cd07864 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDV 201 (302)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHH
Confidence 36899999999999999999999999999999999999999876654332233334567889999998765567889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|++||......+.+..+...++.+....|+... .+..............+...+..++..+.+||..
T Consensus 202 ~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 281 (302)
T cd07864 202 WSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDH 281 (302)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHH
Confidence 999999999999999999988889999999988888777665422 1111111222222334445566789999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||..||.+|||+.++|.||||
T Consensus 282 ~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 282 MLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HccCChhhCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=245.10 Aligned_cols=154 Identities=27% Similarity=0.411 Sum_probs=127.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|++.|+|||++.+ ..++.++||
T Consensus 107 ~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di 184 (324)
T cd05589 107 AACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTE-TSYTRAVDW 184 (324)
T ss_pred HHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-CcccccccCccccCHhHhcC-CCCCcccch
Confidence 3699999999999999999999999999999999999999986432211 22334578999999999976 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+.+..+....... ...++..+.+||.+|
T Consensus 185 wslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~ 235 (324)
T cd05589 185 WGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY-----------------------------PRFLSREAISIMRRL 235 (324)
T ss_pred hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999988777776664321110 124688899999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|+.||.+|| ++.++++||||....+
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 999999999 7999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=240.45 Aligned_cols=159 Identities=25% Similarity=0.404 Sum_probs=125.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .......+|+.|+|||.+.+ ..++.++||
T Consensus 103 ~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv 180 (280)
T cd05608 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTPGFMAPELLQG-EEYDFSVDY 180 (280)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccccCCCcCccCHHHhcC-CCCCccccH
Confidence 3689999999999999999999999999999999999999987654332 22334578999999999986 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...........+.......+. .....++..+.+||.+|
T Consensus 181 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-------------------------TYPDKFSPASKSFCEAL 235 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC-------------------------CCcccCCHHHHHHHHHH
Confidence 99999999999999999865433222222211111100 01135788999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~~ 186 (468)
|+.||.+|| |++++++||||+...|.
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 999999999 89999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=247.27 Aligned_cols=154 Identities=28% Similarity=0.443 Sum_probs=126.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 101 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 178 (323)
T cd05595 101 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDW 178 (323)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccC-CCCCchhch
Confidence 3699999999999999999999999999999999999999986432221 22334578999999999876 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+.......+...... ....+++.+.+||.+|
T Consensus 179 wSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~-----------------------------~p~~~~~~~~~li~~~ 229 (323)
T cd05595 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-----------------------------FPRTLSPEAKSLLAGL 229 (323)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------------------------CCCCCCHHHHHHHHHH
Confidence 99999999999999999887776666555321110 0124788999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|+ ++.++|+|+||....|
T Consensus 230 L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred ccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999998 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=238.44 Aligned_cols=178 Identities=44% Similarity=0.807 Sum_probs=140.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||+|+||+++. ++.++|+|||++..+.... .......++++|+|||.+.+...++.++|
T Consensus 116 ~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D 194 (295)
T cd07837 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVD 194 (295)
T ss_pred HHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHH
Confidence 368999999999999999999999999998 8899999999987554321 12233456889999999876566889999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++|.+||.+.+....+..++...+.+....|.... ......+. . .....+....+.++..+.+||.
T Consensus 195 i~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~i~ 272 (295)
T cd07837 195 IWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFP-Q-WKPQDLSRAVPDLSPEGLDLLQ 272 (295)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcC-c-ccchhHHHhccccCHHHHHHHH
Confidence 9999999999999999999999988888888888877766664321 11111010 0 0111233444678999999999
Q ss_pred HhcCCCCCCCcCHHHHHhccccc
Q 012191 159 TLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
+||..||.+|||+.++|.||||+
T Consensus 273 ~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 273 KMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHccCChhhcCCHHHHhcCCCcC
Confidence 99999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=245.33 Aligned_cols=181 Identities=38% Similarity=0.652 Sum_probs=143.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.||+||||||+|||++.++.++|+|||++..... ......++..|+|||.+.+...++.++||
T Consensus 123 ~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 198 (342)
T cd07879 123 VYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDI 198 (342)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC----CCCCceeeecccChhhhcCccccCchHHH
Confidence 36899999999999999999999999999999999999999865432 22345678899999998765568899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC--CCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|+.||.+.+....+..+....+.+...++..........+.... .....+...++.++..+.+||.
T Consensus 199 ~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (342)
T cd07879 199 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLE 278 (342)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHH
Confidence 99999999999999999998888888888888887776665543222111111000 0112233445678889999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+||+.||.+|||+.++|.||||.....
T Consensus 279 ~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 279 KMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHcCCChhhCcCHHHHhcCcchhhccc
Confidence 999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=249.12 Aligned_cols=159 Identities=29% Similarity=0.435 Sum_probs=124.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC------------------------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR------------------------------ 50 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~------------------------------ 50 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 107 ~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (363)
T cd05628 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186 (363)
T ss_pred HHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhh
Confidence 36999999999999999999999999999999999999999865432110
Q ss_pred ----CCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCC
Q 012191 51 ----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 126 (468)
Q Consensus 51 ----~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~ 126 (468)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++........
T Consensus 187 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 256 (363)
T cd05628 187 RNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI--------- 256 (363)
T ss_pred hccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc---------
Confidence 01124578999999999976 4688999999999999999999999999888777777654211110
Q ss_pred CccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCC---CcCHHHHHhcccccCCCCC
Q 012191 127 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK---RATASAALASEYFSTKPYA 186 (468)
Q Consensus 127 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~k---RpTa~e~L~Hp~F~~~p~~ 186 (468)
+ . ....+++++++||.+|+. +|.+ ||+++++++||||....|.
T Consensus 257 -----~------p-----~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 257 -----F------P-----PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred -----C------C-----CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 0 0 012367899999999876 4554 5899999999999986653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=245.07 Aligned_cols=183 Identities=38% Similarity=0.696 Sum_probs=145.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...... .....++..|+|||++.+...++.++||
T Consensus 124 ~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 199 (343)
T cd07851 124 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDI 199 (343)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhH
Confidence 368999999999999999999999999999999999999998765432 3445678899999998765567899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC--CchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+......+..+...++.+++.++..........+....+. ...+...+..++..+.+||.
T Consensus 200 wslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~ 279 (343)
T cd07851 200 WSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLE 279 (343)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHH
Confidence 9999999999999999999988888999988888887776654332222111111111 11233444567899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
+||+.||.+|||+.++|.||||.....+.
T Consensus 280 ~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 280 KMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred HhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 99999999999999999999999764443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=262.00 Aligned_cols=180 Identities=25% Similarity=0.308 Sum_probs=129.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++|||||||||+|||++.++.+||+|||++..+...........+||+.|+|||++.+ ..|+.++||
T Consensus 273 ~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 351 (501)
T PHA03210 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDI 351 (501)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHH
Confidence 4699999999999999999999999999999999999999998765443333345678999999999977 468999999
Q ss_pred eeeehhhhhhhhcCCC-CCC--CchHHHHHHHHHHcCCCCchhhhc----cCCCccccCCCCCCCCchhhhhc--CCCcH
Q 012191 81 WSVGCVFAELLIGKPI-LQG--RTEVEQLHKIFKLCGSPPDDYWKK----SKLPHATLFKPQQPYDSSLRETF--KDLPT 151 (468)
Q Consensus 81 WSLG~ILyeLltG~~p-f~g--~~~~e~l~~i~~~~g~p~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~--~~~s~ 151 (468)
||||||||||++|..+ |.+ .....++.+++..++....++... ........+.. ....+...+ ..++.
T Consensus 352 wSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~ 428 (501)
T PHA03210 352 WSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDH---AGHSVPPLIRNLGLPA 428 (501)
T ss_pred HHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhccc---CccchhhHHHhcCCCh
Confidence 9999999999998754 432 234556666665554433322110 00000000000 001111111 24678
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 152 TAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
++.++|.+||++||.+|||+.|+|.||||....
T Consensus 429 ~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 429 DFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 899999999999999999999999999998753
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=239.17 Aligned_cols=180 Identities=43% Similarity=0.761 Sum_probs=137.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+||+++.++.+||+|||++........ .......++..|+|||.+.+...++.+
T Consensus 125 ~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (310)
T cd07865 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPP 204 (310)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCch
Confidence 36999999999999999999999999999999999999999876543221 122344678899999998775567889
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCc-cccCCCCCCCCchhhhhc--CCCcHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKPQQPYDSSLRETF--KDLPTTAV 154 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~--~~~s~~l~ 154 (468)
+|||||||++|+|++|.+||.+.+....+..+...++..+.+.|+...... ...+.........+...+ ...+..+.
T Consensus 205 ~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 284 (310)
T cd07865 205 IDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHAL 284 (310)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHH
Confidence 999999999999999999999998888888888888888777665432111 000110001111111111 12467789
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 155 NLIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+||.+||..||.+|||++++|+||||
T Consensus 285 dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 285 DLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHHHHhcCChhhccCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=248.99 Aligned_cols=158 Identities=34% Similarity=0.484 Sum_probs=124.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-------------------------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH------------------------------- 49 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~------------------------------- 49 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 107 ~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (382)
T cd05625 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186 (382)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccccccccccc
Confidence 3699999999999999999999999999999999999999974321000
Q ss_pred ---------------CCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcC
Q 012191 50 ---------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 114 (468)
Q Consensus 50 ---------------~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g 114 (468)
.......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+....+.....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 265 (382)
T cd05625 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT 265 (382)
T ss_pred ccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC
Confidence 000123478999999999976 4689999999999999999999999998887766665543211
Q ss_pred CCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcC---HHHHHhcccccCCCC
Q 012191 115 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPY 185 (468)
Q Consensus 115 ~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~e~L~Hp~F~~~p~ 185 (468)
... ......+++++.+||.+|+ .||.+|++ +.+++.||||....+
T Consensus 266 ~~~-------------------------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 266 SLH-------------------------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred CcC-------------------------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 110 0011357889999999987 59999997 999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=250.12 Aligned_cols=177 Identities=34% Similarity=0.607 Sum_probs=141.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+||+.||.+|-..||+|.||||+|||++.. ..+||||||.|.+...+ ..+.+.++..|+|||+++| ..|+...|+
T Consensus 543 qQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG-~~yd~~iD~ 618 (752)
T KOG0670|consen 543 QQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILG-LPYDYPIDT 618 (752)
T ss_pred HHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc---cccHHHHHHhccCcceeec-CcccCCccc
Confidence 699999999999999999999999999875 56899999999877664 4677788899999999999 569999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCcc-----cc--------------------CCCC
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA-----TL--------------------FKPQ 135 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~-----~~--------------------~~~~ 135 (468)
||+||+||||+||+.+|+|.++...+...+.+-|..|........+... .. .+|.
T Consensus 619 WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt 698 (752)
T KOG0670|consen 619 WSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT 698 (752)
T ss_pred eeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcc
Confidence 9999999999999999999999999999999999988765443222111 00 1111
Q ss_pred CCCCchhhhh--c----CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 136 QPYDSSLRET--F----KDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 136 ~~~~~~l~~~--~----~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
..+...|... + ..+-..+.+||.+||.+||++|+|+.++|.||||+.
T Consensus 699 kdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 699 KDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 1111111111 1 112245899999999999999999999999999975
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=237.41 Aligned_cols=179 Identities=41% Similarity=0.744 Sum_probs=137.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .......++..|+|||++.+...++.++||
T Consensus 109 ~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv 187 (291)
T cd07844 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187 (291)
T ss_pred HHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccccccccccccCCcHHhhcCcccCcHHHH
Confidence 3699999999999999999999999999999999999999986543221 112233567889999998775668899999
Q ss_pred eeeehhhhhhhhcCCCCCCCc-hHHHHHHHHHHcCCCCchhhhccCCCc-cccCCCCCCCCchhhhhcCCCc--HHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKPQQPYDSSLRETFKDLP--TTAVNL 156 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~-~~e~l~~i~~~~g~p~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~s--~~l~dL 156 (468)
||+||++|+|++|.+||.+.. ..+++..+....+.+....|....... .............+...+..++ ..+.+|
T Consensus 188 ~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (291)
T cd07844 188 WGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEEL 267 (291)
T ss_pred HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHH
Confidence 999999999999999998766 567777788888888777775432111 1111000111122334444555 889999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccc
Q 012191 157 IETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
|.+||+.||.+|||+.++|.||||
T Consensus 268 i~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 268 ALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHhccCcccccCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=234.69 Aligned_cols=178 Identities=35% Similarity=0.690 Sum_probs=135.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........ ......++.+|+|||.+.+...++.++||
T Consensus 106 ~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 184 (286)
T cd07847 106 IWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDV 184 (286)
T ss_pred HHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhh
Confidence 46899999999999999999999999999999999999999976654321 22344678899999998775668899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchh---hhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY---WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||++|+|++|.+||.+....+.+..+....+...... +...... .....+.......+...+..++..+.+||
T Consensus 185 ~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li 263 (286)
T cd07847 185 WAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF-KGLSIPEPETREPLESKFPNISSPALSFL 263 (286)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc-ccccCCCcccccCHHHHhccCCHHHHHHH
Confidence 9999999999999999999888777776665554432211 1100000 00011111111233445667899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccc
Q 012191 158 ETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.+||..||.+|||+.++|.||||
T Consensus 264 ~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 264 KGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHhcCCccccCCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=244.93 Aligned_cols=186 Identities=33% Similarity=0.589 Sum_probs=145.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .......++.+|+|||.+.+...++.+
T Consensus 113 ~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 192 (334)
T cd07855 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTA 192 (334)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccc
Confidence 36899999999999999999999999999999999999999875543221 112345788999999998765568899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCC--CCCCCchhhhhcCCCcHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~s~~l~d 155 (468)
+|||||||++|+|++|.+||.+.+...++..+....|.++...+..........+.. .......+...++.++.++.+
T Consensus 193 ~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (334)
T cd07855 193 IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALD 272 (334)
T ss_pred cchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHH
Confidence 999999999999999999999999888999999999988876654322111100000 001111223445678999999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
||.+||+.||.+|||+.++|.||||...+.+
T Consensus 273 li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 273 LLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 9999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=247.24 Aligned_cols=160 Identities=30% Similarity=0.419 Sum_probs=127.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC---CCCCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT---DYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~---~~s~~s 78 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++..............+||+.|+|||++.+.. .++.++
T Consensus 149 ~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~ 228 (371)
T cd05622 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228 (371)
T ss_pred HHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCcc
Confidence 68999999999999999999999999999999999999999766543322334567899999999987532 378899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+.+....+..+........ ......++..+++||.
T Consensus 229 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~ 283 (371)
T cd05622 229 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-------------------------FPDDNDISKEAKNLIC 283 (371)
T ss_pred ceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc-------------------------CCCcCCCCHHHHHHHH
Confidence 999999999999999999999887777776654221110 0011357899999999
Q ss_pred HhcCCCCCC--CcCHHHHHhcccccCCCCC
Q 012191 159 TLLSVEPYK--RATASAALASEYFSTKPYA 186 (468)
Q Consensus 159 ~mL~~DP~k--RpTa~e~L~Hp~F~~~p~~ 186 (468)
.||..++.+ |+++.++++|+||...++.
T Consensus 284 ~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 284 AFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred HHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 999844433 7899999999999886553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=233.28 Aligned_cols=177 Identities=45% Similarity=0.838 Sum_probs=143.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... ........+..|+|||.+.+...++.++||
T Consensus 104 ~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv 182 (282)
T cd07829 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTHEVVTLWYRAPEILLGSKHYSTAVDI 182 (282)
T ss_pred HHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCccccCcCcCChHHhcCCcCCCccccH
Confidence 3689999999999999999999999999999999999999987654332 123344567889999998775578899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCc--cccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH--ATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+.+..+.+..+...++.+.+..|....... ...+ +. .........++.++..+.++|.
T Consensus 183 ~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~i~ 260 (282)
T cd07829 183 WSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF-PK-FPPKDLEKVLPRLDPEGIDLLS 260 (282)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc-cc-cCccchHHhcccccHHHHHHHH
Confidence 999999999999999999999999999999999988888776532221 1111 11 1112234455677899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccc
Q 012191 159 TLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+||..||.+|||+.+++.||||
T Consensus 261 ~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 261 KMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HhhccCcccCCCHHHHhhCcCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=243.77 Aligned_cols=154 Identities=27% Similarity=0.405 Sum_probs=127.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 179 (325)
T cd05602 102 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHK-QPYDRTVDW 179 (325)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcC-CCCCCcccc
Confidence 3699999999999999999999999999999999999999986433211 22345578999999999976 568899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+..... ...+.++..+.+||.+|
T Consensus 180 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~li~~~ 230 (325)
T cd05602 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-----------------------------QLKPNITNSARHLLEGL 230 (325)
T ss_pred ccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-----------------------------CCCCCCCHHHHHHHHHH
Confidence 9999999999999999998887777666643210 01135788999999999
Q ss_pred cCCCCCCCcCHH----HHHhcccccCCCC
Q 012191 161 LSVEPYKRATAS----AALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~----e~L~Hp~F~~~p~ 185 (468)
|+.||.+|+++. ++++|+||....|
T Consensus 231 l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 231 LQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred cccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 999999999875 8999999976444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=236.32 Aligned_cols=178 Identities=42% Similarity=0.788 Sum_probs=139.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+++++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+...++.++||
T Consensus 105 ~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 183 (283)
T cd07835 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDI 183 (283)
T ss_pred HHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccCccccccCCCCCceeecCcccCcHHHH
Confidence 3689999999999999999999999999999999999999987554321 122334568899999988765567889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCC-ccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|.+||.+.+....+..++...+.+....|...... ......+... ..........++..+.+||.+
T Consensus 184 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 262 (283)
T cd07835 184 WSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWA-RQDLSKVVPNLDEDGLDLLSK 262 (283)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccccc-ccchhhhcCCCCHHHHHHHHH
Confidence 99999999999999999999888888888888888877666442211 1000000000 112233456788999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||+.||.+|||+.++|.||||
T Consensus 263 ~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 263 MLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HhcCChhhCcCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=247.47 Aligned_cols=159 Identities=33% Similarity=0.470 Sum_probs=122.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-------------------------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH------------------------------- 49 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~------------------------------- 49 (468)
+.||+.||+|||+.||+||||||+||||+.++.+||+|||++..+....
T Consensus 107 ~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (381)
T cd05626 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186 (381)
T ss_pred HHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccc
Confidence 4699999999999999999999999999999999999999875321100
Q ss_pred ---------------CCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcC
Q 012191 50 ---------------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 114 (468)
Q Consensus 50 ---------------~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g 114 (468)
.......+||+.|+|||++.+ ..++.++||||||||+|||++|.+||.+.+..+....+.....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~ 265 (381)
T cd05626 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN 265 (381)
T ss_pred cccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc
Confidence 000123578999999999976 4589999999999999999999999998877666555532111
Q ss_pred CCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCC--CCCCCcCHHHHHhcccccCCCC
Q 012191 115 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV--EPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 115 ~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~--DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
... ......+++++++||.+||.. ++..|+|+.++|.||||....|
T Consensus 266 ~~~-------------------------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 266 TLH-------------------------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred ccC-------------------------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 110 001124789999999997654 4455999999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=247.65 Aligned_cols=158 Identities=32% Similarity=0.458 Sum_probs=123.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-------------------------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH------------------------------- 49 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~------------------------------- 49 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 107 ~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (376)
T cd05598 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186 (376)
T ss_pred HHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccccccccc
Confidence 3699999999999999999999999999999999999999974321000
Q ss_pred -----------CCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCc
Q 012191 50 -----------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118 (468)
Q Consensus 50 -----------~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~ 118 (468)
.......+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+....+....+........
T Consensus 187 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~- 264 (376)
T cd05598 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH- 264 (376)
T ss_pred chhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcccc-
Confidence 000123478999999999976 5688999999999999999999999998877666555432111000
Q ss_pred hhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCc---CHHHHHhcccccCCCC
Q 012191 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTKPY 185 (468)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp---Ta~e~L~Hp~F~~~p~ 185 (468)
......++..+.+||.+|+ .+|.+|+ |+.++|+||||....+
T Consensus 265 ------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 265 ------------------------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 0011357889999999987 5999999 9999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=245.75 Aligned_cols=159 Identities=29% Similarity=0.405 Sum_probs=121.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||..|+|||++.. ...++.
T Consensus 174 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 252 (353)
T PLN00034 174 ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGY 252 (353)
T ss_pred HHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccccccccCccccCccccccccccCcCCCc
Confidence 4699999999999999999999999999999999999999987654321 22345678999999998743 123456
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++||||||||+|+|++|+.||......+....+........ ......++.++++|
T Consensus 253 ~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~l 307 (353)
T PLN00034 253 AGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-------------------------PEAPATASREFRHF 307 (353)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-------------------------CCCCCccCHHHHHH
Confidence 89999999999999999999974332222111111110000 01113578899999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|.+||..||.+|||+.|+|+||||.....
T Consensus 308 i~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 308 ISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred HHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 99999999999999999999999988543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=236.96 Aligned_cols=181 Identities=43% Similarity=0.782 Sum_probs=142.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++...... ........+++.|+|||.+.+...++.++||
T Consensus 109 ~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 187 (294)
T PLN00009 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEILLGSRHYSTPVDI 187 (294)
T ss_pred HHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-ccccccCceeecccCHHHHhCCCCCCcHHHH
Confidence 68999999999999999999999999985 457999999998755432 1223344678899999998775568889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||+||++|+|++|.+||.+.+..+.+.+++...+.+....|.... ++......+.. ....+....+.++..+.++|.+
T Consensus 188 ~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~ 266 (294)
T PLN00009 188 WSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKW-PPKDLATVVPTLEPAGVDLLSK 266 (294)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccC-CCCCHHHhCcCCChHHHHHHHH
Confidence 999999999999999999988888888888888888888776421 11111111110 0112233345788999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||..||.+||++.++|.||||...+
T Consensus 267 ~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 267 MLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred HccCChhhCcCHHHHhcCchHhHHh
Confidence 9999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=252.25 Aligned_cols=153 Identities=35% Similarity=0.550 Sum_probs=134.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
+||+.||.|||+.+|+|||+||.|||++..|.+|+||||+|+....+ ....+...||+.|||||++.+ ..|+..+|+|
T Consensus 107 ~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e-~pyd~~sDlW 184 (808)
T KOG0597|consen 107 YDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEE-QPYDHTSDLW 184 (808)
T ss_pred HHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcC-CCccchhhHH
Confidence 58999999999999999999999999999999999999999877653 456678899999999999986 6799999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
|||||+|||+.|+|||....-......|.+.--.+| ..++..+++||..+|
T Consensus 185 slGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p-----------------------------~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 185 SLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP-----------------------------STASSSFVNFLQGLL 235 (808)
T ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc-----------------------------ccccHHHHHHHHHHh
Confidence 999999999999999998877777777754222221 257889999999999
Q ss_pred CCCCCCCcCHHHHHhcccccCCCC
Q 012191 162 SVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 162 ~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
..||.+|+|..++|.|||++..-.
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhhh
Confidence 999999999999999999987543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=242.05 Aligned_cols=153 Identities=31% Similarity=0.429 Sum_probs=127.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 104 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di 181 (318)
T cd05582 104 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR-RGHTQSADW 181 (318)
T ss_pred HHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcC-CCCCCccce
Confidence 4699999999999999999999999999999999999999987544321 22334578999999999876 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+.+..+....... ...++..+.+||.+|
T Consensus 182 wslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~ 232 (318)
T cd05582 182 WSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM-----------------------------PQFLSPEAQSLLRAL 232 (318)
T ss_pred eccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999888777666654321110 124678899999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p 184 (468)
|+.||.+||| +.+++.||||....
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 9999999999 78899999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=235.70 Aligned_cols=177 Identities=41% Similarity=0.788 Sum_probs=141.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+...++.++||
T Consensus 106 ~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 184 (284)
T cd07836 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFSNEVVTLWYRAPDVLLGSRTYSTSIDI 184 (284)
T ss_pred HHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cccccccccccccChHHhcCCCCCCcHHHH
Confidence 4689999999999999999999999999999999999999987554321 122344668899999998776667889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC--CchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+.+..+.+..++.....+....|....... .+....+. ...+....+.++..+.++|.
T Consensus 185 ~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 262 (284)
T cd07836 185 WSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP--EYKPTFPRYPPQDLQQLFPHADPLGIDLLH 262 (284)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc--hhcccccCCChHHHHHHhhhcCcHHHHHHH
Confidence 999999999999999999999888999998888888777776433211 11111111 12223344567889999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccc
Q 012191 159 TLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+||+.||.+|||+.++|.||||
T Consensus 263 ~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 263 RLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=242.14 Aligned_cols=184 Identities=40% Similarity=0.664 Sum_probs=147.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ .......++.+|+|||.+.+...++.++
T Consensus 109 ~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~s 188 (330)
T cd07834 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAI 188 (330)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcch
Confidence 36899999999999999999999999999999999999999986654321 1234556789999999998755789999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCC--CCCCCchhhhhcCCCcHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~s~~l~dL 156 (468)
|||||||++|+|++|.+||.+.+..+.+..+....+.++...|..........+.. .......+...+..++..+.+|
T Consensus 189 Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (330)
T cd07834 189 DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDL 268 (330)
T ss_pred hHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHH
Confidence 99999999999999999999999999999999988888876655322221111111 1111123444556789999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|.+||+.||.+|||+.++|.||||....
T Consensus 269 i~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 269 LEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred HHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 9999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=243.14 Aligned_cols=154 Identities=26% Similarity=0.376 Sum_probs=126.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 179 (325)
T cd05604 102 AAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDW 179 (325)
T ss_pred HHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccccCChhhCCHHHHcC-CCCCCcCcc
Confidence 469999999999999999999999999999999999999998643221 122345578999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+.... . ...+.++..+.+||.+|
T Consensus 180 wslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~---------------------------~~~~~~~~~~~~ll~~l 230 (325)
T cd05604 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--L---------------------------VLRPGASLTAWSILEEL 230 (325)
T ss_pred ccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--c---------------------------cCCCCCCHHHHHHHHHH
Confidence 999999999999999999887766666553310 0 01134678899999999
Q ss_pred cCCCCCCCcCH----HHHHhcccccCCCC
Q 012191 161 LSVEPYKRATA----SAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa----~e~L~Hp~F~~~p~ 185 (468)
|..||.+||++ .+++.||||....|
T Consensus 231 l~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 231 LEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred hccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999976 59999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=234.68 Aligned_cols=179 Identities=47% Similarity=0.829 Sum_probs=142.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+...++.++||
T Consensus 104 ~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di 182 (283)
T cd05118 104 LYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182 (283)
T ss_pred HHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHH
Confidence 4689999999999999999999999999999999999999987665432 223345678899999999875568899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCC-ccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|++||.+.+..+.+..+...++.+....|...... ....+................++..+.+||.+
T Consensus 183 ~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 262 (283)
T cd05118 183 WSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQ 262 (283)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHH
Confidence 99999999999999999999988888888888888776666543220 00000000111112234456688999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||..||.+||++.++|.||||
T Consensus 263 ~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 263 MLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HhccCcccCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=254.65 Aligned_cols=150 Identities=28% Similarity=0.477 Sum_probs=124.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE-CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV-NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl-d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++|||||||||+|||+ +..+.++|+|||.+...... +...+.|..|.|||++.. ..|+.++|
T Consensus 421 ~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~-~~yt~acD 495 (612)
T KOG0603|consen 421 AAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAI-QEYTEACD 495 (612)
T ss_pred HHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhcc-CCCCcchh
Confidence 4689999999999999999999999999 58899999999999766543 344467899999999984 67999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++||+||+|+.||...... ..|....+.+... ..+|..+++||.+
T Consensus 496 ~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s---------------------------~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 496 WWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS---------------------------ECVSDEAKDLLQQ 545 (612)
T ss_pred hHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc---------------------------cccCHHHHHHHHH
Confidence 999999999999999999776555 2233333333211 3589999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
||++||.+|+++.+++.||||...+.
T Consensus 546 LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred hccCChhhCcChhhhccCcchhcCCC
Confidence 99999999999999999999944443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=246.15 Aligned_cols=158 Identities=30% Similarity=0.461 Sum_probs=122.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-----------------------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ----------------------------- 51 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~----------------------------- 51 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 107 ~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (377)
T cd05629 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186 (377)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccc
Confidence 369999999999999999999999999999999999999998532210000
Q ss_pred -----------------CccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcC
Q 012191 52 -----------------PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 114 (468)
Q Consensus 52 -----------------~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g 114 (468)
.....+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+.+..+.+..+.....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 265 (377)
T cd05629 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE 265 (377)
T ss_pred cccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC
Confidence 0012468999999999876 4689999999999999999999999998887776666643111
Q ss_pred CCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCC---cCHHHHHhcccccCCCC
Q 012191 115 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR---ATASAALASEYFSTKPY 185 (468)
Q Consensus 115 ~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kR---pTa~e~L~Hp~F~~~p~ 185 (468)
... + .....++.++.+||.+||. +|.+| +|+.++|.||||....|
T Consensus 266 ~~~--------~-----------------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 266 TLY--------F-----------------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred ccC--------C-----------------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 100 0 0012467899999999997 77765 59999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=242.97 Aligned_cols=186 Identities=41% Similarity=0.664 Sum_probs=144.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.+...++.++||
T Consensus 114 ~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 192 (337)
T cd07858 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDV 192 (337)
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccH
Confidence 3699999999999999999999999999999999999999987654322 223445678999999998764568899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC--CchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+.+....+..+....+.+..+.|..........+....+. ...+...++.++..+.+||.
T Consensus 193 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 272 (337)
T cd07858 193 WSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLE 272 (337)
T ss_pred HHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHH
Confidence 9999999999999999999888888888888888877665532111111111000011 11223445678999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
+||+.||.+|||+.++|+||||.....+.
T Consensus 273 ~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 273 KMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred HHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 99999999999999999999998754443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=245.81 Aligned_cols=159 Identities=28% Similarity=0.448 Sum_probs=125.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC------------------------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR------------------------------ 50 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~------------------------------ 50 (468)
+.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 107 ~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (360)
T cd05627 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186 (360)
T ss_pred HHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccccccccccc
Confidence 46999999999999999999999999999999999999999864432110
Q ss_pred ----CCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCC
Q 012191 51 ----QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 126 (468)
Q Consensus 51 ----~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~ 126 (468)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+........
T Consensus 187 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 256 (360)
T cd05627 187 KNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLV--------- 256 (360)
T ss_pred ccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCcee---------
Confidence 01124578999999999976 5689999999999999999999999998887777666643111000
Q ss_pred CccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCc---CHHHHHhcccccCCCCC
Q 012191 127 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTKPYA 186 (468)
Q Consensus 127 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRp---Ta~e~L~Hp~F~~~p~~ 186 (468)
+ .....++.++++||.+|+ .||.+|+ ++.+++.||||....|.
T Consensus 257 -----------~-----p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 257 -----------F-----PPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred -----------c-----CCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 0 001236889999999987 4999998 48999999999987664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=242.66 Aligned_cols=154 Identities=29% Similarity=0.486 Sum_probs=126.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ......++|+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di 179 (318)
T cd05570 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSY-QPYGPAVDW 179 (318)
T ss_pred HHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecCccccCHHHhcC-CCCCcchhh
Confidence 3699999999999999999999999999999999999999986432211 22234568999999999976 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+.......+...... ....++..+.+||.+|
T Consensus 180 wslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~li~~~ 230 (318)
T cd05570 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR-----------------------------YPRWLSKEAKSILKSF 230 (318)
T ss_pred hhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCcCCHHHHHHHHHH
Confidence 99999999999999999888776665555321100 0124678899999999
Q ss_pred cCCCCCCCcCH-----HHHHhcccccCCCC
Q 012191 161 LSVEPYKRATA-----SAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa-----~e~L~Hp~F~~~p~ 185 (468)
|..||.+|||+ .+++.||||....|
T Consensus 231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred ccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999 99999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=244.39 Aligned_cols=182 Identities=29% Similarity=0.492 Sum_probs=144.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
-||+.||++||..+||+|||||+|||+|+.|.|+|+|+|+|..+..+ .+...++||..|||||++.+.. |+.+.|.|
T Consensus 294 AEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g--~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf 370 (591)
T KOG0986|consen 294 AEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG--KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWF 370 (591)
T ss_pred HHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC--CccccccCcccccCHHHHcCCc-ccCCccHH
Confidence 37999999999999999999999999999999999999999887665 5677889999999999998855 99999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
+|||+||||+.|+.||....+......+-.....-+.++ -..+++++++|++.+|
T Consensus 371 ~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey-------------------------~~kFS~eakslc~~LL 425 (591)
T KOG0986|consen 371 SLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY-------------------------SDKFSEEAKSLCEGLL 425 (591)
T ss_pred HHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc-------------------------ccccCHHHHHHHHHHH
Confidence 999999999999999977654433333322222222111 1468999999999999
Q ss_pred CCCCCCCc-----CHHHHHhcccccCCCCCC---CCCCCCCCCCChhHHHhhHHHHHH
Q 012191 162 SVEPYKRA-----TASAALASEYFSTKPYAC---DLSSLPIYPPSKEIDAKHREDARR 211 (468)
Q Consensus 162 ~~DP~kRp-----Ta~e~L~Hp~F~~~p~~~---~~~~~p~~~p~~e~~~k~~~~~~r 211 (468)
..||.+|. ++.++-+||||++..|.- ..-.+|-.|+..++-++...+...
T Consensus 426 ~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeq 483 (591)
T KOG0986|consen 426 TKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQ 483 (591)
T ss_pred ccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhh
Confidence 99999996 578999999999987642 223345667777776666554433
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=241.95 Aligned_cols=154 Identities=31% Similarity=0.531 Sum_probs=125.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 179 (316)
T cd05619 102 AAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLG-QKYNTSVDW 179 (316)
T ss_pred HHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcC-CCCCchhhh
Confidence 3699999999999999999999999999999999999999986432211 12334578999999999876 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+.+..+... .+. + ...++.++.+||.+|
T Consensus 180 wslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~--------------------~-------~~~~~~~~~~li~~~ 230 (316)
T cd05619 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPC--------------------Y-------PRWLTREAKDILVKL 230 (316)
T ss_pred hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC--------------------C-------CccCCHHHHHHHHHH
Confidence 99999999999999999988776665554321 110 0 013678899999999
Q ss_pred cCCCCCCCcCHH-HHHhcccccCCCC
Q 012191 161 LSVEPYKRATAS-AALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~-e~L~Hp~F~~~p~ 185 (468)
|..||.+|+++. ++++||||....|
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 231 FVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred hccCHhhcCCChHHHHcCcccCCCCH
Confidence 999999999996 8999999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=247.66 Aligned_cols=179 Identities=24% Similarity=0.398 Sum_probs=124.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++||
T Consensus 163 ~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 239 (357)
T PHA03209 163 EKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLAGTVETNAPEVLAR-DKYNSKADI 239 (357)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cccccccccccccCCeecCC-CCCCchhhH
Confidence 369999999999999999999999999999999999999998753322 12234578999999999976 458999999
Q ss_pred eeeehhhhhhhhcC-CCCCCCc---------hHHHHHHHHHHcCCCCchhhhccCCCccc-c--C--CCCCCCCchhhhh
Q 012191 81 WSVGCVFAELLIGK-PILQGRT---------EVEQLHKIFKLCGSPPDDYWKKSKLPHAT-L--F--KPQQPYDSSLRET 145 (468)
Q Consensus 81 WSLG~ILyeLltG~-~pf~g~~---------~~e~l~~i~~~~g~p~~~~~~~~~~~~~~-~--~--~~~~~~~~~l~~~ 145 (468)
|||||++|+|+++. ++|.... ....+..++..++..+..+.......... . + ....++.......
T Consensus 240 wSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (357)
T PHA03209 240 WSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQ 319 (357)
T ss_pred HHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHh
Confidence 99999999999854 4444321 12334445555554443332100000000 0 0 0001111100111
Q ss_pred cCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 146 FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 146 ~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
...++.++.+||.+||++||.+||||.|+|+||||++
T Consensus 320 ~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 320 RVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 2356788899999999999999999999999999985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=241.10 Aligned_cols=162 Identities=26% Similarity=0.406 Sum_probs=126.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..............+||+.|+|||++.+ ...++.
T Consensus 108 ~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 187 (331)
T cd05597 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGP 187 (331)
T ss_pred HHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCC
Confidence 4699999999999999999999999999999999999999987654433222233568999999999863 245788
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|..||.+....+.+..+........ +......++..+++|
T Consensus 188 ~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~~l 243 (331)
T cd05597 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ------------------------FPPDVTDVSEEAKDL 243 (331)
T ss_pred cceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc------------------------CCCccCCCCHHHHHH
Confidence 99999999999999999999998877766666543211100 011123478999999
Q ss_pred HHHhcCCCCCC--CcCHHHHHhcccccCCCCC
Q 012191 157 IETLLSVEPYK--RATASAALASEYFSTKPYA 186 (468)
Q Consensus 157 L~~mL~~DP~k--RpTa~e~L~Hp~F~~~p~~ 186 (468)
|.+||..++.+ |+++.++|.||||....|.
T Consensus 244 i~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 244 IRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred HHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 99999765544 7899999999999876553
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=240.95 Aligned_cols=161 Identities=25% Similarity=0.391 Sum_probs=126.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..............+||+.|+|||++.+ ...++.
T Consensus 108 ~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 187 (332)
T cd05623 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGP 187 (332)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCC
Confidence 3699999999999999999999999999999999999999986554332222334578999999999863 345788
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|..||.+.+..+.+..+.......+ +......++.++++|
T Consensus 188 ~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~~s~~~~~l 243 (332)
T cd05623 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ------------------------FPAQVTDVSEDAKDL 243 (332)
T ss_pred cCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc------------------------CCCccccCCHHHHHH
Confidence 99999999999999999999998887777666643211100 011123578999999
Q ss_pred HHHhcCCCCCC--CcCHHHHHhcccccCCCC
Q 012191 157 IETLLSVEPYK--RATASAALASEYFSTKPY 185 (468)
Q Consensus 157 L~~mL~~DP~k--RpTa~e~L~Hp~F~~~p~ 185 (468)
|.+||..++.+ |+++.++++||||....|
T Consensus 244 i~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 244 IRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred HHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 99999765554 689999999999987554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=241.20 Aligned_cols=153 Identities=25% Similarity=0.442 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++|||
T Consensus 103 ~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 180 (329)
T cd05618 103 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRG-EDYGFSVDWW 180 (329)
T ss_pred HHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcC-CCCCCcccee
Confidence 689999999999999999999999999999999999999986432211 22334578999999999976 4688999999
Q ss_pred eeehhhhhhhhcCCCCCCCc--------hHH-HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHH
Q 012191 82 SVGCVFAELLIGKPILQGRT--------EVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~--------~~e-~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 152 (468)
||||++|+|++|..||.... ... ....+.... ......++..
T Consensus 181 slG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----------------------------~~~p~~~~~~ 231 (329)
T cd05618 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----------------------------IRIPRSLSVK 231 (329)
T ss_pred cccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----------------------------CCCCCCCCHH
Confidence 99999999999999995211 011 111111100 0011346788
Q ss_pred HHHHHHHhcCCCCCCCcC------HHHHHhcccccCCCC
Q 012191 153 AVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 185 (468)
Q Consensus 153 l~dLL~~mL~~DP~kRpT------a~e~L~Hp~F~~~p~ 185 (468)
+.+||.+||+.||.+|+| +.++++||||....|
T Consensus 232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999999999999998 589999999987544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=232.33 Aligned_cols=180 Identities=38% Similarity=0.690 Sum_probs=139.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...............++.+|+|||++.+...++.++||
T Consensus 106 ~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv 185 (288)
T cd07833 106 IWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDV 185 (288)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhH
Confidence 36899999999999999999999999999999999999999877665433244556778999999999875478899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCC-cc-ccCCCCCCCCchhhhhcCC-CcHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP-HA-TLFKPQQPYDSSLRETFKD-LPTTAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~-~~-~~~~~~~~~~~~l~~~~~~-~s~~l~dLL 157 (468)
|||||++|+|++|.+||.+....+.+..+...++..+...+...... .. ....+.......+...+.. ++..+.+||
T Consensus 186 ~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 265 (288)
T cd07833 186 WAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFL 265 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHH
Confidence 99999999999999999998888888887777776655433321110 00 0000011111122333333 489999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccc
Q 012191 158 ETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.+||..||.+|||+.+++.||||
T Consensus 266 ~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 266 KACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHhccCchhcccHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=240.31 Aligned_cols=182 Identities=38% Similarity=0.672 Sum_probs=142.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ .......++..|+|||.+.+...++.+
T Consensus 111 ~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 190 (332)
T cd07857 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKA 190 (332)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcH
Confidence 36999999999999999999999999999999999999999976543221 112345789999999998765668899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC---CCCCCCchhhhhcCCCcHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK---PQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~~~~~s~~l~ 154 (468)
+||||+||++|+|++|.+||.+......+..++..++.++.+.+.....+....+. ...+ ...+...++.++..+.
T Consensus 191 ~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 269 (332)
T cd07857 191 IDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIP-KKPFESIFPNANPLAL 269 (332)
T ss_pred HHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccC-CcchHhhCCCCCHHHH
Confidence 99999999999999999999999888899999998888876654432221110000 0000 1122334456788999
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||.+||+.||.+|||+.++|.||||..+
T Consensus 270 ~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 270 DLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 99999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=233.01 Aligned_cols=179 Identities=37% Similarity=0.671 Sum_probs=137.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++.+|+|||.+.+...++.++||
T Consensus 106 ~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 184 (286)
T cd07846 106 LFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDI 184 (286)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhH
Confidence 3689999999999999999999999999999999999999987654332 233445678999999998765567889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCC--ccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLP--HATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+....+.+..+....+............. ......+.......+...++.++..+.+||.
T Consensus 185 ~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 264 (286)
T cd07846 185 WAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAK 264 (286)
T ss_pred HHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHH
Confidence 99999999999999999988888888887766655432211100000 0001111222223344556788999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccc
Q 012191 159 TLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+||..||.+|||+.++|.||||
T Consensus 265 ~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 265 QCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHhcCCcccchhHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=235.62 Aligned_cols=158 Identities=27% Similarity=0.456 Sum_probs=126.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+||++++++.++|+|||++...... ......++++.|+|||++.+ ..++.++||
T Consensus 108 ~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 184 (285)
T cd05605 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYMAPEVVKN-ERYTFSPDW 184 (285)
T ss_pred HHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--CccccccCCCCccCcHHhcC-CCCCccccc
Confidence 369999999999999999999999999999999999999998765432 12234578999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+||++|+|++|..||.+.........+......... .....++..+.+||.+|
T Consensus 185 ws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 185 WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE-------------------------EYSEKFSEAARSICRQL 239 (285)
T ss_pred hhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc-------------------------ccCcccCHHHHHHHHHH
Confidence 99999999999999999887655444433322111110 01134788899999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~~ 186 (468)
|..||.+|| ++.+++.||||....|.
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 999999999 99999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=239.58 Aligned_cols=154 Identities=25% Similarity=0.390 Sum_probs=124.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+||||||+||||+.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 179 (321)
T cd05603 102 AAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRK-EPYDRTVDW 179 (321)
T ss_pred HHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcC-CCCCCcCcc
Confidence 3699999999999999999999999999999999999999986432211 22334578999999999876 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+.......+... +. ......+..+.+||.+|
T Consensus 180 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~--------------------------~~~~~~~~~~~~li~~~ 230 (321)
T cd05603 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---PL--------------------------QLPGGKTVAACDLLVGL 230 (321)
T ss_pred cccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---CC--------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999999999999988766655555321 10 01134677899999999
Q ss_pred cCCCCCCCcCH----HHHHhcccccCCCC
Q 012191 161 LSVEPYKRATA----SAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa----~e~L~Hp~F~~~p~ 185 (468)
|+.||.+|+++ .++++|+||....|
T Consensus 231 l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 231 LHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred ccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 99999999875 59999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-28 Score=246.16 Aligned_cols=152 Identities=30% Similarity=0.491 Sum_probs=127.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+.......... ...+||+.|||||++.+ ..|+.++||
T Consensus 117 lre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~-~~Y~~KADI 194 (467)
T KOG0201|consen 117 LREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQ-SGYDTKADI 194 (467)
T ss_pred hHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccccccccchhhhcc-ccccchhhh
Confidence 5789999999999999999999999999999999999999997766543333 67799999999999985 679999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++.+||++|.||+.....+..+..|-+ ..| ..+. ..+++.+++||..|
T Consensus 195 WSLGITaiEla~GePP~s~~hPmrvlflIpk---~~P----------------------P~L~---~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 195 WSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SAP----------------------PRLD---GDFSPPFKEFVEAC 246 (467)
T ss_pred hhhhHHHHHHhcCCCCCcccCcceEEEeccC---CCC----------------------Cccc---cccCHHHHHHHHHH
Confidence 9999999999999999987665333322211 000 0111 36889999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|..||+.||||.++|.|+|++.
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999987
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=233.45 Aligned_cols=178 Identities=43% Similarity=0.731 Sum_probs=132.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... .......+++.|+|||.+.+...++.++|||
T Consensus 110 ~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 188 (291)
T cd07870 110 FQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIW 188 (291)
T ss_pred HHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHH
Confidence 689999999999999999999999999999999999999986543221 1223345689999999987655678899999
Q ss_pred eeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhcC--CCcHHHHHHH
Q 012191 82 SVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFK--DLPTTAVNLI 157 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~--~~s~~l~dLL 157 (468)
||||++|+|++|.+||.+... .+.+..+....+.+....|.... .+..............+...+. ..+..+.+||
T Consensus 189 slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 268 (291)
T cd07870 189 GAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA 268 (291)
T ss_pred HHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHH
Confidence 999999999999999976543 46667777777777666554321 1110000000001111222222 2367899999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccc
Q 012191 158 ETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.+||..||.+|||+.++|.||||
T Consensus 269 ~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 269 SQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHhCcCcccCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=253.86 Aligned_cols=179 Identities=27% Similarity=0.399 Sum_probs=124.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+||||+.++.++|+|||++......... ......||+.|+|||++.+ ..++.++|
T Consensus 266 ~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sD 344 (461)
T PHA03211 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVD 344 (461)
T ss_pred HHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC-CCCCchHH
Confidence 479999999999999999999999999999999999999999765432221 1224568999999999977 45899999
Q ss_pred eeeeehhhhhhhhcCCCC-CCCc------hHHHHHHHHHHcCCCCchhhhcc--------CCCccccCCCCCCCCchhhh
Q 012191 80 LWSVGCVFAELLIGKPIL-QGRT------EVEQLHKIFKLCGSPPDDYWKKS--------KLPHATLFKPQQPYDSSLRE 144 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf-~g~~------~~e~l~~i~~~~g~p~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~ 144 (468)
|||||||||||++|..++ .... ...++.+++...+....++-... .........+ .+......
T Consensus 345 vwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~~~~~ 422 (461)
T PHA03211 345 IWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRP--AYTRPAWT 422 (461)
T ss_pred HHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCC--ccCCcchh
Confidence 999999999999987544 3221 12344444444333222111000 0000000000 00101112
Q ss_pred hcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 145 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 145 ~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+..++..+.+||.+||++||.+|||+.|||+||||+.
T Consensus 423 ~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 423 RYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 22356778999999999999999999999999999975
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=239.34 Aligned_cols=183 Identities=40% Similarity=0.672 Sum_probs=142.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC----CCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR----QPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ .......++.+|+|||.+.+...++.
T Consensus 113 ~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (337)
T cd07852 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTK 192 (337)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccc
Confidence 36899999999999999999999999999999999999999875543221 12334567899999999876666889
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccc-cCC-CCCCCCchhhhhcCCCcHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT-LFK-PQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~~~~~~s~~l~ 154 (468)
++|||||||++|+|++|++||.+....+....+....+.++...+......... .+. -.......+...++.++.++.
T Consensus 193 ~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 272 (337)
T cd07852 193 GVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL 272 (337)
T ss_pred cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHH
Confidence 999999999999999999999998888888888888777765544332111000 000 000111123444566899999
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||.+||+.||.+|||+.++|+||||+..
T Consensus 273 ~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 273 DLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 99999999999999999999999999774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=240.10 Aligned_cols=154 Identities=25% Similarity=0.423 Sum_probs=119.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 179 (329)
T cd05588 102 SAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDW 179 (329)
T ss_pred HHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccccCCccccCHHHHcC-CCCCCccce
Confidence 369999999999999999999999999999999999999998642211 122334578999999999976 568899999
Q ss_pred eeeehhhhhhhhcCCCCCCCch--------HHH-HHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH
Q 012191 81 WSVGCVFAELLIGKPILQGRTE--------VEQ-LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~--------~e~-l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 151 (468)
|||||++|+|++|..||..... .+. ...+.... . .....++.
T Consensus 180 wslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~---------------------------~~p~~~~~ 230 (329)
T cd05588 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--I---------------------------RIPRSLSV 230 (329)
T ss_pred echHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--C---------------------------CCCCCCCH
Confidence 9999999999999999963211 111 11111100 0 01124678
Q ss_pred HHHHHHHHhcCCCCCCCcC------HHHHHhcccccCCCC
Q 012191 152 TAVNLIETLLSVEPYKRAT------ASAALASEYFSTKPY 185 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpT------a~e~L~Hp~F~~~p~ 185 (468)
.+.+||.+||+.||.+|+| +.+++.||||....|
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 8999999999999999987 799999999976544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=236.80 Aligned_cols=179 Identities=42% Similarity=0.755 Sum_probs=134.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC----CCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN----EGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~----~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
.||+.||.|||+.||+|+||||+|||++. ++.+||+|||++........ .......++.+|+|||++.+...++
T Consensus 115 ~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (316)
T cd07842 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYT 194 (316)
T ss_pred HHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCC
Confidence 68999999999999999999999999999 89999999999876543322 1123346788999999988766688
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCch---------HHHHHHHHHHcCCCCchhhhccC-CCcccc---CCCCCCCC-ch
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYWKKSK-LPHATL---FKPQQPYD-SS 141 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~---------~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~---~~~~~~~~-~~ 141 (468)
.++|||||||++|+|++|.+||.+... ...+..++..++.+....|.... .+.... ......+. ..
T Consensus 195 ~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (316)
T cd07842 195 KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNS 274 (316)
T ss_pred cHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCcc
Confidence 999999999999999999999986543 23566777777777766554311 111111 00011111 11
Q ss_pred hh---hhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 142 LR---ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 142 l~---~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+. +.+...+..+.++|.+||+.||.+|||+.+++.||||
T Consensus 275 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 275 LAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 11 1223678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=230.16 Aligned_cols=175 Identities=41% Similarity=0.762 Sum_probs=137.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+ ..++.++||
T Consensus 113 ~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di 189 (287)
T cd07838 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVVTLWYRAPEVLLQ-SSYATPVDM 189 (287)
T ss_pred HHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC--cccccccccccccChHHhcc-CCCCCcchh
Confidence 368999999999999999999999999999999999999998765433 22233457889999999976 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+.+++...+.+....|..........+... .........+.++..+.+||.+|
T Consensus 190 ~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~ 267 (287)
T cd07838 190 WSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSY--TPRSFKSFVPEICEEGLDLLKKM 267 (287)
T ss_pred hhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccc--cccchhhhhhhhhHHHHHHHHHH
Confidence 9999999999999999999999999999888776665544432221111111111 11122444456788899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|+.||.+|||+.++|.||||
T Consensus 268 l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 268 LTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hccCCccCCCHHHHhcCcCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=240.33 Aligned_cols=180 Identities=38% Similarity=0.684 Sum_probs=142.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.||+|+||||+||+++.++.++|+|||++...... .....+++.|++||.+.+...++.++|+
T Consensus 124 ~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di 199 (343)
T cd07880 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDI 199 (343)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHH
Confidence 369999999999999999999999999999999999999998755432 2344668899999998765567889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC--CCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+.+....+..+++..+.++..++..........+.... .....+......++..+.+||.
T Consensus 200 ~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 279 (343)
T cd07880 200 WSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE 279 (343)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHH
Confidence 99999999999999999998888888888887777766655443221111110000 0111233445678899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
+||+.||.+|||+.++|.||||+...
T Consensus 280 ~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 280 KMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHcCCChhhCCCHHHHhcCccHhhhc
Confidence 99999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=238.46 Aligned_cols=154 Identities=29% Similarity=0.459 Sum_probs=126.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 107 ~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 184 (323)
T cd05615 107 AAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAY-QPYGKSVDW 184 (323)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-ccccCccCCccccCHHHHcC-CCCCCccch
Confidence 3689999999999999999999999999999999999999986543221 12234568999999999876 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+||++|+|++|.+||.+......+..+....... ...++.++.+||.+|
T Consensus 185 wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~~ 235 (323)
T cd05615 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----------------------------PKSLSKEAVSICKGL 235 (323)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------------------------CccCCHHHHHHHHHH
Confidence 999999999999999999888777766665421111 124678899999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
|..||.+|++ ..++++||||....|
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred cccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 9999999997 579999999987544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=239.02 Aligned_cols=178 Identities=25% Similarity=0.321 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+. +|+|+||||+|||++.++.++|+|||++...... ......+|+.|+|||++.+ ..++.++||
T Consensus 110 ~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Di 185 (331)
T cd06649 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDI 185 (331)
T ss_pred HHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccccCCCCcCcCCHhHhcC-CCCCchHhH
Confidence 6899999999986 6999999999999999999999999998755432 2234578999999999976 458999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhcc-CCCcc--ccCC----CCCCCCc--h-h--------
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHA--TLFK----PQQPYDS--S-L-------- 142 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~-~~~~~--~~~~----~~~~~~~--~-l-------- 142 (468)
|||||++|+|++|..||...+..+....+...........+... ..... .... ...+... . +
T Consensus 186 wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
T cd06649 186 WSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP 265 (331)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCC
Confidence 99999999999999999877655433322111100001000000 00000 0000 0000000 0 0
Q ss_pred -hhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 143 -RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 143 -~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
......++.++++||.+||.+||++|||+.++|+||||+..
T Consensus 266 ~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 266 PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00012467899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=238.62 Aligned_cols=182 Identities=36% Similarity=0.638 Sum_probs=134.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||+.||+|+||||+||+++. ++.++|+|||++........ .......++..|+|||.+.+...++.+
T Consensus 120 ~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (342)
T cd07854 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199 (342)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence 469999999999999999999999999975 45789999999875532211 111233578899999988765668889
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhcc--CCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS--KLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
+|||||||++|+|++|..||.+.+..+....+...........+... ..+. ............+....+.++.++.+
T Consensus 200 ~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (342)
T cd07854 200 IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPS-FVRNDGGEPRRPLRDLLPGVNPEALD 278 (342)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhh-hhhhcccccCCCHHHHccCCCHHHHH
Confidence 99999999999999999999988887777776654433322211110 0000 00001112222344555678899999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||.+||+.||.+|||+.++|.||||+..
T Consensus 279 li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 279 FLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHHHhCCCchhccCHHHHhCCCccccc
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=233.25 Aligned_cols=157 Identities=24% Similarity=0.422 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||+.||+||||||+|||++.++.++|+|||++...... .......++..|+|||++.+. .++.++|||
T Consensus 102 ~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 178 (277)
T cd05607 102 AQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGTNGYMAPEILKEE-PYSYPVDWF 178 (277)
T ss_pred HHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCCCCCccCHHHHccC-CCCCchhHH
Confidence 58999999999999999999999999999999999999998765432 223345688999999999774 489999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|..||.+.........+....... .+......++.++.+||.+||
T Consensus 179 slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~li~~~L 234 (277)
T cd05607 179 AMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED------------------------EVKFEHQNFTEESKDICRLFL 234 (277)
T ss_pred HHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc------------------------ccccccccCCHHHHHHHHHHh
Confidence 99999999999999997643322111111110000 000011357889999999999
Q ss_pred CCCCCCCcCH----HHHHhcccccCCCC
Q 012191 162 SVEPYKRATA----SAALASEYFSTKPY 185 (468)
Q Consensus 162 ~~DP~kRpTa----~e~L~Hp~F~~~p~ 185 (468)
+.||.+|||+ .+++.|+||....+
T Consensus 235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 235 AKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 9999999999 77889999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=228.01 Aligned_cols=177 Identities=41% Similarity=0.709 Sum_probs=140.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+|
T Consensus 106 ~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 183 (283)
T cd07830 106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPYTDYVSTRWYRAPEILLRSTSYSSPVDIW 183 (283)
T ss_pred HHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCcCCCCCcccccCceeeecCcCcCCccchh
Confidence 58999999999999999999999999999999999999998765432 2234456788999999987656688999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccc-cCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT-LFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++++|++|.+||.+....+.+..+....+.+....|......... ...........+...+...+..+.+||.+|
T Consensus 184 s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 263 (283)
T cd07830 184 ALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDM 263 (283)
T ss_pred hHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHh
Confidence 9999999999999999999999999999888888877666542211110 000000011123344445578899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|..||.+|||+.|++.||||
T Consensus 264 l~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 264 LRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccCcccCCCHHHHhhCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=237.39 Aligned_cols=155 Identities=25% Similarity=0.450 Sum_probs=120.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 102 ~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 179 (327)
T cd05617 102 AAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRG-EEYGFSVDW 179 (327)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHCC-CCCCchhee
Confidence 3699999999999999999999999999999999999999986432211 22344578999999999976 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCch------HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTE------VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~------~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
|||||++|+|++|..||..... .+.+..+.. ..+. .....++..+.
T Consensus 180 wslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~--------------------------~~p~~~~~~~~ 231 (327)
T cd05617 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--EKPI--------------------------RIPRFLSVKAS 231 (327)
T ss_pred ehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--hCCC--------------------------CCCCCCCHHHH
Confidence 9999999999999999964321 112222111 0000 01124678899
Q ss_pred HHHHHhcCCCCCCCcC------HHHHHhcccccCCCC
Q 012191 155 NLIETLLSVEPYKRAT------ASAALASEYFSTKPY 185 (468)
Q Consensus 155 dLL~~mL~~DP~kRpT------a~e~L~Hp~F~~~p~ 185 (468)
+||.+||+.||.+|++ +.+++.||||....|
T Consensus 232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 9999999999999998 579999999988654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=236.31 Aligned_cols=166 Identities=29% Similarity=0.413 Sum_probs=135.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCC---------------------------------C
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT---------------------------------G 48 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~---------------------------------~ 48 (468)
-+|+.||+|||..|||+|||||+||||-++|.|-|+||.++..... .
T Consensus 186 AEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~ 265 (459)
T KOG0610|consen 186 AEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSS 265 (459)
T ss_pred HHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcc
Confidence 3689999999999999999999999999999999999988632110 0
Q ss_pred CC----------------------CCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHH
Q 012191 49 HR----------------------QPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 106 (468)
Q Consensus 49 ~~----------------------~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l 106 (468)
.. ....+.+||-.|+|||++.|. .-+.++|+|+|||+|||||.|..||.|.+..+.+
T Consensus 266 ~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl 344 (459)
T KOG0610|consen 266 SKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL 344 (459)
T ss_pred ccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH
Confidence 00 111356889999999999984 4689999999999999999999999999999999
Q ss_pred HHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcC----HHHHHhcccccC
Q 012191 107 HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT----ASAALASEYFST 182 (468)
Q Consensus 107 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT----a~e~L~Hp~F~~ 182 (468)
.+|+..--..+. .+.++..++|||+++|..||.+|+. |.||-+||||..
T Consensus 345 ~NIv~~~l~Fp~---------------------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 345 RNIVGQPLKFPE---------------------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred HHHhcCCCcCCC---------------------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 998653222221 1256789999999999999999998 999999999999
Q ss_pred CCCCCCCCCCCCC
Q 012191 183 KPYACDLSSLPIY 195 (468)
Q Consensus 183 ~p~~~~~~~~p~~ 195 (468)
..|+.-....|.+
T Consensus 398 VnWaLir~~~PP~ 410 (459)
T KOG0610|consen 398 VNWALIRCARPPE 410 (459)
T ss_pred CChhheeccCCCc
Confidence 9888544444444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=254.06 Aligned_cols=176 Identities=24% Similarity=0.368 Sum_probs=124.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC-------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT------- 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~------- 72 (468)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||++..............++++.|+|||.+....
T Consensus 261 ~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~ 340 (566)
T PLN03225 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 340 (566)
T ss_pred HHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCcc
Confidence 468999999999999999999999999986 578999999999765543333345567899999999764321
Q ss_pred --------------CCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC
Q 012191 73 --------------DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 138 (468)
Q Consensus 73 --------------~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 138 (468)
.++.++||||||||||||+++.. ........+..++..++.... .|....... +.+.
T Consensus 341 ~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~---~~~~--- 411 (566)
T PLN03225 341 APVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLV-AWRKLVEPR---ASPD--- 411 (566)
T ss_pred ccccccccchhccccCCCCcccHHHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcHH-HHHHhhccc---cchh---
Confidence 23456799999999999998654 444555566666655544322 222111000 0000
Q ss_pred CchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 139 DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 139 ~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
.....+.+......+.+||.+||++||.+|||+.++|+||||+....
T Consensus 412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 00011222334556789999999999999999999999999987544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=237.49 Aligned_cols=181 Identities=38% Similarity=0.656 Sum_probs=139.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+|+||||+||+++.++.++|+|||++..... ......++.+|+|||++.+...++.++||
T Consensus 126 ~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 201 (345)
T cd07877 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDI 201 (345)
T ss_pred HHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhH
Confidence 36999999999999999999999999999999999999999875432 22345678999999998775668899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCC--CCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP--YDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+......+..+....+.++...+..........+....+ ....+...+...++.+.+||.
T Consensus 202 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 281 (345)
T cd07877 202 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 281 (345)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHH
Confidence 999999999999999999888888888887777776665543322111000000000 001122223356888999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+||+.||.+|+|+.++|.||||.....
T Consensus 282 ~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 282 KMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 999999999999999999999997533
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=227.99 Aligned_cols=157 Identities=31% Similarity=0.482 Sum_probs=123.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.+||+.||+|+||||+||+++.++.++|+|||.+.... ..........++..|+|||++.....++.++||
T Consensus 104 ~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 182 (260)
T PF00069_consen 104 AYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDI 182 (260)
T ss_dssp HHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccc
Confidence 3699999999999999999999999999999999999999987542 222344566789999999998734568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...........+...........+ ......+..+.+||.+|
T Consensus 183 ~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~ 240 (260)
T PF00069_consen 183 WSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS----------------------QQSREKSEELRDLIKKM 240 (260)
T ss_dssp HHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT----------------------TSHTTSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccchhhhhhhhhcccccccccc----------------------cccchhHHHHHHHHHHH
Confidence 99999999999999999987444444444332221111000 00012347899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|+.||.+|||+.++++||||
T Consensus 241 l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 241 LSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSSSGGGSTTHHHHHTSGGG
T ss_pred ccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=235.35 Aligned_cols=161 Identities=25% Similarity=0.398 Sum_probs=126.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC----CCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~----~~~s~ 76 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...............||+.|+|||++.+. ..++.
T Consensus 108 ~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 187 (331)
T cd05624 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP 187 (331)
T ss_pred HHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCC
Confidence 36999999999999999999999999999999999999999876554322222335689999999998642 35788
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|..||.+....+.+..+......++ +...+..++..+++|
T Consensus 188 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~~~~~~~~l 243 (331)
T cd05624 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ------------------------FPSHITDVSEEAKDL 243 (331)
T ss_pred cccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc------------------------CCCccccCCHHHHHH
Confidence 99999999999999999999998877766666543211110 011124578999999
Q ss_pred HHHhcCCCCCC--CcCHHHHHhcccccCCCC
Q 012191 157 IETLLSVEPYK--RATASAALASEYFSTKPY 185 (468)
Q Consensus 157 L~~mL~~DP~k--RpTa~e~L~Hp~F~~~p~ 185 (468)
|.+||..++.+ |+++.+++.|+||....|
T Consensus 244 i~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 244 IQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred HHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 99999976654 579999999999987544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=242.88 Aligned_cols=156 Identities=28% Similarity=0.537 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc-cccccCCcccChhhhcCC---------
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGA--------- 71 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~g~--------- 71 (468)
+|||.||.++|..||||.||||.|+|+- .|.+||+|||.|..+........ ...+||+.||+||.+...
T Consensus 467 kqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~ 545 (677)
T KOG0596|consen 467 KQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKS 545 (677)
T ss_pred HHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCc
Confidence 6999999999999999999999999985 48999999999987765543322 367999999999998632
Q ss_pred -CCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCc
Q 012191 72 -TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 150 (468)
Q Consensus 72 -~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s 150 (468)
...+.++||||||||||+|+.|++||..-. .++.++.... .|.. .-.|+.++
T Consensus 546 k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~-~P~~------------------------~Iefp~~~ 598 (677)
T KOG0596|consen 546 KIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAIT-DPNH------------------------EIEFPDIP 598 (677)
T ss_pred ceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhc-CCCc------------------------cccccCCC
Confidence 125678999999999999999999996422 1222332221 1110 00112222
Q ss_pred --HHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 151 --TTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 151 --~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
.++.+++..||..||.+|||+.++|+|||++-.+.
T Consensus 599 ~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 599 ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 23899999999999999999999999999885433
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=233.05 Aligned_cols=157 Identities=26% Similarity=0.470 Sum_probs=122.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... ......|+..|+|||++.+ ..++.++||
T Consensus 108 ~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Di 184 (285)
T cd05630 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKN-ERYTFSPDW 184 (285)
T ss_pred HHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--cccCCCCCccccChHHHcC-CCCCCcccc
Confidence 3689999999999999999999999999999999999999987554321 2234578999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+||++|+|++|.+||.+.................. ......+++++.+||.+|
T Consensus 185 wslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 185 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------------------EEYSEKFSPDARSLCKML 239 (285)
T ss_pred HHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-------------------------hhcCccCCHHHHHHHHHH
Confidence 9999999999999999987543221111111110000 011135778899999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
|+.||.+||| +.++++||||....+
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 9999999999 999999999986433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=251.49 Aligned_cols=153 Identities=27% Similarity=0.414 Sum_probs=126.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+..... ......+||+.|+|||++.+ ..|+.++|
T Consensus 149 ~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~D 227 (496)
T PTZ00283 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKAD 227 (496)
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHH
Confidence 36999999999999999999999999999999999999999876543211 22234578999999999976 45899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||.+.+..+.+..+...... .....+++++.+||.+
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~ 279 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD----------------------------PLPPSISPEMQEIVTA 279 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHH
Confidence 999999999999999999988776666655331110 0113578899999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccC
Q 012191 160 LLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||+.||.+|||+.++|.|||+..
T Consensus 280 ~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 280 LLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HcccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=226.36 Aligned_cols=152 Identities=30% Similarity=0.464 Sum_probs=121.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc--cccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL--TSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~--~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........... ....++..|+|||++.+. .++.++
T Consensus 110 ~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 188 (263)
T cd06625 110 TRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKA 188 (263)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccC-CCCchh
Confidence 36899999999999999999999999999999999999999875543211111 234578899999999874 488999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|+.||...........+...... ......++..+.+||.
T Consensus 189 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~ 241 (263)
T cd06625 189 DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN---------------------------PQLPSHVSPDARNFLR 241 (263)
T ss_pred hhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC---------------------------CCCCccCCHHHHHHHH
Confidence 9999999999999999999876555444443221100 0111357788999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccc
Q 012191 159 TLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
+||..||.+|||+.++|.|+||
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 242 RTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=222.75 Aligned_cols=180 Identities=33% Similarity=0.632 Sum_probs=140.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
|+|||.||.|||++||+|||+||.|++|+.. ..++|+|+|+|.++.++ .....++.+..|--||++.....|+.+-|
T Consensus 138 ~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~--~eYnVRVASRyfKGPELLVdy~~YDYSLD 215 (338)
T KOG0668|consen 138 IYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNVRVASRYFKGPELLVDYQMYDYSLD 215 (338)
T ss_pred HHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC--ceeeeeeehhhcCCchheeechhccccHH
Confidence 5799999999999999999999999999865 46999999999998876 34566788899999999999888999999
Q ss_pred eeeeehhhhhhhhcCCC-CCCCchHHHHHHHHHHcCCCCch-hhhccCCCccccCCC------CCCCCchhh-hhcCCCc
Q 012191 80 LWSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDD-YWKKSKLPHATLFKP------QQPYDSSLR-ETFKDLP 150 (468)
Q Consensus 80 IWSLG~ILyeLltG~~p-f~g~~~~e~l~~i~~~~g~p~~~-~~~~~~~~~~~~~~~------~~~~~~~l~-~~~~~~s 150 (468)
+|||||+|+.|+..+.| |.|.++.+|+-+|.+.+|...-. +..+..+.....|.. ..++..-+. +.-.-.+
T Consensus 216 ~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~ 295 (338)
T KOG0668|consen 216 MWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVS 295 (338)
T ss_pred HHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCC
Confidence 99999999999997755 57889999999999999874322 222222211111111 001111111 1112346
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+++.|||.++|.+|-.+|+||.|++.||||..
T Consensus 296 peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 296 PEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 99999999999999999999999999999975
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=230.46 Aligned_cols=157 Identities=26% Similarity=0.467 Sum_probs=127.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+
T Consensus 108 ~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di 184 (285)
T cd05632 108 AAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPEVLNN-QRYTLSPDY 184 (285)
T ss_pred HHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--CcccCCCCCcCccChHHhcC-CCCCcccch
Confidence 368999999999999999999999999999999999999998654332 22244578999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.........+.......... ....++..+.+||..|
T Consensus 185 ~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~ 239 (285)
T cd05632 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV-------------------------YSAKFSEEAKSICKML 239 (285)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc-------------------------cCccCCHHHHHHHHHH
Confidence 999999999999999998876655544443322111110 1135778899999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
|+.||.+||| +.+++.|+||...++
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 9999999999 899999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=237.45 Aligned_cols=155 Identities=30% Similarity=0.504 Sum_probs=130.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC------CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY 74 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~------g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~ 74 (468)
|+||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+.++ ......+|++.|||||++.. ..|
T Consensus 115 m~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~--~~a~tlcGSplYMAPEV~~~-~~Y 191 (429)
T KOG0595|consen 115 MQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG--SMAETLCGSPLYMAPEVIMS-QQY 191 (429)
T ss_pred HHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch--hHHHHhhCCccccCHHHHHh-ccc
Confidence 6899999999999999999999999999765 46899999999988764 34567799999999999964 579
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
+.++|+||+|+|||+|++|++||...+..+.+..+.+.....+. .-..++..+.
T Consensus 192 dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~--------------------------~~~~~s~~~~ 245 (429)
T KOG0595|consen 192 DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV--------------------------LPAELSNPLR 245 (429)
T ss_pred cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc--------------------------hhhhccCchh
Confidence 99999999999999999999999999998888866442211110 0123556677
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
+|+..+|..+|..|.+..+-+.|++....|
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999999999999999999999999988765
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=232.66 Aligned_cols=160 Identities=29% Similarity=0.430 Sum_probs=127.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC----------------------------C
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ----------------------------P 52 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~----------------------------~ 52 (468)
+.||+.||+|||+.||+|+||||+||+++.++.++|+|||++......... .
T Consensus 109 ~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (316)
T cd05574 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188 (316)
T ss_pred HHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCC
Confidence 369999999999999999999999999999999999999998654322110 1
Q ss_pred ccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccC
Q 012191 53 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 132 (468)
Q Consensus 53 ~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 132 (468)
....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.......+
T Consensus 189 ~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 252 (316)
T cd05574 189 SNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFP--------------- 252 (316)
T ss_pred CCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCC---------------
Confidence 113367889999999976 4578899999999999999999999988877666655532110000
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcC----HHHHHhcccccCCCCCCC
Q 012191 133 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT----ASAALASEYFSTKPYACD 188 (468)
Q Consensus 133 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT----a~e~L~Hp~F~~~p~~~~ 188 (468)
....++..+.+||.+||..||.+||| +.++|.||||+...|+.-
T Consensus 253 ------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~ 300 (316)
T cd05574 253 ------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI 300 (316)
T ss_pred ------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence 01226889999999999999999999 999999999999777643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=223.19 Aligned_cols=150 Identities=26% Similarity=0.442 Sum_probs=122.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||++||+.||+|+||+|+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++||
T Consensus 108 ~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 185 (257)
T cd08223 108 FVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTLIGTPYYMSPELFSN-KPYNYKSDV 185 (257)
T ss_pred HHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-CccccccCCcCccChhHhcC-CCCCchhhh
Confidence 3689999999999999999999999999999999999999987654322 22334567899999999876 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+.......+.... .+ .....++..+.+||.+|
T Consensus 186 ~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 186 WALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--LP--------------------------PMPKDYSPELGELIATM 237 (257)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CC--------------------------CCccccCHHHHHHHHHH
Confidence 999999999999999998776655544443211 10 00124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|+.||.+|||+.++|.||||
T Consensus 238 l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 238 LSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=248.00 Aligned_cols=153 Identities=27% Similarity=0.458 Sum_probs=126.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ......+||+.|+|||++.+ ..++.++|
T Consensus 175 ~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 253 (478)
T PTZ00267 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKAD 253 (478)
T ss_pred HHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHh
Confidence 36999999999999999999999999999999999999999986643321 12334578999999999876 46899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||.+.+..+.+..+......+ ....++..+.+||.+
T Consensus 254 v~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~s~~~~~li~~ 305 (478)
T PTZ00267 254 MWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP----------------------------FPCPVSSGMKALLDP 305 (478)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------------------CCccCCHHHHHHHHH
Confidence 9999999999999999999887776666654321100 012467889999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccC
Q 012191 160 LLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||..||.+|||+.++|.|+|+..
T Consensus 306 ~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 306 LLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=225.58 Aligned_cols=152 Identities=28% Similarity=0.433 Sum_probs=119.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+ ...++.
T Consensus 117 ~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~ 195 (272)
T cd06637 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDF 195 (272)
T ss_pred HHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCc
Confidence 3699999999999999999999999999999999999999987553321 12234567899999999863 235788
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++||||+||++|+|++|..||...........+... +.. ......++..+.+|
T Consensus 196 ~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~------------------------~~~~~~~~~~~~~l 248 (272)
T cd06637 196 KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PAP------------------------RLKSKKWSKKFQSF 248 (272)
T ss_pred hhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CCC------------------------CCCCCCcCHHHHHH
Confidence 999999999999999999999765544333222110 000 00112467889999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccc
Q 012191 157 IETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
|.+||..||.+|||+.++|.||||
T Consensus 249 i~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 249 IESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHcCCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=226.21 Aligned_cols=155 Identities=24% Similarity=0.342 Sum_probs=123.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc----CCCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----g~~~~s~~ 77 (468)
.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... .......++..|+|||++. ....++.+
T Consensus 110 ~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 188 (282)
T cd06643 110 KQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188 (282)
T ss_pred HHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCcc
Confidence 689999999999999999999999999999999999999986543221 2223456789999999984 22457789
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||+||++|+|++|.+||...+..+....+........ .....++..+.+||
T Consensus 189 ~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li 242 (282)
T cd06643 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--------------------------AQPSRWSSEFKDFL 242 (282)
T ss_pred chhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC--------------------------CCccccCHHHHHHH
Confidence 9999999999999999999988776665555533211000 00124678899999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||+.||.+|||+.++|+||||...
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHccCChhhCcCHHHHhcCCCEecc
Confidence 99999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=254.95 Aligned_cols=168 Identities=32% Similarity=0.454 Sum_probs=142.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc----CCCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----g~~~~s~~ 77 (468)
-.|+.||.-||+.|+|||||||+|||||..|.|||+|||.+..+...+.......+|||-|++||+|. +...|+..
T Consensus 182 aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~e 261 (1317)
T KOG0612|consen 182 AEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRE 261 (1317)
T ss_pred HHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCc
Confidence 36889999999999999999999999999999999999999888766666667789999999999995 22568999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHH--cCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL--CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~--~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
+|.||+||++||||.|..||....-++.+.+|+.. ...+|.+ .++|+++++
T Consensus 262 cDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~---------------------------~~VSeeakd 314 (1317)
T KOG0612|consen 262 CDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE---------------------------TDVSEEAKD 314 (1317)
T ss_pred cchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc---------------------------cccCHHHHH
Confidence 99999999999999999999999999999999865 2222211 248999999
Q ss_pred HHHHhcCCCCCCCcC---HHHHHhcccccCCCCCCCCCCCCCCCC
Q 012191 156 LIETLLSVEPYKRAT---ASAALASEYFSTKPYACDLSSLPIYPP 197 (468)
Q Consensus 156 LL~~mL~~DP~kRpT---a~e~L~Hp~F~~~p~~~~~~~~p~~~p 197 (468)
||+++|. +|..|.. ++++-.||||...+|..--...|.+-|
T Consensus 315 LI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 315 LIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred HHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 9999984 7889988 999999999999999554444444444
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-27 Score=220.13 Aligned_cols=149 Identities=33% Similarity=0.535 Sum_probs=132.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++|++.||.|||..+|+||||||+|+|++..+.+||+|||.+.....+ .-...+||.-|.|||...+ ..++..+|+
T Consensus 130 i~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~---kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~ 205 (281)
T KOG0580|consen 130 IKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN---KRKTLCGTLDYLPPEMVEG-RGHDKFVDL 205 (281)
T ss_pred HHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC---CceeeecccccCCHhhcCC-CCccchhhH
Confidence 579999999999999999999999999999999999999998755432 3356799999999999877 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|++|++.||++.|.+||...+..+.+.+|.+.--..| ..++..+.|||.+|
T Consensus 206 w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p-----------------------------~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 206 WSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP-----------------------------STISGGAADLISRL 256 (281)
T ss_pred HHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC-----------------------------cccChhHHHHHHHH
Confidence 9999999999999999999999999999977543322 35789999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|..+|.+|.+..+++.|||...
T Consensus 257 l~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=225.98 Aligned_cols=152 Identities=27% Similarity=0.449 Sum_probs=119.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.. ...++.
T Consensus 127 ~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~ 205 (282)
T cd06636 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDY 205 (282)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCc
Confidence 3689999999999999999999999999999999999999986543221 12234567899999998853 235788
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|.+||...........+... ... ......++..+.+|
T Consensus 206 ~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~------------------------~~~~~~~~~~~~~l 258 (282)
T cd06636 206 RSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PPP------------------------KLKSKKWSKKFIDF 258 (282)
T ss_pred ccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CCC------------------------CCcccccCHHHHHH
Confidence 999999999999999999999766544433332111 000 00113578899999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccc
Q 012191 157 IETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
|.+||..||.+|||+.++|.||||
T Consensus 259 i~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 259 IEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=219.83 Aligned_cols=153 Identities=26% Similarity=0.426 Sum_probs=126.4
Q ss_pred HHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCcc
Q 012191 3 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVD 79 (468)
Q Consensus 3 QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~sD 79 (468)
-++.||.||-++ ||+|||+||+|||+|..|++||||||.+-++.... ..+...|.+.|||||.+.- ...|+..+|
T Consensus 199 a~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaD 276 (391)
T KOG0983|consen 199 AIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRAD 276 (391)
T ss_pred HHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc--ccccccCCccccCccccCCCCCCccchhhh
Confidence 478899999874 89999999999999999999999999997765442 2344578899999999853 346899999
Q ss_pred eeeeehhhhhhhhcCCCCCCC-chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~-~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||+.|+||.||+.||.+. ++.+.+.++... .||. |... ..+++.+.+|+.
T Consensus 277 VWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~-----------------------L~~~-~gFSp~F~~fv~ 330 (391)
T KOG0983|consen 277 VWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL-----------------------LPGH-MGFSPDFQSFVK 330 (391)
T ss_pred hhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC-----------------------CCcc-cCcCHHHHHHHH
Confidence 999999999999999999884 677888888652 2211 1111 238999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.||..|+.+||.-.++|+|||+...
T Consensus 331 ~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 331 DCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHhhcCcccCcchHHHhcCcceeec
Confidence 9999999999999999999998764
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=228.10 Aligned_cols=157 Identities=26% Similarity=0.452 Sum_probs=125.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++||
T Consensus 124 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 201 (292)
T cd06658 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISR-LPYGTEVDI 201 (292)
T ss_pred HHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceeecCccccCHHHHcc-CCCCchhhH
Confidence 3689999999999999999999999999999999999999986543321 22234567899999999865 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+......+..+........ .....++..+.+||.+|
T Consensus 202 ~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV--------------------------KDSHKVSSVLRGFLDLM 255 (292)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc--------------------------ccccccCHHHHHHHHHH
Confidence 9999999999999999988776555544432111000 00124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|..||.+|||+.++|+||||...+.
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccCC
Confidence 9999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=227.53 Aligned_cols=154 Identities=27% Similarity=0.422 Sum_probs=121.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.||+|+||||+|||++.++.++|+|||++...... ......++..|+|||.+.+...++.++||
T Consensus 103 ~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 179 (279)
T cd05633 103 ATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGTAYDSSADW 179 (279)
T ss_pred HHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCcCCCcCccCHHHhcCCCCCCchhhh
Confidence 368999999999999999999999999999999999999998654432 12234689999999998654568899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchH--HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEV--EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~--e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||+||++|+|++|..||.+.... ..+..... ... ......++.++.+||.
T Consensus 180 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~-------------------------~~~~~~~~~~~~~li~ 231 (279)
T cd05633 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TVN-------------------------VELPDSFSPELKSLLE 231 (279)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cCC-------------------------cCCccccCHHHHHHHH
Confidence 99999999999999999754321 11111110 000 0112357889999999
Q ss_pred HhcCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 159 TLLSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 159 ~mL~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
+||..||.+|+ |+.++++||||....+
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 99999999999 6999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=225.53 Aligned_cols=163 Identities=25% Similarity=0.406 Sum_probs=128.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCccccC------CCCCCCccccccCCcccChhhhc--
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSN------TGHRQPLTSRVVTLWYRPPELLL-- 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~~~~------~~~~~~~~~~~gt~~Y~APE~l~-- 69 (468)
++.|+.||.|||.+||.||||||+|||..... -||||||.+..-.. +.....+...+|+..|||||+..
T Consensus 182 vkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~f 261 (463)
T KOG0607|consen 182 VKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVF 261 (463)
T ss_pred HHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhh
Confidence 36799999999999999999999999986554 38999998874322 12223345668899999999863
Q ss_pred --CCCCCCCCcceeeeehhhhhhhhcCCCCCCCc---------------hHHHHHHHHHHcCCCCchhhhccCCCccccC
Q 012191 70 --GATDYGPSVDLWSVGCVFAELLIGKPILQGRT---------------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 132 (468)
Q Consensus 70 --g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~---------------~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 132 (468)
....|+..+|+||||||||.||+|++||.|.- ....++.|.+.....|+..|
T Consensus 262 v~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW----------- 330 (463)
T KOG0607|consen 262 VDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW----------- 330 (463)
T ss_pred ccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh-----------
Confidence 34578999999999999999999999998742 13344555554444444444
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCCCC
Q 012191 133 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 188 (468)
Q Consensus 133 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~ 188 (468)
..++.++++||..+|..|+..|.+|.++|+|||++.....+.
T Consensus 331 --------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka 372 (463)
T KOG0607|consen 331 --------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA 372 (463)
T ss_pred --------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence 689999999999999999999999999999999988654443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=241.84 Aligned_cols=155 Identities=32% Similarity=0.585 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc-CCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL-GATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-g~~~~s~~sD 79 (468)
+|||+||.|||++.|||||||.+|+||+. .|.+||+|||.++....- ........||+.|||||++- |...|+.++|
T Consensus 682 kQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFTGTLQYMAPEvIDqG~RGYG~aAD 760 (1226)
T KOG4279|consen 682 KQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFTGTLQYMAPEVIDQGPRGYGKAAD 760 (1226)
T ss_pred HHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-CccccccccchhhhChHhhccCCcCCCchhh
Confidence 79999999999999999999999999964 689999999998766432 12233567899999999994 5567999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++.||.||+|||..-.... ..+|+. .+|+-..++. ..++.+++.||.+
T Consensus 761 IWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-----------------GmyKvHP~iP-------eelsaeak~Filr 814 (1226)
T KOG4279|consen 761 IWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-----------------GMYKVHPPIP-------EELSAEAKNFILR 814 (1226)
T ss_pred hhhccceeEeeccCCCCeeecCChh--Hhhhhh-----------------cceecCCCCc-------HHHHHHHHHHHHH
Confidence 9999999999999999996432211 111111 1122111221 3578899999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|+.+||.+||+|.++|.+||++..
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999865
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=221.51 Aligned_cols=157 Identities=29% Similarity=0.464 Sum_probs=124.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC---CccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.....++.+
T Consensus 108 ~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~ 187 (267)
T cd06610 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187 (267)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcc
Confidence 469999999999999999999999999999999999999998765543222 12334678899999998765468899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|+|||||++|+|++|..||...+....+..+... .+..+ .. ...+..++..+.+||
T Consensus 188 ~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~----------------~~----~~~~~~~~~~~~~li 244 (267)
T cd06610 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL----------------ET----GADYKKYSKSFRKMI 244 (267)
T ss_pred cchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc----------------CC----ccccccccHHHHHHH
Confidence 99999999999999999999877665544444321 11000 00 001346788999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccc
Q 012191 158 ETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.+||..||.+|||+.++|.||||
T Consensus 245 ~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 245 SLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=233.26 Aligned_cols=147 Identities=31% Similarity=0.472 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHhCC-CeeccCCCCceEECCCC-cEEEEecCCccccCCCCCCCccccccCCcccChhhhcC-CCCCCCCc
Q 012191 2 NQLLHGLEHCHSRG-VLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~g-IvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g-~~~~s~~s 78 (468)
.||+.||.|||+++ |||||||++|||++.++ ++||+|||+++...... ...+...||+.|||||++.+ ...|+.++
T Consensus 149 ldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~ 227 (362)
T KOG0192|consen 149 LDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKS 227 (362)
T ss_pred HHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccc
Confidence 58999999999999 99999999999999997 99999999997665432 34455789999999999985 35799999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++||||++|..||.+.........+......|.. ...+++.+..||.
T Consensus 228 DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~---------------------------p~~~~~~l~~l~~ 280 (362)
T KOG0192|consen 228 DVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI---------------------------PKECPPHLSSLME 280 (362)
T ss_pred hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC---------------------------CccCCHHHHHHHH
Confidence 9999999999999999999998885555444332222211 1237889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
.||..||..||+..+++.
T Consensus 281 ~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 281 RCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HhCCCCCCcCCCHHHHHH
Confidence 999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=236.66 Aligned_cols=152 Identities=29% Similarity=0.440 Sum_probs=136.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|.||+.||.|||++.|+|||||+.|||++.++.|+|+|||+|+...+.. ......+||+.|+.||++.+ .+|+.++||
T Consensus 112 ~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d-~pYn~KSDi 189 (426)
T KOG0589|consen 112 FVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSD-IPYNEKSDI 189 (426)
T ss_pred HHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCC-CCCCccCcc
Confidence 4699999999999999999999999999999999999999999887643 24567799999999999987 679999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|||++-+++|.+.+......+|+.....|-. ..++.+++.||..|
T Consensus 190 WsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----------------------------~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 190 WSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----------------------------SMYSSELRSLVKSM 241 (426)
T ss_pred hhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC----------------------------ccccHHHHHHHHHH
Confidence 99999999999999999999999999999887644432 35788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|..+|..||++.++|.+|....
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999987763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=230.32 Aligned_cols=149 Identities=30% Similarity=0.504 Sum_probs=131.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|+||+.|+.|||.++|+|||||.+|||+|.++.+||+|||++..+... ..++.+||++-|.+||++.|..+-++.+|.
T Consensus 159 FRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDs 236 (668)
T KOG0611|consen 159 FRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDS 236 (668)
T ss_pred HHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--cHHHHhcCCcccCCccccCCCCCCCCccch
Confidence 589999999999999999999999999999999999999999988654 467888999999999999997767899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++||.|+.|..||.|.+....+.+|......- +.-+.++.-||++|
T Consensus 237 WsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE------------------------------P~~PSdA~gLIRwm 286 (668)
T KOG0611|consen 237 WSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE------------------------------PETPSDASGLIRWM 286 (668)
T ss_pred hhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC------------------------------CCCCchHHHHHHHH
Confidence 999999999999999999999888888875432111 23466788999999
Q ss_pred cCCCCCCCcCHHHHHhccccc
Q 012191 161 LSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~ 181 (468)
|.+||.+|.|+.++..|=|.+
T Consensus 287 LmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HhcCcccchhHHHHhhhheee
Confidence 999999999999999996654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=225.16 Aligned_cols=157 Identities=22% Similarity=0.326 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC--CCCCCCc
Q 012191 2 NQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~--~~~s~~s 78 (468)
.|++.||+|||+. ||+||||||+|||++.++.++|+|||++....... ......++..|+|||++.+. ..++.++
T Consensus 114 ~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 191 (288)
T cd06616 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRS 191 (288)
T ss_pred HHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--ccccccCccCccCHHHhccccccCCcchh
Confidence 6899999999975 99999999999999999999999999987554321 22334678899999998764 3688999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||+||++|+|++|.+||..... ....+.......+... . ......++.++.+||.
T Consensus 192 Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~------------------~---~~~~~~~~~~l~~li~ 248 (288)
T cd06616 192 DVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL------------------S---NSEEREFSPSFVNFIN 248 (288)
T ss_pred hhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC------------------C---CcCCCccCHHHHHHHH
Confidence 999999999999999999976542 2222222211111000 0 0011347889999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||+.||.+|||+.+++.||||...
T Consensus 249 ~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 249 LCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHccCChhhCcCHHHHhcChhhhch
Confidence 9999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=220.54 Aligned_cols=151 Identities=32% Similarity=0.615 Sum_probs=120.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-----CCccccccCCcccChhhhcCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-----QPLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-----~~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
+.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+ ..++
T Consensus 112 ~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~ 190 (267)
T cd06628 112 VRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYT 190 (267)
T ss_pred HHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCC
Confidence 36899999999999999999999999999999999999999876542211 01112357888999999876 4578
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++|+|||||++|+|++|..||.+.+....+..+.... .+ .....++..+.+
T Consensus 191 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~ 242 (267)
T cd06628 191 RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--SP--------------------------EIPSNISSEAID 242 (267)
T ss_pred chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--CC--------------------------cCCcccCHHHHH
Confidence 89999999999999999999998776555444432210 00 011346788999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 156 LIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||.+||+.||.+||++.++|+||||
T Consensus 243 li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 243 FLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=224.04 Aligned_cols=157 Identities=28% Similarity=0.421 Sum_probs=122.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...... ........+++.|+|||++.+ ...++.
T Consensus 116 ~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 194 (292)
T cd06644 116 CRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194 (292)
T ss_pred HHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccccceecCCccccCceeeccccccCCCCCc
Confidence 368999999999999999999999999999999999999988654322 122234467889999999853 234678
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|.+||...+....+.++... .++. ......++.++.+|
T Consensus 195 ~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~------------------------~~~~~~~~~~~~~l 248 (292)
T cd06644 195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT------------------------LSQPSKWSMEFRDF 248 (292)
T ss_pred hhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCcc------------------------CCCCcccCHHHHHH
Confidence 999999999999999999999876655444443221 0000 00113467789999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|.+||..||.+||++.++|+||||....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 249 LKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHhcCCcccCcCHHHHhcCccccccc
Confidence 9999999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=223.57 Aligned_cols=157 Identities=26% Similarity=0.408 Sum_probs=122.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++..+... ......++..|+|||++.+...++.++||
T Consensus 103 ~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 179 (278)
T cd05606 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADW 179 (278)
T ss_pred HHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCcCCCcCCcCcHHhcCCCCCCcccch
Confidence 368999999999999999999999999999999999999998755432 12334789999999999765568899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+||++|+|++|..||.+........ +........ ......++..+.+||.+|
T Consensus 180 ~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 180 FSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA-------------------------VELPDSFSPELRSLLEGL 233 (278)
T ss_pred HhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhccC-------------------------CCCCCcCCHHHHHHHHHH
Confidence 999999999999999997653211111 000000000 001124678999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~~ 186 (468)
|..||.+|+ ++.++++||||....|.
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 999999999 99999999999886553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=226.11 Aligned_cols=179 Identities=24% Similarity=0.342 Sum_probs=122.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC------CCccccccCCcccChhhhcCC-CC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGA-TD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~g~-~~ 73 (468)
++||+.||.|||++||+|+||||+|||++.++.++|+|||.+........ .......++..|+|||++.+. ..
T Consensus 107 ~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (314)
T cd08216 107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186 (314)
T ss_pred HHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCC
Confidence 47999999999999999999999999999999999999998864432111 111234567889999998653 35
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccc---------cCCCCCCCCchhhh
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT---------LFKPQQPYDSSLRE 144 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~ 144 (468)
|+.++||||+||++|+|++|..||........+..... +..+.. +.....+... ...+... ......
T Consensus 187 ~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 262 (314)
T cd08216 187 YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCL-LDKSTYPLYEDSMSQSRSSNEHPNNR-DSVDHP 262 (314)
T ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccc-cccCchhhhcCCcCcccccccccchh-hhhhcc
Confidence 78899999999999999999999987655443322221 211110 0000000000 0000000 000011
Q ss_pred hcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 145 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 145 ~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
....++.++.+||..||.+||.+|||+.++|.||||+..
T Consensus 263 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 263 YTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 112456789999999999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=229.57 Aligned_cols=179 Identities=40% Similarity=0.691 Sum_probs=140.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|.|||++.++.++|+|||++..... ......++..|+|||.+.+...++.++||
T Consensus 114 ~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 189 (328)
T cd07856 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDI 189 (328)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----CcCCCcccccccCceeeeccCCcCcHHHH
Confidence 36899999999999999999999999999999999999999875432 22344678899999988765668899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC--CCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+.........+.+.++.++.+++..........+.... .........++.++..+.++|.
T Consensus 190 ~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 269 (328)
T cd07856 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLE 269 (328)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHH
Confidence 99999999999999999998888888888888888887665432111110000000 0011223445678899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||+.||.+|||+.++|.||||...
T Consensus 270 ~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 270 KMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHcCCChhhCCCHHHHhcCCccccc
Confidence 9999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=229.27 Aligned_cols=147 Identities=25% Similarity=0.373 Sum_probs=113.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......+++.|+|||++.+ ..++.++||
T Consensus 181 ~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi 259 (338)
T cd05102 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDV 259 (338)
T ss_pred HHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc-CCCCcccCH
Confidence 59999999999999999999999999999999999999999754322111 1122345678999999876 458999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||+||||++ |.+||.+....+.+...+.. +... .....+++.+.+||.+
T Consensus 260 wslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~~l~~li~~ 312 (338)
T cd05102 260 WSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTRM--------------------------RAPENATPEIYRIMLA 312 (338)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCCC--------------------------CCCCCCCHHHHHHHHH
Confidence 999999999997 99999876544433332221 1100 0012467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.++++
T Consensus 313 cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 313 CWQGDPKERPTFSALVE 329 (338)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=217.23 Aligned_cols=150 Identities=27% Similarity=0.408 Sum_probs=122.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++|+
T Consensus 107 ~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 184 (256)
T cd08529 107 FIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NFANTIVGTPYYLSPELCED-KPYNEKSDV 184 (256)
T ss_pred HHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-chhhccccCccccCHHHhcC-CCCCCccch
Confidence 3689999999999999999999999999999999999999987655432 12234467889999999876 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...+.......+.... .+ .....++..+.++|.+|
T Consensus 185 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 185 WALGVVLYECCTGKHPFDANNQGALILKIIRGV--FP--------------------------PVSQMYSQQLAQLIDQC 236 (256)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCccccCHHHHHHHHHH
Confidence 999999999999999998877665555543211 10 00114678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|+.+|.+||++.++|.|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=228.78 Aligned_cols=180 Identities=23% Similarity=0.317 Sum_probs=120.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-C-----CccccccCCcccChhhhcCC-CC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-Q-----PLTSRVVTLWYRPPELLLGA-TD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~-----~~~~~~gt~~Y~APE~l~g~-~~ 73 (468)
+.||+.||.|||++||+||||||+|||++.++.++++||+.+........ . ......++..|+|||++.+. ..
T Consensus 107 ~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (327)
T cd08227 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQG 186 (327)
T ss_pred HHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCC
Confidence 36899999999999999999999999999999999999986543221100 0 01123457789999998753 35
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCc----------hhhhcc-C------CCccccCC-CC
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD----------DYWKKS-K------LPHATLFK-PQ 135 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~----------~~~~~~-~------~~~~~~~~-~~ 135 (468)
|+.++|||||||++|+|++|..||.............. +..+. +..... . ........ ..
T Consensus 187 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (327)
T cd08227 187 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPR 264 (327)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcC
Confidence 88999999999999999999999986554433332221 11110 000000 0 00000000 00
Q ss_pred C-CCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 136 Q-PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 136 ~-~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
. ............+++.+.+||.+||++||.+|||+.++|+||||..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 265 PSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred ccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0 0000111222356788999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=219.48 Aligned_cols=153 Identities=34% Similarity=0.516 Sum_probs=123.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..... .....++..|++||.+.+. .++.++||
T Consensus 103 ~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~-~~~~~~Dv 176 (260)
T cd05611 103 IAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGV-GDDKMSDW 176 (260)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCC-CCcchhhh
Confidence 36999999999999999999999999999999999999998865432 1234578889999998774 47899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+....+..+.......+ ......++..+.++|.+|
T Consensus 177 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-------------------------EEVKEFCSPEAVDLINRL 231 (260)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC-------------------------CcccccCCHHHHHHHHHH
Confidence 9999999999999999988777665555432111100 011125788999999999
Q ss_pred cCCCCCCCcC---HHHHHhcccccCCC
Q 012191 161 LSVEPYKRAT---ASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpT---a~e~L~Hp~F~~~p 184 (468)
|+.||.+||| +.|+|.||||....
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 9999999995 57999999998743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=225.86 Aligned_cols=155 Identities=28% Similarity=0.498 Sum_probs=123.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++||
T Consensus 122 ~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 199 (296)
T cd06654 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199 (296)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-cccCcccCCccccCHHHHcC-CCCCccchH
Confidence 3689999999999999999999999999999999999999987544321 12233467889999999876 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||........+..+... +.+.. .....++..+.+||.+|
T Consensus 200 ~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~l~~li~~~ 253 (296)
T cd06654 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL-------------------------QNPEKLSAIFRDFLNRC 253 (296)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCC-------------------------CCccccCHHHHHHHHHH
Confidence 99999999999999999877654443332211 11100 00134678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.++|.||||...
T Consensus 254 l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 254 LDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CcCCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=220.38 Aligned_cols=152 Identities=30% Similarity=0.505 Sum_probs=117.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC--CCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+ ..++.++
T Consensus 112 ~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 190 (266)
T cd06651 112 TRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKA 190 (266)
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchh
Confidence 4689999999999999999999999999999999999999986543211 111223457889999999876 4578999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||+||++|+|++|.+||...........+.. .+... .....+++.+.+||
T Consensus 191 Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~~------------------------~~~~~~~~~~~~li- 242 (266)
T cd06651 191 DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTNP------------------------QLPSHISEHARDFL- 242 (266)
T ss_pred hhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCCC------------------------CCchhcCHHHHHHH-
Confidence 999999999999999999987655444433321 11000 00123567788898
Q ss_pred HhcCCCCCCCcCHHHHHhccccc
Q 012191 159 TLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
.||..||.+|||+.++|.||||+
T Consensus 243 ~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 243 GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHhcCChhhCcCHHHHhcCcccc
Confidence 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=222.71 Aligned_cols=154 Identities=28% Similarity=0.434 Sum_probs=120.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC----CCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT----DYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~----~~s~ 76 (468)
+.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.... .++.
T Consensus 134 ~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 212 (291)
T cd06639 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDA 212 (291)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCC
Confidence 36899999999999999999999999999999999999999876543221 122346788999999985432 3678
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|.+||........+..+... .+... .....++..+.+|
T Consensus 213 ~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~-----------------------~~~~~~~~~l~~l 266 (291)
T cd06639 213 RCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPTL-----------------------LHPEKWCRSFNHF 266 (291)
T ss_pred ccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCCC-----------------------CcccccCHHHHHH
Confidence 999999999999999999999877655554443221 10000 0012356789999
Q ss_pred HHHhcCCCCCCCcCHHHHHhccccc
Q 012191 157 IETLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
|.+||..||.+||++.++|+||||+
T Consensus 267 i~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 267 ISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=225.36 Aligned_cols=155 Identities=28% Similarity=0.482 Sum_probs=124.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||
T Consensus 121 ~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 198 (296)
T cd06655 121 CRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198 (296)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCCCccccCcchhcC-CCCCchhhH
Confidence 36899999999999999999999999999999999999999875543321 2233467889999999875 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+....+..+... +.+.. .....++..+.+||.+|
T Consensus 199 ~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~~~~li~~~ 252 (296)
T cd06655 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL-------------------------QNPEKLSPIFRDFLNRC 252 (296)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCccc-------------------------CCcccCCHHHHHHHHHH
Confidence 99999999999999999887766655544321 11110 01135778899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.+++.||||...
T Consensus 253 l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 253 LEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred hhcChhhCCCHHHHhhChHhhhc
Confidence 99999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=218.15 Aligned_cols=154 Identities=31% Similarity=0.486 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.+ ..++.++|+|
T Consensus 100 ~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~ 176 (262)
T cd05572 100 ACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILN-KGYDFSVDYW 176 (262)
T ss_pred HHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcC-CCCCChhhhh
Confidence 689999999999999999999999999999999999999987665432 2233467889999999865 4578899999
Q ss_pred eeehhhhhhhhcCCCCCCCc--hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 82 SVGCVFAELLIGKPILQGRT--EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~--~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||++|+|++|..||.... ..+.+..+......+. + ....+..+.+||.+
T Consensus 177 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------~-------~~~~~~~~~~~i~~ 229 (262)
T cd05572 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--------------------F-------PNYIDKAAKDLIKQ 229 (262)
T ss_pred hhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC--------------------C-------CcccCHHHHHHHHH
Confidence 99999999999999998766 4444444432111100 0 01347889999999
Q ss_pred hcCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 160 LLSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 160 mL~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
||..||.+|+| +.|+++||||+...|
T Consensus 230 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 230 LLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred HccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 99999999999 999999999997544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=219.98 Aligned_cols=152 Identities=27% Similarity=0.425 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC----CCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA----TDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~----~~~s~~ 77 (468)
.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||++... ..++.+
T Consensus 120 ~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 198 (275)
T cd06608 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDAR 198 (275)
T ss_pred HHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCcccc
Confidence 689999999999999999999999999999999999999987654322 222345678899999988532 346788
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|.+||........+..+... +.... .....++..+.+||
T Consensus 199 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~-----------------------~~~~~~~~~~~~li 252 (275)
T cd06608 199 SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPPTL-----------------------KSPENWSKKFNDFI 252 (275)
T ss_pred ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCCCC-----------------------CchhhcCHHHHHHH
Confidence 99999999999999999999866555444443221 00000 00123678899999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccc
Q 012191 158 ETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.+||..||.+|||+.+++.|||+
T Consensus 253 ~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 253 SECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-26 Score=224.93 Aligned_cols=157 Identities=30% Similarity=0.519 Sum_probs=126.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++||
T Consensus 123 ~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 200 (297)
T cd06659 123 CESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISR-TPYGTEVDI 200 (297)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecCccccCHHHHcc-CCCCchhhH
Confidence 3689999999999999999999999999999999999999986544321 12234567899999999876 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||......+.+..+.. .+. .. ......++..+.++|.+|
T Consensus 201 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-~~----------------------~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 201 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP-PK----------------------LKNAHKISPVLRDFLERM 254 (297)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC-CC----------------------ccccCCCCHHHHHHHHHH
Confidence 9999999999999999987776665554421 110 00 011235678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|+.||.+|||+.++++||||.....
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999997655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=222.25 Aligned_cols=156 Identities=27% Similarity=0.512 Sum_probs=125.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++||
T Consensus 121 ~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 198 (285)
T cd06648 121 CLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVISR-LPYGTEVDI 198 (285)
T ss_pred HHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccccccCCccccCHHHhcC-CCCCCcccH
Confidence 3689999999999999999999999999999999999999876543321 11233467899999999876 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+....+..+... .++. ......++..+.+||.+|
T Consensus 199 ~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~------------------------~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPPK------------------------LKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred HHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--CCCC------------------------CcccccCCHHHHHHHHHH
Confidence 99999999999999999887766665554322 1100 000123678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|..||.+|||+.++|+|+||....
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=220.59 Aligned_cols=154 Identities=30% Similarity=0.506 Sum_probs=123.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||
T Consensus 104 ~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~sDv 181 (274)
T cd06609 104 LREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQS-GYDEKADI 181 (274)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhccC-CCCchhhH
Confidence 3689999999999999999999999999999999999999997665432 122344678889999999764 48999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+.......+.... ++. +.. ..++..+.++|.+|
T Consensus 182 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~-----------------------~~~--~~~~~~~~~~l~~~ 234 (274)
T cd06609 182 WSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PPS-----------------------LEG--NKFSKPFKDFVSLC 234 (274)
T ss_pred HHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--CCC-----------------------Ccc--cccCHHHHHHHHHH
Confidence 999999999999999998766544443332211 000 000 12678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.+++.||||...
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=224.05 Aligned_cols=160 Identities=29% Similarity=0.441 Sum_probs=125.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--------------CccccccCCcccChh
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--------------PLTSRVVTLWYRPPE 66 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--------------~~~~~~gt~~Y~APE 66 (468)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||++......... ......++..|+|||
T Consensus 107 ~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 186 (305)
T cd05609 107 FAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186 (305)
T ss_pred HHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCch
Confidence 368999999999999999999999999999999999999987632111000 111235678899999
Q ss_pred hhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc
Q 012191 67 LLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 146 (468)
Q Consensus 67 ~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (468)
.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+. ..
T Consensus 187 ~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~ 239 (305)
T cd05609 187 VILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE--------------------------GD 239 (305)
T ss_pred hccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC--------------------------cc
Confidence 9876 45789999999999999999999999987766655555332111110 00
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCcC---HHHHHhcccccCCCCCC
Q 012191 147 KDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYAC 187 (468)
Q Consensus 147 ~~~s~~l~dLL~~mL~~DP~kRpT---a~e~L~Hp~F~~~p~~~ 187 (468)
..++.++.+||.+||+.||.+||| +.++|+||||...+++.
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 247888999999999999999998 79999999998876654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=221.22 Aligned_cols=153 Identities=29% Similarity=0.462 Sum_probs=131.6
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceee
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 82 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWS 82 (468)
.|+.||.|||+++||+||||.+|+|+|.+|.+||+|||++..-... .......|||+.|+|||++.. ..|+.++|.|.
T Consensus 276 EIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG 353 (516)
T KOG0690|consen 276 EIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWG 353 (516)
T ss_pred HHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc-cceeccccCChhhcCchhhcc-ccccceeehhh
Confidence 6899999999999999999999999999999999999998643322 234567899999999999976 67999999999
Q ss_pred eehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcC
Q 012191 83 VGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 162 (468)
Q Consensus 83 LG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~ 162 (468)
+||++|||+||+.||...+....+..|+..-...| ..++++++.||..+|.
T Consensus 354 ~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP-----------------------------r~ls~eAktLLsGLL~ 404 (516)
T KOG0690|consen 354 VGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP-----------------------------RTLSPEAKTLLSGLLK 404 (516)
T ss_pred hhHHHHHHHhccCcccccchhHHHHHHHhhhccCC-----------------------------ccCCHHHHHHHHHHhh
Confidence 99999999999999998888777777654322221 3589999999999999
Q ss_pred CCCCCCcC-----HHHHHhcccccCCCCC
Q 012191 163 VEPYKRAT-----ASAALASEYFSTKPYA 186 (468)
Q Consensus 163 ~DP~kRpT-----a~e~L~Hp~F~~~p~~ 186 (468)
.||.+|.. |.|+.+|+||....|.
T Consensus 405 kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 405 KDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred cChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 99999974 8999999999998774
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=219.12 Aligned_cols=153 Identities=29% Similarity=0.493 Sum_probs=121.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-----CCCccccccCCcccChhhhcCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
+.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+ ..++
T Consensus 108 ~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~ 186 (265)
T cd06631 108 TKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYG 186 (265)
T ss_pred HHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCc
Confidence 3689999999999999999999999999999999999999987543211 112234467889999999876 4578
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++|||||||++|+|++|..||...+.......+....+..+ .....++..+.+
T Consensus 187 ~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~ 240 (265)
T cd06631 187 RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP--------------------------RLPDSFSAAAID 240 (265)
T ss_pred chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC--------------------------CCCCCCCHHHHH
Confidence 999999999999999999999987665544433322111110 111357888999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 156 LIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||.+||..||.+|||+.++|.||||
T Consensus 241 ~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 241 FVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-26 Score=228.77 Aligned_cols=177 Identities=26% Similarity=0.399 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++...... ......++..|+|||++.+ ..++.++||
T Consensus 110 ~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 185 (333)
T cd06650 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDI 185 (333)
T ss_pred HHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcC-CCCCcHHHH
Confidence 5899999999985 7999999999999999999999999998654322 2234568999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHH--cCCCCchhhhccCCCcc---ccCCCCC-CCCc--hh-----h---h
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKL--CGSPPDDYWKKSKLPHA---TLFKPQQ-PYDS--SL-----R---E 144 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~--~g~p~~~~~~~~~~~~~---~~~~~~~-~~~~--~l-----~---~ 144 (468)
|||||++|+|++|..||......... .++.. .+.+............. ..+.+.. +... .+ . .
T Consensus 186 wslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (333)
T cd06650 186 WSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPP 264 (333)
T ss_pred HHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCc
Confidence 99999999999999999876543332 22211 11111100000000000 0000000 0000 00 0 0
Q ss_pred --hcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 145 --TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 145 --~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
....++.++++||.+||++||.+|||+.++|.|+||+..
T Consensus 265 ~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 265 KLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 011357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=217.56 Aligned_cols=152 Identities=28% Similarity=0.454 Sum_probs=119.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||
T Consensus 105 ~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Di 182 (256)
T cd06612 105 LYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQE-IGYNNKADI 182 (256)
T ss_pred HHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccccCCccccCHHHHhc-CCCCchhhH
Confidence 36899999999999999999999999999999999999999876543321 2233457889999999876 467899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|+|++|.+||...........+.. ..... ......++..+.+||.+|
T Consensus 183 ~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~-----------------------~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 183 WSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPT-----------------------LSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred HHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCC-----------------------CCchhhcCHHHHHHHHHH
Confidence 9999999999999999987655443322211 00000 000124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|+.||.+|||+.++|.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=216.20 Aligned_cols=156 Identities=33% Similarity=0.548 Sum_probs=124.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-------CCccccccCCcccChhhhcCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-------QPLTSRVVTLWYRPPELLLGATD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-------~~~~~~~gt~~Y~APE~l~g~~~ 73 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .......++..|++||.+.+. .
T Consensus 99 ~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~ 177 (265)
T cd05579 99 IAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ-G 177 (265)
T ss_pred HHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCC-C
Confidence 47999999999999999999999999999999999999999865433211 022334567889999998764 4
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
++.++|||||||++|+|++|..||......+....+......++ . ...++..+
T Consensus 178 ~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~-~~~~~~~~ 230 (265)
T cd05579 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP--------------------------E-DVEVSDEA 230 (265)
T ss_pred CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC--------------------------c-cccCCHHH
Confidence 78899999999999999999999988776666555433110000 0 01257889
Q ss_pred HHHHHHhcCCCCCCCcCH---HHHHhcccccCCC
Q 012191 154 VNLIETLLSVEPYKRATA---SAALASEYFSTKP 184 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa---~e~L~Hp~F~~~p 184 (468)
.+||.+||+.+|.+|||+ .++|+||||+...
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999999999999999999 9999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=220.86 Aligned_cols=150 Identities=27% Similarity=0.420 Sum_probs=118.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++...... ....++..|+|||++.+ ..++.++|
T Consensus 115 ~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~-~~~~~~~D 188 (267)
T PHA03390 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKG-HNYDVSFD 188 (267)
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcC-CCCCchhh
Confidence 36999999999999999999999999999988 9999999998765432 23357889999999976 45789999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHH-HHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~-l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||+||++|+|++|..||........ ...+.... ... ....+.+++.+.+||.
T Consensus 189 vwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~~~li~ 242 (267)
T PHA03390 189 WWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK-------------------------LPFIKNVSKNANDFVQ 242 (267)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc-------------------------CCcccccCHHHHHHHH
Confidence 99999999999999999976543321 11111111 000 0112357899999999
Q ss_pred HhcCCCCCCCcC-HHHHHhcccccC
Q 012191 159 TLLSVEPYKRAT-ASAALASEYFST 182 (468)
Q Consensus 159 ~mL~~DP~kRpT-a~e~L~Hp~F~~ 182 (468)
+||+.||.+|++ ++++|+||||..
T Consensus 243 ~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 243 SMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHhccChhhCCchHHHHhcCCcccC
Confidence 999999999996 599999999963
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=219.58 Aligned_cols=155 Identities=22% Similarity=0.377 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC-----CCC
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-----DYG 75 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~-----~~s 75 (468)
.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+.. .++
T Consensus 109 ~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 185 (286)
T cd06622 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYT 185 (286)
T ss_pred HHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCC
Confidence 689999999997 59999999999999999999999999998655322 123346788899999985432 357
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++|||||||++|+|++|..||...........+.......+. .....++.++.+
T Consensus 186 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~ 240 (286)
T cd06622 186 VQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP-------------------------TLPSGYSDDAQD 240 (286)
T ss_pred cccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-------------------------CCCcccCHHHHH
Confidence 8999999999999999999999776554444333322211111 111347889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||.+||..+|.+||++.+++.||||....
T Consensus 241 li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 241 FVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=221.45 Aligned_cols=156 Identities=25% Similarity=0.371 Sum_probs=119.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... .....+++..|+|||.+.+ ..++.++|+
T Consensus 101 ~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 176 (279)
T cd06619 101 AVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISG-EQYGIHSDV 176 (279)
T ss_pred HHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCChhhcCceeecC-CCCCCcchH
Confidence 368999999999999999999999999999999999999998755432 2334578999999999876 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHH---HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVE---QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e---~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||++|+|++|..||....... ............... ......+++++.+||
T Consensus 177 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li 233 (279)
T cd06619 177 WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP-----------------------VLPVGQFSEKFVHFI 233 (279)
T ss_pred HHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-----------------------CCCCCcCCHHHHHHH
Confidence 999999999999999996532111 001111111000000 001124678899999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||..||.+||++.++|.||||...
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=221.46 Aligned_cols=151 Identities=29% Similarity=0.463 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++...... .....+++.|+|||.+.+ ..++.++|||
T Consensus 108 ~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~ 182 (290)
T cd05580 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILS-KGYGKAVDWW 182 (290)
T ss_pred HHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcC-CCCCccccHH
Confidence 68999999999999999999999999999999999999998765433 233467899999999876 3578899999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|..||...........+.. +.+. ....++..+.++|.+||
T Consensus 183 slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---------------------------~~~~~~~~l~~li~~~l 233 (290)
T cd05580 183 ALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKVR---------------------------FPSFFSPDAKDLIRNLL 233 (290)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcc---------------------------CCccCCHHHHHHHHHHc
Confidence 999999999999999988775555555432 1110 01235788999999999
Q ss_pred CCCCCCCc-----CHHHHHhcccccCCCCC
Q 012191 162 SVEPYKRA-----TASAALASEYFSTKPYA 186 (468)
Q Consensus 162 ~~DP~kRp-----Ta~e~L~Hp~F~~~p~~ 186 (468)
..||.+|+ ++.+++.||||....|.
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred cCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 99999999 99999999999886654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=218.47 Aligned_cols=153 Identities=29% Similarity=0.435 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc--CCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL--GATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~--g~~~~s~~sD 79 (468)
.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...... ........++..|+|||.+. ....++.++|
T Consensus 113 ~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~D 191 (267)
T cd06645 113 RETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191 (267)
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccccccccCcccccChhhhccccCCCCCchhh
Confidence 68999999999999999999999999999999999999998655432 12223457889999999874 2245788999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
+|||||++|+|++|.+||........+..+......++ . + .....++..+.+||.+
T Consensus 192 vwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~---------------------~-~~~~~~~~~~~~li~~ 247 (267)
T cd06645 192 IWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--K---------------------L-KDKMKWSNSFHHFVKM 247 (267)
T ss_pred hHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--c---------------------c-cccCCCCHHHHHHHHH
Confidence 99999999999999999876554433332211110000 0 0 0012467789999999
Q ss_pred hcCCCCCCCcCHHHHHhccc
Q 012191 160 LLSVEPYKRATASAALASEY 179 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~ 179 (468)
||..||.+|||+.++|+|||
T Consensus 248 ~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 248 ALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HccCCchhCcCHHHHhcCCC
Confidence 99999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=234.29 Aligned_cols=155 Identities=26% Similarity=0.448 Sum_probs=128.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~~ 77 (468)
+|+|.||.|||+++|||||||..|||+.-+|.|+|+|||.+-.... ....-.+++||++|||||++.+ ..+|+++
T Consensus 137 ~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyk 215 (1187)
T KOG0579|consen 137 YQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYK 215 (1187)
T ss_pred HHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhccccCCcccccchheeeccccCCCchhh
Confidence 6899999999999999999999999999999999999998743322 2233457899999999999854 3579999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||++|.||.-+.||...-+.+..+-+|.+. .|| .. ......+..+.|||
T Consensus 216 aDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePP-TL-----------------------lqPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 216 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-TL-----------------------LQPSHWSRSFSDFL 269 (1187)
T ss_pred hhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCC-cc-----------------------cCcchhhhHHHHHH
Confidence 99999999999999999999988888877777552 111 10 00124567899999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||..||..||+++++|+||||+..
T Consensus 270 k~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 270 KRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHhcCCccCCCHHHHhhCcccccC
Confidence 99999999999999999999999874
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=220.43 Aligned_cols=156 Identities=29% Similarity=0.474 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+. .++.++|||
T Consensus 102 ~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~ 178 (277)
T cd05577 102 AQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQGE-VYDFSVDWF 178 (277)
T ss_pred HHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccCCCCcCCHHHhcCC-CCCchhhhH
Confidence 68999999999999999999999999999999999999998755432 222345678899999998764 488899999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|..||.+.........+.......+ ......+++.+.+||.+||
T Consensus 179 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 179 ALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA-------------------------VEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred HHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc-------------------------ccCCccCCHHHHHHHHHHc
Confidence 999999999999999977554222222211100000 0111346889999999999
Q ss_pred CCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 162 SVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 162 ~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
+.||.+|| ++.+++.||||....|
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 99999999 9999999999987665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=219.19 Aligned_cols=156 Identities=28% Similarity=0.460 Sum_probs=122.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... .......+++.|++||.+.. ...++.
T Consensus 109 ~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~ 187 (280)
T cd06611 109 CRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKDNPYDY 187 (280)
T ss_pred HHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-cccceeecchhhcCHHHHhhcccCCCCCCc
Confidence 4699999999999999999999999999999999999999876543321 12233467889999999852 234678
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|.+||.+......+..+... .++. ......++..+.+|
T Consensus 188 ~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~------------------------~~~~~~~~~~~~~l 241 (280)
T cd06611 188 KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPPT------------------------LDQPSKWSSSFNDF 241 (280)
T ss_pred cccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCCC------------------------cCCcccCCHHHHHH
Confidence 999999999999999999999887665555444221 1100 00012467889999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|.+||..||.+|||+.++|+||||...
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-26 Score=251.25 Aligned_cols=158 Identities=32% Similarity=0.490 Sum_probs=125.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCC--CCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGAT--DYGP 76 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~--~~s~ 76 (468)
.|++.||.|||+.|||||||||.|||++.+|.+|++|||.|..+..... ..+....||+.|||||++.+.. .-.-
T Consensus 1341 ~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~ 1420 (1509)
T KOG4645|consen 1341 KQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGG 1420 (1509)
T ss_pred HHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCc
Confidence 5999999999999999999999999999999999999999987665421 2335678999999999998743 3456
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
+.||||||||+.||+||+.||..-+..-++.-.+.. |. +|+.| ..++.+..+|
T Consensus 1421 A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-gh-----------------~Pq~P---------~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1421 AADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-GH-----------------KPQIP---------ERLSSEGRDF 1473 (1509)
T ss_pred chhhhcccceEEEeecCCCchhhccchhHHHhHHhc-cC-----------------CCCCc---------hhhhHhHHHH
Confidence 899999999999999999999764443322221111 21 12222 2388999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
|+.||..||.+|.++.|+|+|.|-+.....
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence 999999999999999999999997665443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=224.74 Aligned_cols=154 Identities=27% Similarity=0.493 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+|
T Consensus 122 ~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~ 199 (297)
T cd06656 122 RECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIW 199 (297)
T ss_pred HHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cCcCcccCCccccCHHHHcC-CCCCcHHHHH
Confidence 689999999999999999999999999999999999999987654332 12234467889999999876 4578999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|.+||.+.+....+..+.. .+.+.. .....++..+.+||.+||
T Consensus 200 slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~-------------------------~~~~~~~~~~~~li~~~l 253 (297)
T cd06656 200 SLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL-------------------------QNPERLSAVFRDFLNRCL 253 (297)
T ss_pred HHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCC-------------------------CCccccCHHHHHHHHHHc
Confidence 999999999999999977654333222111 111110 011346788999999999
Q ss_pred CCCCCCCcCHHHHHhcccccCC
Q 012191 162 SVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 162 ~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
..||.+|||+.++|.||||...
T Consensus 254 ~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 254 EMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred cCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=218.04 Aligned_cols=155 Identities=25% Similarity=0.410 Sum_probs=120.2
Q ss_pred CHHHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC---CCCCC
Q 012191 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA---TDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~---~~~s~ 76 (468)
+.||+.||+|||++ +++|+||||+|||++.++.+||+|||++...... ...+...++..|+|||.+.+. ..++.
T Consensus 109 ~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 186 (283)
T cd06617 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDAGCKPYMAPERINPELNQKGYDV 186 (283)
T ss_pred HHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc--cccccccCCccccChhhcCCcccccccCc
Confidence 36899999999997 9999999999999999999999999998765432 112334678899999988642 34688
Q ss_pred CcceeeeehhhhhhhhcCCCCCCC-chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~-~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
++|+|||||++|+|++|..||... ...+.+..+... ..+ .. ....++.++.+
T Consensus 187 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-~~------------------------~~~~~~~~l~~ 239 (283)
T cd06617 187 KSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP-QL------------------------PAEKFSPEFQD 239 (283)
T ss_pred cccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC-CC------------------------CccccCHHHHH
Confidence 999999999999999999999643 223333333221 000 00 00236788999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||.+||..||.+|||+.+++.||||....
T Consensus 240 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 240 FVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 99999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=218.63 Aligned_cols=153 Identities=29% Similarity=0.461 Sum_probs=118.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++....... .......+++.|+|||++.. ...++.
T Consensus 130 ~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 208 (286)
T cd06638 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDA 208 (286)
T ss_pred HHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccc
Confidence 3689999999999999999999999999999999999999987654322 12234468899999998853 234788
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++||||+||++|+|++|..||........+..+... .++. ......++..+.+|
T Consensus 209 ~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~~------------------------~~~~~~~~~~~~~l 262 (286)
T cd06638 209 RCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPPT------------------------LHQPELWSNEFNDF 262 (286)
T ss_pred hhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCCc------------------------ccCCCCcCHHHHHH
Confidence 999999999999999999999876554433322110 0000 00001356789999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccc
Q 012191 157 IETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
|.+||+.||.+|||+.++|+|+||
T Consensus 263 i~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 263 IRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHccCCcccCCCHHHHhhcccC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=218.43 Aligned_cols=148 Identities=23% Similarity=0.321 Sum_probs=118.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ .......+++.|+|||.+.+ ..++.++|
T Consensus 130 ~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sD 208 (283)
T cd05048 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESD 208 (283)
T ss_pred HHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhh
Confidence 36899999999999999999999999999999999999999875433221 12233456788999999876 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+.... .+ .....++.++.+|+.
T Consensus 209 v~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~--~~--------------------------~~~~~~~~~~~~l~~ 260 (283)
T cd05048 209 IWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ--LL--------------------------PCPEDCPARVYALMI 260 (283)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--cC--------------------------CCcccCCHHHHHHHH
Confidence 9999999999998 999998877766555543211 00 011357899999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||+.+++++
T Consensus 261 ~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 261 ECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=219.41 Aligned_cols=144 Identities=21% Similarity=0.205 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-CCCCCCcc
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~-~~~s~~sD 79 (468)
.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... .....++..|+|||++.+. ..++.++|
T Consensus 129 ~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~D 204 (283)
T PHA02988 129 IDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDD 204 (283)
T ss_pred HHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----cccccCcccccCHHHhhhccccccchhh
Confidence 589999999998 49999999999999999999999999998755432 2334678899999998652 46899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|||++|..||.+.+..+.+..+......++. ...++..+.+||.+
T Consensus 205 i~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~l~~li~~ 257 (283)
T PHA02988 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL---------------------------PLDCPLEIKCIVEA 257 (283)
T ss_pred hhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC---------------------------CCcCcHHHHHHHHH
Confidence 999999999999999999988776666655432211110 02467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||+.||.+|||+.++|+
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999986
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=222.01 Aligned_cols=178 Identities=25% Similarity=0.307 Sum_probs=121.2
Q ss_pred CHHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|
T Consensus 105 ~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~D 180 (308)
T cd06615 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYTVQSD 180 (308)
T ss_pred HHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---ccccCCCCcCccChhHhcC-CCCCccch
Confidence 3689999999998 59999999999999999999999999998654322 1234577899999999876 45889999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCC-CCchhhhccCCCccccCCCCCCCCchh---------hhhcCCC
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS-PPDDYWKKSKLPHATLFKPQQPYDSSL---------RETFKDL 149 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~l---------~~~~~~~ 149 (468)
||||||++|+|++|..||.+.+.... ..++..... ..........................+ ......+
T Consensus 181 iwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (308)
T cd06615 181 IWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAF 259 (308)
T ss_pred HHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCccc
Confidence 99999999999999999987654332 222211110 000000000000000000000000000 0001136
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+.++.+||.+||..||.+|||+.++|.||||...
T Consensus 260 ~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 260 SDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 7889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=215.07 Aligned_cols=156 Identities=29% Similarity=0.570 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCC-CCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGAT-DYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~-~~s~~sD 79 (468)
.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.... .++.++|
T Consensus 115 ~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~D 194 (272)
T cd06629 115 EQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194 (272)
T ss_pred HHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccch
Confidence 6899999999999999999999999999999999999999865432111 1123345788999999987543 4788999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
+|||||++|+|++|..||......+.+..+......+. . .......++..+.+||.+
T Consensus 195 v~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------~---~~~~~~~~~~~~~~li~~ 251 (272)
T cd06629 195 IWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP--------------------I---PPDVSMNLSPVALDFLNA 251 (272)
T ss_pred hHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc--------------------C---CccccccCCHHHHHHHHH
Confidence 99999999999999999976555444333221110000 0 011224578999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||..||.+|||+.++|+||||
T Consensus 252 ~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 252 CFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HhcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=217.56 Aligned_cols=156 Identities=29% Similarity=0.497 Sum_probs=123.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+...++.++|+
T Consensus 107 ~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 185 (277)
T cd06917 107 IREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADI 185 (277)
T ss_pred HHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-cccccccCCcceeCHHHhccCCccccchhH
Confidence 3689999999999999999999999999999999999999987665433 222344688899999998765667899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.........+... .++ . +. ...++.++.+||.+|
T Consensus 186 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~-----------------~------~~--~~~~~~~~~~~i~~~ 238 (277)
T cd06917 186 WSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPP-----------------R------LE--DNGYSKLLREFVAAC 238 (277)
T ss_pred HHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCC-----------------C------CC--cccCCHHHHHHHHHH
Confidence 99999999999999999876543332211110 000 0 00 012678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|..||.+|||+.+++.|+||+...
T Consensus 239 l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 239 LDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred cCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=220.50 Aligned_cols=154 Identities=21% Similarity=0.214 Sum_probs=115.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC------CCccccccCCcccChhhhcCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGATDY 74 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~g~~~~ 74 (468)
+.||+.||+|||+.+|+||||||+|||++.++.++|+|||++..+..... .......||+.|+|||++.+ ..+
T Consensus 132 ~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~ 210 (294)
T PHA02882 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACV 210 (294)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCC
Confidence 36899999999999999999999999999999999999999976542211 11223468999999999876 458
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
+.++|||||||++|+|++|.+||.+......+....+. +++..... -...+...+..+.
T Consensus 211 ~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~------~~~~~~~~---------------~~~~~~~~~~~~~ 269 (294)
T PHA02882 211 TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC------DFIKRLHE---------------GKIKIKNANKFIY 269 (294)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH------HHHHHhhh---------------hhhccCCCCHHHH
Confidence 99999999999999999999999876432222111110 00000000 0011235678899
Q ss_pred HHHHHhcCCCCCCCcCHHHHHh
Q 012191 155 NLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
+++..|+..+|.+||+..++++
T Consensus 270 ~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 270 DFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhCCCCCCCCHHHHHH
Confidence 9999999999999999999875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=212.43 Aligned_cols=150 Identities=35% Similarity=0.520 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ......++..|++||.+.....++.++|+|
T Consensus 109 ~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~ 186 (258)
T cd06632 109 RQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIW 186 (258)
T ss_pred HHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhH
Confidence 689999999999999999999999999999999999999987654332 233456788999999986533478999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||++|+|++|.+||...........+......+ .....++..+.+||.+||
T Consensus 187 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 187 SLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------------------------PIPDHLSDEAKDFILKCL 239 (258)
T ss_pred HHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCC---------------------------CcCCCcCHHHHHHHHHHh
Confidence 99999999999999997766544444332211000 111346788999999999
Q ss_pred CCCCCCCcCHHHHHhcccc
Q 012191 162 SVEPYKRATASAALASEYF 180 (468)
Q Consensus 162 ~~DP~kRpTa~e~L~Hp~F 180 (468)
..||.+|||+.++|.||||
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=228.40 Aligned_cols=155 Identities=30% Similarity=0.456 Sum_probs=136.4
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceee
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 82 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWS 82 (468)
.+++|++|||.+|||+|||||+|++++.+|-+||.|||+|+.+..+. .....+||+.|.|||+++.. ..+.++|.|+
T Consensus 528 cv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnK-GHD~avDyWa 604 (732)
T KOG0614|consen 528 CVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNK-GHDRAVDYWA 604 (732)
T ss_pred HHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeeecCCcccccchhhhcc-CcchhhHHHH
Confidence 47899999999999999999999999999999999999999888764 44678999999999999874 4689999999
Q ss_pred eehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcC
Q 012191 83 VGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 162 (468)
Q Consensus 83 LG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~ 162 (468)
||+++||||+|.|||.+.+.+..+..|++.+... +....++..+.+||.++..
T Consensus 605 LGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------------------------~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 605 LGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------------------------EFPRRITKTATDLIKKLCR 657 (732)
T ss_pred HHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------------------------hcccccchhHHHHHHHHHh
Confidence 9999999999999999999999999998765322 1113578889999999999
Q ss_pred CCCCCCcC-----HHHHHhcccccCCCCCC
Q 012191 163 VEPYKRAT-----ASAALASEYFSTKPYAC 187 (468)
Q Consensus 163 ~DP~kRpT-----a~e~L~Hp~F~~~p~~~ 187 (468)
.+|.+|.. +.++-.|.||....|..
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 99999976 89999999999877753
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=213.15 Aligned_cols=150 Identities=28% Similarity=0.502 Sum_probs=121.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+
T Consensus 107 ~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv 184 (256)
T cd08218 107 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-ELARTCIGTPYYLSPEICEN-RPYNNKSDI 184 (256)
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hhhhhccCCccccCHHHhCC-CCCCCccch
Confidence 3689999999999999999999999999999999999999987654321 11223457888999999876 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||......+....+... ..+ .....++.++.+||.+|
T Consensus 185 ~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYP--------------------------PVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CCC--------------------------CCcccCCHHHHHHHHHH
Confidence 99999999999999999877666655555321 111 01134678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|+.+|.+||++.++|.||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=218.96 Aligned_cols=157 Identities=29% Similarity=0.516 Sum_probs=125.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+
T Consensus 122 ~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv 199 (292)
T cd06657 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISR-LPYGPEVDI 199 (292)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccCccccCHHHhcC-CCCCchhhH
Confidence 4689999999999999999999999999999999999999886554321 12233567889999998865 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+||++|+|++|.+||.+......+..+.... +. . ......++..+.++|.+|
T Consensus 200 ~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~-~-----------------------~~~~~~~~~~l~~li~~~ 253 (292)
T cd06657 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP-K-----------------------LKNLHKVSPSLKGFLDRL 253 (292)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--Cc-c-----------------------cCCcccCCHHHHHHHHHH
Confidence 999999999999999998876665554443211 00 0 001134678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|..||.+|||+.++|.||||.....
T Consensus 254 l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 254 LVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HhCCcccCcCHHHHhcChHHhccCC
Confidence 9999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=214.59 Aligned_cols=152 Identities=32% Similarity=0.497 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-CCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~-~~~s~~sD 79 (468)
.||+.||+|||+.||+|+||||+||+++. .+.++|+|||++....... .......++..|+|||.+.+. ..++.++|
T Consensus 115 ~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 193 (268)
T cd06624 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193 (268)
T ss_pred HHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-CccccCCCCccccChhhhccccccCCchhh
Confidence 68999999999999999999999999976 6789999999987554321 122334578899999998653 34788999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||+||++|+|++|.+||................... ......+++++.+||.+
T Consensus 194 v~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH--------------------------PEIPESLSAEAKNFILR 247 (268)
T ss_pred hHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC--------------------------CCCCcccCHHHHHHHHH
Confidence 9999999999999999997543221111000000000 00113467889999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||..+|.+|||+.+++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=213.53 Aligned_cols=154 Identities=29% Similarity=0.438 Sum_probs=120.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC--CCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~--~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. ..++.++
T Consensus 107 ~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~ 185 (262)
T cd06613 107 CRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185 (262)
T ss_pred HHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchh
Confidence 3689999999999999999999999999999999999999987654321 122344678899999998653 2578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|+|||||++|+|++|.+||.+.+.......+......++. + .....++.++.+||.
T Consensus 186 Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~-~~~~~~~~~~~~li~ 241 (262)
T cd06613 186 DIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-----------------------L-KDKEKWSPVFHDFIK 241 (262)
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-----------------------c-cchhhhhHHHHHHHH
Confidence 9999999999999999999887765554443221101100 0 001235678999999
Q ss_pred HhcCCCCCCCcCHHHHHhccc
Q 012191 159 TLLSVEPYKRATASAALASEY 179 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~ 179 (468)
+||..||..|||+.++|.|+|
T Consensus 242 ~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 242 KCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=213.48 Aligned_cols=148 Identities=20% Similarity=0.306 Sum_probs=116.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+|+||||+|||++.++.+||+|||++................+..|+|||.+.+ ..++.++||
T Consensus 110 ~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 188 (263)
T cd05052 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDV 188 (263)
T ss_pred HHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHH
Confidence 3699999999999999999999999999999999999999987655432211122233567999998876 467889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+..+....+.... .+ .....++..+.+||.+
T Consensus 189 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~ 240 (263)
T cd05052 189 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--RM--------------------------ERPEGCPPKVYELMRA 240 (263)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--CC--------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 999998876655544442211 00 0113568899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.++++.
T Consensus 241 cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HccCCcccCCCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=214.17 Aligned_cols=156 Identities=31% Similarity=0.525 Sum_probs=118.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+|+||+|+||+++.++ .++|+|||.+........ .......++..|+|||.+.+ ..++.
T Consensus 109 ~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~ 187 (268)
T cd06630 109 TEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGR 187 (268)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCc
Confidence 47999999999999999999999999998776 599999999876543211 11123457889999999876 45789
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++||||+||++|+|++|..||...........+........ .......++.++.++
T Consensus 188 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~ 243 (268)
T cd06630 188 SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPEHLSPGLRDV 243 (268)
T ss_pred ccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC------------------------CCCCchhhCHHHHHH
Confidence 99999999999999999999975543332222222110000 001113467889999
Q ss_pred HHHhcCCCCCCCcCHHHHHhccccc
Q 012191 157 IETLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
|.+||..||.+|||+.++|.||||+
T Consensus 244 i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 244 TLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=215.13 Aligned_cols=151 Identities=28% Similarity=0.459 Sum_probs=118.4
Q ss_pred CHHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||+ .|++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+ ..++.++|
T Consensus 106 ~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~-~~~~~~~D 181 (265)
T cd06605 106 AVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQG-NDYSVKSD 181 (265)
T ss_pred HHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hcccCChhccCHHHHcC-CCCCchhh
Confidence 3689999999999 9999999999999999999999999999865533211 12567889999999876 46889999
Q ss_pred eeeeehhhhhhhhcCCCCCCCc-----hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRT-----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~-----~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
||||||++|+|++|..||.... ..+.+..+.. ...... .. ..++..+.
T Consensus 182 v~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~----------------------~~--~~~~~~~~ 234 (265)
T cd06605 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPRL----------------------PS--GKFSPDFQ 234 (265)
T ss_pred HHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCCC----------------------Ch--hhcCHHHH
Confidence 9999999999999999996542 2222222211 110000 00 11688899
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+||.+||..||.+|||+.++|.||||+.
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=211.32 Aligned_cols=149 Identities=29% Similarity=0.446 Sum_probs=119.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|
T Consensus 107 ~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~D 183 (256)
T cd08220 107 FVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEG-KPYNQKSD 183 (256)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--cccccccCCcccCchhccC-CCCCcccc
Confidence 3689999999999999999999999999865 468999999987664332 2223467889999999876 45788999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||.+.+.......+...... .....++..+.+||..
T Consensus 184 v~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~ 235 (256)
T cd08220 184 IWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA----------------------------PISDRYSPDLRQLILS 235 (256)
T ss_pred hHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----------------------------CCCCCcCHHHHHHHHH
Confidence 999999999999999999887665555444321100 0112467889999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||..||.+|||+.++|+||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=223.26 Aligned_cols=180 Identities=24% Similarity=0.326 Sum_probs=120.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CC-----ccccccCCcccChhhhcCC-CC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QP-----LTSRVVTLWYRPPELLLGA-TD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~-----~~~~~gt~~Y~APE~l~g~-~~ 73 (468)
+.||+.||+|||+.||+||||||+|||++.++.++++||+.+........ .. .....++..|+|||++.+. ..
T Consensus 107 ~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (328)
T cd08226 107 LFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG 186 (328)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCC
Confidence 36999999999999999999999999999999999999986532211110 00 0112345679999998753 34
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCcc--ccC---------------CC--
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--TLF---------------KP-- 134 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~--~~~---------------~~-- 134 (468)
++.++|||||||++|+|++|.+||.+......+..+.......+ |.....+.. ... ..
T Consensus 187 ~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (328)
T cd08226 187 YNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP---LDITTFPCEESRMKNSQSGVDSGIGESVVAAGM 263 (328)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC---ccccccchhhhhhccchhhhhcccccchhcccc
Confidence 78899999999999999999999988766555444433211111 100000000 000 00
Q ss_pred --CCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 135 --QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 135 --~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.......-......++..+.+||.+||++||.+|||+.++|+||||...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 264 TQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000001123467789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=215.82 Aligned_cols=147 Identities=21% Similarity=0.311 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+++.|+|||.+.+ ..++.++||
T Consensus 131 ~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 209 (283)
T cd05091 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDI 209 (283)
T ss_pred HHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhH
Confidence 5999999999999999999999999999999999999999875543221 11223345778999999875 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|||++ |.+||.+....+.+..+......+ ....++..+.+|+..
T Consensus 210 ~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~ 261 (283)
T cd05091 210 WSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP----------------------------CPDDCPAWVYTLMLE 261 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC----------------------------CCCCCCHHHHHHHHH
Confidence 999999999998 889998877766665553321100 113578889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||+.+++..
T Consensus 262 cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 262 CWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HhCCCcccCCCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=217.79 Aligned_cols=151 Identities=30% Similarity=0.476 Sum_probs=120.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...... ....++..|+|||++.+ ...++.++
T Consensus 121 ~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~s 195 (307)
T cd06607 121 CHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKV 195 (307)
T ss_pred HHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCccc
Confidence 368999999999999999999999999999999999999998654432 23467888999998752 34578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+.+.......+... .++. . ....++..+.+||.
T Consensus 196 Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~-------------------~------~~~~~~~~~~~li~ 248 (307)
T cd06607 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT-------------------L------SSNDWSDYFRNFVD 248 (307)
T ss_pred chHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC-------------------C------CchhhCHHHHHHHH
Confidence 9999999999999999999877655544333210 0000 0 00135678999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..||.+|||+.+++.||||...
T Consensus 249 ~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 249 SCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHhcCChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-25 Score=210.98 Aligned_cols=150 Identities=30% Similarity=0.536 Sum_probs=123.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... .......+++.|+|||.+.+. .++.++|+
T Consensus 107 ~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv 184 (256)
T cd08221 107 LFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SMAETVVGTPYYMSPELCQGV-KYNFKSDI 184 (256)
T ss_pred HHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-ccccccCCCccccCHhhcCCC-CCCCcchh
Confidence 3689999999999999999999999999999999999999987654332 123445678999999998764 47889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+....+.. +.... ....++..+.++|.+|
T Consensus 185 ~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~--------------------------~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYTP--------------------------VVSVYSSELISLVHSL 236 (256)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCC--------------------------CccccCHHHHHHHHHH
Confidence 9999999999999999988777666666532 11110 0135678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|..||.+|||+.++|.|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=232.30 Aligned_cols=150 Identities=27% Similarity=0.413 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHhCC--CeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 2 NQLLHGLEHCHSRG--VLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~g--IvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+|||.||.|||++. |+|||||.+||||+.+ |.|||+|+|+|...... .....+|||.|||||++.. .|+..+
T Consensus 150 RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---~aksvIGTPEFMAPEmYEE--~YnE~V 224 (632)
T KOG0584|consen 150 RQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---HAKSVIGTPEFMAPEMYEE--NYNELV 224 (632)
T ss_pred HHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---ccceeccCccccChHHHhh--hcchhh
Confidence 79999999999996 9999999999999865 89999999999877653 3456799999999999874 799999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++++||+|+..||...+...++.+.+. -|..|..+. +--.+++++||+
T Consensus 225 DVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl~-------------------------kV~dPevr~fIe 278 (632)
T KOG0584|consen 225 DVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAALS-------------------------KVKDPEVREFIE 278 (632)
T ss_pred hhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHhh-------------------------ccCCHHHHHHHH
Confidence 999999999999999999988877766655433 244433321 123578999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||.. ...|+|+.|+|.||||...
T Consensus 279 kCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHhcC-chhccCHHHHhhChhhccc
Confidence 99999 9999999999999999875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-25 Score=213.81 Aligned_cols=150 Identities=36% Similarity=0.588 Sum_probs=122.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-------------------CCccccccCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-------------------QPLTSRVVTLW 61 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-------------------~~~~~~~gt~~ 61 (468)
+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .......++..
T Consensus 108 ~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (280)
T cd05581 108 AAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAE 187 (280)
T ss_pred HHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCcc
Confidence 46899999999999999999999999999999999999999876543221 11123456889
Q ss_pred ccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCch
Q 012191 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS 141 (468)
Q Consensus 62 Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (468)
|+|||.+.+ ..++.++|||||||++++|++|..||...+....+..+.......
T Consensus 188 ~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------- 241 (280)
T cd05581 188 YVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF------------------------- 241 (280)
T ss_pred ccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCC-------------------------
Confidence 999998876 457889999999999999999999999887665555554221111
Q ss_pred hhhhcCCCcHHHHHHHHHhcCCCCCCCcCH----HHHHhcccc
Q 012191 142 LRETFKDLPTTAVNLIETLLSVEPYKRATA----SAALASEYF 180 (468)
Q Consensus 142 l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa----~e~L~Hp~F 180 (468)
...+++.+.+||.+||+.||.+|||+ .++|.||||
T Consensus 242 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 242 ----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 12457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=210.60 Aligned_cols=155 Identities=32% Similarity=0.488 Sum_probs=118.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC---ccccccCCcccChhhhcCCC--CCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP---LTSRVVTLWYRPPELLLGAT--DYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~---~~~~~gt~~Y~APE~l~g~~--~~s 75 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......... .....++..|+|||.+.+.. .++
T Consensus 105 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 184 (264)
T cd06626 105 TLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184 (264)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCC
Confidence 3689999999999999999999999999999999999999987655432211 11345688999999987633 378
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++|||||||++|+|++|..||.+............. +..+. ......++..+.+
T Consensus 185 ~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~------------------------~~~~~~~~~~~~~ 239 (264)
T cd06626 185 RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP------------------------IPDSLQLSPEGKD 239 (264)
T ss_pred cccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC------------------------CCcccccCHHHHH
Confidence 8999999999999999999999765332222211111 11100 0011245788999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 156 LIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||.+||+.||.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=215.48 Aligned_cols=154 Identities=31% Similarity=0.432 Sum_probs=116.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ...++.++
T Consensus 112 ~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~ 190 (267)
T cd06646 112 CRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190 (267)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cccCccccCccccCHhHcccccCCCCcchh
Confidence 3689999999999999999999999999999999999999987654321 12233467889999998753 23467899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|+||+||++|+|++|.+||...........+......++ . ......++..+.+||.
T Consensus 191 Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------~-------~~~~~~~~~~~~~li~ 246 (267)
T cd06646 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP-----------------K-------LKDKTKWSSTFHNFVK 246 (267)
T ss_pred hHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC-----------------C-------CccccccCHHHHHHHH
Confidence 999999999999999999865443322221111000000 0 0001246788999999
Q ss_pred HhcCCCCCCCcCHHHHHhccc
Q 012191 159 TLLSVEPYKRATASAALASEY 179 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~ 179 (468)
+||..||.+|||++++|+|+|
T Consensus 247 ~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 247 ISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-25 Score=246.70 Aligned_cols=153 Identities=32% Similarity=0.498 Sum_probs=120.3
Q ss_pred CHHHHHHHHHHHhC-------CCeeccCCCCceEECC-----------------CCcEEEEecCCccccCCCCCCCcccc
Q 012191 1 MNQLLHGLEHCHSR-------GVLHRDIKGSNLLVNN-----------------EGVLKLADFGLANFSNTGHRQPLTSR 56 (468)
Q Consensus 1 m~QLL~gL~yLHs~-------gIvHrDIKp~NILld~-----------------~g~vKL~DFGla~~~~~~~~~~~~~~ 56 (468)
+.||+.||.|||+. +|||+||||+||||+. .+.+||+|||++...... ......
T Consensus 124 a~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~ 201 (1021)
T PTZ00266 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSC 201 (1021)
T ss_pred HHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc--cccccc
Confidence 36999999999995 4999999999999954 235899999999765432 223345
Q ss_pred ccCCcccChhhhcCC-CCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCC
Q 012191 57 VVTLWYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ 135 (468)
Q Consensus 57 ~gt~~Y~APE~l~g~-~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 135 (468)
++|+.|+|||++.+. ..++.++||||||||||+|++|..||........+..++... +.
T Consensus 202 vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~------------------ 261 (1021)
T PTZ00266 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PD------------------ 261 (1021)
T ss_pred CCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CC------------------
Confidence 789999999998643 357889999999999999999999998766555444332211 10
Q ss_pred CCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 136 QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 136 ~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
..+..++.++.+||..||.++|.+|||+.++|.|+||...
T Consensus 262 --------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 262 --------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred --------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 0012467889999999999999999999999999999864
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=207.67 Aligned_cols=150 Identities=33% Similarity=0.518 Sum_probs=119.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.+||..|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+
T Consensus 104 ~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~-~~~~~~Dv 180 (253)
T cd05122 104 CKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGK-PYDYKADI 180 (253)
T ss_pred HHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCC-CCCccccH
Confidence 36899999999999999999999999999999999999999876654321 2345678899999998764 47889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...+....+..+... ..+... ....++..+.++|.+|
T Consensus 181 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~------------------------~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 181 WSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPGLR------------------------NPEKWSDEFKDFLKKC 234 (253)
T ss_pred HHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCCcC------------------------cccccCHHHHHHHHHH
Confidence 99999999999999999877655544443221 110000 0012478899999999
Q ss_pred cCCCCCCCcCHHHHHhccc
Q 012191 161 LSVEPYKRATASAALASEY 179 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~ 179 (468)
|..||.+|||+.++|.|||
T Consensus 235 l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 235 LQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ccCChhhCCCHHHHhcCCC
Confidence 9999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=210.95 Aligned_cols=146 Identities=20% Similarity=0.342 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||+.+++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+ ..++.++|||
T Consensus 110 ~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~ 188 (261)
T cd05072 110 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVW 188 (261)
T ss_pred HHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhh
Confidence 589999999999999999999999999999999999999997665432222233345678999999866 4578899999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |..||.+.+.......+...... .....++.++.+||.+|
T Consensus 189 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~ 240 (261)
T cd05072 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------------------------PRMENCPDELYDIMKTC 240 (261)
T ss_pred hhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999998 99999887766665555332110 01134678899999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|..||.+|||++++++
T Consensus 241 l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 241 WKEKAEERPTFDYLQS 256 (261)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-25 Score=212.79 Aligned_cols=148 Identities=20% Similarity=0.262 Sum_probs=116.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+|+||||+|||++.++.++|+|||++.......... .....+++.|++||.+.+ ..++.++|
T Consensus 118 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~D 196 (272)
T cd05075 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSD 196 (272)
T ss_pred HHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHH
Confidence 3689999999999999999999999999999999999999987654322111 112234678999999876 46889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||.+....+....+.... .+ .....++..+.+||.
T Consensus 197 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~ 248 (272)
T cd05075 197 VWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RL---------------------------KQPPDCLDGLYSLMS 248 (272)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CC---------------------------CCCCCCCHHHHHHHH
Confidence 9999999999999 899998876655544442210 00 001246788999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++++
T Consensus 249 ~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 249 SCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=249.84 Aligned_cols=152 Identities=18% Similarity=0.254 Sum_probs=107.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-------------------cEEEEecCCccccCCCC------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-------------------VLKLADFGLANFSNTGH------------ 49 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-------------------~vKL~DFGla~~~~~~~------------ 49 (468)
|+||+.||.|||++||+||||||+||||+..+ .+||+|||++.......
T Consensus 86 ~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~ 165 (793)
T PLN00181 86 FRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKK 165 (793)
T ss_pred HHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhcccc
Confidence 57999999999999999999999999996544 45555666554221000
Q ss_pred ---CCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCC
Q 012191 50 ---RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL 126 (468)
Q Consensus 50 ---~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~ 126 (468)
.......++|++|+|||++.+ ..|+.++||||||||||||++|.+|+.... ..+..+.... .++ ..
T Consensus 166 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~~------ 234 (793)
T PLN00181 166 QPFPMKQILAMEMSWYTSPEEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-QI------ 234 (793)
T ss_pred CCCcccccccCCCcceEChhhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-hh------
Confidence 000112467999999999877 458999999999999999999988875322 1122221110 000 00
Q ss_pred CccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 127 PHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 127 ~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
......+.+++.+||..||.+|||+.++|+||||...
T Consensus 235 --------------------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 --------------------LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred --------------------hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0113446789999999999999999999999999763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-25 Score=216.05 Aligned_cols=159 Identities=28% Similarity=0.440 Sum_probs=122.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-CCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~-~~~s~~sDI 80 (468)
.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++...............++..|+|||.+.+. ..++.++||
T Consensus 112 ~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv 191 (290)
T cd05613 112 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW 191 (290)
T ss_pred HHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccH
Confidence 5899999999999999999999999999999999999999876544332233345688999999998653 246789999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...........+...+..... ++ ...++..+.+||.+|
T Consensus 192 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------~~-------~~~~~~~~~~ll~~~ 246 (290)
T cd05613 192 WSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------------------PY-------PQEMSALAKDIIQRL 246 (290)
T ss_pred HHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC------------------CC-------CccCCHHHHHHHHHH
Confidence 99999999999999999654332222222221100000 00 124678899999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|+ ++.+++.||||....|
T Consensus 247 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 247 LMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred hcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 999999997 8999999999988654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=209.93 Aligned_cols=149 Identities=30% Similarity=0.473 Sum_probs=120.8
Q ss_pred HHHHHHHHHHH-----hCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 2 NQLLHGLEHCH-----SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 2 ~QLL~gL~yLH-----s~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
.||+.||.||| +.+|+|+||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.
T Consensus 112 ~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~ 189 (265)
T cd08217 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNH-MSYDE 189 (265)
T ss_pred HHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc-cccccccCCCccChhhhcC-CCCCc
Confidence 68999999999 89999999999999999999999999999876654321 1234568999999999876 44788
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|+|||||++|+|++|..||.+.+.......+... ..+ .....++..+.+|
T Consensus 190 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~l 241 (265)
T cd08217 190 KSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KFR--------------------------RIPYRYSSELNEV 241 (265)
T ss_pred hhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--CCC--------------------------CCccccCHHHHHH
Confidence 999999999999999999999887644444333211 100 0112467889999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccc
Q 012191 157 IETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
|.+||..+|.+|||+.++|+|||+
T Consensus 242 ~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 242 IKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=221.76 Aligned_cols=148 Identities=23% Similarity=0.321 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...... ......++..|+|||++.+ ..++.++||
T Consensus 180 ~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 258 (337)
T cd05054 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQSDV 258 (337)
T ss_pred HHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccccH
Confidence 68999999999999999999999999999999999999999765432211 1123345678999999876 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||+||+|++ |.+||.+....+.+...+.....+ .....+++++.+|+.+
T Consensus 259 ~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 259 WSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM---------------------------RAPEYATPEIYSIMLD 311 (337)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC---------------------------CCCccCCHHHHHHHHH
Confidence 999999999997 999998755444333332211000 0012457889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.+|.+|||+.++++|
T Consensus 312 cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 312 CWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=211.89 Aligned_cols=152 Identities=30% Similarity=0.499 Sum_probs=118.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+ ..++.++
T Consensus 112 ~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 190 (265)
T cd06652 112 TRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKA 190 (265)
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcch
Confidence 36899999999999999999999999999999999999999875432111 11233467889999999876 4578999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..||...........+. ..+... .....++..+.++|.
T Consensus 191 Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~------------------------~~~~~~~~~~~~~i~ 243 (265)
T cd06652 191 DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTNP------------------------VLPPHVSDHCRDFLK 243 (265)
T ss_pred hHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCCC------------------------CCchhhCHHHHHHHH
Confidence 99999999999999999998765444443322 111100 011246778999999
Q ss_pred HhcCCCCCCCcCHHHHHhccccc
Q 012191 159 TLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
+|| .+|.+|||++++++|||+.
T Consensus 244 ~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 244 RIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHh-cChhhCCCHHHHhcCcccC
Confidence 999 5999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=208.91 Aligned_cols=150 Identities=33% Similarity=0.503 Sum_probs=121.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+
T Consensus 109 ~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv 186 (258)
T cd08215 109 FVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQN-KPYNYKSDI 186 (258)
T ss_pred HHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhcc-CCCCccccH
Confidence 3689999999999999999999999999999999999999987655432 12233467889999998876 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+|+++|+|++|..||...........+.... .+ .....++..+.++|.+|
T Consensus 187 ~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 187 WSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YP--------------------------PIPSQYSSELRNLVSSL 238 (258)
T ss_pred HHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--CC--------------------------CCCCCCCHHHHHHHHHH
Confidence 999999999999999998776544444432211 00 01125678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|..+|.+|||+.++|.||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=217.20 Aligned_cols=152 Identities=30% Similarity=0.457 Sum_probs=122.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.. ...++.++
T Consensus 127 ~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~s 201 (313)
T cd06633 127 THGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKV 201 (313)
T ss_pred HHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchh
Confidence 36899999999999999999999999999999999999998754322 234467889999999852 24578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+.+....+..+... ..+. .....++..+.+||.
T Consensus 202 Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~-------------------------~~~~~~~~~l~~li~ 254 (313)
T cd06633 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT-------------------------LQSNEWTDSFRGFVD 254 (313)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCC-------------------------CCccccCHHHHHHHH
Confidence 9999999999999999999887766655554321 1100 001245678999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
+||+.+|.+|||+.++|.||||...+
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 255 YCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=212.31 Aligned_cols=147 Identities=22% Similarity=0.329 Sum_probs=116.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|
T Consensus 128 ~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 206 (280)
T cd05049 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESD 206 (280)
T ss_pred HHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhh
Confidence 36899999999999999999999999999999999999999865432211 11123345778999999876 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+.+..+....+... ... .....++..+.+||.
T Consensus 207 i~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~ 258 (280)
T cd05049 207 VWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG--RLL--------------------------QRPRTCPSEVYDIML 258 (280)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CcC--------------------------CCCCCCCHHHHHHHH
Confidence 9999999999998 99999887766655554321 110 001246788999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.|+++
T Consensus 259 ~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 259 GCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCCCcccCCCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=243.07 Aligned_cols=153 Identities=34% Similarity=0.545 Sum_probs=116.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccC-----------------CCCCCCccccccCCccc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN-----------------TGHRQPLTSRVVTLWYR 63 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~-----------------~~~~~~~~~~~gt~~Y~ 63 (468)
|+||++||.|+|++|||||||||.||+++.++.|||+|||+|+... .......+..+||.-|.
T Consensus 703 FreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 703 FREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 5899999999999999999999999999999999999999997611 01122457789999999
Q ss_pred ChhhhcCCC--CCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHH-cCCCCchhhhccCCCccccCCCCCCCCc
Q 012191 64 PPELLLGAT--DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL-CGSPPDDYWKKSKLPHATLFKPQQPYDS 140 (468)
Q Consensus 64 APE~l~g~~--~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 140 (468)
|||++.+.. .|+.++|+||||+||+||+. ||.. .++-...+..+ -|..|.+
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~--------------------- 836 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEP--------------------- 836 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCC---------------------
Confidence 999997765 69999999999999999983 4643 33322222221 1222211
Q ss_pred hhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhccccc
Q 012191 141 SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 141 ~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
...+..--+.-..+|++||+.||.+||||.|+|++.||-
T Consensus 837 --~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 --ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred --cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 011122234467899999999999999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=216.01 Aligned_cols=154 Identities=25% Similarity=0.405 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC---CCCCCC
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA---TDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~---~~~s~~ 77 (468)
.||+.||+|||+ .||+|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+. ..++.+
T Consensus 121 ~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 198 (296)
T cd06618 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--AKTRSAGCAAYMAPERIDPPDPNPKYDIR 198 (296)
T ss_pred HHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC--cccCCCCCccccCHhhcCCCCCccccccc
Confidence 689999999997 599999999999999999999999999987654321 12333567889999998653 247889
Q ss_pred cceeeeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
+|||||||++|+|++|..||..... .+.+..+.... .+. + + ....++.++.+|
T Consensus 199 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~--~---------------~-------~~~~~~~~l~~l 252 (296)
T cd06618 199 ADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PPS--L---------------P-------PNEGFSPDFCSF 252 (296)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CCC--C---------------C-------CCCCCCHHHHHH
Confidence 9999999999999999999976332 33333332211 000 0 0 001467889999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|.+||..||.+|||+.+++.|+||...
T Consensus 253 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 253 VDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHccCChhhCCCHHHHhcChhhhcc
Confidence 999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=210.20 Aligned_cols=149 Identities=30% Similarity=0.448 Sum_probs=119.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+
T Consensus 106 ~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~-~~~~~~~Di 182 (258)
T cd05578 106 ICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR-QGYSVAVDW 182 (258)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcc-cCCCCcccc
Confidence 4689999999999999999999999999999999999999987654332 2234567889999999876 448899999
Q ss_pred eeeehhhhhhhhcCCCCCCCch--HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~--~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|..||..... ...+...... .. ......++..+.++|.
T Consensus 183 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-------------------------~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 183 WSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---AD-------------------------VLYPATWSTEAIDAIN 234 (258)
T ss_pred hhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---cc-------------------------ccCcccCcHHHHHHHH
Confidence 9999999999999999987664 2222221110 00 0011246788999999
Q ss_pred HhcCCCCCCCcCH--HHHHhcccc
Q 012191 159 TLLSVEPYKRATA--SAALASEYF 180 (468)
Q Consensus 159 ~mL~~DP~kRpTa--~e~L~Hp~F 180 (468)
+||..||.+||++ .+++.||||
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=216.83 Aligned_cols=151 Identities=29% Similarity=0.452 Sum_probs=120.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~s 78 (468)
+.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++...... ....++..|+|||.+.+ ...++.++
T Consensus 121 ~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~ 195 (308)
T cd06634 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKV 195 (308)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCccc
Confidence 368999999999999999999999999999999999999998755432 33467889999999853 23578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..||...+..+....+.... .+. .....++..+.+||.
T Consensus 196 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~~~~li~ 248 (308)
T cd06634 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPA--------------------------LQSGHWSEYFRNFVD 248 (308)
T ss_pred chHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CCC--------------------------cCcccccHHHHHHHH
Confidence 99999999999999999997765544444332211 000 001246788999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..+|.+|||+.+++.|+||...
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=213.85 Aligned_cols=155 Identities=29% Similarity=0.476 Sum_probs=123.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+
T Consensus 107 ~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv 184 (277)
T cd06640 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQ-SAYDSKADI 184 (277)
T ss_pred HHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccccccCcccccCHhHhcc-CCCccHHHH
Confidence 3689999999999999999999999999999999999999987654322 12233467889999999876 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+.......+.. +.++ .....++..+.+||.+|
T Consensus 185 ~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPP--------------------------TLTGEFSKPFKEFIDAC 236 (277)
T ss_pred HHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCCC--------------------------CCchhhhHHHHHHHHHH
Confidence 9999999999999999987665443332211 0010 11124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|..||.+|||+.++|.|+||.....
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred cccCcccCcCHHHHHhChHhhhcch
Confidence 9999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=209.92 Aligned_cols=148 Identities=20% Similarity=0.256 Sum_probs=116.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......... ......+..|+|||.+.+ ..++.++|
T Consensus 119 ~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~D 197 (273)
T cd05035 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSD 197 (273)
T ss_pred HHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccc
Confidence 3689999999999999999999999999999999999999987654332111 112234567999998865 56889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++ |.+||.+....+.+..+.... .. .....++..+.+||.
T Consensus 198 v~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~ 249 (273)
T cd05035 198 VWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--RL--------------------------KQPEDCLDELYDLMY 249 (273)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCcCCCHHHHHHHH
Confidence 9999999999999 899998877666554443210 00 011346788999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||+.+++.+
T Consensus 250 ~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 250 SCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-25 Score=217.23 Aligned_cols=155 Identities=28% Similarity=0.496 Sum_probs=122.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......+++.|++||.+.+ ..++.++|+
T Consensus 121 ~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv 198 (293)
T cd06647 121 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198 (293)
T ss_pred HHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhcc-CCCCchhhH
Confidence 46899999999999999999999999999999999999998865543321 2233467889999999876 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||...+....+..+.. .+.+. ......++..+.+||.+|
T Consensus 199 ~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE-------------------------LQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred HHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC-------------------------CCCccccCHHHHHHHHHH
Confidence 9999999999999999987665444332211 01100 001124677899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+||++.++|.|+||...
T Consensus 253 l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 253 LEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ccCChhhCcCHHHHhcCHHHhcC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=208.77 Aligned_cols=149 Identities=32% Similarity=0.501 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+.+|+|+||+|+||+++.++ .++|+|||.+....... .......+++.|+|||.+.+ ..++.++|+
T Consensus 108 ~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv 185 (257)
T cd08225 108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQN-RPYNNKTDI 185 (257)
T ss_pred HHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccccccCCCccccCHHHHcC-CCCCchhhH
Confidence 5899999999999999999999999998886 46999999987654322 22233457889999998876 357889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+....+.... . ....+.++.++.++|.+|
T Consensus 186 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~--------------------------~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY--F--------------------------APISPNFSRDLRSLISQL 237 (257)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--C--------------------------CCCCCCCCHHHHHHHHHH
Confidence 999999999999999998776555444432210 0 011135678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|..+|.+|||+.++|.||||
T Consensus 238 l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 238 FKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred hccChhhCcCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=210.57 Aligned_cols=146 Identities=25% Similarity=0.347 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||+.||+|+||||+||+++.++.++|+|||.+...............++..|+|||.+.+ ..++.++|||
T Consensus 109 ~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dvw 187 (262)
T cd05071 109 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVW 187 (262)
T ss_pred HHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHH
Confidence 689999999999999999999999999999999999999997665432222223345678999998865 4578999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |.+||.+....+.+..+..... . .....++..+.+||.+|
T Consensus 188 slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~l~~li~~~ 239 (262)
T cd05071 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M---------------------------PCPPECPESLHDLMCQC 239 (262)
T ss_pred HHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-C---------------------------CCccccCHHHHHHHHHH
Confidence 99999999999 8899988776665554432110 0 00124678899999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|+.||.+|||+.++++
T Consensus 240 l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 240 WRKEPEERPTFEYLQA 255 (262)
T ss_pred ccCCcccCCCHHHHHH
Confidence 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=209.46 Aligned_cols=147 Identities=24% Similarity=0.352 Sum_probs=116.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||++...............++..|+|||.+.+ ..++.++||
T Consensus 108 ~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 186 (260)
T cd05070 108 AAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 186 (260)
T ss_pred HHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhh
Confidence 3689999999999999999999999999999999999999997654332222222334567999998865 457889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+.+..+....+.... .+ ......+..+.+||.+
T Consensus 187 ~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~ 238 (260)
T cd05070 187 WSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RM---------------------------PCPQDCPISLHELMLQ 238 (260)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC---------------------------CCCCcCCHHHHHHHHH
Confidence 999999999999 899998877666665553211 00 0113467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.+++.
T Consensus 239 ~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 239 CWKKDPEERPTFEYLQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=206.44 Aligned_cols=149 Identities=35% Similarity=0.528 Sum_probs=121.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+ ..++.++|+
T Consensus 99 ~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~ 176 (250)
T cd05123 99 AAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLG-KGYGKAVDW 176 (250)
T ss_pred HHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCC-CCCCchhhH
Confidence 4689999999999999999999999999999999999999987654321 12334567888999999876 347889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...........+.. +..+ ....++..+.+||.+|
T Consensus 177 ~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---------------------------~~~~~~~~l~~~i~~~ 227 (250)
T cd05123 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLR---------------------------FPEFLSPEARDLISGL 227 (250)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCC---------------------------CCCCCCHHHHHHHHHH
Confidence 9999999999999999987766444444432 1110 0123478899999999
Q ss_pred cCCCCCCCcCH---HHHHhcccc
Q 012191 161 LSVEPYKRATA---SAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa---~e~L~Hp~F 180 (468)
|..||.+|||+ .+++.||||
T Consensus 228 l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 228 LQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hcCCHhhCCCcccHHHHHhCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=223.27 Aligned_cols=147 Identities=23% Similarity=0.346 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc-cccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+||||||+|||++.++.+||+|||++........... ....++..|+|||++.+ ..++.++||
T Consensus 219 ~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 297 (374)
T cd05106 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDV 297 (374)
T ss_pred HHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccH
Confidence 6899999999999999999999999999999999999999875543221111 12234567999999875 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||........+..+......+. ....++.++.+||.+
T Consensus 298 wSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~ 350 (374)
T cd05106 298 WSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS---------------------------RPDFAPPEIYSIMKM 350 (374)
T ss_pred HHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc---------------------------CCCCCCHHHHHHHHH
Confidence 999999999997 9999987654443333332111110 001357889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||+.||.+|||+.++++
T Consensus 351 cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 351 CWNLEPTERPTFSQISQ 367 (374)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=213.16 Aligned_cols=153 Identities=30% Similarity=0.463 Sum_probs=120.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+
T Consensus 107 ~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 184 (277)
T cd06642 107 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDFKADI 184 (277)
T ss_pred HHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhhcccCcccccCHHHhCc-CCCchhhhH
Confidence 3689999999999999999999999999999999999999987654321 11223457889999999876 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||...........+.. +.++ .....++..+.+||.+|
T Consensus 185 ~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSPP--------------------------TLEGQYSKPFKEFVEAC 236 (277)
T ss_pred HHHHHHHHHHHhCCCCCcccchhhHHhhhhc--CCCC--------------------------CCCcccCHHHHHHHHHH
Confidence 9999999999999999976544333322211 0000 01124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..+|.+|||+.++|.||||...
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 237 LNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ccCCcccCcCHHHHHHhHHHHHH
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=214.79 Aligned_cols=154 Identities=19% Similarity=0.241 Sum_probs=115.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......... .....++..|+|||++.+ ..++.++|
T Consensus 144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 222 (304)
T cd05096 144 ALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASD 222 (304)
T ss_pred HHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhh
Confidence 3689999999999999999999999999999999999999987554322111 122345778999999876 45899999
Q ss_pred eeeeehhhhhhhh--cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 80 LWSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 80 IWSLG~ILyeLlt--G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
||||||++|+|++ +..||.+.+..+.+..+...........+ ......++..+.+||
T Consensus 223 v~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li 281 (304)
T cd05096 223 VWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY---------------------LFRPPPCPQGLYELM 281 (304)
T ss_pred hHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc---------------------ccCCCCCCHHHHHHH
Confidence 9999999999986 56788776665555444332111100000 001134678899999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..||.+|||+.++..
T Consensus 282 ~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 282 LQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHccCCchhCcCHHHHHH
Confidence 9999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=211.33 Aligned_cols=148 Identities=24% Similarity=0.339 Sum_probs=115.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......... ......++..|+|||++.+ ..++.++|
T Consensus 138 ~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 216 (293)
T cd05053 138 AYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSD 216 (293)
T ss_pred HHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccc
Confidence 368999999999999999999999999999999999999998765432211 1122234567999998865 46889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+..... + .....++..+.+||.
T Consensus 217 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~ 268 (293)
T cd05053 217 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR-M---------------------------EKPQNCTQELYHLMR 268 (293)
T ss_pred eeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-C---------------------------CCCCCCCHHHHHHHH
Confidence 9999999999997 9999987766555444322110 0 001245788999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.++|++
T Consensus 269 ~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 269 DCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcccCcccCcCHHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=212.39 Aligned_cols=155 Identities=32% Similarity=0.550 Sum_probs=122.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+ ..++.++|+
T Consensus 122 ~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv 199 (286)
T cd06614 122 CREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTPYWMAPEVIKR-KDYGPKVDI 199 (286)
T ss_pred HHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-hhhccccCCcccCCHhHhcC-CCCCCcccc
Confidence 3689999999999999999999999999999999999999886544321 11223356788999999876 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|+|++|..||...........+... +.+. ......++..+.+||.+|
T Consensus 200 ~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~l~~li~~~ 253 (286)
T cd06614 200 WSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP-------------------------LKNPEKWSPEFKDFLNKC 253 (286)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC-------------------------CcchhhCCHHHHHHHHHH
Confidence 99999999999999999876665544443221 1100 000123678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|+.+|.+|||+.++|.|+||...
T Consensus 254 l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 254 LVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred hccChhhCcCHHHHhhChHhhcc
Confidence 99999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=209.01 Aligned_cols=152 Identities=31% Similarity=0.512 Sum_probs=121.1
Q ss_pred CHHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|
T Consensus 105 ~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~-~~~~~~~D 182 (264)
T cd06623 105 ARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERIQG-ESYSYAAD 182 (264)
T ss_pred HHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-cccceeecccccCHhhhCC-CCCCchhh
Confidence 4689999999999 9999999999999999999999999999876643321 2224467889999999876 46888999
Q ss_pred eeeeehhhhhhhhcCCCCCCCc---hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC-CcHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD-LPTTAVN 155 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~---~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~s~~l~d 155 (468)
+|||||++|+|++|.+||.... ..+....+.. .... ..... ++..+.+
T Consensus 183 v~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~~l~~ 234 (264)
T cd06623 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPP-------------------------SLPAEEFSPEFRD 234 (264)
T ss_pred HHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCC-------------------------CCCcccCCHHHHH
Confidence 9999999999999999997764 2222322221 1100 00123 7889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+|..||..+|.+|||+.++|+||||+.
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=206.40 Aligned_cols=150 Identities=31% Similarity=0.509 Sum_probs=121.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++||
T Consensus 105 ~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv 182 (254)
T cd06627 105 VYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVIEMS-GASTASDI 182 (254)
T ss_pred HHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-cccccccchhhcCHhhhcCC-CCCcchhH
Confidence 46899999999999999999999999999999999999999976654322 12334678899999998764 47899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|++|+++|+|++|..||...........+.. ... ......++..+.++|.+|
T Consensus 183 ~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~~~i~~~ 234 (254)
T cd06627 183 WSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--DDH--------------------------PPLPEGISPELKDFLMQC 234 (254)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--cCC--------------------------CCCCCCCCHHHHHHHHHH
Confidence 9999999999999999987665544444321 000 001134678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|..+|++|||+.++|.||||
T Consensus 235 l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 235 FQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=207.58 Aligned_cols=147 Identities=29% Similarity=0.474 Sum_probs=118.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++|+
T Consensus 106 ~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv 183 (255)
T cd08219 106 FVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYACTYVGTPYYVPPEIWEN-MPYNNKSDI 183 (255)
T ss_pred HHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cccccccCCccccCHHHHcc-CCcCchhhh
Confidence 3689999999999999999999999999999999999999987654321 12234567889999999876 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...+.......+......+ ....++..+.+||.+|
T Consensus 184 ~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~ 235 (255)
T cd08219 184 WSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP----------------------------LPSHYSYELRSLIKQM 235 (255)
T ss_pred hhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC----------------------------CCcccCHHHHHHHHHH
Confidence 999999999999999998876655544443211100 0124677899999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|+.||.+|||+.++|.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=212.32 Aligned_cols=154 Identities=19% Similarity=0.312 Sum_probs=119.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+|+||||+|||++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 126 ~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv 204 (288)
T cd05061 126 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDM 204 (288)
T ss_pred HHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHH
Confidence 58999999999999999999999999999999999999998754322111 1122244677999999876 457899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+....+....+... +.+ .....++..+.+||.+
T Consensus 205 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~ 256 (288)
T cd05061 205 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYL---------------------------DQPDNCPERVTDLMRM 256 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC---------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 78899877665544444221 000 0012457889999999
Q ss_pred hcCCCCCCCcCHHHHHh------cccccCCC
Q 012191 160 LLSVEPYKRATASAALA------SEYFSTKP 184 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~------Hp~F~~~p 184 (468)
||+.||.+|||+.++++ ||||....
T Consensus 257 ~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 257 CWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 99999999999999987 88887643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=208.86 Aligned_cols=147 Identities=22% Similarity=0.355 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.||+|+||||+||+++.++.+||+|||++...............++..|+|||.+.+ ..++.++|||
T Consensus 107 ~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~ 185 (256)
T cd05059 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVW 185 (256)
T ss_pred HHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHH
Confidence 689999999999999999999999999999999999999987654322111112223457999999876 4688999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |.+||.+.+..+....+...... .....++..+.+|+.+|
T Consensus 186 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~c 237 (256)
T cd05059 186 SFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL----------------------------YRPKLAPTEVYTIMYSC 237 (256)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999998 89999887766655544321100 00124688899999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|..+|.+|||+.++++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=205.81 Aligned_cols=148 Identities=24% Similarity=0.340 Sum_probs=119.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++|
T Consensus 111 ~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 189 (262)
T cd00192 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSD 189 (262)
T ss_pred HHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-Ccchhhc
Confidence 46899999999999999999999999999999999999999976654321 112344568889999998764 6889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+... ... .....++.++.++|.
T Consensus 190 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~ 241 (262)
T cd00192 190 VWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--YRL--------------------------PKPEYCPDELYELML 241 (262)
T ss_pred cHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC--------------------------CCCccCChHHHHHHH
Confidence 9999999999999 69999888766655555331 000 011245889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++.+
T Consensus 242 ~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 242 SCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHccCCcccCcCHHHHHHh
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=208.76 Aligned_cols=146 Identities=23% Similarity=0.361 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...............++..|+|||.+.+ ..++.++|||
T Consensus 109 ~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~ 187 (260)
T cd05069 109 AQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVW 187 (260)
T ss_pred HHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHH
Confidence 689999999999999999999999999999999999999997654332222223345678999998875 4578899999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |..||.+....+....+.... .+ .....++..+.+||.+|
T Consensus 188 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM---------------------------PCPQGCPESLHELMKLC 239 (260)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC---------------------------CCCcccCHHHHHHHHHH
Confidence 99999999999 999998877766665543211 00 01124678899999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|..||.+|||+.++++
T Consensus 240 l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 240 WKKDPDERPTFEYIQS 255 (260)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=208.33 Aligned_cols=146 Identities=23% Similarity=0.366 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++||+|+||||+||+++.++.++|+|||++...............++..|+|||.+.+ ..++.++|||
T Consensus 107 ~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~ 185 (256)
T cd05114 107 QDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVW 185 (256)
T ss_pred HHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhH
Confidence 689999999999999999999999999999999999999987554322212222344567999999875 4688999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |.+||...+..+.+..+........ ....+..+.+||.+|
T Consensus 186 s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~~~~li~~c 237 (256)
T cd05114 186 SFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----------------------------PKLASMTVYEVMYSC 237 (256)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC----------------------------CCCCCHHHHHHHHHH
Confidence 99999999999 9999988877776666643211000 012467899999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|..||.+|||+.++++
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=213.08 Aligned_cols=147 Identities=20% Similarity=0.314 Sum_probs=116.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+|+||||+|||++.++.++|+|||++........ .......++..|+|||.+.+ ..++.++|
T Consensus 129 ~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 207 (291)
T cd05094 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESD 207 (291)
T ss_pred HHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhh
Confidence 36899999999999999999999999999999999999999875443221 11223445788999999876 45888999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||......+.+..+... ..+ .....++..+.+||.
T Consensus 208 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~ 259 (291)
T cd05094 208 VWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--RVL--------------------------ERPRVCPKEVYDIML 259 (291)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC--CCC--------------------------CCCccCCHHHHHHHH
Confidence 9999999999998 99999877665555443221 110 001236788999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.++++
T Consensus 260 ~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 260 GCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHcccChhhCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=212.37 Aligned_cols=147 Identities=21% Similarity=0.306 Sum_probs=116.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+|||++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++|
T Consensus 126 ~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sD 204 (288)
T cd05093 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESD 204 (288)
T ss_pred HHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhh
Confidence 368999999999999999999999999999999999999998755332111 1122344678999999876 46889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||.+....+.+..+... ... .....++.++.+||.
T Consensus 205 iwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~--~~~--------------------------~~~~~~~~~l~~li~ 256 (288)
T cd05093 205 VWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG--RVL--------------------------QRPRTCPKEVYDLML 256 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CcC--------------------------CCCCCCCHHHHHHHH
Confidence 9999999999998 99999887766655555331 110 001246788999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.+++.
T Consensus 257 ~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 257 GCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHccCChhhCCCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=209.10 Aligned_cols=148 Identities=21% Similarity=0.348 Sum_probs=116.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...............++..|+|||.+.+ ..++.++||
T Consensus 106 ~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di 184 (256)
T cd05113 106 CKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-SKFSSKSDV 184 (256)
T ss_pred HHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc-CcccchhHH
Confidence 4689999999999999999999999999999999999999987554332111122334677999999876 458889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||......+....+......+ .....+..+.+||.+
T Consensus 185 ~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~ 236 (256)
T cd05113 185 WAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY----------------------------RPHLASEKVYAIMYS 236 (256)
T ss_pred HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHH
Confidence 999999999998 999998777665555543311100 001357889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.++|.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=214.60 Aligned_cols=151 Identities=30% Similarity=0.443 Sum_probs=121.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.+ ...++.++
T Consensus 131 ~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 205 (317)
T cd06635 131 THGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKV 205 (317)
T ss_pred HHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----cccccCCccccChhhhhcCCCCCCCccc
Confidence 36899999999999999999999999999999999999998865432 233467889999999752 24578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+......+..+......+. ....++..+.+||.
T Consensus 206 Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~ 258 (317)
T cd06635 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---------------------------QSNEWSDYFRNFVD 258 (317)
T ss_pred cHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC---------------------------CCccccHHHHHHHH
Confidence 999999999999999999987766655555543211110 01245678999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||+.+|.+|||+.+++.|+|+...
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhcc
Confidence 9999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=211.10 Aligned_cols=147 Identities=18% Similarity=0.288 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+.|++|+||||+|||++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 126 ~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 204 (277)
T cd05062 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDV 204 (277)
T ss_pred HHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHH
Confidence 58999999999999999999999999999999999999998654322111 1112344678999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+..+.+..+.... .+ .....++..+.+||.+
T Consensus 205 ~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~ 256 (277)
T cd05062 205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-LL---------------------------DKPDNCPDMLFELMRM 256 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cC---------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 789998877655554442211 00 0012467889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||+.+++.+
T Consensus 257 ~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 257 CWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=213.13 Aligned_cols=146 Identities=22% Similarity=0.288 Sum_probs=113.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+|+||||+|||++.++.+||+|||++...... ........+..|+|||.+.+ ..++.++||
T Consensus 125 ~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 201 (297)
T cd05089 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNY-SVYTTKSDV 201 (297)
T ss_pred HHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccce--eccCCCCcCccccCchhhcc-CCCCchhhH
Confidence 368999999999999999999999999999999999999998532211 01111222456999998876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+....+....+...... .....++..+.+||.+
T Consensus 202 wSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~ 253 (297)
T cd05089 202 WSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM----------------------------EKPRNCDDEVYELMRQ 253 (297)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHH
Confidence 999999999997 99999887766655544221100 0112477889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||++++++.
T Consensus 254 ~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 254 CWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=211.94 Aligned_cols=158 Identities=29% Similarity=0.429 Sum_probs=119.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC-CCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~-~~s~~sDI 80 (468)
.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++...............++..|++||.+.+.. .++.++||
T Consensus 112 ~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv 191 (288)
T cd05583 112 AEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191 (288)
T ss_pred HHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhh
Confidence 59999999999999999999999999999999999999998765433222222345788999999986532 36789999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHH-cCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKL-CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|..||...........+... +...+ .....++..+.+||.+
T Consensus 192 ~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~ 245 (288)
T cd05583 192 WSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--------------------------PFPKTMSAEARDFIQK 245 (288)
T ss_pred HHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--------------------------CCCcccCHHHHHHHHH
Confidence 99999999999999999643322111111111 00000 0012467889999999
Q ss_pred hcCCCCCCCcC---HHHHHhcccccCCCC
Q 012191 160 LLSVEPYKRAT---ASAALASEYFSTKPY 185 (468)
Q Consensus 160 mL~~DP~kRpT---a~e~L~Hp~F~~~p~ 185 (468)
||+.||++||| +.++|+||||+...|
T Consensus 246 ~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 246 LLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 99999999998 567899999988655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=207.80 Aligned_cols=147 Identities=22% Similarity=0.359 Sum_probs=116.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+||+++.++.++|+|||++................+..|+|||.+.+ ..++.++||
T Consensus 109 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 187 (261)
T cd05068 109 AAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDV 187 (261)
T ss_pred HHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhH
Confidence 3689999999999999999999999999999999999999997665322111112223457999998876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+....+..+......+ ....++..+.+||.+
T Consensus 188 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~ 239 (261)
T cd05068 188 WSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP----------------------------CPPGCPKELYDIMLD 239 (261)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCcCCHHHHHHHHH
Confidence 999999999999 999998877766665553321100 012467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||+.||.+||++.+++.
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=212.01 Aligned_cols=156 Identities=26% Similarity=0.411 Sum_probs=117.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+ ..++.++||
T Consensus 111 ~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv 186 (287)
T cd06621 111 AESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQG-KPYSITSDV 186 (287)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc---cccccCCccccCHHHhcC-CCCCchhhH
Confidence 3689999999999999999999999999999999999999986544321 123456888999999876 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCc-----hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRT-----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~-----~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
|||||++|+|++|..||.... ..+....+.. ...... ... ...-..+++.+.+
T Consensus 187 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~------------------~~~-~~~~~~~~~~~~~ 244 (287)
T cd06621 187 WSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNPEL------------------KDE-PGNGIKWSEEFKD 244 (287)
T ss_pred HHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCchhh------------------ccC-CCCCCchHHHHHH
Confidence 999999999999999997652 1222222111 000000 000 0000134678999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||.+||..||.+|||+.+++.||||..
T Consensus 245 li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 245 FIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred HHHHHcCCCcccCCCHHHHHhCccccc
Confidence 999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-25 Score=210.89 Aligned_cols=142 Identities=23% Similarity=0.398 Sum_probs=111.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+
T Consensus 91 ~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 165 (237)
T cd05576 91 AAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGI-SEETEACDW 165 (237)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCC-CCCCchhhH
Confidence 368999999999999999999999999999999999999987654432 223345678999998865 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+||++|+|++|..||...... + .. .. . ......++..+.+||.+|
T Consensus 166 wslG~il~el~~g~~~~~~~~~~-----~----~~------------~~-------~-----~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 166 WSLGAILFELLTGKTLVECHPSG-----I----NT------------HT-------T-----LNIPEWVSEEARSLLQQL 212 (237)
T ss_pred HHHHHHHHHHHHCcchhhcCchh-----c----cc------------cc-------c-----cCCcccCCHHHHHHHHHH
Confidence 99999999999999887432110 0 00 00 0 001124678899999999
Q ss_pred cCCCCCCCcCH-----HHHHhcccc
Q 012191 161 LSVEPYKRATA-----SAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa-----~e~L~Hp~F 180 (468)
|+.||.+|+|+ .+++.||||
T Consensus 213 l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 213 LQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHhcCCCccchHHHHcCCCC
Confidence 99999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=215.03 Aligned_cols=147 Identities=21% Similarity=0.305 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++.......... .....++..|+|||.+.+ ..++.++||
T Consensus 116 ~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di 194 (316)
T cd05108 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDV 194 (316)
T ss_pred HHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhh
Confidence 699999999999999999999999999999999999999998665332211 122234667999999876 468899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+....+.. .+......++. ...++.++.+||.+
T Consensus 195 ~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~---------------------------~~~~~~~~~~li~~ 246 (316)
T cd05108 195 WSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ---------------------------PPICTIDVYMIMVK 246 (316)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC---------------------------CCCCCHHHHHHHHH
Confidence 999999999997 99999876654433 23221111110 12356788999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.+++.+
T Consensus 247 cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 247 CWMIDADSRPKFRELIIE 264 (316)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=222.50 Aligned_cols=150 Identities=32% Similarity=0.487 Sum_probs=127.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~sD 79 (468)
.+.|.||.|||+.+.||||||..|||+++.|.|||+|||.|.... +..+++|||+|||||+++- ...|+-++|
T Consensus 133 ~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----PAnsFvGTPywMAPEVILAMDEGqYdgkvD 207 (948)
T KOG0577|consen 133 HGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----PANSFVGTPYWMAPEVILAMDEGQYDGKVD 207 (948)
T ss_pred HHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-----chhcccCCccccchhHheeccccccCCccc
Confidence 367899999999999999999999999999999999999997665 4578899999999999863 357999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++..||.-.+||+...+.+..+..|... .+|.. . -++.+..+.+||..
T Consensus 208 vWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtL------------------------q--s~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 208 VWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTL------------------------Q--SNEWSDYFRNFVDS 260 (948)
T ss_pred eeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCC------------------------C--CchhHHHHHHHHHH
Confidence 999999999999999999888887777776442 11110 0 13567889999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||..-|.+|||.+++|.|+|....
T Consensus 261 CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHhhCcccCCcHHHHhhcchhccC
Confidence 999999999999999999998753
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=210.06 Aligned_cols=147 Identities=19% Similarity=0.265 Sum_probs=113.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++|
T Consensus 115 ~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~D 193 (279)
T cd05109 115 CVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSD 193 (279)
T ss_pred HHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhH
Confidence 369999999999999999999999999999999999999998766432211 1122234678999999876 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++ |.+||...........+ .....++ ....++..+.+||.
T Consensus 194 i~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~---------------------------~~~~~~~~~~~li~ 245 (279)
T cd05109 194 VWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERLP---------------------------QPPICTIDVYMIMV 245 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCC---------------------------CCccCCHHHHHHHH
Confidence 9999999999998 89999766554433322 2111111 01246788999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.+++.
T Consensus 246 ~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 246 KCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-24 Score=204.71 Aligned_cols=147 Identities=28% Similarity=0.465 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|+|
T Consensus 110 ~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~ 185 (256)
T cd08530 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKG-RPYSYKSDIW 185 (256)
T ss_pred HHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCC-CCCCchhhHH
Confidence 58999999999999999999999999999999999999998766543 2223467889999999876 4578899999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
|||+++|+|++|..||...+..+....+... ..+ .....++.++.++|.+||
T Consensus 186 slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 186 SLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYP--------------------------PIPPIYSQDLQNFIRSML 237 (256)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCC--------------------------CCchhhCHHHHHHHHHHc
Confidence 9999999999999999887765544443221 100 011246788999999999
Q ss_pred CCCCCCCcCHHHHHhcccc
Q 012191 162 SVEPYKRATASAALASEYF 180 (468)
Q Consensus 162 ~~DP~kRpTa~e~L~Hp~F 180 (468)
..+|.+|||+.++|+||+.
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=209.33 Aligned_cols=147 Identities=18% Similarity=0.245 Sum_probs=115.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++|++|+||||+|||++.++.++++|||.+...............++..|+|||.+.+ ..++.++||
T Consensus 113 ~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 191 (266)
T cd05064 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDV 191 (266)
T ss_pred HHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHH
Confidence 3689999999999999999999999999999999999999875443221111112234678999999876 568899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+....+.+..+......+ ....++..+.+++..
T Consensus 192 ~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~ 243 (266)
T cd05064 192 WSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP----------------------------APRNCPNLLHQLMLD 243 (266)
T ss_pred HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC----------------------------CCCCCCHHHHHHHHH
Confidence 999999999775 999999887776666553211100 113467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..+|.+|||+.++++
T Consensus 244 c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 244 CWQKERGERPRFSQIHS 260 (266)
T ss_pred HcCCCchhCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-25 Score=224.32 Aligned_cols=152 Identities=28% Similarity=0.441 Sum_probs=125.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC---CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.|||.||.|||-+||+|+||||+|||+... ..+||||||+|++++.. ..-.+.+||+.|+|||++.. ..|..+
T Consensus 670 vtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFRrsVVGTPAYLaPEVLrn-kGyNrS 746 (888)
T KOG4236|consen 670 VTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFRRSVVGTPAYLAPEVLRN-KGYNRS 746 (888)
T ss_pred HHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh--hhhhhhcCCccccCHHHHhh-cccccc
Confidence 3699999999999999999999999999654 46999999999988765 34467799999999999987 569999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~-e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
-|+||+|+|+|.-|.|..||..+.+. +++++- ..-.|. .-|.++++.++||
T Consensus 747 LDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA---aFMyPp-------------------------~PW~eis~~Aidl 798 (888)
T KOG4236|consen 747 LDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA---AFMYPP-------------------------NPWSEISPEAIDL 798 (888)
T ss_pred ccceeeeEEEEEEecccccCCCccchhHHhhcc---ccccCC-------------------------CchhhcCHHHHHH
Confidence 99999999999999999999754432 333221 111111 1235789999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..+|+..-.+|.|.+..|.|||++..
T Consensus 799 In~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHhcchHhhccchhhhcc
Confidence 999999999999999999999999875
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=204.64 Aligned_cols=153 Identities=35% Similarity=0.580 Sum_probs=119.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|
T Consensus 107 ~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~D 185 (260)
T cd06606 107 TRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAAD 185 (260)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC-CCCchhh
Confidence 468999999999999999999999999999999999999998766543210 12345678899999998763 4789999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||...... ...+....... ........++..+.+||.+
T Consensus 186 v~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~~i~~ 239 (260)
T cd06606 186 IWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSG------------------------EPPEIPEHLSEEAKDFLRK 239 (260)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccccC------------------------CCcCCCcccCHHHHHHHHH
Confidence 999999999999999999876521 11111111000 0001112457889999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||..||.+|||+.++|.||||
T Consensus 240 ~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 240 CLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=215.24 Aligned_cols=153 Identities=31% Similarity=0.484 Sum_probs=133.1
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceee
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 82 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWS 82 (468)
.|+-||-|||++||++||||.+|||++.+|.+||+|||++..--... ......+||+.|+|||++.- .+|+.++|.||
T Consensus 458 EiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~-~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa 535 (683)
T KOG0696|consen 458 EIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWA 535 (683)
T ss_pred HHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC-cceeeecCCCcccccceEEe-cccccchhHHH
Confidence 57889999999999999999999999999999999999986432221 23456799999999999874 67999999999
Q ss_pred eehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcC
Q 012191 83 VGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 162 (468)
Q Consensus 83 LG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~ 162 (468)
+||+|||||.|++||.|.++.+.+..|....-..| +.+|.++.+++..+|.
T Consensus 536 ~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP-----------------------------KslSkEAv~ickg~lt 586 (683)
T KOG0696|consen 536 FGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP-----------------------------KSLSKEAVAICKGLLT 586 (683)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc-----------------------------ccccHHHHHHHHHHhh
Confidence 99999999999999999999999999987544333 4688999999999999
Q ss_pred CCCCCCcC-----HHHHHhcccccCCCCC
Q 012191 163 VEPYKRAT-----ASAALASEYFSTKPYA 186 (468)
Q Consensus 163 ~DP~kRpT-----a~e~L~Hp~F~~~p~~ 186 (468)
..|.+|.. -.++-.||||+...|.
T Consensus 587 K~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 587 KHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred cCCccccCCCCccccchhhCcchhhccHH
Confidence 99999975 3678899999998775
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-24 Score=207.09 Aligned_cols=146 Identities=19% Similarity=0.245 Sum_probs=115.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
.||+.||+|||++||+|+||||.|||++.++.++|+|||++......... ......++..|+|||.+.. ..++.++|
T Consensus 102 ~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 180 (257)
T cd05116 102 HQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSD 180 (257)
T ss_pred HHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhH
Confidence 68999999999999999999999999999999999999998765433211 1122233578999998865 45788999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++ |.+||.+....+....+..... + .....+++++.+||.
T Consensus 181 i~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~---------------------------~~~~~~~~~l~~li~ 232 (257)
T cd05116 181 VWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M---------------------------ECPQRCPPEMYDLMK 232 (257)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C---------------------------CCCCCCCHHHHHHHH
Confidence 9999999999997 9999988776666555532110 0 011247889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+||++.++..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=209.96 Aligned_cols=148 Identities=24% Similarity=0.354 Sum_probs=114.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||+|||+++++|+||||+|||++.++ .+||+|||++.......... ......+..|+|||++.+ ..++.
T Consensus 122 ~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 200 (277)
T cd05036 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTS 200 (277)
T ss_pred HHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCc
Confidence 36899999999999999999999999998765 59999999987653221111 112233467999999976 45899
Q ss_pred Ccceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 77 SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 77 ~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
++|||||||++|+|++ |..||.+.+..+....+... ..+ .....++..+.+
T Consensus 201 ~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~ 252 (277)
T cd05036 201 KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRL---------------------------DPPKGCPGPVYR 252 (277)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcC---------------------------CCCCCCCHHHHH
Confidence 9999999999999997 99999887766554443221 100 001346788999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhc
Q 012191 156 LIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~H 177 (468)
||.+||+.||.+|||+.++|+|
T Consensus 253 ~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 253 IMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-24 Score=206.17 Aligned_cols=147 Identities=22% Similarity=0.365 Sum_probs=116.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.|++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+ ..++.++||
T Consensus 108 ~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di 186 (260)
T cd05067 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDV 186 (260)
T ss_pred HHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccch
Confidence 3689999999999999999999999999999999999999987655322222223345678999998865 457889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+.+..+....+......+ ....++.++.+||.+
T Consensus 187 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~ 238 (260)
T cd05067 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------------------------RPDNCPEELYELMRL 238 (260)
T ss_pred HHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHH
Confidence 999999999998 999998877666555442211100 112467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+++++.
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 239 CWKEKPEERPTFEYLRS 255 (260)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-24 Score=207.26 Aligned_cols=146 Identities=21% Similarity=0.339 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ .......++..|+|||.+.+ ..++.++||
T Consensus 126 ~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 204 (277)
T cd05032 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDV 204 (277)
T ss_pred HHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccch
Confidence 5899999999999999999999999999999999999999875443221 11223355778999999865 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+.+..+....+.. +.... ....++..+.+||.+
T Consensus 205 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~~~--------------------------~~~~~~~~~~~li~~ 256 (277)
T cd05032 205 WSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGHLD--------------------------LPENCPDKLLELMRM 256 (277)
T ss_pred HHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--CCCCC--------------------------CCCCCCHHHHHHHHH
Confidence 999999999998 9999988776665554431 11100 012357889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||+.+|.+|||+.+++.
T Consensus 257 ~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 257 CWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=209.71 Aligned_cols=146 Identities=23% Similarity=0.321 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||+.||+|+||||+|||++.++.++|+|||++......... ......+++.|+|||.+.+ ..++.++||
T Consensus 129 ~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 207 (280)
T cd05092 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDI 207 (280)
T ss_pred HHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhH
Confidence 68999999999999999999999999999999999999998654332111 1122234678999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||......+.+..+.... +. .....+++.+.+||.+
T Consensus 208 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~ 259 (280)
T cd05092 208 WSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR--EL--------------------------ERPRTCPPEVYAIMQG 259 (280)
T ss_pred HHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc--cC--------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 999998776665555443211 10 0012467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+||++.+++.
T Consensus 260 cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 260 CWQREPQQRMVIKDIHS 276 (280)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-24 Score=219.41 Aligned_cols=145 Identities=24% Similarity=0.402 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||++|++||+++++|||||-..||||+++..+||+|||+|+....+............-|.|||.+.. ..++.++|||
T Consensus 310 ~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVW 388 (468)
T KOG0197|consen 310 AQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVW 388 (468)
T ss_pred HHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh-CCccccccee
Confidence 599999999999999999999999999999999999999999655443333333344677999999976 4689999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||+||||+| |+.||.+.+..+.+..+.+....|.. ..+|+.+.+|+..|
T Consensus 389 SFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P----------------------------~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 389 SFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP----------------------------EGCPDEVYELMKSC 440 (468)
T ss_pred ehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC----------------------------CCCCHHHHHHHHHH
Confidence 99999999998 99999999999999988665433321 36899999999999
Q ss_pred cCCCCCCCcCHHHHH
Q 012191 161 LSVEPYKRATASAAL 175 (468)
Q Consensus 161 L~~DP~kRpTa~e~L 175 (468)
|..+|++|||.+.+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999998665
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=205.29 Aligned_cols=145 Identities=23% Similarity=0.351 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++|||
T Consensus 111 ~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Diw 188 (261)
T cd05148 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASH-GTFSTKSDVW 188 (261)
T ss_pred HHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-cccCCCCceEecCHHHHcc-CCCCchhhHH
Confidence 6899999999999999999999999999999999999999876543211 1223345678999999876 4688899999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |..||.+....+.+..+......+ ....+++.+.++|.+|
T Consensus 189 slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 189 SFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP----------------------------CPAKCPQEIYKIMLEC 240 (261)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC----------------------------CCCCCCHHHHHHHHHH
Confidence 99999999998 899998877766666554311110 0135678899999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|..||.+|||+.++++
T Consensus 241 l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 241 WAAEPEDRPSFKALRE 256 (261)
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=227.38 Aligned_cols=153 Identities=27% Similarity=0.469 Sum_probs=131.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|.|++.||+|||+++|||||||.+||||+.+.++||+|||++.++..+ ..+...+|++.|.|||++.|....++.+|+
T Consensus 161 F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~ 238 (596)
T KOG0586|consen 161 FRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDI 238 (596)
T ss_pred hHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceeh
Confidence 579999999999999999999999999999999999999999998855 456778999999999999998878999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||+|+|||-|++|..||.|.+-.+.-...+..... ..--++.++.+||++|
T Consensus 239 Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-----------------------------Ip~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 239 WSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-----------------------------IPFYMSCDCEDLLRKF 289 (596)
T ss_pred hhhhhhheeeeecccccCCcccccccchheeeeec-----------------------------ccceeechhHHHHHHh
Confidence 99999999999999999987755544333221100 0123678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|.++|.+|++.+++..|.|....-
T Consensus 290 lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred hccCccccCCHHHhhhhcccchhh
Confidence 999999999999999999998653
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-24 Score=205.66 Aligned_cols=142 Identities=18% Similarity=0.310 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||++||+|+||||+||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++|||
T Consensus 109 ~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~ 183 (256)
T cd05082 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVW 183 (256)
T ss_pred HHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc----CCCCccceeecCHHHHcc-CCCCchhhhH
Confidence 68999999999999999999999999999999999999998654332 122234567999999866 4578899999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |..||...+..+....+.... .+ .....++..+.+||.+|
T Consensus 184 slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 184 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KM--------------------------DAPDGCPPVVYDVMKQC 235 (256)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CC--------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999997 999998766555444442210 00 01135688999999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|..||.+|||+.++++
T Consensus 236 l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 236 WHLDAATRPSFLQLRE 251 (256)
T ss_pred hcCChhhCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-24 Score=207.79 Aligned_cols=142 Identities=20% Similarity=0.289 Sum_probs=109.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc-------EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~-------vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~ 73 (468)
+.||+.||+|||++||+||||||+|||++.++. ++++|||++...... ....++..|+|||.+.....
T Consensus 111 ~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 185 (262)
T cd05077 111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKN 185 (262)
T ss_pred HHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCC
Confidence 369999999999999999999999999987654 899999998654321 23457788999999875567
Q ss_pred CCCCcceeeeehhhhhhh-hcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHH
Q 012191 74 YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLl-tG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 152 (468)
++.++|||||||++|+|+ .|..||.+....+.. .+.... . ......+.+
T Consensus 186 ~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~--~---------------------------~~~~~~~~~ 235 (262)
T cd05077 186 LSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ--C---------------------------MLVTPSCKE 235 (262)
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC--c---------------------------cCCCCChHH
Confidence 899999999999999997 588888765433321 111100 0 001124567
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 153 AVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 153 l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
+.+||.+||+.||.+|||+.++|++
T Consensus 236 ~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 236 LADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHh
Confidence 8999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-24 Score=218.41 Aligned_cols=148 Identities=21% Similarity=0.341 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc-cccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+||||||+|||++.++.+||+|||++........... ....++..|+|||++.+ ..++.++||
T Consensus 221 ~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi 299 (375)
T cd05104 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDV 299 (375)
T ss_pred HHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCH
Confidence 5999999999999999999999999999999999999999876543321111 12234567999999976 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+......+.++......+ ......+.++.+||.+
T Consensus 300 ~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~ 352 (375)
T cd05104 300 WSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM---------------------------LSPECAPSEMYDIMKS 352 (375)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC---------------------------CCCCCCCHHHHHHHHH
Confidence 999999999997 899998765443333332211000 0012356789999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||+.++++.
T Consensus 353 cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 353 CWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=208.51 Aligned_cols=147 Identities=20% Similarity=0.322 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 131 ~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 209 (283)
T cd05090 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDI 209 (283)
T ss_pred HHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhh
Confidence 58999999999999999999999999999999999999999765432211 1123344677999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+.........+.... .+ .....++..+.+||.+
T Consensus 210 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~ 261 (283)
T cd05090 210 WSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-LL---------------------------PCSEDCPPRMYSLMTE 261 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cC---------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 999998876655544443211 00 0113467889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+||++.+++++
T Consensus 262 cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 262 CWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcccCcccCcCHHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-24 Score=206.03 Aligned_cols=148 Identities=21% Similarity=0.350 Sum_probs=116.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++|
T Consensus 112 ~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~D 190 (266)
T cd05033 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASD 190 (266)
T ss_pred HHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccc
Confidence 368999999999999999999999999999999999999999876421111 1112234678999999875 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||......+....+......+. ...++..+.+||.
T Consensus 191 v~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~ 242 (266)
T cd05033 191 VWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP----------------------------PMDCPSALYQLML 242 (266)
T ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CCCCCHHHHHHHH
Confidence 9999999999997 9999987766655555532111110 1246788999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+||++.+++++
T Consensus 243 ~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 243 DCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-24 Score=204.89 Aligned_cols=149 Identities=27% Similarity=0.516 Sum_probs=118.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.|++|+||+|+||+++. +.++|+|||++....... .......++..|+|||.+.+ ..++.++|+
T Consensus 112 ~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv 188 (260)
T cd08222 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKH-QGYDSKSDI 188 (260)
T ss_pred HHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc-ccccCCCCCcCccCHHHHcc-CCCCchhhH
Confidence 368999999999999999999999999975 679999999987654322 12223456888999998865 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||+++|+|++|..||.+.........+.. +..+ .....++.++.+||.+|
T Consensus 189 ~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~ 240 (260)
T cd08222 189 WSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP--------------------------SLPETYSRQLNSIMQSM 240 (260)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCC--------------------------CCcchhcHHHHHHHHHH
Confidence 9999999999999999987666555444422 1111 00134678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|..||.+||++.++|+||||
T Consensus 241 l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 241 LNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred hcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=204.55 Aligned_cols=147 Identities=20% Similarity=0.264 Sum_probs=114.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc--cccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL--TSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~--~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||..||+|+||||+|||++.++.+||+|||++........... ....++..|+|||.+.+ ..++.++
T Consensus 101 ~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 179 (257)
T cd05060 101 AHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKS 179 (257)
T ss_pred HHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccc
Confidence 36899999999999999999999999999999999999999876543322111 11122467999998865 4588999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |.+||...+..+....+... ... .....++..+.+||
T Consensus 180 Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~l~~li 231 (257)
T cd05060 180 DVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERL---------------------------PRPEECPQEIYSIM 231 (257)
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcC---------------------------CCCCCCCHHHHHHH
Confidence 99999999999997 99999877665544443221 000 01134678899999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..||.+|||+.++++
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 232 LSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=205.17 Aligned_cols=147 Identities=24% Similarity=0.365 Sum_probs=117.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||++................+..|+|||.+.+ ..++.++||
T Consensus 109 ~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di 187 (261)
T cd05034 109 AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDV 187 (261)
T ss_pred HHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHH
Confidence 3689999999999999999999999999999999999999987654321111122234568999999876 457899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+....+..+......+ .....+..+.++|.+
T Consensus 188 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~ 239 (261)
T cd05034 188 WSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP----------------------------RPPNCPEELYDLMLQ 239 (261)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHH
Confidence 999999999998 999998887776666654321111 012357889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.++++
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-24 Score=206.11 Aligned_cols=147 Identities=24% Similarity=0.342 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.|++|+||||+|||++.++.++|+|||++...............++..|+|||.+.+ ..++.++|||
T Consensus 114 ~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~ 192 (270)
T cd05056 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVW 192 (270)
T ss_pred HHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhH
Confidence 689999999999999999999999999999999999999987654332111222233567999998865 4688999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |..||.+.+..+.+..+..... + .....++..+.+||.+|
T Consensus 193 slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~~~ 244 (270)
T cd05056 193 MFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-L---------------------------PMPPNCPPTLYSLMTKC 244 (270)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc-C---------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999986 9999988877665554422110 0 01135678999999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|..+|.+|||+.+++..
T Consensus 245 l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 245 WAYDPSKRPRFTELKAQ 261 (270)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-24 Score=205.19 Aligned_cols=147 Identities=22% Similarity=0.296 Sum_probs=112.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++........ .......++..|+|||.+.+ ..++.++
T Consensus 105 ~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 183 (262)
T cd05058 105 LQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKS 183 (262)
T ss_pred HHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHH
Confidence 5899999999999999999999999999999999999999865432211 11112344678999999876 4688999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |.+||......+....+.. +.... ....++..+.+|+
T Consensus 184 Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~--~~~~~--------------------------~~~~~~~~~~~li 235 (262)
T cd05058 184 DVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL--------------------------QPEYCPDPLYEVM 235 (262)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CCCCC--------------------------CCCcCCHHHHHHH
Confidence 99999999999999 5677876655544433321 11000 0023577899999
Q ss_pred HHhcCCCCCCCcCHHHHHhc
Q 012191 158 ETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~H 177 (468)
..||..+|.+|||+.+++..
T Consensus 236 ~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 236 LSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=211.12 Aligned_cols=145 Identities=24% Similarity=0.320 Sum_probs=112.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......++..|+|||.+.+ ..++.++|||
T Consensus 131 ~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~ 207 (303)
T cd05088 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVW 207 (303)
T ss_pred HHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccch
Confidence 689999999999999999999999999999999999999985322110 1111233567999998865 4588999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |.+||.+.+..+....+.... .. .....++..+.+||.+|
T Consensus 208 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~ 259 (303)
T cd05088 208 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RL--------------------------EKPLNCDDEVYDLMRQC 259 (303)
T ss_pred hhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--cC--------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999998 999998776655444331100 00 00123678899999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|..||.+|||+.++|.+
T Consensus 260 l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 260 WREKPYERPSFAQILVS 276 (303)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=202.85 Aligned_cols=148 Identities=22% Similarity=0.318 Sum_probs=117.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++|++|+||+|+||+++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++
T Consensus 103 ~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~ 181 (257)
T cd05040 103 AVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHAS 181 (257)
T ss_pred HHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchh
Confidence 369999999999999999999999999999999999999998766432211 1112345778999998865 4588999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |..||...+..+.+..+.......+ ....++..+.+||
T Consensus 182 Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li 234 (257)
T cd05040 182 DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE---------------------------RPEACPQDIYNVM 234 (257)
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC---------------------------CCccCCHHHHHHH
Confidence 99999999999998 9999988777766665543110000 0124678899999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..+|.+|||+.++++
T Consensus 235 ~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 235 LQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHCCCCcccCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=207.22 Aligned_cols=147 Identities=16% Similarity=0.250 Sum_probs=114.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++|++|+||||+|||++.++.+||+|||++.......... .....++..|+|||.+.+ ..++.++|
T Consensus 115 ~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~D 193 (279)
T cd05111 115 CVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSD 193 (279)
T ss_pred HHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhh
Confidence 3699999999999999999999999999999999999999997654332211 223345678999999876 45899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++ |..||.+.........+ .....++ .....+.++.+++.
T Consensus 194 v~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~---------------------------~~~~~~~~~~~li~ 245 (279)
T cd05111 194 VWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLA---------------------------QPQICTIDVYMVMV 245 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCC---------------------------CCCCCCHHHHHHHH
Confidence 9999999999998 99999887654433332 2111110 00124567899999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.++++
T Consensus 246 ~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 246 KCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHcCCCcccCcCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-24 Score=195.56 Aligned_cols=145 Identities=22% Similarity=0.290 Sum_probs=109.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+++ ||+|||++.++.+++ ||++...... ...+|+.|+|||++.+ ..|+.++||
T Consensus 23 ~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~~~y~aPE~~~~-~~~~~~~Di 87 (176)
T smart00750 23 CLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVDPYFMAPEVIQG-QSYTEKADI 87 (176)
T ss_pred HHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCcccccChHHhcC-CCCcchhhH
Confidence 479999999999998 999999999999999 9998765432 2267899999999977 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH--HHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT--TAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~-e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~--~l~dLL 157 (468)
||||||+|||++|.+||...... ..+..+........ . ... .....++. .+.+||
T Consensus 88 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~----------------~~~---~~~~~~~~~~~~~~~i 145 (176)
T smart00750 88 YSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---P----------------RDR---SNLESVSAARSFADFM 145 (176)
T ss_pred HHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---c----------------ccc---ccHHHHHhhhhHHHHH
Confidence 99999999999999999765443 22333322111000 0 000 00012233 689999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccC
Q 012191 158 ETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+||..||.+|||+.+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-24 Score=207.84 Aligned_cols=153 Identities=30% Similarity=0.463 Sum_probs=122.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+
T Consensus 107 ~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv 184 (277)
T cd06641 107 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDSKADI 184 (277)
T ss_pred HHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhccccCCccccChhhhcc-CCCCchhhH
Confidence 3689999999999999999999999999999999999999986554321 11223467889999999865 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...........+... .++ .....++.++.++|.+|
T Consensus 185 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 185 WSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NPP--------------------------TLEGNYSKPLKEFVEAC 236 (277)
T ss_pred HHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CCC--------------------------CCCcccCHHHHHHHHHH
Confidence 99999999999999999876654444433211 010 01134678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+||++.++|.||||...
T Consensus 237 l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 237 LNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ccCChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=207.71 Aligned_cols=153 Identities=17% Similarity=0.209 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 137 ~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 215 (296)
T cd05051 137 TQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDV 215 (296)
T ss_pred HHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchh
Confidence 68999999999999999999999999999999999999998754332211 1123345678999999876 458899999
Q ss_pred eeeehhhhhhhh--cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLlt--G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++ +..||...+....+..+.......... ........++.++.+||.
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~ 274 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYELML 274 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHHHHH
Confidence 999999999998 778887766666555543321111000 000111346788999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.++++
T Consensus 275 ~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 275 ECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHhccChhcCCCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=209.89 Aligned_cols=147 Identities=24% Similarity=0.327 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......... .....++..|+|||++.+ ..++.++||
T Consensus 144 ~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 222 (304)
T cd05101 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDV 222 (304)
T ss_pred HHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhH
Confidence 589999999999999999999999999999999999999987654322111 122344678999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+..+....+.... .. .....++..+.+||.+
T Consensus 223 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~ 274 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH--RM--------------------------DKPANCTNELYMMMRD 274 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--cC--------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 889998877666555442210 00 0012567889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..+|.+|||+.++|+.
T Consensus 275 cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 275 CWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HcccChhhCCCHHHHHHH
Confidence 999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=201.88 Aligned_cols=147 Identities=22% Similarity=0.326 Sum_probs=114.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...............++..|+|||.+.+ ..++.++|||
T Consensus 100 ~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~ 178 (250)
T cd05085 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVW 178 (250)
T ss_pred HHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHH
Confidence 689999999999999999999999999999999999999986544322111122233567999999865 4578899999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |..||.+.........+...... .....++..+.+|+.+|
T Consensus 179 slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 179 SYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM----------------------------SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999998 99999887666554444221100 01124678999999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|..+|.+|||+.++++.
T Consensus 231 l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 231 WDYKPENRPKFSELQKE 247 (250)
T ss_pred cccCcccCCCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=204.80 Aligned_cols=150 Identities=29% Similarity=0.499 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC--CCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+ ..++.++|
T Consensus 113 ~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 191 (264)
T cd06653 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKAD 191 (264)
T ss_pred HHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcC-CCCCcccc
Confidence 689999999999999999999999999999999999999987543211 111234467889999999876 45788999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
+|||||++|+|++|.+||...........+. ..+... .....++..+.++|.+
T Consensus 192 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~------------------------~~p~~~~~~~~~~i~~ 244 (264)
T cd06653 192 VWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTKP------------------------MLPDGVSDACRDFLKQ 244 (264)
T ss_pred HHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCCC------------------------CCCcccCHHHHHHHHH
Confidence 9999999999999999998765555444332 221110 0113577889999999
Q ss_pred hcCCCCCCCcCHHHHHhcccc
Q 012191 160 LLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||. +|..|||+.++|.|||.
T Consensus 245 ~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 245 IFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred Hhc-CcccCccHHHHhcCCCC
Confidence 999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=209.60 Aligned_cols=146 Identities=24% Similarity=0.335 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 219 (314)
T cd05099 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDV 219 (314)
T ss_pred HHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchh
Confidence 58999999999999999999999999999999999999999755422111 1112233467999999876 468899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+....+.+..+.... .. .....++.++.+||.+
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~ 271 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH--RM--------------------------DKPSNCTHELYMLMRE 271 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 899998877665555443210 00 0113467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.++++
T Consensus 272 cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 272 CWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HcCCCcccCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=202.87 Aligned_cols=147 Identities=22% Similarity=0.343 Sum_probs=115.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.|++|+||+|+||+++..+.++|+|||++...............++..|+|||.+.+ ..++.++|+
T Consensus 108 ~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di 186 (260)
T cd05073 108 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDV 186 (260)
T ss_pred HHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccc
Confidence 3689999999999999999999999999999999999999987654332222223344677999999875 457889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+.+.......+...... .....++.++.+++.+
T Consensus 187 ~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----------------------------PRPENCPEELYNIMMR 238 (260)
T ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC----------------------------CCcccCCHHHHHHHHH
Confidence 999999999998 99999887665555444221100 0113567889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+||++.+++.
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 239 CWKNRPEERPTFEYIQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=203.28 Aligned_cols=147 Identities=22% Similarity=0.330 Sum_probs=111.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc-cccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++........... .....+..|+|||.+.+ ..++.++|
T Consensus 100 ~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 178 (252)
T cd05084 100 VENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-GRYSSESD 178 (252)
T ss_pred HHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC-CCCChHHH
Confidence 36899999999999999999999999999999999999999865432211110 11122456999999876 45788999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||...+.......+.... .+ .....++..+.+||.
T Consensus 179 v~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~ 230 (252)
T cd05084 179 VWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-RL---------------------------PCPELCPDAVYRLME 230 (252)
T ss_pred HHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CC---------------------------CCcccCCHHHHHHHH
Confidence 9999999999997 889997666544443332211 00 001245788999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=223.69 Aligned_cols=151 Identities=21% Similarity=0.353 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCC-CCCCccccccCCcccChhhhcC--CCCCCCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLG--ATDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~s 78 (468)
+||++|+.|||.++|||+|||..|||+.+++.|||+|||++....-. ....+....|...|||||++.. ..+|++.+
T Consensus 495 qQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qS 574 (678)
T KOG0193|consen 495 QQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQS 574 (678)
T ss_pred HHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCccc
Confidence 79999999999999999999999999999999999999998643321 1223444567888999999864 34689999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||||+|||++|..||........+..+-...+.+ .+.....+.+.++++|+.
T Consensus 575 DVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p------------------------d~s~~~s~~pk~mk~Ll~ 630 (678)
T KOG0193|consen 575 DVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP------------------------DLSKIRSNCPKAMKRLLS 630 (678)
T ss_pred chhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc------------------------cchhhhccCHHHHHHHHH
Confidence 99999999999999999998544443333332211111 122333567889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
.||.+++++||+..+||.
T Consensus 631 ~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 631 DCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHhcCcccCccHHHHHH
Confidence 999999999999999986
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=208.01 Aligned_cols=146 Identities=22% Similarity=0.280 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 134 ~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di 212 (290)
T cd05045 134 WQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDV 212 (290)
T ss_pred HHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHH
Confidence 68999999999999999999999999999999999999998754322111 1122234678999998866 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.........+...... .....++.++.+||..
T Consensus 213 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~ 264 (290)
T cd05045 213 WSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM----------------------------ERPENCSEEMYNLMLT 264 (290)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC----------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 99999887665544433211100 0013467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||+.||.+|||+.+++.
T Consensus 265 cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 265 CWKQEPDKRPTFADISK 281 (290)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=201.26 Aligned_cols=147 Identities=24% Similarity=0.348 Sum_probs=116.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...............++..|+|||.+.+ ..++.++||
T Consensus 109 ~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di 187 (258)
T smart00219 109 ALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDV 187 (258)
T ss_pred HHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhcc-CCCCcchhH
Confidence 3689999999999999999999999999999999999999987665432211112236788999999854 568899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+.+.......+..... + .....++..+.++|.+
T Consensus 188 ~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 188 WSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-L---------------------------PKPENCPPEIYKLMLQ 239 (258)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-C---------------------------CCCCcCCHHHHHHHHH
Confidence 999999999998 8899988766665555432110 0 0012368889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 240 CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HCcCChhhCcCHHHHHh
Confidence 99999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=207.02 Aligned_cols=154 Identities=29% Similarity=0.414 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+ .||+|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++||
T Consensus 110 ~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di 185 (284)
T cd06620 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQG-GKYTVKSDV 185 (284)
T ss_pred HHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---ccCccccCcccCCHHHHcc-CCCCccchH
Confidence 589999999997 69999999999999999999999999988644322 1123467899999999876 468889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHH--------HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVE--------QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e--------~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 152 (468)
|||||++|+|++|..||....... ....+.......+. .. ....++..
T Consensus 186 ~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~------~~~~~~~~ 241 (284)
T cd06620 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------------------RL------PSSDFPED 241 (284)
T ss_pred HHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC------------------CC------CchhcCHH
Confidence 999999999999999998654321 01111110000000 00 00136778
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 153 AVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 153 l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+.+||.+||..||.+|||+.++++|+||...
T Consensus 242 ~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 242 LRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=203.28 Aligned_cols=147 Identities=23% Similarity=0.351 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||+.|++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+ ..++.++|||
T Consensus 107 ~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~ 185 (256)
T cd05112 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVW 185 (256)
T ss_pred HHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHH
Confidence 589999999999999999999999999999999999999987554322111222334678999999876 4588899999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |..||........+..+....... .....+..+.+|+.+|
T Consensus 186 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 186 SFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY----------------------------KPRLASQSVYELMQHC 237 (256)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC----------------------------CCCCCCHHHHHHHHHH
Confidence 99999999998 999998877666555543211000 0012568899999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|..+|.+|||+.++++.
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=205.20 Aligned_cols=151 Identities=18% Similarity=0.235 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcC------CCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLG------ATDY 74 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g------~~~~ 74 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......++..|+|||++.. ...+
T Consensus 107 ~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 186 (269)
T cd05042 107 CEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ 186 (269)
T ss_pred HHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccccccccc
Confidence 6899999999999999999999999999999999999999864332211 11122345677999998743 2346
Q ss_pred CCCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 75 GPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
+.++|||||||++|+|++ |.+||......+.+..+.......... ......++..+
T Consensus 187 ~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~ 243 (269)
T cd05042 187 TKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK-----------------------PQLDLKYSDRW 243 (269)
T ss_pred chhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC-----------------------CcccccCCHHH
Confidence 789999999999999998 788998777666555553322111000 01113567888
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHh
Q 012191 154 VNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
.+++..|+ .||.+|||+.++++
T Consensus 244 ~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 244 YEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHh-cCcccccCHHHHHH
Confidence 99999998 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=202.05 Aligned_cols=147 Identities=23% Similarity=0.338 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc-cccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.|++.||.|||++|++|+||+|+|||++.++.++|+|||++........... .....+..|+|||.+.+ ..++.++||
T Consensus 100 ~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di 178 (251)
T cd05041 100 LDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GRYTSESDV 178 (251)
T ss_pred HHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc-CCCCcchhH
Confidence 5899999999999999999999999999999999999999875542211111 11223567999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.........+......+ ....++..+.+||.+
T Consensus 179 ~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~ 230 (251)
T cd05041 179 WSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP----------------------------APQLCPEEIYRLMLQ 230 (251)
T ss_pred HHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC----------------------------CCccCCHHHHHHHHH
Confidence 999999999998 889998776554444432211000 012467889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..+|.+|||+.++|+.
T Consensus 231 ~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 231 CWAYDPENRPSFSEIYNE 248 (251)
T ss_pred HhccChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=203.19 Aligned_cols=147 Identities=19% Similarity=0.243 Sum_probs=114.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC--ccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++|++|+||||+|||++.++.+||+|||++.......... .....++..|+|||.+.+ ..++.++
T Consensus 101 ~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 179 (257)
T cd05115 101 MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRS 179 (257)
T ss_pred HHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchh
Confidence 3689999999999999999999999999999999999999987554322111 112223568999999875 4578899
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |.+||.+....+....+... ..+ ......++++.+||
T Consensus 180 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~l~~li 231 (257)
T cd05115 180 DVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--KRL--------------------------DCPAECPPEMYALM 231 (257)
T ss_pred hHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--CCC--------------------------CCCCCCCHHHHHHH
Confidence 99999999999996 99999887766655444221 110 01124678999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..||.+||++.++++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=204.61 Aligned_cols=148 Identities=29% Similarity=0.476 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+|
T Consensus 113 ~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~ 190 (267)
T cd08228 113 VQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIW 190 (267)
T ss_pred HHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-HHHhcCCCCccccChhhhcc-CCCCchhhHH
Confidence 689999999999999999999999999999999999999987654322 11223467889999999876 4578899999
Q ss_pred eeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|+||++|+|++|..||..... ...+.......+.++. ....++..+.+||.+|
T Consensus 191 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~c 244 (267)
T cd08228 191 SLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--------------------------PTEHYSEKLRELVSMC 244 (267)
T ss_pred HHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC--------------------------ChhhcCHHHHHHHHHH
Confidence 999999999999999865432 2222222222222111 0124678899999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|..+|.+|||+.++|+.
T Consensus 245 l~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 245 IYPDPDQRPDIGYVHQI 261 (267)
T ss_pred CCCCcccCcCHHHHHHH
Confidence 99999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=205.23 Aligned_cols=145 Identities=23% Similarity=0.314 Sum_probs=111.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||+.|++|+||||+|||++.++.+||+|||++....... .......+..|+|||++.+ ..++.++||
T Consensus 118 ~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di 194 (270)
T cd05047 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDV 194 (270)
T ss_pred HHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccCChHHHcc-CCCCchhhH
Confidence 3689999999999999999999999999999999999999975322110 1111223567999998865 568899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+..+.+..+.... .. +....++.++.+||.+
T Consensus 195 ~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~~ 246 (270)
T cd05047 195 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RL--------------------------EKPLNCDDEVYDLMRQ 246 (270)
T ss_pred HHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--CC--------------------------CCCCcCCHHHHHHHHH
Confidence 999999999996 999998766555444432100 00 0112467789999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.+++.
T Consensus 247 ~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 247 CWREKPYERPSFAQILV 263 (270)
T ss_pred HcccChhhCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-24 Score=215.60 Aligned_cols=147 Identities=28% Similarity=0.478 Sum_probs=109.3
Q ss_pred EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCC------chHHHHH
Q 012191 34 LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR------TEVEQLH 107 (468)
Q Consensus 34 vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~------~~~e~l~ 107 (468)
|||+|||.|+.+.. .++..+.|..|++||+++|. .|+..+||||++||+|||+||..+|... .+.+.+.
T Consensus 393 vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGs-gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 393 VKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGS-GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred EEEeeccchhhhhh----hhchhhhhhhccCcceeecC-CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 68888888876553 35666789999999999994 6999999999999999999999999532 3577899
Q ss_pred HHHHHcCCCCchhhhccC-----------CCccccCCCCCCCCchhhhhcC---CCcHHHHHHHHHhcCCCCCCCcCHHH
Q 012191 108 KIFKLCGSPPDDYWKKSK-----------LPHATLFKPQQPYDSSLRETFK---DLPTTAVNLIETLLSVEPYKRATASA 173 (468)
Q Consensus 108 ~i~~~~g~p~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~~~~---~~s~~l~dLL~~mL~~DP~kRpTa~e 173 (468)
.|++++|..|..+....+ +.+...++ ..++...|.+.+. .-..++.+||.-||+++|++||||.+
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK-~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLK-PWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccC-CCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 999999998866533322 11111111 1222333444432 22345889999999999999999999
Q ss_pred HHhcccccCCCCC
Q 012191 174 ALASEYFSTKPYA 186 (468)
Q Consensus 174 ~L~Hp~F~~~p~~ 186 (468)
+|+|||++..+.+
T Consensus 547 cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 547 CLKHPWLNPVAGP 559 (590)
T ss_pred HhcCccccCCCCC
Confidence 9999999976554
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=204.75 Aligned_cols=146 Identities=20% Similarity=0.270 Sum_probs=114.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||+++++|+||||+|||++.++.+||+|||++..+....... .....++..|+|||.+.+ ..++.++||
T Consensus 124 ~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di 202 (280)
T cd05043 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDV 202 (280)
T ss_pred HHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhH
Confidence 589999999999999999999999999999999999999987553322111 122344677999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|++++ |.+||...+..+....+.... .+. ....+++.+.++|.+
T Consensus 203 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~li~~ 254 (280)
T cd05043 203 WSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLA---------------------------QPINCPDELFAVMAC 254 (280)
T ss_pred HHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CCC---------------------------CCCcCCHHHHHHHHH
Confidence 999999999998 999998766555443332210 000 012467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||++|||+.++++
T Consensus 255 ~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 255 CWALDPEERPSFSQLVQ 271 (280)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=208.93 Aligned_cols=148 Identities=24% Similarity=0.353 Sum_probs=113.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++|++|+||||+|||++.++.++|+|||++.......... .....+++.|+|||.+.+ ..++.++|
T Consensus 146 ~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 224 (307)
T cd05098 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSD 224 (307)
T ss_pred HHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHH
Confidence 3689999999999999999999999999999999999999987553221111 112233567999999876 45789999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||.+....+....+.. +... .....++.++.+||.
T Consensus 225 vwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~ 276 (307)
T cd05098 225 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE--GHRM--------------------------DKPSNCTNELYMMMR 276 (307)
T ss_pred HHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc--CCCC--------------------------CCCCcCCHHHHHHHH
Confidence 9999999999998 8899987665444433321 1000 011346788999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..+|.+|||+.+++.+
T Consensus 277 ~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 277 DCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHcccChhhCcCHHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=202.45 Aligned_cols=147 Identities=20% Similarity=0.329 Sum_probs=115.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccc--cccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--RVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~--~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.|++.||+|||+.||+|+||||+||+++.++.++|+|||++............. ...+..|+|||.+.+ ..++.++
T Consensus 113 ~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~ 191 (268)
T cd05063 113 LRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSAS 191 (268)
T ss_pred HHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHh
Confidence 3689999999999999999999999999999999999999987654322111111 122456999999876 4578999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |..||...+..+....+.... ..+ ....++..+.+|+
T Consensus 192 Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~---------------------------~~~~~~~~~~~li 243 (268)
T cd05063 192 DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP---------------------------APMDCPSAVYQLM 243 (268)
T ss_pred HHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC---------------------------CCCCCCHHHHHHH
Confidence 99999999999997 999998877666665553321 110 0124678899999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..||.+||++.++++
T Consensus 244 ~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 244 LQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=202.24 Aligned_cols=146 Identities=32% Similarity=0.508 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+|
T Consensus 113 ~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~ 190 (267)
T cd08229 113 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIW 190 (267)
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-cccccccCCcCccCHHHhcC-CCccchhhHH
Confidence 589999999999999999999999999999999999999987654322 22234467889999999866 4578899999
Q ss_pred eeehhhhhhhhcCCCCCCCchH--HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 82 SVGCVFAELLIGKPILQGRTEV--EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~--e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||++|+|++|..||.+.... .....+.. ...++ .....++..+.+||.+
T Consensus 191 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~~~~li~~ 243 (267)
T cd08229 191 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP--------------------------LPSDHYSEELRQLVNM 243 (267)
T ss_pred HHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCCC--------------------------CCcccccHHHHHHHHH
Confidence 9999999999999999764432 11111111 11000 0012467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.++++
T Consensus 244 ~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 244 CINPDPEKRPDITYVYD 260 (267)
T ss_pred hcCCCcccCCCHHHHHH
Confidence 99999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=210.40 Aligned_cols=147 Identities=23% Similarity=0.328 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......++..|+|||++.+ ..++.++||
T Consensus 141 ~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 219 (334)
T cd05100 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDV 219 (334)
T ss_pred HHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhh
Confidence 58999999999999999999999999999999999999998755432111 1122233567999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+..+....+.... .. .....++..+.+||.+
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~ 271 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH--RM--------------------------DKPANCTHELYMIMRE 271 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 889998877666555442210 00 0112467889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..+|.+|||+.++|.+
T Consensus 272 cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 272 CWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HcccChhhCcCHHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=202.13 Aligned_cols=142 Identities=22% Similarity=0.256 Sum_probs=109.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc--------EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~--------vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~ 72 (468)
+.||+.||+|||+.||+||||||+|||++.++. ++++|||++...... ....++..|+|||++.+..
T Consensus 106 ~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~ 180 (258)
T cd05078 106 AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQ 180 (258)
T ss_pred HHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCC
Confidence 369999999999999999999999999987654 699999988654321 2345678899999998756
Q ss_pred CCCCCcceeeeehhhhhhhhcC-CCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH
Q 012191 73 DYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG~-~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 151 (468)
.++.++|||||||++|+|++|. +||...+........ ...... ....+.
T Consensus 181 ~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~-----------------------------~~~~~~ 230 (258)
T cd05078 181 NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRHQL-----------------------------PAPKWT 230 (258)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-HccccC-----------------------------CCCCcH
Confidence 6889999999999999999984 666654443332211 110000 012456
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 152 TAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
++.+||.+||+.||.+|||+.++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 78999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=207.41 Aligned_cols=147 Identities=22% Similarity=0.347 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+|+||||+|||++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 148 ~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 226 (302)
T cd05055 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDV 226 (302)
T ss_pred HHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHH
Confidence 58999999999999999999999999999999999999998755432211 1112345678999999876 457889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||+||++|+|++ |.+||.+....+.+.........+ ......+..+.+||.+
T Consensus 227 wslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~ 279 (302)
T cd05055 227 WSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM---------------------------AQPEHAPAEIYDIMKT 279 (302)
T ss_pred HHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC---------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 999998766554444332211000 0012457889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..+|.+|||+.+++.
T Consensus 280 cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 280 CWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-24 Score=220.90 Aligned_cols=146 Identities=23% Similarity=0.358 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
++|+.|+.|||.+.|||||||.-||||..+..|||+|||.+...... .....++||..|||||++.. .+++.++|||
T Consensus 219 k~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrn-ePcsEKVDIw 295 (904)
T KOG4721|consen 219 KGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRN-EPCSEKVDIW 295 (904)
T ss_pred HHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhc-CCccccccee
Confidence 68999999999999999999999999999999999999998766543 34567899999999999987 6789999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
||||||||||||..||..-+...++.- .|.... .+ .....+|.-++-||+.||
T Consensus 296 SfGVVLWEmLT~EiPYkdVdssAIIwG----VGsNsL------~L-----------------pvPstcP~GfklL~Kqcw 348 (904)
T KOG4721|consen 296 SFGVVLWEMLTGEIPYKDVDSSAIIWG----VGSNSL------HL-----------------PVPSTCPDGFKLLLKQCW 348 (904)
T ss_pred hhHHHHHHHHhcCCCccccchheeEEe----ccCCcc------cc-----------------cCcccCchHHHHHHHHHH
Confidence 999999999999999976443322111 111100 00 011357788999999999
Q ss_pred CCCCCCCcCHHHHHhc
Q 012191 162 SVEPYKRATASAALAS 177 (468)
Q Consensus 162 ~~DP~kRpTa~e~L~H 177 (468)
+-.|..||++.++|.|
T Consensus 349 ~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 349 NSKPRNRPSFRQILLH 364 (904)
T ss_pred hcCCCCCccHHHHHHH
Confidence 9999999999999988
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=199.85 Aligned_cols=142 Identities=25% Similarity=0.403 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.|++||||||+||+++.++.++|+|||++...... ......+..|+|||.+.+ ..++.++|+|
T Consensus 107 ~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~ 181 (254)
T cd05083 107 LDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKH-KKFSSKSDVW 181 (254)
T ss_pred HHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc----CCCCCCCceecCHHHhcc-CCcCchhhHH
Confidence 68999999999999999999999999999999999999998654321 122234567999998865 4588899999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |.+||.+.+..+....+..... + .....++..+.+||.+|
T Consensus 182 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 182 SYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-M---------------------------EPPEGCPADVYVLMTSC 233 (254)
T ss_pred HHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-C---------------------------CCCCcCCHHHHHHHHHH
Confidence 99999999997 9999988776555444422100 0 00135678899999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|..+|.+|||+.+++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-24 Score=231.18 Aligned_cols=148 Identities=24% Similarity=0.412 Sum_probs=114.8
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC--c------cccccCCcccChhhhc-
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--L------TSRVVTLWYRPPELLL- 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~--~------~~~~gt~~Y~APE~l~- 69 (468)
|+|+++||.+||... |||||||-+||||+.+|.+||||||.|+-........ . .....|+.|++||.+.
T Consensus 150 f~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl 229 (738)
T KOG1989|consen 150 FYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL 229 (738)
T ss_pred HHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh
Confidence 579999999999998 9999999999999999999999999986332221100 0 1224589999999873
Q ss_pred -CCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 70 -GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 70 -g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
.....+.++|||+|||+||.||....||.+.....++.--+ .. ..++.
T Consensus 230 ysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y----~~---------------------------P~~p~ 278 (738)
T KOG1989|consen 230 YSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY----SF---------------------------PPFPN 278 (738)
T ss_pred hcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc----cC---------------------------CCCcc
Confidence 33567999999999999999999999998653332222111 01 11246
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhccc
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALASEY 179 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~ 179 (468)
++..+.+||..||+.||.+||++.+++.+-+
T Consensus 279 ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 279 YSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred HHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 7889999999999999999999999997543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=201.55 Aligned_cols=148 Identities=22% Similarity=0.280 Sum_probs=114.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||+.||+|+||||+|||++.++.+||+|||++......... ......+++.|++||.+.+ ..++.++|
T Consensus 119 ~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sD 197 (273)
T cd05074 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSD 197 (273)
T ss_pred HHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-Cccchhhh
Confidence 368999999999999999999999999999999999999998765432211 1122344577999998865 45788999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||.+.+..+....+.... ... ....++..+.+|+.
T Consensus 198 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~l~~ 249 (273)
T cd05074 198 VWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLK---------------------------QPPDCLEDVYELMC 249 (273)
T ss_pred hHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCC---------------------------CCCCCCHHHHHHHH
Confidence 9999999999999 899998776655444443210 000 00246788999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..+|.+|||+.+++..
T Consensus 250 ~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 250 QCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=203.54 Aligned_cols=147 Identities=23% Similarity=0.333 Sum_probs=114.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++|++|+||||+|||++.++.++|+|||++........ ........+..|+|||.+.+ ..++.++|
T Consensus 136 ~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 214 (288)
T cd05050 136 AKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESD 214 (288)
T ss_pred HHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhH
Confidence 36899999999999999999999999999999999999999865432211 11122234567999999876 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+.... .. .....++..+.+||.
T Consensus 215 v~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~ 266 (288)
T cd05050 215 VWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN--VL--------------------------SCPDNCPLELYNLMR 266 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CC--------------------------CCCCCCCHHHHHHHH
Confidence 9999999999997 888998776665554442210 00 011246788999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.|+++
T Consensus 267 ~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 267 LCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=204.27 Aligned_cols=153 Identities=18% Similarity=0.229 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++|++|+||||+|||++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 136 ~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 214 (295)
T cd05097 136 VQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDV 214 (295)
T ss_pred HHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhH
Confidence 68999999999999999999999999999999999999998754332211 1122344678999999876 458999999
Q ss_pred eeeehhhhhhhh--cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLlt--G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++ +..||...+..+.+..+........... .......++..+.+||.
T Consensus 215 wSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~ 273 (295)
T cd05097 215 WAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQI---------------------YLSQTPLCPSPVFKLMM 273 (295)
T ss_pred HHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccc---------------------cCCCCCCCCHHHHHHHH
Confidence 999999999988 6788887766555554433211100000 00111246789999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.++++
T Consensus 274 ~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 274 RCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=194.51 Aligned_cols=152 Identities=41% Similarity=0.635 Sum_probs=119.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.+|.|||+.||+|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+ ..++.++||
T Consensus 93 ~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~-~~~~~~~Di 169 (244)
T smart00220 93 ARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLG-KGYGKAVDV 169 (244)
T ss_pred HHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHcc-CCCCchhhH
Confidence 3689999999999999999999999999999999999999987665431 2344567889999999875 457889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|+||+++|+|++|..||........+............ .....++..+.+++.+|
T Consensus 170 ~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 170 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-------------------------PPEWKISPEAKDLIRKL 224 (244)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------cccccCCHHHHHHHHHH
Confidence 99999999999999999874333333222221100000 00012678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccc
Q 012191 161 LSVEPYKRATASAALASEYF 180 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F 180 (468)
|..||.+||++.++++||||
T Consensus 225 l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 225 LVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccCCchhccCHHHHhhCCCC
Confidence 99999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=197.26 Aligned_cols=152 Identities=28% Similarity=0.445 Sum_probs=110.9
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEECCCCcEEEEecCCccccCCC---CC-----CCccccccCCcccChhhhcC
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG---HR-----QPLTSRVVTLWYRPPELLLG 70 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~---~~-----~~~~~~~gt~~Y~APE~l~g 70 (468)
|.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.++...-. .. +.......|..|+|||++.-
T Consensus 133 f~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v 212 (302)
T KOG2345|consen 133 FLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV 212 (302)
T ss_pred HHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec
Confidence 468999999999999 999999999999999999999999998643321 10 11123356899999999853
Q ss_pred C--CCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 71 A--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 71 ~--~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
. ...+.++|||||||+||.|+.|..||.- ++..-|+..-.. ...+..+. .-..
T Consensus 213 k~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~GgSlaLAv-----------~n~q~s~P-----~~~~ 267 (302)
T KOG2345|consen 213 KSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQGGSLALAV-----------QNAQISIP-----NSSR 267 (302)
T ss_pred ccCcccccccchhhhhHHHHHHHHcCCcchH---------HhhcCCeEEEee-----------eccccccC-----CCCC
Confidence 2 3467899999999999999999999952 222112111000 00000000 0123
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
+++.+.+||..||+.||.+||++.++|.+
T Consensus 268 yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 268 YSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 78999999999999999999999999965
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=205.56 Aligned_cols=148 Identities=19% Similarity=0.262 Sum_probs=113.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++|
T Consensus 115 ~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~D 193 (303)
T cd05110 115 CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSD 193 (303)
T ss_pred HHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHH
Confidence 369999999999999999999999999999999999999999765432211 1223345678999999876 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+.........+ .....++ .....+..+.++|.
T Consensus 194 iwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~---------------------------~~~~~~~~~~~li~ 245 (303)
T cd05110 194 VWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLP---------------------------QPPICTIDVYMVMV 245 (303)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCC---------------------------CCCCCCHHHHHHHH
Confidence 9999999999997 89999876543332222 2111110 01235678899999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
.||..||.+|||+.+++..
T Consensus 246 ~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 246 KCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-23 Score=199.77 Aligned_cols=146 Identities=23% Similarity=0.349 Sum_probs=113.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCC-----cEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-----~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
.||+.||.|||+.+++|+||+|+||+++.++ .++|+|||++........ .......++..|+|||.+.+ ..++
T Consensus 113 ~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 191 (269)
T cd05044 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFT 191 (269)
T ss_pred HHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcc
Confidence 5899999999999999999999999999877 899999999865432211 11122344678999999876 4578
Q ss_pred CCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 76 PSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
.++|||||||++|+|++ |..||...+..+....+.... .+ .....++..+.
T Consensus 192 ~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~ 243 (269)
T cd05044 192 TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL---------------------------QKPENCPDKIY 243 (269)
T ss_pred cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc---------------------------CCcccchHHHH
Confidence 99999999999999998 999998777665544432110 00 01134678899
Q ss_pred HHHHHhcCCCCCCCcCHHHHHh
Q 012191 155 NLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
+||.+||..+|.+|||+.++++
T Consensus 244 ~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 244 QLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-23 Score=201.55 Aligned_cols=149 Identities=21% Similarity=0.356 Sum_probs=115.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...............++..|+|||.+.+ ..++.++||
T Consensus 123 ~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di 201 (275)
T cd05046 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDV 201 (275)
T ss_pred HHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhH
Confidence 3699999999999999999999999999999999999999986443222222334455778999998876 347889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+......+..+... ... | .....++..+.++|.+
T Consensus 202 ~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~---~----------------------~~~~~~~~~l~~~i~~ 254 (275)
T cd05046 202 WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLE---L----------------------PVPEGCPSRLYKLMTR 254 (275)
T ss_pred HHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcC---C----------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 88899776655544443211 100 0 0012467889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||+.+++..
T Consensus 255 ~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 255 CWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HcCCCcccCCCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-23 Score=201.95 Aligned_cols=161 Identities=22% Similarity=0.306 Sum_probs=112.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++
T Consensus 113 ~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~ 191 (283)
T cd05080 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYAS 191 (283)
T ss_pred HHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCccc
Confidence 368999999999999999999999999999999999999998765432211 1122244667999999875 4578999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHH-cCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL-CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++|..||...... +..+... .+......+.. ..... .. ......++..+.+|+
T Consensus 192 Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~---~~-------~~~~~~~~~~~~~li 257 (283)
T cd05080 192 DVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIE--LLERG---MR-------LPCPKNCPQEVYILM 257 (283)
T ss_pred ccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhh--hhhcC---CC-------CCCCCCCCHHHHHHH
Confidence 9999999999999999998654321 1111110 00000000000 00000 00 001135678999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
..||..||.+|||+.+++.
T Consensus 258 ~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 258 KNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHhccChhhCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-23 Score=228.23 Aligned_cols=102 Identities=33% Similarity=0.476 Sum_probs=82.9
Q ss_pred ccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC
Q 012191 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ 136 (468)
Q Consensus 57 ~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 136 (468)
+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+....+.+..+.......+
T Consensus 541 vGT~~Y~APE~l~~-~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p------------------- 600 (669)
T cd05610 541 LGTPDYLAPELLLG-KPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP------------------- 600 (669)
T ss_pred eeCccccCHHHcCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------------------
Confidence 45889999999987 4589999999999999999999999999887777766643211110
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 137 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 137 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
.....++..+.++|..||..||.+|||+.++|.||||....+
T Consensus 601 -------~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~~~~~~~ 642 (669)
T cd05610 601 -------EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDW 642 (669)
T ss_pred -------cccccCCHHHHHHHHHHcccChhHCcCHHHHHhCHhhcCCCH
Confidence 001246788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=203.05 Aligned_cols=153 Identities=18% Similarity=0.271 Sum_probs=113.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc-cccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||+.||+|+||||+|||++.++.++|+|||++..+........ ....++..|++||.+.+ ..++.++||
T Consensus 137 ~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di 215 (296)
T cd05095 137 TQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDV 215 (296)
T ss_pred HHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhh
Confidence 5899999999999999999999999999999999999999875543221111 12234577999998766 458999999
Q ss_pred eeeehhhhhhhh--cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLI--GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLlt--G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|||++ |..||...+..+.+.........-. . ..+ ......++..+.+||.
T Consensus 216 wSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~-------~~~----------~~~~~~~~~~~~~li~ 274 (296)
T cd05095 216 WAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG----R-------QVY----------LPKPALCPDSLYKLML 274 (296)
T ss_pred hHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcc----c-------ccc----------CCCCCCCCHHHHHHHH
Confidence 999999999998 7788877666554443322110000 0 000 0011246788999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
.||+.||.+|||+.++++
T Consensus 275 ~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 275 SCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHcCCCcccCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-23 Score=199.94 Aligned_cols=151 Identities=21% Similarity=0.318 Sum_probs=112.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCC------CCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGA------TDY 74 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~------~~~ 74 (468)
.||+.||+|||+.+|+|+||||+|||++.++.++|+|||++....... ........++..|+|||++... ..+
T Consensus 106 ~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 185 (268)
T cd05086 106 CEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQ 185 (268)
T ss_pred HHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCC
Confidence 589999999999999999999999999999999999999875322111 1112234678899999987431 235
Q ss_pred CCCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 75 GPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
+.++|||||||++|+|++ |.+||....+.+.+..+....... . +.+. ....+++.+
T Consensus 186 ~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~-----------~~~~---------~~~~~~~~~ 242 (268)
T cd05086 186 TKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---L-----------FKPQ---------LELPYSERW 242 (268)
T ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---c-----------CCCc---------cCCCCcHHH
Confidence 778999999999999996 578898777766666654321110 0 0000 112467788
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHh
Q 012191 154 VNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
.++|..|| .+|.+|||+.++++
T Consensus 243 ~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 243 YEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHh-hCcccCCCHHHHHH
Confidence 99999999 78999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-23 Score=198.48 Aligned_cols=143 Identities=23% Similarity=0.368 Sum_probs=113.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... .....+..|+|||.+.+ ..++.++||
T Consensus 108 ~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~ape~~~~-~~~~~~~Di 182 (256)
T cd05039 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALRE-KKFSTKSDV 182 (256)
T ss_pred HHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc----ccCCCcccccCchhhcC-CcCCcHHHH
Confidence 3689999999999999999999999999999999999999987653221 12334567999998865 457889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||...+..+....+.... .+ .....+++.+.+||.+
T Consensus 183 ~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~ 234 (256)
T cd05039 183 WSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM---------------------------EAPEGCPPEVYKVMKD 234 (256)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC---------------------------CCccCCCHHHHHHHHH
Confidence 999999999997 999998776555444332210 00 0012467899999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..+|.+|||+.+++.
T Consensus 235 ~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 235 CWELDPAKRPTFKQLRE 251 (256)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=218.90 Aligned_cols=158 Identities=33% Similarity=0.523 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCcccc---------CCCC-----------------------
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS---------NTGH----------------------- 49 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~---------~~~~----------------------- 49 (468)
-+|.+|+++.|..|+|||||||+|||||.+|.|||.||||++-+ ..+.
T Consensus 736 AEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL 815 (1034)
T KOG0608|consen 736 AELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVL 815 (1034)
T ss_pred HHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHH
Confidence 46889999999999999999999999999999999999998521 1110
Q ss_pred ---------CCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchh
Q 012191 50 ---------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120 (468)
Q Consensus 50 ---------~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~ 120 (468)
.......+||+.|+|||++.. ..|+..||.||.|||||||+.|++||...+..+...++..
T Consensus 816 ~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n--------- 885 (1034)
T KOG0608|consen 816 ERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN--------- 885 (1034)
T ss_pred HHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee---------
Confidence 001134588999999999986 5689999999999999999999999988877665544422
Q ss_pred hhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcC---HHHHHhcccccCCCCC
Q 012191 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT---ASAALASEYFSTKPYA 186 (468)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpT---a~e~L~Hp~F~~~p~~ 186 (468)
|.. |.. ..-..+++.++.+||.++. -+++.|.. ++++-.||||+...|.
T Consensus 886 w~~--------~l~--------~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 886 WRN--------FLH--------IPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred hhh--------ccc--------cccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchH
Confidence 211 000 0112478999999999975 57888874 7789999999987664
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-23 Score=208.76 Aligned_cols=148 Identities=24% Similarity=0.313 Sum_probs=112.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 186 ~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 264 (343)
T cd05103 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDV 264 (343)
T ss_pred HHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhH
Confidence 58999999999999999999999999999999999999998754322111 1112234567999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+......+.........+. ....+++.+.+++..
T Consensus 265 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~ 317 (343)
T cd05103 265 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLD 317 (343)
T ss_pred HHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC---------------------------CCCCCCHHHHHHHHH
Confidence 999999999996 9999977543333222221110000 001256789999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.++++|
T Consensus 318 cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.9e-23 Score=199.17 Aligned_cols=146 Identities=23% Similarity=0.364 Sum_probs=113.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-Cccccc---cCCcccChhhhcCCCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRV---VTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~---gt~~Y~APE~l~g~~~~s~~ 77 (468)
.||+.||.|||++|++|+||||+||+++.++.++|+|||++......... ...... .+..|+|||.+.+ ..++.+
T Consensus 113 ~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~ 191 (269)
T cd05065 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSA 191 (269)
T ss_pred HHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-Ccccch
Confidence 68999999999999999999999999999999999999998755432211 111111 2457999999875 457899
Q ss_pred cceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 78 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 78 sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
+|||||||++|||++ |..||.+....+....+......+ ....++..+.++
T Consensus 192 ~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~l 243 (269)
T cd05065 192 SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP----------------------------PPMDCPTALHQL 243 (269)
T ss_pred hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC----------------------------CcccCCHHHHHH
Confidence 999999999999886 999998877665555553211100 012467889999
Q ss_pred HHHhcCCCCCCCcCHHHHHh
Q 012191 157 IETLLSVEPYKRATASAALA 176 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~ 176 (468)
+..||..+|.+|||+.+++.
T Consensus 244 i~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 244 MLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-23 Score=202.01 Aligned_cols=142 Identities=23% Similarity=0.308 Sum_probs=109.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-------cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~ 73 (468)
+.||+.||+|||++||+||||||+|||++..+ .++|+|||++...... ....++..|+|||.+.+...
T Consensus 123 ~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~ 197 (274)
T cd05076 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNS 197 (274)
T ss_pred HHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCC
Confidence 36999999999999999999999999997643 4899999987543221 23356788999999876566
Q ss_pred CCCCcceeeeehhhhhhh-hcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHH
Q 012191 74 YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLl-tG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 152 (468)
++.++|||||||++|+|+ +|.+||.+....+....+ ...... ....+..
T Consensus 198 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~-----------------------------~~~~~~~ 247 (274)
T cd05076 198 LSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-EKKHRL-----------------------------PEPSCKE 247 (274)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH-HhccCC-----------------------------CCCCChH
Confidence 899999999999999985 699999876554432221 110000 0123467
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 153 AVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 153 l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
+.+||.+||+.+|.+|||+.++|++
T Consensus 248 ~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 248 LATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHh
Confidence 8999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=200.44 Aligned_cols=163 Identities=22% Similarity=0.327 Sum_probs=111.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++||+|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++
T Consensus 115 ~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~ 193 (284)
T cd05079 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIAS 193 (284)
T ss_pred HHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc-CCCCccc
Confidence 369999999999999999999999999999999999999998765432211 1123455778999999876 4588899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|+++..++..... ...+..+....+..... . ........ .......++..+.+||.
T Consensus 194 Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~--~~~~~~~~-----~~~~~~~~~~~~~~li~ 260 (284)
T cd05079 194 DVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMTVTR-L--VRVLEEGK-----RLPRPPNCPEEVYQLMR 260 (284)
T ss_pred cchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccccHHH-H--HHHHHcCc-----cCCCCCCCCHHHHHHHH
Confidence 999999999999998766533211 11111111110000000 0 00000000 00112357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||+.+++..
T Consensus 261 ~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 261 KCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-23 Score=199.71 Aligned_cols=147 Identities=21% Similarity=0.347 Sum_probs=115.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCcc--ccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT--SRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~--~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||+.|++|+||||+|||++.++.++|+|||++...........+ ...++..|++||.+.+ ..++.++
T Consensus 112 ~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~ 190 (267)
T cd05066 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSAS 190 (267)
T ss_pred HHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchh
Confidence 368999999999999999999999999999999999999998765433211111 1223567999999876 4588999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|+|||||++|++++ |..||.+....+....+......+ ....++..+.+|+
T Consensus 191 Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li 242 (267)
T cd05066 191 DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP----------------------------APMDCPAALHQLM 242 (267)
T ss_pred hhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC----------------------------CCCCCCHHHHHHH
Confidence 99999999999886 999998776665555543221100 0124678899999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||+.+|.+|||+.++++
T Consensus 243 ~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 243 LDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHcccCchhCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=198.00 Aligned_cols=141 Identities=24% Similarity=0.304 Sum_probs=108.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-------cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-C
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-T 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~-~ 72 (468)
+.||+.||.|||++||+|+||||+|||++.++ .++|+|||++..... .....++..|+|||.+.+. .
T Consensus 107 ~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~ 181 (259)
T cd05037 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQA 181 (259)
T ss_pred HHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCC
Confidence 36999999999999999999999999999887 799999999875543 1223456789999998764 3
Q ss_pred CCCCCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH
Q 012191 73 DYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 151 (468)
.++.++|||||||++|+|++ |..||...+..+....... .... + .....
T Consensus 182 ~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~--------------------~---------~~~~~ 231 (259)
T cd05037 182 SLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRL--------------------P---------MPDCA 231 (259)
T ss_pred CcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCC--------------------C---------CCCch
Confidence 68899999999999999999 5777766543322222110 0000 0 01126
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 152 TAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
.+.+||.+||..||.+|||+.++|+
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 7899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=196.83 Aligned_cols=147 Identities=32% Similarity=0.513 Sum_probs=112.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++||
T Consensus 112 ~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di 189 (267)
T cd08224 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDI 189 (267)
T ss_pred HHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-cccceecCCccccCHHHhcc-CCCCchhcH
Confidence 3689999999999999999999999999999999999999987654321 12234467889999999876 458889999
Q ss_pred eeeehhhhhhhhcCCCCCCCch--HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~--~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|..||..... ......+... ..+ + .+ ...++..+.++|.
T Consensus 190 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~----------------~-~~--------~~~~~~~~~~~i~ 242 (267)
T cd08224 190 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYP----------------P-LP--------ADHYSEELRDLVS 242 (267)
T ss_pred HHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CCC----------------C-CC--------hhhcCHHHHHHHH
Confidence 9999999999999999965432 1111111110 000 0 00 1246778999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..+|.+|||+.++++
T Consensus 243 ~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 243 RCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHcCCCcccCCCHHHHHH
Confidence 999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-23 Score=198.98 Aligned_cols=146 Identities=23% Similarity=0.408 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+ .||+|+||+|+|||++.++.++|+|||++....... ......++..|++||.+.+ ..++.++|+
T Consensus 120 ~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv 196 (269)
T cd08528 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADV 196 (269)
T ss_pred HHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHH
Confidence 589999999996 789999999999999999999999999987654432 3345567889999999976 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||...........+......+. ....++..+.+||.+|
T Consensus 197 ~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~c 249 (269)
T cd08528 197 WAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL---------------------------PEGMYSEDVTDVITSC 249 (269)
T ss_pred HHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC---------------------------CcccCCHHHHHHHHHH
Confidence 9999999999999999987665554444432111110 0124678899999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|+.||.+|||+.++..+
T Consensus 250 l~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 250 LTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCCCCccCCCHHHHHHH
Confidence 99999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=197.67 Aligned_cols=151 Identities=21% Similarity=0.276 Sum_probs=110.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCC------CCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGA------TDY 74 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~------~~~ 74 (468)
.||+.||+|||+.||+|+||||+||+++.++.++|+|||++......... ......++..|+|||++.+. ..+
T Consensus 107 ~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 186 (269)
T cd05087 107 CEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ 186 (269)
T ss_pred HHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCC
Confidence 58999999999999999999999999999999999999998644322111 11233567789999998542 135
Q ss_pred CCCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 75 GPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
+.++|||||||++|+|++ |.+||......+............. + . ......++..+
T Consensus 187 ~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~-----~---------~~~~~~~~~~~ 243 (269)
T cd05087 187 TKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL---------P-----K---------PRLKLPLSDRW 243 (269)
T ss_pred CccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC---------C-----C---------CccCCCCChHH
Confidence 789999999999999996 9999987665544332211100000 0 0 00012356778
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHh
Q 012191 154 VNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..|+ .+|.+|||+.+++.
T Consensus 244 ~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 244 YEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHHh-cCcccCCCHHHHHH
Confidence 99999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-23 Score=220.65 Aligned_cols=153 Identities=29% Similarity=0.429 Sum_probs=116.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CC--cEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EG--VLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g--~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~ 73 (468)
+.|++.||+|||+.+||||||||.||||+. ++ .++|+|||+++....+... ......||-.|+|||++....
T Consensus 612 l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~- 690 (903)
T KOG1027|consen 612 LSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR- 690 (903)
T ss_pred HHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-
Confidence 479999999999999999999999999976 34 5899999999887655332 234567899999999998744
Q ss_pred CCCCcceeeeehhhhhhhhc-CCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHH
Q 012191 74 YGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG-~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 152 (468)
-..++||||||||+|+.++| ..||...-. .-.+|... .. ++...-+....+
T Consensus 691 ~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~--~~------------------------~L~~L~~~~d~e 742 (903)
T KOG1027|consen 691 KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTG--NY------------------------TLVHLEPLPDCE 742 (903)
T ss_pred cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcC--cc------------------------ceeeeccCchHH
Confidence 46699999999999999986 889964322 22233221 10 000000111127
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 153 AVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 153 l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+.+||.+||++||..||+|.++|.||||=+
T Consensus 743 A~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 743 AKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred HHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 999999999999999999999999999944
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=204.77 Aligned_cols=182 Identities=29% Similarity=0.483 Sum_probs=126.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCC-------------------------------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTG------------------------------- 48 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~------------------------------- 48 (468)
|+.|+.||.++|.+|||||||||.|+|++.. +.-.|+|||+|......
T Consensus 138 l~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~ 217 (418)
T KOG1167|consen 138 LRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATAS 217 (418)
T ss_pred HHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccccccccc
Confidence 4679999999999999999999999999865 66889999998611000
Q ss_pred ---C---------CCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCC-CCchHHHHHHHHHHcCC
Q 012191 49 ---H---------RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQ-GRTEVEQLHKIFKLCGS 115 (468)
Q Consensus 49 ---~---------~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~-g~~~~e~l~~i~~~~g~ 115 (468)
. ...-..+.||+.|+|||++.+...-+.++||||.|+|++.++++..||. ..++...+..|....|.
T Consensus 218 ~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~ 297 (418)
T KOG1167|consen 218 KPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGS 297 (418)
T ss_pred CCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhCh
Confidence 0 0001235789999999999988888999999999999999999998874 44444555555444332
Q ss_pred C--------Cch--hhhccCCCccc------------cCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHH
Q 012191 116 P--------PDD--YWKKSKLPHAT------------LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 173 (468)
Q Consensus 116 p--------~~~--~~~~~~~~~~~------------~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e 173 (468)
- +.. +|.....+... ...+...+..........++..+.+||.+||..||.+|+||++
T Consensus 298 ~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEe 377 (418)
T KOG1167|consen 298 AEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAED 377 (418)
T ss_pred HHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHH
Confidence 1 111 34322211100 0000000001112223345678999999999999999999999
Q ss_pred HHhcccccC
Q 012191 174 ALASEYFST 182 (468)
Q Consensus 174 ~L~Hp~F~~ 182 (468)
+|.||||..
T Consensus 378 ALkHpFF~~ 386 (418)
T KOG1167|consen 378 ALKHPFFDE 386 (418)
T ss_pred HhcCcCCcc
Confidence 999999984
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=212.24 Aligned_cols=147 Identities=21% Similarity=0.290 Sum_probs=113.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 244 ~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 322 (400)
T cd05105 244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDV 322 (400)
T ss_pred HHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhH
Confidence 68999999999999999999999999999999999999998755432211 1223345678999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+......+.........++ ....++..+.+||.+
T Consensus 323 wSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~ 375 (400)
T cd05105 323 WSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA---------------------------KPDHATQEVYDIMVK 375 (400)
T ss_pred HHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHH
Confidence 999999999997 9999987544333322222110000 012467889999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||+.||.+|||+.++.+
T Consensus 376 cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 376 CWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HCccCHhHCcCHHHHHH
Confidence 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=198.37 Aligned_cols=147 Identities=22% Similarity=0.297 Sum_probs=114.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+|+||||+|||++.++.+||+|||++.......... .....++..|+|||.+.. ..++.++|
T Consensus 115 ~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~D 193 (279)
T cd05057 115 CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSD 193 (279)
T ss_pred HHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhh
Confidence 3689999999999999999999999999999999999999997665332111 111223567999998865 46788999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
+|||||++|+|++ |..||.+....+....+... ...+ .....+..+.++|.
T Consensus 194 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~~~~ 245 (279)
T cd05057 194 VWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLP---------------------------QPPICTIDVYMVLV 245 (279)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCCC---------------------------CCCCCCHHHHHHHH
Confidence 9999999999998 99999887665544444321 1100 01235678899999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.++++
T Consensus 246 ~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 246 KCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHcCCChhhCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=215.83 Aligned_cols=166 Identities=27% Similarity=0.390 Sum_probs=113.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCC-------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD------- 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~------- 73 (468)
+.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...............+|+.|+|||.+.....
T Consensus 315 ~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~ 394 (507)
T PLN03224 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAP 394 (507)
T ss_pred HHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchh
Confidence 3689999999999999999999999999999999999999986554332211222344789999998853211
Q ss_pred ------------CC--CCcceeeeehhhhhhhhcCC-CCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCC
Q 012191 74 ------------YG--PSVDLWSVGCVFAELLIGKP-ILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPY 138 (468)
Q Consensus 74 ------------~s--~~sDIWSLG~ILyeLltG~~-pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 138 (468)
|+ ...||||+|||+|+|++|.. ||.+...... .++.+.. ....|..... ..+
T Consensus 395 ~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~~~-~~~~~r~~~~---------~~~ 461 (507)
T PLN03224 395 AMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQYDN-DLNRWRMYKG---------QKY 461 (507)
T ss_pred hhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhccc-hHHHHHhhcc---------cCC
Confidence 12 24799999999999999874 6654221111 1110000 0111211100 001
Q ss_pred CchhhhhcCCCcHHHHHHHHHhcCCCC---CCCcCHHHHHhcccccC
Q 012191 139 DSSLRETFKDLPTTAVNLIETLLSVEP---YKRATASAALASEYFST 182 (468)
Q Consensus 139 ~~~l~~~~~~~s~~l~dLL~~mL~~DP---~kRpTa~e~L~Hp~F~~ 182 (468)
. ...+...++.+++||.+||..+| .+|+|+.|+|+||||..
T Consensus 462 ~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 462 D---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred C---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1 11245678999999999999876 68999999999999964
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.8e-23 Score=200.60 Aligned_cols=147 Identities=27% Similarity=0.396 Sum_probs=112.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+++|+|+||++.|||++.++.+||+|||++........ ...........|+|||.+.+. .++.++|
T Consensus 109 ~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ksD 187 (259)
T PF07714_consen 109 AIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG-EYTKKSD 187 (259)
T ss_dssp HHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS-EESHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 36999999999999999999999999999999999999999876632211 111223456789999998763 4789999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||+++|||++ |..||...+..+....+..... + .....++..+.+||.
T Consensus 188 VysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 188 VYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-L---------------------------PIPDNCPKDIYSLIQ 239 (259)
T ss_dssp HHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-T---------------------------TSBTTSBHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccc-c---------------------------eeccchhHHHHHHHH
Confidence 9999999999999 7899988877776666633211 1 011357889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
.||..||.+|||+.++++
T Consensus 240 ~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHT-SSGGGS--HHHHHH
T ss_pred HHcCCChhhCcCHHHHHh
Confidence 999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=227.24 Aligned_cols=149 Identities=25% Similarity=0.357 Sum_probs=113.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-----------------CCCccccccCCcccC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----------------RQPLTSRVVTLWYRP 64 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-----------------~~~~~~~~gt~~Y~A 64 (468)
.||+.||+|||++||+||||||+|||++.++.++|+|||++....... .......+||+.|+|
T Consensus 120 ~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmA 199 (932)
T PRK13184 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMA 199 (932)
T ss_pred HHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCC
Confidence 589999999999999999999999999999999999999997652110 001123468999999
Q ss_pred hhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhh
Q 012191 65 PELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRE 144 (468)
Q Consensus 65 PE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 144 (468)
||.+.+ ..++.++|||||||++|+|++|.+||.+.......... ....+. . ..
T Consensus 200 PE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~--~i~~P~-~-----------------------~~ 252 (932)
T PRK13184 200 PERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD--VILSPI-E-----------------------VA 252 (932)
T ss_pred HHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhh--hccChh-h-----------------------cc
Confidence 999876 45789999999999999999999999875443222111 111110 0 01
Q ss_pred hcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 145 TFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 145 ~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
.+..+++.+.+++.+||..||.+|++..+.|.+
T Consensus 253 p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 253 PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 123678889999999999999999887776654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-23 Score=196.20 Aligned_cols=155 Identities=23% Similarity=0.344 Sum_probs=122.0
Q ss_pred HHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC-CCCCCccee
Q 012191 4 LLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVDLW 81 (468)
Q Consensus 4 LL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~-~~s~~sDIW 81 (468)
.+.||.||-.. .||||||||+|||++..|.+||||||.+-.+... ...+...|...|+|||.+.... .|+.++|+|
T Consensus 176 tV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvW 253 (361)
T KOG1006|consen 176 TVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVW 253 (361)
T ss_pred ehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhh
Confidence 36799999864 8999999999999999999999999998654432 2235567888999999986543 489999999
Q ss_pred eeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||++|||+.||..||.+-+. .+++..+. .|.||.-.. ....-+++..+..+|..|
T Consensus 254 SLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~~---------------------~~~~~~~s~~~~~fintC 310 (361)
T KOG1006|consen 254 SLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILLF---------------------DKECVHYSFSMVRFINTC 310 (361)
T ss_pred hhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeecC---------------------cccccccCHHHHHHHHHH
Confidence 999999999999999987543 34444443 244432111 011125788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..|-..||...+++.+||++..
T Consensus 311 l~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 311 LIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred hhcccccCcchhhhhcCchhhhh
Confidence 99999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=196.83 Aligned_cols=164 Identities=20% Similarity=0.265 Sum_probs=110.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC--ccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......... .....++..|+|||.+.+ ..++.++
T Consensus 114 ~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 192 (284)
T cd05081 114 ASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVAS 192 (284)
T ss_pred HHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHH
Confidence 3689999999999999999999999999999999999999997654322111 111223456999999876 4588999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|||++|..++...... ....+.... ......+.... ....... ......++..+.+||.
T Consensus 193 Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~li~ 260 (284)
T cd05081 193 DVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDK-QGQMIVYHLIE-----LLKNNGR-----LPAPPGCPAEIYAIMK 260 (284)
T ss_pred HHHHHHHHHHHHhhcCCcCCCcchh-hhhhccccc-ccccchHHHHH-----HHhcCCc-----CCCCCCCCHHHHHHHH
Confidence 9999999999999987766433211 111110000 00000000000 0000000 0112357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..+|.+|||+.+++..
T Consensus 261 ~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 261 ECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHccCChhhCCCHHHHHHH
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=203.91 Aligned_cols=155 Identities=27% Similarity=0.467 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
+..|.||+|||...-+|||||..|||++.+|..||+|||.|-.+...- ......+||+.|||||++.. ..|+..+|||
T Consensus 136 ~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIW 213 (502)
T KOG0574|consen 136 RDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIEE-IGYDTKADIW 213 (502)
T ss_pred HHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCccccCcccccHHHHHH-hccchhhhHh
Confidence 567899999999999999999999999999999999999986554321 22346689999999999976 5689999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhc
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLL 161 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL 161 (468)
|||+...||.-|+|||..-.... .|+-.--.||..|. .....+.++-|||+.||
T Consensus 214 SLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF~-----------------------KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 214 SLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTFK-----------------------KPEEWSSEFNDFIRSCL 267 (502)
T ss_pred hhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCCC-----------------------ChHhhhhHHHHHHHHHh
Confidence 99999999999999997644332 22222222222211 11235778999999999
Q ss_pred CCCCCCCcCHHHHHhcccccCCC
Q 012191 162 SVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 162 ~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
...|++|.||.++++|+|.++.+
T Consensus 268 iK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred cCCHHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999999998754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-22 Score=193.88 Aligned_cols=151 Identities=21% Similarity=0.348 Sum_probs=110.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||+.||+|+||||+||+++.++.++|+|||++......... ......++..|++||.+.+ ..++.++
T Consensus 115 ~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~ 193 (284)
T cd05038 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSAS 193 (284)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc-CCCCccc
Confidence 368999999999999999999999999999999999999999766532111 1112234567999998876 4578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHH-----------HHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcC
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQ-----------LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 147 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~-----------l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 147 (468)
|||||||++|+|++|..||........ ...+...+.... . .....
T Consensus 194 Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~-----~~~~~ 249 (284)
T cd05038 194 DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE-------------------R-----LPRPP 249 (284)
T ss_pred chHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC-------------------c-----CCCCc
Confidence 999999999999999988865322110 011111000000 0 00012
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
.++..+.+||.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 250 SCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 45688999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=207.00 Aligned_cols=148 Identities=21% Similarity=0.265 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ .......++..|+|||.+.+ ..++.++||
T Consensus 246 ~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 324 (401)
T cd05107 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDV 324 (401)
T ss_pred HHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHH
Confidence 5899999999999999999999999999999999999999875432211 11223356788999999876 457899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|||++ |..||......+.+.........++ ....++..+.+||.+
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~ 377 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA---------------------------KPAHASDEIYEIMQK 377 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC---------------------------CCCCCCHHHHHHHHH
Confidence 999999999998 8899987655554433322110000 012467889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+||++.++|..
T Consensus 378 cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 378 CWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HcCCChhHCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=192.19 Aligned_cols=153 Identities=27% Similarity=0.460 Sum_probs=120.7
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceee
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 82 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWS 82 (468)
.|+.||.|||++||++||||.+|+|++..|.+||.|+|+++.--. ........+||+.|+|||++.| ..|+.++|.|+
T Consensus 359 ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~-~gd~tstfcgtpnyiapeilrg-eeygfsvdwwa 436 (593)
T KOG0695|consen 359 EICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWA 436 (593)
T ss_pred HHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC-CCcccccccCCCcccchhhhcc-cccCceehHHH
Confidence 588999999999999999999999999999999999999864322 2233456799999999999988 57999999999
Q ss_pred eehhhhhhhhcCCCCCC--------CchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 83 VGCVFAELLIGKPILQG--------RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 83 LG~ILyeLltG~~pf~g--------~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
||++++||+.|+.||.- +++.-.+.-|++.....| ..++-.+.
T Consensus 437 lgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip-----------------------------rslsvkas 487 (593)
T KOG0695|consen 437 LGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP-----------------------------RSLSVKAS 487 (593)
T ss_pred HHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc-----------------------------ceeehhhH
Confidence 99999999999999952 122222333322111111 24566678
Q ss_pred HHHHHhcCCCCCCCcC------HHHHHhcccccCCCCC
Q 012191 155 NLIETLLSVEPYKRAT------ASAALASEYFSTKPYA 186 (468)
Q Consensus 155 dLL~~mL~~DP~kRpT------a~e~L~Hp~F~~~p~~ 186 (468)
.+|...|+.||.+|.. ..++-.|+||+...|.
T Consensus 488 ~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 488 HVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred HHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 8999999999999964 6889999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-21 Score=210.00 Aligned_cols=164 Identities=28% Similarity=0.417 Sum_probs=129.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
|+||+.||.|||+.||.|||||++||++..+|.+||+|||.+..+..... ......+|+-.|+|||++.+.......
T Consensus 426 fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~ 505 (601)
T KOG0590|consen 426 FKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRA 505 (601)
T ss_pred HHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcch
Confidence 58999999999999999999999999999999999999999976654433 344567889999999999886655668
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||+|+|+..|++|+.||.-....+....... ...+..........+..++...+.+|
T Consensus 506 vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~lp~~~~~~~ 565 (601)
T KOG0590|consen 506 VDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN--------------------YSDQRNIFEGPNRLLSLLPRETRIII 565 (601)
T ss_pred hhhhhccceEEEEecCCCccccccccccchhhhc--------------------cccccccccChHHHHHhchhhHHHHH
Confidence 9999999999999999999965433222110000 00011112233445567899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
.+||++||.+|+|+++||+.+||+...
T Consensus 566 ~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 566 YRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHccCChhheecHHHHhhChHhhhcc
Confidence 999999999999999999999999754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=188.43 Aligned_cols=156 Identities=24% Similarity=0.427 Sum_probs=118.5
Q ss_pred CHHHHHHHHHHHhC--CCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCC------CccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSR--GVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~--gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.||.+. -|||-||||.|||+.+ -|.+||.|||++..+...... ......||.||+|||.+.
T Consensus 574 iMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 574 IMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred HHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceee
Confidence 46999999999987 4999999999999843 367999999999887654322 122457899999999985
Q ss_pred C---CCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHH---HHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhh
Q 012191 70 G---ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL---HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR 143 (468)
Q Consensus 70 g---~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~ 143 (468)
- ....+.++||||+|||||.++.|+.||..+.....+ .-|++.. + ..|
T Consensus 654 VgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAt----E-----------VqF----------- 707 (775)
T KOG1151|consen 654 VGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKAT----E-----------VQF----------- 707 (775)
T ss_pred cCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcce----e-----------ccC-----------
Confidence 2 345688999999999999999999999754332211 1111100 0 000
Q ss_pred hhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 144 ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 144 ~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
..-+.++.++++||++||.+.-++|+.+.++..||||.-
T Consensus 708 P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 708 PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 111457899999999999999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-20 Score=208.13 Aligned_cols=146 Identities=23% Similarity=0.351 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCcccc-ccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~-~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.|+.||+++++|||||-..|+||+....+||+|||+|+.+........... .-...|||||.+.. ..++.++||
T Consensus 809 ~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDv 887 (1025)
T KOG1095|consen 809 LDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDV 887 (1025)
T ss_pred HHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccch
Confidence 4899999999999999999999999999999999999999984433322222222 22467999999986 569999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||+|||+++ |..||.+....+.+....+.-..++ ...++..+.+||..
T Consensus 888 WsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~----------------------------P~~CP~~ly~lM~~ 939 (1025)
T KOG1095|consen 888 WSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP----------------------------PSYCPEKLYQLMLQ 939 (1025)
T ss_pred hhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC----------------------------CCCCChHHHHHHHH
Confidence 999999999998 8999999998888876655321111 13578899999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||+.+|++||+...+++
T Consensus 940 CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 940 CWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HccCChhhCccHHHHHh
Confidence 99999999999999997
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=201.58 Aligned_cols=155 Identities=27% Similarity=0.446 Sum_probs=125.2
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC----CCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT----DYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~----~~s~~ 77 (468)
+.+|.||.|||.+.++|||||..|||++.++.|||+|||.+....... ..-...+||++|||||++.... .|+..
T Consensus 130 re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R 208 (953)
T KOG0587|consen 130 REILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYR 208 (953)
T ss_pred HHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccc
Confidence 678999999999999999999999999999999999999987666433 2334568999999999996532 36778
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|+||||++..||--|.||+...-....+..| ...||... ..+...+..+.+||
T Consensus 209 ~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPkL-----------------------krp~kWs~~FndFI 262 (953)
T KOG0587|consen 209 SDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKL-----------------------KRPKKWSKKFNDFI 262 (953)
T ss_pred cchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCccc-----------------------cchhhHHHHHHHHH
Confidence 99999999999999999999776555444433 22222111 11245678899999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
..||..|..+||+..++|+|||.+..
T Consensus 263 s~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 263 STCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred HHHHhhccccCcchhhhccCCccccc
Confidence 99999999999999999999999843
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-20 Score=199.26 Aligned_cols=145 Identities=25% Similarity=0.359 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCcc-ccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.|++||-++.+|||||-..|+||..+-.|||+|||+++........... .......|||||.++. ..|+.++||
T Consensus 610 ~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDV 688 (774)
T KOG1026|consen 610 TQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDV 688 (774)
T ss_pred HHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-Ccccchhhh
Confidence 69999999999999999999999999999999999999999755443222222 2233678999999975 579999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||+||+|||+++ |..||.|-++.+.+..|...-- -+...++|.++.+||..
T Consensus 689 Ws~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l----------------------------L~~Pe~CP~~vY~LM~~ 740 (774)
T KOG1026|consen 689 WSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL----------------------------LSCPENCPTEVYSLMLE 740 (774)
T ss_pred hhhhhhhhhhhccccCcccccchHHHHHHHHcCCc----------------------------ccCCCCCCHHHHHHHHH
Confidence 999999999997 9999999999999988854211 12224789999999999
Q ss_pred hcCCCCCCCcCHHHHH
Q 012191 160 LLSVEPYKRATASAAL 175 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L 175 (468)
||+.+|.+||++.||-
T Consensus 741 CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 741 CWNENPKRRPSFKEIH 756 (774)
T ss_pred HhhcCcccCCCHHHHH
Confidence 9999999999998874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=187.46 Aligned_cols=157 Identities=27% Similarity=0.399 Sum_probs=106.8
Q ss_pred HHHHHHHHHHHhCC---CeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCcccc-ccCCcccChhhhcCCCCCCCC
Q 012191 2 NQLLHGLEHCHSRG---VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR-VVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~g---IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~-~gt~~Y~APE~l~g~~~~s~~ 77 (468)
.+++.||+|||... |||||||++|||+|.+...||+|||+|....... ...... .||..|++||.+.. ...+.+
T Consensus 181 ~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~-~~~~~~~~gt~gY~~PEy~~~-g~lt~K 258 (361)
T KOG1187|consen 181 LGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD-TSVSTTVMGTFGYLAPEYAST-GKLTEK 258 (361)
T ss_pred HHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc-cceeeecCCCCccCChhhhcc-CCcCcc
Confidence 46899999999965 9999999999999999999999999995443211 111222 78999999999865 467899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCc---hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhh-hhcC--CCcH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR-ETFK--DLPT 151 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~---~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~--~~s~ 151 (468)
+||||||++|+||++|+.+..... ...........+... ++ .....+. +. ..+. ..-.
T Consensus 259 sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--------~~--~eiiD~~------l~~~~~~~~~~~~ 322 (361)
T KOG1187|consen 259 SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--------KL--REIVDPR------LKEGEYPDEKEVK 322 (361)
T ss_pred cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--------ch--hheeCCC------ccCCCCChHHHHH
Confidence 999999999999999998876432 111111111111110 00 0001111 10 0001 1122
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 152 TAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
.+..+...|++.+|.+||++.+++.
T Consensus 323 ~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 323 KLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 3678899999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-20 Score=171.89 Aligned_cols=107 Identities=31% Similarity=0.509 Sum_probs=89.9
Q ss_pred HHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC---CCCCCCCc
Q 012191 3 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG---ATDYGPSV 78 (468)
Q Consensus 3 QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g---~~~~s~~s 78 (468)
.++.||.|||++ .|+|||+||+||||+.+|.+|+||||.+-.+...- ..+-..|.-.|+|||.+.. ...|+.++
T Consensus 156 Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vks 233 (282)
T KOG0984|consen 156 SVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKS 233 (282)
T ss_pred HHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeeh
Confidence 478999999986 89999999999999999999999999987665431 2233567788999999853 23689999
Q ss_pred ceeeeehhhhhhhhcCCCCC-CCchHHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQ-GRTEVEQLHKIFK 111 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~-g~~~~e~l~~i~~ 111 (468)
||||||+.+.||.+++.||. ..++.+++.++.+
T Consensus 234 DvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 234 DVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 99999999999999999995 4678888888865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=196.90 Aligned_cols=96 Identities=34% Similarity=0.547 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEEC--CCC--cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEG--VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld--~~g--~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
..|..||.|||++||+||||||.||++- .+| ..||+|||.|+....+ ..+++.+||..|.+||++.....|+..
T Consensus 127 ~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~t 204 (732)
T KOG4250|consen 127 SDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN--SLFTSLVGTEEYLHPELYERQKKYTAT 204 (732)
T ss_pred HHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC--CeeeeecCchhhcChHHHhhccCcCce
Confidence 4678899999999999999999999973 334 4799999999988765 478899999999999999855689999
Q ss_pred cceeeeehhhhhhhhcCCCCCC
Q 012191 78 VDLWSVGCVFAELLIGKPILQG 99 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g 99 (468)
+|.|||||++|++.||..||-.
T Consensus 205 VDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 205 VDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred eehhhhhhHHHHHhccCCCCCc
Confidence 9999999999999999999943
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=189.92 Aligned_cols=146 Identities=26% Similarity=0.360 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.|.+.||+|||+++++||||-..|+|++.++.+||+|||++......... .........|+|||.+... .|+.++|||
T Consensus 269 ~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~-~~s~kTDV~ 346 (474)
T KOG0194|consen 269 YDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTG-IFSFKTDVW 346 (474)
T ss_pred HHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeec-cccccCcceecChhhhccC-ccccccchh
Confidence 57899999999999999999999999999999999999998654311111 1112346789999999764 799999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++||+++ |..||.+....+...+|.......+. ....+..+..++.+|
T Consensus 347 sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~---------------------------~~~~p~~~~~~~~~c 399 (474)
T KOG0194|consen 347 SFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI---------------------------PSKTPKELAKVMKQC 399 (474)
T ss_pred heeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC---------------------------CCCCHHHHHHHHHHh
Confidence 99999999998 88999999999888888442211110 024678899999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
+..||++|||+.++.+
T Consensus 400 ~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 400 WKKDPEDRPTMSTIKK 415 (474)
T ss_pred ccCChhhccCHHHHHH
Confidence 9999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=194.25 Aligned_cols=148 Identities=21% Similarity=0.349 Sum_probs=128.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCcccccc--CCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV--TLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l~g~~~~s~~s 78 (468)
++-|+.|+.||-++|+|||||-..|||++.+-.+|++|||+++.+..+.....+..-| ...|.|||.+.- ..++.++
T Consensus 737 LrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsAS 815 (996)
T KOG0196|consen 737 LRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSAS 815 (996)
T ss_pred HHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh-cccCchh
Confidence 3568899999999999999999999999999999999999999886655333444333 578999999865 5789999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
||||+|+++||.++ |..||...++.+.+..|.+....|+. .++|..+..|+
T Consensus 816 DVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP----------------------------mDCP~aL~qLM 867 (996)
T KOG0196|consen 816 DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP----------------------------MDCPAALYQLM 867 (996)
T ss_pred hccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC----------------------------CCCcHHHHHHH
Confidence 99999999999876 99999999999999999887776653 36899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhc
Q 012191 158 ETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~H 177 (468)
..||+.|-..||+..+++.+
T Consensus 868 ldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-20 Score=192.15 Aligned_cols=145 Identities=23% Similarity=0.331 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
+||+.||.|||+..+|||||-..|||+.....|||+|||+++.+...............-|||||.+.- ..++.++|||
T Consensus 498 ~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVW 576 (974)
T KOG4257|consen 498 YQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVW 576 (974)
T ss_pred HHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccch-hcccchhhHH
Confidence 699999999999999999999999999999999999999999887654333333333667999998854 5689999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
.|||.+||++. |..||.|-.+.+.+-.|.+.-.. .+.+.+|+.+..|+.+|
T Consensus 577 MFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl----------------------------P~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 577 MFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL----------------------------PCPPNCPPALYSLMSKC 628 (974)
T ss_pred HHHHHHHHHHHhcCCccccccccceEEEecCCCCC----------------------------CCCCCCChHHHHHHHHH
Confidence 99999999986 99999987766655444322111 12257899999999999
Q ss_pred cCCCCCCCcCHHHHH
Q 012191 161 LSVEPYKRATASAAL 175 (468)
Q Consensus 161 L~~DP~kRpTa~e~L 175 (468)
|.+||.+||+..++.
T Consensus 629 WayeP~kRPrftei~ 643 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIK 643 (974)
T ss_pred hccCcccCCcHHHHH
Confidence 999999999987764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=191.60 Aligned_cols=146 Identities=25% Similarity=0.358 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccc--cCCcccChhhhcCCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRV--VTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~--gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+||+.|++||++..+|||||-..|||+..+..+||+|||+++.............. ....|||||.+.. ..|+.++|
T Consensus 425 ~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSD 503 (609)
T KOG0200|consen 425 YQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSD 503 (609)
T ss_pred HHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Ccccccch
Confidence 69999999999999999999999999999999999999999855443222222222 2345999999987 67999999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCc-hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~-~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||+|++|||+++ |..||.+-. ..+.+..+.... .. +....++.++.+++
T Consensus 504 VWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~-r~---------------------------~~P~~c~~eiY~iM 555 (609)
T KOG0200|consen 504 VWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN-RM---------------------------EQPEHCSDEIYDLM 555 (609)
T ss_pred hhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC-CC---------------------------CCCCCCCHHHHHHH
Confidence 9999999999998 889998854 333333332211 10 11134688999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
..||+.+|.+||+..++.+
T Consensus 556 ~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 556 KSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhCCCcccCCCHHHHHH
Confidence 9999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.9e-19 Score=186.19 Aligned_cols=151 Identities=21% Similarity=0.295 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-c-cccccCCcccChhhhcCCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-L-TSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~-~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
.||+.|+.||.++++|||||-..|||+-....|||||||+.+.+..+.... + ........|+|||.|.. ..++.++|
T Consensus 219 ~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSD 297 (1039)
T KOG0199|consen 219 MQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASD 297 (1039)
T ss_pred HHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccch
Confidence 699999999999999999999999999999999999999998776543221 1 12234567999999975 56999999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
+|++||+||||++ |..||.|.....++++|-+.-. -..-+.+++++.+++.
T Consensus 298 vWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er----------------------------LpRPk~csedIY~imk 349 (1039)
T KOG0199|consen 298 VWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER----------------------------LPRPKYCSEDIYQIMK 349 (1039)
T ss_pred hhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc----------------------------CCCCCCChHHHHHHHH
Confidence 9999999999998 7899999999988888742111 1112468999999999
Q ss_pred HhcCCCCCCCcCHHHHHhccccc
Q 012191 159 TLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
.||..+|.+|||+..|.+.-+..
T Consensus 350 ~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 350 NCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HhccCCccccccHHHHHHhHHHH
Confidence 99999999999999887554443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.6e-19 Score=193.85 Aligned_cols=157 Identities=31% Similarity=0.460 Sum_probs=130.5
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-------------C-CCccccccCCcccChhhh
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-------------R-QPLTSRVVTLWYRPPELL 68 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-------------~-~~~~~~~gt~~Y~APE~l 68 (468)
+++.+++|||+.||+|||+||+|+||..-|.+|+.|||+.+..-... . -.....+||+.|+|||++
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 45789999999999999999999999999999999999975321100 0 011245889999999999
Q ss_pred cCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 69 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 69 ~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
.. ..|+..+|+|++|+|+|+++.|..||.|++..+.+...+......++.. ..
T Consensus 231 lr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d--------------------------ea 283 (1205)
T KOG0606|consen 231 LR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED--------------------------EA 283 (1205)
T ss_pred hh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC--------------------------cC
Confidence 86 5699999999999999999999999999999999888876555544432 35
Q ss_pred CcHHHHHHHHHhcCCCCCCCc---CHHHHHhcccccCCCCC
Q 012191 149 LPTTAVNLIETLLSVEPYKRA---TASAALASEYFSTKPYA 186 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRp---Ta~e~L~Hp~F~~~p~~ 186 (468)
+++++++||..+|..+|..|. .+-++-+|+||+...|.
T Consensus 284 ~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 284 LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 789999999999999999995 57788899999987775
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-18 Score=166.76 Aligned_cols=141 Identities=30% Similarity=0.434 Sum_probs=103.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC--CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYG 75 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s 75 (468)
.||++||.|||+.++||||||.+||||-. ...|||||||+....+.. ....--+..|.+||++.. .-...
T Consensus 128 ~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ 203 (378)
T KOG1345|consen 128 AQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVN 203 (378)
T ss_pred HHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEec
Confidence 69999999999999999999999999833 347999999998654421 122233667999998743 22356
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHH-HHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~-l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
+.+|||.||+|+|.+|+|.+||+.....+. +....+ |...+ ...+...|..+++.+.
T Consensus 204 ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~---------w~~rk-------------~~~~P~~F~~fs~~a~ 261 (378)
T KOG1345|consen 204 PSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ---------WLKRK-------------NPALPKKFNPFSEKAL 261 (378)
T ss_pred ccccchheeeeeeeeecCCCcchhhhccCchHHHHHH---------Hhccc-------------CccCchhhcccCHHHH
Confidence 789999999999999999999985332211 111111 11111 1134556778999999
Q ss_pred HHHHHhcCCCCCCC
Q 012191 155 NLIETLLSVEPYKR 168 (468)
Q Consensus 155 dLL~~mL~~DP~kR 168 (468)
.+.++-|..++.+|
T Consensus 262 r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 262 RLFKKSLTPRFKDR 275 (378)
T ss_pred HHHHHhcCCccccc
Confidence 99999999999999
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-18 Score=179.17 Aligned_cols=146 Identities=19% Similarity=0.304 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
-||..|++||..+++|||||-..|+|+..+..|||+|||+++++...............-|.|||.|.- ..++.++|||
T Consensus 372 tQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVW 450 (1157)
T KOG4278|consen 372 TQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVW 450 (1157)
T ss_pred HHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccc-cccccchhhH
Confidence 489999999999999999999999999999999999999999887543222222233677999998864 4588999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
+|||+|||+.| |-.||+|.+....+..+.+.+. -+....+++.+.+|++.|
T Consensus 451 AFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR----------------------------M~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 451 AFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR----------------------------MDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred HHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc----------------------------ccCCCCCCHHHHHHHHHH
Confidence 99999999987 8899999776655544432110 011146899999999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|+|.|.+||+..|+-+
T Consensus 503 W~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 503 WNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred hcCCcccCccHHHHHH
Confidence 9999999999988743
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-18 Score=195.68 Aligned_cols=157 Identities=20% Similarity=0.274 Sum_probs=104.2
Q ss_pred CHHHHHHHHHHH---hCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCH---SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLH---s~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||+||| +.+|+||||||+||+++.++..++. |+....... .....+|+.|+|||++.+ ..|+.+
T Consensus 786 ~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~ 858 (968)
T PLN00113 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRET-KDITEK 858 (968)
T ss_pred HHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccC-CCCCcc
Confidence 368999999999 6799999999999999998887775 555432221 123367899999999876 568999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchH-HHHHHHHHHcC-CCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCG-SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~-e~l~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
+|||||||++|||++|+.||...... ..+........ ......| ..+...... ........++.+
T Consensus 859 sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~~~~~~~~~~~ 925 (968)
T PLN00113 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW----------IDPSIRGDV---SVNQNEIVEVMN 925 (968)
T ss_pred cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe----------eCccccCCC---CccHHHHHHHHH
Confidence 99999999999999999998532110 01111111110 0000000 000000000 000112345789
Q ss_pred HHHHhcCCCCCCCcCHHHHHhc
Q 012191 156 LIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~H 177 (468)
++.+||+.||.+|||+.++++.
T Consensus 926 l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 926 LALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHhhCcCCchhCcCHHHHHHH
Confidence 9999999999999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.9e-18 Score=154.05 Aligned_cols=117 Identities=39% Similarity=0.657 Sum_probs=99.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.|++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||.+.....++.+.|
T Consensus 98 ~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D 176 (215)
T cd00180 98 LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSD 176 (215)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhh
Confidence 368999999999999999999999999999 89999999999876654321 1233456788999999876436788999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
+|++|+++++| ..+.++|..
T Consensus 177 ~~~lg~~~~~l------------------------------------------------------------~~~~~~l~~ 196 (215)
T cd00180 177 IWSLGVILYEL------------------------------------------------------------PELKDLIRK 196 (215)
T ss_pred hHHHHHHHHHH------------------------------------------------------------HHHHHHHHH
Confidence 99999999999 236789999
Q ss_pred hcCCCCCCCcCHHHHHhcc
Q 012191 160 LLSVEPYKRATASAALASE 178 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp 178 (468)
||..||.+|||+.+++.++
T Consensus 197 ~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 197 MLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HhhCCcccCcCHHHHhhCC
Confidence 9999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=173.91 Aligned_cols=153 Identities=18% Similarity=0.246 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCcc-ccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.|++||.+.++|||||-+.|+|++.++++||+|||+++-+..+...... ..+....|+|+|.++- ..++.++|+
T Consensus 644 tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDv 722 (807)
T KOG1094|consen 644 TQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDV 722 (807)
T ss_pred HHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh-ccccchhhh
Confidence 59999999999999999999999999999999999999999855544333333 2344788999998875 468999999
Q ss_pred eeeehhhhhhh--hcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELL--IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLl--tG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|+||+++||++ |...||...++.....+....+....... ......-++..+.+||.
T Consensus 723 WafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~---------------------~l~~P~~cp~~lyelml 781 (807)
T KOG1094|consen 723 WAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV---------------------VLSRPPACPQGLYELML 781 (807)
T ss_pred hhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce---------------------eccCCCcCcHHHHHHHH
Confidence 99999999985 57899988887777666654433222111 01112357888999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
.|+..|-.+|||.+++..
T Consensus 782 ~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 782 RCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHhchhhhcCCCHHHHHH
Confidence 999999999999999854
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-17 Score=165.31 Aligned_cols=146 Identities=25% Similarity=0.347 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccc-cccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS-RVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~-~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||..|++|||++||||.||-..|++|++.-.+||+|=.+++..-+.....+.. ......||+||.+.. ..|+.++|+
T Consensus 403 sQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDv 481 (563)
T KOG1024|consen 403 SQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDV 481 (563)
T ss_pred HHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhh
Confidence 489999999999999999999999999999999999998887555443332221 223567999999976 569999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||++||||++ |+.|+-.-+..+..+.+.+.... .+| -++|.++..++.-
T Consensus 482 WsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl-------------------aQP---------~NCPDeLf~vMac 533 (563)
T KOG1024|consen 482 WSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL-------------------AQP---------FNCPDELFTVMAC 533 (563)
T ss_pred HHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee-------------------cCC---------CCCcHHHHHHHHH
Confidence 999999999998 89999888888777766443211 111 2689999999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..+|++||+.+++..
T Consensus 534 CWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 534 CWALLPEERPSFSQLVI 550 (563)
T ss_pred HHhcCcccCCCHHHHHH
Confidence 99999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-17 Score=168.27 Aligned_cols=164 Identities=27% Similarity=0.325 Sum_probs=106.9
Q ss_pred HHHHHHHHHHh---------CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCC
Q 012191 3 QLLHGLEHCHS---------RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGAT 72 (468)
Q Consensus 3 QLL~gL~yLHs---------~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~ 72 (468)
-|++||+|||+ ..|+|||||..||||.+++++.|+|||+|..+.++... .....+||..|||||+|.|..
T Consensus 315 SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgai 394 (534)
T KOG3653|consen 315 SMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI 394 (534)
T ss_pred HHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhc
Confidence 57899999997 35999999999999999999999999999887765432 334579999999999998876
Q ss_pred CCC-----CCcceeeeehhhhhhhhcCCCCC-CCchHHHHHHHHHHcCC-CCchhhhccCCCccccCCCCCCCCchhhhh
Q 012191 73 DYG-----PSVDLWSVGCVFAELLIGKPILQ-GRTEVEQLHKIFKLCGS-PPDDYWKKSKLPHATLFKPQQPYDSSLRET 145 (468)
Q Consensus 73 ~~s-----~~sDIWSLG~ILyeLltG~~pf~-g~~~~e~l~~i~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 145 (468)
.+. ...||||+|.|||||++.-..+. +....-++.-- ..+|. |.-+.....- ..+...|+. ...
T Consensus 395 nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe-~evG~hPt~e~mq~~V-----V~kK~RP~~---p~~ 465 (534)
T KOG3653|consen 395 NLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE-AEVGNHPTLEEMQELV-----VRKKQRPKI---PDA 465 (534)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh-HHhcCCCCHHHHHHHH-----HhhccCCCC---hhh
Confidence 655 26899999999999998654332 21111110000 01111 1111000000 000000111 111
Q ss_pred cC--CCcHHHHHHHHHhcCCCCCCCcCHHHHH
Q 012191 146 FK--DLPTTAVNLIETLLSVEPYKRATASAAL 175 (468)
Q Consensus 146 ~~--~~s~~l~dLL~~mL~~DP~kRpTa~e~L 175 (468)
|. .....+.+.|+.||..||+.|+||.=+-
T Consensus 466 W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 466 WRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred hhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 11 2345588999999999999999986543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.6e-17 Score=170.35 Aligned_cols=156 Identities=30% Similarity=0.420 Sum_probs=122.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc--CCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL--GATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~--g~~~~s~~sD 79 (468)
+..++||+|||+.|-+|||||..|||+++.|.+|++|||.+-.+...- ....+.+||+.|||||+.. ....|...+|
T Consensus 119 Retl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~KrksfiGtpywmapEvaaverkggynqlcd 197 (829)
T KOG0576|consen 119 RETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 197 (829)
T ss_pred hhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hhhhcccCCccccchhHHHHHhccccccccc
Confidence 456899999999999999999999999999999999999886554321 2235679999999999862 3346899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||++|+...||---++|....-....+..+-+....|+.- +.-...++.+-+|++.
T Consensus 198 iwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l------------------------kDk~kws~~fh~fvK~ 253 (829)
T KOG0576|consen 198 IWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL------------------------KDKTKWSEFFHNFVKG 253 (829)
T ss_pred ccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc------------------------cCCccchHHHHHHHHH
Confidence 9999999999988888876665555555554433333210 0112356778999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccC
Q 012191 160 LLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+|..+|.+|||++.+|.|||...
T Consensus 254 altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 254 ALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HhcCCCccCCChhhheeceeecc
Confidence 99999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.3e-17 Score=170.70 Aligned_cols=95 Identities=34% Similarity=0.680 Sum_probs=87.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|+|++.|+++||+.||||||||-+|+.++.+|.+||+|||.+.+...+ ++...+||..|.|||++.|..+.+...||
T Consensus 676 FkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdi 752 (772)
T KOG1152|consen 676 FKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDI 752 (772)
T ss_pred HHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchh
Confidence 589999999999999999999999999999999999999999877654 56778999999999999987777899999
Q ss_pred eeeehhhhhhhhcCCCCC
Q 012191 81 WSVGCVFAELLIGKPILQ 98 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~ 98 (468)
|+||++||.++....||.
T Consensus 753 walgillytivykenpyy 770 (772)
T KOG1152|consen 753 WALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhheeeEEEeccCCCc
Confidence 999999999999888875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=147.60 Aligned_cols=163 Identities=34% Similarity=0.523 Sum_probs=122.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCCC-----CccccccCCcccChhhhcCC--C
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ-----PLTSRVVTLWYRPPELLLGA--T 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~-----~~~~~~gt~~Y~APE~l~g~--~ 72 (468)
+.|++.++.|+|..|++||||||+||+++..+ .++++|||.+......... .....+++.+|++||.+.+. .
T Consensus 107 ~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~ 186 (384)
T COG0515 107 LAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186 (384)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCC
Confidence 46899999999999999999999999999988 7999999998755443221 34667889999999999874 4
Q ss_pred CCCCCcceeeeehhhhhhhhcCCCCCCCch---HHHHHHHHHHcCCC-CchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 73 DYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSP-PDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG~~pf~g~~~---~e~l~~i~~~~g~p-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
.+....|+|++|++++++++|..||..... .......+.....+ .... ...... ..
T Consensus 187 ~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~---~~ 246 (384)
T COG0515 187 YASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP-----------------LSPSNP---EL 246 (384)
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc-----------------cCcccc---ch
Confidence 678899999999999999999999887764 33333333332222 0000 000000 22
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
....+.+++..|+..+|..|.+..+...++|+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 247 ISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred hhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 34678999999999999999999999998776654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-17 Score=163.11 Aligned_cols=130 Identities=27% Similarity=0.436 Sum_probs=89.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-------CCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-------TDY 74 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~-------~~~ 74 (468)
.|+++.+++||..||+|+||+|+|+|++.+|.+.|+||+.....+.. ......+..|.|||+.... ..+
T Consensus 152 ~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~ 227 (288)
T PF14531_consen 152 VQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPY 227 (288)
T ss_dssp HHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE
T ss_pred HHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCccccee
Confidence 58899999999999999999999999999999999999987655431 1213446779999987432 347
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
+.+.|.|+||+++|.|+||..||.......... | .+..+ .++|+.++
T Consensus 228 t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~-------------~-------------------~f~~C-~~~Pe~v~ 274 (288)
T PF14531_consen 228 TFATDAWQLGITLYSLWCGRLPFGLSSPEADPE-------------W-------------------DFSRC-RDMPEPVQ 274 (288)
T ss_dssp -HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG-------------G-------------------GGTTS-S---HHHH
T ss_pred eeccCHHHHHHHHHHHHHccCCCCCCCcccccc-------------c-------------------cchhc-CCcCHHHH
Confidence 889999999999999999999997543211000 0 11222 37899999
Q ss_pred HHHHHhcCCCCCCC
Q 012191 155 NLIETLLSVEPYKR 168 (468)
Q Consensus 155 dLL~~mL~~DP~kR 168 (468)
.||..||+.||.+|
T Consensus 275 ~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 275 FLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHT-SSGGGS
T ss_pred HHHHHHccCCcccC
Confidence 99999999999987
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.7e-16 Score=165.70 Aligned_cols=146 Identities=20% Similarity=0.249 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCcc-ccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+||++||.|||++++|||||-..|+|+.....+||.|||++............ .....+-|+|-|.+.. ..|+.++||
T Consensus 805 ~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDV 883 (1177)
T KOG1025|consen 805 YQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDV 883 (1177)
T ss_pred HHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhh
Confidence 69999999999999999999999999999999999999999877765433222 2233566888888865 569999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||+||.+|||+| |..|+.+....++-..+.+.. .. ...+..+-++..++.+
T Consensus 884 WsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RL---------------------------sqPpiCtiDVy~~mvk 935 (1177)
T KOG1025|consen 884 WSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RL---------------------------SQPPICTIDVYMVMVK 935 (1177)
T ss_pred hhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cC---------------------------CCCCCccHHHHHHHHH
Confidence 999999999998 999998876655433332211 11 0113467789999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..|+..||++.++..
T Consensus 936 Cwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 936 CWMIDADSRPTFKELAE 952 (1177)
T ss_pred HhccCcccCccHHHHHH
Confidence 99999999999998865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-16 Score=168.35 Aligned_cols=143 Identities=31% Similarity=0.469 Sum_probs=121.3
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceee
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWS 82 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWS 82 (468)
.++.|++++|+.||+|+|+|++||+++.+|.+++.|||+.+..-.... .+||..|||||++.+ ...++|.||
T Consensus 105 elaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~cgt~eymApEI~~g---h~~a~D~ws 176 (612)
T KOG0603|consen 105 ELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIING---HLSAADWWS 176 (612)
T ss_pred HHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----cccchhhhhhHhhhc---cCCcccchh
Confidence 578899999999999999999999999999999999999876544322 289999999999974 568899999
Q ss_pred eehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcC
Q 012191 83 VGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLS 162 (468)
Q Consensus 83 LG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~ 162 (468)
+|+++++|++|..||.+ +....|.+..-..| ..++..+.+++..|+.
T Consensus 177 ~gvl~felltg~~pf~~----~~~~~Il~~~~~~p-----------------------------~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 177 FGVLAFELLTGTLPFGG----DTMKRILKAELEMP-----------------------------RELSAEARSLFRQLFK 223 (612)
T ss_pred hhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-----------------------------hhhhHHHHHHHHHHHh
Confidence 99999999999999988 67777766433222 2466789999999999
Q ss_pred CCCCCCcC-----HHHHHhcccccCCCCC
Q 012191 163 VEPYKRAT-----ASAALASEYFSTKPYA 186 (468)
Q Consensus 163 ~DP~kRpT-----a~e~L~Hp~F~~~p~~ 186 (468)
.+|.+|.- +.++++|+||....|-
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHh
Confidence 99999975 5799999999987664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.9e-16 Score=145.87 Aligned_cols=109 Identities=39% Similarity=0.647 Sum_probs=88.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+...............++..|++||.+.+...++.++|+
T Consensus 104 ~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv 183 (225)
T smart00221 104 LRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDI 183 (225)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhH
Confidence 36899999999999999999999999999999999999999876654321122345677889999988444567789999
Q ss_pred eeeehhhhhhhhcCCCCCC-CchH-HHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQG-RTEV-EQLHKI 109 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g-~~~~-e~l~~i 109 (468)
|+|||++++|++|+.||.+ .... .....+
T Consensus 184 ~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 184 WSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred HHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 9999999999999999977 4444 444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.6e-16 Score=172.70 Aligned_cols=149 Identities=31% Similarity=0.427 Sum_probs=103.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccc--cCCCCCCCcccc----ccCCcccChhhhcCCC--
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSR----VVTLWYRPPELLLGAT-- 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~--~~~~~~~~~~~~----~gt~~Y~APE~l~g~~-- 72 (468)
+.|||.||.-||..||+|||||.+||||+.-+-+.|+||..-+. +.......++.+ ..-.+|+|||.+....
T Consensus 126 aFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~ 205 (1431)
T KOG1240|consen 126 AFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGK 205 (1431)
T ss_pred HHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccc
Confidence 47999999999999999999999999999999999999976432 111111112211 2246799999986422
Q ss_pred --------CCCCCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhh
Q 012191 73 --------DYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLR 143 (468)
Q Consensus 73 --------~~s~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~ 143 (468)
..+++.||||+||+++||++ |+|||.- .++-...... ... ...+-
T Consensus 206 ~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~-~~~---------------------~e~~L 259 (1431)
T KOG1240|consen 206 TSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN-ADD---------------------PEQLL 259 (1431)
T ss_pred cccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC-ccC---------------------HHHHH
Confidence 14678999999999999988 7999951 2222211100 000 00111
Q ss_pred hhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 144 ETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 144 ~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
+... +..+++||..|++.||++|.+|++.|+-
T Consensus 260 e~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 EKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 3468999999999999999999999976
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.5e-16 Score=163.64 Aligned_cols=145 Identities=31% Similarity=0.553 Sum_probs=107.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-----CCCccccccCCcccChhhhcCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-----RQPLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
+.|+..|++| +|.+|+|+||.||++..+..+||.|||+........ ....+..+||.||++||.+.+ ..|+
T Consensus 365 ~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~ 440 (516)
T KOG1033|consen 365 FKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYS 440 (516)
T ss_pred HHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhh
Confidence 3688889999 999999999999999999999999999987665443 234567799999999999987 5799
Q ss_pred CCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 76 PSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
.++|||+||+||+||+. -...|. ....+..+. -|..|+.+| .++ +.-.
T Consensus 441 ~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r--~g~ip~~~~-------------------------~d~-p~e~ 489 (516)
T KOG1033|consen 441 EKVDIYALGLILAELLIQFSTQFE---RIATLTDIR--DGIIPPEFL-------------------------QDY-PEEY 489 (516)
T ss_pred hhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhh--cCCCChHHh-------------------------hcC-cHHH
Confidence 99999999999999986 221111 111111111 123332222 122 3346
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 155 NLIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
.||.+||...|.+||++.+.--|+|.
T Consensus 490 ~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 490 TLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHHHHhcCCCcccCchHHHHhhhhhc
Confidence 89999999999999988877777664
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=155.17 Aligned_cols=150 Identities=25% Similarity=0.364 Sum_probs=103.3
Q ss_pred HHHHHHHHHHHhC--------CCeeccCCCCceEECCCCcEEEEecCCccccCCCC---CCCccccccCCcccChhhhcC
Q 012191 2 NQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQPLTSRVVTLWYRPPELLLG 70 (468)
Q Consensus 2 ~QLL~gL~yLHs~--------gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~g 70 (468)
.-++.||+|||.. .|.|||||..|||+..++.+.|+|+|+|....... ....+..+||..|||||+|..
T Consensus 315 lS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 315 LSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred HHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 3578999999962 39999999999999999999999999997665432 124467899999999999965
Q ss_pred CCCC-----CCCcceeeeehhhhhhhhc----------CCCCCCC----chHHHHHHHHHHcCCCCchhhhccCCCcccc
Q 012191 71 ATDY-----GPSVDLWSVGCVFAELLIG----------KPILQGR----TEVEQLHKIFKLCGSPPDDYWKKSKLPHATL 131 (468)
Q Consensus 71 ~~~~-----s~~sDIWSLG~ILyeLltG----------~~pf~g~----~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~ 131 (468)
.... -..+||||||.|+||+... ++||.+- ...+.+.+++-.-
T Consensus 395 tin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~------------------ 456 (513)
T KOG2052|consen 395 TINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQ------------------ 456 (513)
T ss_pred hcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeec------------------
Confidence 3221 1258999999999999753 3566432 2223333322110
Q ss_pred CCCCCCCCchhhhhcCCCc--HHHHHHHHHhcCCCCCCCcCHHHH
Q 012191 132 FKPQQPYDSSLRETFKDLP--TTAVNLIETLLSVEPYKRATASAA 174 (468)
Q Consensus 132 ~~~~~~~~~~l~~~~~~~s--~~l~dLL~~mL~~DP~kRpTa~e~ 174 (468)
.+...+...|...+ ..+..||+.||..||.-|.||--+
T Consensus 457 -----~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 457 -----KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred -----ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 01111122222222 346789999999999999998554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-14 Score=146.03 Aligned_cols=153 Identities=24% Similarity=0.330 Sum_probs=106.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC--CCC--cEEEEecCCccccCCCCC-----CCccccccCCcccChhhhcCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEG--VLKLADFGLANFSNTGHR-----QPLTSRVVTLWYRPPELLLGA 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld--~~g--~vKL~DFGla~~~~~~~~-----~~~~~~~gt~~Y~APE~l~g~ 71 (468)
+-|||+|+.|||.+||.|||||.+||||. +++ .+.|+|||++-......- ......-|.-..+|||+....
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 36999999999999999999999999983 343 488999998743322111 111234567788999998642
Q ss_pred CCC-----CCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc
Q 012191 72 TDY-----GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 146 (468)
Q Consensus 72 ~~~-----s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (468)
... -.++|.|++|.+.||++....||.+..+.-.-..-+.. ..+....
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe---------------------------~qLPalp 479 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE---------------------------SQLPALP 479 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh---------------------------hhCCCCc
Confidence 211 13789999999999999999999874432211111110 0112222
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCcCH---HHHHhcccc
Q 012191 147 KDLPTTAVNLIETLLSVEPYKRATA---SAALASEYF 180 (468)
Q Consensus 147 ~~~s~~l~dLL~~mL~~DP~kRpTa---~e~L~Hp~F 180 (468)
..+++.+++|+..+|+.||++|+++ ..+|+--.|
T Consensus 480 ~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 480 SRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred ccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 4678899999999999999999984 455654333
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3e-12 Score=129.91 Aligned_cols=150 Identities=27% Similarity=0.234 Sum_probs=105.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCC-----CcEEEEecCCccccC--CCCC----CC---ccccccCCcccChhh
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-----GVLKLADFGLANFSN--TGHR----QP---LTSRVVTLWYRPPEL 67 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~-----g~vKL~DFGla~~~~--~~~~----~~---~~~~~gt~~Y~APE~ 67 (468)
.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++.+. .... .. .....||..|.++.+
T Consensus 129 ~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~ 208 (322)
T KOG1164|consen 129 IQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINV 208 (322)
T ss_pred HHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHH
Confidence 589999999999999999999999999765 369999999998322 1111 11 123458999999998
Q ss_pred hcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcC
Q 012191 68 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 147 (468)
Q Consensus 68 l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 147 (468)
..+ ...+...|+||++.++.+|+.|..||.+.........+......... .....
T Consensus 209 H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~ 263 (322)
T KOG1164|consen 209 HLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLT------------------------DRFGD 263 (322)
T ss_pred hCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcc------------------------ccccC
Confidence 887 45789999999999999999999999776543333332221110000 00112
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
..+..+..++..+-..+...+|....+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 264 LKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred CChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 34566777777777778888887666544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.4e-13 Score=150.40 Aligned_cols=158 Identities=33% Similarity=0.517 Sum_probs=125.4
Q ss_pred CHHHHHHHHHHH-hCCCeeccCCCCceEECCCC-cEEEEecCCccccCC--CCCCCcccccc-CCcccChhhhcCCCCCC
Q 012191 1 MNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNT--GHRQPLTSRVV-TLWYRPPELLLGATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLH-s~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~--~~~~~~~~~~g-t~~Y~APE~l~g~~~~s 75 (468)
+.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||+|..+.. +........+| ++.|.|||.+.+.....
T Consensus 129 ~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~ 208 (601)
T KOG0590|consen 129 LPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRG 208 (601)
T ss_pred hhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcC
Confidence 468999999999 99999999999999999999 999999999987665 33344556788 99999999998866678
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
...|+||+|+++.-+++|..|+.......... ..|...+ ...-...|..++....+
T Consensus 209 ~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~~~-------------~~~~~~~~~~~~~~~~~ 264 (601)
T KOG0590|consen 209 PSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKSNK-------------GRFTQLPWNSISDQAHD 264 (601)
T ss_pred CCcccccccccccccccCCCCccccccccccc-----------eeecccc-------------cccccCccccCChhhhh
Confidence 89999999999999999999986433222000 0011000 00012344678889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
++.++|..+|..|.+..++-.++|+..
T Consensus 265 ~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 265 LLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccCCchhccccccccccccccc
Confidence 999999999999999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=8e-12 Score=131.88 Aligned_cols=154 Identities=27% Similarity=0.395 Sum_probs=108.7
Q ss_pred CHHHHHHHHHHHhCCC-eeccCCCCceEECCCCcEEEEecCCccccCCC-CCCCccccccCCcccChhhhcCCCC-----
Q 012191 1 MNQLLHGLEHCHSRGV-LHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPPELLLGATD----- 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gI-vHrDIKp~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~l~g~~~----- 73 (468)
++.|+.||+|||.--| .|+.|+..|++++....+||.|||+....... .........-..-|.|||++.+...
T Consensus 54 ~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~ 133 (484)
T KOG1023|consen 54 IRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLES 133 (484)
T ss_pred HHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccc
Confidence 4789999999999866 99999999999999999999999998765421 0011111223456899999976321
Q ss_pred -CCCCcceeeeehhhhhhhhcCCCCCCCch----HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 74 -YGPSVDLWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 74 -~s~~sDIWSLG~ILyeLltG~~pf~g~~~----~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
.+.+.||||+|+|++|+++...||..... .+.+..+.+ .+.. ++.+.+... ..
T Consensus 134 ~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~--------------------~~rP~i~~~-~e 191 (484)
T KOG1023|consen 134 ALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGSN--------------------PFRPSIELL-NE 191 (484)
T ss_pred cccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-cCCC--------------------CcCcchhhh-hh
Confidence 35679999999999999999999976332 233333322 1111 111111111 14
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
+++++..++..|+..+|.+||++.++-.
T Consensus 192 ~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 192 LPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cchHHHHHHHHhcccChhhCccHHHHHh
Confidence 5668999999999999999999988753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.1e-12 Score=119.76 Aligned_cols=101 Identities=20% Similarity=0.153 Sum_probs=75.8
Q ss_pred CHHHHHHHHHHHhCCCeeccC-CCCceEECCCCcEEEEecCCccccCCCCCC----C--------ccccccCCcccChhh
Q 012191 1 MNQLLHGLEHCHSRGVLHRDI-KGSNLLVNNEGVLKLADFGLANFSNTGHRQ----P--------LTSRVVTLWYRPPEL 67 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDI-Kp~NILld~~g~vKL~DFGla~~~~~~~~~----~--------~~~~~gt~~Y~APE~ 67 (468)
+.|++.+|.+||.+||+|||| ||+|||++.++.++|+|||++......... . ......++.|+.|+.
T Consensus 97 ~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~ 176 (218)
T PRK12274 97 FRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVE 176 (218)
T ss_pred HHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHH
Confidence 368899999999999999999 799999999999999999999865543210 0 001124677888875
Q ss_pred hcCCCCCC-CCcceeeeehhhhhhhhcCCCCCCCc
Q 012191 68 LLGATDYG-PSVDLWSVGCVFAELLIGKPILQGRT 101 (468)
Q Consensus 68 l~g~~~~s-~~sDIWSLG~ILyeLltG~~pf~g~~ 101 (468)
-.-....+ ...+.++.|+.+|.++|+..++.+++
T Consensus 177 ~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 177 RRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 43221223 45688899999999999998886654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-11 Score=125.02 Aligned_cols=88 Identities=20% Similarity=0.298 Sum_probs=65.4
Q ss_pred CHHHHHHHHHHHhCCCeeccC-CCCceEECCCCcEEEEecCCccccCCCCC-------CCccccccCCcccChhhhcCC-
Q 012191 1 MNQLLHGLEHCHSRGVLHRDI-KGSNLLVNNEGVLKLADFGLANFSNTGHR-------QPLTSRVVTLWYRPPELLLGA- 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDI-Kp~NILld~~g~vKL~DFGla~~~~~~~~-------~~~~~~~gt~~Y~APE~l~g~- 71 (468)
+.|++.||.|||++||+|||| ||+|||++.++.++|+|||++..+..... ...+...+++.|.+||.+...
T Consensus 117 ~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 117 FRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred HHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 468999999999999999999 99999999999999999999986654321 112445678889999988532
Q ss_pred ----CCCCCCccee-eeehhhh
Q 012191 72 ----TDYGPSVDLW-SVGCVFA 88 (468)
Q Consensus 72 ----~~~s~~sDIW-SLG~ILy 88 (468)
...+...|-| .-|=+.+
T Consensus 197 ~~~~~~~~~~~dgW~~TGDlg~ 218 (365)
T PRK09188 197 RKILARKSLPSRIWLATGKKVY 218 (365)
T ss_pred hccccccccccCcEEeCCCEEE
Confidence 1223446666 4555444
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.3e-11 Score=127.27 Aligned_cols=156 Identities=25% Similarity=0.353 Sum_probs=115.4
Q ss_pred HHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccc--------cccCCcccChhhhcCCCC
Q 012191 3 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--------RVVTLWYRPPELLLGATD 73 (468)
Q Consensus 3 QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~--------~~gt~~Y~APE~l~g~~~ 73 (468)
++..||.|+|.. ++||++|.|++|.++..+.+||+.|+++.....+...++.. ..-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 345789999975 89999999999999999999999999886544322222211 122567999999987 56
Q ss_pred CCCCcceeeeehhhhhhh-hcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHH
Q 012191 74 YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLl-tG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 152 (468)
.+.++|+||+||++|.+. .|++.+.+.........-....+... ...-..++.+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~-------------------------~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA-------------------------FGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc-------------------------ccccccCcHH
Confidence 789999999999999999 67777765543332222211111110 0001578999
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 153 AVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 153 l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
+++-|.++|..++..||++.+++..+||.+-.
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999999998753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-10 Score=110.83 Aligned_cols=147 Identities=24% Similarity=0.255 Sum_probs=105.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCC---CcEEEEecCCccccCCCCCC------CccccccCCcccChhhhcCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGAT 72 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~---g~vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~g~~ 72 (468)
-|++.-|+|+|.+++|||||||+|+|+.-. ..+.|+|||++..+...... .-....||..|.+--...+.
T Consensus 118 DQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~- 196 (341)
T KOG1163|consen 118 DQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI- 196 (341)
T ss_pred HHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhh-
Confidence 389999999999999999999999998543 46899999999765543211 12345788899888777663
Q ss_pred CCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHH
Q 012191 73 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 152 (468)
.-+...|+=|+|.+|..+..|..||+|-......++..+.... .....+..++..+|.+
T Consensus 197 eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek---------------------K~s~~ie~LC~G~P~E 255 (341)
T KOG1163|consen 197 EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK---------------------KMSTPIEVLCKGFPAE 255 (341)
T ss_pred hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh---------------------hcCCCHHHHhCCCcHH
Confidence 3567899999999999999999999987554433333222110 0122345566788888
Q ss_pred HHHHHHHhcCCCCCCCcC
Q 012191 153 AVNLIETLLSVEPYKRAT 170 (468)
Q Consensus 153 l~dLL~~mL~~DP~kRpT 170 (468)
+...|.-|=..--.+-|.
T Consensus 256 F~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 256 FAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred HHHHHHHHhhcCCCCCCc
Confidence 888888775555555554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.6e-10 Score=113.21 Aligned_cols=107 Identities=31% Similarity=0.420 Sum_probs=86.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCC-----cEEEEecCCccccCCCCCC------CccccccCCcccChhhhcC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLG 70 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-----~vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~g 70 (468)
.||+.-++|+|++.+|.|||||+|+||...+ .|.|+|||+|+.+...... ...+..||..||+--..+|
T Consensus 131 ~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG 210 (449)
T KOG1165|consen 131 KQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG 210 (449)
T ss_pred HHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc
Confidence 6899999999999999999999999996543 5899999999876654321 1235678999999888887
Q ss_pred CCCCCCCcceeeeehhhhhhhhcCCCCCCC---chHHHHHHH
Q 012191 71 ATDYGPSVDLWSVGCVFAELLIGKPILQGR---TEVEQLHKI 109 (468)
Q Consensus 71 ~~~~s~~sDIWSLG~ILyeLltG~~pf~g~---~~~e~l~~i 109 (468)
. .-+...|+=|||-||.++|.|..||+|- +..+-+++|
T Consensus 211 r-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 211 R-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred c-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 4 4678899999999999999999999874 444445554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=9e-11 Score=113.52 Aligned_cols=75 Identities=16% Similarity=0.295 Sum_probs=58.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.+|..||..|++|+||||+||+++.+| ++|+|||......... +-+.+.-...|+.++|+|
T Consensus 142 ~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~--------------a~d~~vler~y~~~~di~ 206 (232)
T PRK10359 142 AKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK--------------AKDRIDLERHYGIKNEIK 206 (232)
T ss_pred HHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchh--------------hHHHHHHHhHhccccccc
Confidence 5899999999999999999999999999988 9999999875443211 111122223577899999
Q ss_pred eeehhhhhhh
Q 012191 82 SVGCVFAELL 91 (468)
Q Consensus 82 SLG~ILyeLl 91 (468)
+||+++..+.
T Consensus 207 ~lg~~~~~~~ 216 (232)
T PRK10359 207 DLGYYLLIYK 216 (232)
T ss_pred ceeEeehHHH
Confidence 9999987664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.2e-10 Score=126.18 Aligned_cols=159 Identities=29% Similarity=0.366 Sum_probs=123.4
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCC------C---------------C----C-----CC
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT------G---------------H----R-----QP 52 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~------~---------------~----~-----~~ 52 (468)
.+.+++++||...+.|+|++|.|+|+..++..++.||+....... . . . ..
T Consensus 912 ~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~ 991 (1205)
T KOG0606|consen 912 ERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARR 991 (1205)
T ss_pred HHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhc
Confidence 467889999999999999999999999999999999984321110 0 0 0 01
Q ss_pred ccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccC
Q 012191 53 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF 132 (468)
Q Consensus 53 ~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 132 (468)
....++|+.|.+||.+++.. -+..+|+|++|+++++.++|.+||...+....+..|....-..+
T Consensus 992 ~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p--------------- 1055 (1205)
T KOG0606|consen 992 KHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWP--------------- 1055 (1205)
T ss_pred cccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCC---------------
Confidence 12346799999999998854 57889999999999999999999999888777766643221111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHH---HHHhcccccCCCCCCC
Q 012191 133 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AALASEYFSTKPYACD 188 (468)
Q Consensus 133 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~---e~L~Hp~F~~~p~~~~ 188 (468)
.-....+..+++++..+|..+|.+|..+. ++-.|+||+...|...
T Consensus 1056 -----------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1056 -----------EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred -----------CCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 11124678899999999999999999987 8889999998877643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.5e-09 Score=120.65 Aligned_cols=92 Identities=26% Similarity=0.349 Sum_probs=76.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC-------CCcEEEEecCCccccCC-CCCCCccccccCCcccChhhhcCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------EGVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELLLGATD 73 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~-------~g~vKL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l~g~~~ 73 (468)
.|||.-|++||..+|||+||||+|+||.. ...++|+|||.+.-+.. .....+...+.|-.+-.+|...| ..
T Consensus 801 ~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rp 879 (974)
T KOG1166|consen 801 CQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RP 879 (974)
T ss_pred HHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CC
Confidence 58999999999999999999999999942 33599999999854332 11235566778889999998887 67
Q ss_pred CCCCcceeeeehhhhhhhhcC
Q 012191 74 YGPSVDLWSVGCVFAELLIGK 94 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~ 94 (468)
|+..+|.|.|+.+++.||.|+
T Consensus 880 WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 880 WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred CchhhhhHHHHHHHHHHHHHH
Confidence 999999999999999999996
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.6e-09 Score=99.55 Aligned_cols=45 Identities=20% Similarity=0.273 Sum_probs=40.0
Q ss_pred CHHHHHHHHHH-HhCCCeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 1 MNQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 1 m~QLL~gL~yL-Hs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
+.||+.+|.+| |+.||+||||||+|||++ ++.++|+|||++....
T Consensus 123 ~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 123 YLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 36899999999 799999999999999998 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.3e-09 Score=98.06 Aligned_cols=44 Identities=20% Similarity=0.322 Sum_probs=40.9
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
.||+.+|.+||. .||+||||||+|||++ ++.++|+|||++....
T Consensus 124 ~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 124 EQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 689999999999 9999999999999998 7899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.7e-09 Score=100.42 Aligned_cols=138 Identities=15% Similarity=0.192 Sum_probs=99.2
Q ss_pred HHHHHHHHHHhCC--CeeccCCCCceEECCCCcEEEE--ecCCccccCCCCCCCccccccCCcccChhhhcCCCCC--CC
Q 012191 3 QLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLA--DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDY--GP 76 (468)
Q Consensus 3 QLL~gL~yLHs~g--IvHrDIKp~NILld~~g~vKL~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~--s~ 76 (468)
.|+.|++|||+.. |.---|....++||++-+.+|. |--++- . .....-.+.|++||.+...... -.
T Consensus 297 diargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--q------e~gr~y~pawmspealqrkped~n~r 368 (448)
T KOG0195|consen 297 DIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q------EVGRAYSPAWMSPEALQRKPEDLNIR 368 (448)
T ss_pred HHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--e------ccccccCcccCCHHHHhcCchhcchh
Confidence 6889999999974 4455688889999998766553 432221 0 1223446889999999754322 24
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|+|||++++|||.|...||..-...+.-.+|.- -|.- ....+.++..+..|
T Consensus 369 aadmwsfaillwel~trevpfadlspmecgmkial-eglr--------------------------v~ippgis~hm~kl 421 (448)
T KOG0195|consen 369 AADMWSFAILLWELNTREVPFADLSPMECGMKIAL-EGLR--------------------------VHIPPGISRHMNKL 421 (448)
T ss_pred hhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-cccc--------------------------ccCCCCccHHHHHH
Confidence 79999999999999999999988777766555421 1110 01125688889999
Q ss_pred HHHhcCCCCCCCcCHHHHH
Q 012191 157 IETLLSVEPYKRATASAAL 175 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L 175 (468)
+.-|++.||.+||....++
T Consensus 422 m~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHhcCCCCcCCCcceeh
Confidence 9999999999999876654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.4e-09 Score=109.14 Aligned_cols=149 Identities=26% Similarity=0.345 Sum_probs=111.6
Q ss_pred HHHH----HHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCc----cccccCCcccChhhhcCCCC
Q 012191 3 QLLH----GLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPL----TSRVVTLWYRPPELLLGATD 73 (468)
Q Consensus 3 QLL~----gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~----~~~~gt~~Y~APE~l~g~~~ 73 (468)
+.+. ||.++|+.+++|-|+||.||++..+ ..++++|||+...+..+..... ....+...|++||++.+ -
T Consensus 226 ~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l 303 (524)
T KOG0601|consen 226 DWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--L 303 (524)
T ss_pred hhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--c
Confidence 4556 9999999999999999999999998 7899999999987766542211 12245677999999976 5
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCC--chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGR--TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~--~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 151 (468)
++...||+++|.++.+..++..++... ....++..++ .+ .+.+...+.
T Consensus 304 ~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip-------------------------~e~~~~~s~ 353 (524)
T KOG0601|consen 304 ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IP-------------------------LEFCEGGSS 353 (524)
T ss_pred cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----Cc-------------------------hhhhcCcch
Confidence 789999999999999999887666433 2111111110 11 112234555
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 152 TAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
++...+..|+..+|..|+++..++.+++....
T Consensus 354 ~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 354 SLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 66669999999999999999999999998753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.4e-08 Score=96.30 Aligned_cols=43 Identities=26% Similarity=0.499 Sum_probs=40.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
.||+.+|.+||+.||+|+||||.|||++.++.++|+|||.+..
T Consensus 149 ~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 149 QAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 6899999999999999999999999999989999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.7e-08 Score=94.18 Aligned_cols=45 Identities=20% Similarity=0.398 Sum_probs=40.8
Q ss_pred CHHHHHHHHHHHhCC-CeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 1 MNQLLHGLEHCHSRG-VLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 1 m~QLL~gL~yLHs~g-IvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
+.||+.+|.+||+.| |+|+||||+||+++ ++.++|+|||.+....
T Consensus 154 ~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 154 YDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred HHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 368999999999999 99999999999999 7899999999886443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.1e-07 Score=89.55 Aligned_cols=46 Identities=17% Similarity=0.410 Sum_probs=42.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 47 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~ 47 (468)
.||+.++.++|..||+|+||+|+||+++.++.++|+|||++.....
T Consensus 132 ~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 132 DEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred HHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 6899999999999999999999999999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.5e-07 Score=90.17 Aligned_cols=42 Identities=21% Similarity=0.225 Sum_probs=35.1
Q ss_pred CHHHHHHH-HHHHhCCCeeccCCCCceEECC----CCcEEEEecCCc
Q 012191 1 MNQLLHGL-EHCHSRGVLHRDIKGSNLLVNN----EGVLKLADFGLA 42 (468)
Q Consensus 1 m~QLL~gL-~yLHs~gIvHrDIKp~NILld~----~g~vKL~DFGla 42 (468)
|+|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 110 ~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 110 LRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 36788788 9999999999999999999974 347999995443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.9e-07 Score=85.18 Aligned_cols=44 Identities=25% Similarity=0.387 Sum_probs=40.4
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
.|++.++.+||. .||+|+||||+||+++ ++.++|+|||.+....
T Consensus 121 ~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 121 DQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred HHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 689999999999 9999999999999999 8999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.6e-06 Score=87.73 Aligned_cols=156 Identities=18% Similarity=0.216 Sum_probs=101.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc-C---CCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL-G---ATDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-g---~~~~s~~ 77 (468)
+.|+.+.+-||+.|.+-+|+.++|||+++++.|.|.|-..-..... .......+|...|.+||+-. + .-.-+..
T Consensus 124 RnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~ 201 (637)
T COG4248 124 RNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTAN 201 (637)
T ss_pred HHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccC--CceEecccCccccCCHHHhccccccccCCCcc
Confidence 4688999999999999999999999999999999998543322221 23345668899999999764 1 1224567
Q ss_pred cceeeeehhhhhhhhc-CCCCCCCchH----HHH-HHHHHHcCCCCchhhhccCCCccccCCCCCCCCc-hhhhhcCCCc
Q 012191 78 VDLWSVGCVFAELLIG-KPILQGRTEV----EQL-HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS-SLRETFKDLP 150 (468)
Q Consensus 78 sDIWSLG~ILyeLltG-~~pf~g~~~~----e~l-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~s 150 (468)
.|.|.||+++++||.| +.||.|-... .-+ ..|.... +..+ ...+..+.. ...--|.-++
T Consensus 202 hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~------------f~ya--~~~~~g~~p~P~~~P~~~Lp 267 (637)
T COG4248 202 HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR------------FAYA--SDQRRGLKPPPRSIPLSMLP 267 (637)
T ss_pred ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce------------eeec--hhccCCCCCCCCCCChhhcC
Confidence 9999999999999987 8999773210 000 0111100 0000 001111111 1122344678
Q ss_pred HHHHHHHHHhcCC--CCCCCcCHHH
Q 012191 151 TTAVNLIETLLSV--EPYKRATASA 173 (468)
Q Consensus 151 ~~l~dLL~~mL~~--DP~kRpTa~e 173 (468)
+++..|..+|+.. ++.-|||++.
T Consensus 268 p~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 268 PDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHHHHHHHhcccCCCCCCCCHHH
Confidence 9999999999874 3568999753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.5e-07 Score=91.28 Aligned_cols=147 Identities=18% Similarity=0.202 Sum_probs=94.7
Q ss_pred HHHHHHHHHHHhCC--CeeccCCCCceEECCCCcEEEEecCCccccCCCC---CC-CccccccCCcccChhhhcCCCCCC
Q 012191 2 NQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQ-PLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 2 ~QLL~gL~yLHs~g--IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~---~~-~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
-||+.||.|||+.. |+|+++..+.|++..+|.+||.--.... ..+.- .. ......+-+.|.+||.-.. ...+
T Consensus 183 tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~ 260 (458)
T KOG1266|consen 183 TQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTT 260 (458)
T ss_pred HHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcc-cccc
Confidence 48999999999985 9999999999999999988876422211 11000 00 0011234577899986432 3456
Q ss_pred CCcceeeeehhhhhhhhcCCCC-CCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf-~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
.++|||++|+...+|..+..-- .+....+.-..|...... .-..--+
T Consensus 261 ~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~--------------------------------len~lqr 308 (458)
T KOG1266|consen 261 GASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG--------------------------------LENGLQR 308 (458)
T ss_pred cchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee--------------------------------ccCcccc
Confidence 7899999999999997765331 111111111111111000 0011124
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
++|.+||+-.|..||++.++|.||.+-.
T Consensus 309 ~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 309 GSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred CcCcccccCCCCCCcchhhhhcCceeee
Confidence 6899999999999999999999987654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.4e-07 Score=84.31 Aligned_cols=43 Identities=30% Similarity=0.607 Sum_probs=39.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
+.||+.+|.+||+.|++|+||+|.||+++ ++.++|+|||++..
T Consensus 96 ~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 96 LREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 36899999999999999999999999999 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=9e-07 Score=83.49 Aligned_cols=42 Identities=36% Similarity=0.661 Sum_probs=39.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
.||+.+|.+||+.|++|+||+|.|||++ ++.++|+|||++..
T Consensus 102 ~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 102 REIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 5789999999999999999999999999 78899999998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.20 E-value=9.6e-07 Score=95.96 Aligned_cols=44 Identities=32% Similarity=0.587 Sum_probs=40.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCcccc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 45 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~ 45 (468)
+.||+.+|.+||+.||+||||||+|||+ .++.++|+|||++...
T Consensus 434 ~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 434 VRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred HHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 3689999999999999999999999999 6788999999998653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.1e-06 Score=91.37 Aligned_cols=89 Identities=25% Similarity=0.402 Sum_probs=67.5
Q ss_pred CHHHHHHHHHHH-hCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLH-s~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
|+||+.||.||| +.+++|++|..+.|+|+..|..||++|.++........ +......--.|..|+.+.. -....|
T Consensus 110 l~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~---s~~s~D 185 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP---SEWSID 185 (690)
T ss_pred HHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc---cccchh
Confidence 579999999998 56899999999999999999999999998754432211 1122222334777775532 124679
Q ss_pred eeeeehhhhhhhhc
Q 012191 80 LWSVGCVFAELLIG 93 (468)
Q Consensus 80 IWSLG~ILyeLltG 93 (468)
.|-|||++++++.|
T Consensus 186 ~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 186 SWGLGCLIEELFNG 199 (690)
T ss_pred hhhHHHHHHHHhCc
Confidence 99999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-06 Score=92.46 Aligned_cols=144 Identities=23% Similarity=0.260 Sum_probs=102.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccC-hhhhcCCCCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP-PELLLGATDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~A-PE~l~g~~~~s~~sD 79 (468)
.|++.++.++|+..++|+|++|+||++..+ +..++.|||+...+... .......-++.| .|++.....+..+.|
T Consensus 373 ~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~ 448 (524)
T KOG0601|consen 373 AQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKAD 448 (524)
T ss_pred HHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee----cccccccccccccchhhccccccccccc
Confidence 589999999999999999999999999887 77899999988643221 111223444553 666666567888999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
+++||.-+.+.+++.+.-...+.. ..|+. ......+.....+..+...
T Consensus 449 ~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~-----------------------------~~~p~~~~~~~~~q~~~kv 496 (524)
T KOG0601|consen 449 IFSLGLSVDEAITGSPLSESGVQS---LTIRS-----------------------------GDTPNLPGLKLQLQVLLKV 496 (524)
T ss_pred cccccccccccccCcccCcccccc---eeeec-----------------------------ccccCCCchHHhhhhhhhh
Confidence 999999999999987654322111 11110 1111123344678889999
Q ss_pred hcCCCCCCCcCHHHHHhccccc
Q 012191 160 LLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
|+..|+..|+.+.++..|.=|.
T Consensus 497 ~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 497 MINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hcCCccccchhhhhhcccchhh
Confidence 9999999999999998886554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.96 E-value=7e-06 Score=71.42 Aligned_cols=44 Identities=27% Similarity=0.446 Sum_probs=39.4
Q ss_pred HHHHHHHHHHHhC---CCeeccCCCCceEECCCCcEEEEecCCcccc
Q 012191 2 NQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEGVLKLADFGLANFS 45 (468)
Q Consensus 2 ~QLL~gL~yLHs~---gIvHrDIKp~NILld~~g~vKL~DFGla~~~ 45 (468)
.+++.+|.+||.. +++|+||+|.||+++..+.++++|||.+...
T Consensus 93 ~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 93 EQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred HHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 5788999999985 7999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.5e-05 Score=72.18 Aligned_cols=42 Identities=29% Similarity=0.464 Sum_probs=37.7
Q ss_pred HHHHHHHHHHHhCCC-----eeccCCCCceEECCCCcEEEEecCCccc
Q 012191 2 NQLLHGLEHCHSRGV-----LHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 2 ~QLL~gL~yLHs~gI-----vHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
.+|+.+|..||..++ +|+|++|.||+++ ++.++|+||+.+..
T Consensus 90 ~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 90 EKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 578999999999985 9999999999998 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.4e-05 Score=75.66 Aligned_cols=44 Identities=18% Similarity=0.273 Sum_probs=38.5
Q ss_pred HHHHHHHHHH-HhCCCeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 2 NQLLHGLEHC-HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 2 ~QLL~gL~yL-Hs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
.|++.+|..| |..||||+||++.|||+. ++.+.|+|||.+....
T Consensus 131 ~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 131 YQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 5788999988 899999999999999996 4789999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=5.8e-05 Score=70.48 Aligned_cols=42 Identities=29% Similarity=0.569 Sum_probs=35.7
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCcccc
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 45 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~ 45 (468)
.+-.-+.-||..||+|+||.++||++...+ +.++|||++.+.
T Consensus 100 ~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 100 EVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred HHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 445567889999999999999999997754 999999998643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.48 E-value=9.6e-05 Score=70.33 Aligned_cols=44 Identities=27% Similarity=0.483 Sum_probs=39.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCccc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANF 44 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~~ 44 (468)
+.+|...+.-||..||+|+|+++.|||++.++ .+.|+||+.+..
T Consensus 124 l~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 124 LRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 36788899999999999999999999999887 799999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0001 Score=73.21 Aligned_cols=43 Identities=21% Similarity=0.307 Sum_probs=38.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-------CCcEEEEecCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------EGVLKLADFGLAN 43 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-------~g~vKL~DFGla~ 43 (468)
+++|+..+.-||..||+|+||++.|||++. +..+.|+||+.+.
T Consensus 144 l~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 144 IKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 357889999999999999999999999975 4679999999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00015 Score=76.97 Aligned_cols=40 Identities=25% Similarity=0.438 Sum_probs=36.2
Q ss_pred HHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 7 gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
.+..+|..|++|+|+||.||+++.++.++|+|||++..+.
T Consensus 269 ~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 4678999999999999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00047 Score=64.48 Aligned_cols=42 Identities=29% Similarity=0.555 Sum_probs=36.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLAN 43 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~ 43 (468)
++|-+.|.-||..+|+|+||..+||++..++ .+.++|||++.
T Consensus 120 ~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 120 RRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred HHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 5667789999999999999999999997765 35899999975
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00049 Score=64.78 Aligned_cols=44 Identities=30% Similarity=0.517 Sum_probs=32.8
Q ss_pred HHHHHHHHH-HHhCCCeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 2 NQLLHGLEH-CHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 2 ~QLL~gL~y-LHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.+....
T Consensus 113 ~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 113 EEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 356664444 679999999999999999876 99999999886443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0019 Score=62.27 Aligned_cols=40 Identities=23% Similarity=0.423 Sum_probs=35.3
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.|.++|.-||+.|++|+|++|.|++++++ .++++||+...
T Consensus 143 ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 143 KIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 57889999999999999999999999865 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0027 Score=69.06 Aligned_cols=38 Identities=24% Similarity=0.422 Sum_probs=33.0
Q ss_pred HHHhCCCeeccCCCCceEECCCC----cEEEEecCCccccCC
Q 012191 10 HCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNT 47 (468)
Q Consensus 10 yLHs~gIvHrDIKp~NILld~~g----~vKL~DFGla~~~~~ 47 (468)
-+...|++|+|+||.||+++.++ .++++|||++.....
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 35678999999999999999888 999999999876544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0041 Score=59.61 Aligned_cols=42 Identities=17% Similarity=0.174 Sum_probs=37.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCc--EEEEecCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLAN 43 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~--vKL~DFGla~ 43 (468)
++|...|.-||..|+.|+|+-+.|||++.++. ++++||.-+.
T Consensus 135 ~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 135 KAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 57888999999999999999999999987677 9999998664
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.012 Score=68.03 Aligned_cols=140 Identities=21% Similarity=0.263 Sum_probs=90.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCC---ceEECCCCcEEEE--ecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGS---NLLVNNEGVLKLA--DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~---NILld~~g~vKL~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
.+++.||.|+|+..+.|.-|... +-.++..+.+.+. ||+.......... .........+.++|..... .+..
T Consensus 293 ~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~-~~~~ 369 (1351)
T KOG1035|consen 293 QKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKEN-TAKK 369 (1351)
T ss_pred HHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccc-cchh
Confidence 47889999999996666555444 3334455666666 8887765543321 1222335557777776542 2333
Q ss_pred --CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCc-HHH
Q 012191 77 --SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP-TTA 153 (468)
Q Consensus 77 --~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s-~~l 153 (468)
..|+|++|..+..+..|..+-.-. ... ...+...+ ...
T Consensus 370 ~r~~dL~~lgll~~~~~~~~~i~~~~------~~~---------------------------------~~~l~~~~~~~~ 410 (1351)
T KOG1035|consen 370 SRLTDLWCLGLLLLQLSQGEDISEKS------AVP---------------------------------VSLLDVLSTSEL 410 (1351)
T ss_pred hhhhHHHHHHHHHhhhhhcCcccccc------cch---------------------------------hhhhccccchhh
Confidence 469999999999888776442110 000 01111111 267
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 154 VNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+++.+|+.-++++|+.+.++|.|+|.+..
T Consensus 411 ~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 411 LDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 889999999999999999999999998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.038 Score=54.82 Aligned_cols=42 Identities=26% Similarity=0.472 Sum_probs=35.6
Q ss_pred HHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 3 QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
.|+.-+..+-..||||+|+.+-|||++.+|.+.++||--+..
T Consensus 210 ~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 210 KILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred HHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 456666666689999999999999999999999999976543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.088 Score=56.38 Aligned_cols=123 Identities=19% Similarity=0.228 Sum_probs=85.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||..||.++|+.|+.-+-|.+.+||++.+..++|...|......... . |.+.+ -..-|.
T Consensus 399 ~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------------~--~~le~----~Qq~D~ 459 (655)
T KOG3741|consen 399 ISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------------T--EPLES----QQQNDL 459 (655)
T ss_pred HHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-------------C--cchhH----HhhhhH
Confidence 4699999999999999999999999999998888888777655443321 0 11222 134688
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
=.||.+++.|.||..--.-.+..... .+......++.+++++|.-+
T Consensus 460 ~~lG~ll~aLAt~~~ns~~~d~~~~s----------------------------------~~~~I~~~yS~D~rn~v~yl 505 (655)
T KOG3741|consen 460 RDLGLLLLALATGTENSNRTDSTQSS----------------------------------HLTRITTTYSTDLRNVVEYL 505 (655)
T ss_pred HHHHHHHHHHhhcccccccccchHHH----------------------------------HHHHhhhhhhHHHHHHHHHH
Confidence 88999999999985221111111110 01222346788899999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
...++.+ -++.++|.+
T Consensus 506 ~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 506 ESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HhcCccc-ccHHHHHHH
Confidence 9999987 588888865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.057 Score=59.13 Aligned_cols=150 Identities=19% Similarity=0.172 Sum_probs=98.2
Q ss_pred HHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceeeee
Q 012191 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVG 84 (468)
Q Consensus 5 L~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG 84 (468)
+.+|+++|+.-=+|+| ||+..+ +..+..||+....+.... ......+++.++|||+..+ ..+....|+|++|
T Consensus 346 t~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~ 417 (829)
T KOG0576|consen 346 TRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLA 417 (829)
T ss_pred cccccccccccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcc-cccccCCCccCCC
Confidence 4578888887778888 777755 678999999876554432 2345678999999998866 3578899999999
Q ss_pred hhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCC
Q 012191 85 CVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVE 164 (468)
Q Consensus 85 ~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~D 164 (468)
.-..+|--|.+|-.. |+........-+....+.. ...|... .-.++...||.-.
T Consensus 418 ~~~~~~ap~~pPr~~----------------P~~~~~~~g~~p~s~~L~~--------~~aw~~~--~~~~~~~~~~~g~ 471 (829)
T KOG0576|consen 418 VSAIQMAPGLPPRSS----------------PPAVLPMIGNGPNSPMLTD--------KSAWSPV--FHRDFPAPCLNGL 471 (829)
T ss_pred cchhhcCCCCCCCCC----------------CccccCCCCCCCCccccch--------hhhcCcc--cccCCcccccCCC
Confidence 887777777777543 1100000000000000000 0111111 0115778899999
Q ss_pred CCCCcCHHHHHhcccccCCCCCCC
Q 012191 165 PYKRATASAALASEYFSTKPYACD 188 (468)
Q Consensus 165 P~kRpTa~e~L~Hp~F~~~p~~~~ 188 (468)
|..+++...++.|.+|...|.-..
T Consensus 472 P~~pkv~mgacfsKvfngCpl~i~ 495 (829)
T KOG0576|consen 472 PPTPKVHMGACFSKVFNGCPLRIH 495 (829)
T ss_pred CCCCcchhhHHHHHHhccCcccce
Confidence 999999999999999998876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.046 Score=51.16 Aligned_cols=31 Identities=29% Similarity=0.509 Sum_probs=27.0
Q ss_pred CCCeeccCCCCceEECC--CCcEEEEecCCccc
Q 012191 14 RGVLHRDIKGSNLLVNN--EGVLKLADFGLANF 44 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~--~g~vKL~DFGla~~ 44 (468)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 56899999999999998 56789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.086 Score=53.00 Aligned_cols=30 Identities=37% Similarity=0.588 Sum_probs=27.0
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.25 E-value=0.12 Score=50.67 Aligned_cols=44 Identities=20% Similarity=0.332 Sum_probs=37.1
Q ss_pred HHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 2 NQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 2 ~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
.++++.+.-|-. .|+||+||..-|||+. ++.+.|+|||-+....
T Consensus 173 ~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 173 EDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 467777777766 8999999999999998 8899999999886444
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.12 E-value=0.033 Score=59.66 Aligned_cols=92 Identities=22% Similarity=0.264 Sum_probs=69.6
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
.++++|||++|.|+.++..|...+...+..+++..+.+..-.+..... -.........++...
T Consensus 108 ~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~-----------------~a~e~~~~~~~d~~~ 170 (725)
T KOG1093|consen 108 IGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLS-----------------TAMEHLIQLLADKKR 170 (725)
T ss_pred CCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHH-----------------HHHHHHHHHhhhHhH
Confidence 346999999999999999999999988888888888775433221110 000012223567778
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 154 VNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
..++.+|+...|..||...++++++-|..
T Consensus 171 ~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 171 LPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHhccCCccccccccchhHHhcCccHHH
Confidence 89999999999999999999999998875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.86 E-value=0.12 Score=51.40 Aligned_cols=30 Identities=33% Similarity=0.564 Sum_probs=26.7
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988778899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.81 E-value=0.079 Score=53.38 Aligned_cols=30 Identities=33% Similarity=0.550 Sum_probs=26.1
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.|+||+|+.+.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999876666899999774
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=92.63 E-value=0.09 Score=50.67 Aligned_cols=30 Identities=30% Similarity=0.431 Sum_probs=25.6
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.+++|+|+.+.|||++..+..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999876666799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.089 Score=49.32 Aligned_cols=30 Identities=30% Similarity=0.557 Sum_probs=21.1
Q ss_pred CCCeeccCCCCceEEC-CCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVN-NEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld-~~g~vKL~DFGla~ 43 (468)
..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 4699999999999999 56667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=91.95 E-value=0.18 Score=50.25 Aligned_cols=29 Identities=28% Similarity=0.509 Sum_probs=25.4
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.69 E-value=0.14 Score=51.08 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=26.1
Q ss_pred CCeeccCCCCceEECCC----CcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNNE----GVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~~----g~vKL~DFGla~ 43 (468)
+++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999875 889999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.65 E-value=0.13 Score=49.11 Aligned_cols=30 Identities=23% Similarity=0.412 Sum_probs=26.4
Q ss_pred CCCeeccCCCCceEECC-CCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNN-EGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~-~g~vKL~DFGla~ 43 (468)
.+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 36999999999999998 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=90.98 E-value=0.16 Score=48.99 Aligned_cols=28 Identities=29% Similarity=0.396 Sum_probs=25.3
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=90.97 E-value=0.034 Score=66.08 Aligned_cols=91 Identities=11% Similarity=0.013 Sum_probs=69.7
Q ss_pred HHHHHHHHhCC-----CeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 5 LHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 5 L~gL~yLHs~g-----IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.+..-+|... .+|++||+-|.+|..+..++++++|+.+...+ ........++++.|+.|++... ..++.++|
T Consensus 1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsd 1422 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNE-IKFTKRSD 1422 (2724)
T ss_pred HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHH-HhhhhHHH
Confidence 44555555431 68999999999999999999999999873332 2233344566888999988765 45777799
Q ss_pred eeeeehhhhhhhhcCCCC
Q 012191 80 LWSVGCVFAELLIGKPIL 97 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf 97 (468)
+|..||.+|.+..|.++|
T Consensus 1423 ilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHHhcccHHH
Confidence 999999999999887776
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=90.80 E-value=0.18 Score=48.67 Aligned_cols=30 Identities=23% Similarity=0.216 Sum_probs=26.4
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 358999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.66 E-value=0.2 Score=47.20 Aligned_cols=28 Identities=36% Similarity=0.554 Sum_probs=24.7
Q ss_pred CeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 16 VLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 16 IvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
.+|+|+.|.||++.+++ ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 58999999999998877 88999998753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.33 E-value=0.27 Score=53.42 Aligned_cols=38 Identities=29% Similarity=0.509 Sum_probs=32.8
Q ss_pred HHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCC
Q 012191 10 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT 47 (468)
Q Consensus 10 yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~ 47 (468)
.+=..|++|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 280 q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33457999999999999999999999999999866554
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=90.27 E-value=0.2 Score=48.86 Aligned_cols=29 Identities=41% Similarity=0.594 Sum_probs=25.4
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
.++|+|+.|.||+++.++ +.|+||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=89.59 E-value=0.24 Score=46.85 Aligned_cols=29 Identities=38% Similarity=0.647 Sum_probs=20.8
Q ss_pred CCeeccCCCCceEE-CCCCcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLV-NNEGVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILl-d~~g~vKL~DFGla~ 43 (468)
.++|.||.+.|||+ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=88.62 E-value=0.37 Score=47.97 Aligned_cols=29 Identities=34% Similarity=0.481 Sum_probs=26.9
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
-++|+|+.|+|+|+++.+.++|+||..|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCC
Confidence 48999999999999999999999999874
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=87.72 E-value=0.48 Score=47.70 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=27.4
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
+++|+|+.+.|||++.++.+-|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=87.45 E-value=0.48 Score=44.54 Aligned_cols=30 Identities=23% Similarity=0.408 Sum_probs=25.2
Q ss_pred CCCeeccCCCCceEECCCC-----cEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEG-----VLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g-----~vKL~DFGla~ 43 (468)
..++|||+.+.||++..++ .+.|+||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4689999999999997543 58999999874
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=86.91 E-value=0.41 Score=47.67 Aligned_cols=30 Identities=20% Similarity=0.402 Sum_probs=25.3
Q ss_pred CCeeccCCCCceEECCCCc-EEEEecCCccc
Q 012191 15 GVLHRDIKGSNLLVNNEGV-LKLADFGLANF 44 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~-vKL~DFGla~~ 44 (468)
.++|+|+++.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=86.45 E-value=0.43 Score=49.09 Aligned_cols=29 Identities=21% Similarity=0.560 Sum_probs=25.7
Q ss_pred CCeeccCCCCceEECC-CCcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNN-EGVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~-~g~vKL~DFGla~ 43 (468)
.++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999976 4689999999875
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.01 E-value=0.59 Score=47.99 Aligned_cols=28 Identities=25% Similarity=0.469 Sum_probs=25.1
Q ss_pred CeeccCCCCceEECCCCc-EEEEecCCcc
Q 012191 16 VLHRDIKGSNLLVNNEGV-LKLADFGLAN 43 (468)
Q Consensus 16 IvHrDIKp~NILld~~g~-vKL~DFGla~ 43 (468)
+||+|+.|.|||++.+.. +-++||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998874 8899999763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=85.69 E-value=0.69 Score=45.03 Aligned_cols=37 Identities=32% Similarity=0.425 Sum_probs=31.8
Q ss_pred HHHHHHHHh--CCCeeccCCCCceEECCCCcEEEEecCC
Q 012191 5 LHGLEHCHS--RGVLHRDIKGSNLLVNNEGVLKLADFGL 41 (468)
Q Consensus 5 L~gL~yLHs--~gIvHrDIKp~NILld~~g~vKL~DFGl 41 (468)
+.+|.-.|+ .+.+|+|..|+||+-|..|.+||.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 456777884 4799999999999999999999999664
|
The function of this family is unknown. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=85.22 E-value=1 Score=42.37 Aligned_cols=44 Identities=32% Similarity=0.271 Sum_probs=37.4
Q ss_pred HHHHHHHHHHHh---CCCeeccCCCCceEECCCCcEEEEecCCcccc
Q 012191 2 NQLLHGLEHCHS---RGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 45 (468)
Q Consensus 2 ~QLL~gL~yLHs---~gIvHrDIKp~NILld~~g~vKL~DFGla~~~ 45 (468)
.||+..+++|+. ..+.-.|++++|+-++.++.+|++|...+...
T Consensus 66 ~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 66 LQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 478888888887 45888999999999999999999999876433
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=83.25 E-value=0.91 Score=53.47 Aligned_cols=30 Identities=37% Similarity=0.568 Sum_probs=25.7
Q ss_pred CCCeeccCCCCceEECCCC--cEE-EEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEG--VLK-LADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g--~vK-L~DFGla~ 43 (468)
.++||+|+.+.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 555 99999875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.83 E-value=0.95 Score=46.23 Aligned_cols=32 Identities=22% Similarity=0.412 Sum_probs=28.5
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCccccC
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLANFSN 46 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~~~~ 46 (468)
.++|+|+++.||+|+..+.+=|+||+++..-.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 48999999999999999889999999986544
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=81.58 E-value=0.92 Score=46.22 Aligned_cols=28 Identities=25% Similarity=0.204 Sum_probs=23.5
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999995 3 57899999763
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=81.46 E-value=1.6 Score=44.66 Aligned_cols=28 Identities=36% Similarity=0.624 Sum_probs=24.7
Q ss_pred CeeccCCCCceEECC-CCcEEEEecCCcc
Q 012191 16 VLHRDIKGSNLLVNN-EGVLKLADFGLAN 43 (468)
Q Consensus 16 IvHrDIKp~NILld~-~g~vKL~DFGla~ 43 (468)
++|.||.+.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 4789999999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 468 | ||||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-38 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-37 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-37 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-37 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-37 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-37 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-37 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-37 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-35 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-35 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-35 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-34 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-34 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-34 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-34 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-34 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-34 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-34 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-34 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-34 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-34 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-34 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-34 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-34 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-34 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-34 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-34 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-34 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-34 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-34 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-34 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-34 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-34 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-34 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-34 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-34 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-34 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-34 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-34 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-34 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-34 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-34 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-34 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-34 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-34 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-34 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-34 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-33 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-33 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-33 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-32 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-32 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-32 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-31 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-31 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-31 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-30 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-30 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-30 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-30 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-30 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-30 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-30 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-30 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-29 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-29 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-29 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-29 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-29 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-29 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-29 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-29 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-29 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-29 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-29 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-29 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-29 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-29 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-29 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-29 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-29 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-29 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-29 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-29 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-29 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-29 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-29 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-29 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-29 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-29 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-29 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-29 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-29 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-29 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-29 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-29 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-29 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-29 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-29 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-29 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-29 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-29 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-29 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-29 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-29 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-29 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-29 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-29 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-29 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-29 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-29 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-29 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-29 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-29 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-29 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-29 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-29 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-29 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-29 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-29 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-29 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-29 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-29 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-29 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-29 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-29 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-29 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-29 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-29 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-29 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-29 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-29 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-29 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-29 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-29 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-29 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-29 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-29 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-29 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-29 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-29 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-29 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-29 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-29 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-29 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-29 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-29 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-29 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-29 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-29 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-29 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-29 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-29 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-29 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-29 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-29 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-29 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-28 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-28 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-28 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-28 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-28 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-28 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-28 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-28 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-28 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-28 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-28 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-28 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-26 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-26 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-26 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-26 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-26 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-26 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-26 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-25 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-25 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-25 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-25 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-25 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-25 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-25 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-25 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-24 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-24 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-24 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-24 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-24 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-24 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-24 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-24 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-24 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-24 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-24 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-24 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-24 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-24 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-24 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-24 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-24 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-24 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-24 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-24 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-24 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-24 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-24 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-24 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-23 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-23 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-21 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-21 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-20 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-20 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-20 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-20 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-20 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-20 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-20 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-20 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-20 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-20 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-19 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-19 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-19 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-19 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-19 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-19 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-19 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-19 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-04 |
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-113
Identities = 82/219 (37%), Positives = 116/219 (52%), Gaps = 8/219 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRV 57
M LL+GL + H +LHRD+K +N+L+ +GVLKLADFGLA + T+RV
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
VTLWYRPPELLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +LCGS
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249
Query: 118 DDYWKK-SKLPHATLFKPQQPYDSSLRETFKDL--PTTAVNLIETLLSVEPYKRATASAA 174
+ W + + +++ K A++LI+ LL ++P +R + A
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309
Query: 175 LASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 213
L ++F + P DL + + + RRK
Sbjct: 310 LNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAP--PRRKH 346
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-105
Identities = 87/229 (37%), Positives = 120/229 (52%), Gaps = 7/229 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M L GLE+ H +LHRD+K +NLL++ GVLKLADFGLA + +R T +VVT
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTR 176
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELL GA YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P ++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W LP FK L F ++LI+ L P R TA+ AL +Y
Sbjct: 237 WPDMCSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
Query: 180 FSTKPYACDLSSLPIYPPSKEIDAKHRE---DARRKKVGGRVRGAETRK 225
FS +P LP E + +RK+ +G +K
Sbjct: 295 FSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKK 343
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 2e-89
Identities = 79/217 (36%), Positives = 111/217 (51%), Gaps = 9/217 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
+ QLL GL +CH + VLHRD+K NLL+N G LKLADFGLA S + + VVT
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVT 163
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYRPP++LLG+TDY +D+W VGC+F E+ G+P+ G T EQLH IF++ G+P ++
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
W + + +L L + +L+ LL E R +A A+
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
Query: 179 YFSTKPYACDLSSLPIYP---PSKEIDAKHREDARRK 212
+F + LP KEI + R
Sbjct: 284 FFLSLGERIH--KLPDTTSIFALKEIQLQKEASLRSA 318
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 5e-89
Identities = 74/207 (35%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
QLL GL CH +LHRD+K NLL+N G LKL DFGLA F +S VVT
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSSEVVT 171
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR P++L+G+ Y S+D+WS GC+ AE++ GKP+ G + EQL IF + G+P +
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFKD-----LPTTAVNLIETLLSVEPYKRATASA 173
W +KLP Q+P LR+ + L ++ + LL + P R +A
Sbjct: 232 LWPSVTKLPKYNPNIQQRPP-RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290
Query: 174 ALASEYFSTKPYACDLSSLPIYPPSKE 200
AL +F+ + + +
Sbjct: 291 ALHHPWFAEYYHHASMGGSRSHHHHHH 317
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 3e-87
Identities = 74/186 (39%), Positives = 106/186 (56%), Gaps = 9/186 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
M Q L GL+ H+ ++HRD+K N+LV + G +KLADFGLA + ++ LT VVT
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVT 182
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR PE+LL +T Y VD+WSVGC+FAE+ KP+ G +E +QL KIF L G PP+D
Sbjct: 183 LWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
W + LP P + ++ ++ + L+ +L+ P+KR +A AL
Sbjct: 242 DWPRDVSLPRGAF--PPRGP-RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
Query: 179 YFSTKP 184
Y
Sbjct: 299 YLHKDE 304
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 1e-86
Identities = 79/207 (38%), Positives = 114/207 (55%), Gaps = 11/207 (5%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA + + LTS VVT
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 182
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P ++
Sbjct: 183 LWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
W + LP + + D+ +L+ L+ P KR +A +AL+
Sbjct: 242 DWPRDVALPRQAFHSKSA---QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 179 YFSTKPYACD--LSSLPIYPPSKEIDA 203
YF + S LP + E++
Sbjct: 299 YFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 1e-86
Identities = 74/186 (39%), Positives = 105/186 (56%), Gaps = 4/186 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
+ QLL G+ HCH +LHRD+K NLL+N++G LKLADFGLA F + T VVT
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVT 182
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR P++L+G+ Y SVD+WS+GC+FAE++ GKP+ G T+ +QL KIF + G+P
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
W + +LP Q ++L+ +L +P KR +A A+
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 179 YFSTKP 184
YF
Sbjct: 303 YFKDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 1e-86
Identities = 73/183 (39%), Positives = 109/183 (59%), Gaps = 5/183 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
+ QLL+G+ +CH R VLHRD+K NLL+N EG LK+ADFGLA F + T +VT
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVT 163
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
LWYR P++L+G+ Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 120 YWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
W ++LP K L + ++L+ +L ++P +R TA AL
Sbjct: 224 NWPNVTELPKYDPNFTVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 179 YFS 181
YF
Sbjct: 283 YFK 285
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 3e-86
Identities = 83/187 (44%), Positives = 111/187 (59%), Gaps = 6/187 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
+ QLL GL CHSR VLHRD+K NLL+N G LKLA+FGLA F + ++ VVT
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVT 164
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 118
LWYRPP++L GA Y S+D+WS GC+FAEL G+P+ G +QL +IF+L G+P +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 119 DYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ W +KLP + P P +SL L T +L++ LL P +R +A AL
Sbjct: 225 EQWPSMTKLPDYKPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
Query: 178 EYFSTKP 184
YFS
Sbjct: 284 PYFSDFC 290
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 7e-85
Identities = 69/203 (33%), Positives = 99/203 (48%), Gaps = 5/203 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
Q L + CH +HRD+K N+L+ V+KL DFG A + G V T
Sbjct: 108 TWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVAT 165
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
WYR PELL+G T YGP VD+W++GCVFAELL G P+ G+++V+QL+ I K G
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225
Query: 120 YWKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ + S + + K P L F ++ A+ L++ L ++P +R T L
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285
Query: 178 EYFSTKPYACDLSSLPIYPPSKE 200
YF DL+ P
Sbjct: 286 PYFENIREIEDLAKEHDKPAENL 308
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 5e-84
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQ--PLT 54
+ Q+L G+ + H+ VLHRD+K +N+LV G +K+AD G A N+ + L
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 55 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---------EQ 105
VVT WYR PELLLGA Y ++D+W++GC+FAELL +PI R E +Q
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 106 LHKIFKLCGSPPDDYWKK-SKLPHATLFKP---QQPYDSS-----LRETFKDLPTTAVNL 156
L +IF + G P D W+ K+P + + Y + + + + A +L
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 157 IETLLSVEPYKRATASAALASEYFSTKPYACDLSSLP---IYPPSKEIDAKHREDA---- 209
++ LL+++P KR T+ A+ YF P YP + + + +D
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKK 373
Query: 210 RRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
+++ G T + ++ P++
Sbjct: 374 NQQQQQGNNHTNGTGHPGNQDSSHTQGPPLK 404
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 5e-84
Identities = 65/212 (30%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
+ Q+++G+ CHS ++HRDIK N+LV+ GV+KL DFG A + G + V T
Sbjct: 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVAT 187
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
WYR PELL+G YG +VD+W++GC+ E+ +G+P+ G ++++QL+ I G+
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247
Query: 120 YWKK-SKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ + +K P + P+ L + L ++L + L ++P KR + L
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307
Query: 178 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDA 209
++F +A S+E+ K ++DA
Sbjct: 308 DFFQMDGFAER--------FSQELQLKVQKDA 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-83
Identities = 74/192 (38%), Positives = 110/192 (57%), Gaps = 9/192 (4%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-----NEGVLKLADFGLA-NFSNTGHRQPLT 54
+ QL++G+ CHSR LHRD+K NLL++ VLK+ DFGLA F + T
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI--PIRQFT 195
Query: 55 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 114
++TLWYRPPE+LLG+ Y SVD+WS+ C++AE+L+ P+ G +E++QL KIF++ G
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255
Query: 115 SPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 173
P D W + LP P+ + R L ++L+ +L ++P KR +A
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315
Query: 174 ALASEYFSTKPY 185
AL YFS +
Sbjct: 316 ALEHPYFSHNDF 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-68
Identities = 75/183 (40%), Positives = 101/183 (55%), Gaps = 5/183 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVT 59
M QL L + HS G+ HRDIK NLL++ + VLKL DFG A G +P S + +
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICS 219
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+YR PEL+ GATDY S+D+WS GCV AELL+G+PI G + V+QL +I K+ G+P +
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 120 YWKKSKLPHATLFK-PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
++ P+ T FK PQ + P A+ L LL P R T A A
Sbjct: 280 QIREMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338
Query: 179 YFS 181
+F
Sbjct: 339 FFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-66
Identities = 73/183 (39%), Positives = 102/183 (55%), Gaps = 5/183 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVT 59
M QLL L + HS G+ HRDIK NLL++ GVLKL DFG A G +P S + +
Sbjct: 147 MYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICS 204
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+YR PEL+ GAT+Y ++D+WS GCV AEL+ G+P+ G + ++QL +I K+ G+P +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASE 178
K+ P+ K Q + F P A++LI LL P R TA AL
Sbjct: 265 QI-KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 179 YFS 181
+F
Sbjct: 324 FFD 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-64
Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 3 QLLHGLE--HCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVT 59
QL+ + H S V HRDIK N+LVN G LKL DFG A + +P + + +
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYICS 194
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+YR PEL+ G Y +VD+WSVGC+FAE+++G+PI +G QLH+I ++ G P +
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254
Query: 120 YWKKSKLPHATLFKPQ---QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
+K H + P+ + + A +L+ LL P +R AL
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314
Query: 177 SEYFSTKPYACDLSSLPIYPP 197
YF + LP
Sbjct: 315 HPYFD--ELHDPATKLPNNKD 333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 5e-64
Identities = 71/184 (38%), Positives = 105/184 (57%), Gaps = 7/184 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVT 59
+ QL + HS G+ HRDIK NLLVN + LKL DFG A +P + + +
Sbjct: 147 IYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICS 204
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+YR PEL+LGAT+Y PS+DLWS+GCVF EL++GKP+ G T ++QL +I ++ G+P +
Sbjct: 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKE 264
Query: 120 YWKKSKLPHATLFK-PQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ PH T + P R+ + P+ A++L+E +L EP R A+A
Sbjct: 265 QMIRMN-PHYTEVRFPTLK-AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322
Query: 178 EYFS 181
+F
Sbjct: 323 PFFD 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 8e-61
Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 12/192 (6%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVT 59
M ++L L++CHS G++HRD+K N+++++E L+L D+GLA F + G Q RV +
Sbjct: 136 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVAS 193
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPP- 117
+++ PELL+ Y S+D+WS+GC+ A ++ K P G +QL +I K+ G+
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRAT 170
DY K + F S R E + A++ ++ LL + R T
Sbjct: 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
Query: 171 ASAALASEYFST 182
A A+ YF T
Sbjct: 314 AREAMEHPYFYT 325
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-59
Identities = 68/183 (37%), Positives = 101/183 (55%), Gaps = 4/183 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA--NFSNTGHRQPLTSRVVTL 60
Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA + H LT V T
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PE++L + Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 121 WKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
A + P+ + F + + A++L++ +L+ P+KR ALA
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 179 YFS 181
Y
Sbjct: 316 YLE 318
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-58
Identities = 68/184 (36%), Positives = 102/184 (55%), Gaps = 6/184 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLA--NFSNTGHRQPLTSRVVT 59
QLL GL++ HS VLHRD+K +NL +N E VLK+ DFGLA + H+ L+ +VT
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
WYR P LLL +Y ++D+W+ GC+FAE+L GK + G E+EQ+ I + ++
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247
Query: 120 YWKK--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
++ S +P +P L + + AV+ +E +L+ P R TA AL+
Sbjct: 248 DRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306
Query: 178 EYFS 181
Y S
Sbjct: 307 PYMS 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 8e-58
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 5/182 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+L GL H GV+HRD+ N+L+ + + + DF LA T V WY
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWY 199
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PEL++ + VD+WS GCV AE+ K + +G T QL+KI ++ G+P +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259
Query: 123 KSKLPHATLF-KPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
P A + + + A++LI +L P +R + AL Y
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319
Query: 180 FS 181
F
Sbjct: 320 FE 321
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-58
Identities = 68/181 (37%), Positives = 103/181 (56%), Gaps = 6/181 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL++ HS GV+HRD+K NL VN + LK+ DFGLA ++ +T VVT WY
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWY 189
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AE+L GK + +G+ ++QL +I K+ G P ++ +
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 123 KSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
K A + P + F A +L+E +L ++ KR TA+ AL +F
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
Query: 181 S 181
Sbjct: 310 E 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-57
Identities = 67/181 (37%), Positives = 105/181 (58%), Gaps = 6/181 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL + H+ G++HRD+K NL VN + LK+ DFGLA +++ +T VVT WY
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 191
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+PP ++ +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 123 KSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+ + A + P + AVNL+E +L ++ +R TA ALA YF
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 181 S 181
Sbjct: 312 E 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-57
Identities = 73/197 (37%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGLA + +T V T WY
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWY 195
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + K
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 123 KSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
K A + + F AV+L+E +L ++ KR TA+ ALA YF
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 181 STKPYACDLSSLPIYPP 197
+ Y D P+ P
Sbjct: 316 A--QYH-DPDDEPVADP 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-57
Identities = 66/191 (34%), Positives = 97/191 (50%), Gaps = 12/191 (6%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA---------NFSNTGHRQPL 53
Q L ++ H V+HRD+K SNLL+N+ LK+ DFGLA N TG + +
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 113
V T WYR PE++L + Y ++D+WS GC+ AEL + +PI GR QL IF +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239
Query: 114 GSPPDDYWKKS-KLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
G+P D + + P A + P L + F + ++L++ +L +P KR T
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299
Query: 171 ASAALASEYFS 181
A AL Y
Sbjct: 300 AKEALEHPYLQ 310
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-54
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 38/217 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------------- 42
QL+ +++ HS G+LHRD+K SN+L+N E +K+ADFGL+
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 43 NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE 102
+ + LT V T WYR PE+LLG+T Y +D+WS+GC+ E+L GKPI G +
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 103 VEQLHKIFKLCGSPPDDYW----------------KKSKLPHATLFKPQQPYDSSLRETF 146
+ QL +I + P ++ +K ++ + + + L +
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 147 KDLPTT--AVNLIETLLSVEPYKRATASAALASEYFS 181
A++L++ LL P KR +A+ AL + S
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-53
Identities = 70/265 (26%), Positives = 108/265 (40%), Gaps = 70/265 (26%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------------- 42
LL G+++ HS G+LHRD+K +N LVN + +K+ DFGLA
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 43 ------NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL----- 91
++ LT VVT WYR PEL+L +Y ++D+WS+GC+FAELL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 92 ------IGKPILQG--------------------RTEVEQLHKIFKLCGSPPDDYWKKSK 125
P+ G R +QL+ IF + G+P ++ + +
Sbjct: 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343
Query: 126 LPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183
A + P L E F A++L++ +L P KR T + LA +F
Sbjct: 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK-- 401
Query: 184 PYACDLSSLPIYPPSKEIDAKHRED 208
+ E +A +
Sbjct: 402 ---------EVRIAEVETNATEKVR 417
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-52
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 192
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++LG Y +VD+WSVGC+ E++ G + G ++Q +K+ + G+P ++ K
Sbjct: 193 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 123 K---------SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIETLLSVEP 165
K P ++ + E K + A +L+ +L ++
Sbjct: 252 KLQPTVRTYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 166 YKRATASAALASEYFSTKPYACDLSSLPIYPPSKEID 202
KR + AL Y + + D S PP
Sbjct: 308 SKRISVDEALQHPYIN--VWY-DPSEAEAPPPKIPDK 341
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-51
Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT +Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 229
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++ K
Sbjct: 230 RAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288
Query: 123 K---------SKLPHATLFKPQQPYDS--------SLRETFKDLPTTAVNLIETLLSVEP 165
K P + + E K + A +L+ +L ++P
Sbjct: 289 KLQPTVRNYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 166 YKRATASAALASEYFSTKPYACDLSSLPIYPPSK 199
KR + AL Y + + D + + PP
Sbjct: 345 AKRISVDDALQHPYIN--VWY-DPAEVEAPPPQI 375
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-50
Identities = 69/257 (26%), Positives = 106/257 (41%), Gaps = 62/257 (24%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------------- 42
LL G H G++HRD+K +N L+N + +K+ DFGLA
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 43 -NFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-------- 93
N ++ LTS VVT WYR PEL+L +Y S+D+WS GC+FAELL
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 94 ---KPILQG-----------------RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 133
P+ G ++ +QL+ IF + G+P +D K P +
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316
Query: 134 PQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACDLSS 191
P+ +L++ + + +NL+E++L P KR T AL Y
Sbjct: 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK---------- 366
Query: 192 LPIYPPSKEIDAKHRED 208
+ E + +
Sbjct: 367 -DVRKKKLENFSTKKII 382
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 40/196 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNT 47
Q+L L + HS+G++HRD+K N+ ++ +K+ DFGLA + +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 48 GHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 107
G LTS + T Y E+L G Y +D++S+G +F E++ P G V L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 108 KIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYK 167
K+ + P D+ + +I L+ +P K
Sbjct: 240 KLRSVSIEFPPDFD-------------------------DNKMKVEKKIIRLLIDHDPNK 274
Query: 168 RATASAALASEYFSTK 183
R A L S + K
Sbjct: 275 RPGARTLLNSGWLPVK 290
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 32/182 (17%), Positives = 53/182 (29%), Gaps = 27/182 (14%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
QL+ + S+G++H NL + +G L L D T + V +
Sbjct: 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPV 255
Query: 61 WYRPPELLLG-ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-D 118
Y P E L + +++ W +G + C P
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRV---------------------WCLFLPFG 294
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
K DS + LP LI L+ + +R A+ +
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
Query: 179 YF 180
F
Sbjct: 355 EF 356
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQPLTSRVVTL 60
+L L+ H ++H D+K N+L+ +G +K+ DFG + + + Q + + + +
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QRVYTYIQSR 263
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
+YR PE++LGA YG +D+WS+GC+ AELL G P+L G E +QL + +L G P
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322
Query: 121 WKKSK----------LPHATLFKPQQ------PYDSSLRETFKDLPTTA----------- 153
SK P S R + P +
Sbjct: 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382
Query: 154 ---VNLIETLLSVEPYKRATASAALASEYFSTKP 184
++ ++ L +P R T AL + +
Sbjct: 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 43/191 (22%), Positives = 70/191 (36%), Gaps = 21/191 (10%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSR 56
+ ++ G+ H G++HR+IK N++ + + V KL DFG A + S
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSL 175
Query: 57 VVTLWYRPPELLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQGRTEVEQ 105
T Y P++ A YG +VDLWS+G F G R E
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 106 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 165
++KI S +K++ + P SL + L ++ +L +
Sbjct: 236 MYKIITGKPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQ 291
Query: 166 YKRATASAALA 176
K A
Sbjct: 292 EKCWGFDQFFA 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 42/196 (21%), Positives = 73/196 (37%), Gaps = 40/196 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVT 59
+L + H G++H D+K +N L+ + G+LKL DFG+AN S+V T
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 60 LWYRPPELLLGA----------TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHK 108
+ Y PPE + + P D+WS+GC+ + GK Q + +LH
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251
Query: 109 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
I + ++ ++++ L +P +R
Sbjct: 252 IID--PNHEIEFP-------------------------DIPEKDLQDVLKCCLKRDPKQR 284
Query: 169 ATASAALASEYFSTKP 184
+ LA Y +
Sbjct: 285 ISIPELLAHPYVQIQT 300
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 46/247 (18%), Positives = 86/247 (34%), Gaps = 40/247 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVT 59
+L + H G++H D+K +N L+ + G+LKL DFG+AN S+V T
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 60 LWYRPPELLLG----------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHK 108
+ Y PPE + + P D+WS+GC+ + GK Q + +LH
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232
Query: 109 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
I + ++ ++++ L +P +R
Sbjct: 233 IID--PNHEIEFPDI-------------------------PEKDLQDVLKCCLKRDPKQR 265
Query: 169 ATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTR 228
+ LA Y + + + + K + + + + +
Sbjct: 266 ISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 325
Query: 229 KSHGMSK 235
+SH S
Sbjct: 326 ESHNSSS 332
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA + T
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTP 205
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE+L + VD+WS+GC+ LL+GKP + E +I K +Y
Sbjct: 206 NYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY 258
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+P K + A +LI+ +L +P R T + L E+F
Sbjct: 259 ----SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295
Query: 181 ST--KPYACDLSSLPIYPPSKEIDAKHREDARRKKVG 215
++ P ++ L I PP I + + RK +
Sbjct: 296 TSGYIPARLPITCLTI-PPRFSIAPSSLDPSNRKPLT 331
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 46/247 (18%), Positives = 83/247 (33%), Gaps = 40/247 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVT 59
+L + H G++H D+K +N L+ + G+LKL DFG+AN S+V
Sbjct: 161 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 60 LWYRPPELLLGATD----------YGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHK 108
+ Y PPE + + P D+WS+GC+ + GK Q + +LH
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 109 IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
I P ++++ L +P +R
Sbjct: 280 IIDPNHEIE--------FP-------------------DIPEKDLQDVLKCCLKRDPKQR 312
Query: 169 ATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTR 228
+ LA Y + + + + K + + + + +
Sbjct: 313 ISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 372
Query: 229 KSHGMSK 235
+SH S
Sbjct: 373 ESHNSSS 379
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 48/218 (22%), Positives = 81/218 (37%), Gaps = 43/218 (19%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------LKLADFGLAN 43
Q+ + HS + H D+K N L V ++ +K+ DFG A
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 44 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 103
+ + + ++ V T YR PE++L + D+WS+GC+ E +G +
Sbjct: 186 YDD----EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 104 EQLHKIFKLCGSPPDDYWKKSKLPHATLF---KPQQPYDSSLRETF----KDLPT----- 151
E L + ++ G P +K++ F + SS K L
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRK--YFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 152 -----TAVNLIETLLSVEPYKRATASAALASEYFSTKP 184
+LI+ +L +P KR T AL +F
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 41/217 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------LKLADFGLAN 43
QL H L H + H D+K N L VN+E +++ADFG A
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 44 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 103
F + + T+ V T YRPPE++L + D+WS+GC+ E G + Q
Sbjct: 191 FDH----EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245
Query: 104 EQLHKIFKLCGSPPDDYWKKSKLPH----------------ATLFKPQQPYDSSLRETFK 147
E L + K+ G P +++ + + +P S + +
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 148 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184
+ +L+ +L +P +R T + AL +F+
Sbjct: 306 EHVQL-FDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 42/191 (21%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------NFSNTGH 49
Q+ +E HS+G++HRD+K SN+ + V+K+ DFGL +
Sbjct: 170 FIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 50 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
T +V T Y PE + G +Y VD++S+G + ELL T++E++ I
Sbjct: 230 YATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFS-----TQMERVRII 283
Query: 110 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 169
+ + K P F +++ +LS P +R
Sbjct: 284 TDV---------RNLKFP----------------LLFTQKYPQEHMMVQDMLSPSPTERP 318
Query: 170 TASAALASEYF 180
A+ + + F
Sbjct: 319 EATDIIENAIF 329
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 44/218 (20%)
Query: 3 QLLHGLEHCHSR--GVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHRQPLTSRVV 58
Q+ L + ++H D+K N+L+ N +K+ DFG + Q + +
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQ 220
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
+ +YR PE+LLG Y ++D+WS+GC+ E+ G+P+ G EV+Q++KI ++ G PP
Sbjct: 221 SRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279
Query: 119 DYWKKS---------------------------------KLPHATLFKPQQPYDSSLRET 145
++ KL + + P E+
Sbjct: 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES 339
Query: 146 FKDLPTTA--VNLIETLLSVEPYKRATASAALASEYFS 181
+ +LI +L +P R AL +F
Sbjct: 340 GHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 32/203 (15%), Positives = 62/203 (30%), Gaps = 49/203 (24%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q++ L H G++H ++ +++++ G + L F V+ +
Sbjct: 214 QVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVSRGF 268
Query: 63 RPPELL----------LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 112
PPEL T S D W++G V + + + IF+
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS 328
Query: 113 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
C K++P L+E L R
Sbjct: 329 C---------------------------------KNIPQPVRALLEGFLRYPKEDRLLPL 355
Query: 173 AALASEYFSTKPYACDLSSLPIY 195
A+ + + + ++LP+Y
Sbjct: 356 QAMETPEY-EQLRTELSAALPLY 377
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 43/191 (22%), Positives = 70/191 (36%), Gaps = 21/191 (10%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSR 56
+ ++ G+ H G++HR+IK N++ + + V KL DFG A + S
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSL 175
Query: 57 VVTLWYRPPELLLGATD-------YGPSVDLWSVGCVFAELLIGKP----ILQGRTEVEQ 105
T Y P++ A YG +VDLWS+G F G R E
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 106 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 165
++KI S +K++ + P SL + L ++ +L +
Sbjct: 236 MYKIITGKPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQ 291
Query: 166 YKRATASAALA 176
K A
Sbjct: 292 EKCWGFDQFFA 302
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 35/200 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNT-GHRQPLTSRVVT 59
+ Q++ G ++ H V+HRD+K NL +N + +K+ DFGLA G R T
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGT 178
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
Y PE+L + VD+WS+GC+ LL+GKP + E +I K +
Sbjct: 179 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------E 231
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
Y +P K + A +LI+ +L +P R T + L E+
Sbjct: 232 Y----SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 180 FST--KPYACDLSSLPIYPP 197
F++ P ++ L I P
Sbjct: 269 FTSGYIPARLPITCLTIPPR 288
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 44/220 (20%), Positives = 82/220 (37%), Gaps = 47/220 (21%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSN-LLVNNEGV------------------------LKLA 37
++L L + + H D+K N LL + +KL
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 38 DFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL 97
DFG A F + S + T YR PE++L + S D+WS GCV AEL G +
Sbjct: 205 DFGCATFKS----DYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLF 259
Query: 98 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF------KPQQPYDSSLRETFKDLPT 151
+ +E L + + P + ++ + + + K P ++S + K +
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319
Query: 152 TA-----------VNLIETLLSVEPYKRATASAALASEYF 180
+ + ++L ++P R + + L ++
Sbjct: 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 47/184 (25%), Positives = 75/184 (40%), Gaps = 38/184 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
Q+ G+++ HS+ +++RD+K SN+ + + +K+ DFGL + N G R T T
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGT 184
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
L Y PE + DYG VDL+++G + AELL T E L
Sbjct: 185 LRYMSPEQISS-QDYGKEVDLYALGLILAELLHV-----CDTAFETSKFFTDL------- 231
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
+ + +D + L++ LLS +P R S L +
Sbjct: 232 --RDGIIS--------DIFDKKEK-----------TLLQKLLSKKPEDRPNTSEILRTLT 270
Query: 180 FSTK 183
K
Sbjct: 271 VWKK 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 55/180 (30%), Positives = 81/180 (45%), Gaps = 31/180 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M+Q++ G+ + HS G+LHRD+ SNLL+ +K+ADFGLA H + T T
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTP 176
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE+ + +G D+WS+GC+F LLIG+P T L+K+ DY
Sbjct: 177 NYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY 229
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
++P L A +LI LL P R + S+ L +
Sbjct: 230 ----EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 33/239 (13%)
Query: 3 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNE------GVLKLADFGLANFSNTGHRQPLTS 55
QLL GL++ H R G++H DIK N+L+ +K+AD G A + + + T+
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EHYTN 194
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKI 109
+ T YR PE+LLGA +G D+WS C+ EL+ G + + + + + +I
Sbjct: 195 SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 110 FKLCGSPP----------DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA---VNL 156
+L G P ++ L P + L E +K A +
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 157 IETLLSVEPYKRATASAALASEYFSTKPYACDLS--SLPIYPPSKEIDAKHREDARRKK 213
+ +L ++P KRA A + + ++ +Y +I E K+
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVRDHKR 372
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 39/190 (20%), Positives = 68/190 (35%), Gaps = 36/190 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHR--QPL 53
+ Q GL H HS ++HRD+K N+L++ ++DFGL G
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 54 TSRVVTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIF 110
+ T + PE+L +VD++S GCVF ++ G + + +
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243
Query: 111 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
+ + A LIE +++++P KR +
Sbjct: 244 ACSLDCLHPEKHEDVI--------------------------ARELIEKMIAMDPQKRPS 277
Query: 171 ASAALASEYF 180
A L +F
Sbjct: 278 AKHVLKHPFF 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 51/247 (20%), Positives = 90/247 (36%), Gaps = 33/247 (13%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
Q+ L+H H R +LHRDIK N+ + +G ++L DFG+A N+ + + T
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGTP 189
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
+Y PE+ Y D+W++GCV EL K + + + KI GS P
Sbjct: 190 YYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFP--- 243
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+ Y LR +L+ L P R + ++ L +
Sbjct: 244 ----PVS--------LHYSYDLR-----------SLVSQLFKRNPRDRPSVNSILEKGFI 280
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLAPVE 240
+ + L + +K K R + + + ++K A
Sbjct: 281 AKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAK---RPASGQNSISVMPAQKITKPAAKY 337
Query: 241 DVAVRTQ 247
+ + +
Sbjct: 338 GIPLAYK 344
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 41/208 (19%), Positives = 80/208 (38%), Gaps = 22/208 (10%)
Query: 3 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
+L+ + H+ + + HRD+K SN+L++ G +KL+DFG + + + T
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK---IKGSRGTYE 215
Query: 62 YRPPELLLGATDY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH-KIFKLCGSPPDD 119
+ PPE + Y G VD+WS+G + + + +L I +
Sbjct: 216 FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT------KN 269
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
+ P + + L ++ ++ L P +R T+ AL E+
Sbjct: 270 I----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 180 FSTKPYACDLSSLPIYPPSKEIDAKHRE 207
+ + SKE+ K ++
Sbjct: 326 LADTNIE------DLREFSKELYKKRKK 347
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 40/185 (21%), Positives = 65/185 (35%), Gaps = 11/185 (5%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRV 57
++ + L + H ++HRD+K N+++ + K+ D G A + G + T V
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFV 184
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
TL Y PELL Y +VD WS G + E + G + Q H +
Sbjct: 185 GTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR--EKSN 241
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ L A F P + L ++ +L +R T
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK---LERWLQCMLMWHQRQRGTDPQNPNV 298
Query: 178 EYFST 182
F
Sbjct: 299 GCFQA 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 44/192 (22%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-----------NFSNTGH 49
Q+ +E HS+G++HRD+K SN+ + V+K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 50 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
T +V T Y PE + G Y VD++S+G + ELL P T++E++ +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PF---STQMERVRTL 237
Query: 110 FKLC-GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
+ P + +K +++ +LS P +R
Sbjct: 238 TDVRNLKFPPLFTQKYP--------------------------CEYVMVQDMLSPSPMER 271
Query: 169 ATASAALASEYF 180
A + + F
Sbjct: 272 PEAINIIENAVF 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 46/183 (25%), Positives = 73/183 (39%), Gaps = 35/183 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANF---SNTGHRQPLTS 55
M Q+ L + H++G+ HRDIK N L N +KL DFGL+ N G +T+
Sbjct: 174 MRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 56 RVVTLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCG 114
+ T ++ PE+L + YGP D WS G + LL+G G + + + ++
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN--K 291
Query: 115 SP--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
+ + L A +L+ LL+ +R A
Sbjct: 292 KLCFENPNY-------------------------NVLSPLARDLLSNLLNRNVDERFDAM 326
Query: 173 AAL 175
AL
Sbjct: 327 RAL 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 48/185 (25%), Positives = 74/185 (40%), Gaps = 35/185 (18%)
Query: 1 MNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 55
M QL L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N +
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKT 175
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
V T +Y PE + Y D+WS+GC+ EL P ++ E KI + G
Sbjct: 176 FVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GK 232
Query: 116 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
++P Y L +I +L+++ Y R + L
Sbjct: 233 FR-------RIP--------YRYSDELN-----------EIITRMLNLKDYHRPSVEEIL 266
Query: 176 ASEYF 180
+
Sbjct: 267 ENPLI 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 37/183 (20%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
L L H HS+G++H D+K +N+ + G KL DFGL G + +
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE---VQEGDPR 221
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
Y PELL G YG + D++S+G E+ + E ++ + G P ++
Sbjct: 222 YMAPELLQG--SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQ--GYLPPEFT 274
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 181
S LR +++ +L +P RATA A LA
Sbjct: 275 AG--------------LSSELR-----------SVLVMMLEPDPKLRATAEALLALPVL- 308
Query: 182 TKP 184
+P
Sbjct: 309 RQP 311
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 53/180 (29%), Positives = 81/180 (45%), Gaps = 33/180 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ +L + L +CHS+ V+HRDIK NLL+ + G LK+ADFG + + + R L TL
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TL 171
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PPE++ G + VDLWS+G + E L+GKP + T E +I ++ ++
Sbjct: 172 DYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF 224
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
P + A +LI LL P +R L +
Sbjct: 225 ----TFP-------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 52/206 (25%), Positives = 81/206 (39%), Gaps = 47/206 (22%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-------------LKLADFGLANFSNT 47
+ Q+ G+ H HS ++HRD+K N+LV+ + ++DFGL ++
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 48 GH---RQPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELL-IGKPIL 97
G R L + T +R PELL + + S+D++S+GCVF +L GK
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 98 QGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157
+ E I + L + +D SL D LI
Sbjct: 241 GDKYSRES--NIIR----------GIFSLDE-----MKCLHDRSLIAEATD-------LI 276
Query: 158 ETLLSVEPYKRATASAALASEYFSTK 183
++ +P KR TA L F K
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLFWPK 302
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 32/199 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRV 57
M Q+L G+ + H ++HRDIK N+L+ N +K+ DFGL++F + L R+
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRL 209
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T +Y PE+L Y D+WS G + LL G P G+ + + + K+ K
Sbjct: 210 GTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ WK + A LI+ +L+ + KR TA AL S
Sbjct: 268 FNDWKN-------------------------ISDEAKELIKLMLTYDYNKRCTAEEALNS 302
Query: 178 EYFSTKPYACDLSSLPIYP 196
+ + S
Sbjct: 303 RWIKKYANNINKSDQKTLC 321
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 24/182 (13%), Positives = 50/182 (27%), Gaps = 37/182 (20%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q++ L H G++H ++ +++++ G + L F P+
Sbjct: 219 QVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPET 278
Query: 63 RPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
+L T + D W++G + + IF+ C
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC----- 333
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
K++P L+E L R A+ +
Sbjct: 334 ----------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365
Query: 179 YF 180
+
Sbjct: 366 EY 367
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 32/197 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L G+ + H ++HRD+K NLL+ + + +++ DFGL+ + + ++
Sbjct: 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKI 189
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T +Y PE+L G Y D+WS G + LL G P G E + L K+ K +
Sbjct: 190 GTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
WKK + +A +LI +L+ P R +A AL
Sbjct: 248 LPQWKK-------------------------VSESAKDLIRKMLTYVPSMRISARDALDH 282
Query: 178 EYFSTKPYACDLSSLPI 194
E+ T +P
Sbjct: 283 EWIQTYTKEQISVDVPS 299
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 51/183 (27%), Positives = 77/183 (42%), Gaps = 36/183 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M LL + H ++HRD+K N+L++++ +KL DFG + + G + L T
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTP 187
Query: 61 WYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
Y PE++ + + YG VD+WS G + LL G P R ++ L I + G+
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGN 245
Query: 116 P--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 173
W +T KD L+ L V+P KR TA
Sbjct: 246 YQFGSPEWD------------------DYSDTVKD-------LVSRFLVVQPQKRYTAEE 280
Query: 174 ALA 176
ALA
Sbjct: 281 ALA 283
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 41/200 (20%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+L L +CH R V+HRDIK NLL+ +G LK+ADFG + + + R+ + TL Y
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDY 178
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PPE++ G + VDLW G + E L+G P + E +I + D
Sbjct: 179 LPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL-- 229
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF-- 180
K P L + +LI LL P +R + +
Sbjct: 230 --KFP-------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268
Query: 181 STKPYACDLSSLPIYPPSKE 200
+++ LP S +
Sbjct: 269 NSRRV------LPPVYQSTQ 282
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L G+ + H ++HRD+K NLL+ + + ++K+ DFGL+ + + R+
Sbjct: 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERL 199
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T +Y PE+L Y D+WS+G + LL G P G+T+ E L K+ K +
Sbjct: 200 GTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
WK + A +LI+ +L + +R +A AL
Sbjct: 258 SPEWKN-------------------------VSEGAKDLIKQMLQFDSQRRISAQQAL 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 32/178 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+ G+ + H ++HRD+K N+L+ + + +K+ DFGL+ + R+
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI 184
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T +Y PE+L G Y D+WS G + LL G P G+ E + L ++ +
Sbjct: 185 GTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
W+ + A +LI +L+ P R TA+ L
Sbjct: 243 LPQWRT-------------------------ISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 37/182 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L + +CHS G++HR++K NLL+ ++ +KLADFGLA N +
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFA 168
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP- 116
T Y PE+L Y VD+W+ G + LL+G P + +I G+
Sbjct: 169 GTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYD 225
Query: 117 -PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
P W + A +LI+++L+V P KR TA A
Sbjct: 226 YPSPEWDTVTP--------------------------EAKSLIDSMLTVNPKKRITADQA 259
Query: 175 LA 176
L
Sbjct: 260 LK 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 50/176 (28%), Positives = 70/176 (39%), Gaps = 33/176 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTLW 61
QL LEH HSR V+HRDIK +N+ + GV+KL D GL FS+ S V T +
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPY 201
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQL-HKIFKLCGSPPDD 119
Y PE + Y D+WS+GC+ E+ + G + L KI + P
Sbjct: 202 YMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPP- 257
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
P Y LR L+ ++ +P KR +
Sbjct: 258 -------------LPSDHYSEELR-----------QLVNMCINPDPEKRPDVTYVY 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 58/198 (29%), Positives = 83/198 (41%), Gaps = 38/198 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
M +L + +CH V HRD+K N L + LKL DFGLA G + + ++V
Sbjct: 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKV 169
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP- 116
T +Y P++L G YGP D WS G + LL G P T+ E + KI G+
Sbjct: 170 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFT 225
Query: 117 -PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
P+ W S A +LI LL+ P +R T+ A
Sbjct: 226 FPEKDWLNVSP--------------------------QAESLIRRLLTKSPKQRITSLQA 259
Query: 175 LASEYFSTKPYACDLSSL 192
L E+F + + + L
Sbjct: 260 LEHEWFEKQLSSSPRNLL 277
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 48/184 (26%), Positives = 71/184 (38%), Gaps = 38/184 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
M + ++ HS + HRD+K NLL ++ VLKL DFG A + L +
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPC 190
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGS 115
T +Y PE +LG Y S D+WS+G + LL G P T + + G
Sbjct: 191 YTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249
Query: 116 P--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
P+ W + S+ A LI LL +P +R T +
Sbjct: 250 YGFPNPEWSEVSE--------------------------DAKQLIRLLLKTDPTERLTIT 283
Query: 173 AALA 176
+
Sbjct: 284 QFMN 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 38/182 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+ G+ + H ++HRD+K N+L+ ++ +K+ DFGL+ + R+
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI 184
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP- 116
T +Y PE+L G Y D+WS G + LL G P G+ E + L ++ G
Sbjct: 185 GTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYA 240
Query: 117 -PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
W+ S A +LI +L+ P R TA+
Sbjct: 241 FDLPQWRTISD--------------------------DAKDLIRKMLTFHPSLRITATQC 274
Query: 175 LA 176
L
Sbjct: 275 LE 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 33/179 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRV 57
M Q+++ L + HS+ V+H+D+K N+L + +K+ DFGLA + + T+
Sbjct: 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAA 187
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T Y PE+ D D+WS G V LL G G + E K
Sbjct: 188 GTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-------- 237
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
+ + + L AV+L++ +L+ +P +R +A+ L
Sbjct: 238 ----TYKEP--------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 38/182 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L +++ H G++HRD+K NLL + + DFGL+ G +++
Sbjct: 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTAC 168
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP- 116
T Y PE+L Y +VD WS+G + LL G P TE + KI + G
Sbjct: 169 GTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYE 225
Query: 117 -PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
+W S+ +A + I LL +P +R T A
Sbjct: 226 FESPFWDDISE--------------------------SAKDFICHLLEKDPNERYTCEKA 259
Query: 175 LA 176
L+
Sbjct: 260 LS 261
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 52/183 (28%), Positives = 74/183 (40%), Gaps = 36/183 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M LL + H+ ++HRD+K N+L+++ ++L+DFG + G + L T
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTP 263
Query: 61 WYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
Y PE+L + D YG VDLW+ G + LL G P R ++ L I + G
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQ 321
Query: 116 P--PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 173
W T KD LI LL V+P R TA
Sbjct: 322 YQFSSPEW------------------DDRSSTVKD-------LISRLLQVDPEARLTAEQ 356
Query: 174 ALA 176
AL
Sbjct: 357 ALQ 359
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 43/175 (24%), Positives = 65/175 (37%), Gaps = 32/175 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL-KLADFG----LANFSNTGHRQPLTSRV 57
Q L GLE+ H+R +LH D+K N+L++++G L DFG L
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T + PE+++G VD+WS C+ +L G T+ + K+ PP
Sbjct: 218 GTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEPP 273
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
P + S I+ L EP RA+A
Sbjct: 274 ----------------PIREIPPSCAPLTAQ-------AIQEGLRKEPVHRASAM 305
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 55/250 (22%), Positives = 93/250 (37%), Gaps = 46/250 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
M + +++ HS + HRD+K NLL ++ +LKL DFG A + + LT+
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPC 224
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGS 115
T +Y PE +LG Y S D+WS+G + LL G P + + G
Sbjct: 225 YTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
Query: 116 P--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
P+ W + S+ LI LL EP +R T +
Sbjct: 284 YEFPNPEWSEVSE--------------------------EVKMLIRNLLKTEPTQRMTIT 317
Query: 173 AALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHG 232
+ + P++ + K R + ++++ + T R +
Sbjct: 318 EFMNHPWIMQSTKV---PQTPLHTSRVLKEDKERWEDVKEEMTSALA------TMRVDYE 368
Query: 233 MSKLAPVEDV 242
K+ +ED
Sbjct: 369 QIKIKKIEDA 378
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 37/182 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L + +CHS G++HR++K NLL+ ++ +KLADFGLA N +
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFA 191
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP- 116
T Y PE+L Y VD+W+ G + LL+G P + +I G+
Sbjct: 192 GTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYD 248
Query: 117 -PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
P W + A +LI+++L+V P KR TA A
Sbjct: 249 YPSPEWDTVTP--------------------------EAKSLIDSMLTVNPKKRITADQA 282
Query: 175 LA 176
L
Sbjct: 283 LK 284
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 35/182 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
Q+L +++ H G++HRD+K N+L++++ ++K+ DFG + + +
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC 302
Query: 58 VTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCG 114
T Y PE+L+ Y +VD WS+G + L G P + RT+V +I
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 115 SPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASA 173
+ + W + S+ A++L++ LL V+P R T
Sbjct: 363 NFIPEVWAEVSE--------------------------KALDLVKKLLVVDPKARFTTEE 396
Query: 174 AL 175
AL
Sbjct: 397 AL 398
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 33/199 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
Q+L +++ H G++HRD+K N+L++++ ++K+ DFG + + +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC 177
Query: 58 VTLWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCG 114
T Y PE+L+ Y +VD WS+G + L G P + RT+V +I
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 115 SPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
+ + W ++ A++L++ LL V+P R T A
Sbjct: 238 NFIPEVW-------------------------AEVSEKALDLVKKLLVVDPKARFTTEEA 272
Query: 175 LASEYFSTKPYACDLSSLP 193
L + + L
Sbjct: 273 LRHPWLQDEDMKRKFQDLL 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 47/198 (23%), Positives = 74/198 (37%), Gaps = 42/198 (21%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
Q++ ++HCHSRGV+HRDIK N+L++ G KL DFG H +P T T
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRV 203
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDY 120
Y PPE + + +WS+G + L+ + +CG P +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGIL-------------------LYDM--VCGDIPFERD 242
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
++ A L P + LI L+ +P R + L +
Sbjct: 243 ---QEILEAELHFPAH------------VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287
Query: 181 STKPYACDLSSLPIYPPS 198
P + P+
Sbjct: 288 -QTPAEDVPLNPSKGGPA 304
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 55/187 (29%), Positives = 75/187 (40%), Gaps = 39/187 (20%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
M +L+ + H H GV+HRD+K NLL +E +K+ DFG A QPL +
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPC 170
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFK--L 112
TL Y PE LL Y S DLWS+G + +L G+ Q +I K
Sbjct: 171 FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229
Query: 113 CGSP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRA 169
G + WK S+ A +LI+ LL+V+P KR
Sbjct: 230 KGDFSFEGEAWKNVSQ--------------------------EAKDLIQGLLTVDPNKRL 263
Query: 170 TASAALA 176
S
Sbjct: 264 KMSGLRY 270
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 32/196 (16%), Positives = 65/196 (33%), Gaps = 55/196 (28%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVL-------------------KLADFGLAN 43
Q+ GL + HS ++H DIK SN+ ++ + K+ D G
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV- 181
Query: 44 FSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEV 103
+ E+L + P D++++ +P+ +
Sbjct: 182 ----TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NG 234
Query: 104 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSV 163
+Q H+I + G P +P L + F + L++ ++
Sbjct: 235 DQWHEIRQ--GRLPR-------IP------------QVLSQEFTE-------LLKVMIHP 266
Query: 164 EPYKRATASAALASEY 179
+P +R +A A +
Sbjct: 267 DPERRPSAMALVKHSV 282
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 41/170 (24%), Positives = 68/170 (40%), Gaps = 30/170 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
L+ G+E+ H + ++HRDIK SNLLV +G +K+ADFG++N L++ V T +
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAF 203
Query: 63 RPPELLLGAT-DY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
PE L + G ++D+W++G + G+ + KI
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS------QAL 257
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
+ P D+ +LI +L P R
Sbjct: 258 ----EFPD-----------------QPDIAEDLKDLITRMLDKNPESRIV 286
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 34/181 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHRQPLTSR 56
+ Q+L G+ + HS+ + H D+K N+++ ++ V +KL DFG+A+ G +
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNI 171
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
T + PE++ G D+WS+G + LL G G T+ E L I +
Sbjct: 172 FGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 117 PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
++Y+ S+L A + I LL +P +R T + +L
Sbjct: 231 DEEYFSNTSEL--------------------------AKDFIRRLLVKDPKRRMTIAQSL 264
Query: 176 A 176
Sbjct: 265 E 265
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 53/179 (29%), Positives = 76/179 (42%), Gaps = 43/179 (24%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
Q+L GL++ H ++HRDIKG N+L+N GVLK++DFG + G + TL
Sbjct: 130 QILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQ 188
Query: 62 YRPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE++ YG + D+WS+GC E+ GKP P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--------------------P---- 224
Query: 121 WKKSKLPHATLFK-------PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
+ + P A +FK P+ P S K I +P KRA A+
Sbjct: 225 FYELGEPQAAMFKVGMFKVHPEIPESMS--AEAKA-------FILKCFEPDPDKRACAN 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 38/182 (20%), Positives = 71/182 (39%), Gaps = 36/182 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--------QP 52
+ + GLE H++G HRD+K +N+L+ +EG L D G N + Q
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 53 LTSRVVTLWYRPPELLLGA--TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF 110
++ T+ YR PEL D+WS+GCV ++ G+ + +
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL- 258
Query: 111 KLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
+ + +P + S+L L+ ++++V+P++R
Sbjct: 259 AVQN--------QLSIP------QSPRHSSALW-----------QLLNSMMTVDPHQRPH 293
Query: 171 AS 172
Sbjct: 294 IP 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 34/180 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSR 56
+ Q+L+G+ + HS + H D+K N+++ + +K+ DFGLA+ + G +
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNI 177
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
T + PE++ G D+WS+G + LL G G T+ E L + +
Sbjct: 178 FGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 117 PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
D+Y+ S L A + I LL +P KR T +L
Sbjct: 237 EDEYFSNTSAL--------------------------AKDFIRRLLVKDPKKRMTIQDSL 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 34/180 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSR 56
+ Q+L G+ + H++ + H D+K N+++ +KL DFGLA+ G +
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNI 178
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
T + PE++ G D+WS+G + LL G G T+ E L I +
Sbjct: 179 FGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 117 PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
++++ S+L A + I LL E KR T AL
Sbjct: 238 DEEFFSHTSEL--------------------------AKDFIRKLLVKETRKRLTIQEAL 271
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 45/248 (18%), Positives = 80/248 (32%), Gaps = 43/248 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVV 58
++Q+ L+ HS + H DI+ N++ +K+ +FG A G
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFT 165
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
Y PE+ + D+WS+G + LL G T + + I + +
Sbjct: 166 APEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
+ + K++ A++ ++ LL E R TAS AL
Sbjct: 225 EAF-------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 179 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVR-------GAETRKTTRKSH 231
+ K + + + + KK V G R S
Sbjct: 260 WLKQKIERVSTKVI------RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSV 313
Query: 232 GMSKLAPV 239
K+A +
Sbjct: 314 AKVKVASI 321
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 54/182 (29%), Positives = 78/182 (42%), Gaps = 36/182 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L + HCH GV+HR++K NLL+ ++ +KLADFGLA G +Q
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFA 174
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP- 116
T Y PE+L YG VDLW+ G + LL+G P + +I G+
Sbjct: 175 GTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYD 231
Query: 117 -PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
P W + A +LI +L++ P KR TA+ A
Sbjct: 232 FPSPEWDTVTP--------------------------EAKDLINKMLTINPSKRITAAEA 265
Query: 175 LA 176
L
Sbjct: 266 LK 267
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 58/249 (23%), Positives = 90/249 (36%), Gaps = 53/249 (21%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSR 56
+ + +E+ H++GV+HRD+K SN+L N +++ DFG A L +
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTP 180
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHKIFKLC 113
T + PE+L Y + D+WS+G + +L G T E L +I
Sbjct: 181 CYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
Query: 114 GSPPDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
S YW S TA +L+ +L V+P++R TA+
Sbjct: 240 FSLSGGYWNSVSD--------------------------TAKDLVSKMLHVDPHQRLTAA 273
Query: 173 AALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH- 231
L P+ LP Y +R+DA G +
Sbjct: 274 LVLRH------PWIVHWDQLPQYQL-------NRQDAPHLVKGAMAATYSALNRNQSPVL 320
Query: 232 ---GMSKLA 237
G S LA
Sbjct: 321 EPVGRSTLA 329
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 32/207 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLW 61
QL+ GLE+ HS+G++H+DIK NLL+ G LK++ G+A + + +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 62 YRPPELLLGATDY-GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
++PPE+ G + G VD+WS G + G +G + I K Y
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------GSY 230
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+P D +L++ +L EP KR + +F
Sbjct: 231 ----AIP-------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHRE 207
K + + +PI P D
Sbjct: 268 -RKKHPPAEAPVPIPPSPDTKDRWRSM 293
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 44/179 (24%), Positives = 68/179 (37%), Gaps = 32/179 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVV 58
M Q GL+H H ++H DIK N++ +K+ DFGLA N + +
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTA 212
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T + PE++ G D+W++G + LL G G ++E L + + +
Sbjct: 213 TAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 271
Query: 119 DYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
D + S A + I+ LL EP KR T AL
Sbjct: 272 DAFSSVSPE--------------------------AKDFIKNLLQKEPRKRLTVHDALE 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 49/203 (24%), Positives = 77/203 (37%), Gaps = 45/203 (22%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG T T
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRV 213
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDY 120
Y PPE + +G S +WS+G + ++ +CG P +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDM---------------------VCGDIPFEH- 251
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
++ +F Q+ + + +LI L++ P R T +
Sbjct: 252 --DEEIIRGQVFFRQR------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297
Query: 181 ---STKPYACDLSSLPIYP-PSK 199
++ + P PSK
Sbjct: 298 QDVLLPQETAEIHLHSLSPGPSK 320
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 34/180 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSR 56
+ Q+L G+ + H++ + H D+K N+++ +KL DFGLA+ G +
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNI 178
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
T + PE++ G D+WS+G + LL G G T+ E L I +
Sbjct: 179 FGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 117 PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
++++ + S+L A + I LL E KR T AL
Sbjct: 238 DEEFFSQTSEL--------------------------AKDFIRKLLVKETRKRLTIQEAL 271
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 32/205 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q++ +++CH + ++HRD+K NLL++ + +K+ADFG +N G L + Y
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPY 179
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PEL G GP VD+WS+G + L+ G G+ E ++ + G ++
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY- 236
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182
+ T NL++ L + P KR T + +
Sbjct: 237 --------------------------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI-N 269
Query: 183 KPYACDLSSLPIYPPSKEIDAKHRE 207
+ D + P D K +
Sbjct: 270 AGHEEDELKPFVEPELDISDQKRID 294
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 47/216 (21%), Positives = 70/216 (32%), Gaps = 37/216 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVV 58
M Q+ GL H H +H D+K N++ LKL DFGL + Q +
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTG 318
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T + PE+ G G D+WSVG + LL G G + E L + + D
Sbjct: 319 TAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 377
Query: 119 DYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ S+ + I LL +P R T AL
Sbjct: 378 SAFSGISED--------------------------GKDFIRKLLLADPNTRMTIHQALEH 411
Query: 178 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 213
+ + + K R+ + K
Sbjct: 412 PWLTP-----GNAPGRDSQIPSSRYTKIRDSIKTKY 442
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 40/180 (22%), Positives = 72/180 (40%), Gaps = 33/180 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L G+ + H ++H D+K N+L+++ G +K+ DFG++ L +
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIM 194
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T Y PE+L + D+W++G + LL G E I ++
Sbjct: 195 GTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253
Query: 118 DDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
++ + S+L A + I++LL P KR TA L+
Sbjct: 254 EETFSSVSQL--------------------------ATDFIQSLLVKNPEKRPTAEICLS 287
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 38/202 (18%), Positives = 75/202 (37%), Gaps = 40/202 (19%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
QL+ + + + ++HRDIK N+++ + +KL DFG A + G + T+ Y
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEY 195
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP-DDYW 121
PE+L+G GP +++WS+G L + P +
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTL---------------------VFEENPFCELE 234
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 181
+ + A + P + ++L+ LL P +R T + +
Sbjct: 235 ETVE---AAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV- 278
Query: 182 TKPYACDLSSLPIYPPSKEIDA 203
T+P + + ++
Sbjct: 279 TQPVNLADYTWEEVFRVNKPES 300
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 41/201 (20%), Positives = 69/201 (34%), Gaps = 47/201 (23%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHR------Q 51
+ + L+ H++G+ HRD+K N+L + +K+ DF L +
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 52 PLTSRVVTLWYRPPELLLG----ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLH 107
L + + Y PE++ A+ Y DLWS+G + IL
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-------IL---------- 219
Query: 108 KIFKLCGSPP----DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT--------TAVN 155
L G PP A ++S + + P A +
Sbjct: 220 ----LSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHISCAAKD 274
Query: 156 LIETLLSVEPYKRATASAALA 176
LI LL + +R +A+ L
Sbjct: 275 LISKLLVRDAKQRLSAAQVLQ 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 49/194 (25%), Positives = 71/194 (36%), Gaps = 32/194 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVV 58
M Q+ G+ H H +LH D+K N+L N +K+ DFGLA + L
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFG 250
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T + PE++ D+WSVG + LL G G + E L+ I D
Sbjct: 251 TPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 119 DYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ ++ S+ A I LL E R +AS AL
Sbjct: 310 EEFQDISEE--------------------------AKEFISKLLIKEKSWRISASEALKH 343
Query: 178 EYFSTKPYACDLSS 191
+ S LS+
Sbjct: 344 PWLSDHKLHSRLSA 357
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 29/170 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLW 61
QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA +R+ L +++ TL
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PELL + VD+WS G V +L G+ P Q ++ +
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------- 223
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
+ +K + + + L+ +L P R T
Sbjct: 224 --------KKTYLNP----------WKKIDSAPLALLHKILVENPSARIT 255
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 47/202 (23%), Positives = 74/202 (36%), Gaps = 30/202 (14%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLW 61
QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA +R + L TL
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PELL + VD+WS G V +L G+ P Q ++ +
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------- 223
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+ +K + + + L+ +L P R T ++
Sbjct: 224 --------KKTYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265
Query: 181 STKPYACDLSSLPIYPPSKEID 202
KP +
Sbjct: 266 -NKPLKKGAKRPRVTSGGVSES 286
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 49/184 (26%), Positives = 72/184 (39%), Gaps = 40/184 (21%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L + + H G++HRD+K NLL LK+ADFGL+ + +
Sbjct: 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVC 211
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGS 115
T Y PE+L G YGP VD+WSVG + LL G +F+ L
Sbjct: 212 GTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRRILNCE 267
Query: 116 P--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
+W + S A +L+ L+ ++P KR T
Sbjct: 268 YYFISPWWDEVSL--------------------------NAKDLVRKLIVLDPKKRLTTF 301
Query: 173 AALA 176
AL
Sbjct: 302 QALQ 305
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 51/252 (20%), Positives = 83/252 (32%), Gaps = 39/252 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFG-LANFSNTGHRQ-----PLTSR 56
+L L++ H G +HR +K S++L++ +G + L+ + + G RQ
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 57 VVTLWYRPPELLL-GATDYGPSVDLWSVGCVFAELLIGKP-------------ILQGRT- 101
V L + PE+L Y D++SVG EL G L G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255
Query: 102 ----------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151
E + + S D S + P PY + F
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH--- 312
Query: 152 TAVNLIETLLSVEPYKRATASAALASEYF-STKPYACDLSSLPIYPPSKEIDAKHREDAR 210
+E L P R +AS L +F K A + + P + + + +
Sbjct: 313 ----FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQD 368
Query: 211 RKKVGGRVRGAE 222
+ G V E
Sbjct: 369 HSGIFGLVTNLE 380
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 33/173 (19%), Positives = 62/173 (35%), Gaps = 34/173 (19%)
Query: 3 QLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVT 59
Q+L GL+ H+R ++HRD+K N+ + G +K+ D GLA + + + T
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGT 193
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ PE + Y SVD+++ G E+ + Q+++
Sbjct: 194 PEFMAPE--MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------- 241
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
T +D K+ +IE + +R +
Sbjct: 242 ---------VTSGVKPASFDKVAIPEVKE-------IIEGCIRQNKDERYSIK 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 46/187 (24%)
Query: 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS--- 55
Q ++H H + ++HRD+K NLL++N+G +KL DFG A + ++
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 56 --------RVVTLWYRPPEL--LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ 105
R T YR PE+ L G D+W++GC+ L + + ++
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261
Query: 106 LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEP 165
++ + + PP D + +LI +L V P
Sbjct: 262 VNGKYSI---PPHD-----------------TQYTVFH-----------SLIRAMLQVNP 290
Query: 166 YKRATAS 172
+R + +
Sbjct: 291 EERLSIA 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 31/167 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLW 61
+++ LE+ H +G++HRD+K N+L+N + +++ DFG A + +Q + V T
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
Y PELL S DLW++GC+ +L+ G P + E KI K
Sbjct: 198 YVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK---------- 246
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
+ P + A +L+E LL ++ KR
Sbjct: 247 LEYDFP-------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 30/196 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTSR---VV 58
++L GLE+ H G +HRD+K N+L+ +G +++ADFG++ F + G R V
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T + PE++ Y D+WS G EL G ++ L + PP
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPP- 245
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLR--ETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
+L Q + + ++F+ +I L +P KR TA+ L
Sbjct: 246 -----------SLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAELLR 287
Query: 177 SEYFSTKPYACDLSSL 192
++F A + L
Sbjct: 288 HKFFQK---AKNKEFL 300
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 43/184 (23%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLA-NFSNTGHRQPLTSR 56
M Q+L L +CH ++HRD+K +L+ N +KL FG+A +G R
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGR 193
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCG 114
V T + PE++ YG VD+W G + LL G G E ++F+ + G
Sbjct: 194 VGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKG 247
Query: 115 SP--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 171
W S+ +A +L+ +L ++P +R T
Sbjct: 248 KYKMNPRQWSHISE--------------------------SAKDLVRRMLMLDPAERITV 281
Query: 172 SAAL 175
AL
Sbjct: 282 YEAL 285
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 40/183 (21%), Positives = 60/183 (32%), Gaps = 58/183 (31%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRV 57
M + +++ HS + HRD+K NLL ++ +LKL DFG A
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------- 167
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCGS 115
E Y S D+WS+G + LL G P + + G
Sbjct: 168 -------KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
Query: 116 P--PDDYWKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
P+ W + S+ LI LL EP +R T +
Sbjct: 219 YEFPNPEWSEVSE--------------------------EVKMLIRNLLKTEPTQRMTIT 252
Query: 173 AAL 175
+
Sbjct: 253 EFM 255
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 46/168 (27%), Positives = 71/168 (42%), Gaps = 31/168 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L +++CH V+HRD+K N+L++ K+ADFGL+N + G L + + Y
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNY 176
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ G GP VD+WS G + LL G KI +
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------GVF-- 228
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
+P + L + L+ +L V+P KRAT
Sbjct: 229 --YIP-------------------EYLNRSVATLLMHMLQVDPLKRAT 255
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 49/212 (23%), Positives = 74/212 (34%), Gaps = 36/212 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
QLL G+ +CHS + HRD+K N L+ + LK+ DFG + S + S V T
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTP 181
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK--LCG--SP 116
Y PE+LL G D+WS G +L+G + E K + L S
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241
Query: 117 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
PDD + +LI + +P R +
Sbjct: 242 PDDIR---------------------------ISPECCHLISRIFVADPATRISIPEIKT 274
Query: 177 SEYFSTKPYACDLSSLPIYPPSKEIDAKHRED 208
+F K DL + + + +
Sbjct: 275 HSWF-LKNLPADLMNESNTGSQFQEPEQPMQS 305
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 31/168 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q++ +E+CH ++HRD+K NLL+++ +K+ADFGL+N G+ L + + Y
Sbjct: 116 QIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNY 173
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ G GP VD+WS G V +L+G+ K+ Y
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY-- 225
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
+P L A +LI ++ +P +R T
Sbjct: 226 --VMP-------------------DFLSPGAQSLIRRMIVADPMQRIT 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVT 59
+ L LE HS V+HRDIK N+L+ +G +KL DFG A + ++ ++ V T
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGT 179
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
++ PE++ YGP VD+WS+G + E++ G+P L ++ + +
Sbjct: 180 PYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIATNGT-- 233
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
P L P++ L F+D + L ++ KR +A L ++
Sbjct: 234 -------P--ELQNPEK-----LSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQF 272
Query: 180 FSTKPYACDLSSL 192
A LSSL
Sbjct: 273 LKI---AKPLSSL 282
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 51/254 (20%), Positives = 90/254 (35%), Gaps = 84/254 (33%)
Query: 3 QLLHGLEHCHSR-GVLHRDIKGSNLLVNNE------------------------------ 31
Q+L GL++ H++ ++H DIK N+L++
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 32 -------------------GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 72
+K+AD G A + + + + +R YR E+L+G+
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEVLIGS- 268
Query: 73 DYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSK- 125
Y D+WS C+ EL G + + + + + + I +L G P K
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328
Query: 126 ----------LPHATLFKPQ-------QPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
L H T KP + Y+ S E + + +L + P KR
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT-----DFLLPMLELIPEKR 383
Query: 169 ATASAALASEYFST 182
ATA+ L + ++
Sbjct: 384 ATAAECLRHPWLNS 397
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 8e-20
Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 32/200 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L G+++CH V+HRD+K N+L++ K+ADFGL+N + G L + + Y
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNY 181
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ G GP VD+WS G + LL G KI +
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD------GIF-- 233
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182
P + L + ++L++ +L V+P KRAT E+F
Sbjct: 234 --YTP-------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF-K 271
Query: 183 KPYACDLSSLPIYPPSKEID 202
+ L S ID
Sbjct: 272 QDLPKYLFPEDPSYSSTMID 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
L GLE+ H +HRDIK N+L+N EG KLADFG+A T + + T ++
Sbjct: 133 STLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFW 191
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ Y D+WS+G E+ GKP ++ + IF + +PP
Sbjct: 192 MAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTNPP----- 242
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182
P T KP+ + F D ++ L P +RATA+ L + +
Sbjct: 243 ----P--TFRKPEL-----WSDNFTD-------FVKQCLVKSPEQRATATQLLQHPFVRS 284
Query: 183 KPYACDLSSL-PIYPPSKEIDAKHREDARRKK 213
A +S L + + ++ K +E +R++
Sbjct: 285 ---AKGVSILRDLINEAMDVKLKRQESQQREE 313
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q++ GLEH H R +++RD+K N+L++++G ++++D GLA G + T +
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGF 355
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PELLLG +Y SVD +++G E++ + + R E + ++ +
Sbjct: 356 MAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----------- 403
Query: 123 KSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKR 168
L + T+ + + E LL +P KR
Sbjct: 404 ------RVLEQA---------VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 32/166 (19%), Positives = 59/166 (35%), Gaps = 21/166 (12%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----------EGVLKLADFGLANFSNT-G 48
++L+ +E H ++H DIK N ++ N L L D G +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 49 HRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPI-LQGRTEVEQLH 107
T++ T ++ E+L + +D + V +L G + ++ +
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
Query: 108 KIFKLCGSPPDDYWKKSKLPHATLFKPQ---QPYDSSLRETFKDLP 150
+F+ P D W + H L P P LR+ K +
Sbjct: 297 GLFR--RLPHLDMWN--EFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 33/191 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 61
+L L + H++GV+HRDIK ++L+ +G +KL+DFG A S ++ S V T +
Sbjct: 149 AVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPY 206
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
+ PE++ + Y VD+WS+G + E++ G+P + + +L SPP
Sbjct: 207 WMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPY---FSDSPVQAMKRLRDSPP---- 258
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 181
P L + + +D +E +L +P +RATA L +
Sbjct: 259 -----P--KLKNSHK-----VSPVLRDF-------LERMLVRDPQERATAQELLDHPFLL 299
Query: 182 TKPYACDLSSL 192
L
Sbjct: 300 Q---TGLPECL 307
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 37/166 (22%), Positives = 72/166 (43%), Gaps = 28/166 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
++ GLE H +++RD+K N+L+++ G ++++D GLA + Q + RV T+ Y
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGY 351
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ Y S D W++GC+ E++ G+ Q R + + ++
Sbjct: 352 MAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------ 398
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
+ + + A +L LL +P +R
Sbjct: 399 RLVKEVPEEYSER-------------FSPQARSLCSQLLCKDPAER 431
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 31/177 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L L HS+ ++HRD+K N+L+ EG ++LADFG++ N Q S + T ++
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYW 183
Query: 63 RPPELLLGAT----DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
PE+++ T Y D+WS+G E+ +P E+ + + K+ S P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDP- 239
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
P TL P S F+D ++ L P R +A+ L
Sbjct: 240 --------P--TLLTP-----SKWSVEFRD-------FLKIALDKNPETRPSAAQLL 274
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 42/172 (24%), Positives = 63/172 (36%), Gaps = 31/172 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ ++ H G +HRDIK N+L++ G ++LADFG V T Y
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 63 RPPELLLG------ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
PE+L YGP D W++G E+ G+ + E KI
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH----- 284
Query: 117 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
K L P + +P A + I+ LL P R
Sbjct: 285 -----YKEHLSL-----PLVD---------EGVPEEARDFIQRLLC-PPETR 316
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 36/177 (20%)
Query: 3 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 60
++ L + GV+HRD+K SN+L++ G +KL DFG+ + +
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCA 188
Query: 61 WYRPPE----LLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGS 115
Y PE DY D+WS+G EL G+ P +T+ E L K+ +
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EE 246
Query: 116 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
PP LP F F+ ++ L+ + KR +
Sbjct: 247 PP-------LLPGHMGFSGD----------FQS-------FVKDCLTKDHRKRPKYN 279
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 37/171 (21%), Positives = 65/171 (38%), Gaps = 36/171 (21%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+L+ L++ ++ ++HRD+K N+L++ G + + DF +A + +T+ T Y
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--AMLPRETQITTMAGTKPY 180
Query: 63 RPPELLL--GATDYGPSVDLWSVGCVFAELLIGKP---ILQGRTEVEQLHKIFKLCGSPP 117
PE+ Y +VD WS+G ELL G+ I + E +H
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------ 234
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
P V+L++ LL P +R
Sbjct: 235 ----TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQR 262
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 40/166 (24%), Positives = 72/166 (43%), Gaps = 29/166 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ GLEH H+R V++RD+K +N+L++ G ++++D GLA + + V T Y
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGY 356
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE+L Y S D +S+GC+ +LL G + ++ H+I +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR----------- 404
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
+ P +L+E LL + +R
Sbjct: 405 --MTLTMAVELPDS------------FSPELRSLLEGLLQRDVNRR 436
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 31/166 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+L L+H HS G+++RD+K N+L++ EG +KL DFGL+ + H + S T+ Y
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEY 192
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ + S D WS G + E+L G QG+ E + I K
Sbjct: 193 MAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----------A 241
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
K +P + L A +L+ L P R
Sbjct: 242 KLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 38/216 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ L GL + HS ++HRD+K N+L++ G++KL DFG A P S V T
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTP 214
Query: 61 WYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
++ PE++L + Y VD+WS+G EL KP L + + ++ + +
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNES- 270
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
P L E F++ +++ L P R T+ L
Sbjct: 271 --------P--ALQSGH------WSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHR 307
Query: 179 YFSTKPYACDLSSL-PIYPPSKEIDAKHREDARRKK 213
+ + + + +K+ + RK
Sbjct: 308 FVLR---ERPPTVIMDLIQRTKDAVRELDNLQYRKM 340
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 49/169 (28%), Positives = 67/169 (39%), Gaps = 29/169 (17%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ L+ HS G +HRD+K N+L++ G LKLADFG N + V T Y
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 63 RPPELLL---GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
PE+L G YG D WSVG E+L+G + V KI
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN-------- 287
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
K+ L P D+ A NLI L+ + R
Sbjct: 288 --HKNSLTF-----PDDN----------DISKEAKNLICAFLT-DREVR 318
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
++ L H H +G+++RD+K N+++N++G +KL DFGL + + T+ Y
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEY 187
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE+L+ + + +VD WS+G + ++L G P G + + KI K
Sbjct: 188 MAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK----------C 236
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
K LP L A +L++ LL R
Sbjct: 237 KLNLP-------------------PYLTQEARDLLKKLLKRNAASR 263
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 61
++L GL++ HS +HRDIK +N+L++ G +KLADFG+ ++T ++ + V T +
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPF 184
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
+ PE++ + Y D+WS+G EL G+P +E+ + +F + + P
Sbjct: 185 WMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLIPKNNP---- 236
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 181
P TL + + + K+ +E L+ EP R TA L ++
Sbjct: 237 -----P--TL-------EGNYSKPLKE-------FVEACLNKEPSFRPTAKELLKHKFI- 274
Query: 182 TKPYACDLSSL-PIYPPSKEIDAKHRED 208
A S L + K A+ D
Sbjct: 275 -LRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV- 58
+ Q+ L+ H+ G HRD+K N+LV+ + L DFG+A+ ++ Q V
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ--LGNTVG 197
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
TL+Y PE + D++++ CV E L G P
Sbjct: 198 TLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSP 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 4/111 (3%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ ++ H +HRDIK N+L++ G ++LADFG + V T Y
Sbjct: 183 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 63 RPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
PE+L YGP D WS+G E+L G+ + VE KI
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 25/102 (24%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 59
+ ++L L + HS G+++ D+K N+++ E + KL D G R + T
Sbjct: 188 LLEILPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAV------SRINSFGYLYGT 240
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT 101
++ PE++ + D+++VG A L + P GR
Sbjct: 241 PGFQAPEIVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV- 58
+ L H G++HRD+K +N++++ +K+ DFG+A +++G+ T+ V+
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
T Y PE G + D++S+GCV E+L G+P
Sbjct: 182 TAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 41/176 (23%), Positives = 71/176 (40%), Gaps = 33/176 (18%)
Query: 3 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 60
+ L H ++HRDIK SN+L++ G +KL DFG+ ++ + T
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCR 189
Query: 61 WYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP 116
Y PE + + Y D+WS+G EL G+ P + + +QL ++ K G P
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP 247
Query: 117 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
P +L + ++ + S F + + L+ + KR
Sbjct: 248 P-------QLSN----SEEREFSPS----FIN-------FVNLCLTKDESKRPKYK 281
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 49/175 (28%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHRQPL 53
+++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL T G
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG----- 167
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 113
T Y PE+L DYG +VD W +G V E++ G+ + I
Sbjct: 168 -----TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-- 219
Query: 114 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
++ + P + L A +L+ LL +P +R
Sbjct: 220 --------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVV- 58
NQ+L G++H H ++HRDIK N+L+++ LK+ DFG+A S T Q T+ V+
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLG 174
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKP 95
T+ Y PE G D++S+G V E+L+G+P
Sbjct: 175 TVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 49/175 (28%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHRQPL 53
++ L + HS +++RD+K N+L++++G + L DFGL + ++T G
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCG----- 201
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 113
T Y PE+L Y +VD W +G V E+L G P R E I
Sbjct: 202 -----TPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-- 253
Query: 114 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
K +L ++ +A +L+E LL + KR
Sbjct: 254 --------KPLQLK-------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 40/175 (22%), Positives = 69/175 (39%), Gaps = 49/175 (28%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHRQPL 53
+++ L H +G+++RD+K N+L+++EG KLADFG+ + T G
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG----- 186
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 113
T Y PE+L YGP+VD W++G + E+L G + E + I
Sbjct: 187 -----TPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-- 238
Query: 114 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
+ P L A ++++ ++ P R
Sbjct: 239 --------DEVVYP-------------------TWLHEDATGILKSFMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 49/175 (28%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHRQPL 53
++ GL S+G+++RD+K N+++++EG +K+ADFG+ + T G
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG----- 183
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 113
T Y PE++ YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 184 -----TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-- 235
Query: 114 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
P K + AV + + L++ P KR
Sbjct: 236 --------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 263
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 36/131 (27%), Positives = 57/131 (43%), Gaps = 14/131 (10%)
Query: 3 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTL 60
++ LEH HS V+HRD+K SN+L+N G +K+ DFG+ + +
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 61 WYRPPELLLGATD---YGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP 116
Y PE + + Y D+WS+G EL I + P T +QL ++ +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPS 231
Query: 117 P---DDYWKKS 124
P D +
Sbjct: 232 PQLPADKFSAE 242
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 28/168 (16%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ LEH H G+++RDIK N+L+++ G + L DFGL+ + T+ Y
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 63 RPPELLLGATD-YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIF-KLCGSPPDDY 120
P+++ G + +VD WS+G + ELL G E +I ++ S P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--- 283
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
P +++ A +LI+ LL +P KR
Sbjct: 284 ----PYP-------------------QEMSALAKDLIQRLLMKDPKKR 308
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 31/166 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
+++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ N + T Y
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDY 184
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE+LLG Y SVD WS G + E+LIG+ G+ E E H I
Sbjct: 185 IAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----------D 233
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
P + L A +L+ L EP KR
Sbjct: 234 NPFYP-------------------RWLEKEAKDLLVKLFVREPEKR 260
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 9/155 (5%)
Query: 3 QLLHGLEHCHSRG-VLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVTL 60
++ GL + + ++HRD+K SN+LVN+ G +KL DFG++ ++ S V T
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTR 194
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE L G T Y D+WS+G E+ +G+ + E +
Sbjct: 195 SYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155
+ + P L + DS +L VN
Sbjct: 254 PPRPRTPGRPL--NKFGMDSRPPMAIFELLDYIVN 286
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 31/166 (18%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
++ GL S+G+++RD+K N+++++EG +K+ADFG+ N + T Y
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDY 508
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
PE++ YG SVD W+ G + E+L G+ +G E E I +
Sbjct: 509 IAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----------H 557
Query: 123 KSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
P K + AV + + L++ P KR
Sbjct: 558 NVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGL-ANFSNTGHRQPLTSRVVTLW 61
++L GL H H V+HRDIKG N+L+ +KL DFG+ A T R+ + + T +
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 194
Query: 62 YRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKP 95
+ PE++ + Y DLWS+G E+ G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 32/167 (19%)
Query: 3 QLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61
+++ L++ HS + V++RD+K NL+++ +G +K+ DFGL + + T
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE 314
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYW 121
Y PE+L DYG +VD W +G V E++ G+ + + I
Sbjct: 315 YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------- 363
Query: 122 KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
++ + P + L A +L+ LL +P +R
Sbjct: 364 EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 41/186 (22%), Positives = 77/186 (41%), Gaps = 62/186 (33%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHRQPL 53
++ L + H RG+++RD+K N+L+++EG +KL D+G+ + ++T G
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG----- 172
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 113
T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 173 -----TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS------------------ 208
Query: 114 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLPTTAVNLIETLLS 162
P + P ++ F + L A +++++ L+
Sbjct: 209 -------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN 255
Query: 163 VEPYKR 168
+P +R
Sbjct: 256 KDPKER 261
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 23/91 (25%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-SNTGHRQPLTSRVVTLWYRPP 65
G+++ H++ ++HRD+K +N+ ++ + +K+ DFGLA S ++ + P
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 66 ELLLGATD--YGPSVDLWSVGCVFAELLIGK 94
E++ Y D+++ G V EL+ G+
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 42/170 (24%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW- 61
++ LE+ HS+ +++RD+K N+L++ G +K+ DFG A + TL
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VTYTLCG 165
Query: 62 ---YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
Y PE++ Y S+D WS G + E+L G ++ KI
Sbjct: 166 TPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN------- 217
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
+ + P +L+ L++ + +R
Sbjct: 218 ---AELRFP-------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 42/170 (24%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-- 60
Q++ E+ HS +++RD+K NLL++ +G +++ DFG A + + R TL
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA--------KRVKGRTWTLCG 200
Query: 61 --WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
PE++L Y +VD W++G + E+ G P ++ KI
Sbjct: 201 TPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------- 252
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
K + P + +L+ LL V+ KR
Sbjct: 253 ---GKVRFP-------------------SHFSSDLKDLLRNLLQVDLTKR 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 41/186 (22%), Positives = 77/186 (41%), Gaps = 62/186 (33%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNT--GHRQPL 53
++ L + H RG+++RD+K N+L+++EG +KL D+G+ + ++T G
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG----- 215
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC 113
T Y PE+L G DYG SVD W++G + E++ G+
Sbjct: 216 -----TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS------------------ 251
Query: 114 GSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-----------KDLPTTAVNLIETLLS 162
P + P ++ F + L A +++++ L+
Sbjct: 252 -------------PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN 298
Query: 163 VEPYKR 168
+P +R
Sbjct: 299 KDPKER 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 6 HGLEHCHSR---GVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLW 61
G+ + HS ++HRD+K NLL+ G VLK+ DFG A T +T+ +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAA 168
Query: 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
+ PE+ G ++Y D++S G + E++ +
Sbjct: 169 WMAPEVFEG-SNYSEKCDVFSWGIILWEVITRR 200
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 30/101 (29%), Positives = 44/101 (43%), Gaps = 16/101 (15%)
Query: 7 GLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTS 55
GL H H+ + HRD+K N+LV G +AD GLA + + P +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 56 RVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELL 91
RV T Y PPE+L + D++S G + E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 35/115 (30%), Positives = 47/115 (40%), Gaps = 15/115 (13%)
Query: 7 GLEHCHSR----------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR 56
GL + H + HRDIK N+L+ N +ADFGLA G T
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 57 VV-TLWYRPPELLLGA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQL 106
V T Y PE+L GA D +D++++G V EL G + L
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 31/101 (30%), Positives = 40/101 (39%), Gaps = 16/101 (15%)
Query: 7 GLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLA---NFSNTGHRQPLTS 55
GL H H + HRD+K N+LV G +AD GLA + S
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 56 RVVTLWYRPPELLLGATDYGPS-----VDLWSVGCVFAELL 91
RV T Y PE+L VD+W+ G V E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 29/101 (28%), Positives = 43/101 (42%), Gaps = 16/101 (15%)
Query: 7 GLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTS 55
GL H H + HRD+K N+LV G +AD GLA ++
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 56 RVVTLWYRPPELLLGAT-----DYGPSVDLWSVGCVFAELL 91
RV T Y PE+L + + D++++G VF E+
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 7 GLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRP 64
G+ + H+R ++HR++K NLLV+ + +K+ DFGL+ + S T +
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMA 207
Query: 65 PELLLGATDYGPSVDLWSVGCVFAELLIGK 94
PE+L D++S G + EL +
Sbjct: 208 PEVLRD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 22/100 (22%), Positives = 46/100 (46%), Gaps = 13/100 (13%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA----NFSNTGHRQPLTSRVVTLWY 62
G+ + H++G+LH+D+K N+ +N G + + DFGL L + L +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 63 RPPELLLGATD--------YGPSVDLWSVGCVFAELLIGK 94
PE++ + + D++++G ++ EL +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 20/97 (20%), Positives = 43/97 (44%), Gaps = 12/97 (12%)
Query: 6 HGLEHCHSRG--VLHRDIKGSNLLVNNEG-----VLKLADFGLANFSNTGHRQPLTSRVV 58
G+E+ ++ ++HRD++ N+ + + K+ADFGL+ S ++ +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLG 188
Query: 59 TLWYRPPELLLGATD-YGPSVDLWSVGCVFAELLIGK 94
+ PE + + Y D +S + +L G+
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 22/110 (20%)
Query: 7 GLEHCHS---------RGVLHRDIKGSNLLVNNEGVLKLADFGLA-------NFSNTGHR 50
GL + H+ + HRD+ N+LV N+G ++DFGL+
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 51 QPLTSRVVTLWYRPPELLLGATD------YGPSVDLWSVGCVFAELLIGK 94
S V T+ Y PE+L GA + VD++++G ++ E+ +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 19/117 (16%), Positives = 29/117 (24%), Gaps = 29/117 (24%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M L + H GV S + V+ +G + LA
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
P P D+ +G LL+ + L L + P
Sbjct: 175 -TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-------------NFSNTGHRQPL 53
G+ + HS ++HRD+ N LV + +ADFGLA R+
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
+ V ++ PE++ G Y VD++S G V E++
Sbjct: 180 YTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEII 216
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 15/99 (15%)
Query: 7 GLEHCHSRG---VLHRDIKGSNLLVNNEG--------VLKLADFGLANFSNTGHRQPLTS 55
G+ + H ++HRD+K SN+L+ + +LK+ DFGLA HR S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMS 173
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK 94
+ PE++ + + D+WS G + ELL G+
Sbjct: 174 AAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 11/87 (12%), Positives = 30/87 (34%), Gaps = 8/87 (9%)
Query: 10 HCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 69
H + + +++++ + +++ + + R+ + PE L
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQ 181
Query: 70 G--ATDYGPSVDLWSVGCVFAELLIGK 94
S D+WS + EL+ +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPP 65
G+ H +HRDIK +N+L++ K++DFGLA S + +TSR+V T Y P
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204
Query: 66 ELLLG-ATDYGPSVDLWSVGCVFAELLIGKP 95
E L G T D++S G V E++ G P
Sbjct: 205 EALRGEITP---KSDIYSFGVVLLEIITGLP 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 23/107 (21%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
++L LE+ H +H DIK +NLL+ N + LAD+GL+ + G+ +
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ----- 213
Query: 60 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK 94
P + G ++ S+ D+ +G L GK
Sbjct: 214 --ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 37/152 (24%), Positives = 59/152 (38%), Gaps = 41/152 (26%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANF---SNTGHRQPLTSR 56
Q++ +E+ HS+ +HRD+K N L+ ++ + DFGLA + T P
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---- 168
Query: 57 VVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK---PILQGRT 101
YR + L G Y S+ DL S+G V +G L+ T
Sbjct: 169 -----YRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222
Query: 102 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 133
+ ++ +I + KK P L K
Sbjct: 223 KRQKYERISE----------KKMSTPIEVLCK 244
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 37/154 (24%), Positives = 57/154 (37%), Gaps = 43/154 (27%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLV-----NNEGVLKLADFGLANF---SNTGHRQPLT 54
QL+ +E+ HS+ +++RD+K N L+ + V+ + DF LA T P
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP-- 170
Query: 55 SRVVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK---PILQG 99
YR + L G Y S+ DL ++G +F L G L+
Sbjct: 171 -------YREHKSLTGTARYM-SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222
Query: 100 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 133
T E+ KI K P L +
Sbjct: 223 DTLKERYQKIGD----------TKRATPIEVLCE 246
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 32/124 (25%), Positives = 47/124 (37%), Gaps = 24/124 (19%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
++L LE+ H +H DIK SNLL+N N + L D+GLA + G +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA----- 214
Query: 60 LWYRPPELLLGATDY---------GPS--VDLWSVGCVFAELLIGK-P--ILQGRTEVEQ 105
P G ++ PS DL +G + L G P + +
Sbjct: 215 --ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272
Query: 106 LHKI 109
KI
Sbjct: 273 DSKI 276
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 41/178 (23%), Positives = 65/178 (36%), Gaps = 52/178 (29%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLV-----NNEGVLKLADFGLANF---SNTGHRQPLT 54
Q+L ++ H + +++RDIK N L+ N ++ + DFG+ F T P
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-- 171
Query: 55 SRVVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK---PILQG 99
YR + L G Y S+ DL ++G VF L G L+
Sbjct: 172 -------YREKKNLSGTARYM-SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223
Query: 100 RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQ-----PYDSSLRETFKDLP 150
T ++ +I + KK P L P++ Y +L F P
Sbjct: 224 ATNKQKYERIGE----------KKQSTPLRELCAGFPEEFYKYMHYARNLA--FDATP 269
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-TLWYRPP 65
GL + H+R ++HRD+K N+L++ V K+ DFG++ + L++ V TL Y P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210
Query: 66 ELLLGATDYGPS------VDLWSVGCVFAELLIGKPILQGRTEVEQLH 107
E Y D++S G V E+L + + E ++
Sbjct: 211 E-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 5e-09
Identities = 28/190 (14%), Positives = 55/190 (28%), Gaps = 32/190 (16%)
Query: 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 59
++QL L + HRD+ N+L+ + KL S P V+
Sbjct: 167 LHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI----PSCGLQVS 222
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ DY S VF ++ + + + G + + I++L ++
Sbjct: 223 II-----------DYTLSRLERDGIVVFCDVSMDEDLFTG--DGDYQFDIYRLMKKENNN 269
Query: 120 YWKKSKLPH---------ATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRAT 170
W + + K K + T+L+ +
Sbjct: 270 RWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324
Query: 171 ASAALASEYF 180
A+ L
Sbjct: 325 ATDLLCQHSL 334
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 15/107 (14%)
Query: 5 LHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--HRQPLTSRVV-TLW 61
LH +HC + ++HRD+K +N+L++ E + DFGLA + H +T+ V T+
Sbjct: 147 LH--DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIG 200
Query: 62 YRPPE-LLLG-ATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQ 105
+ PE L G +++ D++ G + EL+ G + R +
Sbjct: 201 HIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 21/107 (19%), Positives = 37/107 (34%), Gaps = 23/107 (21%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
+LL LE H +H ++ N+ V ++ + LA +G A + +G
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV----- 221
Query: 60 LWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK 94
G ++ S+ DL S+G + L G
Sbjct: 222 --EGSRSPHEGDLEFI-SMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 40/152 (26%), Positives = 58/152 (38%), Gaps = 41/152 (26%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANF---SNTGHRQPLTSR 56
Q+++ +E HS+ LHRDIK N L+ + + DFGLA ++T P
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP---- 166
Query: 57 VVTLWYRPPELLLGATDYGPSV------------DLWSVGCVFAELLIGK---PILQGRT 101
YR + L G Y SV DL S+G V L G L+ T
Sbjct: 167 -----YRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
Query: 102 EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK 133
+ ++ KI + KK L +
Sbjct: 221 KKQKYEKISE----------KKVATSIEALCR 242
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPP 65
G+ + +HRD++ +N+LV V K+ADFGLA + W P
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 66 ELLLGATDYGPSVDLWSVGCVFAELL 91
L G + D+WS G + EL
Sbjct: 352 AALYGR--FTIKSDVWSFGILLTELT 375
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL-WYRPP 65
G+ + +HRD++ +N+LV V K+ADFGLA + W P
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 66 ELLLGATDYGPSVDLWSVGCVFAELL 91
L G + D+WS G + EL
Sbjct: 435 AALYGR--FTIKSDVWSFGILLTELT 458
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG-HRQPLTSRVVTLWYRPP 65
+E+ + +HR++ N LV ++K+ADFGL+ + ++ W P
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 66 ELLLGATDYGPSVDLWSVGCVFAELL 91
L + D+W+ G + E+
Sbjct: 390 SLAYNK--FSIKSDVWAFGVLLWEIA 413
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 15/36 (41%), Positives = 25/36 (69%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+E+ S+ +HRD+ N LV + VLK++DFG++
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 5e-06
Identities = 68/510 (13%), Positives = 130/510 (25%), Gaps = 177/510 (34%)
Query: 94 KPILQGRTEVEQLHKIF-KLCGSPP------------DDY-WKKSKLPHATLFKPQQP-- 137
I+ + V ++F L +Y + S + + +QP
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT----EQRQPSM 107
Query: 138 ----YDSSLRETFKDLPTTA----------VNLIETLLSVEPY------------KRATA 171
Y + D A + L + LL + P K A
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 172 SAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSH 231
S K I+ + + + + + + + + T+R H
Sbjct: 168 LDVCLSYKVQCKM------DFKIFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 232 GMSKLAPVEDV--AVRTQFAKKINGHSLHILKD--------------------------D 263
+ + + +R K + L +L + D
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279
Query: 264 ELSGREVQKPLVDNREEA----------SHVKNASHGDIPFS----GPLQVS-----TSS 304
LS +D+ + D+P P ++S
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD 339
Query: 305 GFA-WAKRRKDDASIRSHTRSTSRGQVINALEPSAALHTRNNY----------------- 346
G A W + + + +S +N LEP+ R +
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESS----LNVLEPA---EYRKMFDRLSVFPPSAHIPTILL 392
Query: 347 -----DSRKHENGDIINGSRTDS-----------RGHDSLEAVKIAMLNQWSQLER---- 386
D K + ++N S +K+ + N+ L R
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE-YALHRSIVD 451
Query: 387 ----PDSFDASD--------------GYHSQELSLALYQREEMATKRN---NLGFQDQGE 425
P +FD+ D G+H + + E M R + F +Q
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP----ERMTLFRMVFLDFRFLEQ-- 505
Query: 426 KVEFSGPLLSQSHRIDELL---ERHERQIR 452
K+ + S I L + ++ I
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYIC 535
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 17/40 (42%), Positives = 27/40 (67%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 13/36 (36%), Positives = 22/36 (61%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 14/40 (35%), Positives = 24/40 (60%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ +E+ + +HRD+ N LV ++K+ADFGL+
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 16/40 (40%), Positives = 26/40 (65%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 16/40 (40%), Positives = 26/40 (65%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+E+ ++ +HRD+ N+LV NE +K+ DFGL
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 15/49 (30%), Positives = 23/49 (46%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
LL G+ + V+HRD+ N LV V+K++DFG+
Sbjct: 103 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+N+LL G+ R +HRD++ +N+LV++ K+ADFGLA
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 12/36 (33%), Positives = 21/36 (58%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+ S +HRD+ N LV+ + +K++DFG+
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 16/40 (40%), Positives = 26/40 (65%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+++ SR +HRD+ N+LV +E +K+ DFGL
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 17/49 (34%), Positives = 31/49 (63%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ QLL G+ + H++ +HRD+ N+L++N+ ++K+ DFGLA
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 15/42 (35%), Positives = 24/42 (57%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 16/30 (53%), Positives = 24/30 (80%)
Query: 13 SRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
S+ LHRD+ N LVN++GV+K++DFGL+
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 13/36 (36%), Positives = 22/36 (61%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+E+ +HRD+ N+LV+ + V K++DFGL
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 16/36 (44%), Positives = 25/36 (69%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 160 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
++LL G+E+ SR +HRD+ N+LV +E +K+ADFGLA
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 16/36 (44%), Positives = 24/36 (66%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+ R +HRD++ +N+LV+ V K+ADFGLA
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 13/36 (36%), Positives = 22/36 (61%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+ S+ +HRD+ N+L+ + + K+ DFGLA
Sbjct: 157 GMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 12/40 (30%), Positives = 26/40 (65%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+ + G++HR++ N+L+ + +++ADFG+A
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 16/49 (32%), Positives = 28/49 (57%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ QL+ G+ + G +HRD+ N+LV++ V K++DFGL+
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 15/42 (35%), Positives = 24/42 (57%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 16/49 (32%), Positives = 28/49 (57%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ QL+ G+++ G +HRD+ N+L+N+ V K++DFGL
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 17/36 (47%), Positives = 26/36 (72%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+E+ S+ +HRD+ N+LV + V+K+ADFGLA
Sbjct: 203 GMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 14/49 (28%), Positives = 26/49 (53%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
M L+ G+++ ++HRD+ N+LV +K++DFGL+
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 10/49 (20%), Positives = 26/49 (53%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+++++ G+ + ++ +HRD+ N +V + +K+ DFG+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 18/49 (36%), Positives = 25/49 (51%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
LLH G+ S+ +HRD+ N+L+ N V K+ DFGLA
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 15/96 (15%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF-------SNTGHRQPLTS 55
QL L + S+ +HRDI N+LV++ +KL DFGL+ + + + P+
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-- 556
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91
W P + + + D+W G E+L
Sbjct: 557 ----KWMAPESINFRR--FTSASDVWMFGVCMWEIL 586
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 14/49 (28%), Positives = 28/49 (57%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ L+ G+++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
QLLH G+++ + +HRD+ N+LV V K+ADFGL+
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 17/36 (47%), Positives = 25/36 (69%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 14/40 (35%), Positives = 24/40 (60%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+ + S+ +HRD+ NLL+ ++K+ DFGL
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 15/36 (41%), Positives = 23/36 (63%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+E + +HRD+ N+LV + V+K+ DFGLA
Sbjct: 184 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 14/49 (28%), Positives = 26/49 (53%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ L+ G+E+ SR +HRD+ N ++ + + +ADFGL+
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 17/40 (42%), Positives = 25/40 (62%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
QL L + S+ +HRDI N+LV++ +KL DFGL+
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 12/42 (28%), Positives = 26/42 (61%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
++Q+ G+++ +HRD+ N+L+ + K++DFGL+
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 16/49 (32%), Positives = 29/49 (59%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ QL+ G+++ + +HRD+ N+LVN+ V K++DFGL+
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 14/40 (35%), Positives = 25/40 (62%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ G+E+ + +HRD+ N +++ +K+ADFGLA
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 17/36 (47%), Positives = 25/36 (69%)
Query: 7 GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
G+E+ S+ +HRD+ N+LV V+K+ADFGLA
Sbjct: 215 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 15/49 (30%), Positives = 27/49 (55%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ LL G+E+ +R LHRD+ N ++ ++ + +ADFGL+
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 13/42 (30%), Positives = 27/42 (64%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
++Q+ G+++ + +HRD+ N+L+ N K++DFGL+
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 14/49 (28%), Positives = 27/49 (55%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ L+ G++ S+ +HRD+ N +++ + +K+ADFGLA
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 14/49 (28%), Positives = 26/49 (53%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+H G+E+ S V+H+D+ N+LV ++ +K++D GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 15/40 (37%), Positives = 23/40 (57%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
Q+ + + S +HRDI N+LV + +KL DFGL+
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 12/42 (28%), Positives = 27/42 (64%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
++Q+ G+++ + +HR++ N+L+ N K++DFGL+
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 16/49 (32%), Positives = 24/49 (48%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ L G+ + R +HRD+ N LV V+K+ADFGL+
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 15/49 (30%), Positives = 28/49 (57%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
++Q+LH G+ + S+ +HRD+ N LV ++K+ DFG++
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 15/49 (30%), Positives = 24/49 (48%), Gaps = 7/49 (14%)
Query: 1 MNQLLH-------GLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA 42
+ QLL G+ + +HRD+ N LV V+K+ DFG++
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.97 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.96 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.95 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.95 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.95 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.94 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.93 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.93 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.93 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.93 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.93 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.92 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.92 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.92 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.92 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.92 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.92 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.92 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.92 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.92 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.92 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.92 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.92 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.92 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.92 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.92 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.91 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.91 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.91 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.91 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.91 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.91 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.91 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.9 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.87 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.83 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.77 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.34 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.01 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 96.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.65 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 96.26 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.12 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 92.62 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.82 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 90.9 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 90.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 89.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 88.79 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 88.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 88.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 86.49 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 85.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 85.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 85.15 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 82.98 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 82.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 82.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 81.22 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=336.40 Aligned_cols=187 Identities=34% Similarity=0.563 Sum_probs=153.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCC---CCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG---HRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||.|||++|||||||||+|||++.++.+||+|||++..+... .....+..+||++|+|||++.+...|+.+
T Consensus 164 ~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~ 243 (398)
T 4b99_A 164 LYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA 243 (398)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTH
T ss_pred HHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCCh
Confidence 479999999999999999999999999999999999999999865432 12344567999999999999887778999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC--CCCCCCchhhhhcCCCcHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~s~~l~d 155 (468)
+||||+|||+|||++|.+||.+.+..+++..|+...|.++...|..........+. ........+...++.+++++++
T Consensus 244 ~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 323 (398)
T 4b99_A 244 IDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALS 323 (398)
T ss_dssp HHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHH
T ss_pred hheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHH
Confidence 99999999999999999999999999999999999999998877543222111100 0011123456677889999999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
||.+||.+||.+||||.|+|+||||+....+.
T Consensus 324 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 324 LLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred HHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence 99999999999999999999999999876544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.32 Aligned_cols=156 Identities=28% Similarity=0.501 Sum_probs=134.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+.... ...+..+||++|+|||++.+ ..|+.++||
T Consensus 176 ~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~-~~y~~~~Di 253 (346)
T 4fih_A 176 CLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISR-LPYGPEVDI 253 (346)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-CcccccccCcCcCCHHHHCC-CCCCcHHHH
Confidence 4799999999999999999999999999999999999999998765432 34566799999999999876 569999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||||||++|.+||.+.+..+.+..|..... +.. ..+..+++++++||.+|
T Consensus 254 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~-------------------------~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 254 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRL-------------------------KNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCC-------------------------SCGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC-------------------------CccccCCHHHHHHHHHH
Confidence 9999999999999999999998888887765321 110 11245889999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|+.||.+|||+.|+|+||||+...
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=310.58 Aligned_cols=151 Identities=28% Similarity=0.483 Sum_probs=122.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ......+||+.|+|||++.+...++.++||
T Consensus 118 ~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~Di 195 (275)
T 3hyh_A 118 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDV 195 (275)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--CccCCeeECcccCChhhhcCCCCCCChhhh
Confidence 479999999999999999999999999999999999999999866543 234567899999999999886656789999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|+|++|.+||.+.+..+.+..+....... ...+++++++||.+|
T Consensus 196 wSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 196 WSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----------------------------PKFLSPGAAGLIKRM 246 (275)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999988888777775422111 124789999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|+.||.+|||+.|+|+||||+.
T Consensus 247 L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHT
T ss_pred ccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=322.59 Aligned_cols=183 Identities=30% Similarity=0.485 Sum_probs=136.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCC---------------------------CCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGH---------------------------RQP 52 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~---------------------------~~~ 52 (468)
|+||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ...
T Consensus 123 ~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (361)
T 4f9c_A 123 MLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQ 202 (361)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-----------------------
T ss_pred HHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccccccccccc
Confidence 5799999999999999999999999999876 799999999997544321 112
Q ss_pred ccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCC-CCCchHHHHHHHHHHcCCCCchhhhccC------
Q 012191 53 LTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPPDDYWKKSK------ 125 (468)
Q Consensus 53 ~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf-~g~~~~e~l~~i~~~~g~p~~~~~~~~~------ 125 (468)
.+..+||++|+|||++.+...|+.++||||+|||+|+|++|++|| .+.++.+++..|+..+|.++...+....
T Consensus 203 ~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~ 282 (361)
T 4f9c_A 203 VAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILC 282 (361)
T ss_dssp ---CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEE
T ss_pred ccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccc
Confidence 345689999999999988777999999999999999999999887 5677889999999988865433221100
Q ss_pred ---CCcc------------cc----CCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 126 ---LPHA------------TL----FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 126 ---~~~~------------~~----~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+.. .. +...........+.+..++++++|||.+||++||.+|+||.|+|+||||++.
T Consensus 283 ~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 283 SKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp SSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000 00 0000000011223456789999999999999999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.84 Aligned_cols=156 Identities=30% Similarity=0.489 Sum_probs=135.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+.... .......+||+.|+|||++.+ ..|+.++|
T Consensus 138 ~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~D 216 (311)
T 4aw0_A 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSD 216 (311)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHH
T ss_pred HHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC-CCCCcHHH
Confidence 4799999999999999999999999999999999999999998775433 234556799999999999987 56899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||||||+|++|.+||.+.+..+.+.+|.......+ ..+++++++||.+
T Consensus 217 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~dli~~ 267 (311)
T 4aw0_A 217 LWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP-----------------------------EKFFPKARDLVEK 267 (311)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----------------------------TTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------------cccCHHHHHHHHH
Confidence 99999999999999999999999988888866321111 2478899999999
Q ss_pred hcCCCCCCCcCHHH------HHhcccccCCCCC
Q 012191 160 LLSVEPYKRATASA------ALASEYFSTKPYA 186 (468)
Q Consensus 160 mL~~DP~kRpTa~e------~L~Hp~F~~~p~~ 186 (468)
||+.||.+|||+.| +++||||+...|.
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 99999999999987 5889999887664
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.04 Aligned_cols=155 Identities=28% Similarity=0.507 Sum_probs=134.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+.... ......+||++|+|||++.+ ..|+.++||
T Consensus 253 ~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~-~~y~~~~Di 330 (423)
T 4fie_A 253 CLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISR-LPYGPEVDI 330 (423)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCCCEECTTTCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccccccccCcCcCCHHHHCC-CCCCcHHHH
Confidence 4799999999999999999999999999999999999999998765432 34566799999999999976 569999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||||||++|.+||.+.+..+.+..|..... +.. ..+..+++++++||.+|
T Consensus 331 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~-------------------------~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 331 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRL-------------------------KNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCC-------------------------SCTTSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC-------------------------cccccCCHHHHHHHHHH
Confidence 9999999999999999999999888887755321 110 11246899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.|+|+||||+..
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCCChhHCcCHHHHhcCHHhcCC
Confidence 99999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=308.52 Aligned_cols=154 Identities=31% Similarity=0.434 Sum_probs=131.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... ......+||+.|+|||++.+ ..|+.++||
T Consensus 132 ~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~-~~y~~~~Di 209 (304)
T 3ubd_A 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR-RGHTQSADW 209 (304)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHT-SCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-ccccccccCcccCCHHHhcc-CCCCCCCcc
Confidence 4799999999999999999999999999999999999999997654322 33456789999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||||||++|.+||.+.+..+.+..|....... ...+++++++||.+|
T Consensus 210 wSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~ 260 (304)
T 3ubd_A 210 WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-----------------------------PQFLSPEAQSLLRML 260 (304)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred cchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-----------------------------CCcCCHHHHHHHHHH
Confidence 999999999999999999999999888886532111 124789999999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
|+.||.+||| ++|+|+||||+...|
T Consensus 261 L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 261 FKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp TCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred cccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 9999999998 589999999998655
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=304.83 Aligned_cols=151 Identities=23% Similarity=0.376 Sum_probs=124.4
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||+|||++| ||||||||+||||+. ++.+||+|||+|..... ......+||+.|+|||++.+ .|+.+
T Consensus 135 ~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~---~~~~~~~GTp~YmAPE~~~~--~y~~~ 209 (290)
T 3fpq_A 135 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE--KYDES 209 (290)
T ss_dssp HHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT--CCCTH
T ss_pred HHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---CccCCcccCccccCHHHcCC--CCCcH
Confidence 479999999999999 999999999999985 78999999999976443 23456789999999999875 59999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||||||++|.+||.+......+...... +..+.. ....+++++++||
T Consensus 210 ~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~~-------------------------~~~~~~~~~~~li 263 (290)
T 3fpq_A 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPAS-------------------------FDKVAIPEVKEII 263 (290)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGG-------------------------GGGCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCCC-------------------------CCccCCHHHHHHH
Confidence 99999999999999999999876665554443321 111111 1135678999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccC
Q 012191 158 ETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+||..||.+|||+.|+|+||||++
T Consensus 264 ~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.38 Aligned_cols=153 Identities=26% Similarity=0.472 Sum_probs=132.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ...+..+||+.|+|||++.+ ..|+.++||
T Consensus 131 ~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~l~~-~~y~~~~Di 208 (350)
T 4b9d_A 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACIGTPYYLSPEICEN-KPYNNKSDI 208 (350)
T ss_dssp HHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHHHHHHSCCTTCCHHHHTT-CCCCHHHHH
T ss_pred HHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-ccccccCCCccccCHHHHCC-CCCCcHHHH
Confidence 4799999999999999999999999999999999999999998664321 12345689999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||||||++|.+||.+.+..+.+.+|......+ ....+++++++||.+|
T Consensus 209 wSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----------------------------~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 209 WALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP----------------------------VSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHH
Confidence 999999999999999999999988888886532111 1135789999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|+.||.+|||+.|+|+||||+..
T Consensus 261 L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp TCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ccCChhHCcCHHHHhcCHHhhcC
Confidence 99999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.54 Aligned_cols=156 Identities=28% Similarity=0.345 Sum_probs=126.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCCC----CccccccCCcccChhhhcCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQ----PLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|..+...... .....+||+.|+|||++.+ ..|+
T Consensus 156 ~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~ 234 (336)
T 4g3f_A 156 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCD 234 (336)
T ss_dssp HHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCC
T ss_pred HHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCC
Confidence 47999999999999999999999999999988 5999999999876543211 1234579999999999987 5699
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++||||||||||||++|.+||.+.+..+.+.+|... .++ +.+..+.+++.+.+
T Consensus 235 ~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~------------------------~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP------------------------IREIPPSCAPLTAQ 288 (336)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG------------------------GGGSCTTSCHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC------------------------chhcCccCCHHHHH
Confidence 9999999999999999999999988776666666542 111 12233578999999
Q ss_pred HHHHhcCCCCCCCcCHHHHH-------------hcccccCC
Q 012191 156 LIETLLSVEPYKRATASAAL-------------ASEYFSTK 183 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L-------------~Hp~F~~~ 183 (468)
||.+||+.||.+|||+.|++ +|||+...
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999999999999984 67887653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=315.47 Aligned_cols=160 Identities=28% Similarity=0.408 Sum_probs=139.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC--CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~--g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
|+||+.||+|||++||+||||||+|||++.+ +.+||+|||++..+... ......+||++|+|||++.+ ..|+.++
T Consensus 261 ~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~~~~~~GT~~y~APEv~~~-~~y~~~~ 337 (573)
T 3uto_A 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG-KPVGYYT 337 (573)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SEEEEECSSGGGCCHHHHTT-CCBCHHH
T ss_pred HHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--CceeeeEECccccCHHHhCC-CCCCcHH
Confidence 4799999999999999999999999999854 89999999999877654 34556789999999999987 5689999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||||||+|++|.+||.+.+..+.+..|......++.. .+..+++++++||.
T Consensus 338 DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~dli~ 392 (573)
T 3uto_A 338 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------------------------AFSGISEDGKDFIR 392 (573)
T ss_dssp HHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG-------------------------GGTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHH
Confidence 99999999999999999999999999998887654443332 23568999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYACD 188 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~ 188 (468)
+||..||.+|||+.|+|+||||+...++..
T Consensus 393 ~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred HHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 999999999999999999999998766554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=291.48 Aligned_cols=155 Identities=26% Similarity=0.438 Sum_probs=112.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-----------CCccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-----------QPLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-----------~~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+....... ...+..+||+.|+|||++.
T Consensus 124 ~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 203 (299)
T 4g31_A 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT
T ss_pred HHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence 46999999999999999999999999999999999999999987654321 1224568999999999998
Q ss_pred CCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCC
Q 012191 70 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149 (468)
Q Consensus 70 g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (468)
+ ..|+.++||||||||||||++ ||.+.. +....+......... ..+...
T Consensus 204 ~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~~~~~~~~p-------------------------~~~~~~ 252 (299)
T 4g31_A 204 G-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLTDVRNLKFP-------------------------PLFTQK 252 (299)
T ss_dssp T-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHHHHHTTCCC-------------------------HHHHHH
T ss_pred C-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHHHHhcCCCC-------------------------CCCccc
Confidence 7 569999999999999999996 776533 222222222111110 112234
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
++.+.+||.+||+.||.+|||+.|+|+||||+...|+
T Consensus 253 ~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 253 YPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 5678899999999999999999999999999876553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.62 Aligned_cols=187 Identities=36% Similarity=0.637 Sum_probs=145.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--------------------------CCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--------------------------QPLT 54 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--------------------------~~~~ 54 (468)
++||+.||.|||++||+||||||+||||+.++.+||+|||++........ ...+
T Consensus 162 ~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (458)
T 3rp9_A 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241 (458)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC------------------------
T ss_pred HHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccccccccccccc
Confidence 47999999999999999999999999999999999999999976542211 1345
Q ss_pred ccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhh-----------cCCCCCCCc--------------------hH
Q 012191 55 SRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-----------GKPILQGRT--------------------EV 103 (468)
Q Consensus 55 ~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLlt-----------G~~pf~g~~--------------------~~ 103 (468)
..+||++|+|||++.....|+.++||||||||||||++ |.++|.|.. ..
T Consensus 242 ~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~ 321 (458)
T 3rp9_A 242 GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNR 321 (458)
T ss_dssp ---CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHH
T ss_pred CCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCH
Confidence 66889999999988766779999999999999999998 788887764 36
Q ss_pred HHHHHHHHHcCCCCchhhhccCCCccccCCC--CCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhccccc
Q 012191 104 EQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 104 e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
+++..|+..+|.++.+.+..........+.. .......+...++.+++++++||.+||.+||.+|||+.|+|+||||+
T Consensus 322 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~ 401 (458)
T 3rp9_A 322 DQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401 (458)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence 7889999999999987765433221111111 11122345667788999999999999999999999999999999999
Q ss_pred CCCCCC
Q 012191 182 TKPYAC 187 (468)
Q Consensus 182 ~~p~~~ 187 (468)
...++.
T Consensus 402 ~~~~~~ 407 (458)
T 3rp9_A 402 EVRIAE 407 (458)
T ss_dssp TTCCGG
T ss_pred hcCCCc
Confidence 876654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=277.51 Aligned_cols=182 Identities=42% Similarity=0.715 Sum_probs=148.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+...++.++||
T Consensus 107 ~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 185 (292)
T 3o0g_A 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHH
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHH
Confidence 3699999999999999999999999999999999999999998665332 234456789999999999876668999999
Q ss_pred eeeehhhhhhhhcCCC-CCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~p-f~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|..| |.+.+..+.+..++..++.+....|............+..+....+....+.++..+++||.+
T Consensus 186 wslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 265 (292)
T 3o0g_A 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265 (292)
T ss_dssp HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHH
Confidence 9999999999976655 788888899999999999998887765322111111112222334445566789999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||+.||.+|||+.|+|+||||+..
T Consensus 266 ~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 266 LLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HhccChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=277.90 Aligned_cols=178 Identities=40% Similarity=0.751 Sum_probs=149.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......++|+.|+|||++.+ ..++.++||
T Consensus 126 ~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 202 (308)
T 3g33_A 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDM 202 (308)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHT-SCCCSTHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC--cccCCccccccccCchHHcC-CCCCchHHH
Confidence 479999999999999999999999999999999999999999766533 33456688999999999987 458999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..++..++.++...|..........+.+.. ...+....+.+++.+.+||.+|
T Consensus 203 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~ 280 (308)
T 3g33_A 203 WSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRG--PRPVQSVVPEMEESGAQLLLEM 280 (308)
T ss_dssp HHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCC--CCCHHHHSCSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCC--CCcHHHhCccccHHHHHHHHHH
Confidence 99999999999999999999999999999999999988887653322222222221 2344566678999999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|++||.+|||+.++|+||||+..
T Consensus 281 L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 281 LTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TCSSTTTSCCHHHHHTSTTC---
T ss_pred hcCCCccCCCHHHHhcCccccCC
Confidence 99999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=289.89 Aligned_cols=183 Identities=36% Similarity=0.669 Sum_probs=150.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..+..++|++|+|||++.+...|+.++||
T Consensus 134 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 209 (367)
T 1cm8_A 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDI 209 (367)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHH
T ss_pred HHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhH
Confidence 47999999999999999999999999999999999999999986543 24566889999999999876679999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCC--CCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKP--QQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||+|+|++|.+||.+.+..+++..|+..+|.++.+++..........+.. .......+...+..+++.+.+||.
T Consensus 210 wslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 289 (367)
T 1cm8_A 210 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289 (367)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999988775432211110000 000112345566788999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
+||.+||.+|||+.++|+||||.....+.
T Consensus 290 ~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 290 KMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 99999999999999999999999865443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.78 Aligned_cols=184 Identities=36% Similarity=0.599 Sum_probs=143.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCC--------------------CCCCccccccCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG--------------------HRQPLTSRVVTL 60 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~--------------------~~~~~~~~~gt~ 60 (468)
+.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+... .....+..+||+
T Consensus 115 ~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 194 (388)
T 3oz6_A 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATR 194 (388)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGG
T ss_pred HHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccC
Confidence 369999999999999999999999999999999999999999765321 112245568999
Q ss_pred cccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC-------
Q 012191 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK------- 133 (468)
Q Consensus 61 ~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~------- 133 (468)
+|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|+..++.|..+.+.....+....+.
T Consensus 195 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 274 (388)
T 3oz6_A 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV 274 (388)
T ss_dssp GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHC
T ss_pred CcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccc
Confidence 9999999987677999999999999999999999999999999999999999999987766443222111000
Q ss_pred --CCCCCCchhh---------hhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 134 --PQQPYDSSLR---------ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 134 --~~~~~~~~l~---------~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
........+. .....+++++++||.+||.+||.+|||+.++|+||||+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 275 EIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp C-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred cccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 0000000000 01126789999999999999999999999999999998653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.71 Aligned_cols=182 Identities=39% Similarity=0.722 Sum_probs=148.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......++|+.|+|||++.+...++.++||
T Consensus 125 ~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 203 (311)
T 3niz_A 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203 (311)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHh
Confidence 4799999999999999999999999999999999999999998765322 234456789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCc-cccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|.+||.+.+..+.+..+...++.+....|....... .............+....+.+++++.+||.+
T Consensus 204 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 283 (311)
T 3niz_A 204 WSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSN 283 (311)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHH
Confidence 999999999999999999999999999999999988877766432211 1100111111223455567889999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||++||.+|||+.++|+||||+..
T Consensus 284 ~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 284 MLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred HcCCChhHCCCHHHHhcCcccccC
Confidence 999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.40 Aligned_cols=183 Identities=39% Similarity=0.655 Sum_probs=149.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC-CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
++||+.||.|||++||+||||||+||||+ .++.+||+|||++...... ......++|++|+|||++.+...|+.++|
T Consensus 147 ~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (394)
T 4e7w_A 147 MYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAPELIFGATNYTTNID 224 (394)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC--CCCcccccCcCccCHHHHcCCCCCCcHHH
Confidence 36999999999999999999999999998 7899999999999876443 23455688999999999988777999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc-CCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~s~~l~dLL~ 158 (468)
|||||||+|+|++|.+||.+.+..+++..+.+.+|.+..+.+............+... ...+...+ ..+++++.+||.
T Consensus 225 iwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~ 303 (394)
T 4e7w_A 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIR-PHPFSKVFRPRTPPDAIDLIS 303 (394)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCC-CCCHHHHSCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhcccccc-CCcHHHhccccCCHHHHHHHH
Confidence 9999999999999999999999999999999999999887665432211111111111 11223333 358999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
+||.+||.+|||+.++|+||||+...+.
T Consensus 304 ~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 304 RLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp HHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred HHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 9999999999999999999999976543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=276.19 Aligned_cols=179 Identities=40% Similarity=0.780 Sum_probs=142.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+...++.++||
T Consensus 106 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 184 (288)
T 1ob3_A 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184 (288)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cccccccccccccCchheeCCCCCCcHHHH
Confidence 4699999999999999999999999999999999999999997654321 233455789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCC--CCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQ--PYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+....+.+..++..++.+....|........ +.+.. .....+......+++++.+||.
T Consensus 185 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 262 (288)
T 1ob3_A 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK--YDPNFTVYEPLPWESFLKGLDESGIDLLS 262 (288)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT--CCTTCCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc--cccccccccCccHHHHhhhcCHHHHHHHH
Confidence 9999999999999999999999999999999999888777654221100 11100 0111233445678999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccC
Q 012191 159 TLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+||..||.+|||+.++|+||||+.
T Consensus 263 ~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 263 KMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHcCCCcccCCCHHHHhcCcchhh
Confidence 999999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=279.80 Aligned_cols=183 Identities=38% Similarity=0.714 Sum_probs=147.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......++|+.|+|||++.+...++.++|||
T Consensus 115 ~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 193 (317)
T 2pmi_A 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIW 193 (317)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHH
T ss_pred HHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHH
Confidence 599999999999999999999999999999999999999998665322 2334567899999999998766789999999
Q ss_pred eeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCC---CCCCCchhh-hhcCCCcHHHHHH
Q 012191 82 SVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKP---QQPYDSSLR-ETFKDLPTTAVNL 156 (468)
Q Consensus 82 SLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~---~~~~~~~l~-~~~~~~s~~l~dL 156 (468)
||||++|+|++|.+||.+.+..+.+..++..++.++...|.... ++....... ...+...+. .....++.++.+|
T Consensus 194 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 273 (317)
T 2pmi_A 194 SCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDF 273 (317)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHH
Confidence 99999999999999999999999999999999999888886532 111110000 011111111 1223688999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|.+||+.||.+|||+.++|+||||+....
T Consensus 274 i~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 274 LHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred HHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 99999999999999999999999997544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=290.66 Aligned_cols=182 Identities=40% Similarity=0.642 Sum_probs=147.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+||||+.+ +.+||+|||++...... ......++|++|+|||++.+...|+.++|
T Consensus 162 ~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 239 (420)
T 1j1b_A 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSID 239 (420)
T ss_dssp HHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC--CCceeeeeCCCcCCHHHHcCCCCCCchhh
Confidence 3699999999999999999999999999965 57899999999866443 23345688999999999987667999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc-CCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~s~~l~dLL~ 158 (468)
|||||||||||++|.+||.+.+..+++..+++.+|.+..+.|............+... ...+...+ ..+++++++||.
T Consensus 240 iwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~Li~ 318 (420)
T 1j1b_A 240 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK-AHPWTKVFRPRTPPEAIALCS 318 (420)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCC-CCCHHHHSCTTSCHHHHHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccC-CCCHHHhcCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999887776533211111111111 11222222 467899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+||.+||.+|||+.|+|+||||.....
T Consensus 319 ~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 319 RLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HhccCChhHCCCHHHHhCCHhhccccc
Confidence 999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=300.36 Aligned_cols=181 Identities=34% Similarity=0.633 Sum_probs=139.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++||+||||||+||||+.++.+||+|||++...... ...+..+||++|+|||++.+ ..|+.++||
T Consensus 170 ~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 246 (464)
T 3ttj_A 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDI 246 (464)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C--CCC----CCCTTCCHHHHTT-CCCCTTHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcC-CCCCHHHHH
Confidence 479999999999999999999999999999999999999999866543 34566789999999999987 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCC-chhhhhcCC-----------
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-SSLRETFKD----------- 148 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~----------- 148 (468)
||||||+|+|++|.+||.+.+..+++..|++.+|.+..++|..........+.....+. ..+...++.
T Consensus 247 wSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (464)
T 3ttj_A 247 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 326 (464)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccccc
Confidence 99999999999999999999999999999999999988877543211000000000000 111112211
Q ss_pred -CcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 149 -LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 149 -~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
.++++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 327 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 327 LKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 267899999999999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=289.89 Aligned_cols=184 Identities=39% Similarity=0.647 Sum_probs=142.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..+..++|++|+|||++.+...|+.++||
T Consensus 138 ~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 213 (367)
T 2fst_X 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDI 213 (367)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHH
T ss_pred HHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc----cCCCcCcCcCccChHHHcCCcCCCchhhH
Confidence 47999999999999999999999999999999999999999976543 24556889999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCC--CCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQ--QPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||+|+|++|.+||.+.+..+++..|++.+|.++.+.+..........+... ..-...+...+..+++.+.+||.
T Consensus 214 wslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 293 (367)
T 2fst_X 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293 (367)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999998877654332111111000 00112345666788999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYACD 188 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~ 188 (468)
+||.+||.+|||+.++|+||||.....+.+
T Consensus 294 ~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 294 KMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 999999999999999999999998655443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=311.65 Aligned_cols=154 Identities=27% Similarity=0.419 Sum_probs=128.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+... .....+||+.|+|||++.+...|+.++||
T Consensus 298 ~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDi 374 (689)
T 3v5w_A 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADW 374 (689)
T ss_dssp HHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHH
Confidence 479999999999999999999999999999999999999999876543 23567999999999999765679999999
Q ss_pred eeeehhhhhhhhcCCCCCCCch---HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~---~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
||||||||||++|.+||.+.+. .+....+... .+ . ....+++++++||
T Consensus 375 WSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~--~-------------------------~p~~~S~~a~dLI 425 (689)
T 3v5w_A 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AV--E-------------------------LPDSFSPELRSLL 425 (689)
T ss_dssp HHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CC--C-------------------------CCTTSCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CC--C-------------------------CCccCCHHHHHHH
Confidence 9999999999999999987543 2223333221 10 0 1135889999999
Q ss_pred HHhcCCCCCCCcC-----HHHHHhcccccCCCCC
Q 012191 158 ETLLSVEPYKRAT-----ASAALASEYFSTKPYA 186 (468)
Q Consensus 158 ~~mL~~DP~kRpT-----a~e~L~Hp~F~~~p~~ 186 (468)
.+||+.||.+|++ +.++++||||+...|.
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred HHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence 9999999999998 8999999999987664
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=279.51 Aligned_cols=187 Identities=42% Similarity=0.737 Sum_probs=154.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......++|+.|+|||++.+...++.++||
T Consensus 118 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 196 (346)
T 1ua2_A 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDM 196 (346)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHH
T ss_pred HHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhh
Confidence 4699999999999999999999999999999999999999997664332 234556789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhcc-CCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKS-KLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||+|+|++|.+||.+.+..+.+..++..++.+....|... ..+....+.... ...+...+..++.++++||.+
T Consensus 197 wslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ 274 (346)
T 1ua2_A 197 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQG 274 (346)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHH
T ss_pred HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccC--CCChHHhhccCCHHHHHHHHH
Confidence 99999999999999999999999999999999999988877653 222222111111 123445567889999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCCCCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPYACDLS 190 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~ 190 (468)
||..||.+|||+.|+|+||||+..+.+....
T Consensus 275 ~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~ 305 (346)
T 1ua2_A 275 LFLFNPCARITATQALKMKYFSNRPGPTPGC 305 (346)
T ss_dssp HHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred HhccChhhCCCHHHHhcChhhhcCCCCCCcc
Confidence 9999999999999999999999887765443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=292.98 Aligned_cols=187 Identities=36% Similarity=0.643 Sum_probs=146.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---------------------CCccccccC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---------------------QPLTSRVVT 59 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---------------------~~~~~~~gt 59 (468)
++||+.||.|||++||+||||||+||||+.++.+||+|||++........ ...+..+||
T Consensus 135 ~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 214 (432)
T 3n9x_A 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214 (432)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCC
Confidence 47999999999999999999999999999999999999999986653321 124677899
Q ss_pred CcccChhhhcCCCCCCCCcceeeeehhhhhhhh-----------cCCCCCCCc-----------------hHHHHHHHHH
Q 012191 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-----------GKPILQGRT-----------------EVEQLHKIFK 111 (468)
Q Consensus 60 ~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLlt-----------G~~pf~g~~-----------------~~e~l~~i~~ 111 (468)
++|+|||++.....|+.++||||||||+|||++ |.++|.+.. ...++..|+.
T Consensus 215 ~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~ 294 (432)
T 3n9x_A 215 RWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294 (432)
T ss_dssp CTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHH
T ss_pred ccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHH
Confidence 999999998766779999999999999999997 567776654 4788999999
Q ss_pred HcCCCCchhhhccCCCccccCC--CCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 112 LCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 112 ~~g~p~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
.+|.|+.+.+..........+. ........+...++.+++.+++||.+||.+||.+|||+.|+|+||||+...++.
T Consensus 295 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 295 IIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 9999998776543322111110 011122345566788999999999999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=279.87 Aligned_cols=184 Identities=39% Similarity=0.714 Sum_probs=145.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......++|++|+|||++.+...++.++||
T Consensus 106 ~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 184 (324)
T 3mtl_A 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDM 184 (324)
T ss_dssp HHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHH
Confidence 3699999999999999999999999999999999999999997554321 233455789999999999876778999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCc-cccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|.+||.+.+..+++..+...++.+....|....... ...+.........+......+++++.+||.+
T Consensus 185 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 264 (324)
T 3mtl_A 185 WGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTK 264 (324)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999888776422110 0111111112233455567889999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
||++||.+|||+.|+|+||||.....
T Consensus 265 ~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 265 LLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred HcCcCcccCCCHHHHhcChhhhhccc
Confidence 99999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=282.36 Aligned_cols=155 Identities=22% Similarity=0.359 Sum_probs=120.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCC--CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGA--TDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~--~~~s~~ 77 (468)
+.||+.||+|||+++||||||||+||||+.++.+||+|||+|....... .......+||+.|+|||++.+. ..|+.+
T Consensus 138 ~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k 217 (307)
T 3omv_A 138 ARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217 (307)
T ss_dssp HHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHH
T ss_pred HHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcH
Confidence 3699999999999999999999999999999999999999998654322 2334566899999999999753 358999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||||||++|++||.+.+....+..+.......+. +......+++.+.+||
T Consensus 218 sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-----------------------~~~~~~~~~~~l~~li 274 (307)
T 3omv_A 218 SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-----------------------LSKLYKNCPKAMKRLV 274 (307)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-----------------------STTSCTTSCHHHHHHH
T ss_pred HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-----------------------cccccccchHHHHHHH
Confidence 99999999999999999999987776666555432211110 1122356889999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcc
Q 012191 158 ETLLSVEPYKRATASAALASE 178 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp 178 (468)
.+||+.||.+|||+.+++++-
T Consensus 275 ~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 275 ADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999987653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-33 Score=278.92 Aligned_cols=187 Identities=41% Similarity=0.736 Sum_probs=148.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC---CCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......++|+.|+|||++.+...++.+
T Consensus 130 ~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 209 (351)
T 3mi9_A 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP 209 (351)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTH
T ss_pred HHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcH
Confidence 4799999999999999999999999999999999999999997654321 2233456789999999999876678999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCc-cccCCCCCCCCchhhhhcC--CCcHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKPQQPYDSSLRETFK--DLPTTAV 154 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~--~~s~~l~ 154 (468)
+||||||||+|+|++|.+||.+.+....+..+...++.++...|....... ...+.........+...+. ..++.+.
T Consensus 210 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (351)
T 3mi9_A 210 IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 289 (351)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHH
Confidence 999999999999999999999999999999999999999888776532111 1111111111111111111 2477899
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
+||.+||..||.+|||+.|+|+||||...+.+.
T Consensus 290 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 290 DLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred HHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 999999999999999999999999999877654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=285.31 Aligned_cols=188 Identities=38% Similarity=0.722 Sum_probs=139.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE----CCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDY 74 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl----d~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~ 74 (468)
+.||+.||.|||++||+||||||+|||| +.++.+||+|||++........ ......+||++|+|||++.+...|
T Consensus 134 ~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 213 (405)
T 3rgf_A 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY 213 (405)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSC
T ss_pred HHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcc
Confidence 4699999999999999999999999999 6778999999999986653211 233456889999999999876678
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCch---------HHHHHHHHHHcCCCCchhhhccC-CCcccc----CCC----CC
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRTE---------VEQLHKIFKLCGSPPDDYWKKSK-LPHATL----FKP----QQ 136 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~~---------~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~----~~~----~~ 136 (468)
+.++||||||||+|+|++|.+||.+... .+++..++..+|.++...|.... .+.... +.. ..
T Consensus 214 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (405)
T 3rgf_A 214 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 293 (405)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTC
T ss_pred cchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcc
Confidence 9999999999999999999999987655 58899999999999988876532 111100 000 00
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCCCC
Q 012191 137 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYACD 188 (468)
Q Consensus 137 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~ 188 (468)
.....+.......+..+.+||.+||.+||.+|||+.|||+||||...+++..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 294 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTS 345 (405)
T ss_dssp CHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCCS
T ss_pred hhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCcc
Confidence 0001111122234778999999999999999999999999999999877653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=281.88 Aligned_cols=179 Identities=38% Similarity=0.700 Sum_probs=147.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC-CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... .......+|+.|+|||++.+...|+.++|
T Consensus 147 ~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (383)
T 3eb0_A 147 IYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSID 224 (383)
T ss_dssp HHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchh
Confidence 46999999999999999999999999997 6789999999999866543 23455678999999999988677999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc-CCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF-KDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~s~~l~dLL~ 158 (468)
|||||||+|+|++|.+||.+.+..+++..+++.+|.++.+.+............+... ...+...+ ..+++++.+||.
T Consensus 225 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK-AKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC-CCCHHHHSCTTCCHHHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC-cccHHhhCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999887766543222211111111 11222222 458899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccC
Q 012191 159 TLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+||.+||.+|||+.|+|+||||+.
T Consensus 304 ~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHccCChhhCCCHHHHhcCHHHHH
Confidence 999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-33 Score=293.13 Aligned_cols=224 Identities=24% Similarity=0.396 Sum_probs=165.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC---CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld---~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ......+||+.|+|||++.+ .|+.+
T Consensus 127 ~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ 202 (486)
T 3mwu_A 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG--TYDEK 202 (486)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS--CCCHH
T ss_pred HHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--CccCCCcCCCCCCCHHHhCC--CCCch
Confidence 47999999999999999999999999995 4567999999999766543 23456689999999999976 58999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+.+..+.+..+.......+.. .+..+++.+++||
T Consensus 203 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li 257 (486)
T 3mwu_A 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP-------------------------QWRTISDDAKDLI 257 (486)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG-------------------------GGGGSCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-------------------------ccCCCCHHHHHHH
Confidence 999999999999999999999999888888876543332222 2346789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCCCChhHHHhhHHHHHHhhhcCcccccccccccccccCCCCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLA 237 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~p~~e~~~k~~~~~~r~~~~~~~~~~~~~k~~~~~~~~~~~~ 237 (468)
.+||..||.+|||+.++|+||||+...... +.. .............++.. .....+.......+..+.
T Consensus 258 ~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~ia~~l~ 325 (486)
T 3mwu_A 258 RKMLTFHPSLRITATQCLEHPWIQKYSSET-----PTI-SDLPSLESAMTNIRQFQ------AEKKLAQAALLYMASKLT 325 (486)
T ss_dssp HHHTCSSTTTSCCHHHHHHCHHHHHTCCCC-----CCG-GGHHHHHHHHHHHHHHH------HSCHHHHHHHHHHHHHHC
T ss_pred HHHcCCChhhCcCHHHHhcCHhhccCcccC-----ccc-cccccHHHHHHHHHHHH------HHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999998743221 100 01111111111111111 111122222233344456
Q ss_pred ChHHHHHHhhhhhhhcCCCCcccccccc
Q 012191 238 PVEDVAVRTQFAKKINGHSLHILKDDEL 265 (468)
Q Consensus 238 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~ 265 (468)
+.+++....+.|...|.++++.+..+|+
T Consensus 326 ~~~~~~~l~~~F~~~D~d~dG~I~~~El 353 (486)
T 3mwu_A 326 TLDETKQLTEIFRKLDTNNDGMLDRDEL 353 (486)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSSBCHHHH
T ss_pred cHHHHHHHHHHHHHhCCCCCceeeHHHH
Confidence 8899999999999999999999998876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=275.19 Aligned_cols=183 Identities=40% Similarity=0.784 Sum_probs=140.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC-----CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-----NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld-----~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
+.||+.||.|||++||+||||||+|||++ ..+.+||+|||++....... ......++|+.|+|||++.+...++
T Consensus 138 ~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ 216 (329)
T 3gbz_A 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYS 216 (329)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCC
T ss_pred HHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCC
Confidence 47999999999999999999999999994 45569999999997665322 2344567899999999998766789
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhc-CCCcHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETF-KDLPTTA 153 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~-~~~s~~l 153 (468)
.++||||||||+|+|++|.+||.+....+.+..++..++.++...|.... .+......+... ...+...+ ..++.++
T Consensus 217 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 295 (329)
T 3gbz_A 217 TSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR-GKTLKRVLGALLDDEG 295 (329)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC-CCCHHHHHGGGSCHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhc-cccHhhhcccccCHHH
Confidence 99999999999999999999999999999999999999998887775422 111111111111 11222222 3478999
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 154 VNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
.+||.+||.+||.+|||+.++|+||||+...|
T Consensus 296 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 296 LDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred HHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 99999999999999999999999999998665
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=278.23 Aligned_cols=184 Identities=36% Similarity=0.632 Sum_probs=149.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||++|+|||++.+...++.++
T Consensus 134 ~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 213 (364)
T 3qyz_A 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213 (364)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHH
T ss_pred HHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcch
Confidence 36999999999999999999999999999999999999999976653221 1234568899999999987766789999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccC--CCCCCCCchhhhhcCCCcHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
|||||||++|+|++|.+||.+.+..+.+..+...++.++.+.+..........+ .........+...+..++.++.+|
T Consensus 214 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 293 (364)
T 3qyz_A 214 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293 (364)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHH
T ss_pred hHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHH
Confidence 999999999999999999999999999999999999998776643221110000 000111223455667889999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|.+||.+||.+|||+.++|+||||+...
T Consensus 294 i~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 294 LDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 9999999999999999999999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=274.36 Aligned_cols=185 Identities=34% Similarity=0.635 Sum_probs=149.2
Q ss_pred CHHHHHHHHHHH--hCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCH--SRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLH--s~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.||| ++||+||||||+|||++. ++.+||+|||++...... .......+|+.|+|||++.+...++.+
T Consensus 135 ~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~ 212 (360)
T 3e3p_A 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTA 212 (360)
T ss_dssp HHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC--CCcccccCCcceeCHHHHcCCCCCCcH
Confidence 368999999999 999999999999999996 899999999999866543 233456789999999999876678999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCcccc--C-CCCCCCCchhhhhcCCCcHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATL--F-KPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~--~-~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
+||||||||+|+|++|.+||.+.+....+..+...++.++.+.|.......... + ....++...+......++..+.
T Consensus 213 ~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (360)
T 3e3p_A 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHH
Confidence 999999999999999999999999999999999999999888776543221111 1 1111111112222234788999
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
+||.+||+.||.+|||+.++|+||||+....+.
T Consensus 293 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 293 DLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 999999999999999999999999999865543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=290.08 Aligned_cols=223 Identities=28% Similarity=0.407 Sum_probs=169.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ .|+.+
T Consensus 152 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ 227 (504)
T 3q5i_A 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEK 227 (504)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTH
T ss_pred HHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCch
Confidence 47999999999999999999999999998776 6999999999876543 33456689999999999875 58999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+.+..+.+..+.......+. ..+..+++++++||
T Consensus 228 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li 282 (504)
T 3q5i_A 228 CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF-------------------------NDWKNISDEAKELI 282 (504)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-------------------------cccCCCCHHHHHHH
Confidence 99999999999999999999999988888887664322222 23357899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCCCChhHHHhhHHHHHHhhhcCcccccccccccccccCCCCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLA 237 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~p~~e~~~k~~~~~~r~~~~~~~~~~~~~k~~~~~~~~~~~~ 237 (468)
.+||.+||.+|||+.++|+||||+....... ..............++ +......+..........+.
T Consensus 283 ~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~~kl~~a~l~~i~~~~~ 349 (504)
T 3q5i_A 283 KLMLTYDYNKRCTAEEALNSRWIKKYANNIN-------KSDQKTLCGALSNMRK------FEGSQKLAQAAILFIGSKLT 349 (504)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHHTCCCCC-------GGGHHHHHHHHHHHHH------CCCCSHHHHHHHHHHHHHTS
T ss_pred HHHcCCChhHCCCHHHHhcCHhhhhchhccc-------ccchhhHHHHHHHHHH------HHHHHHHHHHHHHHhhccCC
Confidence 9999999999999999999999987432110 0011111111111111 22222233333334444556
Q ss_pred ChHHHHHHhhhhhhhcCCCCcccccccc
Q 012191 238 PVEDVAVRTQFAKKINGHSLHILKDDEL 265 (468)
Q Consensus 238 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~ 265 (468)
+.+++....+.|..+|.++++.+..+|+
T Consensus 350 ~~~~~~~l~~~F~~~D~d~dG~I~~~El 377 (504)
T 3q5i_A 350 TLEERKELTDIFKKLDKNGDGQLDKKEL 377 (504)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEECHHHH
T ss_pred cHHHHHHHHHHHHeeCCCCCCeEcHHHH
Confidence 8899999999999999999999998885
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-33 Score=282.73 Aligned_cols=182 Identities=34% Similarity=0.612 Sum_probs=132.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......++|+.|+|||++.+ ..|+.++||
T Consensus 133 ~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 209 (371)
T 2xrw_A 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDI 209 (371)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHTT-CCCCTTHHH
T ss_pred HHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc--cccCCceecCCccCHHHhcC-CCCCchHhH
Confidence 469999999999999999999999999999999999999999765432 23345688999999999987 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCC-chhhhhcC------------
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-SSLRETFK------------ 147 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~------------ 147 (468)
||||||+|+|++|.+||.+.+..+++..++..++.+..+++................+. ..+...++
T Consensus 210 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (371)
T 2xrw_A 210 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289 (371)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccc
Confidence 99999999999999999999999999999999998877766432110000000000000 01111111
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
..+..+++||.+||..||.+|||+.++|+||||+....
T Consensus 290 ~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 290 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred cccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 12678999999999999999999999999999987544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=271.79 Aligned_cols=154 Identities=28% Similarity=0.494 Sum_probs=132.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||++|+|||++.+...++.++||
T Consensus 120 ~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 197 (328)
T 3fe3_A 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197 (328)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHH
T ss_pred HHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--CccccccCCcceeCcccccCCCcCCchhhh
Confidence 479999999999999999999999999999999999999999766543 234567899999999999886555689999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+....+.......+ ..+++++.+||.+|
T Consensus 198 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~~li~~~ 248 (328)
T 3fe3_A 198 WSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----------------------------FYMSTDCENLLKRF 248 (328)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------------CCCCHHHHHHHHHH
Confidence 9999999999999999999988887777755221111 23688999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|..||.+|||+.++|+||||+....
T Consensus 249 L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 249 LVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp CCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred CCCChhHCcCHHHHhcCHhhcCCCc
Confidence 9999999999999999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=284.09 Aligned_cols=178 Identities=28% Similarity=0.541 Sum_probs=141.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc--EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~--vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++||+||||||+||||+.++. +||+|||++..... .....++|+.|+|||++.+ ..|+.++
T Consensus 206 ~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~ 280 (429)
T 3kvw_A 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSRFYRAPEVILG-ARYGMPI 280 (429)
T ss_dssp HHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHHT-BCCCTHH
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC----cccccCCCCCccChHHHhC-CCCCchH
Confidence 469999999999999999999999999999887 99999999976543 2345688999999999987 4589999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC-------------------------
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK------------------------- 133 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~------------------------- 133 (468)
||||||||+|+|++|.+||.+.+..+++..++..++.++..++............
T Consensus 281 DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (429)
T 3kvw_A 281 DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSR 360 (429)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECT
T ss_pred HHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999988766543211000000
Q ss_pred ----CCCCCCchhhhhc-CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 134 ----PQQPYDSSLRETF-KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 134 ----~~~~~~~~l~~~~-~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
...+....+...+ ...++.+.+||.+||++||.+|||+.|||+||||+..
T Consensus 361 ~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 361 RGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred hhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 0001111111222 2457889999999999999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-33 Score=292.58 Aligned_cols=224 Identities=26% Similarity=0.392 Sum_probs=166.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC---CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||.|||++||+||||||+|||++.. +.+||+|||++...... ......+||+.|+|||++.+ .|+.+
T Consensus 142 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~ 217 (494)
T 3lij_A 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPEVLRK--KYDEK 217 (494)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--BCBCCCCSCTTTCCHHHHTT--CBCTH
T ss_pred HHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--ccccccCCCcCeeCHHHHcc--cCCCc
Confidence 4799999999999999999999999999764 45999999999876543 33456689999999999864 58999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+.+..+.+..+.......+... +..+++.+++||
T Consensus 218 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li 272 (494)
T 3lij_A 218 CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE-------------------------WKNVSEGAKDLI 272 (494)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG-------------------------GTTSCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh-------------------------cccCCHHHHHHH
Confidence 9999999999999999999999999888888866443333222 356889999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCCCChhHHHhhHHHHHHhhhcCcccccccccccccccCCCCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLA 237 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~p~~e~~~k~~~~~~r~~~~~~~~~~~~~k~~~~~~~~~~~~ 237 (468)
.+||+.||.+|||+.++|+||||+........ ....+....+ .+..++ +......+.......+..+.
T Consensus 273 ~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~--~~~~~~~~~~----~~~~~~------~~~~~~l~qa~l~~ia~~~~ 340 (494)
T 3lij_A 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKKES--GIELPSLANA----IENMRK------FQNSQKLAQAALLYMASKLT 340 (494)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC-----CCCCSSH----HHHHHT------TTTCCHHHHHHHHHHHHHSC
T ss_pred HHHCCCChhhCccHHHHhcCcccccCcccccc--cccccccHHH----HHHHHH------HHHhHHHHHHHHHHHHHhcc
Confidence 99999999999999999999999863211000 0001111111 111111 11111122222222333455
Q ss_pred ChHHHHHHhhhhhhhcCCCCcccccccc
Q 012191 238 PVEDVAVRTQFAKKINGHSLHILKDDEL 265 (468)
Q Consensus 238 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~ 265 (468)
+.+++....+.|...|.++++.+..+|+
T Consensus 341 ~~~~~~~l~~~F~~~D~d~dG~I~~~El 368 (494)
T 3lij_A 341 SQEETKELTDIFRHIDKNGDGQLDRQEL 368 (494)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEECHHHH
T ss_pred cHHHHHHHHHHHHHhCcCCCCeEcHHHH
Confidence 8899999999999999999999998886
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-33 Score=293.67 Aligned_cols=223 Identities=26% Similarity=0.364 Sum_probs=164.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE---CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .|+.+
T Consensus 132 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ 207 (484)
T 3nyv_A 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPEVLHG--TYDEK 207 (484)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC--CSHHHHTTGGGTCCHHHHHT--CCCTH
T ss_pred HHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc--cccccCCCCccccCceeecC--CCCCc
Confidence 4799999999999999999999999999 46788999999999876543 23456689999999999976 58999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+.+..+.+..+.......+.. .+..+++.+++||
T Consensus 208 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li 262 (484)
T 3nyv_A 208 CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP-------------------------QWKKVSESAKDLI 262 (484)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-------------------------GGGGSCHHHHHHH
T ss_pred ceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-------------------------ccccCCHHHHHHH
Confidence 999999999999999999999999988888876643333222 2346789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCCCCCChhHHHhhHHHHHHhhhcCcccccccccccccccCCCCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLA 237 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~~~p~~e~~~k~~~~~~r~~~~~~~~~~~~~k~~~~~~~~~~~~ 237 (468)
.+||..||.+|||+.++|+||||+.......... .+.........+.-... ...+..........+.
T Consensus 263 ~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~----------~kl~qa~l~~i~~~~~ 329 (484)
T 3nyv_A 263 RKMLTYVPSMRISARDALDHEWIQTYTKEQISVD---VPSLDNAILNIRQFQGT----------QKLAQAALLYMGSKLT 329 (484)
T ss_dssp HHHTCSSGGGSCCHHHHHTSHHHHHHTC-----C---CCBCHHHHHHHHHHHHH----------HHHHHHHHHHHHHHHH
T ss_pred HHHCCCChhHCcCHHHHhhChhhccccccccccc---ccchHHHHHHHHHHhhh----------hHHHHHHHHHHHhccC
Confidence 9999999999999999999999986433211111 11112111111111111 0111111111222234
Q ss_pred ChHHHHHHhhhhhhhcCCCCcccccccc
Q 012191 238 PVEDVAVRTQFAKKINGHSLHILKDDEL 265 (468)
Q Consensus 238 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~ 265 (468)
+.+++....+.|...|.++++.+..+|+
T Consensus 330 ~~~~~~~l~~~F~~~D~d~dG~I~~~El 357 (484)
T 3nyv_A 330 SQDETKELTAIFHKMDKNGDGQLDRAEL 357 (484)
T ss_dssp HHHHHHHHHHHHHHHCTTCSSEEEHHHH
T ss_pred cHHHHHHHHHHHHHhCcCCCceEeHHHH
Confidence 6788889999999999999999988776
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=274.42 Aligned_cols=182 Identities=37% Similarity=0.653 Sum_probs=145.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....++|++|+|||++.+...++.++||
T Consensus 150 ~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (371)
T 4exu_A 150 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDI 225 (371)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHH
T ss_pred HHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc----CcCCcccCccccCHHHhcCCCCCCcHHhH
Confidence 36999999999999999999999999999999999999999976543 23456789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccC--CCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+.+..+.+..+....+.++.+++..........+ .........+...+..+++.+.+||.
T Consensus 226 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 305 (371)
T 4exu_A 226 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 305 (371)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHH
Confidence 9999999999999999999999999999999999988777654321111000 00011122345556788999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
+||++||.+|||+.++|+||||+....+
T Consensus 306 ~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 306 KMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 9999999999999999999999875443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=265.16 Aligned_cols=185 Identities=34% Similarity=0.592 Sum_probs=140.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+...++.++||
T Consensus 108 ~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 186 (311)
T 4agu_A 108 TWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDV 186 (311)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cccCCCcCCccccChHHHhcCCCCCcchhh
Confidence 3699999999999999999999999999999999999999997665322 233456789999999999876778999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCcc--ccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHA--TLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+....+.+..+...++......+........ ....+.......+...++.++..+.+||.
T Consensus 187 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 266 (311)
T 4agu_A 187 WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLK 266 (311)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHH
Confidence 9999999999999999999999999988888877765543222111100 00111112223345566789999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
+||..||.+|||+.++|+||||+.....
T Consensus 267 ~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 267 GCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp HHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred HHccCChhhcCCHHHHhcChHHHhccCH
Confidence 9999999999999999999999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=274.26 Aligned_cols=155 Identities=28% Similarity=0.429 Sum_probs=133.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC----cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ ..|+.
T Consensus 121 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ 197 (361)
T 2yab_A 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNY-EPLGL 197 (361)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT--CCCCCCCSCGGGCCHHHHTT-CCCCT
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC--CccccCCCCccEECchHHcC-CCCCc
Confidence 47999999999999999999999999998877 7999999999876543 23456689999999999976 56899
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++||||||||+|+|++|.+||.+.+..+.+..+.......+..+ +..++..+++|
T Consensus 198 ~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~l 252 (361)
T 2yab_A 198 EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF-------------------------FSQTSELAKDF 252 (361)
T ss_dssp HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH-------------------------HTTSCHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh-------------------------ccCCCHHHHHH
Confidence 99999999999999999999999998888888766443333322 35688999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|.+||..||.+|||+.++|+||||+..
T Consensus 253 i~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 253 IRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=262.35 Aligned_cols=180 Identities=41% Similarity=0.716 Sum_probs=148.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++||
T Consensus 126 ~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 202 (326)
T 1blx_A 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDL 202 (326)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC--CCccccccccceeCHHHHhc-CCCCcchhH
Confidence 369999999999999999999999999999999999999999765432 23345678999999999976 458999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+...++.+....|..........+... ....+......++..+.+||.+|
T Consensus 203 ~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~ 280 (326)
T 1blx_A 203 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKC 280 (326)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhccc--CcchhhhccccCCHHHHHHHHHH
Confidence 9999999999999999999999999999999999888777764322111111111 11234455678899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|..||.+|||+.++|+||||+....
T Consensus 281 L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 281 LTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cCCCcccCCCHHHHhcCccccccch
Confidence 9999999999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=271.47 Aligned_cols=176 Identities=23% Similarity=0.399 Sum_probs=136.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-------------------------CCcEEEEecCCccccCCCCCCCccc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------------------------EGVLKLADFGLANFSNTGHRQPLTS 55 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-------------------------~g~vKL~DFGla~~~~~~~~~~~~~ 55 (468)
+.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ...
T Consensus 143 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~ 218 (360)
T 3llt_A 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGS 218 (360)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCS
T ss_pred HHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcC
Confidence 369999999999999999999999999975 788999999999765432 345
Q ss_pred cccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC--
Q 012191 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK-- 133 (468)
Q Consensus 56 ~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~-- 133 (468)
..||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+....+.++...+..........+.
T Consensus 219 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 297 (360)
T 3llt_A 219 IINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297 (360)
T ss_dssp CCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEET
T ss_pred ccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCc
Confidence 678999999999987 46899999999999999999999999999999999999988888876655432211110000
Q ss_pred ----CCCCCC----chh-------hhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhccccc
Q 012191 134 ----PQQPYD----SSL-------RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 134 ----~~~~~~----~~l-------~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
...+.. ..+ .......++.+.+||.+||++||.+|||+.++|+||||+
T Consensus 298 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp TTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred ccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 000000 000 001112357788999999999999999999999999995
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=272.66 Aligned_cols=148 Identities=22% Similarity=0.307 Sum_probs=117.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||+++||||||||+||||+.++.+||+|||+++....... ...+..+||+.|+|||++.+ ..|+.++|
T Consensus 164 ~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sD 242 (329)
T 4aoj_A 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESD 242 (329)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHH
T ss_pred HHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCcccc
Confidence 36999999999999999999999999999999999999999986544322 22345678999999999987 56899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||||||+| |+.||.+.+..+.+..+..... ++ ....+++++.+||.
T Consensus 243 vwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~-~~---------------------------~p~~~~~~~~~li~ 294 (329)
T 4aoj_A 243 VWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE-LE---------------------------RPRACPPEVYAIMR 294 (329)
T ss_dssp HHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC-CC---------------------------CCTTCCHHHHHHHH
T ss_pred ccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CC---------------------------CcccccHHHHHHHH
Confidence 9999999999998 8999999988888777754211 10 01357899999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||+.|++.+
T Consensus 295 ~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 295 GCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHCCSSTTTSCCHHHHHHH
T ss_pred HHcCcChhHCcCHHHHHHH
Confidence 9999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=271.26 Aligned_cols=148 Identities=22% Similarity=0.308 Sum_probs=124.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||+++||||||||+||||+.++.+||+|||+++...... ....+..+||+.|+|||++.+ ..|+.++|
T Consensus 151 ~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksD 229 (308)
T 4gt4_A 151 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSD 229 (308)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccch
Confidence 3699999999999999999999999999999999999999997654322 223445688999999999986 46999999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||||||++ |.+||.+.+..+.+..+......+ ....++..+.+||.
T Consensus 230 VwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~~~~li~ 281 (308)
T 4gt4_A 230 IWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP----------------------------CPDDCPAWVYALMI 281 (308)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CcccchHHHHHHHH
Confidence 9999999999998 899999998888777764421111 11357899999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||+.+++++
T Consensus 282 ~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 282 ECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=266.63 Aligned_cols=187 Identities=34% Similarity=0.592 Sum_probs=144.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC---------CccccccCCcccChhhhcCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---------PLTSRVVTLWYRPPELLLGA 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~---------~~~~~~gt~~Y~APE~l~g~ 71 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....+||+.|+|||++.+.
T Consensus 118 ~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 197 (353)
T 2b9h_A 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS 197 (353)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSC
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccC
Confidence 369999999999999999999999999999999999999999765432111 12345789999999998766
Q ss_pred CCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccc-cCCC-CCCCCchhhhhcCC
Q 012191 72 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHAT-LFKP-QQPYDSSLRETFKD 148 (468)
Q Consensus 72 ~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~-~~~~-~~~~~~~l~~~~~~ 148 (468)
..++.++|||||||++|+|++|.+||.+.+....+..++...+.+......... ..... .... .......+...+..
T Consensus 198 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
T 2b9h_A 198 AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR 277 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhccc
Confidence 678999999999999999999999999999999999999888877633211100 00000 0000 00011234555678
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
+++.+.+||.+||..||.+|||+.++|+||||+....+.
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 278 VNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred CCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 999999999999999999999999999999999876544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=276.93 Aligned_cols=148 Identities=24% Similarity=0.314 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||+++||||||||+|||++.++.+||+|||+|+........ .....+||+.|+|||++.+ ..|+.++||
T Consensus 192 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDV 270 (353)
T 4ase_A 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDV 270 (353)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccE
Confidence 69999999999999999999999999999999999999999866543222 2234578999999999987 569999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||+||||++ |.+||.+....+.+..++.....++ ....+++++.+||.+
T Consensus 271 wS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~ 323 (353)
T 4ase_A 271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLD 323 (353)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHH
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC---------------------------CCccCCHHHHHHHHH
Confidence 999999999998 9999998765554444433211111 012478899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||+.++++|
T Consensus 324 c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 324 CWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCcChhHCcCHHHHHHH
Confidence 999999999999999987
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=271.30 Aligned_cols=151 Identities=21% Similarity=0.289 Sum_probs=124.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||+++||||||||+||||+.++.+||+|||+++........ ......||+.|+|||++.+ ..|+.++|
T Consensus 134 ~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~D 212 (299)
T 4asz_A 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESD 212 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhh
Confidence 369999999999999999999999999999999999999999765433221 1223468999999999986 46999999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||+||||+| |++||.+.+..+.+..+......+ ....+++++.+||.
T Consensus 213 VwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~~~~li~ 264 (299)
T 4asz_A 213 VWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ----------------------------RPRTCPQEVYELML 264 (299)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccchHHHHHHHH
Confidence 9999999999998 899999998888887775522110 01357899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccC
Q 012191 159 TLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+||+.||.+|||+.+++ +|++.
T Consensus 265 ~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 265 GCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp HHTCSSGGGSCCHHHHH--HHHHH
T ss_pred HHcCCChhHCcCHHHHH--HHHHH
Confidence 99999999999999994 56653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=268.69 Aligned_cols=181 Identities=38% Similarity=0.652 Sum_probs=143.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++..... .....++|+.|+|||++.+...++.++||
T Consensus 132 ~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 207 (353)
T 3coi_A 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDI 207 (353)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC----CccccccCcCcCCHHHHhCcCCCCchhhH
Confidence 36999999999999999999999999999999999999999976543 23456789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC--CCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|..||.+.+..+.+..+.+..+.++.+++..........+. ........+...+..+++.+.+||.
T Consensus 208 ~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 287 (353)
T 3coi_A 208 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 287 (353)
T ss_dssp HHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHH
Confidence 99999999999999999999999999999999999887766543211000000 0000011233445678999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+||..||.+|||+.++|+||||+....
T Consensus 288 ~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 288 KMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHcCCCcccCCCHHHHhcCcchhhccC
Confidence 999999999999999999999987544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=273.03 Aligned_cols=178 Identities=27% Similarity=0.511 Sum_probs=137.0
Q ss_pred CHHHHHHHHHHH--hCCCeeccCCCCceEEC--CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCH--SRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLH--s~gIvHrDIKp~NILld--~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.||| +.||+||||||+||||+ .++.+||+|||++..... .....++|+.|+|||++.+ ..|+.
T Consensus 163 ~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~ 237 (382)
T 2vx3_A 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSRFYRSPEVLLG-MPYDL 237 (382)
T ss_dssp HHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHTT-CCCCT
T ss_pred HHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc----ccccccCCccccChHHHcC-CCCCc
Confidence 369999999999 57999999999999995 467899999999987643 2345688999999999987 45899
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCC--------Ccccc---------CCCCCCCC
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKL--------PHATL---------FKPQQPYD 139 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~--------~~~~~---------~~~~~~~~ 139 (468)
++||||||||+|+|++|.+||.+.+..+++..+...++.++...+..... +.... .....+..
T Consensus 238 ~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (382)
T 2vx3_A 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGT 317 (382)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTC
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcch
Confidence 99999999999999999999999999999999999999888766543211 00000 00000111
Q ss_pred chhhhhcC------------------CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 140 SSLRETFK------------------DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 140 ~~l~~~~~------------------~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
..+...+. ...+.+++||.+||++||.+|||+.|+|+||||+..
T Consensus 318 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 318 RKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 11111111 012478999999999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=268.41 Aligned_cols=156 Identities=25% Similarity=0.381 Sum_probs=134.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC--CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... .......+|+.|+|||++.+ ..++.++
T Consensus 108 ~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 184 (321)
T 1tki_A 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH-DVVSTAT 184 (321)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEEEEESCGGGSCHHHHTT-CEECHHH
T ss_pred HHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--CccccccCChhhcCcHHhcC-CCCCchh
Confidence 479999999999999999999999999987 789999999999876543 23445678999999999976 4578999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+.+..+.+..+......++. ..+..++.++.+||.
T Consensus 185 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~ 239 (321)
T 1tki_A 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------------------------EAFKEISIEAMDFVD 239 (321)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-------------------------HHHTTSCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-------------------------hhhccCCHHHHHHHH
Confidence 9999999999999999999999988888887764433332 234578999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
+||..||.+|||+.++|+||||+...
T Consensus 240 ~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 240 RLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHcCCChhHCcCHHHHhcChhhccCc
Confidence 99999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=266.69 Aligned_cols=182 Identities=32% Similarity=0.647 Sum_probs=141.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......+|++|+|||++.+...++.++||
T Consensus 130 ~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 208 (331)
T 4aaa_A 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDV 208 (331)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHH
T ss_pred HHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHH
Confidence 3699999999999999999999999999999999999999997654322 233456789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCc-cccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPH-ATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~-~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+....+.+..+....+......+.... .+. .....+...........++.+++.+.+||.
T Consensus 209 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 288 (331)
T 4aaa_A 209 WAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAK 288 (331)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHH
Confidence 999999999999999999999999999998888876654332110 000 001111222233455666789999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..||.+|||+.++|+||||+..
T Consensus 289 ~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 289 KCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HHhccCcccCCCHHHHhcCchhccC
Confidence 9999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=267.26 Aligned_cols=182 Identities=30% Similarity=0.502 Sum_probs=138.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .......+|++|+|||++.+...++.++||
T Consensus 140 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 217 (362)
T 3pg1_A 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217 (362)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHH
T ss_pred HHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHH
Confidence 469999999999999999999999999999999999999999754432 233456789999999999876678999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC---CCCCCCchhhhhcCCCcHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK---PQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||++|+|++|.+||.+.+..+.+..+....+.+....+.....+....+. ...............+++.+.+||
T Consensus 218 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 297 (362)
T 3pg1_A 218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297 (362)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHH
Confidence 99999999999999999999999999999999998876544322111100000 000111233455567899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
.+||..||.+|||+.++|+||||+...
T Consensus 298 ~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 298 AKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=260.37 Aligned_cols=155 Identities=27% Similarity=0.461 Sum_probs=130.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 122 ~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 199 (297)
T 3fxz_A 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199 (297)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHHC-SCBCTHHHH
T ss_pred HHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccCCccCCcCccChhhhcC-CCCCcHHHH
Confidence 4699999999999999999999999999999999999999987665432 23345688999999999987 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+....+..+........ .....++..+.+||.+|
T Consensus 200 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------------------------QNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------------------------SCGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------------CCccccCHHHHHHHHHH
Confidence 9999999999999999999888777666654321110 01135788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.++|+||||+..
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=271.98 Aligned_cols=155 Identities=27% Similarity=0.450 Sum_probs=128.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 130 ~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 207 (353)
T 3txo_A 130 AAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQE-MLYGPAVDW 207 (353)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHH-HHCTTHHHH
T ss_pred HHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-ccccccCCCcCeEChhhcCC-CCcCCccCC
Confidence 3699999999999999999999999999999999999999997543221 23455689999999999976 458999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..|.......+ ..++..+.+||.+|
T Consensus 208 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~~~~~~~li~~l 258 (353)
T 3txo_A 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP-----------------------------TWLHEDATGILKSF 258 (353)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHHH
T ss_pred CcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------------CCCCHHHHHHHHHH
Confidence 9999999999999999999999888888865321111 23788999999999
Q ss_pred cCCCCCCCcCH------HHHHhcccccCCCCC
Q 012191 161 LSVEPYKRATA------SAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRpTa------~e~L~Hp~F~~~p~~ 186 (468)
|..||.+||++ .++++||||+...|.
T Consensus 259 L~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 259 MTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp TCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred hhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 99999999998 999999999986553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=263.76 Aligned_cols=155 Identities=28% Similarity=0.422 Sum_probs=132.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC----cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ ..++.
T Consensus 120 ~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ 196 (326)
T 2y0a_A 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNY-EPLGL 196 (326)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT--SCCCCCCSCTTTCCHHHHTT-CCCCT
T ss_pred HHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC--CccccccCCcCcCCceeecC-CCCCc
Confidence 47999999999999999999999999998887 7999999999876543 23445679999999999876 46899
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++||||||||+|+|++|.+||.+.+..+.+..+.......+. ..+..++..+.+|
T Consensus 197 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l 251 (326)
T 2y0a_A 197 EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-------------------------EYFSNTSALAKDF 251 (326)
T ss_dssp HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-------------------------HHHTTSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-------------------------cccccCCHHHHHH
Confidence 999999999999999999999999888888777654333222 2235688999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|.+||..||.+|||+.++|+||||+..
T Consensus 252 i~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 252 IRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=275.31 Aligned_cols=155 Identities=34% Similarity=0.519 Sum_probs=132.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC---CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld---~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||.|||++||+||||||+|||++ .++.+||+|||++....... ......+||+.|+|||++.+ ..|+.+
T Consensus 116 ~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~ 193 (444)
T 3soa_A 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRK-DPYGKP 193 (444)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-CBCCCSCSCGGGCCHHHHTT-CCBCTH
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-ceeecccCCcccCCHHHhcC-CCCCCc
Confidence 47999999999999999999999999998 45789999999997665432 33455689999999999976 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+.+..+.+..+.......+... +..+++++.+||
T Consensus 194 ~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li 248 (444)
T 3soa_A 194 VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE-------------------------WDTVTPEAKDLI 248 (444)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT-------------------------TTTSCHHHHHHH
T ss_pred cccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc-------------------------cccCCHHHHHHH
Confidence 9999999999999999999999998888888766443333222 246889999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccC
Q 012191 158 ETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+||+.||.+|||+.++|+||||+.
T Consensus 249 ~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 249 NKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHcCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.33 Aligned_cols=163 Identities=26% Similarity=0.394 Sum_probs=135.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc----CCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----g~~~~s~ 76 (468)
+.||+.||.|||++||+||||||+||||+.++.+||+|||++..............+||+.|+|||++. +...|+.
T Consensus 181 ~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~ 260 (437)
T 4aw2_A 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260 (437)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECT
T ss_pred HHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCC
Confidence 369999999999999999999999999999999999999999766544333344568999999999986 2356899
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|||++|.+||.+.+..+.+.+|+....... + ...+..+++++++|
T Consensus 261 ~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~----------------p~~~~~~s~~~~dL 316 (437)
T 4aw2_A 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--------F----------------PTQVTDVSENAKDL 316 (437)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------C----------------CSSCCCSCHHHHHH
T ss_pred cCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc--------C----------------CcccccCCHHHHHH
Confidence 99999999999999999999999999888888865321110 0 01124589999999
Q ss_pred HHHhcCCCCCC--CcCHHHHHhcccccCCCCCC
Q 012191 157 IETLLSVEPYK--RATASAALASEYFSTKPYAC 187 (468)
Q Consensus 157 L~~mL~~DP~k--RpTa~e~L~Hp~F~~~p~~~ 187 (468)
|.+||..+|.+ |+++.++++||||+...|..
T Consensus 317 i~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 317 IRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp HHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred HHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 99999999988 99999999999999877753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=264.66 Aligned_cols=154 Identities=28% Similarity=0.440 Sum_probs=130.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 111 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 188 (337)
T 1o6l_A 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDW 188 (337)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSS-SCBCTTHHH
T ss_pred HHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-CcccccccChhhCChhhhcC-CCCCchhhc
Confidence 3699999999999999999999999999999999999999997543221 23456689999999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+.......+....... ...+++++.+||.+|
T Consensus 189 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-----------------------------PRTLSPEAKSLLAGL 239 (337)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred ccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999988877777765421111 025789999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|| ++.++++||||....|
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999 9999999999987655
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=268.49 Aligned_cols=154 Identities=32% Similarity=0.520 Sum_probs=130.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ ..|+.+
T Consensus 134 ~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~ 210 (362)
T 2bdw_A 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKK-DPYSKP 210 (362)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--CSCCCSCSCTTTCCHHHHTT-CCCCTH
T ss_pred HHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--cccccCCCCccccCHHHHcc-CCCCch
Confidence 47999999999999999999999999998654 5999999999766543 23455689999999999976 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+.+..+.+..+.......+.. .+..+++++.+||
T Consensus 211 ~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li 265 (362)
T 2bdw_A 211 VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-------------------------EWDTVTPEAKSLI 265 (362)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------------------------GGGGSCHHHHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHH
Confidence 999999999999999999999988888877776543332222 2246789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccC
Q 012191 158 ETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+||..||.+|||+.++|+||||..
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=261.71 Aligned_cols=187 Identities=34% Similarity=0.609 Sum_probs=141.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC-CCCcEEEEecCCccccCCCC--CCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld-~~g~vKL~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||+|||++||+|+||||+|||++ .++.+||+|||++....... ........+|.+|+|||++.+...++.+
T Consensus 126 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 205 (320)
T 2i6l_A 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKA 205 (320)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHH
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCch
Confidence 36999999999999999999999999997 56799999999997654321 1223445679999999998776678999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccC-CCCCCCCchhhhhcCCCcHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF-KPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
+|||||||++|+|++|..||.+.+..+.+..+...........+........... .........+......++..+.+|
T Consensus 206 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (320)
T 2i6l_A 206 IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF 285 (320)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHH
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHH
Confidence 9999999999999999999999999988888888766655444332110000000 000001122345556789999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
|.+||..||.+|||+.++|+||||+...++.
T Consensus 286 i~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 286 LEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred HHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 9999999999999999999999999876653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=274.16 Aligned_cols=164 Identities=26% Similarity=0.387 Sum_probs=133.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC------CCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG------ATDY 74 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g------~~~~ 74 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..............+||+.|+|||++.+ ...|
T Consensus 168 ~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~ 247 (412)
T 2vd5_A 168 LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247 (412)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEE
T ss_pred HHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCC
Confidence 3689999999999999999999999999999999999999998765443223345689999999999973 2468
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
+.++||||||||+|||++|.+||.+.+..+.+.+|........ + ......++++++
T Consensus 248 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~----------------p~~~~~~s~~~~ 303 (412)
T 2vd5_A 248 GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS--------L----------------PLVDEGVPEEAR 303 (412)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------C----------------C----CCCHHHH
T ss_pred ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC--------C----------------CccccCCCHHHH
Confidence 9999999999999999999999999998888888764211000 0 001135889999
Q ss_pred HHHHHhcCCCCCCC---cCHHHHHhcccccCCCCCCCC
Q 012191 155 NLIETLLSVEPYKR---ATASAALASEYFSTKPYACDL 189 (468)
Q Consensus 155 dLL~~mL~~DP~kR---pTa~e~L~Hp~F~~~p~~~~~ 189 (468)
+||.+||. +|.+| ++++++++||||+...|....
T Consensus 304 dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 304 DFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp HHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred HHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 99999999 99998 599999999999998776543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=268.77 Aligned_cols=177 Identities=27% Similarity=0.491 Sum_probs=136.3
Q ss_pred CHHHHHHHHHHHhC-CCeeccCCCCceEECCCC-----------------------------------------------
Q 012191 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEG----------------------------------------------- 32 (468)
Q Consensus 1 m~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g----------------------------------------------- 32 (468)
+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 152 ~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (397)
T 1wak_A 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231 (397)
T ss_dssp HHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGG
T ss_pred HHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccccc
Confidence 47999999999998 999999999999998775
Q ss_pred --cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCc------hHH
Q 012191 33 --VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVE 104 (468)
Q Consensus 33 --~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~------~~e 104 (468)
.+||+|||++..... .....++|+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+ ...
T Consensus 232 ~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 306 (397)
T 1wak_A 232 KLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306 (397)
T ss_dssp GCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHH
T ss_pred ccceEeccccccccccc----cCccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHH
Confidence 799999999976653 2345678999999999987 458999999999999999999999998654 567
Q ss_pred HHHHHHHHcCCCCchhhhccCCCccccC--------CCCCCCC--chhhhh---cCCCcHHHHHHHHHhcCCCCCCCcCH
Q 012191 105 QLHKIFKLCGSPPDDYWKKSKLPHATLF--------KPQQPYD--SSLRET---FKDLPTTAVNLIETLLSVEPYKRATA 171 (468)
Q Consensus 105 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~--------~~~~~~~--~~l~~~---~~~~s~~l~dLL~~mL~~DP~kRpTa 171 (468)
.+..+...++.++...+........... ....+.. ..+... ....+..+.+||.+||+.||.+|||+
T Consensus 307 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 386 (397)
T 1wak_A 307 HIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386 (397)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH
T ss_pred HHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH
Confidence 7888888899888766543322111000 0000000 001111 12345678999999999999999999
Q ss_pred HHHHhcccccC
Q 012191 172 SAALASEYFST 182 (468)
Q Consensus 172 ~e~L~Hp~F~~ 182 (468)
.++|+||||++
T Consensus 387 ~e~l~hp~~~~ 397 (397)
T 1wak_A 387 AECLRHPWLNS 397 (397)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhhCccccC
Confidence 99999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=258.60 Aligned_cols=153 Identities=27% Similarity=0.410 Sum_probs=126.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCC--CCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~--~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+... ++.++
T Consensus 143 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 221 (298)
T 2zv2_A 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKAL 221 (298)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHH
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchh
Confidence 4699999999999999999999999999999999999999998665432 22345678999999999876432 46789
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..||.+.........+.......+ ....+++.+.+||.
T Consensus 222 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~ 274 (298)
T 2zv2_A 222 DVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFP---------------------------DQPDIAEDLKDLIT 274 (298)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------------------SSSCCCHHHHHHHH
T ss_pred hhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCC---------------------------CccccCHHHHHHHH
Confidence 999999999999999999998877666555543211110 11357899999999
Q ss_pred HhcCCCCCCCcCHHHHHhccccc
Q 012191 159 TLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
+||..||.+|||+.++|+||||+
T Consensus 275 ~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 275 RMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHhhcChhhCCCHHHHhcCcccc
Confidence 99999999999999999999996
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=273.89 Aligned_cols=161 Identities=30% Similarity=0.419 Sum_probs=134.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCC---CCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD---YGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~---~s~~ 77 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..............+||+.|+|||++.+... |+.+
T Consensus 174 ~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~ 253 (410)
T 3v8s_A 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253 (410)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETH
T ss_pred HHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCc
Confidence 3699999999999999999999999999999999999999998765443333446789999999999976332 7889
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+.+..+.+.+|......... .....++.++++||
T Consensus 254 ~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------p~~~~~s~~~~~li 308 (410)
T 3v8s_A 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF-------------------------PDDNDISKEAKNLI 308 (410)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC-------------------------CTTCCCCHHHHHHH
T ss_pred ceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC-------------------------CCcccccHHHHHHH
Confidence 99999999999999999999999988888888653211100 01135789999999
Q ss_pred HHhcCCCCCC--CcCHHHHHhcccccCCCCC
Q 012191 158 ETLLSVEPYK--RATASAALASEYFSTKPYA 186 (468)
Q Consensus 158 ~~mL~~DP~k--RpTa~e~L~Hp~F~~~p~~ 186 (468)
.+||..+|.+ |+++.++++||||+...|.
T Consensus 309 ~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 309 CAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp HHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred HHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 9999999988 9999999999999987664
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=260.85 Aligned_cols=152 Identities=23% Similarity=0.381 Sum_probs=131.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....+||+.|+|||++.+ ..|+.++||
T Consensus 112 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 186 (318)
T 1fot_A 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVST-KPYNKSIDW 186 (318)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCCCCSCTTTCCHHHHTT-CCBCTTHHH
T ss_pred HHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----ccccccCCccccCHhHhcC-CCCCcccch
Confidence 36999999999999999999999999999999999999999976543 2345688999999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+....+..+.......+ ..++.++.+||.+|
T Consensus 187 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~~~~~~~li~~l 237 (318)
T 1fot_A 187 WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP-----------------------------PFFNEDVKDLLSRL 237 (318)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------------CCCCHHHHHHHHHH
Confidence 9999999999999999999888888877765321111 24788999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~~ 186 (468)
|..||.+|+ ++.++++||||+...|.
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred hccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 999999999 99999999999986653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=264.90 Aligned_cols=154 Identities=27% Similarity=0.443 Sum_probs=131.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 127 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 204 (353)
T 2i0e_A 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDW 204 (353)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT-CCBSTHHHH
T ss_pred HHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcC-CCcCCcccc
Confidence 3699999999999999999999999999999999999999997543221 23455689999999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..|.......+ ..++.++.+||.+|
T Consensus 205 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~~li~~l 255 (353)
T 2i0e_A 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP-----------------------------KSMSKEAVAICKGL 255 (353)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHHH
T ss_pred cchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------------CCCCHHHHHHHHHH
Confidence 9999999999999999999988888888765221111 25789999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|| ++.++++||||+...|
T Consensus 256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp TCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred hhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 999999999 4799999999998665
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=267.82 Aligned_cols=155 Identities=31% Similarity=0.419 Sum_probs=132.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE--CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl--d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... .....+||+.|+|||++.+ ..++.++
T Consensus 193 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~ 269 (373)
T 2x4f_A 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNY-DFVSFPT 269 (373)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCCCSSCTTCCHHHHTT-CBCCHHH
T ss_pred HHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccccCCCcEeChhhccC-CCCCcHH
Confidence 3699999999999999999999999999 566789999999998765432 3345578999999999876 4688899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||||+|+|++|..||.+.+..+.+..+......++. ..+..+++++++||.
T Consensus 270 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 270 DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-------------------------EEFQDISEEAKEFIS 324 (373)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS-------------------------GGGTTSCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh-------------------------hhhccCCHHHHHHHH
Confidence 9999999999999999999999998888888764332221 223568899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..||.+|||+.++|+||||+..
T Consensus 325 ~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHcCCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=260.62 Aligned_cols=159 Identities=26% Similarity=0.409 Sum_probs=131.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... .......+|+.|+|||++.+ ..++.+
T Consensus 137 ~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~ 213 (327)
T 3lm5_A 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNY-DPITTA 213 (327)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTT-CCCCTH
T ss_pred HHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc--cccccccCCcCccCCeeecC-CCCCch
Confidence 469999999999999999999999999987 789999999999876543 22345678999999999976 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|..||.+.+..+.+..+.......+. ..+..++..+.+||
T Consensus 214 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li 268 (327)
T 3lm5_A 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-------------------------ETFSSVSQLATDFI 268 (327)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------------------TTTTTSCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-------------------------hhhcccCHHHHHHH
Confidence 99999999999999999999999888887777664433322 12246789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPYAC 187 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~ 187 (468)
.+||..||.+|||+.++|+||||+...+..
T Consensus 269 ~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 269 QSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp HHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred HHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 999999999999999999999999877653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-31 Score=266.36 Aligned_cols=155 Identities=32% Similarity=0.481 Sum_probs=131.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 124 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 201 (345)
T 1xjd_A 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLG-QKYNHSVDW 201 (345)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcC-CCCCChhhh
Confidence 3699999999999999999999999999999999999999997543221 23456689999999999987 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+....... ...++.++.+||.+|
T Consensus 202 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~l 252 (345)
T 1xjd_A 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY-----------------------------PRWLEKEAKDLLVKL 252 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC-----------------------------CcccCHHHHHHHHHH
Confidence 999999999999999999998888877775421110 024788999999999
Q ss_pred cCCCCCCCcCHH-HHHhcccccCCCCC
Q 012191 161 LSVEPYKRATAS-AALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRpTa~-e~L~Hp~F~~~p~~ 186 (468)
|..||.+||++. ++++||||+...|.
T Consensus 253 L~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 253 FVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred hcCCHhHcCCChHHHHcCccccCCCHH
Confidence 999999999998 99999999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=259.95 Aligned_cols=181 Identities=30% Similarity=0.561 Sum_probs=133.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ......+|..|+|||++.+...++.++|
T Consensus 136 ~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~D 213 (330)
T 3nsz_A 136 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLD 213 (330)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHH
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--ccccccccccccChhhhcCCCcCCchhh
Confidence 46999999999999999999999999999777 89999999998765432 3445678999999999987677899999
Q ss_pred eeeeehhhhhhhhcCCCC-CCCchHHHHHHHHHHcCCCCchh-hhccCCCcccc----CC--CCCCCCchh-hhhcCCCc
Q 012191 80 LWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPPDDY-WKKSKLPHATL----FK--PQQPYDSSL-RETFKDLP 150 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf-~g~~~~e~l~~i~~~~g~p~~~~-~~~~~~~~~~~----~~--~~~~~~~~l-~~~~~~~s 150 (468)
||||||++|+|++|..|| .+....+.+..+...++.+.... +.......... .. ....+...+ ......++
T Consensus 214 iwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (330)
T 3nsz_A 214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 293 (330)
T ss_dssp HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCC
T ss_pred HHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCC
Confidence 999999999999999888 45566677777766655432111 11111000000 00 000000000 11123478
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+++.+||.+||.+||.+|||+.++|+||||+..
T Consensus 294 ~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 294 PEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 999999999999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=257.48 Aligned_cols=176 Identities=26% Similarity=0.453 Sum_probs=137.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-------------------CCcEEEEecCCccccCCCCCCCccccccCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-------------------EGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-------------------~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~ 61 (468)
+.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... .....+|+.
T Consensus 124 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~ 199 (339)
T 1z57_A 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRH 199 (339)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGG
T ss_pred HHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCcc
Confidence 469999999999999999999999999987 667999999999765432 344578999
Q ss_pred ccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCc-
Q 012191 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS- 140 (468)
Q Consensus 62 Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~- 140 (468)
|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...+......... ......+..
T Consensus 200 y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~ 277 (339)
T 1z57_A 200 YRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYF-HHDRLDWDEH 277 (339)
T ss_dssp GCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGE-ETTEECCCTT
T ss_pred ccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHH-hhcccccccc
Confidence 999999986 46899999999999999999999999999999999888888888887765543211100 000000000
Q ss_pred -h-----------h---hhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 141 -S-----------L---RETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 141 -~-----------l---~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
. + .......++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred ccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 0 0 0011224678999999999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=259.04 Aligned_cols=160 Identities=28% Similarity=0.435 Sum_probs=129.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC--cEEEEecCCccccCCC---CCCCccccccCCcccChhhhcCC-CCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTG---HRQPLTSRVVTLWYRPPELLLGA-TDY 74 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g--~vKL~DFGla~~~~~~---~~~~~~~~~gt~~Y~APE~l~g~-~~~ 74 (468)
+.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+... .........+|+.|+|||++.+. ..+
T Consensus 174 ~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 174 MRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence 36999999999999999999999999998776 8999999999765332 11223456789999999999653 568
Q ss_pred CCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 75 GPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 75 s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
+.++|||||||++|+|++|..||.+....+.+..+.......+. ..+..+++.+.
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~ 308 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLAR 308 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHH
Confidence 89999999999999999999999999988888777653322221 12235789999
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+||.+||..||.+|||+.++|+||||+...+
T Consensus 309 ~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 309 DLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=259.28 Aligned_cols=177 Identities=27% Similarity=0.471 Sum_probs=138.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE-------------------CCCCcEEEEecCCccccCCCCCCCccccccCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV-------------------NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLW 61 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl-------------------d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~ 61 (468)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... .....+|+.
T Consensus 129 ~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~ 204 (355)
T 2eu9_A 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRH 204 (355)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGG
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCc
Confidence 3699999999999999999999999999 56788999999999765432 345578999
Q ss_pred ccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCc-
Q 012191 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDS- 140 (468)
Q Consensus 62 Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~- 140 (468)
|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++..++........ .+.....+..
T Consensus 205 y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~ 282 (355)
T 2eu9_A 205 YRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKY-FYKGGLVWDEN 282 (355)
T ss_dssp GCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGG-EETTEECCCTT
T ss_pred ccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhh-hcccccccccc
Confidence 999999976 4689999999999999999999999999999999999999999888776544321110 0000000000
Q ss_pred -----hhh----------hhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 141 -----SLR----------ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 141 -----~l~----------~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+. ......+..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 283 SSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred cchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 000 0011235679999999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=262.09 Aligned_cols=155 Identities=32% Similarity=0.528 Sum_probs=131.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-----CCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-----TDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~-----~~~s 75 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+. ..++
T Consensus 206 ~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 283 (365)
T 2y7j_A 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYG 283 (365)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBC
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC--cccccCCCCCCccChhhccccccccCcCCC
Confidence 469999999999999999999999999999999999999999876543 234556889999999998632 3578
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++||||||||+|+|++|.+||.+......+..+......++. ..+..++..+.+
T Consensus 284 ~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~ 338 (365)
T 2y7j_A 284 KEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS-------------------------PEWDDRSSTVKD 338 (365)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH-------------------------HHHSSSCHHHHH
T ss_pred chhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-------------------------cccccCCHHHHH
Confidence 8999999999999999999999998887777776553322221 223567899999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||.+||..||.+|||+.++|+||||+.
T Consensus 339 li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 339 LISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999973
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=262.19 Aligned_cols=155 Identities=26% Similarity=0.435 Sum_probs=126.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc---EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~---vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++.++. +||+|||++....... ......+||+.|+|||++.+ ..|+.+
T Consensus 136 ~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~ 213 (351)
T 3c0i_A 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKP 213 (351)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTH
T ss_pred HHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcC-CCCCch
Confidence 469999999999999999999999999986654 9999999998765432 22345689999999999976 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+.. ...+..+.......+ ...+..++..+.+||
T Consensus 214 ~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li 267 (351)
T 3c0i_A 214 VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN-------------------------PRQWSHISESAKDLV 267 (351)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC-------------------------HHHHTTSCHHHHHHH
T ss_pred HhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC-------------------------ccccccCCHHHHHHH
Confidence 999999999999999999998754 344444443222111 123356889999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||..||.+|||+.++|+||||+..
T Consensus 268 ~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 268 RRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHCCCChhHCcCHHHHhcChhhcCC
Confidence 99999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=258.60 Aligned_cols=154 Identities=29% Similarity=0.489 Sum_probs=127.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 127 ~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 204 (327)
T 3a62_A 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDW 204 (327)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTT-SCCCTHHHH
T ss_pred HHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcC-CCCCCcccc
Confidence 3699999999999999999999999999999999999999987543221 22345678999999999976 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+.......+ ..++..+.+||.+|
T Consensus 205 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~~~~~~~li~~~ 255 (327)
T 3a62_A 205 WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP-----------------------------PYLTQEARDLLKKL 255 (327)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-----------------------------TTSCHHHHHHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------------CCCCHHHHHHHHHH
Confidence 9999999999999999999988888877765321111 24788999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|| ++.++|+||||+...|
T Consensus 256 L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 256 LKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp SCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 999999999 8999999999987654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=262.75 Aligned_cols=151 Identities=25% Similarity=0.377 Sum_probs=131.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....+||+.|+|||++.+ ..|+.++||
T Consensus 147 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di 221 (350)
T 1rdq_E 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS-KGYNKAVDW 221 (350)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcC-CCCCCcCCE
Confidence 369999999999999999999999999999999999999999866532 345688999999999986 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+....... ...++..+.+||.+|
T Consensus 222 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~~~~~~~li~~l 272 (350)
T 1rdq_E 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----------------------------PSHFSSDLKDLLRNL 272 (350)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------------------CTTCCHHHHHHHHHH
T ss_pred ecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999998888887776521111 024788999999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
|+.||.+||+ +.++++||||....|
T Consensus 273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred hhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 9999999998 999999999997655
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=250.26 Aligned_cols=153 Identities=35% Similarity=0.569 Sum_probs=131.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE---CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++...... .......+|+.|+|||++.+ .++.+
T Consensus 112 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~ 187 (277)
T 3f3z_A 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVLEG--LYGPE 187 (277)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTT
T ss_pred HHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--cchhccCCCCCccChHHhcc--cCCch
Confidence 3699999999999999999999999999 77889999999999776543 23345678999999999876 48999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|..||.+.+..+....+.......+.. .+..+++.+.+||
T Consensus 188 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li 242 (277)
T 3f3z_A 188 CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK-------------------------DWLNVSPQAESLI 242 (277)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-------------------------HHTTSCHHHHHHH
T ss_pred hhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-------------------------hhhcCCHHHHHHH
Confidence 999999999999999999999998888887776644333322 2246789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccC
Q 012191 158 ETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+||+.||.+|||+.++|+||||+.
T Consensus 243 ~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 243 RRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHccCChhhCcCHHHHhcCHHHhc
Confidence 9999999999999999999999976
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=269.40 Aligned_cols=154 Identities=27% Similarity=0.449 Sum_probs=129.6
Q ss_pred CHHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||+ .||+||||||+||||+.++.+||+|||++...... .......+||+.|+|||++.+ ..|+.++|
T Consensus 254 ~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 331 (446)
T 4ejn_A 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEYLAPEVLED-NDYGRAVD 331 (446)
T ss_dssp HHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHT-SCCCTHHH
T ss_pred HHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-CcccccccCCccccCHhhcCC-CCCCCccc
Confidence 3699999999998 99999999999999999999999999999754322 223456789999999999976 56899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||||+|+|++|.+||.+.+....+..+.......+ ..+++++.+||.+
T Consensus 332 iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~~~~~~~li~~ 382 (446)
T 4ejn_A 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-----------------------------RTLGPEAKSLLSG 382 (446)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHH
T ss_pred hhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------------ccCCHHHHHHHHH
Confidence 99999999999999999999888877777654221111 2478899999999
Q ss_pred hcCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 160 LLSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 160 mL~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
||..||.+|| |+.++|+||||+...|
T Consensus 383 ~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 383 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 9999999999 9999999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=250.32 Aligned_cols=157 Identities=31% Similarity=0.508 Sum_probs=131.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc---EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~---vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+|||++.++. +||+|||++...... .......+|+.|+|||++.+ ..++.+
T Consensus 111 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~ 187 (284)
T 3kk8_A 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKK-DPYSKP 187 (284)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--CBCCCSCSCGGGCCHHHHTT-CCBCTH
T ss_pred HHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--ccccCCCCCcCCcCchhhcC-CCCCcc
Confidence 469999999999999999999999999986655 999999999766543 23345678999999999976 458999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|..||.+.........+.......+.. .+..+++.+.+||
T Consensus 188 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li 242 (284)
T 3kk8_A 188 VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-------------------------EWDTVTPEAKSLI 242 (284)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------------------------TTTTSCHHHHHHH
T ss_pred cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch-------------------------hhcccCHHHHHHH
Confidence 999999999999999999999988888777775543322211 1246789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
.+||+.||.+|||+.++|+||||+....
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 243 DSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=266.71 Aligned_cols=155 Identities=25% Similarity=0.428 Sum_probs=124.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .......+||+.|+|||++.+ ..|+.++||
T Consensus 159 ~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~Di 236 (396)
T 4dc2_A 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDW 236 (396)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-CCccccccCCcccCCchhhcC-CCCChHHHH
Confidence 369999999999999999999999999999999999999999753322 133456789999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCc---------hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH
Q 012191 81 WSVGCVFAELLIGKPILQGRT---------EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~---------~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 151 (468)
||||||+|+|++|.+||.+.. .......+...... ....++.
T Consensus 237 wslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----------------------------~p~~~s~ 287 (396)
T 4dc2_A 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----------------------------IPRSLSV 287 (396)
T ss_dssp HHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-----------------------------CCTTSCH
T ss_pred HHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-----------------------------CCCcCCH
Confidence 999999999999999996432 12222333221100 0135789
Q ss_pred HHHHHHHHhcCCCCCCCcCH------HHHHhcccccCCCCC
Q 012191 152 TAVNLIETLLSVEPYKRATA------SAALASEYFSTKPYA 186 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa------~e~L~Hp~F~~~p~~ 186 (468)
++++||.+||+.||.+||++ .++++||||+...|.
T Consensus 288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 99999999999999999995 899999999987653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=268.94 Aligned_cols=155 Identities=28% Similarity=0.446 Sum_probs=118.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... ......+||+.|+|||++.+ ..|+.+
T Consensus 167 ~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~ 243 (400)
T 1nxk_A 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKS 243 (400)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCC-CCSSSH
T ss_pred HHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC--CccccCCCCCCccCHhhcCC-CCCCCc
Confidence 479999999999999999999999999987 788999999999865432 23456688999999999865 568999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHH----HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVE----QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e----~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
+||||||||+|+|++|.+||.+..... ....+.......+ ...+..++.++
T Consensus 244 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~ 298 (400)
T 1nxk_A 244 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-------------------------NPEWSEVSEEV 298 (400)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC-------------------------TTTTTTSCHHH
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC-------------------------CcccccCCHHH
Confidence 999999999999999999998754322 2222222111111 11234688999
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 154 VNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||.+||..||.+|||+.++|+||||...
T Consensus 299 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 299 KMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=260.72 Aligned_cols=154 Identities=26% Similarity=0.438 Sum_probs=124.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 116 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 193 (345)
T 3a8x_A 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRG-EDYGFSVDW 193 (345)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCC-CCCChHHhH
Confidence 3699999999999999999999999999999999999999997533221 23456689999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCC---------chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH
Q 012191 81 WSVGCVFAELLIGKPILQGR---------TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~---------~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 151 (468)
||||||+|+|++|.+||... ........+...... ....++.
T Consensus 194 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----------------------------~p~~~s~ 244 (345)
T 3a8x_A 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----------------------------IPRSLSV 244 (345)
T ss_dssp HHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----------------------------CCTTSCH
T ss_pred HHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----------------------------CCCCCCH
Confidence 99999999999999999752 122223333221100 0125788
Q ss_pred HHHHHHHHhcCCCCCCCcCH------HHHHhcccccCCCC
Q 012191 152 TAVNLIETLLSVEPYKRATA------SAALASEYFSTKPY 185 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa------~e~L~Hp~F~~~p~ 185 (468)
.+.+||.+||..||.+||++ .++++||||+...|
T Consensus 245 ~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 99999999999999999995 89999999998665
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=255.72 Aligned_cols=155 Identities=28% Similarity=0.416 Sum_probs=131.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC----cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+|+||||+|||++.++ .+||+|||++...... .......+|+.|+|||++.+ ..++.
T Consensus 121 ~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ 197 (321)
T 2a2a_A 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNY-EPLGL 197 (321)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT--CCCCCCCSCGGGCCHHHHTT-CCCCT
T ss_pred HHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc--ccccccCCCCCccCcccccC-CCCCC
Confidence 36999999999999999999999999999887 7999999999866543 23345678999999999976 46899
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|..||.+.+..+.+..+.......+. ..+..++..+.+|
T Consensus 198 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~l 252 (321)
T 2a2a_A 198 EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE-------------------------EFFSHTSELAKDF 252 (321)
T ss_dssp HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------------------------HHHTTCCHHHHHH
T ss_pred ccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-------------------------hhhcccCHHHHHH
Confidence 999999999999999999999998888887777553322221 2235688999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|.+||..||.+|||+.++|+||||+..
T Consensus 253 i~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 253 IRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=265.84 Aligned_cols=156 Identities=28% Similarity=0.445 Sum_probs=131.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC--CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++. .+.+||+|||++...... ......++|+.|+|||++.+ ..++.++
T Consensus 155 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 231 (387)
T 1kob_A 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYT 231 (387)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEEEECSSGGGCCHHHHTT-CCBCHHH
T ss_pred HHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--cceeeeccCCCccCchhccC-CCCCCcc
Confidence 479999999999999999999999999974 467999999999876543 23345578999999999976 4688999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||||+|+|++|.+||.+.+..+.+..+.......+. ..+..+++++.+||.
T Consensus 232 DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 232 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-------------------------DAFSSVSPEAKDFIK 286 (387)
T ss_dssp HHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-------------------------STTTTSCHHHHHHHH
T ss_pred cEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------------cccccCCHHHHHHHH
Confidence 9999999999999999999999888887777553222111 123468899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
+||..||.+|||+.++|+||||+...
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 287 NLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-31 Score=268.96 Aligned_cols=152 Identities=29% Similarity=0.508 Sum_probs=122.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||
T Consensus 114 ~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 191 (336)
T 3h4j_B 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDV 191 (336)
T ss_dssp HHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHH
T ss_pred HHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--cccccccCCcCcCCHHHHcCCCCCCCccch
Confidence 479999999999999999999999999999999999999999866543 234556899999999999875545789999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.........+ . .........+++.+.+||.+|
T Consensus 192 wslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------~--------------~~~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 192 WSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------N--------------SCVYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp HHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------C--------------SSCCCCCTTSCHHHHHHHHTT
T ss_pred hHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------H--------------cCCCCCcccCCHHHHHHHHHH
Confidence 99999999999999999764321110000 0 000011135789999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.++|+||||+..
T Consensus 243 L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=260.46 Aligned_cols=157 Identities=28% Similarity=0.410 Sum_probs=125.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... .......+||+.|+|||++.+...++.++|
T Consensus 111 ~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 190 (323)
T 3tki_A 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190 (323)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHH
T ss_pred HHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCccc
Confidence 4799999999999999999999999999999999999999997654322 223345688999999999987555578899
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||.+................. ...+..++..+.+||.+
T Consensus 191 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~ 244 (323)
T 3tki_A 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------------------LNPWKKIDSAPLALLHK 244 (323)
T ss_dssp HHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------------------STTGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------------------CCccccCCHHHHHHHHH
Confidence 9999999999999999998765543222222111110 01124578999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||..||.+|||+.|+|+||||+..
T Consensus 245 ~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 245 ILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HccCChhhCcCHHHHhhChhhccc
Confidence 999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=257.32 Aligned_cols=148 Identities=30% Similarity=0.429 Sum_probs=119.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+ .++.++||
T Consensus 163 ~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~Di 238 (311)
T 3p1a_A 163 LRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GAGEVQEGDPRYMAPELLQG--SYGTAADV 238 (311)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT--CCSTHHHH
T ss_pred HHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CCCcccCCCccccCHhHhcC--CCCchhhH
Confidence 369999999999999999999999999999999999999998766543 23345578999999999886 58999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..+|.+..... .+.. +..+ ......+++.+.+||.+|
T Consensus 239 wslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~-------------------------~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 239 FSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLP-------------------------PEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp HHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCC-------------------------HHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCC-------------------------cccccCCCHHHHHHHHHH
Confidence 999999999999987776543322 2111 1111 122346889999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|+.||.+|||+.++|+||||++
T Consensus 289 L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 289 LEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp SCSSTTTSCCHHHHHTSGGGSC
T ss_pred cCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-30 Score=263.15 Aligned_cols=154 Identities=27% Similarity=0.400 Sum_probs=131.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 145 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 222 (373)
T 2r5t_A 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHK-QPYDRTVDW 222 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTT-CCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-CccccccCCccccCHHHhCC-CCCCchhhh
Confidence 3699999999999999999999999999999999999999997543221 23456689999999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|+|++|.+||.+.+..+.+..|....... ...++..+.+||.+|
T Consensus 223 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~li~~l 273 (373)
T 2r5t_A 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL-----------------------------KPNITNSARHLLEGL 273 (373)
T ss_dssp HHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC-----------------------------CSSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC-----------------------------CCCCCHHHHHHHHHH
Confidence 999999999999999999998888888876521110 135789999999999
Q ss_pred cCCCCCCCcCH----HHHHhcccccCCCC
Q 012191 161 LSVEPYKRATA----SAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa----~e~L~Hp~F~~~p~ 185 (468)
|+.||.+||++ .+++.||||+...|
T Consensus 274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp TCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred cccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 99999999986 69999999998665
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=255.07 Aligned_cols=156 Identities=27% Similarity=0.484 Sum_probs=129.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 147 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 224 (321)
T 2c30_A 147 CEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISR-SLYATEVDI 224 (321)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcC-CCCCchhhH
Confidence 3699999999999999999999999999999999999999987665432 22345678999999999976 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+......+..+.... ++. ......+++.+.+||.+|
T Consensus 225 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~------------------------~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--PPK------------------------LKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--CCC------------------------CTTGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCC------------------------cCccccCCHHHHHHHHHH
Confidence 999999999999999999888777766654321 100 001134788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|..||.+|||+.++|+||||....
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=260.31 Aligned_cols=178 Identities=30% Similarity=0.565 Sum_probs=133.3
Q ss_pred CHHHHHHHHHHHhC-CCeeccCCCCceEEC------CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCC
Q 012191 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVN------NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~-gIvHrDIKp~NILld------~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~ 73 (468)
+.||+.||.|||++ ||+||||||+||||+ ..+.+||+|||++..... ......+|+.|+|||++.+ ..
T Consensus 137 ~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~ 211 (373)
T 1q8y_A 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-AP 211 (373)
T ss_dssp HHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CC
T ss_pred HHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC----CCCCCCCCccccCcHHHhC-CC
Confidence 36999999999998 999999999999994 344799999999976653 2345578999999999987 45
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCc------hHHHHHHHHHHcCCCCchhhhccCCCcc-----ccCCCCC-----C
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHA-----TLFKPQQ-----P 137 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~------~~e~l~~i~~~~g~p~~~~~~~~~~~~~-----~~~~~~~-----~ 137 (468)
++.++||||||||+|+|++|.+||.+.. ....+..+...++.++...+...+.... ..+.... +
T Consensus 212 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (373)
T 1q8y_A 212 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291 (373)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc
Confidence 8999999999999999999999998754 5677888888899888766544322100 0000000 0
Q ss_pred CCchhhhhc---CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 138 YDSSLRETF---KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 138 ~~~~l~~~~---~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
....+...+ ..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 000111111 2356789999999999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-30 Score=259.88 Aligned_cols=156 Identities=30% Similarity=0.474 Sum_probs=118.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... ......+||+.|+|||++.+ ..++.+
T Consensus 154 ~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~ 230 (349)
T 2w4o_A 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRG-CAYGPE 230 (349)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTT-CCCCTH
T ss_pred HHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--cccccccCCCCccCHHHhcC-CCCCcc
Confidence 469999999999999999999999999975 789999999999765432 22345678999999999976 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHH-HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e-~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
+||||||||+|+|++|..||.+..... .+..+.......+ ...+..++..+.+|
T Consensus 231 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~l 285 (349)
T 2w4o_A 231 VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI-------------------------SPWWDEVSLNAKDL 285 (349)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC-------------------------TTTTTTSCHHHHHH
T ss_pred cchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC-------------------------CchhhhCCHHHHHH
Confidence 999999999999999999997766544 4444433221111 11234688999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|.+||..||.+|||+.++|+||||....
T Consensus 286 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 286 VRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-30 Score=249.90 Aligned_cols=152 Identities=30% Similarity=0.449 Sum_probs=120.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE---CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++...... .......+|+.|+|||++.+ .++.+
T Consensus 130 ~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~ 205 (285)
T 3is5_A 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVFKR--DVTFK 205 (285)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHTT--CCCHH
T ss_pred HHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc--ccCcCcccccCcCChHHhcc--CCCcc
Confidence 3699999999999999999999999999 44578999999999765543 22345678999999999864 57899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|..||.+....+....+........ .....+++.+.+||
T Consensus 206 ~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li 259 (285)
T 3is5_A 206 CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA--------------------------VECRPLTPQAVDLL 259 (285)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------------------C--CCCCHHHHHHH
T ss_pred cCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc--------------------------cccCcCCHHHHHHH
Confidence 9999999999999999999998877666555433211110 11134788999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccC
Q 012191 158 ETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+||..||.+|||+.++|+||||+.
T Consensus 260 ~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 260 KQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=269.04 Aligned_cols=152 Identities=32% Similarity=0.541 Sum_probs=130.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||
T Consensus 122 ~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 199 (476)
T 2y94_A 122 FQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDI 199 (476)
T ss_dssp HHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHH
T ss_pred HHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--ccccccCCCcCeEChhhccCCCCCCCccee
Confidence 479999999999999999999999999999999999999999876543 234556899999999999875545789999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|+|++|..||.+.+....+..+.......+ ..+++.+.+||.+|
T Consensus 200 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 200 WSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP-----------------------------QYLNPSVISLLKHM 250 (476)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC-----------------------------TTCCHHHHHHHHHH
T ss_pred hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC-----------------------------ccCCHHHHHHHHHH
Confidence 9999999999999999999887777777654221111 24688999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.++|+||||+..
T Consensus 251 L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 251 LQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TCSSTTTSCCHHHHHTCHHHHTT
T ss_pred cCCCchhCcCHHHHHhCHHhhhc
Confidence 99999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=248.51 Aligned_cols=151 Identities=34% Similarity=0.544 Sum_probs=125.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ......+|+.|+|||++.+ ..++.++||
T Consensus 115 ~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 190 (279)
T 3fdn_A 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEG-RMHDEKVDL 190 (279)
T ss_dssp HHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTT-CCCCTTHHH
T ss_pred HHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---cccccCCCCCccCHhHhcc-CCCCccchh
Confidence 369999999999999999999999999999999999999988654432 2345578999999999976 467899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+..+....+.......+ ..++..+.+||.+|
T Consensus 191 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~li~~~ 241 (279)
T 3fdn_A 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP-----------------------------DFVTEGARDLISRL 241 (279)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----------------------------TTSCHHHHHHHHHH
T ss_pred HhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC-----------------------------CcCCHHHHHHHHHH
Confidence 9999999999999999999888777777654321111 24678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|..||.+|||+.++|+||||+...
T Consensus 242 l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 242 LKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred hccChhhCCCHHHHhhCccccCCc
Confidence 999999999999999999998743
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=261.42 Aligned_cols=156 Identities=28% Similarity=0.416 Sum_probs=124.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC----CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE----GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~----g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||+|||++||+||||||+|||+... +.+||+|||++....... ......++|+.|+|||++.+ ..|+.
T Consensus 122 ~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ 199 (342)
T 2qr7_A 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLER-QGYDA 199 (342)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-CCBCCSSCCSSCCCHHHHHH-HHHHH
T ss_pred HHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-CceeccCCCccccCHHHhcC-CCCCC
Confidence 4799999999999999999999999998543 359999999998665432 23345678999999999976 34788
Q ss_pred CcceeeeehhhhhhhhcCCCCCCC---chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGR---TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~---~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
++|||||||++|+|++|.+||.+. +..+.+..+.......+. ..+..++.++
T Consensus 200 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~ 254 (342)
T 2qr7_A 200 ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG-------------------------GYWNSVSDTA 254 (342)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-------------------------TTTTTSCHHH
T ss_pred ccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-------------------------cccccCCHHH
Confidence 999999999999999999999863 444555555432211111 1234688999
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 154 VNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||.+||..||.+|||+.++|+||||..+
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 999999999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=261.45 Aligned_cols=154 Identities=25% Similarity=0.393 Sum_probs=126.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ......+||+.|+|||++.+ ...|+.++
T Consensus 121 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 198 (384)
T 4fr4_A 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198 (384)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTH
T ss_pred HHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--CceeccCCCccccCCeeeccCCCCCCCccc
Confidence 369999999999999999999999999999999999999999876543 34456789999999999964 23588999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCch---HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~---~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
||||||||+|+|++|.+||.+... .+.+..+....... ...++..+.+
T Consensus 199 DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------------------------p~~~s~~~~~ 249 (384)
T 4fr4_A 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY-----------------------------PSAWSQEMVS 249 (384)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHH
T ss_pred eeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC-----------------------------CCcCCHHHHH
Confidence 999999999999999999975432 23333332211110 1357889999
Q ss_pred HHHHhcCCCCCCCcC-HHHHHhcccccCCCC
Q 012191 156 LIETLLSVEPYKRAT-ASAALASEYFSTKPY 185 (468)
Q Consensus 156 LL~~mL~~DP~kRpT-a~e~L~Hp~F~~~p~ 185 (468)
||.+||+.||.+||+ +.++++||||....|
T Consensus 250 li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred HHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 999999999999998 999999999998765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=280.31 Aligned_cols=155 Identities=27% Similarity=0.441 Sum_probs=133.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 448 ~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~Dv 525 (674)
T 3pfq_A 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDW 525 (674)
T ss_dssp HHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTC-CCBSTHHHH
T ss_pred HHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-cccccccCCCcccCHhhhcC-CCCCccceE
Confidence 3699999999999999999999999999999999999999997543222 23456789999999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||||||++|.+||.+.+..+.+..|.......+ ..++.++.+||.+|
T Consensus 526 wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~~li~~l 576 (674)
T 3pfq_A 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP-----------------------------KSMSKEAVAICKGL 576 (674)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC-----------------------------TTSCHHHHHHHHHH
T ss_pred echHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC-----------------------------ccCCHHHHHHHHHH
Confidence 9999999999999999999999888888865221111 35789999999999
Q ss_pred cCCCCCCCcCH-----HHHHhcccccCCCCC
Q 012191 161 LSVEPYKRATA-----SAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRpTa-----~e~L~Hp~F~~~p~~ 186 (468)
|..||.+|+++ .++++||||+...|.
T Consensus 577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp SCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred ccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 99999999997 999999999987663
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=253.67 Aligned_cols=159 Identities=25% Similarity=0.384 Sum_probs=117.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc---EEEEecCCccccCCCC------CCCccccccCCcccChhhhcCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGH------RQPLTSRVVTLWYRPPELLLGA 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~---vKL~DFGla~~~~~~~------~~~~~~~~gt~~Y~APE~l~g~ 71 (468)
+.||+.||+|||++||+||||||+|||++.++. +||+|||++....... .......+||+.|+|||++.+.
T Consensus 117 ~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 196 (316)
T 2ac3_A 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196 (316)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHT
T ss_pred HHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcc
Confidence 469999999999999999999999999988765 9999999987553221 1122345689999999998641
Q ss_pred ----CCCCCCcceeeeehhhhhhhhcCCCCCCCch---------------HHHHHHHHHHcCCCCchhhhccCCCccccC
Q 012191 72 ----TDYGPSVDLWSVGCVFAELLIGKPILQGRTE---------------VEQLHKIFKLCGSPPDDYWKKSKLPHATLF 132 (468)
Q Consensus 72 ----~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~---------------~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 132 (468)
..++.++|||||||++|+|++|.+||.+... ...+..+.......+
T Consensus 197 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--------------- 261 (316)
T 2ac3_A 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP--------------- 261 (316)
T ss_dssp SHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC---------------
T ss_pred cccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC---------------
Confidence 3478899999999999999999999987542 122233322111111
Q ss_pred CCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 133 KPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 133 ~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
...+..++..+++||.+||..||.+|||+.++|+||||+...
T Consensus 262 ----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 262 ----------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp ----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ----------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 122346889999999999999999999999999999998743
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=261.98 Aligned_cols=158 Identities=21% Similarity=0.258 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC-CCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-ATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g-~~~~s~~sDI 80 (468)
.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .....+|+.|+|||++.+ ...|+.++||
T Consensus 201 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~Di 276 (371)
T 3q60_A 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNA 276 (371)
T ss_dssp HHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred HHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccH
Confidence 79999999999999999999999999999999999999999866432 224566799999999975 2468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+..... ...|......... . .......+..+++.+.+||.+|
T Consensus 277 wSlG~il~elltg~~Pf~~~~~~~-------------~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 277 WQLGLSIYRVWCLFLPFGLVTPGI-------------KGSWKRPSLRVPG--T-----DSLAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp HHHHHHHHHHHHSSCSTTBCCTTC-------------TTCCCBCCTTSCC--C-----CSCCCTTSSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcCccc-------------ccchhhhhhhhcc--c-----cccchhhccCCCHHHHHHHHHH
Confidence 999999999999999998653210 0011100000000 0 0000112357899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|+.||.+|||+.++|+||||+..
T Consensus 337 L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 337 LNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cCCChhhCCCHHHHhcCHHHHHH
Confidence 99999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=260.64 Aligned_cols=158 Identities=27% Similarity=0.386 Sum_probs=111.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc--EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~--vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++. +||+|||++...... ......+||++|+|||++.+...++.++
T Consensus 122 ~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 199 (361)
T 3uc3_A 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIA 199 (361)
T ss_dssp HHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCee
Confidence 479999999999999999999999999987765 999999998743322 2234567899999999998755444559
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+......+..+.......... . .....+++.+.+||.
T Consensus 200 DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~------~-----------------~~~~~~s~~~~~li~ 256 (361)
T 3uc3_A 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS------I-----------------PDDIRISPECCHLIS 256 (361)
T ss_dssp HHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC------C-----------------CTTSCCCHHHHHHHH
T ss_pred eeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC------C-----------------CCcCCCCHHHHHHHH
Confidence 99999999999999999998755432222222211110000 0 001247899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..||.+|||+.++|+||||...
T Consensus 257 ~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 257 RIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHccCChhHCcCHHHHHhCcchhcC
Confidence 9999999999999999999999763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=259.50 Aligned_cols=156 Identities=37% Similarity=0.582 Sum_probs=106.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ......++|+.|+|||++.+ ..|+.+
T Consensus 112 ~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~ 189 (325)
T 3kn6_A 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQ-NGYDES 189 (325)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHH
T ss_pred HHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCCCcCccCHHHhcC-CCCCCc
Confidence 47999999999999999999999999997765 79999999997655432 33455678999999999876 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCch-------HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCc
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTE-------VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 150 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~-------~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s 150 (468)
+|||||||++|+|++|.+||.+... .+.+..+.......+ ...+..++
T Consensus 190 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s 244 (325)
T 3kn6_A 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE-------------------------GEAWKNVS 244 (325)
T ss_dssp HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-------------------------SHHHHTSC
T ss_pred cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-------------------------cccccCCC
Confidence 9999999999999999999987543 233333322211111 12234689
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+++++||.+||..||.+|||+.++|+||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 999999999999999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=261.11 Aligned_cols=185 Identities=19% Similarity=0.253 Sum_probs=123.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC------CCCccccccCCcccChhhhcCC-CC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH------RQPLTSRVVTLWYRPPELLLGA-TD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~------~~~~~~~~gt~~Y~APE~l~g~-~~ 73 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......+||+.|+|||++.+. ..
T Consensus 134 ~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 213 (389)
T 3gni_B 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG 213 (389)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSC
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCC
Confidence 4699999999999999999999999999999999999999875432211 1112334789999999999764 46
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCC--------CCchhhhccC-CCcc----ccCCCC----C
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS--------PPDDYWKKSK-LPHA----TLFKPQ----Q 136 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~--------p~~~~~~~~~-~~~~----~~~~~~----~ 136 (468)
|+.++||||||||+|+|++|.+||.+......+..+...... +...+..... .... ...... .
T Consensus 214 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (389)
T 3gni_B 214 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS 293 (389)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------
T ss_pred CCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccc
Confidence 899999999999999999999999887665554443321100 0000000000 0000 000000 0
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 137 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 137 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
............+++.+.+||.+||++||.+|||+.++|+||||+....
T Consensus 294 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 294 NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp ------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 0000111234568899999999999999999999999999999987544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=246.79 Aligned_cols=157 Identities=31% Similarity=0.486 Sum_probs=131.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc-----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL-----GATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~-----g~~~~s 75 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .......+|+.|+|||++. ....++
T Consensus 130 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 207 (298)
T 1phk_A 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYG 207 (298)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBC
T ss_pred HHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCC--cccccccCCccccCHHHhccccccccccCC
Confidence 369999999999999999999999999999999999999999776543 2334567899999999985 234578
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++|||||||++|+|++|..||.+.+.......+.......+. ..+..++..+.+
T Consensus 208 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~l~~ 262 (298)
T 1phk_A 208 KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS-------------------------PEWDDYSDTVKD 262 (298)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------------------TTGGGSCHHHHH
T ss_pred cccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc-------------------------ccccccCHHHHH
Confidence 8999999999999999999999998887777766553322211 112457899999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||.+||..||.+|||+.++|+||||+...
T Consensus 263 li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 263 LVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 99999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.61 Aligned_cols=156 Identities=26% Similarity=0.463 Sum_probs=119.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCC--------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGA-------- 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~-------- 71 (468)
+.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+...... .....+||+.|+|||++.+.
T Consensus 161 ~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 239 (390)
T 2zmd_A 161 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239 (390)
T ss_dssp HHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC--------
T ss_pred HHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccc
Confidence 47999999999999999999999999995 589999999999876543221 23456799999999998652
Q ss_pred --CCCCCCcceeeeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 72 --TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 72 --~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
..|+.++||||||||||+|++|.+||.+... ...+..+........ ....
T Consensus 240 ~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 292 (390)
T 2zmd_A 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE---------------------------FPDI 292 (390)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC---------------------------CCCC
T ss_pred cccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC---------------------------CCcc
Confidence 3588899999999999999999999987543 333333322110000 0023
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
.+..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 293 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred chHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 467899999999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=266.72 Aligned_cols=144 Identities=19% Similarity=0.254 Sum_probs=117.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC---------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--------- 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~--------- 71 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .....+| +.|+|||++.+.
T Consensus 212 ~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~ 286 (377)
T 3byv_A 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDR 286 (377)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccc
Confidence 37999999999999999999999999999999999999999975432 3345567 999999999864
Q ss_pred -CCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCc
Q 012191 72 -TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 150 (468)
Q Consensus 72 -~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s 150 (468)
..|+.++|||||||++|+|++|..||.+......+.. +...+..++
T Consensus 287 ~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~ 333 (377)
T 3byv_A 287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW---------------------------------IFRSCKNIP 333 (377)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG---------------------------------GGSSCCCCC
T ss_pred cccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh---------------------------------hhhhccCCC
Confidence 2589999999999999999999999976442211111 111224678
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 334 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=249.25 Aligned_cols=153 Identities=26% Similarity=0.425 Sum_probs=114.1
Q ss_pred CHHHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhh---cCCCCCCC
Q 012191 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELL---LGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l---~g~~~~s~ 76 (468)
+.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++...... .......+|+.|+|||++ .....++.
T Consensus 115 ~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~ 192 (290)
T 3fme_A 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDIDAGCKPYMAPERINPELNQKGYSV 192 (290)
T ss_dssp HHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCH
T ss_pred HHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc--ccccccCCCccccChhhcChhhcCcCCCc
Confidence 36999999999998 9999999999999999999999999999766543 222344789999999997 33456888
Q ss_pred CcceeeeehhhhhhhhcCCCCCC-CchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g-~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
++|||||||++|+|++|..||.. ......+..+..... +. .....++..+.+
T Consensus 193 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~~~ 245 (290)
T 3fme_A 193 KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQ--------------------------LPADKFSAEFVD 245 (290)
T ss_dssp HHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-CC--------------------------CCTTTSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-CC--------------------------cccccCCHHHHH
Confidence 99999999999999999999986 344444444433211 10 001357889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||.+||..||.+|||+.++|+||||+.
T Consensus 246 li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 246 FTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHhhcChhhCcCHHHHHhCccccc
Confidence 999999999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=260.94 Aligned_cols=156 Identities=29% Similarity=0.464 Sum_probs=123.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-CCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~-~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...........+||+.|+|||++.+. ..++.++|
T Consensus 165 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 244 (355)
T 1vzo_A 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 244 (355)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhh
Confidence 36999999999999999999999999999999999999999976543333334456789999999999753 35788999
Q ss_pred eeeeehhhhhhhhcCCCCCCCch----HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~----~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
|||||||||+|++|..||..... ......+... .+ .....++..+.+
T Consensus 245 vwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~---------------------------~~~~~~~~~~~~ 295 (355)
T 1vzo_A 245 WWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EP---------------------------PYPQEMSALAKD 295 (355)
T ss_dssp HHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CC---------------------------CCCTTSCHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--CC---------------------------CCCcccCHHHHH
Confidence 99999999999999999975432 2222222221 10 011357888999
Q ss_pred HHHHhcCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 156 LIETLLSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 156 LL~~mL~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
||.+||..||.+|| |+.++|+||||....|
T Consensus 296 li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 296 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp HHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 99999999999999 9999999999987544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=245.60 Aligned_cols=151 Identities=31% Similarity=0.487 Sum_probs=127.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... ......+++.|+|||++.+ ..++.++||
T Consensus 120 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 195 (284)
T 2vgo_A 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEG-KTHDEKVDL 195 (284)
T ss_dssp HHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---CBCCCCSCGGGCCHHHHTT-CCBCTTHHH
T ss_pred HHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc---ccccccCCCCcCCHHHhcc-CCCCcccch
Confidence 369999999999999999999999999999999999999998755432 2234578999999999976 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+....+....+....... ...++..+.+||.+|
T Consensus 196 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~ 246 (284)
T 2vgo_A 196 WCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF-----------------------------PPFLSDGSKDLISKL 246 (284)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC-----------------------------CCcCCHHHHHHHHHH
Confidence 999999999999999999888777666654321110 134788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|..||.+|||+.++|+||||+...
T Consensus 247 l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 247 LRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp SCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred hhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=255.39 Aligned_cols=156 Identities=28% Similarity=0.476 Sum_probs=116.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcC---------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLG--------- 70 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g--------- 70 (468)
+.||+.||.|||++||+||||||+|||++ ++.+||+|||++......... .....+||+.|+|||++.+
T Consensus 114 ~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 192 (343)
T 3dbq_A 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192 (343)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-------
T ss_pred HHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccc
Confidence 47999999999999999999999999996 688999999999866543221 2345678999999999864
Q ss_pred -CCCCCCCcceeeeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 71 -ATDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 71 -~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
...++.++||||||||+|+|++|.+||.+... ...+..+....... .....
T Consensus 193 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 245 (343)
T 3dbq_A 193 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI---------------------------EFPDI 245 (343)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC---------------------------CCCCC
T ss_pred cccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc---------------------------CCccc
Confidence 24578899999999999999999999987543 23333332111000 00123
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
.+..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 246 ~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 567899999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=249.61 Aligned_cols=154 Identities=29% Similarity=0.476 Sum_probs=129.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE---CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++...... ......+|+.|+|||++.+ ..++.+
T Consensus 112 ~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~ 187 (304)
T 2jam_A 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQ-KPYSKA 187 (304)
T ss_dssp HHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSS-CSCCHH
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhcc-CCCCch
Confidence 3699999999999999999999999999 77889999999998654332 2344578999999999876 468899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|.+||.+.+....+..+.......+. ..+..++..+.+||
T Consensus 188 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li 242 (304)
T 2jam_A 188 VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES-------------------------PFWDDISESAKDFI 242 (304)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT-------------------------TTTTTSCHHHHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-------------------------cccccCCHHHHHHH
Confidence 99999999999999999999998888777777653322211 12246789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||..||.+|||+.++|+||||...
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=245.42 Aligned_cols=152 Identities=22% Similarity=0.354 Sum_probs=122.6
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEEC-CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||+.| |+|+||||+|||++ .++.+||+|||++...... ......+|+.|+|||++.+ .++.+
T Consensus 135 ~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~ 209 (290)
T 1t4h_A 135 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE--KYDES 209 (290)
T ss_dssp HHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT--CCCTH
T ss_pred HHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc---ccccccCCcCcCCHHHHhc--cCCCc
Confidence 369999999999999 99999999999997 7889999999999755432 3345678999999998875 58999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|..||.+......+....... ..+. ......++.+.+||
T Consensus 210 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~l~~li 263 (290)
T 1t4h_A 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPA-------------------------SFDKVAIPEVKEII 263 (290)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCG-------------------------GGGGCCCHHHHHHH
T ss_pred chHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-CCcc-------------------------ccCCCCCHHHHHHH
Confidence 999999999999999999998866554444332211 1110 11234678899999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||..||.+|||+.++|+||||+..
T Consensus 264 ~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 264 EGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHccCChhhCCCHHHHhhCcccccC
Confidence 99999999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=246.21 Aligned_cols=157 Identities=27% Similarity=0.391 Sum_probs=129.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCCC-CCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGAT-DYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~~-~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ........+|+.|+|||++.+.. .++.++
T Consensus 115 ~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 194 (305)
T 2wtk_C 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV 194 (305)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHH
T ss_pred HHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchh
Confidence 3699999999999999999999999999999999999999997664322 12233556899999999987632 246789
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..||.+.+..+.+..+...... ....++..+.+||.
T Consensus 195 Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~l~~li~ 245 (305)
T 2wtk_C 195 DIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-----------------------------IPGDCGPPLSDLLK 245 (305)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-----------------------------CCSSSCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC-----------------------------CCCccCHHHHHHHH
Confidence 9999999999999999999998877776666442110 11357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
+||..||.+|||+.++|+||||+....+
T Consensus 246 ~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 246 GMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHccCChhhCCCHHHHhcCcccccCCCC
Confidence 9999999999999999999999886443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=255.17 Aligned_cols=151 Identities=29% Similarity=0.448 Sum_probs=127.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....+||+.|+|||++.+ ...++.++
T Consensus 160 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 234 (348)
T 1u5q_A 160 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKV 234 (348)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHH
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----CCcccCCcceeCHhhhccccCCCCCcHH
Confidence 36899999999999999999999999999999999999999976543 234578999999999863 34688999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||||+|+|++|.+||.+.+....+..+..... +. .....++..+.+||.
T Consensus 235 DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 235 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA--------------------------LQSGHWSEYFRNFVD 287 (348)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC--------------------------CCCTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC--------------------------CCCCCCCHHHHHHHH
Confidence 999999999999999999998887777666544211 10 001356888999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||+.||.+|||+.++|+||||...
T Consensus 288 ~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHcccChhhCcCHHHHhhChhhhcc
Confidence 9999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=244.66 Aligned_cols=155 Identities=27% Similarity=0.429 Sum_probs=126.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC----cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+|+||||+|||++.++ .+||+|||++...... .......+|+.|+|||++.+ ..++.
T Consensus 114 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~ 190 (283)
T 3bhy_A 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPEIVNY-EPLGL 190 (283)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTT-CCCCT
T ss_pred HHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCC--CcccccCCCcCccCcceecC-CCCCc
Confidence 36999999999999999999999999998877 7999999999766543 22345578999999999876 46889
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|..||.+.+..+.+..+.......+ ...+..++..+.+|
T Consensus 191 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~l 245 (283)
T 3bhy_A 191 EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-------------------------EEYFSNTSELAKDF 245 (283)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTCCHHHHHH
T ss_pred chhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-------------------------chhcccCCHHHHHH
Confidence 99999999999999999999999888777776654322221 22335678999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|.+||..||.+|||+.++|+||||+..
T Consensus 246 i~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 246 IRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=262.63 Aligned_cols=156 Identities=26% Similarity=0.460 Sum_probs=117.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCccccCCCCCCCccccccCCcccChhhhcC--CCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG--ATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g--~~~~s 75 (468)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ ...|+
T Consensus 245 ~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~ 322 (419)
T 3i6u_A 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYN 322 (419)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTH
T ss_pred HHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCC
Confidence 47999999999999999999999999997544 5999999999876543 23345688999999999853 34678
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHH-HHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHK-IFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
.++|||||||++|+|++|.+||.+......+.. +....... ....+..++..+.
T Consensus 323 ~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~ 377 (419)
T 3i6u_A 323 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-------------------------IPEVWAEVSEKAL 377 (419)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC-------------------------CHHHHTTSCHHHH
T ss_pred chhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC-------------------------CchhhcccCHHHH
Confidence 899999999999999999999986544322222 22111111 1234457899999
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||.+||..||.+|||+.++|+||||+..
T Consensus 378 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 378 DLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 99999999999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-30 Score=254.74 Aligned_cols=153 Identities=24% Similarity=0.323 Sum_probs=109.2
Q ss_pred HHHHHHHHHHHhC--------CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC---CccccccCCcccChhhhcC
Q 012191 2 NQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLG 70 (468)
Q Consensus 2 ~QLL~gL~yLHs~--------gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~g 70 (468)
.|++.||+|||++ +||||||||+||||+.++.+||+|||++......... .....+||++|+|||++.+
T Consensus 107 ~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp HHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcc
Confidence 6899999999987 9999999999999999999999999999766543221 2234689999999999976
Q ss_pred CC-----CCCCCcceeeeehhhhhhhhcCCCCCCCch--------------HHHHHHHHHHcCCCCchhhhccCCCcccc
Q 012191 71 AT-----DYGPSVDLWSVGCVFAELLIGKPILQGRTE--------------VEQLHKIFKLCGSPPDDYWKKSKLPHATL 131 (468)
Q Consensus 71 ~~-----~~s~~sDIWSLG~ILyeLltG~~pf~g~~~--------------~e~l~~i~~~~g~p~~~~~~~~~~~~~~~ 131 (468)
.. .|+.++||||||||||||++|.+||..... .+.+.......+
T Consensus 187 ~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 249 (303)
T 3hmm_A 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----------------- 249 (303)
T ss_dssp CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-----------------
T ss_pred cccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhccc-----------------
Confidence 32 356789999999999999999887643221 111111111000
Q ss_pred CCCCCCCCchhhhhc--CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 132 FKPQQPYDSSLRETF--KDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 132 ~~~~~~~~~~l~~~~--~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
+.|. +...+ ...+..+.+||.+||+.||.+|||+.++++.
T Consensus 250 ~rp~------~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 250 LRPN------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCC------CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCCC------CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0010 01111 1234578899999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=243.85 Aligned_cols=156 Identities=28% Similarity=0.419 Sum_probs=124.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+...++.++|
T Consensus 111 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 190 (276)
T 2yex_A 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190 (276)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHH
T ss_pred HHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcch
Confidence 36999999999999999999999999999999999999999976543221 22345678999999999987554577899
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHH-HHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~-l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++|..||.+...... +..+...... ...+..++..+.+||.
T Consensus 191 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------------------LNPWKKIDSAPLALLH 243 (276)
T ss_dssp HHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---------------------------STTGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---------------------------cCchhhcCHHHHHHHH
Confidence 99999999999999999987654322 2222111000 0112457899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..||.+|||+.++|+||||+..
T Consensus 244 ~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 244 KILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHCCCCchhCCCHHHHhcCccccCh
Confidence 9999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-29 Score=243.74 Aligned_cols=152 Identities=31% Similarity=0.479 Sum_probs=119.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... .......+|+.|+|||++.+...++.++||
T Consensus 117 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 194 (276)
T 2h6d_A 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDI 194 (276)
T ss_dssp HHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHH
T ss_pred HHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--cceecccCCccccCHHHHcCCCCCCccchH
Confidence 369999999999999999999999999999999999999999766543 223445789999999999875444689999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+......+..+....... ...++..+.+||.+|
T Consensus 195 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~ 245 (276)
T 2h6d_A 195 WSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI-----------------------------PEYLNRSVATLLMHM 245 (276)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC-----------------------------chhcCHHHHHHHHHH
Confidence 999999999999999999887776666654321111 124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|+.||.+|||+.++|+||||+..
T Consensus 246 l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 246 LQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp TCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCChhhCCCHHHHHhChhhccC
Confidence 99999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=254.31 Aligned_cols=145 Identities=23% Similarity=0.425 Sum_probs=120.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||
T Consensus 136 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 213 (335)
T 3dls_A 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213 (335)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHH
T ss_pred HHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC--CceeccCCCccccChhhhcCCCCCCCcccc
Confidence 369999999999999999999999999999999999999999876543 233456789999999999875545889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||...... .. .. ......++.++.+||.+|
T Consensus 214 wslG~il~el~~g~~pf~~~~~~------~~---~~--------------------------~~~~~~~~~~l~~li~~~ 258 (335)
T 3dls_A 214 WSLGVTLYTLVFEENPFCELEET------VE---AA--------------------------IHPPYLVSKELMSLVSGL 258 (335)
T ss_dssp HHHHHHHHHHHHSSCSCSSGGGG------TT---TC--------------------------CCCSSCCCHHHHHHHHHH
T ss_pred hhHHHHHHHHHhCCCchhhHHHH------Hh---hc--------------------------cCCCcccCHHHHHHHHHH
Confidence 99999999999999999752210 00 00 000124788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|..||.+|||+.++|+||||+.
T Consensus 259 L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 259 LQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp TCSSGGGSCCHHHHHHCTTTTC
T ss_pred ccCChhhCcCHHHHhcCccccC
Confidence 9999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=273.99 Aligned_cols=153 Identities=27% Similarity=0.505 Sum_probs=126.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+||||+.+|.+||+|||++...... ......+||+.|+|||++.+ ..|+.++||
T Consensus 292 ~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APEvl~~-~~~~~~~Di 368 (576)
T 2acx_A 292 AAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDW 368 (576)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--CCEECCCSCGGGCCHHHHTT-CEESSHHHH
T ss_pred HHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC--ccccccCCCccccCHHHHcC-CCCCccchH
Confidence 369999999999999999999999999999999999999999876543 23455689999999999976 458999999
Q ss_pred eeeehhhhhhhhcCCCCCCCch----HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTE----VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~----~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
||||||+|+|++|.+||.+... ......+... +.. ....+++++++|
T Consensus 369 wSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~~~-------------------------~p~~~s~~~~dL 419 (576)
T 2acx_A 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PEE-------------------------YSERFSPQARSL 419 (576)
T ss_dssp HHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----CCC-------------------------CCTTSCHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----ccc-------------------------CCccCCHHHHHH
Confidence 9999999999999999987642 2222222221 100 013578999999
Q ss_pred HHHhcCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 157 IETLLSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 157 L~~mL~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|.+||..||.+|| ++.++++||||+...|
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 9999999999999 8999999999998655
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=246.94 Aligned_cols=156 Identities=26% Similarity=0.421 Sum_probs=120.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ...++.
T Consensus 135 ~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 213 (326)
T 2x7f_A 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDF 213 (326)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCT
T ss_pred HHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCc
Confidence 3699999999999999999999999999999999999999987654321 12334578999999999863 245889
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|..||.+......+..+.... .+. .....++..+.+|
T Consensus 214 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-------------------------~~~~~~~~~l~~l 266 (326)
T 2x7f_A 214 KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APR-------------------------LKSKKWSKKFQSF 266 (326)
T ss_dssp THHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC-------------------------CSCSCSCHHHHHH
T ss_pred cchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--ccc-------------------------CCccccCHHHHHH
Confidence 9999999999999999999998887766655543311 000 0113578899999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|.+||..||.+|||+.++|+||||+..+
T Consensus 267 i~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 267 IESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 9999999999999999999999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=243.62 Aligned_cols=155 Identities=31% Similarity=0.450 Sum_probs=129.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++||
T Consensus 121 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 198 (294)
T 2rku_A 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDV 198 (294)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHTT-SCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-cccccccCCCCcCCcchhcc-CCCCchhhH
Confidence 3699999999999999999999999999999999999999997664322 22344578999999999976 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+....+.+..+....... ...++..+.+||.+|
T Consensus 199 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI-----------------------------PKHINPVAASLIQKM 249 (294)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC-----------------------------ccccCHHHHHHHHHH
Confidence 999999999999999999888776665553311100 124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
|+.||.+|||+.++|+||||.....+
T Consensus 250 l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 250 LQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred cccChhhCcCHHHHhhChheecCCcC
Confidence 99999999999999999999986554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-29 Score=247.68 Aligned_cols=151 Identities=27% Similarity=0.446 Sum_probs=116.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-----------CCccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-----------QPLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-----------~~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||++.
T Consensus 170 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 249 (332)
T 3qd2_B 170 FIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249 (332)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHH
T ss_pred HHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhc
Confidence 36999999999999999999999999999999999999999987654321 1224457899999999998
Q ss_pred CCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCC
Q 012191 70 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149 (468)
Q Consensus 70 g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (468)
+ ..++.++|||||||++|+|++|..++.. .......+.. +..+ ..+...
T Consensus 250 ~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~~--------------------------~~~~~~ 298 (332)
T 3qd2_B 250 G-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKFP--------------------------LLFTQK 298 (332)
T ss_dssp C-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCCC--------------------------HHHHHH
T ss_pred C-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCCC--------------------------cccccC
Confidence 7 4689999999999999999998766421 1111111111 1111 112345
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 677899999999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-30 Score=266.60 Aligned_cols=143 Identities=17% Similarity=0.218 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc---------CCC
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL---------GAT 72 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~---------g~~ 72 (468)
.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ....+| +.|+|||++. ...
T Consensus 218 ~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~ 292 (413)
T 3dzo_A 218 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPT 292 (413)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCE
T ss_pred HHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCc
Confidence 79999999999999999999999999999999999999998765432 345567 9999999994 334
Q ss_pred CCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHH
Q 012191 73 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTT 152 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~ 152 (468)
.|+.++||||||||+|+|++|..||.+.+..+....+ ......+++.
T Consensus 293 ~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~ 339 (413)
T 3dzo_A 293 LMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI---------------------------------FRSCKNIPQP 339 (413)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG---------------------------------GSSCCCCCHH
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH---------------------------------HhhcccCCHH
Confidence 5788999999999999999999999875432211111 1112367899
Q ss_pred HHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 153 AVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 153 l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+.+||.+||..||.+|||+.++|+||||+.
T Consensus 340 ~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 340 VRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=246.86 Aligned_cols=164 Identities=28% Similarity=0.466 Sum_probs=121.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC----CCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR----QPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+...++.
T Consensus 127 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (303)
T 2vwi_A 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF 206 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCT
T ss_pred HHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCc
Confidence 36999999999999999999999999999999999999999876543211 11234578999999999875456889
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|..||.+......+....... ++. . ............++..+.+|
T Consensus 207 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~-~----------------~~~~~~~~~~~~~~~~~~~l 267 (303)
T 2vwi_A 207 KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--PPS-L----------------ETGVQDKEMLKKYGKSFRKM 267 (303)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--CCC-T----------------TC-----CCCCCCCHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--CCc-c----------------ccccccchhhhhhhHHHHHH
Confidence 9999999999999999999998876655544332211 110 0 00001122335688999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|.+||..||.+|||+.++|+||||+..
T Consensus 268 i~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 268 ISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred HHHHccCChhhCcCHHHHhhChhhhcC
Confidence 999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-29 Score=266.53 Aligned_cols=155 Identities=26% Similarity=0.454 Sum_probs=127.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+||||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++||
T Consensus 295 ~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~Di 372 (543)
T 3c4z_A 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDY 372 (543)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC-cccccccCCccccChhhhcC-CCCChHHhc
Confidence 3699999999999999999999999999999999999999998765432 22344589999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCc----hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~----~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
||||||+|+|++|.+||.+.. ..+....+....... ...++..+.+|
T Consensus 373 wSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~l 423 (543)
T 3c4z_A 373 FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY-----------------------------PDKFSPASKDF 423 (543)
T ss_dssp HHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHH
T ss_pred CcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC-----------------------------CcccCHHHHHH
Confidence 999999999999999998763 233444443311100 13578999999
Q ss_pred HHHhcCCCCCCCcC-----HHHHHhcccccCCCCC
Q 012191 157 IETLLSVEPYKRAT-----ASAALASEYFSTKPYA 186 (468)
Q Consensus 157 L~~mL~~DP~kRpT-----a~e~L~Hp~F~~~p~~ 186 (468)
|.+||..||.+||+ +.+++.||||+...|.
T Consensus 424 i~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 424 CEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp HHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred HHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 99999999999996 5899999999987653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-29 Score=248.39 Aligned_cols=155 Identities=27% Similarity=0.467 Sum_probs=122.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc---EEEEecCCccccCCCCCCCccccccCCcccChhhhc--CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL--GATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~---vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~--g~~~~s 75 (468)
+.||+.||.|||++||+|+||||+|||++.++. +||+|||++...... .......+|+.|+|||++. +...++
T Consensus 120 ~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~ 197 (322)
T 2ycf_A 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYN 197 (322)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCT
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc--cccccccCCcCccCchhhccCCCCCCC
Confidence 369999999999999999999999999987654 999999999766432 1223457899999999984 345688
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHH-HHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQL-HKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
.++|||||||++|+|++|.+||.+......+ ..+....... ....+..++..+.
T Consensus 198 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~ 252 (322)
T 2ycf_A 198 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-------------------------IPEVWAEVSEKAL 252 (322)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-------------------------CHHHHTTSCHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-------------------------CchhhhhcCHHHH
Confidence 9999999999999999999999765433222 2222211111 1233456889999
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+||.+||..||.+|||+.++|+||||+.
T Consensus 253 ~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 253 DLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 9999999999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-29 Score=248.93 Aligned_cols=154 Identities=31% Similarity=0.452 Sum_probs=129.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++||
T Consensus 147 ~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 224 (335)
T 2owb_A 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDV 224 (335)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHHT-SCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-ccccccCCCccccCHHHhcc-CCCCchhhH
Confidence 4699999999999999999999999999999999999999997664322 22345678999999999976 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+....+.+..+....... ...++..+.+||.+|
T Consensus 225 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI-----------------------------PKHINPVAASLIQKM 275 (335)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC-----------------------------CccCCHHHHHHHHHH
Confidence 999999999999999999888777666654321110 124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|..||.+|||+.++|+|+||+....
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ccCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999999999999987644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-29 Score=242.08 Aligned_cols=147 Identities=20% Similarity=0.286 Sum_probs=115.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-------------------CcEEEEecCCccccCCCCCCCccccccCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-------------------GVLKLADFGLANFSNTGHRQPLTSRVVTLW 61 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-------------------g~vKL~DFGla~~~~~~~~~~~~~~~gt~~ 61 (468)
+.||+.||.|||++||+|+||||+|||++.+ ..+||+|||++...... ....+|+.
T Consensus 121 ~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~ 195 (289)
T 1x8b_A 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----QVEEGDSR 195 (289)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS-----CCCCCCGG
T ss_pred HHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc-----cccCCCcc
Confidence 4699999999999999999999999999844 47999999999866542 23468999
Q ss_pred ccChhhhcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCch
Q 012191 62 YRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSS 141 (468)
Q Consensus 62 Y~APE~l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (468)
|+|||++.+...++.++|||||||++|+|++|.+++...... ..+.. +..+
T Consensus 196 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~--~~~~------------------------ 246 (289)
T 1x8b_A 196 FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQ--GRLP------------------------ 246 (289)
T ss_dssp GCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHHHT--TCCC------------------------
T ss_pred ccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHHHc--CCCC------------------------
Confidence 999999987556678999999999999999999887654332 22211 1100
Q ss_pred hhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 142 LRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 142 l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.....++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 247 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 247 --RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp --CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred --CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 1113578999999999999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=244.36 Aligned_cols=152 Identities=36% Similarity=0.542 Sum_probs=101.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++||
T Consensus 118 ~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 195 (278)
T 3cok_A 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-EKHYTLCGTPNYISPEIATR-SAHGLESDV 195 (278)
T ss_dssp HHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHH
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-CcceeccCCCCcCCcchhcC-CCCCchhhH
Confidence 4699999999999999999999999999999999999999997665322 12234578999999999876 457899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||........+..+.. . . + .....++.++.+||.+|
T Consensus 196 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~------------------~--~-----~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 196 WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----A------------------D--Y-----EMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp HHHHHHHHHHHHSSCSSCCCSCC-----CCS----S------------------C--C-----CCCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----c------------------c--c-----CCccccCHHHHHHHHHH
Confidence 9999999999999999987554332222100 0 0 0 01134788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.++|+||||...
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC--
T ss_pred cccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=241.60 Aligned_cols=155 Identities=28% Similarity=0.462 Sum_probs=114.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-------------CCCccccccCCcccChhh
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-------------RQPLTSRVVTLWYRPPEL 67 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~ 67 (468)
+.||+.||+|||++||+|+||||+|||++.++.+||+|||++....... ........+|+.|+|||+
T Consensus 122 ~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 201 (303)
T 1zy4_A 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHH
T ss_pred HHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence 3699999999999999999999999999999999999999987654221 122345578999999999
Q ss_pred hcCCCCCCCCcceeeeehhhhhhhhcCCCCCCC-chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc
Q 012191 68 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 146 (468)
Q Consensus 68 l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~-~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (468)
+.+...++.++|||||||++|+|++ ||... .....+..+.......+. ...
T Consensus 202 ~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~ 253 (303)
T 1zy4_A 202 LDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPP-------------------------DFD 253 (303)
T ss_dssp HTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCT-------------------------TCC
T ss_pred ccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCc-------------------------ccc
Confidence 9876578999999999999999998 45432 233333333221111111 111
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 147 KDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 147 ~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
...+..+.+||.+||..||.+|||+.++|+||||...
T Consensus 254 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 254 DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred ccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 3567889999999999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.4e-29 Score=242.21 Aligned_cols=154 Identities=27% Similarity=0.507 Sum_probs=127.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC---CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE---GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++...... .......+|+.|+|||++.+ .++.+
T Consensus 127 ~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~ 202 (287)
T 2wei_A 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG--TYDEK 202 (287)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC--SSCSCHHHHHTTCCHHHHTT--CCCTH
T ss_pred HHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC--CccccccCcccccChHHhcC--CCCCc
Confidence 3699999999999999999999999999764 46999999998766543 22344568999999999876 48899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|.+||.+.+..+.+..+.......+. ..+..++..+.+||
T Consensus 203 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li 257 (287)
T 2wei_A 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-------------------------PQWRTISDDAKDLI 257 (287)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-------------------------GGGTTSCHHHHHHH
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-------------------------hhhhhcCHHHHHHH
Confidence 99999999999999999999998887777666543211111 12346789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||..||.+|||+.++|+||||+..
T Consensus 258 ~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 258 RKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=241.68 Aligned_cols=156 Identities=28% Similarity=0.428 Sum_probs=127.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++||
T Consensus 131 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 208 (314)
T 3com_A 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQE-IGYNCVADI 208 (314)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCCCSCGGGCCHHHHSS-SCBCTTHHH
T ss_pred HHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCccCCCCCccChhhcCC-CCCCccccH
Confidence 3689999999999999999999999999999999999999997655322 22345578999999999976 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.........+.... ++. + .....++..+.+||.+|
T Consensus 209 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-~-----------------------~~~~~~~~~l~~li~~~ 262 (314)
T 3com_A 209 WSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PPT-F-----------------------RKPELWSDNFTDFVKQC 262 (314)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC-C-----------------------SSGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--Ccc-c-----------------------CCcccCCHHHHHHHHHH
Confidence 999999999999999998877666554443211 100 0 01124688999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|..||.+|||+.++|+||||+...
T Consensus 263 l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 263 LVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp TCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ccCChhhCcCHHHHHhCHHHhcCC
Confidence 999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-29 Score=247.14 Aligned_cols=157 Identities=23% Similarity=0.422 Sum_probs=123.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||++.+ ..++.++
T Consensus 122 ~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 200 (311)
T 3ork_A 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARS 200 (311)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHT-CCCCHHH
T ss_pred HHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC-CCCCchH
Confidence 36999999999999999999999999999999999999999976543321 12234568999999999987 4688999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..||.+....+....+......++ ......++.++.+||.
T Consensus 201 Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~ 255 (311)
T 3ork_A 201 DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-------------------------SARHEGLSADLDAVVL 255 (311)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH-------------------------HHHSTTCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc-------------------------ccccCCCCHHHHHHHH
Confidence 999999999999999999999888777666654322221 1223568899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..||.+||++.++|.|+|+...
T Consensus 256 ~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 256 KALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHhcCHhhChhhHHHHHHHHHHHh
Confidence 9999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=246.82 Aligned_cols=171 Identities=23% Similarity=0.399 Sum_probs=128.6
Q ss_pred CHHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC-Cc
Q 012191 1 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP-SV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~-~s 78 (468)
+.||+.||.|||+ .||+|+||||+|||++.++.+||+|||++...... ......+|+.|+|||++.+...++. ++
T Consensus 157 ~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 233 (348)
T 2pml_X 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKV 233 (348)
T ss_dssp HHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHH
T ss_pred HHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchh
Confidence 3699999999999 99999999999999999999999999999866443 3345678999999999987545555 99
Q ss_pred ceeeeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++|..||.+... .+.+..+.......+... .....+. ...........++..+.+||
T Consensus 234 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~~~~l~~li 303 (348)
T 2pml_X 234 DIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR--------NHFLYPL--TNKKSTCSNNFLSNEDIDFL 303 (348)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS--------SSSTTTT--CC--------CCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch--------hhhhccc--cccccccchhhcCHHHHHHH
Confidence 999999999999999999998776 555555533211111100 0000000 00011222356899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
.+||..||.+|||+.++|+||||+...
T Consensus 304 ~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 304 KLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHccCChhhCCCHHHHhcCccccCCC
Confidence 999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=242.62 Aligned_cols=157 Identities=27% Similarity=0.387 Sum_probs=123.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc----CCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL----GATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~----g~~~~s~ 76 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++. ....++.
T Consensus 123 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 201 (302)
T 2j7t_A 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201 (302)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTT
T ss_pred HHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCch
Confidence 3699999999999999999999999999999999999999875322110 1123457899999999984 3356889
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|.+||.+.+....+..+........ .....++..+.+|
T Consensus 202 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~l 255 (302)
T 2j7t_A 202 KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--------------------------LTPSKWSVEFRDF 255 (302)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------------------------SSGGGSCHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc--------------------------CCccccCHHHHHH
Confidence 99999999999999999999998887776665544211100 0013467889999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
|.+||..||.+|||+.++|+||||+...
T Consensus 256 i~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 256 LKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9999999999999999999999998743
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=241.46 Aligned_cols=154 Identities=25% Similarity=0.392 Sum_probs=115.4
Q ss_pred CHHHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCC
Q 012191 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s 75 (468)
+.||+.||.|||+. ||+|+||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ...++
T Consensus 130 ~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 207 (318)
T 2dyl_A 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYD 207 (318)
T ss_dssp HHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC--------CC
T ss_pred HHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--ccccccCCCccccChhhcccccccccCCc
Confidence 36899999999995 9999999999999999999999999998765433 22334578999999999852 34678
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCC-chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGR-TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAV 154 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~-~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~ 154 (468)
.++|||||||++|+|++|..||... ...+.+..+.... ++. ......++..+.
T Consensus 208 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~------------------------~~~~~~~~~~l~ 261 (318)
T 2dyl_A 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PPL------------------------LPGHMGFSGDFQ 261 (318)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CCC------------------------CCSSSCCCHHHH
T ss_pred cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CCC------------------------CCccCCCCHHHH
Confidence 8999999999999999999999874 4445555554321 100 001135789999
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
+||.+||..||.+|||+.++|+||||+.
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 9999999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-29 Score=249.83 Aligned_cols=146 Identities=30% Similarity=0.465 Sum_probs=120.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC-CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ......+|+.|+|||++.+...++.++|
T Consensus 155 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~D 231 (320)
T 3a99_A 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAA 231 (320)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred HHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccch
Confidence 36999999999999999999999999998 7789999999999876542 3345678999999999977555578899
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||.+... +.. +... ....+++.+.+||.+
T Consensus 232 i~slG~il~el~~g~~pf~~~~~------~~~--~~~~---------------------------~~~~~~~~~~~li~~ 276 (320)
T 3a99_A 232 VWSLGILLYDMVCGDIPFEHDEE------IIR--GQVF---------------------------FRQRVSSECQHLIRW 276 (320)
T ss_dssp HHHHHHHHHHHHHSSCSCCSHHH------HHH--CCCC---------------------------CSSCCCHHHHHHHHH
T ss_pred HHhHHHHHHHHHHCCCCCCChhh------hhc--cccc---------------------------ccccCCHHHHHHHHH
Confidence 99999999999999999976421 111 0000 013578899999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||..||.+|||+.++|+||||+...
T Consensus 277 ~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 277 CLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HccCChhhCcCHHHHhcCHhhcCcc
Confidence 9999999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=238.92 Aligned_cols=153 Identities=30% Similarity=0.463 Sum_probs=127.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++||
T Consensus 125 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 202 (303)
T 3a7i_A 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDSKADI 202 (303)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cccCccCCCcCccCHHHHhc-CCCCchhhh
Confidence 3699999999999999999999999999999999999999997665432 22345578999999999976 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.........+.... ++ .....++..+.+||.+|
T Consensus 203 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 203 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN--PP--------------------------TLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC--------------------------CCCSSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--CC--------------------------CCccccCHHHHHHHHHH
Confidence 999999999999999998877766555543311 10 01135788999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|..||.+|||+.++|+||||...
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHH
T ss_pred cCCChhhCcCHHHHhhChhhhcC
Confidence 99999999999999999999763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=238.37 Aligned_cols=155 Identities=32% Similarity=0.509 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECC-CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-CCCCCCcc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNN-EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA-TDYGPSVD 79 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~-~~~s~~sD 79 (468)
.||+.||.|||++||+|+||||+|||++. ++.+||+|||++....... .......+|+.|+|||++.+. ..++.++|
T Consensus 129 ~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 207 (295)
T 2clq_A 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207 (295)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHH
T ss_pred HHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHH
Confidence 69999999999999999999999999987 8999999999997654321 123345789999999998653 23788999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||.+.................+ .....++..+.+||.+
T Consensus 208 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP--------------------------EIPESMSAEAKAFILK 261 (295)
T ss_dssp HHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC--------------------------CCCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc--------------------------cccccCCHHHHHHHHH
Confidence 99999999999999999976443322111111111110 0113578899999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||..||.+|||+.++|+||||+..
T Consensus 262 ~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 262 CFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp TTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-29 Score=250.19 Aligned_cols=158 Identities=27% Similarity=0.438 Sum_probs=100.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... ......+|+.|+|||++.+ ..++.+
T Consensus 134 ~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~ 209 (336)
T 3fhr_A 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGP-EKYDKS 209 (336)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHH
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc---ccccCCCCcCccChhhhCC-CCCCch
Confidence 479999999999999999999999999976 455999999999765532 2345577999999999865 457889
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|..||.+.........+......... .+ ....+..++..+.+||
T Consensus 210 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------~~---~~~~~~~~~~~~~~li 268 (336)
T 3fhr_A 210 CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY------------------GF---PNPEWSEVSEDAKQLI 268 (336)
T ss_dssp HHHHHHHHHHHHHHHSSCCC---------------------------------------CC---CTTTSTTCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc------------------cc---CchhhccCCHHHHHHH
Confidence 99999999999999999999776544332211111000000 00 0112346889999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||..||.+|||+.++|+||||+..
T Consensus 269 ~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 269 RLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHCCCChhHCcCHHHHhcCcccccc
Confidence 99999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=254.87 Aligned_cols=158 Identities=30% Similarity=0.437 Sum_probs=116.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-------------CcEEEEecCCccccCCCCCC---CccccccCCcccC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-------------GVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRP 64 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-------------g~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~A 64 (468)
+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......... .....+||+.|+|
T Consensus 121 ~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~a 200 (434)
T 2rio_A 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA 200 (434)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSC
T ss_pred HHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccC
Confidence 3699999999999999999999999999654 47999999999876543221 2234578999999
Q ss_pred hhhhcC------CCCCCCCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCC
Q 012191 65 PELLLG------ATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 137 (468)
Q Consensus 65 PE~l~g------~~~~s~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 137 (468)
||++.+ ...++.++||||||||+|+|++ |..||.+....+ ..+.......+.. .
T Consensus 201 PE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~-----------------~ 261 (434)
T 2rio_A 201 PELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM-----------------K 261 (434)
T ss_dssp HHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC-----------------T
T ss_pred HHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc-----------------c
Confidence 999965 2458899999999999999998 999997655433 2222211111000 0
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 138 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 138 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
......++.++.+||.+||+.||.+|||+.++|+||||..
T Consensus 262 -----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 262 -----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp -----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred -----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 0001235688999999999999999999999999999964
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=247.17 Aligned_cols=179 Identities=23% Similarity=0.343 Sum_probs=121.6
Q ss_pred CHHHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+. ||+|+||||+|||++.++.+||+|||++...... ......+|+.|+|||++.+ ..++.++|
T Consensus 137 ~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~D 212 (360)
T 3eqc_A 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSD 212 (360)
T ss_dssp HHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTT-CCCSHHHH
T ss_pred HHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcC-CCCCchhh
Confidence 36899999999996 9999999999999999999999999998654322 2344578999999999976 46899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHc-CCCCchhhhccCC--Ccccc-CCCCCCCC--chh---------hh
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLC-GSPPDDYWKKSKL--PHATL-FKPQQPYD--SSL---------RE 144 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~-g~p~~~~~~~~~~--~~~~~-~~~~~~~~--~~l---------~~ 144 (468)
||||||++|+|++|..||.+.+..+....+.... +......+..... ..... ........ ..+ ..
T Consensus 213 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (360)
T 3eqc_A 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL 292 (360)
T ss_dssp HHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCC
Confidence 9999999999999999998876655433321111 1111100000000 00000 00000000 000 00
Q ss_pred hcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 145 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 145 ~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
....++.++.+||.+||.+||.+|||+.++|+||||+..
T Consensus 293 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 293 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 012478899999999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-28 Score=239.48 Aligned_cols=157 Identities=27% Similarity=0.468 Sum_probs=115.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCC--------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGA-------- 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~-------- 71 (468)
+.||+.||.|||++||+|+||||+|||++ ++.+||+|||++......... ......+|+.|+|||++.+.
T Consensus 133 ~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 211 (313)
T 3cek_A 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211 (313)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC-------
T ss_pred HHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccccccccc
Confidence 36999999999999999999999999996 489999999999766543211 22345789999999998652
Q ss_pred --CCCCCCcceeeeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 72 --TDYGPSVDLWSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 72 --~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
..++.++|||||||++|+|++|..||.+... ...+..+....... .....
T Consensus 212 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 264 (313)
T 3cek_A 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI---------------------------EFPDI 264 (313)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC---------------------------CCCCC
T ss_pred ccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc---------------------------CCccc
Confidence 3578899999999999999999999976543 23333322110000 00123
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
.+..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 265 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred chHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 5788999999999999999999999999999987544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-28 Score=254.53 Aligned_cols=156 Identities=27% Similarity=0.398 Sum_probs=113.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-----CCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcC--C
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----EGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLG--A 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-----~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g--~ 71 (468)
+.||+.||.|||++||+||||||+|||++. ...+||+|||++........ ......+||++|+|||++.+ .
T Consensus 124 ~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 203 (432)
T 3p23_A 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203 (432)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC--
T ss_pred HHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccc
Confidence 479999999999999999999999999953 23588999999976653321 22345679999999999974 3
Q ss_pred CCCCCCcceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCc
Q 012191 72 TDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 150 (468)
Q Consensus 72 ~~~s~~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s 150 (468)
..++.++||||||||+|+|++ |.+||........ ..+ .+......+ ......+
T Consensus 204 ~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~---~~~~~~~~~----------------------~~~~~~~ 257 (432)
T 3p23_A 204 ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL---LGACSLDCL----------------------HPEKHED 257 (432)
T ss_dssp -CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH---TTCCCCTTS----------------------CTTCHHH
T ss_pred cCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH---hccCCcccc----------------------Ccccccc
Confidence 456789999999999999999 8999965443322 222 111111000 0001245
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 258 ~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 66899999999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-28 Score=244.21 Aligned_cols=171 Identities=22% Similarity=0.339 Sum_probs=122.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE----CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG------ 70 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl----d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g------ 70 (468)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... .......+|+.|+|||++..
T Consensus 118 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 195 (319)
T 4euu_A 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKD 195 (319)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHHTSCCC
T ss_pred HHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC--CceeecccCCCccCHHHhhhcccccc
Confidence 3699999999999999999999999999 77788999999999876543 23345678999999999862
Q ss_pred -CCCCCCCcceeeeehhhhhhhhcCCCCCCCc----hHHHHHHHHHHcCCCCchhhhccCCCccc--cCCCCCCCCchhh
Q 012191 71 -ATDYGPSVDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHAT--LFKPQQPYDSSLR 143 (468)
Q Consensus 71 -~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~----~~e~l~~i~~~~g~p~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 143 (468)
...++.++||||||||+|+|++|..||.... ..+.+..+... .+...|......... .+....+...
T Consensus 196 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 269 (319)
T 4euu_A 196 HQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG---KPSGAISGVQKAENGPIDWSGDMPVSC--- 269 (319)
T ss_dssp CCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH---CCTTCCEEEECSTTCCEEEESSCCTTC---
T ss_pred ccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC---CCcccchhhhcccCCccccCccCCccc---
Confidence 2568899999999999999999999996432 34444444332 222222211100000 0000111110
Q ss_pred hhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhccc
Q 012191 144 ETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179 (468)
Q Consensus 144 ~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~ 179 (468)
.....++..+.+||.+||..||.+|||+.|+|+||-
T Consensus 270 ~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred ccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111345678999999999999999999999999963
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-28 Score=240.97 Aligned_cols=154 Identities=19% Similarity=0.276 Sum_probs=114.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+++.|+|||++.+ ..++.++|
T Consensus 143 ~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 221 (323)
T 3qup_A 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSD 221 (323)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccc
Confidence 46999999999999999999999999999999999999999976544322 12223456788999999976 45899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||.+....+....+....... ....++..+.+||.
T Consensus 222 i~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~ 273 (323)
T 3qup_A 222 VWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK----------------------------QPPECMEEVYDLMY 273 (323)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC----------------------------CCCccCHHHHHHHH
Confidence 9999999999999 999999888777666654321110 11357889999999
Q ss_pred HhcCCCCCCCcC-------HHHHHhcccccCC
Q 012191 159 TLLSVEPYKRAT-------ASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpT-------a~e~L~Hp~F~~~ 183 (468)
+||..||.+||| +.+++.|+|+...
T Consensus 274 ~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 274 QCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 999999999999 7888899999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-28 Score=239.38 Aligned_cols=146 Identities=28% Similarity=0.483 Sum_probs=119.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC-CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++ .++.+||+|||++...... ......+|..|+|||++.+...++.++|
T Consensus 145 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~D 221 (312)
T 2iwi_A 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPAT 221 (312)
T ss_dssp HHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHH
T ss_pred HHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccch
Confidence 36999999999999999999999999998 7899999999999876543 3345678999999999876554456899
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||.+... +.... . .....++..+.+||.+
T Consensus 222 i~slG~il~~l~~g~~pf~~~~~------~~~~~--~---------------------------~~~~~~~~~~~~li~~ 266 (312)
T 2iwi_A 222 VWSLGILLYDMVCGDIPFERDQE------ILEAE--L---------------------------HFPAHVSPDCCALIRR 266 (312)
T ss_dssp HHHHHHHHHHHHHSSCSCCSHHH------HHHTC--C---------------------------CCCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCChHH------Hhhhc--c---------------------------CCcccCCHHHHHHHHH
Confidence 99999999999999999976321 11110 0 0013578899999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
||..||.+|||+.++|+||||+...
T Consensus 267 ~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 267 CLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HccCChhhCcCHHHHhcChhhcCch
Confidence 9999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=234.71 Aligned_cols=157 Identities=29% Similarity=0.447 Sum_probs=120.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...............||+.|+|||++.+ ..++.++||
T Consensus 117 ~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 195 (294)
T 4eqm_A 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDI 195 (294)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHT-CCCCTTHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcC-CCCCchHhH
Confidence 3699999999999999999999999999999999999999998765443333445678999999999987 458899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+........... ..+. ........++..+.++|.+|
T Consensus 196 ~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~----------------------~~~~~~~~~~~~l~~li~~~ 251 (294)
T 4eqm_A 196 YSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVPN----------------------VTTDVRKDIPQSLSNVILRA 251 (294)
T ss_dssp HHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CCCC----------------------HHHHSCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cCCC----------------------cchhcccCCCHHHHHHHHHH
Confidence 99999999999999999998877665544321 1110 11223356899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|..||.+||+..+.|.+.|..-
T Consensus 252 l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 252 TEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp SCSSGGGSCSSHHHHHHHHHTS
T ss_pred hcCCHhHccccHHHHHHHHHHH
Confidence 9999999997777777777543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=238.05 Aligned_cols=153 Identities=22% Similarity=0.344 Sum_probs=116.4
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+ ..++.++
T Consensus 143 ~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 220 (309)
T 3p86_A 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRD-EPSNEKS 220 (309)
T ss_dssp HHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTT-CCCCTTH
T ss_pred HHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-cccccCCCCccccChhhhcC-CCCCchh
Confidence 369999999999999 9999999999999999999999999997544321 22345678999999999987 4589999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..||.+.+..+....+......+ .....+++.+.+||.
T Consensus 221 DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~ 273 (309)
T 3p86_A 221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---------------------------EIPRNLNPQVAAIIE 273 (309)
T ss_dssp HHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC---------------------------CCCTTSCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHH
Confidence 99999999999999999999888777666553322111 011357889999999
Q ss_pred HhcCCCCCCCcCHHHHHh--cccccC
Q 012191 159 TLLSVEPYKRATASAALA--SEYFST 182 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~--Hp~F~~ 182 (468)
+||..||.+|||+.++++ .+++..
T Consensus 274 ~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999998 566654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=233.89 Aligned_cols=152 Identities=22% Similarity=0.255 Sum_probs=120.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc-----EEEEecCCccccCCCCCC------CccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-----LKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~-----vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.|||++||+||||||+|||++.++. +||+|||++......... ......||+.|+|||++.
T Consensus 112 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 191 (298)
T 1csn_A 112 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 191 (298)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhc
Confidence 479999999999999999999999999987765 999999999866543221 234557899999999997
Q ss_pred CCCCCCCCcceeeeehhhhhhhhcCCCCCCC---chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc
Q 012191 70 GATDYGPSVDLWSVGCVFAELLIGKPILQGR---TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 146 (468)
Q Consensus 70 g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~---~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (468)
+ ..++.++|||||||++|+|++|..||.+. .....+..+......+ ......
T Consensus 192 ~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~ 246 (298)
T 1csn_A 192 G-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST------------------------PLRELC 246 (298)
T ss_dssp T-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS------------------------CHHHHT
T ss_pred C-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc------------------------cHHHHH
Confidence 6 45899999999999999999999999874 3334444443321111 112334
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 147 KDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 147 ~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
..+++.+.+||..||..||.+|||+.++++.
T Consensus 247 ~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 247 AGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 5789999999999999999999999999853
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=231.54 Aligned_cols=148 Identities=21% Similarity=0.279 Sum_probs=122.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++...............+|+.|+|||++.+ ..++.++||
T Consensus 110 ~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 188 (268)
T 3sxs_A 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDV 188 (268)
T ss_dssp HHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHH
T ss_pred HHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhh
Confidence 3699999999999999999999999999999999999999998765543333334456778999999976 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+....+....+........ ...+++.+.+||.+
T Consensus 189 ~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR----------------------------PHLASDTIYQIMYS 240 (268)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----------------------------CTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC----------------------------CCcChHHHHHHHHH
Confidence 999999999998 9999998887777666543211110 12357889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||+.++|++
T Consensus 241 ~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=235.27 Aligned_cols=148 Identities=23% Similarity=0.345 Sum_probs=110.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++||
T Consensus 122 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 200 (281)
T 1mp8_A 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDV 200 (281)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHH
T ss_pred HHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhccc-CCCCCccCc
Confidence 3699999999999999999999999999999999999999998765433223334456788999999975 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+....+.+..+...... .....+++.+.+||.+
T Consensus 201 ~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~ 252 (281)
T 1mp8_A 201 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTK 252 (281)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHH
T ss_pred hHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHH
Confidence 999999999996 99999988776666655432110 0113578999999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.+++++
T Consensus 253 ~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 253 CWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-28 Score=233.94 Aligned_cols=153 Identities=29% Similarity=0.437 Sum_probs=124.3
Q ss_pred CHHHHHHHHHHHhCC-----CeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCC
Q 012191 1 MNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~g-----IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
+.||+.||.|||+.| |+|+||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++
T Consensus 117 ~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~ 194 (279)
T 2w5a_A 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYN 194 (279)
T ss_dssp HHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CC
T ss_pred HHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc-ccccccCCCccccChHHhcc-CCCC
Confidence 369999999999999 9999999999999999999999999987654321 11234578999999999976 4588
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++|||||||++|+|++|.+||.+.+..+....+...... .....++..+.+
T Consensus 195 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~ 246 (279)
T 2w5a_A 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----------------------------RIPYRYSDELNE 246 (279)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------------------------CCCTTSCHHHHH
T ss_pred chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc----------------------------cCCcccCHHHHH
Confidence 9999999999999999999999988877666665442110 001257889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||.+||..||.+|||+.++|+|+||...
T Consensus 247 li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 247 IITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 9999999999999999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-28 Score=233.26 Aligned_cols=148 Identities=22% Similarity=0.326 Sum_probs=122.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++||
T Consensus 112 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 190 (269)
T 4hcu_A 112 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDV 190 (269)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcC-CCCCchhhh
Confidence 3689999999999999999999999999999999999999997665433233344566788999999976 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+....+....+........ ...++..+.+||.+
T Consensus 191 ~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 191 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------------------------PRLASTHVYQIMNH 242 (269)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------------------------CTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC----------------------------CCcCCHHHHHHHHH
Confidence 999999999999 9999999888777776644211110 12467889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.+++++
T Consensus 243 ~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCcccCcCHHHHHHH
Confidence 999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=242.91 Aligned_cols=147 Identities=24% Similarity=0.342 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||+|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++||
T Consensus 210 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv 288 (370)
T 2psq_A 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDV 288 (370)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHH
T ss_pred HHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHH
Confidence 6999999999999999999999999999999999999999986554322 22234466889999999987 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+....+.+..+.... .+ .....++..+.+||.+
T Consensus 289 wslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~~ 340 (370)
T 2psq_A 289 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH--RM--------------------------DKPANCTNELYMMMRD 340 (370)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--CC--------------------------CCCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--CC--------------------------CCCCCCCHHHHHHHHH
Confidence 999999999999 999998877666555443211 00 0113578899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.+++++
T Consensus 341 ~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 341 CWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=233.31 Aligned_cols=148 Identities=22% Similarity=0.349 Sum_probs=122.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++||
T Consensus 126 ~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 204 (283)
T 3gen_A 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDI 204 (283)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc-CCCCchhhH
Confidence 3699999999999999999999999999999999999999997665432223334456788999999976 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+..+....+........ ...+++.+.+||.+
T Consensus 205 ~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~ 256 (283)
T 3gen_A 205 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR----------------------------PHLASEKVYTIMYS 256 (283)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC----------------------------CCcCCHHHHHHHHH
Confidence 999999999998 9999999888777776654321111 12457889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.++|+|
T Consensus 257 ~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 257 CWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=241.36 Aligned_cols=149 Identities=23% Similarity=0.309 Sum_probs=120.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|
T Consensus 199 ~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 277 (359)
T 3vhe_A 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSD 277 (359)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC-CCCCchhh
Confidence 36999999999999999999999999999999999999999976543221 22334567889999999976 46899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||+|+|++ |.+||.+....+.+.........+. ....+++.+.+||.
T Consensus 278 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 278 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTML 330 (359)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHH
T ss_pred hhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC---------------------------CCCCCCHHHHHHHH
Confidence 9999999999998 9999988765555444443221111 01246889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.++++|
T Consensus 331 ~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHH
Confidence 9999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=232.39 Aligned_cols=151 Identities=22% Similarity=0.267 Sum_probs=118.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE---CCCCcEEEEecCCccccCCCCC------CCccccccCCcccChhhhcCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGA 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl---d~~g~vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~g~ 71 (468)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ .......+|+.|+|||++.+
T Consensus 111 ~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 189 (296)
T 4hgt_A 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG- 189 (296)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC-
Confidence 3699999999999999999999999999 7889999999999986654322 12235578999999999987
Q ss_pred CCCCCCcceeeeehhhhhhhhcCCCCCCCchH---HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 72 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEV---EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 72 ~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~---e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
..++.++|||||||++|+|++|..||.+.... ..+..+....... ........
T Consensus 190 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~ 245 (296)
T 4hgt_A 190 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST------------------------PIEVLCKG 245 (296)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS------------------------CHHHHTTT
T ss_pred CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc------------------------hhhhhhcc
Confidence 45889999999999999999999999764322 2222222111001 11223356
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
+++.+.+||..||+.||.+|||+.++++
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 246 YPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 7899999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=232.38 Aligned_cols=154 Identities=21% Similarity=0.375 Sum_probs=113.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcC--CCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLG--ATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g--~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ........+|+.|+|||++.. ...++.+
T Consensus 126 ~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 205 (289)
T 3og7_A 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205 (289)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHH
T ss_pred HHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcc
Confidence 3699999999999999999999999999999999999999987554321 223345578999999999862 3457889
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|..||.+....+.+..+.......+ .+......+++.+.+||
T Consensus 206 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li 262 (289)
T 3og7_A 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-----------------------DLSKVRSNCPKRMKRLM 262 (289)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-----------------------CTTSSCTTSCHHHHHHH
T ss_pred cchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-----------------------chhhccccCCHHHHHHH
Confidence 9999999999999999999988776666555544322111 01122346789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhc
Q 012191 158 ETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~H 177 (468)
.+||..||.+|||+.++|+.
T Consensus 263 ~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 263 AECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHH
Confidence 99999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=231.75 Aligned_cols=151 Identities=23% Similarity=0.280 Sum_probs=118.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE---CCCCcEEEEecCCccccCCCCCC------CccccccCCcccChhhhcCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGA 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl---d~~g~vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~g~ 71 (468)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......... ......+|+.|+|||++.+
T Consensus 111 ~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 189 (296)
T 3uzp_A 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG- 189 (296)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC-
Confidence 3699999999999999999999999999 47889999999999866543221 1245578999999999987
Q ss_pred CCCCCCcceeeeehhhhhhhhcCCCCCCCc---hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 72 TDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 72 ~~~s~~sDIWSLG~ILyeLltG~~pf~g~~---~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
..++.++|||||||++|+|++|..||.+.. ....+..+.......+ .......
T Consensus 190 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~ 245 (296)
T 3uzp_A 190 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------------------------IEVLCKG 245 (296)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC------------------------HHHHTTT
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc------------------------hHHHHhh
Confidence 458899999999999999999999998643 2223333322111111 1222356
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
+++.+.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 246 YPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 8899999999999999999999999886
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-28 Score=241.08 Aligned_cols=157 Identities=25% Similarity=0.416 Sum_probs=102.7
Q ss_pred CHHHHHHHHHHHhC-CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc---CCCCCCC
Q 012191 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL---GATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~-gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~---g~~~~s~ 76 (468)
+.||+.||.|||+. ||+|+||||+|||++.++.+||+|||++...... .......+|+.|+|||++. ....++.
T Consensus 131 ~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 208 (327)
T 3aln_A 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDV 208 (327)
T ss_dssp HHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------CCS
T ss_pred HHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc--cccccCCCCccccCceeeccccCcCCCCc
Confidence 36899999999999 9999999999999999999999999999765433 2223447899999999984 2345889
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~-e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
++|||||||++|+|++|..||.+.... +.+..+.. +.++ .+. ......++..+.+
T Consensus 209 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~-------------------~~~---~~~~~~~~~~l~~ 264 (327)
T 3aln_A 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP-------------------QLS---NSEEREFSPSFIN 264 (327)
T ss_dssp HHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SCCC-------------------CCC---CCSSCCCCHHHHH
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CCCC-------------------CCC---CcccccCCHHHHH
Confidence 999999999999999999999764321 11111000 0000 000 0112457899999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||.+||..||.+|||+.++|+||||...
T Consensus 265 li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 265 FVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 9999999999999999999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=231.44 Aligned_cols=147 Identities=20% Similarity=0.265 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||++||+|+||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++|||
T Consensus 120 ~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~ 198 (281)
T 3cc6_A 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVW 198 (281)
T ss_dssp HHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred HHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccH
Confidence 699999999999999999999999999999999999999998665433333344566889999999975 4588999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|+|++ |..||...........+......+ ....+++.+.+||.+|
T Consensus 199 slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~ 250 (281)
T 3cc6_A 199 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP----------------------------KPDLCPPVLYTLMTRC 250 (281)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHH
Confidence 99999999998 999998776665555543321111 0124688899999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|..||.+|||+.+++++
T Consensus 251 l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 251 WDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCchhCcCHHHHHHH
Confidence 99999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=243.93 Aligned_cols=153 Identities=20% Similarity=0.296 Sum_probs=124.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC---cEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g---~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+||||||+||||+.++ .+||+|||++....... ........+|+.|+|||++.+ ..++.
T Consensus 187 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ 265 (367)
T 3l9p_A 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTS 265 (367)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCH
T ss_pred HHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCc
Confidence 36999999999999999999999999999555 59999999997542211 122334567899999999976 46899
Q ss_pred Ccceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 77 SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 77 ~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
++|||||||++|+|++ |.+||.+....+.+..+....... ....++..+.+
T Consensus 266 ~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~ 317 (367)
T 3l9p_A 266 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD----------------------------PPKNCPGPVYR 317 (367)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHH
Confidence 9999999999999998 999999988877776664422111 01357888999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||.+||+.||.+|||+.++|++.++..
T Consensus 318 li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 318 IMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 999999999999999999999987754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=236.49 Aligned_cols=148 Identities=18% Similarity=0.220 Sum_probs=117.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......+|..|+|||++.+ ..++.++|
T Consensus 121 ~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 199 (325)
T 3kex_A 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSD 199 (325)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCChhhH
Confidence 369999999999999999999999999999999999999999876544322 2344567889999999976 45899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+........ ...++..+.+||.
T Consensus 200 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~li~ 251 (325)
T 3kex_A 200 VWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ----------------------------PQICTIDVYMVMV 251 (325)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC----------------------------CTTBCTTTTHHHH
T ss_pred hHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC----------------------------CCcCcHHHHHHHH
Confidence 9999999999999 9999998776665555433111000 0235667889999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++++
T Consensus 252 ~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 252 KCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHTCSCTTTSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=236.77 Aligned_cols=154 Identities=19% Similarity=0.165 Sum_probs=118.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC--cEEEEecCCccccCCCCC------CCccccccCCcccChhhhcCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGAT 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g--~vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~g~~ 72 (468)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+..... .......+|+.|+|||++.+ .
T Consensus 157 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~ 235 (345)
T 2v62_A 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-V 235 (345)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-C
T ss_pred HHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-C
Confidence 46999999999999999999999999998877 999999999976543211 12245578999999999987 4
Q ss_pred CCCCCcceeeeehhhhhhhhcCCCCCCC--chHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcC--C
Q 012191 73 DYGPSVDLWSVGCVFAELLIGKPILQGR--TEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK--D 148 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG~~pf~g~--~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~ 148 (468)
.++.++|||||||++|+|++|..||.+. ................+.. +..... .
T Consensus 236 ~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~ 293 (345)
T 2v62_A 236 ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQS----------------------VLKWAPSGS 293 (345)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHH----------------------HHHHSCTTS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHH----------------------HHhhccccc
Confidence 6899999999999999999999999653 2222222222222222211 112222 6
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
++..+.+||..||..||.+|||+.++++.
T Consensus 294 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 294 SCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp CCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 88999999999999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=237.93 Aligned_cols=148 Identities=21% Similarity=0.278 Sum_probs=118.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|
T Consensus 123 ~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 201 (327)
T 3poz_A 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSD 201 (327)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCchhh
Confidence 369999999999999999999999999999999999999999866543221 2234456889999999986 46899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+......+ ....++..+.+||.
T Consensus 202 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~ 253 (327)
T 3poz_A 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----------------------------QPPICTIDVYMIMV 253 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTBCHHHHHHHH
T ss_pred hhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHH
Confidence 9999999999999 999998877665544443221111 01346788999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||+.++|++
T Consensus 254 ~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 254 KCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHTCSCGGGSCCHHHHHHH
T ss_pred HHcCCChhhCCCHHHHHHH
Confidence 9999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=239.12 Aligned_cols=148 Identities=23% Similarity=0.327 Sum_probs=122.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|
T Consensus 197 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 275 (382)
T 3tt0_A 197 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSD 275 (382)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhH
Confidence 36999999999999999999999999999999999999999976654322 22334566889999999987 56899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+....... ....++.++.+||.
T Consensus 276 iwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~ 327 (382)
T 3tt0_A 276 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD----------------------------KPSNCTNELYMMMR 327 (382)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCSSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHH
Confidence 9999999999999 999999888776666554321100 11357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++++
T Consensus 328 ~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 328 DCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-27 Score=234.55 Aligned_cols=150 Identities=22% Similarity=0.284 Sum_probs=117.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc-----EEEEecCCccccCCCCCC------CccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV-----LKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~-----vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||+|||++||+||||||+|||++.++. +||+|||++..+...... ......||+.|+|||++.
T Consensus 111 ~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 190 (330)
T 2izr_A 111 AIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL 190 (330)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHc
Confidence 369999999999999999999999999998887 999999999865443221 124568899999999998
Q ss_pred CCCCCCCCcceeeeehhhhhhhhcCCCCCCCc---hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc
Q 012191 70 GATDYGPSVDLWSVGCVFAELLIGKPILQGRT---EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 146 (468)
Q Consensus 70 g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~---~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (468)
+ ..++.++||||||||+|+|++|..||.+.. ..+.+..+.......+ .....
T Consensus 191 ~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~ 245 (330)
T 2izr_A 191 G-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP------------------------IEVLC 245 (330)
T ss_dssp T-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC------------------------HHHHT
T ss_pred C-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC------------------------HHHHh
Confidence 7 568999999999999999999999998743 3344444432211111 11122
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 147 KDLPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 147 ~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
..++ ++.+||..||..||.+||++.++++
T Consensus 246 ~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp TTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3455 8999999999999999999988875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-27 Score=239.42 Aligned_cols=154 Identities=21% Similarity=0.207 Sum_probs=117.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC--CCCcEEEEecCCccccCCCCC------CCccccccCCcccChhhhcCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGAT 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld--~~g~vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~g~~ 72 (468)
+.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+..... ......+||+.|+|||++.+ .
T Consensus 158 ~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~ 236 (364)
T 3op5_A 158 SLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-V 236 (364)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-C
T ss_pred HHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-C
Confidence 46999999999999999999999999998 889999999999976543211 11234568999999999987 4
Q ss_pred CCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHH-cCCCCchhhhccCCCccccCCCCCCCCchhhhhc--CCC
Q 012191 73 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL-CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF--KDL 149 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~ 149 (468)
.++.++|||||||++|+|++|..||.+......+...... ....... .+...+ ..+
T Consensus 237 ~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~ 295 (364)
T 3op5_A 237 APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIAS---------------------LMDKCFPAANA 295 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHH---------------------HHHHHSCTTCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHH---------------------HHHHhcccccC
Confidence 5899999999999999999999999864333222222111 1000000 011111 467
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
+.++.+||..||..||.+|||+.++++
T Consensus 296 ~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 296 PGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 899999999999999999999999885
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-27 Score=233.60 Aligned_cols=157 Identities=18% Similarity=0.277 Sum_probs=125.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|
T Consensus 144 ~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 222 (322)
T 1p4o_A 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSD 222 (322)
T ss_dssp HHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhh
Confidence 36899999999999999999999999999999999999999875543211 11223456889999999876 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||.+.+..+....+..... + .....++..+.+||.
T Consensus 223 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~l~~li~ 274 (322)
T 1p4o_A 223 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-L---------------------------DKPDNCPDMLFELMR 274 (322)
T ss_dssp HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-C---------------------------CCCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-C---------------------------CCCCCCCHHHHHHHH
Confidence 9999999999999 8999998877766665543110 0 011357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc------ccccCCCCC
Q 012191 159 TLLSVEPYKRATASAALAS------EYFSTKPYA 186 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H------p~F~~~p~~ 186 (468)
+||..||.+|||+.+++++ ++|+...+.
T Consensus 275 ~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 275 MCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred HHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 9999999999999999987 666554443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-27 Score=236.32 Aligned_cols=148 Identities=21% Similarity=0.276 Sum_probs=113.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..|+.++|
T Consensus 123 ~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 201 (327)
T 3lzb_A 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSD 201 (327)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC-CCCChHHH
Confidence 36999999999999999999999999999999999999999976643322 12234456788999999986 46899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||.+....+....+......+ ....++..+.+||.
T Consensus 202 i~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~ 253 (327)
T 3lzb_A 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----------------------------QPPICTIDVYMIMR 253 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHH
Confidence 9999999999999 999999877766555543321111 01347888999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.++|+.
T Consensus 254 ~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 254 KCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999963
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-27 Score=234.84 Aligned_cols=147 Identities=21% Similarity=0.323 Sum_probs=118.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC--ccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||++.+ ..++.++
T Consensus 157 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~ 235 (325)
T 3kul_A 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSAS 235 (325)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-CEECHHH
T ss_pred HHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHH
Confidence 3689999999999999999999999999999999999999998765432221 223345778999999976 4588999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |..||.+....+....+......+ ....++..+.+||
T Consensus 236 Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li 287 (325)
T 3kul_A 236 DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP----------------------------APMGCPHALHQLM 287 (325)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC----------------------------CCCCcCHHHHHHH
Confidence 99999999999999 999999988887777665432111 0135788999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..||.+|||+.++++
T Consensus 288 ~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 288 LDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHHH
Confidence 9999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=226.64 Aligned_cols=148 Identities=22% Similarity=0.328 Sum_probs=121.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...............++..|+|||++.+ ..++.++||
T Consensus 110 ~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 188 (267)
T 3t9t_A 110 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDV 188 (267)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcC-CCccchhch
Confidence 3699999999999999999999999999999999999999997654332222334466788999999976 457899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+....+....+....... ....++..+.+||.+
T Consensus 189 ~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 189 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----------------------------KPRLASTHVYQIMNH 240 (267)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTSCHHHHHHHHH
T ss_pred hhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC----------------------------CCccCcHHHHHHHHH
Confidence 999999999999 899999888777766664321100 012467889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.+++++
T Consensus 241 ~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-27 Score=226.76 Aligned_cols=152 Identities=22% Similarity=0.371 Sum_probs=123.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...............+++.|+|||++.+ ..++.++||
T Consensus 115 ~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 193 (279)
T 1qpc_A 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDV 193 (279)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHH
T ss_pred HHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhh
Confidence 3699999999999999999999999999999999999999998765443333344456788999999975 457889999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+..+.+..+....... ....++..+.+||.+
T Consensus 194 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~ 245 (279)
T 1qpc_A 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV----------------------------RPDNCPEELYQLMRL 245 (279)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC----------------------------CcccccHHHHHHHHH
Confidence 999999999999 999999888777666654321100 013578899999999
Q ss_pred hcCCCCCCCcCHHHHHh--ccccc
Q 012191 160 LLSVEPYKRATASAALA--SEYFS 181 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~--Hp~F~ 181 (468)
||..||.+|||+.++++ ..+|.
T Consensus 246 ~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 246 CWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999986 34444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-27 Score=231.74 Aligned_cols=148 Identities=20% Similarity=0.254 Sum_probs=119.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|
T Consensus 156 ~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 234 (314)
T 2ivs_A 156 AWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSD 234 (314)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHH
T ss_pred HHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhh
Confidence 36999999999999999999999999999999999999999976643321 12233456788999999976 45789999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+.........+.... .. .....+++.+.+||.
T Consensus 235 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~li~ 286 (314)
T 2ivs_A 235 VWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH--RM--------------------------ERPDNCSEEMYRLML 286 (314)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC--cC--------------------------CCCccCCHHHHHHHH
Confidence 9999999999999 999998877665554443211 00 011357899999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++++
T Consensus 287 ~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 287 QCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=225.08 Aligned_cols=146 Identities=25% Similarity=0.381 Sum_probs=113.0
Q ss_pred CHHHHHHHHHHHhCC---CeeccCCCCceEECC--------CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSRG---VLHRDIKGSNLLVNN--------EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~g---IvHrDIKp~NILld~--------~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.|||++| |+|+||||+|||++. ++.+||+|||++...... ......+|+.|+|||++.
T Consensus 111 ~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~ 187 (271)
T 3dtc_A 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMAPEVIR 187 (271)
T ss_dssp HHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHH
T ss_pred HHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc---cccCCCCccceeCHHHhc
Confidence 369999999999999 899999999999986 678999999999765543 223457899999999997
Q ss_pred CCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCC
Q 012191 70 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149 (468)
Q Consensus 70 g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (468)
+ ..++.++|||||||++|+|++|..||.+.+.......+......++ ....+
T Consensus 188 ~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 239 (271)
T 3dtc_A 188 A-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP---------------------------IPSTC 239 (271)
T ss_dssp H-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC---------------------------CCTTC
T ss_pred c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC---------------------------CCccc
Confidence 6 4588999999999999999999999998887666555432111110 11357
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
++.+.+||.+||..||.+|||+.+++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 8899999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-27 Score=231.31 Aligned_cols=149 Identities=23% Similarity=0.309 Sum_probs=118.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|
T Consensus 154 ~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 232 (316)
T 2xir_A 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSD 232 (316)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhH
Confidence 369999999999999999999999999999999999999999765433221 2234466889999999976 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+......+.........+. ....+++.+.+||.
T Consensus 233 i~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~ 285 (316)
T 2xir_A 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTML 285 (316)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCC---------------------------CCCCCCHHHHHHHH
Confidence 9999999999998 9999988665444433333211110 01246889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.++++|
T Consensus 286 ~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 286 DCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-27 Score=235.05 Aligned_cols=150 Identities=20% Similarity=0.241 Sum_probs=120.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|
T Consensus 178 ~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 256 (344)
T 1rjb_A 178 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSD 256 (344)
T ss_dssp HHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHh
Confidence 369999999999999999999999999999999999999999765433221 1233456888999999876 45899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+......+..+......++ ....+++.+.+||.
T Consensus 257 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~ 309 (344)
T 1rjb_A 257 VWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQ 309 (344)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHH
Confidence 9999999999998 9999988765555544433211110 01246889999999
Q ss_pred HhcCCCCCCCcCHHHHHhcc
Q 012191 159 TLLSVEPYKRATASAALASE 178 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp 178 (468)
+||..||.+|||+.+++++-
T Consensus 310 ~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 310 SCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHTCSSGGGSCCHHHHHHHH
T ss_pred HHcCCCchhCcCHHHHHHHH
Confidence 99999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-27 Score=228.62 Aligned_cols=148 Identities=20% Similarity=0.308 Sum_probs=120.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.++|+|||++...............+|+.|+|||++.+ ..++.++||
T Consensus 117 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 195 (288)
T 3kfa_A 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDV 195 (288)
T ss_dssp HHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhcc-CCCCchhhH
Confidence 3699999999999999999999999999999999999999998766443333344566888999999976 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+.+.......+...... .....+++.+.+||.+
T Consensus 196 ~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~ 247 (288)
T 3kfa_A 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----------------------------ERPEGCPEKVYELMRA 247 (288)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC----------------------------CCCCCCCHHHHHHHHH
Confidence 999999999999 99999887766555544332110 0113578899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.++++.
T Consensus 248 ~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 248 CWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HhCCChhhCcCHHHHHHH
Confidence 999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=229.23 Aligned_cols=149 Identities=22% Similarity=0.334 Sum_probs=119.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-ccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-LTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......... .....+|+.|+|||++.+ ..++.++|
T Consensus 151 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 229 (313)
T 1t46_A 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESD 229 (313)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHH
Confidence 3689999999999999999999999999999999999999997665432211 223456788999999876 46889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+......+..+......+. ....++..+.+||.
T Consensus 230 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~ 282 (313)
T 1t46_A 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMK 282 (313)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC---------------------------CcccCCHHHHHHHH
Confidence 9999999999998 9999988765555544443221110 01357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++++
T Consensus 283 ~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 283 TCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCchhCcCHHHHHHH
Confidence 9999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-27 Score=233.30 Aligned_cols=148 Identities=23% Similarity=0.317 Sum_probs=119.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|
T Consensus 180 ~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 258 (343)
T 1luf_A 180 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESD 258 (343)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccc
Confidence 36999999999999999999999999999999999999999976543211 12234567889999999876 45899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+.... .. .....++..+.+||.
T Consensus 259 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li~ 310 (343)
T 1luf_A 259 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN--IL--------------------------ACPENCPLELYNLMR 310 (343)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHHH
T ss_pred cHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC--cC--------------------------CCCCCCCHHHHHHHH
Confidence 9999999999998 999999888777666654321 10 011357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++++
T Consensus 311 ~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 311 LCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcccCcccCCCHHHHHHH
Confidence 9999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=243.95 Aligned_cols=147 Identities=22% Similarity=0.360 Sum_probs=121.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...............+++.|+|||++.+ ..++.++||
T Consensus 290 ~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 368 (454)
T 1qcf_A 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDV 368 (454)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHH
Confidence 3699999999999999999999999999999999999999998664322122233455788999999975 458999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||+||||++ |..||.+.+..+.+..+......+. ...+++.+.+||.+
T Consensus 369 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 369 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR----------------------------PENCPEELYNIMMR 420 (454)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC----------------------------CTTSCHHHHHHHHH
T ss_pred HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CCCCCHHHHHHHHH
Confidence 999999999999 9999999888877776654321110 13578899999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.+++.
T Consensus 421 cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhHCcCHHHHHH
Confidence 99999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=225.32 Aligned_cols=148 Identities=22% Similarity=0.286 Sum_probs=116.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC---CCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH---RQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ........+|+.|+|||.+.+ ..++.+
T Consensus 130 ~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 208 (298)
T 3pls_A 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTK 208 (298)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHH
T ss_pred HHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChh
Confidence 3699999999999999999999999999999999999999997554321 122234567889999999976 468899
Q ss_pred cceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 78 VDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 78 sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
+|||||||++|+|++ |.+||.+.+..+....+......+ ....++..+.+|
T Consensus 209 ~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~l 260 (298)
T 3pls_A 209 SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP----------------------------QPEYCPDSLYQV 260 (298)
T ss_dssp HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHH
T ss_pred hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC----------------------------CCccchHHHHHH
Confidence 999999999999999 556666665555554443321111 013467899999
Q ss_pred HHHhcCCCCCCCcCHHHHHhc
Q 012191 157 IETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~H 177 (468)
|.+||..||.+|||+.++++.
T Consensus 261 i~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 261 MQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=229.42 Aligned_cols=148 Identities=20% Similarity=0.281 Sum_probs=114.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .......+++.|+|||++.+ ..++.++|
T Consensus 153 ~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 231 (313)
T 3brb_A 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSD 231 (313)
T ss_dssp HHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHH
T ss_pred HHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhh
Confidence 36999999999999999999999999999999999999999976543321 11233456788999999976 56889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |.+||.+.........+...... .....++..+.+||.
T Consensus 232 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~ 283 (313)
T 3brb_A 232 VWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL----------------------------KQPEDCLDELYEIMY 283 (313)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----------------------------CCBTTCCHHHHHHHH
T ss_pred hHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC----------------------------CCCccccHHHHHHHH
Confidence 9999999999999 99999887776666555432110 011357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++++
T Consensus 284 ~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 284 SCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=234.07 Aligned_cols=155 Identities=17% Similarity=0.201 Sum_probs=118.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC--cEEEEecCCccccCCCCC------CCccccccCCcccChhhhcCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG--VLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLLGAT 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g--~vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~g~~ 72 (468)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++........ .......+|+.|+|||++.+ .
T Consensus 165 ~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~ 243 (352)
T 2jii_A 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-C 243 (352)
T ss_dssp HHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-C
T ss_pred HHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-C
Confidence 47999999999999999999999999999988 899999999976543211 12234578999999999977 4
Q ss_pred CCCCCcceeeeehhhhhhhhcCCCCCCCc-hHHHHHHHHH-HcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCc
Q 012191 73 DYGPSVDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFK-LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 150 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG~~pf~g~~-~~e~l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s 150 (468)
.++.++|||||||++|+|++|..||.+.. ....+..... ....+.. +. .....+..++
T Consensus 244 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~-------------------~~~~~~~~~~ 303 (352)
T 2jii_A 244 GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP-FV-------------------GPCGHWIRPS 303 (352)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC-EE-------------------CTTSCEECCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhh-hh-------------------hhccccCCCc
Confidence 68899999999999999999999998764 3333322222 2111111 00 0011124678
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
..+.+||.+||..||.+|||+.++++
T Consensus 304 ~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 304 ETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 99999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=226.90 Aligned_cols=149 Identities=19% Similarity=0.230 Sum_probs=121.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++
T Consensus 116 ~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 194 (287)
T 1u59_A 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRS 194 (287)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHH
T ss_pred HHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhcc-CCCCchh
Confidence 36999999999999999999999999999999999999999987653322 11223456889999999975 4578999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |..||.+....+....+.... .+ .....+++.+.+||
T Consensus 195 Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--~~--------------------------~~~~~~~~~l~~li 246 (287)
T 1u59_A 195 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--RM--------------------------ECPPECPPELYALM 246 (287)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHH
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--cC--------------------------CCCCCcCHHHHHHH
Confidence 99999999999998 999999887776665553311 10 01135789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcc
Q 012191 158 ETLLSVEPYKRATASAALASE 178 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp 178 (468)
.+||..||.+|||+.+++++.
T Consensus 247 ~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 247 SDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=228.61 Aligned_cols=149 Identities=26% Similarity=0.362 Sum_probs=107.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++||
T Consensus 140 ~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 218 (309)
T 2h34_A 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADI 218 (309)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHH
T ss_pred HHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhH
Confidence 3699999999999999999999999999999999999999997665443334445678999999999876 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.........+ ...... .......++..+.+||.+|
T Consensus 219 ~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~-------------------------~~~~~~~~~~~l~~li~~~ 272 (309)
T 2h34_A 219 YALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPR-------------------------PSTVRPGIPVAFDAVIARG 272 (309)
T ss_dssp HHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCC-------------------------GGGTSTTCCTHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCC-------------------------ccccCCCCCHHHHHHHHHh
Confidence 99999999999999999887655332222 211111 1122346788999999999
Q ss_pred cCCCCCCCc-CHHHHHh
Q 012191 161 LSVEPYKRA-TASAALA 176 (468)
Q Consensus 161 L~~DP~kRp-Ta~e~L~ 176 (468)
|..||.+|| |+.++++
T Consensus 273 l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 273 MAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp TCSSGGGSCSSHHHHHH
T ss_pred ccCCHHHHHHhHHHHHH
Confidence 999999999 7877775
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-27 Score=228.27 Aligned_cols=142 Identities=20% Similarity=0.267 Sum_probs=111.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc--------EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV--------LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~--------vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~ 72 (468)
+.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .....+|+.|+|||++.+..
T Consensus 119 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 193 (289)
T 4fvq_A 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPK 193 (289)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGG
T ss_pred HHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCC
Confidence 369999999999999999999999999988876 99999999865432 23346788999999998756
Q ss_pred CCCCCcceeeeehhhhhhhhc-CCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH
Q 012191 73 DYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG-~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 151 (468)
.++.++|||||||++|+|++| .+||.......... +....... ....+.
T Consensus 194 ~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~~-----------------------------~~~~~~ 243 (289)
T 4fvq_A 194 NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQL-----------------------------PAPKAA 243 (289)
T ss_dssp GCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCCC-----------------------------CCCSSC
T ss_pred CCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCCC-----------------------------CCCCCH
Confidence 689999999999999999995 45555544443333 22211111 023456
Q ss_pred HHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 152 TAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
.+.+||.+||+.||.+|||+.+++++
T Consensus 244 ~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 244 ELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=227.03 Aligned_cols=149 Identities=26% Similarity=0.351 Sum_probs=119.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......+|..|+|||++.+ ..++.++
T Consensus 127 ~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 205 (291)
T 1u46_A 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHAS 205 (291)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHH
T ss_pred HHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcC-CCCCchh
Confidence 369999999999999999999999999999999999999999776543221 1223456788999999976 4578899
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |..||.+.+..+.+..+......++ ....++..+.+||
T Consensus 206 Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li 258 (291)
T 1u46_A 206 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---------------------------RPEDCPQDIYNVM 258 (291)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC---------------------------CCcCcCHHHHHHH
Confidence 99999999999999 9999999888777766643221111 1135789999999
Q ss_pred HHhcCCCCCCCcCHHHHHhc
Q 012191 158 ETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~H 177 (468)
.+||..||.+|||+.+++++
T Consensus 259 ~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 259 VQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCcccCcCHHHHHHH
Confidence 99999999999999999973
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-27 Score=237.91 Aligned_cols=169 Identities=24% Similarity=0.264 Sum_probs=116.2
Q ss_pred CHHHHHHHHHHHhC----------CCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSR----------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~----------gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.|||+. ||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.
T Consensus 127 ~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 206 (322)
T 3soc_A 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206 (322)
T ss_dssp HHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcc
Confidence 36999999999999 999999999999999999999999999976654322 2234467899999999997
Q ss_pred CC----CCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhh
Q 012191 70 GA----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 145 (468)
Q Consensus 70 g~----~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 145 (468)
+. ..++.++|||||||++|+|++|.+||.+................+....+....... .....+...
T Consensus 207 ~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 278 (322)
T 3soc_A 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK--------KKRPVLRDY 278 (322)
T ss_dssp TCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS--------CCCCCCCGG
T ss_pred cccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc--------cCCCCcccc
Confidence 63 234567899999999999999999998754321111111111111111111000000 000001111
Q ss_pred c--CCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 146 F--KDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 146 ~--~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
+ ...+..+.+||.+||+.||.+|||+.++++.
T Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 279 WQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 1235669999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=226.05 Aligned_cols=142 Identities=26% Similarity=0.435 Sum_probs=107.7
Q ss_pred HHHHHHHHHHHh---CCCeeccCCCCceEECCCCc-EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 2 NQLLHGLEHCHS---RGVLHRDIKGSNLLVNNEGV-LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 2 ~QLL~gL~yLHs---~gIvHrDIKp~NILld~~g~-vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...... .....||+.|+|||++.+ ..++.+
T Consensus 109 ~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~ 183 (307)
T 2eva_A 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEG-SNYSEK 183 (307)
T ss_dssp HHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTC-CCCCTH
T ss_pred HHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCC-CCCCcH
Confidence 589999999999 89999999999999988886 799999998755432 234568999999999976 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCch--HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTE--VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~--~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
+|||||||++|+|++|..||..... ......+.. +..+ .....++..+.+
T Consensus 184 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~l~~ 235 (307)
T 2eva_A 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTRP--------------------------PLIKNLPKPIES 235 (307)
T ss_dssp HHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCCC--------------------------CCBTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCCC--------------------------CcccccCHHHHH
Confidence 9999999999999999999975432 222222211 1110 112457889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHh
Q 012191 156 LIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~ 176 (468)
||.+||..||.+|||+.++++
T Consensus 236 li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999997
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=232.11 Aligned_cols=146 Identities=24% Similarity=0.318 Sum_probs=116.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+++.|+|||++.+ ..++.++||
T Consensus 148 ~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 224 (327)
T 1fvr_A 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDV 224 (327)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcc
Confidence 369999999999999999999999999999999999999998643321 12233456889999999876 457899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+.+..+....+...... .....++..+.+||.+
T Consensus 225 ~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~ 276 (327)
T 1fvr_A 225 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL----------------------------EKPLNCDDEVYDLMRQ 276 (327)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC----------------------------CCCTTBCHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC----------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 99999988876665554321100 0113578899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.++|++
T Consensus 277 ~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 277 CWREKPYERPSFAQILVS 294 (327)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999976
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=223.82 Aligned_cols=145 Identities=23% Similarity=0.353 Sum_probs=114.8
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEECCCCc-----EEEEecCCccccCCCCCCCccccccCCcccChhhhcC-CC
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGV-----LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-AT 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld~~g~-----vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g-~~ 72 (468)
+.||+.||.|||++| |+|+||||+|||++.++. +||+|||++..... ......+|+.|+|||++.+ ..
T Consensus 128 ~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~ 203 (287)
T 4f0f_A 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEE 203 (287)
T ss_dssp HHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSC
T ss_pred HHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCC
Confidence 369999999999999 999999999999988776 99999999874432 3345678999999999843 24
Q ss_pred CCCCCcceeeeehhhhhhhhcCCCCCCCchHHH--HHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCc
Q 012191 73 DYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQ--LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLP 150 (468)
Q Consensus 73 ~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~--l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s 150 (468)
.++.++|||||||++|+|++|..||.+...... ...+.. .+..+ .....++
T Consensus 204 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~ 256 (287)
T 4f0f_A 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRP--------------------------TIPEDCP 256 (287)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCCCC--------------------------CCCTTSC
T ss_pred CcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCCCC--------------------------CCCcccC
Confidence 568899999999999999999999987553322 222222 11111 0113578
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
+.+.+||.+||..||.+|||+.++++
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 257 PRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=230.70 Aligned_cols=164 Identities=20% Similarity=0.219 Sum_probs=117.5
Q ss_pred CHHHHHHHHHHHhC---CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSR---GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~---gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...............||+.|+|||++.+ ..++.+
T Consensus 137 ~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 215 (326)
T 3uim_A 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEK 215 (326)
T ss_dssp HHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHH
T ss_pred HHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhcc-CCCCcc
Confidence 36899999999999 99999999999999999999999999998765444444455668999999999976 357899
Q ss_pred cceeeeehhhhhhhhcCCCCCCCc----hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTA 153 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~----~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l 153 (468)
+|||||||++|+|++|..||.... ....+....... .... ... ....... ........+..+
T Consensus 216 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~-----~~~--~~~~~~~-----~~~~~~~~~~~l 281 (326)
T 3uim_A 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL--LKEK-----KLE--ALVDVDL-----QGNYKDEEVEQL 281 (326)
T ss_dssp HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT--TSSC-----CST--TSSCTTC-----TTSCCHHHHHHH
T ss_pred ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH--hhch-----hhh--hhcChhh-----ccccCHHHHHHH
Confidence 999999999999999999996211 000011111000 0000 000 0000000 001112345789
Q ss_pred HHHHHHhcCCCCCCCcCHHHHHhccc
Q 012191 154 VNLIETLLSVEPYKRATASAALASEY 179 (468)
Q Consensus 154 ~dLL~~mL~~DP~kRpTa~e~L~Hp~ 179 (468)
.+||.+||+.||.+|||+.++|+|-.
T Consensus 282 ~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 282 IQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 99999999999999999999998854
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=229.80 Aligned_cols=148 Identities=24% Similarity=0.332 Sum_probs=120.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|
T Consensus 163 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 241 (334)
T 2pvf_A 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSD 241 (334)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHH
Confidence 36999999999999999999999999999999999999999976654321 12233456788999999876 45789999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|+|++ |..||.+....+....+....... ....++..+.+||.
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~ 293 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD----------------------------KPANCTNELYMMMR 293 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC----------------------------CCccCCHHHHHHHH
Confidence 9999999999999 999999887776666554321100 11357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||..||.+|||+.+++++
T Consensus 294 ~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 294 DCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=226.19 Aligned_cols=146 Identities=19% Similarity=0.248 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++
T Consensus 135 ~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 213 (298)
T 3f66_A 135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKS 213 (298)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHH
T ss_pred HHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcC-CCCChHH
Confidence 6999999999999999999999999999999999999999976543221 12234466789999999976 4588999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |.+||.+....+....+........ ...++..+.+||
T Consensus 214 Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li 265 (298)
T 3f66_A 214 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----------------------------PEYCPDPLYEVM 265 (298)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC----------------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC----------------------------CccCCHHHHHHH
Confidence 99999999999999 6778877766655555433211110 124678899999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..||.+|||+.++++
T Consensus 266 ~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 266 LKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=240.01 Aligned_cols=153 Identities=25% Similarity=0.395 Sum_probs=118.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...............+++.|+|||++.+ ..++.++||
T Consensus 286 ~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv 364 (452)
T 1fmk_A 286 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 364 (452)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc-CCCCccccH
Confidence 3699999999999999999999999999999999999999997665432222334456788999999876 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |..||.+....+.+..+......+ ....+++.+.+||.+
T Consensus 365 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQ 416 (452)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTSCHHHHHHHHH
T ss_pred HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHH
Confidence 999999999999 999999988877776664321111 013578899999999
Q ss_pred hcCCCCCCCcCHHHHHh--cccccC
Q 012191 160 LLSVEPYKRATASAALA--SEYFST 182 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~--Hp~F~~ 182 (468)
||..||.+|||+.++++ ..+|..
T Consensus 417 cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HccCChhhCcCHHHHHHHHHHHhcc
Confidence 99999999999999987 355554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=230.42 Aligned_cols=153 Identities=20% Similarity=0.282 Sum_probs=121.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+|+||||+|||++. +..+||+|||++........ .......+|+.|+|||++.+ ..++.
T Consensus 146 ~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 224 (327)
T 2yfx_A 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTS 224 (327)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCH
T ss_pred HHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCc
Confidence 369999999999999999999999999984 44699999999875433221 22234567889999999876 45889
Q ss_pred Ccceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 77 SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 77 ~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
++|||||||++|+|++ |..||.+....+.+..+....... ....++..+.+
T Consensus 225 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~ 276 (327)
T 2yfx_A 225 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD----------------------------PPKNCPGPVYR 276 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHH
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHH
Confidence 9999999999999998 999999887776666554321100 01357889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||.+||..||.+|||+.+++++.|+..
T Consensus 277 li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 277 IMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999988754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=224.84 Aligned_cols=146 Identities=27% Similarity=0.398 Sum_probs=117.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++||
T Consensus 128 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 204 (284)
T 2a19_B 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDL 204 (284)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHH
T ss_pred HHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhh
Confidence 3699999999999999999999999999999999999999997765432 2345578999999999976 468999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.... .....+.. +. ....++..+.+||.+|
T Consensus 205 ~slG~il~~l~~~~~~~~~~~--~~~~~~~~--~~-----------------------------~~~~~~~~~~~li~~~ 251 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFETS--KFFTDLRD--GI-----------------------------ISDIFDKKEKTLLQKL 251 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHHH--HHHHHHHT--TC-----------------------------CCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCcchhHH--HHHHHhhc--cc-----------------------------ccccCCHHHHHHHHHH
Confidence 999999999999998874321 11111110 00 0124678899999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|..||.+|||+.+++++.++-.
T Consensus 252 l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 252 LSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=231.00 Aligned_cols=148 Identities=22% Similarity=0.310 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcce
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++||
T Consensus 171 ~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 249 (333)
T 2i1m_A 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDV 249 (333)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHH
Confidence 69999999999999999999999999999999999999999765433221 1223456788999999876 458899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+......+..+......+. ....++..+.+||.+
T Consensus 250 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~ 302 (333)
T 2i1m_A 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA---------------------------QPAFAPKNIYSIMQA 302 (333)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHH
Confidence 999999999998 9999988765555555443221111 012357889999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||+.+++++
T Consensus 303 ~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 303 CWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HhccChhhCcCHHHHHHH
Confidence 999999999999999964
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-26 Score=224.79 Aligned_cols=156 Identities=28% Similarity=0.362 Sum_probs=114.3
Q ss_pred CHHHHHHHHHHH--------hCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC---CccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCH--------SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLH--------s~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.||| +.||+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.
T Consensus 111 ~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 190 (301)
T 3q4u_A 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190 (301)
T ss_dssp HHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhc
Confidence 369999999999 999999999999999999999999999999765433221 123447899999999997
Q ss_pred CCCC-----CCCCcceeeeehhhhhhhhc----------CCCCCCCc----hHHHHHHHHHHcCCCCchhhhccCCCccc
Q 012191 70 GATD-----YGPSVDLWSVGCVFAELLIG----------KPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHAT 130 (468)
Q Consensus 70 g~~~-----~s~~sDIWSLG~ILyeLltG----------~~pf~g~~----~~e~l~~i~~~~g~p~~~~~~~~~~~~~~ 130 (468)
+... ++.++|||||||++|+|++| .+||.+.. ....+..+....+..+.
T Consensus 191 ~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------ 258 (301)
T 3q4u_A 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN------------ 258 (301)
T ss_dssp TCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC------------
T ss_pred CcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCC------------
Confidence 6432 34689999999999999999 88885532 22333332221111100
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 131 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 131 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
... ......++..+.+||.+||+.||.+|||+.++++.
T Consensus 259 -------~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 259 -------IPN--RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp -------CCG--GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred -------CCh--hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 000 00112356789999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-27 Score=231.37 Aligned_cols=148 Identities=26% Similarity=0.410 Sum_probs=97.8
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-----------CccccccCCcccChhh
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-----------PLTSRVVTLWYRPPEL 67 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~ 67 (468)
+.||+.||.|||+.| |+|+||||+|||++.++.+||+|||++......... ......+|+.|+|||+
T Consensus 142 ~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 221 (337)
T 3ll6_A 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI 221 (337)
T ss_dssp HHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----------------------------
T ss_pred HHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhh
Confidence 369999999999999 999999999999999999999999999766543211 1114468999999999
Q ss_pred hc--CCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhh
Q 012191 68 LL--GATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRET 145 (468)
Q Consensus 68 l~--g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 145 (468)
+. ....++.++|||||||++|+|++|..||.+......+... . .. ..
T Consensus 222 ~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~-~~---------------------------~~ 270 (337)
T 3ll6_A 222 IDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK---Y-SI---------------------------PP 270 (337)
T ss_dssp --CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------C-CC---------------------------CT
T ss_pred hhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc---c-cC---------------------------Cc
Confidence 84 2345788999999999999999999999765433222111 0 00 00
Q ss_pred cCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhccc
Q 012191 146 FKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179 (468)
Q Consensus 146 ~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~ 179 (468)
....+..+.+||.+||+.||.+|||+.++|++-+
T Consensus 271 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 271 HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1245567899999999999999999999998743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=224.34 Aligned_cols=147 Identities=19% Similarity=0.249 Sum_probs=118.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......+++.|+|||++.+ ..++.++
T Consensus 123 ~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 201 (291)
T 1xbb_A 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKS 201 (291)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHH
T ss_pred HHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhh
Confidence 369999999999999999999999999999999999999999766543221 1223345788999999976 3578899
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |..||.+....+....+.... .+ .....++..+.+||
T Consensus 202 Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~l~~li 253 (291)
T 1xbb_A 202 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--RM--------------------------GCPAGCPREMYDLM 253 (291)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCCCCCHHHHHHH
Confidence 99999999999999 999999887766655553311 00 01135789999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..||.+|||+.++++
T Consensus 254 ~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 254 NLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-26 Score=225.08 Aligned_cols=149 Identities=17% Similarity=0.275 Sum_probs=114.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCC----CCCCccccccCCcccChhhhcC------
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTG----HRQPLTSRVVTLWYRPPELLLG------ 70 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~----~~~~~~~~~gt~~Y~APE~l~g------ 70 (468)
+.||+.||.|||++||+|+||||+|||++ ++.+||+|||++...... .........+|+.|+|||++.+
T Consensus 136 ~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 214 (319)
T 2y4i_B 136 AQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214 (319)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--
T ss_pred HHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhcccccc
Confidence 36999999999999999999999999998 689999999998654321 1122334568999999999875
Q ss_pred --CCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 71 --ATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 71 --~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
...++.++|||||||++|+|++|..||.+.........+........ ....
T Consensus 215 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 267 (319)
T 2y4i_B 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL---------------------------SQIG 267 (319)
T ss_dssp CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC---------------------------CCSS
T ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC---------------------------CcCC
Confidence 23478899999999999999999999998887766655533211100 0124
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
++..+.+||.+||..||.+|||+.++++.
T Consensus 268 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 268 MGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 67789999999999999999999999963
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-27 Score=229.73 Aligned_cols=161 Identities=23% Similarity=0.300 Sum_probs=117.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......||+.|+|||++.+ .++.++|
T Consensus 139 ~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~D 216 (307)
T 2nru_A 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSD 216 (307)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHH
T ss_pred HHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccch
Confidence 368999999999999999999999999999999999999999765543221 1234578999999999876 4789999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|.+||.+......+..+..........+... ... .+.......+..+.+||.+
T Consensus 217 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~------~~~~~~~~~~~~l~~li~~ 282 (307)
T 2nru_A 217 IYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY--------IDK------KMNDADSTSVEAMYSVASQ 282 (307)
T ss_dssp HHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH--------SCS------SCSCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh--------ccc------cccccchHHHHHHHHHHHH
Confidence 99999999999999999987654333333322211111000000 000 0001112346779999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.+++++
T Consensus 283 cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 283 CLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HTCSSTTTSCCHHHHHHH
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=224.75 Aligned_cols=163 Identities=19% Similarity=0.289 Sum_probs=110.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......++..|+|||++.+ ..++.++
T Consensus 120 ~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 198 (295)
T 3ugc_A 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVAS 198 (295)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH-CCCCHHH
T ss_pred HHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHH
Confidence 36999999999999999999999999999999999999999976654321 11233456778999999976 4589999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..||...... . ....+..+...+........ ..... .......+++++.+||.
T Consensus 199 Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~l~~li~ 266 (295)
T 3ugc_A 199 DVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQGQMIVFHLIEL--LKNNG-----RLPRPDGCPDEIYMIMT 266 (295)
T ss_dssp HHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCCTHHHHHHHHHH--HHTTC-----CCCCCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCccccchhHHHHHHH--HhccC-----cCCCCcCcCHHHHHHHH
Confidence 9999999999999999998653221 1 11111111100000000000 00000 00112357899999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.++++
T Consensus 267 ~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 267 ECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHSCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCCCHHHHHH
Confidence 999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-26 Score=227.62 Aligned_cols=148 Identities=22% Similarity=0.339 Sum_probs=114.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC--ccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......... .....+|+.|+|||++.+ ..++.++
T Consensus 153 ~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 231 (333)
T 1mqb_A 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSAS 231 (333)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhccc-CCCCchh
Confidence 3699999999999999999999999999999999999999997665432111 123345788999999976 4688999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |..||.+....+.+..+......+ ....++..+.+||
T Consensus 232 Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li 283 (333)
T 1mqb_A 232 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP----------------------------TPMDCPSAIYQLM 283 (333)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCBHHHHHHH
T ss_pred hhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC----------------------------CcccCCHHHHHHH
Confidence 99999999999998 999999888777666654321111 0125788999999
Q ss_pred HHhcCCCCCCCcCHHHHHhc
Q 012191 158 ETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~H 177 (468)
.+||..||.+|||+.+++++
T Consensus 284 ~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 284 MQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHTCSSTTTSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-27 Score=232.52 Aligned_cols=162 Identities=20% Similarity=0.261 Sum_probs=116.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+ ..++.++|
T Consensus 145 ~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 223 (321)
T 2qkw_B 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSD 223 (321)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHH
T ss_pred HHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC-CCCCcccc
Confidence 36899999999999999999999999999999999999999976543221 22334568999999999876 45899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHH---HHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKI---FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i---~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
||||||++|+|++|..||.+....+....+ ....... .+. ....+.. . ......++..+.+|
T Consensus 224 i~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~--~---~~~~~~~~~~l~~l 288 (321)
T 2qkw_B 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG--------QLE--QIVDPNL--A---DKIRPESLRKFGDT 288 (321)
T ss_dssp HHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT--------CCC--SSSSSSC--T---TCSCHHHHHHHHHH
T ss_pred hHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc--------cHH--HhcChhh--c---cccCHHHHHHHHHH
Confidence 999999999999999999765432111100 0000000 000 0000000 0 01112456789999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcc
Q 012191 157 IETLLSVEPYKRATASAALASE 178 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp 178 (468)
|.+||..||.+|||+.++|++-
T Consensus 289 i~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 289 AVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCcccCcCHHHHHHHH
Confidence 9999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=243.65 Aligned_cols=151 Identities=25% Similarity=0.275 Sum_probs=119.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE---CCCCcEEEEecCCccccCCCCCC------CccccccCCcccChhhhcCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGA 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl---d~~g~vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~g~ 71 (468)
+.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...... ......||+.|+|||++.+
T Consensus 109 ~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~- 187 (483)
T 3sv0_A 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG- 187 (483)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-
T ss_pred HHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC-
Confidence 4699999999999999999999999999 57899999999999876543221 1225678999999999987
Q ss_pred CCCCCCcceeeeehhhhhhhhcCCCCCCCch---HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 72 TDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 72 ~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~---~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
..++.++||||||||||+|++|..||.+... ...+..+...... ..+......
T Consensus 188 ~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------------------------~~~~~l~~~ 243 (483)
T 3sv0_A 188 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA------------------------TSIEALCRG 243 (483)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH------------------------SCHHHHHTT
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc------------------------ccHHHHhcC
Confidence 4589999999999999999999999987543 3333333221100 112333457
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
++.++.+||..||..||.+||++.+|++
T Consensus 244 ~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 244 YPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999999999999999998775
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-26 Score=226.18 Aligned_cols=144 Identities=23% Similarity=0.349 Sum_probs=112.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC-------------ccccccCCcccChhh
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP-------------LTSRVVTLWYRPPEL 67 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~-------------~~~~~gt~~Y~APE~ 67 (468)
+.||+.||+|||++||+|+||||+|||++.++.+||+|||++.......... ....+||+.|+|||+
T Consensus 114 ~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 193 (310)
T 3s95_A 114 AKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193 (310)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHH
Confidence 3699999999999999999999999999999999999999997654332211 114578999999999
Q ss_pred hcCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHH-----HHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchh
Q 012191 68 LLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-----QLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSL 142 (468)
Q Consensus 68 l~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e-----~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l 142 (468)
+.+ ..++.++|||||||++|+|++|..||....... .......
T Consensus 194 ~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~------------------------------- 241 (310)
T 3s95_A 194 ING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD------------------------------- 241 (310)
T ss_dssp HTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-------------------------------
T ss_pred hcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-------------------------------
Confidence 976 568999999999999999999999886432100 0000000
Q ss_pred hhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 143 RETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 143 ~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0112457788999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-26 Score=217.77 Aligned_cols=143 Identities=13% Similarity=0.208 Sum_probs=116.9
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCC--CCC
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD--YGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~--~s~ 76 (468)
+.||+.||.|||++| |+|+||||+|||++.++.++|+|||++..... ....+|+.|+|||++.+... ++.
T Consensus 117 ~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~ 190 (271)
T 3kmu_A 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRR 190 (271)
T ss_dssp HHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHH
T ss_pred HHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc------cCccCCccccChhhhccCCCCCCCc
Confidence 369999999999999 99999999999999999999999988754322 34578999999999976322 233
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|..||.+.........+......+. ....++..+.+|
T Consensus 191 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l 243 (271)
T 3kmu_A 191 SADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT---------------------------IPPGISPHVSKL 243 (271)
T ss_dssp HHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC---------------------------CCTTCCHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHH
Confidence 79999999999999999999998887777666544221111 113578899999
Q ss_pred HHHhcCCCCCCCcCHHHHHh
Q 012191 157 IETLLSVEPYKRATASAALA 176 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~ 176 (468)
|.+||+.||.+|||+.++++
T Consensus 244 i~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 244 MKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-26 Score=234.66 Aligned_cols=147 Identities=25% Similarity=0.350 Sum_probs=116.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc-cccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++........... ....+++.|+|||++.+ ..++.++|
T Consensus 219 ~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 297 (377)
T 3cbl_A 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESD 297 (377)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHH
T ss_pred HHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhh
Confidence 36899999999999999999999999999999999999999875443211111 12234678999999975 45889999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++ |..||.+....+....+.... .++ ....++..+.+||.
T Consensus 298 vwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 298 VWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLP---------------------------CPELCPDAVFRLME 349 (377)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCC---------------------------CCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC---------------------------CCCCCCHHHHHHHH
Confidence 9999999999998 999999887766655543311 110 01246889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.++++
T Consensus 350 ~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-26 Score=221.62 Aligned_cols=143 Identities=17% Similarity=0.301 Sum_probs=111.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .....+++.|+|||++.+ ..++.++||
T Consensus 123 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di 197 (278)
T 1byg_A 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDV 197 (278)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCC-CCCCchhcH
Confidence 368999999999999999999999999999999999999998755432 223356889999999976 468899999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+....+....+.... . ......+++.+.+||.+
T Consensus 198 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--~--------------------------~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 198 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--K--------------------------MDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--C--------------------------CCCCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--C--------------------------CCCcccCCHHHHHHHHH
Confidence 999999999998 999998876655554442210 0 00113578999999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.++++
T Consensus 250 ~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HhcCChhhCCCHHHHHH
Confidence 99999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-26 Score=232.99 Aligned_cols=147 Identities=20% Similarity=0.354 Sum_probs=108.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCc--cccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL--TSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~--~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........... ....+++.|+|||++.+ ..++.++
T Consensus 153 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 231 (373)
T 2qol_A 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSAS 231 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHH-CCCCHHH
T ss_pred HHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchh
Confidence 36999999999999999999999999999999999999999976654322111 12244678999999976 4688999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |..||.+....+....+......+. ...++..+.+||
T Consensus 232 Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li 283 (373)
T 2qol_A 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP----------------------------PMDCPAALYQLM 283 (373)
T ss_dssp HHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC----------------------------CTTCBHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CccccHHHHHHH
Confidence 99999999999997 9999998887776666543221110 125788999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||+.||.+|||+.++++
T Consensus 284 ~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 284 LDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCcChhhCcCHHHHHH
Confidence 9999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-26 Score=234.82 Aligned_cols=147 Identities=19% Similarity=0.248 Sum_probs=108.5
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC---CccccccCCcccChhhhcCCCCCCCCc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++
T Consensus 199 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 277 (373)
T 3c1x_A 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKS 277 (373)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHH-CCCCHHH
T ss_pred HHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcHH
Confidence 69999999999999999999999999999999999999999765432211 1233456788999999976 4688999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|+|++ |.+||.+.+..+....+....... ....++..+.+||
T Consensus 278 DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------~p~~~~~~l~~li 329 (373)
T 3c1x_A 278 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL----------------------------QPEYCPDPLYEVM 329 (373)
T ss_dssp HHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC----------------------------CCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHH
Confidence 99999999999999 788888766555444443211000 0124788999999
Q ss_pred HHhcCCCCCCCcCHHHHHhc
Q 012191 158 ETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~H 177 (468)
.+||..||.+|||+.+++++
T Consensus 330 ~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 330 LKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.6e-27 Score=232.77 Aligned_cols=177 Identities=23% Similarity=0.291 Sum_probs=113.3
Q ss_pred CHHHHHHHHHHHhC---------CCeeccCCCCceEECCCCcEEEEecCCccccCCCC-------CCCccccccCCcccC
Q 012191 1 MNQLLHGLEHCHSR---------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-------RQPLTSRVVTLWYRP 64 (468)
Q Consensus 1 m~QLL~gL~yLHs~---------gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-------~~~~~~~~gt~~Y~A 64 (468)
+.||+.||.|||+. ||+||||||+||||+.++.+||+|||++....... .......+||+.|+|
T Consensus 117 ~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 196 (336)
T 3g2f_A 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA 196 (336)
T ss_dssp HHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCC
T ss_pred HHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeC
Confidence 36999999999999 99999999999999999999999999997654321 112234578999999
Q ss_pred hhhhcCC------CCCCCCcceeeeehhhhhhhhcCCCC-CCCchHHHHHHHHHHcCCCC-chhhhccCCCccccCCCCC
Q 012191 65 PELLLGA------TDYGPSVDLWSVGCVFAELLIGKPIL-QGRTEVEQLHKIFKLCGSPP-DDYWKKSKLPHATLFKPQQ 136 (468)
Q Consensus 65 PE~l~g~------~~~s~~sDIWSLG~ILyeLltG~~pf-~g~~~~e~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~ 136 (468)
||++.+. ..++.++|||||||++|+|++|..|| .+....+....+....+..+ ...+..... .....+..
T Consensus 197 PE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 274 (336)
T 3g2f_A 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS--REKQRPKF 274 (336)
T ss_dssp HHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHT--TSCCCCCC
T ss_pred chhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhc--ccccCCCC
Confidence 9999763 23556899999999999999996554 43321111111111111111 110000000 00000000
Q ss_pred CCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHH------hcccccC
Q 012191 137 PYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL------ASEYFST 182 (468)
Q Consensus 137 ~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L------~Hp~F~~ 182 (468)
+ .. ......++..+.+||.+||..||.+|||+.+++ .++|-++
T Consensus 275 ~--~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 275 P--EA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp C--TT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred C--cc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 0 00 000122566899999999999999999999995 4556554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-26 Score=242.65 Aligned_cols=146 Identities=19% Similarity=0.306 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||+|||++||+||||||+||||+.++.+||+|||++...............+++.|+|||++.+ ..++.++|||
T Consensus 325 ~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvw 403 (495)
T 1opk_A 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVW 403 (495)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHH
T ss_pred HHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHH
Confidence 699999999999999999999999999999999999999998765433223334456788999999976 4588999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||+||||++ |..||.+.+..+....+...... .....++..+.+||.+|
T Consensus 404 SlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~c 455 (495)
T 1opk_A 404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----------------------------ERPEGCPEKVYELMRAC 455 (495)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999999 99999987766555544321100 01135789999999999
Q ss_pred cCCCCCCCcCHHHHHh
Q 012191 161 LSVEPYKRATASAALA 176 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~ 176 (468)
|+.||.+|||+.++++
T Consensus 456 l~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 456 WQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCcChhHCcCHHHHHH
Confidence 9999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-26 Score=223.09 Aligned_cols=162 Identities=22% Similarity=0.324 Sum_probs=114.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++||+|+||||+|||++.++.+||+|||++........ .......+|..|+|||++.+ ..++.++
T Consensus 132 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 210 (302)
T 4e5w_A 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIAS 210 (302)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHH
T ss_pred HHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcch
Confidence 36999999999999999999999999999999999999999987654322 12334567888999999976 4578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..|+..... .+....+......... ........... ......+++.+.+||.
T Consensus 211 Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~l~~li~ 277 (302)
T 4e5w_A 211 DVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQMTVT-RLVNTLKEGKR-------LPCPPNCPDEVYQLMR 277 (302)
T ss_dssp HHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGGGHHH-HHHHHHHTTCC-------CCCCTTCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccccCHH-HHHHHHhccCC-------CCCCCCCCHHHHHHHH
Confidence 999999999999999987643211 1111111111100000 00000000000 0112367899999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.++++
T Consensus 278 ~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 278 KCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCCCCHHHHHH
Confidence 999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=223.77 Aligned_cols=155 Identities=25% Similarity=0.337 Sum_probs=110.7
Q ss_pred CHHHHHHHHHHHhC--------CCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC---CccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSR--------GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~--------gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.
T Consensus 140 ~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 219 (337)
T 3mdy_A 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219 (337)
T ss_dssp HHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcc
Confidence 36999999999999 9999999999999999999999999999765433221 123457899999999997
Q ss_pred CCCCCCCC------cceeeeehhhhhhhhc----------CCCCCCCc----hHHHHHHHHHHcCCCCchhhhccCCCcc
Q 012191 70 GATDYGPS------VDLWSVGCVFAELLIG----------KPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHA 129 (468)
Q Consensus 70 g~~~~s~~------sDIWSLG~ILyeLltG----------~~pf~g~~----~~e~l~~i~~~~g~p~~~~~~~~~~~~~ 129 (468)
+.. +... +||||||||+|+|++| ..||.... ....+..+.......+
T Consensus 220 ~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------ 286 (337)
T 3mdy_A 220 ESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP------------ 286 (337)
T ss_dssp TCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC------------
T ss_pred ccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCc------------
Confidence 643 3443 8999999999999999 56664321 1222222221111000
Q ss_pred ccCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 130 TLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 130 ~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
. +.. ......++..+.+||.+||+.||.+|||+.+++++
T Consensus 287 -----~--~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 287 -----S--FPN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp -----C--CCG--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -----c--ccc--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 0 000 00112467789999999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=221.77 Aligned_cols=149 Identities=31% Similarity=0.506 Sum_probs=105.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... .......+++.|+|||++.+ ..++.++||
T Consensus 142 ~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 219 (310)
T 2wqm_A 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDI 219 (310)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTT-CCCCHHHHH
T ss_pred HHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC-ccccccCCCeeEeChHHhCC-CCCCchhhH
Confidence 3699999999999999999999999999999999999999987654322 22334578999999999876 468899999
Q ss_pred eeeehhhhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|..||.+... ...+.........++. ....++..+.+||.+
T Consensus 220 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~ 273 (310)
T 2wqm_A 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--------------------------PSDHYSEELRQLVNM 273 (310)
T ss_dssp HHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC--------------------------CTTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC--------------------------cccccCHHHHHHHHH
Confidence 9999999999999999976432 2222222221111110 013578899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.+++++
T Consensus 274 ~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 274 CINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-26 Score=225.51 Aligned_cols=139 Identities=26% Similarity=0.396 Sum_probs=104.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... ..|+.+
T Consensus 123 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~------------------------~~~~~~ 178 (299)
T 3m2w_A 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------------------EKYDKS 178 (299)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT------------------------CGGGGH
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc------------------------ccCCch
Confidence 469999999999999999999999999998 78899999999864321 236778
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|.+||.+.........+.... ...... .....+..++.++.+||
T Consensus 179 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~------------------~~~~~~---~~~~~~~~~~~~~~~li 237 (299)
T 3m2w_A 179 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------------------RMGQYE---FPNPEWSEVSEEVKMLI 237 (299)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS------------------CTTCCS---SCHHHHTTSCHHHHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH------------------hhcccc---CCchhcccCCHHHHHHH
Confidence 999999999999999999997654432111100000 000000 01223357899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
.+||..||.+|||+.++|+||||....
T Consensus 238 ~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 238 RNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHcccChhhCCCHHHHhcChhhcccc
Confidence 999999999999999999999998743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=235.56 Aligned_cols=143 Identities=18% Similarity=0.301 Sum_probs=116.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .....+++.|+|||++.+ ..++.++||
T Consensus 295 ~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~sDv 369 (450)
T 1k9a_A 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDV 369 (450)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHS-SCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcC-CCCCcHHHH
Confidence 369999999999999999999999999999999999999999754322 122356889999999976 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|||++ |..||.+.+..+.+..+......+ ....+++.+.+||.+
T Consensus 370 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 370 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------------------------APDGCPPAVYDVMKN 421 (450)
T ss_dssp HHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCcCCHHHHHHHHH
Confidence 999999999998 999998877666665553321100 113578999999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||..||.+|||+.+++.
T Consensus 422 cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhHCcCHHHHHH
Confidence 99999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-26 Score=242.49 Aligned_cols=153 Identities=25% Similarity=0.388 Sum_probs=123.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++...............++..|+|||++.+ ..++.++||
T Consensus 369 ~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv 447 (535)
T 2h8h_A 369 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 447 (535)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhH
Confidence 3699999999999999999999999999999999999999997654321112233456788999999876 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||||||++ |..||.+....+.+..+......+ ....++..+.+||.+
T Consensus 448 wSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~ 499 (535)
T 2h8h_A 448 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQ 499 (535)
T ss_dssp HHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHH
Confidence 999999999999 999999988877776664321110 013578899999999
Q ss_pred hcCCCCCCCcCHHHHHhc--ccccC
Q 012191 160 LLSVEPYKRATASAALAS--EYFST 182 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H--p~F~~ 182 (468)
||..||.+|||+.++++. .+|..
T Consensus 500 cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 500 CWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HcCCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999873 55543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-26 Score=226.90 Aligned_cols=161 Identities=22% Similarity=0.250 Sum_probs=115.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++
T Consensus 133 ~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 211 (327)
T 3lxl_A 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQS 211 (327)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhcc-CCCChHH
Confidence 369999999999999999999999999999999999999999876543221 2234467888999999976 4578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCc--hhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD--DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
|||||||++|+|++|..||........... ......+. ........ ... ......+++.+.+|
T Consensus 212 Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~---------~~~~~~~~~~l~~l 276 (327)
T 3lxl_A 212 DVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALSRLLELLEE----GQR---------LPAPPACPAEVHEL 276 (327)
T ss_dssp HHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHHHHHHHHHT----TCC---------CCCCTTCCHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHHHHHHHhhc----ccC---------CCCCCcccHHHHHH
Confidence 999999999999999999875433211100 00000000 00000000 000 01124678999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhc
Q 012191 157 IETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~H 177 (468)
|.+||..||.+|||+.+++++
T Consensus 277 i~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 277 MKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-26 Score=238.71 Aligned_cols=169 Identities=24% Similarity=0.376 Sum_probs=119.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEE----CCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC-----
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV----NNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA----- 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILl----d~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~----- 71 (468)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+.
T Consensus 118 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 195 (396)
T 4eut_A 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKD 195 (396)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG--GGSSCSSSCCTTCCHHHHHHHCC--C
T ss_pred HHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC--CccccccCCccccCHHHhhccccccc
Confidence 3699999999999999999999999999 77788999999999876543 233456789999999998641
Q ss_pred --CCCCCCcceeeeehhhhhhhhcCCCCCCC----chHHHHHHHHHHcCCCCchhhhccCCCcc--ccCCCCCCCCchhh
Q 012191 72 --TDYGPSVDLWSVGCVFAELLIGKPILQGR----TEVEQLHKIFKLCGSPPDDYWKKSKLPHA--TLFKPQQPYDSSLR 143 (468)
Q Consensus 72 --~~~s~~sDIWSLG~ILyeLltG~~pf~g~----~~~e~l~~i~~~~g~p~~~~~~~~~~~~~--~~~~~~~~~~~~l~ 143 (468)
..++.++|||||||++|+|++|..||.+. ...+.+..+.. +.|+ ..|........ ..+....+...
T Consensus 196 ~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~p~-~~~~~~~~~~~~~~~~~~~~~~~~--- 269 (396)
T 4eut_A 196 HQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS-GAISGVQKAENGPIDWSGDMPVSC--- 269 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--SCCT-TCCEEEECSTTCCEEEESSCCTTC---
T ss_pred cccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--CCCc-ccchhheeccCCCcccCccCCccc---
Confidence 34678999999999999999999999643 23444444433 2332 22221110000 00001111111
Q ss_pred hhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 144 ETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 144 ~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 270 ~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1113456778999999999999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-26 Score=248.55 Aligned_cols=174 Identities=23% Similarity=0.269 Sum_probs=121.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCc---EEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV---LKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~---vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||+.||+||||||+|||++.++. +||+|||++...... .......+|+.|+|||++.+ ..++.+
T Consensus 127 ~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~k 203 (676)
T 3qa8_A 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPELLEQ-KKYTVT 203 (676)
T ss_dssp HHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC--CCCCCCCSCCTTCSSCSSCC-SCCSTT
T ss_pred HHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc--cccccccCCcccCChHHhcc-CCCCch
Confidence 368999999999999999999999999987664 999999999876543 23355688999999999876 568999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||++|+|++|..||.+......+.......... .............+....+.. ......++..+.+||
T Consensus 204 sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~l~g~~~~~~~lp~p---~~l~~~ls~~L~dLI 278 (676)
T 3qa8_A 204 VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE--HIVVYDDLTGAVKFSSVLPTP---NHLSGILAGKLERWL 278 (676)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------CCSCCCCSSSCCCCSSSCCS---CCCCGGGHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch--hhhhhhhhccccccccccCCc---hhhchhhhHHHHHHH
Confidence 999999999999999999998765443321111100000 000000000000111111111 122235788999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccC
Q 012191 158 ETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
.+||.+||.+|||+.++|+||||..
T Consensus 279 ~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 279 QCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp HHHSCSSCC---CCTTCCCCTTHHH
T ss_pred HHHccCCHhhCcCHHHHhcCHHHHH
Confidence 9999999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=245.15 Aligned_cols=147 Identities=19% Similarity=0.256 Sum_probs=117.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..... .......+|+.|+|||++.+ ..|+.++
T Consensus 475 ~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~s 553 (635)
T 4fl3_A 475 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKS 553 (635)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCCHHH
T ss_pred HHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCCcHH
Confidence 36999999999999999999999999999999999999999986654321 12233456788999999976 4689999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
||||||||+|||++ |..||.+.+..+....+....... ....++.++.+||
T Consensus 554 DvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li 605 (635)
T 4fl3_A 554 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG----------------------------CPAGCPREMYDLM 605 (635)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHH
Confidence 99999999999998 999999988877776664421110 1135789999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
..||..||.+|||+.++++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-25 Score=244.28 Aligned_cols=148 Identities=24% Similarity=0.363 Sum_probs=118.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..++.++||
T Consensus 497 ~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di 575 (656)
T 2j0j_A 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDV 575 (656)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhH
Confidence 3699999999999999999999999999999999999999998765443333334456789999999976 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++ |.+||.+....+.+..+......+ ....+++.+.+||.+
T Consensus 576 wSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~ 627 (656)
T 2j0j_A 576 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----------------------------MPPNCPPTLYSLMTK 627 (656)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccccHHHHHHHHH
Confidence 999999999997 999999988877777665421111 113578899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.++++.
T Consensus 628 ~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 628 CWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHH
Confidence 999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-25 Score=241.39 Aligned_cols=152 Identities=20% Similarity=0.244 Sum_probs=118.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC--ccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP--LTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++
T Consensus 442 ~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~s 520 (613)
T 2ozo_A 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRS 520 (613)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCCHHH
T ss_pred HHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHH
Confidence 3699999999999999999999999999999999999999998664332111 122344688999999975 4689999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
||||||||||||++ |..||.+.+..+.+..+...... .....+++.+.+||
T Consensus 521 DvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li 572 (613)
T 2ozo_A 521 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----------------------------ECPPECPPELYALM 572 (613)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCcCCHHHHHHH
Confidence 99999999999998 99999998887777666432110 01135789999999
Q ss_pred HHhcCCCCCCCcCHHHHH---hccccc
Q 012191 158 ETLLSVEPYKRATASAAL---ASEYFS 181 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L---~Hp~F~ 181 (468)
..||..||.+|||+.+++ ++-|+.
T Consensus 573 ~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 573 SDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999985 455544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-25 Score=223.02 Aligned_cols=151 Identities=23% Similarity=0.333 Sum_probs=113.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .......+|..|+|||++.+ ..++.++
T Consensus 140 ~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 218 (318)
T 3lxp_A 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYAS 218 (318)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcC-CCCCcHH
Confidence 36999999999999999999999999999999999999999987654322 12234467888999999976 4578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHH-----------HHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcC
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQ-----------LHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFK 147 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~-----------l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 147 (468)
|||||||++|+|++|..||........ ...+........ ......
T Consensus 219 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~ 274 (318)
T 3lxp_A 219 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE------------------------RLPRPD 274 (318)
T ss_dssp HHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC------------------------CCCCCT
T ss_pred HHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc------------------------CCCCCc
Confidence 999999999999999999975432110 001111000000 001113
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
.++..+.+||.+||..||.+|||+.++++
T Consensus 275 ~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 275 KCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 57899999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-26 Score=225.04 Aligned_cols=150 Identities=24% Similarity=0.385 Sum_probs=111.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--------CccccccCCcccChhhhcCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--------PLTSRVVTLWYRPPELLLGAT 72 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--------~~~~~~gt~~Y~APE~l~g~~ 72 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+..
T Consensus 140 ~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 219 (317)
T 2buj_A 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219 (317)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCC
Confidence 469999999999999999999999999999999999999998654321100 012335689999999986532
Q ss_pred --CCCCCcceeeeehhhhhhhhcCCCCCCCchH-HHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCC
Q 012191 73 --DYGPSVDLWSVGCVFAELLIGKPILQGRTEV-EQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDL 149 (468)
Q Consensus 73 --~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~-e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (468)
.++.++|||||||++|+|++|..||...... ..+.......... .....+
T Consensus 220 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 272 (317)
T 2buj_A 220 HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI---------------------------PQSPRH 272 (317)
T ss_dssp EEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C---------------------------CCCTTS
T ss_pred CcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC---------------------------CccccC
Confidence 3688999999999999999999999532110 0011111100000 001357
Q ss_pred cHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 150 PTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 150 s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
+..+.+||.+||..||.+|||+.+++++
T Consensus 273 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 8899999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=225.60 Aligned_cols=146 Identities=16% Similarity=0.157 Sum_probs=111.7
Q ss_pred CHHHHHHHHHHH-hCCCeeccCCCCceEECCCC--------------------cEEEEecCCccccCCCCCCCccccccC
Q 012191 1 MNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEG--------------------VLKLADFGLANFSNTGHRQPLTSRVVT 59 (468)
Q Consensus 1 m~QLL~gL~yLH-s~gIvHrDIKp~NILld~~g--------------------~vKL~DFGla~~~~~~~~~~~~~~~gt 59 (468)
++||+.||.||| ++||+||||||+||||+.++ .+||+|||++...... ..+||
T Consensus 167 ~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt 240 (336)
T 2vuw_A 167 LHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFC 240 (336)
T ss_dssp HHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECC
T ss_pred HHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEe
Confidence 479999999999 99999999999999999887 8999999999866532 34789
Q ss_pred CcccChhhhcCCCCCCCCcceeeeehh-hhhhhhcCCCCCCCch-HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCC
Q 012191 60 LWYRPPELLLGATDYGPSVDLWSVGCV-FAELLIGKPILQGRTE-VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQP 137 (468)
Q Consensus 60 ~~Y~APE~l~g~~~~s~~sDIWSLG~I-LyeLltG~~pf~g~~~-~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 137 (468)
+.|+|||++.+.. +.++|||||+++ .++++.|..||.+... ......+.........
T Consensus 241 ~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------- 299 (336)
T 2vuw_A 241 DVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK------------------- 299 (336)
T ss_dssp CCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC-------------------
T ss_pred ecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc-------------------
Confidence 9999999998743 789999998777 8889999999954221 1122222221111000
Q ss_pred CCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHH-hccccc
Q 012191 138 YDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL-ASEYFS 181 (468)
Q Consensus 138 ~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L-~Hp~F~ 181 (468)
.....+..+++++++||.+||++| ||.|+| +||||+
T Consensus 300 ---~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 300 ---CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ---CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ---cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 001223457889999999999987 999999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=220.67 Aligned_cols=156 Identities=23% Similarity=0.276 Sum_probs=113.2
Q ss_pred CHHHHHHHHHHH--------hCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC---CccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCH--------SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLH--------s~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.||| +.||+|+||||+|||++.++.+||+|||++......... ......+|+.|+|||++.
T Consensus 145 ~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 224 (342)
T 1b6c_B 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224 (342)
T ss_dssp HHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhc
Confidence 369999999999 899999999999999999999999999999766543221 234557899999999997
Q ss_pred CCCCC-----CCCcceeeeehhhhhhhhc----------CCCCCCCc----hHHHHHHHHHHcCCCCchhhhccCCCccc
Q 012191 70 GATDY-----GPSVDLWSVGCVFAELLIG----------KPILQGRT----EVEQLHKIFKLCGSPPDDYWKKSKLPHAT 130 (468)
Q Consensus 70 g~~~~-----s~~sDIWSLG~ILyeLltG----------~~pf~g~~----~~e~l~~i~~~~g~p~~~~~~~~~~~~~~ 130 (468)
+.... +.++|||||||++|+|++| ..||.... ....+..........+
T Consensus 225 ~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------- 291 (342)
T 1b6c_B 225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP------------- 291 (342)
T ss_dssp SCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC-------------
T ss_pred ccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCC-------------
Confidence 64322 2579999999999999999 67776542 1222222211100000
Q ss_pred cCCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 131 LFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 131 ~~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
. ..... ....++..+.+||.+||..||.+|||+.+++++
T Consensus 292 ----~--~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 292 ----N--IPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp ----C--CCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ----C--Ccccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 0 00000 012345679999999999999999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-25 Score=227.33 Aligned_cols=143 Identities=19% Similarity=0.226 Sum_probs=109.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-----------CCcEEEEecCCccccCC-CCCCCccccccCCcccChhhh
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----------EGVLKLADFGLANFSNT-GHRQPLTSRVVTLWYRPPELL 68 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-----------~g~vKL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~l 68 (468)
+.||+.||+|||++||+||||||+||||+. ++.+||+|||++..... .........+||+.|+|||++
T Consensus 178 ~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 257 (365)
T 3e7e_A 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML 257 (365)
T ss_dssp HHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH
T ss_pred HHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh
Confidence 469999999999999999999999999998 89999999999965431 112334566899999999999
Q ss_pred cCCCCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCC
Q 012191 69 LGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKD 148 (468)
Q Consensus 69 ~g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (468)
.+ ..|+.++||||||||+|+|++|.+||...... .|.... .+ .. ..
T Consensus 258 ~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------------~~~~~~-----~~----------~~--~~ 303 (365)
T 3e7e_A 258 SN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----------------ECKPEG-----LF----------RR--LP 303 (365)
T ss_dssp TT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT----------------EEEECS-----CC----------TT--CS
T ss_pred cC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC----------------ceeech-----hc----------cc--cC
Confidence 87 45899999999999999999999999643221 000000 00 00 02
Q ss_pred CcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 149 LPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 149 ~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
.++.+.+++..||+.+|.+|++..+.|.+
T Consensus 304 ~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 304 HLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp SHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred cHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 36678899999999999999765555544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.5e-25 Score=218.75 Aligned_cols=163 Identities=20% Similarity=0.294 Sum_probs=113.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ......++..|+|||++.+ ..++.++
T Consensus 151 ~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 229 (326)
T 2w1i_A 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVAS 229 (326)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHH
T ss_pred HHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC-CCCCchh
Confidence 369999999999999999999999999999999999999999876543221 1223456778999999976 3578899
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|..||...... +....+......+....+.. ....... ......++..+.+||.
T Consensus 230 Di~slG~il~el~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~l~~li~ 297 (326)
T 2w1i_A 230 DVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVFHLIE--LLKNNGR-----LPRPDGCPDEIYMIMT 297 (326)
T ss_dssp HHHHHHHHHHHHHHTTCGGGSHHHH-----HHHHHCTTCCTHHHHHHHHH--HHHTTCC-----CCCCTTCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCCHHH-----HHHhhccccchhhhHHHHHH--HhhcCCC-----CCCCCcccHHHHHHHH
Confidence 9999999999999999988643211 11111111110000000000 0000000 0011357899999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||..||.+|||+.++++
T Consensus 298 ~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 298 ECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHSCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-23 Score=230.24 Aligned_cols=138 Identities=24% Similarity=0.347 Sum_probs=112.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.+ .+||+|||++...... ...+||+.|+|||++.+ .++.++||
T Consensus 188 ~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~sDi 259 (681)
T 2pzi_A 188 LLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRT--GPTVATDI 259 (681)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHH--CSCHHHHH
T ss_pred HHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcC--CCCCceeh
Confidence 4799999999999999999999999999875 8999999999866532 45578999999999976 35889999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||||+|++|.+||.+.... +.+. . ......++.+.+||.+|
T Consensus 260 ~slG~~l~~l~~g~~~~~~~~~~----------~~~~---------------------~----~~~~~~~~~l~~li~~~ 304 (681)
T 2pzi_A 260 YTVGRTLAALTLDLPTRNGRYVD----------GLPE---------------------D----DPVLKTYDSYGRLLRRA 304 (681)
T ss_dssp HHHHHHHHHHHSCCCEETTEECS----------SCCT---------------------T----CHHHHHCHHHHHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCcccccc----------cccc---------------------c----ccccccCHHHHHHHhhh
Confidence 99999999999999888652110 0000 0 00012457899999999
Q ss_pred cCCCCCCCcCHHHHHhccccc
Q 012191 161 LSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~ 181 (468)
|..||.+||+..++|.|+|+.
T Consensus 305 l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 305 IDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999884
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.7e-22 Score=196.79 Aligned_cols=125 Identities=20% Similarity=0.160 Sum_probs=95.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||++++ |++ .++.++||
T Consensus 135 ~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------------------~~~--------~~~~~~Di 185 (286)
T 3uqc_A 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMP--------DANPQDDI 185 (286)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------------------CCT--------TCCHHHHH
T ss_pred HHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------------------ccC--------CCCchhHH
Confidence 4799999999999999999999999999999999998543 222 26789999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|..||.+.+....+.... ................+++.+.+||.+|
T Consensus 186 ~slG~il~elltg~~Pf~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~ 243 (286)
T 3uqc_A 186 RGIGASLYALLVNRWPLPEAGVRSGLAPAE----------------------RDTAGQPIEPADIDRDIPFQISAVAARS 243 (286)
T ss_dssp HHHHHHHHHHHHSEECSCCCSBCCCSEECC----------------------BCTTSCBCCHHHHCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCcCCcchhhHHHH----------------------HHhccCCCChhhcccCCCHHHHHHHHHH
Confidence 999999999999999998754321110000 0000001112344467899999999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|+.||.+| |+.++++.
T Consensus 244 l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 244 VQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HCTTSSCC-CHHHHHHH
T ss_pred cccCCccC-CHHHHHHH
Confidence 99999999 99999974
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-20 Score=204.18 Aligned_cols=93 Identities=19% Similarity=0.129 Sum_probs=64.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
|.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ......+||+.|+|||++.+ .+..++|+
T Consensus 345 ~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g--~~~~~~d~ 421 (569)
T 4azs_A 345 LGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE--NKSWNGFW 421 (569)
T ss_dssp HHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC------------
T ss_pred HHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC--CCCCcccc
Confidence 4799999999999999999999999999999999999999998665432 33456789999999999987 46778999
Q ss_pred eeeehhhhhhhhcCCC
Q 012191 81 WSVGCVFAELLIGKPI 96 (468)
Q Consensus 81 WSLG~ILyeLltG~~p 96 (468)
|++|+++++|+++..+
T Consensus 422 ~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 422 RSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------CCCCTTHHH
T ss_pred cccccchhhhccccch
Confidence 9999999999876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.8e-14 Score=153.16 Aligned_cols=95 Identities=19% Similarity=0.256 Sum_probs=75.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCC------ccccccCCcccChhhhcCC-CC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQP------LTSRVVTLWYRPPELLLGA-TD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~------~~~~~gt~~Y~APE~l~g~-~~ 73 (468)
+.||+.||.|||++||+||||||+|||++. .+||+|||++.......... ....+||+.|+|||++.+. ..
T Consensus 437 ~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~ 514 (540)
T 3en9_A 437 AYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEG 514 (540)
T ss_dssp HHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHH
Confidence 479999999999999999999999999998 99999999998765421111 1356789999999998641 24
Q ss_pred CCCCcceeeeehhhhhhhhcCCCC
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPIL 97 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf 97 (468)
|+..+|+|+..+-..+.+.++..|
T Consensus 515 Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 515 YKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHhHHHHHHHHHHHHHhcccc
Confidence 677889999887777776665554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=1.3e-10 Score=114.34 Aligned_cols=54 Identities=24% Similarity=0.267 Sum_probs=47.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||.|||++||+||||||+|||++ ++.+||+|||++.. +..|.|||++.
T Consensus 199 ~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 199 LDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred HHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 36999999999999999999999999999 99999999999853 23478899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=4.2e-09 Score=101.74 Aligned_cols=43 Identities=16% Similarity=0.291 Sum_probs=39.8
Q ss_pred CHHHHHHHHHHH-hCCCeeccCCCCceEECCCCcEEEEecCCcccc
Q 012191 1 MNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGVLKLADFGLANFS 45 (468)
Q Consensus 1 m~QLL~gL~yLH-s~gIvHrDIKp~NILld~~g~vKL~DFGla~~~ 45 (468)
+.||+.||.||| +.||+||||||+|||++. .++|+|||++...
T Consensus 176 ~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 176 FNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 368999999999 999999999999999988 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.20 E-value=5.6e-07 Score=92.56 Aligned_cols=43 Identities=19% Similarity=0.264 Sum_probs=38.6
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCC----------cEEEEecCCccc
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----------VLKLADFGLANF 44 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g----------~vKL~DFGla~~ 44 (468)
.||+.+|.+||..|||||||||.|||++.++ .+.|+||+-+..
T Consensus 212 ~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 212 ADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp HHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 6999999999999999999999999998776 389999997653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.00049 Score=64.54 Aligned_cols=28 Identities=29% Similarity=0.305 Sum_probs=24.9
Q ss_pred CeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 16 VLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 16 IvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
++|+|++|.|||++.++.+.|+||+.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876667799999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00021 Score=69.84 Aligned_cols=78 Identities=17% Similarity=0.226 Sum_probs=49.3
Q ss_pred CCeeccCCCCceEECC--CCcEEEEecCCccccCCCCCCCccccccCCcc---cChhhhcCC-CCCC------------C
Q 012191 15 GVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWY---RPPELLLGA-TDYG------------P 76 (468)
Q Consensus 15 gIvHrDIKp~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y---~APE~l~g~-~~~s------------~ 76 (468)
.++|+|+++.||+++. .+.+.|+||+.+....+. ........+ ..|+.+... ..|+ .
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-----~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~ 266 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-----NDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRM 266 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-----HHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-----HHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHH
Confidence 5899999999999988 456889999998654321 111111111 233321100 0111 1
Q ss_pred CcceeeeehhhhhhhhcCCCC
Q 012191 77 SVDLWSVGCVFAELLIGKPIL 97 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf 97 (468)
..+.|+++.++|.+.+|.++|
T Consensus 267 ~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 267 KEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHcCCHHH
Confidence 258999999999999998766
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0007 Score=64.22 Aligned_cols=30 Identities=27% Similarity=0.371 Sum_probs=25.2
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
..++|+|++|.|||++..+.+.|+||+.+.
T Consensus 183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0023 Score=63.76 Aligned_cols=31 Identities=23% Similarity=0.437 Sum_probs=26.4
Q ss_pred CCCeeccCCCCceEECCCCc--EEEEecCCccc
Q 012191 14 RGVLHRDIKGSNLLVNNEGV--LKLADFGLANF 44 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~--vKL~DFGla~~ 44 (468)
.+++|+|+++.|||++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 46899999999999987753 68999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.12 E-value=0.014 Score=56.92 Aligned_cols=30 Identities=17% Similarity=0.274 Sum_probs=27.2
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.16 E-value=0.044 Score=55.92 Aligned_cols=32 Identities=13% Similarity=0.421 Sum_probs=27.8
Q ss_pred HhCCCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 12 HSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 12 Hs~gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
+...++|+|+++.|||++.++ +.|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356799999999999998876 99999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.82 E-value=0.064 Score=52.08 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=25.8
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999887666899999764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=90.90 E-value=0.082 Score=49.82 Aligned_cols=28 Identities=25% Similarity=0.380 Sum_probs=25.1
Q ss_pred CeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 16 VLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 16 IvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
++|+|+.+.|||++..+.+-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 8999999999999987777799999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=90.36 E-value=0.14 Score=49.99 Aligned_cols=31 Identities=32% Similarity=0.384 Sum_probs=27.0
Q ss_pred CCCeeccCCCCceEECCC----CcEEEEecCCccc
Q 012191 14 RGVLHRDIKGSNLLVNNE----GVLKLADFGLANF 44 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~----g~vKL~DFGla~~ 44 (468)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6799999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.18 E-value=0.16 Score=49.39 Aligned_cols=28 Identities=25% Similarity=0.208 Sum_probs=24.3
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999998 4 89999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=88.79 E-value=0.12 Score=50.87 Aligned_cols=32 Identities=16% Similarity=0.232 Sum_probs=26.5
Q ss_pred hCCCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 13 SRGVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 13 s~gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
...++|+|+++.|||+++...+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 35799999999999998644578999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=88.31 E-value=0.19 Score=48.83 Aligned_cols=31 Identities=26% Similarity=0.410 Sum_probs=25.7
Q ss_pred CCCeeccCCCCceEECC---CCc-EEEEecCCccc
Q 012191 14 RGVLHRDIKGSNLLVNN---EGV-LKLADFGLANF 44 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~---~g~-vKL~DFGla~~ 44 (468)
..++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 36899999999999987 455 58999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=86.49 E-value=0.26 Score=49.06 Aligned_cols=28 Identities=29% Similarity=0.521 Sum_probs=23.8
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
+++|+|+++.|||++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999998654 8999998774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=85.87 E-value=0.35 Score=48.51 Aligned_cols=30 Identities=17% Similarity=0.310 Sum_probs=25.3
Q ss_pred hCCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 13 SRGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 13 s~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
...++|+|+.+.|||++.+ .+.|+||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 3579999999999999875 48899998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=85.81 E-value=1.4 Score=41.40 Aligned_cols=57 Identities=16% Similarity=0.078 Sum_probs=33.2
Q ss_pred ccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcceeeeehhhhhhh
Q 012191 19 RDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELL 91 (468)
Q Consensus 19 rDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIWSLG~ILyeLl 91 (468)
+=+.|..|+|..+|.|.+.+ ..+. .....+.|||.+. ...+.+.=|||||+++|.-+
T Consensus 74 ~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 74 RVRSAAQIRVWRDGAVTLAP-AADD-------------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp CCCSGGGEEEETTSCEEECC-C-------------------------CCSS--SSSCHHHHHHHHHHHHHHHH
T ss_pred eecCCcceEEecCCceeccc-cccc-------------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHh
Confidence 33456889999999887764 1110 0122356888653 23456778999999999876
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=85.15 E-value=0.33 Score=48.01 Aligned_cols=31 Identities=29% Similarity=0.416 Sum_probs=27.3
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=82.98 E-value=0.54 Score=48.83 Aligned_cols=15 Identities=27% Similarity=0.368 Sum_probs=14.1
Q ss_pred CCeeccCCCCceEEC
Q 012191 15 GVLHRDIKGSNLLVN 29 (468)
Q Consensus 15 gIvHrDIKp~NILld 29 (468)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=82.70 E-value=0.39 Score=49.24 Aligned_cols=29 Identities=31% Similarity=0.470 Sum_probs=23.7
Q ss_pred CCeeccCCCCceEECCC----------------------------CcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNNE----------------------------GVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~~----------------------------g~vKL~DFGla~ 43 (468)
.++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~ 306 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 306 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence 48999999999999875 678899988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=82.70 E-value=0.5 Score=45.43 Aligned_cols=29 Identities=17% Similarity=0.264 Sum_probs=24.5
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCccc
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLANF 44 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~~ 44 (468)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 4566789999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=81.22 E-value=0.64 Score=47.03 Aligned_cols=29 Identities=34% Similarity=0.507 Sum_probs=25.9
Q ss_pred CCeeccCCCCceEECCC----CcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNNE----GVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~~----g~vKL~DFGla~ 43 (468)
.++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 58999999999999876 689999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 468 | ||||
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-31 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-29 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-24 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-23 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-23 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-22 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-21 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-20 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-20 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-19 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-19 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-19 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-19 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-13 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-48
Identities = 82/195 (42%), Positives = 110/195 (56%), Gaps = 4/195 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M L GLE+ H +LHRD+K +NLL++ GVLKLADFGLA + +R T +VVT
Sbjct: 106 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTR 164
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PELL GA YG VD+W+VGC+ AELL+ P L G ++++QL +IF+ G+P ++
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224
Query: 121 WKK-SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W LP FK L F ++LI+ L P R TA+ AL +Y
Sbjct: 225 WPDMCSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282
Query: 180 FSTKPYACDLSSLPI 194
FS +P LP
Sbjct: 283 FSNRPGPTPGCQLPR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-48
Identities = 81/195 (41%), Positives = 108/195 (55%), Gaps = 6/195 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRV 57
M LL+GL + H +LHRD+K +N+L+ +GVLKLADFGLA + T+RV
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
VTLWYRPPELLLG DYGP +DLW GC+ AE+ PI+QG TE QL I +LCGS
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 118 DDYW---KKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAA 174
+ W +L Q R A++LI+ LL ++P +R + A
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 175 LASEYFSTKPYACDL 189
L ++F + P DL
Sbjct: 303 LNHDFFWSDPMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-43
Identities = 74/216 (34%), Positives = 112/216 (51%), Gaps = 7/216 (3%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 58
+ Q+L GL++ HS VLHRD+K SNLL+N LK+ DFGLA + H LT V
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T WYR PE++L + Y S+D+WSVGC+ AE+L +PI G+ ++QL+ I + GSP
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 119 DYWKKSKLPHATLFKPQQPYDS--SLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
+ A + P+ + F + + A++L++ +L+ P+KR ALA
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
Query: 177 SEYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRK 212
Y D S PI + D + + + K
Sbjct: 295 HPYLEQYY---DPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-42
Identities = 74/211 (35%), Positives = 109/211 (51%), Gaps = 6/211 (2%)
Query: 3 QLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWY 62
Q+L GL++ HS ++HRD+K SNL VN + LK+ DFGLA ++ T V T WY
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWY 184
Query: 63 RPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWK 122
R PE++L Y +VD+WSVGC+ AELL G+ + G ++QL I +L G+P + K
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 123 K--SKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
K S+ + Q + F AV+L+E +L ++ KR TA+ ALA YF
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304
Query: 181 STKPYACDLSSLPIYPPSKEIDAKHREDARR 211
+ D Y S E ++ +
Sbjct: 305 AQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 4e-42
Identities = 70/180 (38%), Positives = 104/180 (57%), Gaps = 1/180 (0%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ QLL+G+ +CH R VLHRD+K NLL+N EG LK+ADFGLA R+ +VTL
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTL 164
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR P++L+G+ Y ++D+WSVGC+FAE++ G P+ G +E +QL +IF++ G+P
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
W K L + ++L+ +L ++P +R TA AL YF
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-42
Identities = 71/214 (33%), Positives = 116/214 (54%), Gaps = 6/214 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ Q+L GL + H+ G++HRD+K NL VN + LK+ DFGLA ++ +T VVT
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTR 182
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PE++L Y +VD+WSVGC+ AE++ GK + +G ++QL +I K+ G+PP ++
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 121 WKKSKLPHATLFKPQQPY--DSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
++ + A + P + AVNL+E +L ++ +R TA ALA
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302
Query: 179 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRK 212
YF + D + Y S + + ++ +R
Sbjct: 303 YFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-42
Identities = 73/202 (36%), Positives = 101/202 (50%), Gaps = 5/202 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVT 59
M QL L + HS G+ HRDIK NLL++ + VLKL DFG A G +P S + +
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICS 185
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+YR PEL+ GATDY S+D+WS GCV AELL+G+PI G + V+QL +I K+ G+P +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
++ + PQ + P A+ L LL P R T A A +
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 180 FSTKPYACDLSSLPIYPPSKEI 201
F LP + +
Sbjct: 306 F--DELRDPNVKLPNGRDTPAL 325
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 7e-42
Identities = 79/182 (43%), Positives = 103/182 (56%), Gaps = 2/182 (1%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ QLL GL CHSR VLHRD+K NLL+N G LKLA+FGLA R ++ VVTL
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTL 165
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDD 119
WYRPP++L GA Y S+D+WS GC+FAEL P+ G +QL +IF+L G+P ++
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
W P P +SL L T +L++ LL P +R +A AL Y
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
Query: 180 FS 181
FS
Sbjct: 286 FS 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-40
Identities = 76/186 (40%), Positives = 104/186 (55%), Gaps = 3/186 (1%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ QLL GL CHS VLHRD+K NLL+N EG +KLADFGLA R T VVTL
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTL 166
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PE+LLG Y +VD+WS+GC+FAE++ + + G +E++QL +IF+ G+P +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
W + + L +L+ +L +P KR +A AALA +F
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 181 S--TKP 184
TKP
Sbjct: 287 QDVTKP 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-40
Identities = 73/180 (40%), Positives = 104/180 (57%), Gaps = 5/180 (2%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M QLL GL+ HS V+HRD+K N+LV + G +KLADFGLA + TS VVTL
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
WYR PE+LL ++ Y VDLWSVGC+FAE+ KP+ +G ++V+QL KI + G P ++
Sbjct: 180 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
W + F + + + D+ +L+ L+ P KR +A +AL+ YF
Sbjct: 239 WPRDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-37
Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 28/186 (15%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 59
+QL+ G+ + H G+ HRDIK NLL++ LK++DFGLA +R+ L +++ T
Sbjct: 109 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
L Y PELL + VD+WS G V +L G+ ++ Q + +K + +
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
+K + + + L+ +L P R T +
Sbjct: 229 --------------------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262
Query: 180 FSTKPY 185
+ KP
Sbjct: 263 Y-NKPL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-37
Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 33/181 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ +L + L +CHS+ V+HRDIK NLL+ + G LK+ADFG + + + R + TL
Sbjct: 112 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTL 168
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PPE++ G + VDLWS+G + E L+GKP + T E +I ++ + PD
Sbjct: 169 DYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-- 225
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+ A +LI LL P +R L +
Sbjct: 226 ---------------------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
Query: 181 S 181
+
Sbjct: 259 T 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-35
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 32/201 (15%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ L LE HS V+HRDIK N+L+ +G +KL DFG + ++ V T
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTP 180
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
++ PE++ YGP VD+WS+G + E++ G+P + L+ I G+P
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQN 238
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEYF 180
+K L + + L ++ KR +A L ++
Sbjct: 239 PEK-------------------------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 181 STKPYACDLSSL-PIYPPSKE 200
A LSSL P+ +KE
Sbjct: 274 KI---AKPLSSLTPLIAAAKE 291
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-35
Identities = 66/228 (28%), Positives = 119/228 (52%), Gaps = 17/228 (7%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ Q+L G++H HS G++HRD+K SN++V ++ LK+ DFGLA + T +T VVT
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTR 182
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
+YR PE++LG Y +VD+WSVGC+ E++ K + GR ++Q +K+ + G+P ++
Sbjct: 183 YYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 121 WKKSKLPHATLFKPQQPYDS-------------SLRETFKDLPTTAVNLIETLLSVEPYK 167
KK + + + Y + E K + A +L+ +L ++P K
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 168 RATASAALASEYFSTKPYACDLSSLPIYPPSKEID-AKHREDARRKKV 214
R + AL Y + ++ + P K++D +H + ++ +
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (328), Expect = 3e-35
Identities = 50/185 (27%), Positives = 75/185 (40%), Gaps = 32/185 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
M LL + H ++HRD+K N+L++++ +KL DFG + + G + L T
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTP 173
Query: 61 WYRPPELLLGATD-----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
Y PE++ + + YG VD+WS G + LL G P R ++ L I
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 116 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
W D T +L+ L V+P KR TA AL
Sbjct: 234 FGSPEW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
Query: 176 ASEYF 180
A +F
Sbjct: 269 AHPFF 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 3e-35
Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 12/192 (6%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVT 59
M ++L L++CHS G++HRD+K N+++++E L+L D+GLA F + G RV +
Sbjct: 135 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVAS 192
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSP-P 117
+++ PELL+ Y S+D+WS+GC+ A ++ K P G +QL +I K+ G+
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLR-------ETFKDLPTTAVNLIETLLSVEPYKRAT 170
DY K + F S R E + A++ ++ LL + R T
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312
Query: 171 ASAALASEYFST 182
A A+ YF T
Sbjct: 313 AREAMEHPYFYT 324
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 130 bits (329), Expect = 8e-35
Identities = 48/232 (20%), Positives = 76/232 (32%), Gaps = 30/232 (12%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVV 58
M Q+ GL H H +H D+K N++ + LKL DFGL + +
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTG 187
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T + PE+ G G D+WSVG + LL G G + E L + + D
Sbjct: 188 TAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
+ + + I LL +P R T AL
Sbjct: 247 SAF-------------------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281
Query: 179 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKS 230
+ + S +P +K D+ + + + + RK
Sbjct: 282 WLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-34
Identities = 43/196 (21%), Positives = 75/196 (38%), Gaps = 20/196 (10%)
Query: 1 MNQLLHGLEHCHSR-GVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVT 59
++ GL + + ++HRD+K SN+LVN+ G +KL DFG++ S V T
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGT 166
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVE-QLHKIFKLCGSPPD 118
Y PE L G T Y D+WS+G E+ +G+ + E +L ++ G +
Sbjct: 167 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 119 DYWK-----KSKLPHATLFKPQQPYDSSLRETFKDLPTT---------AVNLIETLLSVE 164
+ + + +P L + P + + L
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 165 PYKRATASAALASEYF 180
P +RA + +
Sbjct: 286 PAERADLKQLMVHAFI 301
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-34
Identities = 42/185 (22%), Positives = 69/185 (37%), Gaps = 31/185 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
Q L L + H ++HRD+K N+L +G +KLADFG++ NT Q S + T
Sbjct: 116 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTP 174
Query: 61 WYRPPELLLGATD----YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
++ PE+++ T Y D+WS+G E+ +P + L KI K P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPP 233
Query: 117 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
+ + + ++ L R T S L
Sbjct: 234 TLAQPSR-------------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
Query: 177 SEYFS 181
+ +
Sbjct: 269 HPFVT 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (316), Expect = 2e-33
Identities = 48/215 (22%), Positives = 80/215 (37%), Gaps = 36/215 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ L GL + HS ++HRD+K N+L++ G++KL DFG A+ P S V T
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFVGTP 175
Query: 61 WYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
++ PE++L + Y VD+WS+G EL KP L + L+ I + P
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPA 233
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
N +++ L P R T+ L
Sbjct: 234 LQS-------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268
Query: 179 YFSTKPYACDLSSLP--IYPPSKEIDAKHREDARR 211
+ + + L +E+D ++
Sbjct: 269 FVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 125 bits (316), Expect = 5e-33
Identities = 48/215 (22%), Positives = 78/215 (36%), Gaps = 35/215 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV--NNEGVLKLADFGLANFSNTGHRQPLTSRVV 58
M Q GL+H H ++H DIK N++ +K+ DFGLA N +
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTA 190
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T + PE++ G D+W++G + LL G G ++E L + + +
Sbjct: 191 TAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 249
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
D + + A + I+ LL EP KR T AL
Sbjct: 250 DAFSS-------------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284
Query: 179 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKK 213
+ D S+L PS + ++ +
Sbjct: 285 WLKG-----DHSNLTSRIPSSRYNKIRQKIKEKYA 314
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-32
Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 31/186 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 59
+++ LE+ H +G++HRD+K N+L+N + +++ DFG A + +Q + V T
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
Y PELL + S DLW++GC+ +L+ G P + E KI KL P+
Sbjct: 174 AQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 232
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
++ K A +L+E LL ++ KR
Sbjct: 233 FFPK-----------------------------ARDLVEKLLVLDATKRLGCEEMEGYGP 263
Query: 180 FSTKPY 185
P+
Sbjct: 264 LKAHPF 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-32
Identities = 42/236 (17%), Positives = 77/236 (32%), Gaps = 33/236 (13%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVV 58
++Q+ L+ HS + H DI+ N++ +K+ +FG A G
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFT 165
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
Y PE+ + D+WS+G + LL G T + + I + +
Sbjct: 166 APEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
+ + K++ A++ ++ LL E R TAS AL
Sbjct: 225 EAF-------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 179 YFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMS 234
+ K + + ++D R+ R G+S
Sbjct: 260 WLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCG---GAIRSQKGVS 312
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-31
Identities = 34/180 (18%), Positives = 70/180 (38%), Gaps = 26/180 (14%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 59
Q G+++ H++ ++HRD+K +N+ ++ + +K+ DFGLA + ++ +
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 60 LWYRPPELLLGATD--YGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
+ + PE++ Y D+++ G V EL+ G+ +Q+ + P
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
D L + + P L+ L + +R LAS
Sbjct: 230 D-----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-30
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 35/184 (19%)
Query: 1 MNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTS 55
M QL L+ CH R VLHRD+K +N+ ++ + +KL DFGLA N +
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKA 173
Query: 56 RVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGS 115
V T +Y PE + Y D+WS+GC+ EL P ++ E KI +
Sbjct: 174 FVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---- 228
Query: 116 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
K ++P+ +I +L+++ Y R + L
Sbjct: 229 -----GKFRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSVEEIL 264
Query: 176 ASEY 179
+
Sbjct: 265 ENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 3e-29
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 31/209 (14%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLV---NNEGVLKLADFGLANFSNTGHRQPLTSRV 57
+ Q+L +++ H G++HRD+K NLL + + + ++DFGL+ + G L++
Sbjct: 113 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTAC 170
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T Y PE+L Y +VD WS+G + LL G P + + +I K
Sbjct: 171 GTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
YW D+ +A + I L+ +P KR T AL
Sbjct: 230 SPYW-------------------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264
Query: 178 EYFSTKPYACDLSSLPIYPPSKEIDAKHR 206
+ + + K+ AK +
Sbjct: 265 PWIAGDTALDKNIHQSVSEQIKKNFAKSK 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-29
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGV----LKLADFGLANFSNTGHRQPLTSR 56
+ Q+L+G+ + HS + H D+K N+++ + V +K+ DFGLA+ + G+ +
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNI 176
Query: 57 VVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSP 116
T + PE++ G D+WS+G + LL G G T+ E L + +
Sbjct: 177 FGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 117 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
D+Y+ + A + I LL +P KR T +L
Sbjct: 236 EDEYF-------------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
Query: 177 SEYFSTKPYACDLSSLPIYPP 197
+ K LSS +P
Sbjct: 271 HPWIKPKDTQQALSSAWSHPQ 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-28
Identities = 35/183 (19%), Positives = 63/183 (34%), Gaps = 34/183 (18%)
Query: 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRV 57
Q+L GL+ H+R ++HRD+K N+ + G +K+ D GLA + +
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVI 174
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T + PE+ Y SVD+++ G E+ + Q+++ G P
Sbjct: 175 GTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKP 231
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ K +IE + +R + L
Sbjct: 232 ASFD-------------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266
Query: 178 EYF 180
+F
Sbjct: 267 AFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-28
Identities = 52/244 (21%), Positives = 90/244 (36%), Gaps = 36/244 (14%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPLTSRV 57
M + +++ HS + HRD+K NLL +LKL DFG A + + + +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPC 174
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPP 117
T +Y PE+L Y S D+WS+G + LL G P + +
Sbjct: 175 YTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
++ P S + E K LI LL EP +R T + +
Sbjct: 234 --------------YEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITEFMNH 272
Query: 178 EYFSTKPYACDLSSLPIYPPSKEIDAKHREDARRKKVGGRVRGAETRKTTRKSHGMSKLA 237
+ + + P++ + K R + ++++ T R + K+
Sbjct: 273 PWIMQ---STKVPQTPLHTSRVLKEDKERWEDVKEEM------TSALATMRVDYEQIKIK 323
Query: 238 PVED 241
+ED
Sbjct: 324 KIED 327
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-27
Identities = 43/181 (23%), Positives = 68/181 (37%), Gaps = 39/181 (21%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVT 59
Q+L + HCH+ GVLHRDIK N+L++ N G LKL DFG T T
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGT 172
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
Y PPE + +G S +WS+G + +++ G + E+ + F+
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-------- 224
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASEY 179
+ + + +LI L++ P R T +
Sbjct: 225 ---------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257
Query: 180 F 180
Sbjct: 258 M 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 110 bits (277), Expect = 2e-27
Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+++ GLEH H+R V++RD+K +N+L++ G ++++D GLA + ++ + V T
Sbjct: 113 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTH 169
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE+L Y S D +S+GC+ +LL G + ++ H+I ++ + +
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVEL 228
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE-- 178
+L+E LL + +R A E
Sbjct: 229 P-------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
Query: 179 ---YFST----KPYACDLSSLPIYPPSKEIDAKHREDAR 210
+F + + P+ PP E++A D
Sbjct: 264 ESPFFRSLDWQMVFLQKYPP-PLIPPRGEVNAADAFDIG 301
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 9e-27
Identities = 49/175 (28%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+++ GL+ HS+G+++RD+K N+L++ +G +K+ADFG+ + G + + T
Sbjct: 109 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTP 167
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE+LLG Y SVD WS G + E+LIG+ G+ E E H I P
Sbjct: 168 DYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR-- 224
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
L A +L+ L EP KR +
Sbjct: 225 ---------------------------WLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 9e-27
Identities = 43/204 (21%), Positives = 71/204 (34%), Gaps = 40/204 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
Q+ G+ + +HRD++ +N+LV V K+ADFGLA +
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ PE L + D+WS G + EL G+ G E L ++ + P
Sbjct: 179 KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--S 177
+ P + +L+ EP +R T A
Sbjct: 238 ----------------------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 178 EYFSTKPYACDLSSLPIYPPSKEI 201
+YF+ S+ P Y P + +
Sbjct: 270 DYFT--------STEPQYQPGENL 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-26
Identities = 47/205 (22%), Positives = 83/205 (40%), Gaps = 32/205 (15%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ +++ LEH H G+++RDIK N+L+++ G + L DFGL+ + T+
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 61 WYRPPELLLGA-TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
Y P+++ G + + +VD WS+G + ELL G E +I +
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAA 174
Y +++ A +LI+ LL +P KR A
Sbjct: 255 YP-------------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
Query: 175 LASEYFSTKPYACDLSSLPIYPPSK 199
+F + DL++ + P K
Sbjct: 290 KEHLFFQKINWD-DLAAKKVPAPFK 313
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 104 bits (261), Expect = 7e-26
Identities = 31/179 (17%), Positives = 56/179 (31%), Gaps = 33/179 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----EGVLKLADFGLANF------SNTGH 49
Q+L ++ H + +++RDIK N L+ ++ + DFG+ F
Sbjct: 107 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 50 RQPLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKI 109
+ + T Y LG + DL ++G VF L G QG K
Sbjct: 167 YREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
Query: 110 FKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR 168
++ ++ + LRE P + ++
Sbjct: 226 ERIG---------------------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (257), Expect = 6e-25
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 36/233 (15%)
Query: 1 MNQLLHGLEHCH-SRGVLHRDIKGSNLLVNNEGV------LKLADFGLANFSNTGHRQPL 53
QLL GL++ H G++H DIK N+L+ +K+AD G A + + + +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 54 TSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLH 107
+R YR PE+LLGA +G D+WS C+ EL+ G + + + + +
Sbjct: 191 QTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 108 KIFKLCGSPPDDYWKKSKLPHATL-------------FKPQQPYDSSLRETFKDLPTTAV 154
+I +L G P + K F P + + + KD
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 155 NLIETLLSVEPYKRATASAALASEYFSTKPYACDLSSLPIYPPSKEIDAKHRE 207
+ + +L ++P KRA A + + L I P +E+ +
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLKD-----TLGMEEIRVPDRELYGSGSD 353
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 100 bits (251), Expect = 1e-24
Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 28/180 (15%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 58
+ L H G++HRD+K +N++++ +K+ DFG+A + + +
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
T Y PE G + D++S+GCV E+L G+P G + V ++ + PP
Sbjct: 177 TAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALASE 178
+ L ++ L+ P R +A + ++
Sbjct: 236 ARH-------------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (253), Expect = 1e-24
Identities = 40/215 (18%), Positives = 75/215 (34%), Gaps = 40/215 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
++ LE+ HS+ +++RD+K N+L++ G +K+ DFG A + + T
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTP 165
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE++ Y S+D WS G + E+L G ++ KI P +
Sbjct: 166 DYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 224
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAAL 175
+ +L+ L++ + +R
Sbjct: 225 NED-----------------------------VKDLLSRLITRDLSQRLGNLQNGTEDVK 255
Query: 176 ASEYFSTKPYACDLSSLPIYPPSKEIDAKHREDAR 210
+F + L S I P + + + D
Sbjct: 256 NHPWFKEVVWE-KLLSRNIETPYEPPIQQGQGDTS 289
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 5e-24
Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 36/186 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+++ LE+ HSR V++RDIK NL+++ +G +K+ DFGL + + + T
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTP 169
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
Y PE+L DYG +VD W +G V E++ G+ + I
Sbjct: 170 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------- 219
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAAL 175
+ + P + L A +L+ LL +P +R + A +
Sbjct: 220 -----------EEIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 176 ASEYFS 181
+F
Sbjct: 260 EHRFFL 265
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (249), Expect = 6e-24
Identities = 39/202 (19%), Positives = 74/202 (36%), Gaps = 40/202 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
Q++ E+ HS +++RD+K NLL++ +G +++ DFG A + + T
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTP 202
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
PE++L Y +VD W++G + E+ G P ++ KI P +
Sbjct: 203 EALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKR-----ATASAAL 175
+L+ LL V+ KR +
Sbjct: 262 SSD-----------------------------LKDLLRNLLQVDLTKRFGNLKNGVNDIK 292
Query: 176 ASEYFSTKPYACDLSSLPIYPP 197
++F+T + + + P
Sbjct: 293 NHKWFATTDWI-AIYQRKVEAP 313
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.8 bits (245), Expect = 1e-23
Identities = 36/174 (20%), Positives = 64/174 (36%), Gaps = 31/174 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLA-NFSNTGHRQPLTSRVVT 59
Q+ G+ + R +HRD+ N LV V+K+ADFGL+ N + + + + +
Sbjct: 146 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 205
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 118
+ + PPE + Y D+W+ G V E+ G G E ++ +
Sbjct: 206 IRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-------- 256
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
D ++ ++ P NL+ S P R +
Sbjct: 257 --------------------DGNILACPENCPLELYNLMRLCWSKLPADRPSFC 290
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 1e-23
Identities = 41/178 (23%), Positives = 62/178 (34%), Gaps = 31/178 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 58
Q+ G+ + S+ +HRD+ NLL+ ++K+ DFGL N H R V
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPP 117
+ PE L T + + D W G E+ G+ G + LHKI K P
Sbjct: 177 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
+D P N++ + +P R T A
Sbjct: 236 RP---------------------------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 34/174 (19%), Positives = 63/174 (36%), Gaps = 30/174 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPL-TSRVVT 59
Q+ G+E + +HRD+ N+LV + V+K+ DFGLA + + + +
Sbjct: 170 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 118
+ + PE L Y D+WS G + E+ +G G +K+ +
Sbjct: 230 VKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ------- 281
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
FK QP ++++ + + KR +
Sbjct: 282 -----------NGFKMDQP---------FYATEEIYIIMQSCWAFDSRKRPSFP 315
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 3e-23
Identities = 32/181 (17%), Positives = 60/181 (33%), Gaps = 31/181 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG---VLKLADFGLANFSNTG------HRQ 51
+Q++ +E+ HS+ +HRD+K N L+ ++ + DFGLA +
Sbjct: 109 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168
Query: 52 PLTSRVVTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFK 111
+ T Y LG + DL S+G V +G QG + K +
Sbjct: 169 ENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
Query: 112 LCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATA 171
+ ++ + + K P+ + S+ +
Sbjct: 228 IS---------------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266
Query: 172 S 172
S
Sbjct: 267 S 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 3e-23
Identities = 36/176 (20%), Positives = 61/176 (34%), Gaps = 30/176 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ G+ + V+HRD+ N LV V+K++DFG+ F T +
Sbjct: 107 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ PE+ + Y D+WS G + E+ GK + R+ E + I
Sbjct: 167 KWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---------- 215
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
+T F+ +P + T ++ P R S L
Sbjct: 216 ---------STGFRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 4e-23
Identities = 38/180 (21%), Positives = 63/180 (35%), Gaps = 15/180 (8%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ---PLTSRV 57
+ + + + HRD+K N+LV G +AD GLA ++ RV
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 58 VTLWYRPPELLLGA-----TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKL 112
T Y PE+L + + D++++G VF E+ I G E QL +
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLV 232
Query: 113 CGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS 172
P + +K +P P E + + ++ R TA
Sbjct: 233 PSDPSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTAL 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 7e-23
Identities = 35/184 (19%), Positives = 66/184 (35%), Gaps = 32/184 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
Q+ G+ R +HRD++ +N+LV++ K+ADFGLA +
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ PE + T + D+WS G + E++ G+ G T E + + +
Sbjct: 175 KWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------- 225
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA--S 177
++ +P + P L+ P R T +
Sbjct: 226 -----------GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
Query: 178 EYFS 181
++F+
Sbjct: 266 DFFT 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 2e-22
Identities = 27/176 (15%), Positives = 60/176 (34%), Gaps = 34/176 (19%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ +E+ +HRD+ N+LV+ + V K++DFGL +++ + + +
Sbjct: 109 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPV 164
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ PE L + D+WS G + E+ G+ + + ++ K
Sbjct: 165 KWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------- 215
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
+K P P +++ ++ R +
Sbjct: 216 -----------GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 3e-22
Identities = 35/177 (19%), Positives = 67/177 (37%), Gaps = 30/177 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ +E+ S+ LHRD+ N LVN++GV+K++DFGL+ + +
Sbjct: 106 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ PPE+L+ + + D+W+ G + E+ +GK + T E I
Sbjct: 166 RWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------- 214
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
A + +P ++ + + +R T L+
Sbjct: 215 ---------AQGLRLYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.7 bits (232), Expect = 5e-22
Identities = 33/180 (18%), Positives = 64/180 (35%), Gaps = 34/180 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-- 58
+ + G+++ +HRD+ N+LVN+ V K++DFGL+ F P + +
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 59 --TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGS 115
+ + PE + + + D+WS G V E++ G+ T + ++ I +
Sbjct: 194 KIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252
Query: 116 PPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
PP D P+ L+ + R +
Sbjct: 253 PPPM----------------------------DCPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 2e-21
Identities = 35/177 (19%), Positives = 67/177 (37%), Gaps = 30/177 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
QL L + S+ +HRDI N+LV++ +KL DFGL+ + + + +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ PE + + + D+W G E+L+ G QG + + +I
Sbjct: 174 KWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------- 224
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
++ +P + P T +L+ + +P +R + A
Sbjct: 225 -GERLPMP-------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.6 bits (219), Expect = 2e-20
Identities = 30/188 (15%), Positives = 66/188 (35%), Gaps = 35/188 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 58
++Q+ G+++ +HRD+ N+L+ + K++DFGL+ ++ + + T
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPP 117
+ + PE + + D+WS G + E G+ +G E + K
Sbjct: 173 PVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------ 225
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AA 174
++ P P +L+ + + R +
Sbjct: 226 ---GERMGCP-------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELR 263
Query: 175 LASEYFST 182
L + Y+
Sbjct: 264 LRNYYYDV 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 88.2 bits (218), Expect = 3e-20
Identities = 26/175 (14%), Positives = 54/175 (30%), Gaps = 28/175 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
Q+ +E+ + +HRD+ N LV ++K+ADFGL+ +
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDY 120
+ PE L + D+W+ G + E+ ++ Q++++ +
Sbjct: 181 KWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP- 238
Query: 121 WKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
+ P L+ P R + +
Sbjct: 239 --------------------------EGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-19
Identities = 35/178 (19%), Positives = 70/178 (39%), Gaps = 32/178 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTL 60
+ G+++ + +HRD+ N+LV V K+ADFGL+ ++ T + +
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPV 190
Query: 61 WYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ E L + Y + D+WS G + E++ +G G T E K+ +
Sbjct: 191 RWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-------- 241
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
++ ++P + +L+ +PY+R + + L S
Sbjct: 242 -----------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-19
Identities = 31/177 (17%), Positives = 55/177 (31%), Gaps = 29/177 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 59
Q+ G+ + R ++HRD+ N+LV +K+ DFGLA ++
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ + E +L Y D+WS G EL+ GS P D
Sbjct: 177 IKWMALESILHRI-YTHQSDVWSYGVTVWELM--------------------TFGSKPYD 215
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
S++ + P ++ ++ R +
Sbjct: 216 GIPASEISSILEKGERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.3 bits (213), Expect = 2e-19
Identities = 32/187 (17%), Positives = 67/187 (35%), Gaps = 35/187 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 58
++Q+ G+++ + +HRD+ N+L+ N K++DFGL+ ++ + ++
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPP 117
L + PE + + D+WS G E L G+ + E + I +
Sbjct: 175 PLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------ 227
Query: 118 DDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATAS---AA 174
K+ + P + P L+ + R
Sbjct: 228 ---GKRMECP-------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQR 265
Query: 175 LASEYFS 181
+ + Y+S
Sbjct: 266 MRACYYS 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 6e-19
Identities = 33/177 (18%), Positives = 59/177 (33%), Gaps = 30/177 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 59
Q+ G+ S+ +HRD+ N+L+ + + K+ DFGLA +
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELL-IGKPILQGRTEVEQLHKIFKLCGSPPD 118
+ + PE + Y D+WS G EL +G G + +K+ K
Sbjct: 211 VKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
+ P ++++T +P KR T +
Sbjct: 270 P---------------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 8e-19
Identities = 29/178 (16%), Positives = 60/178 (33%), Gaps = 30/178 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF--SNTGHRQPLTSRVV 58
+ + G+++ + +HRD+ N+LVN+ V K++DFGL+ + + +
Sbjct: 116 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 59 TLWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPD 118
+ + PE + + D+WS G V E++ ++ K P
Sbjct: 176 PIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 234
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
D P+ L+ E +R + ++
Sbjct: 235 P---------------------------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 1e-18
Identities = 36/176 (20%), Positives = 61/176 (34%), Gaps = 29/176 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLT-SRVVT 59
Q+ G+E+ S+ +HRD+ N+LV + V+K+ADFGLA + T + +
Sbjct: 141 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDD 119
+ + PE L Y D+WS G + E+ VE+L K+ K
Sbjct: 201 VKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP 259
Query: 120 YWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
+ ++ P +R T +
Sbjct: 260 ---------------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 2e-18
Identities = 34/177 (19%), Positives = 54/177 (30%), Gaps = 30/177 (16%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVV-T 59
Q+ G+E SR +HRD+ N+L++ + V+K+ DFGLA
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPD 118
L + PE + Y D+WS G + E+ G E+ + K
Sbjct: 200 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 258
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAAL 175
+ EP +R T S +
Sbjct: 259 P---------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELV 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 2e-18
Identities = 29/179 (16%), Positives = 62/179 (34%), Gaps = 31/179 (17%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLAN-FSNTGHRQPLTSRVVT 59
++ G+ + ++ +HRD+ N +V + +K+ DFG+ T + + ++
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 60 LWYRPPELLLGATDYGPSVDLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPD 118
+ + PE L + D+WS G V E+ + QG + + L +
Sbjct: 199 VRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-------- 249
Query: 119 DYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177
+ L + + P L+ P R + ++S
Sbjct: 250 --------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 4e-18
Identities = 29/180 (16%), Positives = 60/180 (33%), Gaps = 33/180 (18%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANF---SNTGHRQPLTSRV 57
Q+ G++ S+ +HRD+ N +++ + +K+ADFGLA T
Sbjct: 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSP 116
+ + + E L + D+WS G + EL+ G P + + +
Sbjct: 196 LPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----- 249
Query: 117 PDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALA 176
++ P + P ++ + R + S ++
Sbjct: 250 ----GRRLLQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.4 bits (156), Expect = 9e-13
Identities = 16/87 (18%), Positives = 35/87 (40%), Gaps = 12/87 (13%)
Query: 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSR---V 57
++ +L + + RG++H D+ N+LV+ EG+ + DF + + + R
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRN 167
Query: 58 VTLWYRPPELLLGATDYGPSVDLWSVG 84
+ ++ Y D+ S
Sbjct: 168 IITYFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.98 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.94 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.05 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 90.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 89.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 86.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 84.55 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=321.74 Aligned_cols=191 Identities=42% Similarity=0.728 Sum_probs=160.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||++|+|||++.+...|+.++||
T Consensus 106 ~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 184 (299)
T d1ua2a_ 106 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDM 184 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHH
T ss_pred HHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-ccccceecChhhccHHHHccCCCCChhhhh
Confidence 4799999999999999999999999999999999999999997665432 233456899999999999876778999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccC-CCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSK-LPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||+|+|++|.+||.+.++.+++.+|++.++.+....|.... ......+... ....+...+..+++++++||.+
T Consensus 185 wSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dll~~ 262 (299)
T d1ua2a_ 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF--PGIPLHHIFSAAGDDLLDLIQG 262 (299)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC--CCCCHHHHCTTCCHHHHHHHHH
T ss_pred hhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC--CCCChHHhcccCCHHHHHHHHH
Confidence 999999999999999999999999999999999999888776432 2222222111 1223456677889999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCCCCCCCCCCCCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTKPYACDLSSLPI 194 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~~p~ 194 (468)
||++||.+||||.|+|+||||++.|.+++.+.+|.
T Consensus 263 ~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 263 LFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp HHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred HccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 99999999999999999999999999887766653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=304.24 Aligned_cols=178 Identities=42% Similarity=0.729 Sum_probs=150.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..|+.++||
T Consensus 122 ~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~Di 198 (305)
T d1blxa_ 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDL 198 (305)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHH
T ss_pred HHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcC-CCCChhehh
Confidence 479999999999999999999999999999999999999998755432 34456789999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|||++|.+||.+.+..+++..++..++.+....|..........+... ....+......+++.+++||.+|
T Consensus 199 wSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~m 276 (305)
T d1blxa_ 199 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKC 276 (305)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHH
T ss_pred hchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccc--cccchhhccccCCHHHHHHHHHH
Confidence 9999999999999999999999999999999999998887765333222222211 11223445567899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCC
Q 012191 161 LSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
|++||.+||||.|+|+||||+..
T Consensus 277 L~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 277 LTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCChhHCcCHHHHhcChhhcCc
Confidence 99999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-36 Score=301.02 Aligned_cols=188 Identities=41% Similarity=0.742 Sum_probs=148.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ......+||++|+|||++.+...|+.+
T Consensus 123 ~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k 202 (318)
T d3blha1 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP 202 (318)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcH
Confidence 47999999999999999999999999999999999999999976653221 233446789999999999887789999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCc-cccCCCCCCCCchhhhhcC--CCcHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPH-ATLFKPQQPYDSSLRETFK--DLPTTAV 154 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~--~~s~~l~ 154 (468)
+|||||||++|+|++|++||.+.++.+.+..+...++.++...+....... ...+.........+...+. ..++.++
T Consensus 203 ~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (318)
T d3blha1 203 IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282 (318)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHH
T ss_pred HHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHH
Confidence 999999999999999999999999999999999999998877665432211 1111111111222222221 2467899
Q ss_pred HHHHHhcCCCCCCCcCHHHHHhcccccCCCCCCC
Q 012191 155 NLIETLLSVEPYKRATASAALASEYFSTKPYACD 188 (468)
Q Consensus 155 dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~ 188 (468)
+||.+||++||.+||||.|+|+||||++.|.|++
T Consensus 283 dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 283 DLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred HHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 9999999999999999999999999998877654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=297.95 Aligned_cols=185 Identities=39% Similarity=0.681 Sum_probs=152.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++|||||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.....++.++||
T Consensus 108 ~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~Di 186 (298)
T d1gz8a_ 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186 (298)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-ccceeecccceeeehhhhccccCCCccccc
Confidence 4799999999999999999999999999999999999999997665432 345566899999999998876777899999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|++||.+.+..+++.++....+.+.+..|....................+...+..++.++++||.+|
T Consensus 187 wSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~m 266 (298)
T d1gz8a_ 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266 (298)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred cccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHH
Confidence 99999999999999999999999999999999999888777643221111111111112234556678899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 161 LSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
|.+||.+|||+.|+|+||||++...|
T Consensus 267 L~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 267 LHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccCChhHCcCHHHHhCCHhhccCCCC
Confidence 99999999999999999999876443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-37 Score=297.41 Aligned_cols=149 Identities=34% Similarity=0.526 Sum_probs=129.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .....+||+.|+|||++.+ ..|+.++||
T Consensus 112 ~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~~~Gt~~Y~APE~~~~-~~~~~~~Di 187 (263)
T d2j4za1 112 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEG-RMHDEKVDL 187 (263)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---CCEETTEEGGGCCHHHHTT-CCCCTTHHH
T ss_pred HHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---cccccCCCCcccCHHHHcC-CCCCchhhh
Confidence 479999999999999999999999999999999999999999765543 3455689999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||+||+|++|.+||.+.+..+.+..+....... ...+++++++||.+|
T Consensus 188 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 188 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-----------------------------PDFVTEGARDLISRL 238 (263)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred hhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CccCCHHHHHHHHHH
Confidence 999999999999999999998888887775421111 124789999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|+.||.+|||+.|+|+||||+.
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=305.24 Aligned_cols=181 Identities=39% Similarity=0.616 Sum_probs=150.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
++||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+...|+.++|
T Consensus 128 ~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 205 (350)
T d1q5ka_ 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSID 205 (350)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC--cccccccccccccChHHhhcccCCCccee
Confidence 47999999999999999999999999999775 8999999999876543 34456789999999999987778999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||+|||+|||++|.+||.+.+..+++..+++.+|.+..+.|............+..............+++++.+||.+
T Consensus 206 IwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 285 (350)
T d1q5ka_ 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285 (350)
T ss_dssp HHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHH
T ss_pred ecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999888765433222222222222222233345789999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||.+||.+||||.|+|+||||+..
T Consensus 286 mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 286 LLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhccc
Confidence 999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-37 Score=299.67 Aligned_cols=156 Identities=28% Similarity=0.414 Sum_probs=127.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ....+..+||+.|+|||++.+...++.++|
T Consensus 109 ~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~D 188 (271)
T d1nvra_ 109 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188 (271)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHH
T ss_pred HHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCcee
Confidence 4799999999999999999999999999999999999999998765332 223456789999999999987555678899
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||||||+|++|.+||.+..+.............. ...+..+++++++||.+
T Consensus 189 iwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~s~~~~~li~~ 242 (271)
T d1nvra_ 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------------------LNPWKKIDSAPLALLHK 242 (271)
T ss_dssp HHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------------------STTGGGSCHHHHHHHHH
T ss_pred eeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------------------CCccccCCHHHHHHHHH
Confidence 9999999999999999998766544333332211111 11124678999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccC
Q 012191 160 LLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||+.||.+|||+.|+|+||||+.
T Consensus 243 ~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 243 ILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HcCCChhHCcCHHHHhcCHhhCc
Confidence 99999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-36 Score=295.06 Aligned_cols=181 Identities=39% Similarity=0.725 Sum_probs=145.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++|||||||||+|||++.++.+||+|||++....... ......++++.|+|||++.+...++.++||
T Consensus 106 ~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~Di 184 (286)
T d1ob3a_ 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184 (286)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred HHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cccceecccchhhhHHHHhCCCCCCcceee
Confidence 4799999999999999999999999999999999999999998765432 233455789999999999887778999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|||++|++||.+.+..+++.++....+.+....|........................+..+++.+.+||.+|
T Consensus 185 wslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 264 (286)
T d1ob3a_ 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264 (286)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHH
T ss_pred hhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHH
Confidence 99999999999999999999999999999999999988777643221111111111112223455677899999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|++||.+|||+.|+|+||||++
T Consensus 265 L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 265 LKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccCChhHCcCHHHHhcCcccCc
Confidence 9999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-36 Score=302.12 Aligned_cols=185 Identities=36% Similarity=0.662 Sum_probs=151.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..+..++|+.|+|||++.+...++.++||
T Consensus 127 ~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 202 (346)
T d1cm8a_ 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDI 202 (346)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHH
T ss_pred HHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC----ccccccccccccCHHHHcCCCCCCccchh
Confidence 47999999999999999999999999999999999999999986653 34567899999999999887778999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCC--CCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFK--PQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||+||++|+|++|.+||.+.+....+..+....+.++..++..........+. ........+...+..+++.+++||.
T Consensus 203 wSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 282 (346)
T d1cm8a_ 203 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 282 (346)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHH
T ss_pred hcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHH
Confidence 99999999999999999999999999999999999998877654322111100 0001122344556788999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYACDL 189 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~ 189 (468)
+||.+||.+|||+.|||+||||+....+.+.
T Consensus 283 ~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~ 313 (346)
T d1cm8a_ 283 KMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313 (346)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred HHCcCChhHCcCHHHHhcChhhCcCCCcccc
Confidence 9999999999999999999999986544433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-36 Score=297.11 Aligned_cols=154 Identities=28% Similarity=0.481 Sum_probs=132.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... ......+||+.|+|||++.+ ..|+.++||
T Consensus 122 ~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~~~~~Di 199 (293)
T d1yhwa1 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199 (293)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHSS-SCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccccccCCCccChhhhcC-CCCCchhce
Confidence 4799999999999999999999999999999999999999998765432 23456689999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||++|+|++|.+||.+.+..+.+..+.... .+... ....+++++++||.+|
T Consensus 200 wSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~~-------------------------~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQ-------------------------NPEKLSAIFRDFLNRC 253 (293)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCCCS-------------------------SGGGSCHHHHHHHHHH
T ss_pred ehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCC-------------------------CcccCCHHHHHHHHHH
Confidence 999999999999999999988888777765532 11111 1135789999999999
Q ss_pred cCCCCCCCcCHHHHHhcccccC
Q 012191 161 LSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|..||.+|||+.|+|+||||+.
T Consensus 254 L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp TCSSTTTSCCHHHHTTCGGGGG
T ss_pred ccCChhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.8e-36 Score=302.03 Aligned_cols=163 Identities=28% Similarity=0.396 Sum_probs=138.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC--CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN--EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
++||+.||.|||++|||||||||+|||++. ++.+||+|||++...... .......||+.|+|||++.+ ..|+.++
T Consensus 130 ~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~gT~~Y~aPEv~~~-~~~~~~~ 206 (350)
T d1koaa2 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG-KPVGYYT 206 (350)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SCEEEECSCTTTCCHHHHHT-CCBCHHH
T ss_pred HHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--cccceecCcccccCHHHHcC-CCCChhH
Confidence 479999999999999999999999999964 578999999999876543 33456789999999999987 5689999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||||+|+|++|.+||.+.+..+.+..|......++.. .+..+++++++||.
T Consensus 207 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~ 261 (350)
T d1koaa2 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------------------------AFSGISEDGKDFIR 261 (350)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG-------------------------GGGGCCHHHHHHHH
T ss_pred hhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHH
Confidence 99999999999999999999999998888887654333322 22468899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCCCCCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPYACDLSS 191 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~~~~~~~ 191 (468)
+||+.||.+|||+.|+|+||||+...++.....
T Consensus 262 ~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~ 294 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 294 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCC
T ss_pred HHccCChhHCcCHHHHhcCcccCCCCCCCchhh
Confidence 999999999999999999999998766554433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-36 Score=294.31 Aligned_cols=156 Identities=29% Similarity=0.474 Sum_probs=129.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... .......+||+.|+|||++.+ ..|+.++|
T Consensus 114 ~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~D 192 (288)
T d1uu3a_ 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSD 192 (288)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT-CCCCHHHH
T ss_pred HHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeecc-CCCCcccc
Confidence 4799999999999999999999999999999999999999998765432 223455689999999999987 46899999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||+||+|++|.+||.+.+..+.+.+|....... ...+++++++||.+
T Consensus 193 iwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 193 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-----------------------------PEKFFPKARDLVEK 243 (288)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-----------------------------CTTCCHHHHHHHHT
T ss_pred eehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC-----------------------------CccCCHHHHHHHHH
Confidence 9999999999999999999999888888775421111 12578999999999
Q ss_pred hcCCCCCCCcCHHH------HHhcccccCCCCC
Q 012191 160 LLSVEPYKRATASA------ALASEYFSTKPYA 186 (468)
Q Consensus 160 mL~~DP~kRpTa~e------~L~Hp~F~~~p~~ 186 (468)
||+.||.+|||++| +++||||++..|.
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 99999999999987 5789999886654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=288.76 Aligned_cols=150 Identities=23% Similarity=0.376 Sum_probs=123.5
Q ss_pred CHHHHHHHHHHHhCC--CeeccCCCCceEEC-CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRG--VLHRDIKGSNLLVN-NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~g--IvHrDIKp~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||+|||++| |+||||||+|||++ .++.+||+|||++...... .....+||+.|+|||++.+ .|+.+
T Consensus 118 ~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~--~~~~~ 192 (270)
T d1t4ha_ 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE--KYDES 192 (270)
T ss_dssp HHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT--CCCTH
T ss_pred HHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCC--CCCCc
Confidence 479999999999999 99999999999996 4789999999999765432 3456789999999999876 58999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||+|+|++|.+||.+......+.+.+.. +..+.. ....+++++.+||
T Consensus 193 ~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~-------------------------~~~~~~~~~~~li 246 (270)
T d1t4ha_ 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPAS-------------------------FDKVAIPEVKEII 246 (270)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGG-------------------------GGGCCCHHHHHHH
T ss_pred CchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCcc-------------------------cCccCCHHHHHHH
Confidence 99999999999999999999876655544333221 111111 1135788899999
Q ss_pred HHhcCCCCCCCcCHHHHHhccccc
Q 012191 158 ETLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
.+||+.||.+|||+.|+|+||||+
T Consensus 247 ~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-35 Score=294.43 Aligned_cols=155 Identities=28% Similarity=0.485 Sum_probs=120.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC---CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN---NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld---~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||+|||++||+||||||+|||+. .++.+||+|||++...... ......+||+.|+|||++.+ ..|+.+
T Consensus 113 ~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--~~~~~~~GT~~y~APE~~~~-~~~~~~ 189 (307)
T d1a06a_ 113 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQ-KPYSKA 189 (307)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHTT-CCCCTH
T ss_pred HHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--CeeeeeeeCccccCcHHHcC-CCCCcH
Confidence 47999999999999999999999999995 4689999999999866543 23455689999999999987 568999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||+||+|++|.+||.+....+....+......++. ..+..+|+++++||
T Consensus 190 ~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li 244 (307)
T d1a06a_ 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS-------------------------PYWDDISDSAKDFI 244 (307)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT-------------------------TTTTTSCHHHHHHH
T ss_pred HHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC-------------------------ccccCCCHHHHHHH
Confidence 99999999999999999999999888888877653322221 12246899999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||+.||.+|||+.|+|+||||+..
T Consensus 245 ~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-35 Score=295.29 Aligned_cols=154 Identities=28% Similarity=0.440 Sum_probs=132.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+ ..|+.++||
T Consensus 111 ~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~Di 188 (337)
T d1o6la_ 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDW 188 (337)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGGSS-SCBCTTHHH
T ss_pred HHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-CcccccceeCHHHhhhhhccC-CCCChhhcc
Confidence 479999999999999999999999999999999999999999865432 234556789999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|||++|.+||.+.+..+.+..+....... ...+++++++||.+|
T Consensus 189 wSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-----------------------------PRTLSPEAKSLLAGL 239 (337)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------------------CTTSCHHHHHHHHHH
T ss_pred cchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC-----------------------------CccCCHHHHHHHHhh
Confidence 999999999999999999999888877775532111 135789999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|+.||.+|+ |+.++|+||||+...|
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ccCCchhhcccccccHHHHHcCcccccCCH
Confidence 999999999 4999999999987544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-35 Score=297.87 Aligned_cols=151 Identities=25% Similarity=0.402 Sum_probs=132.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++|||||||||+||||+.+|.+||+|||++...... ....+||+.|+|||++.+ ..|+.++||
T Consensus 147 ~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~-~~~~~~~Di 221 (350)
T d1rdqe_ 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS-KGYNKAVDW 221 (350)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----cccccCccccCCHHHHcC-CCCCccccc
Confidence 479999999999999999999999999999999999999999876532 345689999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||||+|++|.+||.+.+....+.+|......++ ..+++++.+||.+|
T Consensus 222 wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP-----------------------------SHFSSDLKDLLRNL 272 (350)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------------------TTCCHHHHHHHHHH
T ss_pred cchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC-----------------------------ccCCHHHHHHHHHH
Confidence 9999999999999999999998888888765321111 35789999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|+ |++++|+||||+...|
T Consensus 273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred hhhCHHhccccccccHHHHHcCccccCCCH
Confidence 999999995 9999999999998655
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=293.19 Aligned_cols=155 Identities=26% Similarity=0.373 Sum_probs=128.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC----CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG----ATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g----~~~~s~ 76 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ...|+.
T Consensus 116 ~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~ 194 (288)
T d2jfla1 116 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194 (288)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTT
T ss_pred HHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCCh
Confidence 4799999999999999999999999999999999999999986543211 12345689999999999853 345889
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|.+||.+.+..+.+.++.... ++. ......+++++++|
T Consensus 195 k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~~------------------------~~~~~~~s~~~~~l 248 (288)
T d2jfla1 195 KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PPT------------------------LAQPSRWSSNFKDF 248 (288)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CCC------------------------CSSGGGSCHHHHHH
T ss_pred hhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCC------------------------CCccccCCHHHHHH
Confidence 9999999999999999999999988888777775521 110 00113578999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 157 IETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
|.+||+.||.+|||+.|+|+||||+.
T Consensus 249 i~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 249 LKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-35 Score=298.79 Aligned_cols=155 Identities=28% Similarity=0.456 Sum_probs=135.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEEC--CCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVN--NEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld--~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
|+||+.||.|||++||+||||||+||||+ .++.+||+|||++...... .......+|+.|+|||++.+ ..|+.++
T Consensus 133 ~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 209 (352)
T d1koba_ 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYT 209 (352)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEEEECSSGGGCCHHHHTT-CCBCHHH
T ss_pred HHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--CceeeccCcccccCHHHHcC-CCCCCcc
Confidence 47999999999999999999999999997 5689999999999877654 33456688999999999976 5689999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||+||+|++|.+||.+.+..+.+..+......++.. .+..+++++.+||.
T Consensus 210 DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~ 264 (352)
T d1koba_ 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-------------------------AFSSVSPEAKDFIK 264 (352)
T ss_dssp HHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS-------------------------TTTTSCHHHHHHHH
T ss_pred chHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHH
Confidence 99999999999999999999999999888887654433322 22468999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||+.||.+|||+.|+|+||||+..
T Consensus 265 ~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 265 NLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-35 Score=292.44 Aligned_cols=151 Identities=28% Similarity=0.432 Sum_probs=129.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCC--CCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGA--TDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~--~~~s~~s 78 (468)
++||+.||.|||++||+||||||+||||+.++.+||+|||++..... ....+||+.|+|||++.+. ..|+.++
T Consensus 121 ~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~ 195 (309)
T d1u5ra_ 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKV 195 (309)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHH
T ss_pred HHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----CCccccCccccCHHHHhccCCCCcCchh
Confidence 47999999999999999999999999999999999999999976543 2456899999999999652 3588999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||++|+|++|.+||.+.+..+.+..+........ ....+++.+++||.
T Consensus 196 DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---------------------------QSGHWSEYFRNFVD 248 (309)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------------------------SCTTSCHHHHHHHH
T ss_pred hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---------------------------CCCCCCHHHHHHHH
Confidence 999999999999999999999888887777754221110 01357899999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||+.||.+|||+.++|+||||...
T Consensus 249 ~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHCcCChhHCcCHHHHHhCHHhcCC
Confidence 9999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-36 Score=297.49 Aligned_cols=179 Identities=24% Similarity=0.318 Sum_probs=121.6
Q ss_pred CHHHHHHHHHHHh-CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|...... ..+..+||++|+|||++.+ ..|+.++|
T Consensus 110 ~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~-~~y~~~~D 185 (322)
T d1s9ja_ 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSD 185 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHC-SCCCTTHH
T ss_pred HHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---ccccccCCccccCchHHcC-CCCCcHHH
Confidence 4799999999997 59999999999999999999999999999865432 2346789999999999987 56999999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHH-HHHHHHHcCCCCchh----hhccCCCc-cccCCCCCCCCchhhh---------
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQ-LHKIFKLCGSPPDDY----WKKSKLPH-ATLFKPQQPYDSSLRE--------- 144 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~-l~~i~~~~g~p~~~~----~~~~~~~~-~~~~~~~~~~~~~l~~--------- 144 (468)
|||+|||+|||++|+.||.+.+..+. ...+....+.+.... +....... .....+.......+..
T Consensus 186 iWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (322)
T d1s9ja_ 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265 (322)
T ss_dssp HHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccC
Confidence 99999999999999999987654332 222222222221110 00000000 0000000000000000
Q ss_pred hcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 145 TFKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 145 ~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
....++.++++||.+||.+||.+||||.|+|+||||+..
T Consensus 266 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 012368899999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-35 Score=288.22 Aligned_cols=157 Identities=28% Similarity=0.411 Sum_probs=133.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC----cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG----VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
++||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .......+|+.|+|||++.+ ..|+.
T Consensus 119 ~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~--~~~~~~~~t~~y~APE~~~~-~~~~~ 195 (293)
T d1jksa_ 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNY-EPLGL 195 (293)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS--CBCSCCCCCGGGCCHHHHTT-CCBCT
T ss_pred HHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC--ccccccCCCCcccCHHHHcC-CCCCC
Confidence 47999999999999999999999999998776 4999999999876544 23455688999999999976 56899
Q ss_pred CcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 77 SVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 77 ~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
++|||||||++|+|++|.+||.+.+..+.+..+......++. ..+..++..+++|
T Consensus 196 ~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~l 250 (293)
T d1jksa_ 196 EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-------------------------EYFSNTSALAKDF 250 (293)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH-------------------------HHHTTSCHHHHHH
T ss_pred cccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-------------------------hhcCCCCHHHHHH
Confidence 999999999999999999999999998888888654333222 2235689999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
|.+||+.||.+|||++|+|+||||+...+
T Consensus 251 i~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred HHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 99999999999999999999999987544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-35 Score=290.94 Aligned_cols=151 Identities=23% Similarity=0.383 Sum_probs=132.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+||||+.+|.+||+|||++..... .....+||+.|+|||++.+ ..|+.++||
T Consensus 110 ~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----~~~~~~Gt~~Y~APE~l~~-~~y~~~~Di 184 (316)
T d1fota_ 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVST-KPYNKSIDW 184 (316)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCCCCSCTTTCCHHHHTT-CCBCTTHHH
T ss_pred HHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----ccccccCcccccCHHHHcC-CCCCchhhc
Confidence 47999999999999999999999999999999999999999987653 2345789999999999976 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
|||||+||+|++|..||.+.+..+.+.++.......+ ..+++++.+||.+|
T Consensus 185 wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p-----------------------------~~~s~~~~~li~~~ 235 (316)
T d1fota_ 185 WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP-----------------------------PFFNEDVKDLLSRL 235 (316)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC-----------------------------TTSCHHHHHHHHHH
T ss_pred cccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC-----------------------------CCCCHHHHHHHHHH
Confidence 9999999999999999999998888888765321111 35789999999999
Q ss_pred cCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 161 LSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
|..||.+|+ |++++|+||||+...|
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred hhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 999999996 9999999999988654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=282.32 Aligned_cols=182 Identities=42% Similarity=0.715 Sum_probs=147.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++||+||||||+|||++.++.+||+|||.+....... .......+++.|+|||++.+...++.++||
T Consensus 107 ~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di 185 (292)
T d1unla_ 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHH
T ss_pred HHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccceeeccccchhhhhHhccCCCCCchhhc
Confidence 4799999999999999999999999999999999999999998765432 233455678999999999876678999999
Q ss_pred eeeehhhhhhhhcCCC-CCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~p-f~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|+|++|..| |.+.+..+++..+....+.+....|............+..............+++.+.+||.+
T Consensus 186 wSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~ 265 (292)
T d1unla_ 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265 (292)
T ss_dssp HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHH
T ss_pred cccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHH
Confidence 9999999999998876 577788888999999999888777654222111111122223334455567889999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||++||.+||||+|+|+||||++.
T Consensus 266 mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 266 LLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HccCChhHCcCHHHHhcChhhcCC
Confidence 999999999999999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-35 Score=297.82 Aligned_cols=156 Identities=26% Similarity=0.403 Sum_probs=128.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++|||||||||+||||+.+|.+||+|||++..+... .....+||+.|+|||++.+...|+.++||
T Consensus 113 ~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~Di 189 (364)
T d1omwa3 113 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADW 189 (364)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC---cccccccccccchhHHhhcCCCCCcccch
Confidence 479999999999999999999999999999999999999999876543 33456899999999999766679999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||||+|++|.+||.+.........+ ......+. .....+++++++||.+|
T Consensus 190 wSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~-------------------------~~~~~~s~~~~~li~~~ 243 (364)
T d1omwa3 190 FSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAV-------------------------ELPDSFSPELRSLLEGL 243 (364)
T ss_dssp HHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCC-------------------------CCCSSSCHHHHHHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCC-------------------------CCCCCCCHHHHHHHHHH
Confidence 99999999999999999876543332222 21111111 11135889999999999
Q ss_pred cCCCCCCCcC-----HHHHHhcccccCCCC
Q 012191 161 LSVEPYKRAT-----ASAALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpT-----a~e~L~Hp~F~~~p~ 185 (468)
|..||.+||| |+++|+||||+...|
T Consensus 244 L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 244 LQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp TCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred cccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 9999999999 899999999998654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=290.00 Aligned_cols=186 Identities=37% Similarity=0.627 Sum_probs=148.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
++||+.||+|||++|||||||||+||||+.++.+||+|||++........ ......+||+.|+|||++.....|+.++
T Consensus 115 ~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 194 (345)
T d1pmea_ 115 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194 (345)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHH
T ss_pred HHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchh
Confidence 47999999999999999999999999999999999999999976544322 2335567899999999987767789999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccc--cCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHAT--LFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
||||+||++|+|++|.+||.+.+..++...+...++.+.............. ...........+...++.+++++++|
T Consensus 195 DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 274 (345)
T d1pmea_ 195 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHH
T ss_pred hhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHH
Confidence 9999999999999999999999999998888888877765543221111100 01111112223456677899999999
Q ss_pred HHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 157 IETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
|.+||+.||.+||||.|+|+||||+....+
T Consensus 275 i~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 275 LDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 999999999999999999999999976443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=289.92 Aligned_cols=181 Identities=39% Similarity=0.659 Sum_probs=145.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||+|||++||+||||||+|||++.++.+|++|||++..... ......||+.|+|||++.+...++.++||
T Consensus 127 ~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~Di 202 (348)
T d2gfsa1 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDI 202 (348)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHH
T ss_pred HHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc----ccccccccccccCchhhcCCccCCcccch
Confidence 47999999999999999999999999999999999999999875542 34556789999999998887778999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccC--CCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLF--KPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||++|+|++|.+||.+.+.......+....+.+..+.+..........+ .........+...+..+++++++||.
T Consensus 203 wSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 282 (348)
T d2gfsa1 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 282 (348)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHH
Confidence 9999999999999999999999999999999988887766543222111100 00111122345566789999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+||.+||.+||||.|+|+||||+....
T Consensus 283 ~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 283 KMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 999999999999999999999997543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-35 Score=284.62 Aligned_cols=150 Identities=29% Similarity=0.450 Sum_probs=118.0
Q ss_pred CHHHHHHHHHHHhCC-----CeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCC
Q 012191 1 MNQLLHGLEHCHSRG-----VLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~g-----IvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s 75 (468)
+.||+.||.|||++| |+||||||+||||+.++.+||+|||++....... ......+||+.|+|||++.+ ..|+
T Consensus 115 ~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~ 192 (269)
T d2java1 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYN 192 (269)
T ss_dssp HHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTT-CCCC
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC-CccccCCCCcccCCHHHHcC-CCCC
Confidence 479999999999976 9999999999999999999999999998765432 23456789999999999976 5689
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++||||||||+|+|++|.+||.+.+..+....+.... .+ .....+++++.+
T Consensus 193 ~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~--~~--------------------------~~~~~~s~~l~~ 244 (269)
T d2java1 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR--------------------------RIPYRYSDELNE 244 (269)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CC--------------------------CCCTTSCHHHHH
T ss_pred hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCcccCHHHHH
Confidence 99999999999999999999999988888777775421 11 011357899999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccc
Q 012191 156 LIETLLSVEPYKRATASAALASEYF 180 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F 180 (468)
||.+||+.||.+|||+.|+|+|||.
T Consensus 245 li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 245 IITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-34 Score=281.14 Aligned_cols=155 Identities=32% Similarity=0.492 Sum_probs=133.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcC-----CCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLG-----ATDYG 75 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g-----~~~~s 75 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||.+.+ ...++
T Consensus 116 ~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~ 193 (277)
T d1phka_ 116 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYG 193 (277)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBC
T ss_pred HHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCC
Confidence 4799999999999999999999999999999999999999998776542 3456789999999999863 34578
Q ss_pred CCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 76 PSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 76 ~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
.++||||+|||||+|++|..||.+.+..+.+..+......++. ..+..+|+++++
T Consensus 194 ~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~ 248 (277)
T d1phka_ 194 KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS-------------------------PEWDDYSDTVKD 248 (277)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------------------TTGGGSCHHHHH
T ss_pred chheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC-------------------------cccccCCHHHHH
Confidence 8999999999999999999999999988888877653222211 123468999999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhcccccC
Q 012191 156 LIETLLSVEPYKRATASAALASEYFST 182 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~Hp~F~~ 182 (468)
||.+||+.||.+|||+.|+|+||||+.
T Consensus 249 li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 249 LVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 999999999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=282.68 Aligned_cols=145 Identities=29% Similarity=0.434 Sum_probs=121.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC-CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE-GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...... ..+..+||+.|+|||++.+...++.++|
T Consensus 116 ~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~D 192 (273)
T d1xwsa_ 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAA 192 (273)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred HHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccc
Confidence 4799999999999999999999999999854 79999999999765432 3456789999999999987666678899
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||++|+|++|..||.+.+. +... .. . ....+|+++++||.+
T Consensus 193 iwSlGvilyell~g~~Pf~~~~~------i~~~--~~--------------------~-------~~~~~s~~~~~li~~ 237 (273)
T d1xwsa_ 193 VWSLGILLYDMVCGDIPFEHDEE------IIRG--QV--------------------F-------FRQRVSSECQHLIRW 237 (273)
T ss_dssp HHHHHHHHHHHHHSSCSCCSHHH------HHHC--CC--------------------C-------CSSCCCHHHHHHHHH
T ss_pred cccceeeehhHhhCCCCCCCchH------Hhhc--cc--------------------C-------CCCCCCHHHHHHHHH
Confidence 99999999999999999976421 2211 10 0 013578999999999
Q ss_pred hcCCCCCCCcCHHHHHhcccccCC
Q 012191 160 LLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
||+.||.+|||+.|+|+||||++.
T Consensus 238 ~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 238 CLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-33 Score=282.30 Aligned_cols=183 Identities=30% Similarity=0.542 Sum_probs=138.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCC-cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEG-VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
++||+.||+|||++||+||||||+||||+.++ .+||+|||++...... ......++|+.|+|||.+.+...|+.++|
T Consensus 135 ~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 212 (328)
T d3bqca1 135 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQMYDYSLD 212 (328)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--CCCCSCCSCGGGCCHHHHTTCCCCCTHHH
T ss_pred HHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC--CcccccccCccccCcccccCCCCCCcccc
Confidence 47999999999999999999999999998655 6999999999876554 23456688999999999988777899999
Q ss_pred eeeeehhhhhhhhcCCCCCC-CchHHHHHHHHHHcCCCCchhhh-ccCCCccccCCC------CCCCCc-hhhhhcCCCc
Q 012191 80 LWSVGCVFAELLIGKPILQG-RTEVEQLHKIFKLCGSPPDDYWK-KSKLPHATLFKP------QQPYDS-SLRETFKDLP 150 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g-~~~~e~l~~i~~~~g~p~~~~~~-~~~~~~~~~~~~------~~~~~~-~l~~~~~~~s 150 (468)
|||+||++|+|++|..||.. .+...+...+...+|.+....|. .........+.. ...... ........++
T Consensus 213 iwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 292 (328)
T d3bqca1 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292 (328)
T ss_dssp HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCC
T ss_pred hhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCC
Confidence 99999999999999999865 45666777777777654332222 111111111100 000000 0111234578
Q ss_pred HHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCC
Q 012191 151 TTAVNLIETLLSVEPYKRATASAALASEYFSTKPY 185 (468)
Q Consensus 151 ~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~ 185 (468)
+++++||.+||.+||.+|||++|||+||||++..|
T Consensus 293 ~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 293 PEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999999999999999999999999999997544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=289.53 Aligned_cols=159 Identities=26% Similarity=0.424 Sum_probs=124.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
++||+.||+|||++||+||||||+|||++. .+.+||+|||++...... ......+||+.|+|||++.+ ..|+.+
T Consensus 117 ~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~y~~~ 193 (335)
T d2ozaa1 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKS 193 (335)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC--CCCCCCSCCCSSCCCCCCCG-GGGSHH
T ss_pred HHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC--CccccccCCcccCCcHHHcC-CCCCHH
Confidence 479999999999999999999999999975 467999999999876543 23456789999999999876 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+||||||||||+|++|.+||.+.+.......+......... .+. ...+..+++++++||
T Consensus 194 ~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~------------------~~~---~~~~~~~s~~~~~li 252 (335)
T d2ozaa1 194 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------EFP---NPEWSEVSEEVKMLI 252 (335)
T ss_dssp HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS------------------SCC---TTHHHHSCHHHHHHH
T ss_pred HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC------------------CCC---CcccccCCHHHHHHH
Confidence 99999999999999999999887655544444322111100 000 112245889999999
Q ss_pred HHhcCCCCCCCcCHHHHHhcccccCC
Q 012191 158 ETLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
.+||+.||.+|||+.|+|+||||...
T Consensus 253 ~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 253 RNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHHccCChhHCcCHHHHHcCHHhhCC
Confidence 99999999999999999999999753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.1e-34 Score=283.30 Aligned_cols=155 Identities=25% Similarity=0.388 Sum_probs=134.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCC--CcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNE--GVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~--g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...... ......++|+.|+|||.+.+ ..|+.++
T Consensus 108 ~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~~~~~~~t~~y~ape~~~~-~~~~~~~ 184 (321)
T d1tkia_ 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH-DVVSTAT 184 (321)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEEEEESCGGGSCHHHHTT-CEECHHH
T ss_pred HHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--CcccccccccccccchhccC-CCCCchh
Confidence 4799999999999999999999999999854 58999999999876543 23445678999999999876 4689999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||||+|+|++|.+||.+.+..+.+..|......++.. .+..+++++++||.
T Consensus 185 DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~ 239 (321)
T d1tkia_ 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-------------------------AFKEISIEAMDFVD 239 (321)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH-------------------------HHTTSCHHHHHHHH
T ss_pred hcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh-------------------------hccCCCHHHHHHHH
Confidence 99999999999999999999999999999887754444433 33568999999999
Q ss_pred HhcCCCCCCCcCHHHHHhcccccCC
Q 012191 159 TLLSVEPYKRATASAALASEYFSTK 183 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~~~ 183 (468)
+||..||.+|||+.|+|+||||+..
T Consensus 240 ~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 240 RLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.9e-34 Score=283.00 Aligned_cols=154 Identities=32% Similarity=0.511 Sum_probs=132.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...+..+||+.|+|||++.+ ..|+.++||
T Consensus 109 ~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 186 (320)
T d1xjda_ 109 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLG-QKYNHSVDW 186 (320)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred HHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-ccccccCCCCCcCCHHHHcC-CCCCchhhh
Confidence 4799999999999999999999999999999999999999997655332 33455689999999999987 568999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||||+|+|++|..||.+.+..+.+.++... .+. ....+++++++||.+|
T Consensus 187 wSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~---------------------------~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 187 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPF---------------------------YPRWLEKEAKDLLVKL 237 (320)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC---------------------------CCTTSCHHHHHHHHHH
T ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---------------------------CCccCCHHHHHHHHHh
Confidence 99999999999999999999988888877542 111 0125789999999999
Q ss_pred cCCCCCCCcCHH-HHHhcccccCCCC
Q 012191 161 LSVEPYKRATAS-AALASEYFSTKPY 185 (468)
Q Consensus 161 L~~DP~kRpTa~-e~L~Hp~F~~~p~ 185 (468)
|+.||.+|||+. ++++||||+...|
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred cccCCCCCcCHHHHHHhCchhccCCH
Confidence 999999999995 8999999987544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.7e-34 Score=287.53 Aligned_cols=183 Identities=34% Similarity=0.591 Sum_probs=136.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
++||+.||.|||++||+||||||+|||++.++.+|++|||++...... ...+..++|+.|+|||++.+ ..++.++||
T Consensus 125 ~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~-~~~~~~~Di 201 (355)
T d2b1pa1 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDI 201 (355)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHTT-CCCCTTHHH
T ss_pred HHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc--cccccccccccccChhhhcC-CCCCCCccc
Confidence 479999999999999999999999999999999999999998765543 34456688999999999987 578999999
Q ss_pred eeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCC-ch------------hhhhcC
Q 012191 81 WSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYD-SS------------LRETFK 147 (468)
Q Consensus 81 WSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~------------l~~~~~ 147 (468)
||+||++|+|++|.+||.+.+...++.++....+.+..++|..........+....... .. ......
T Consensus 202 wSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (355)
T d2b1pa1 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281 (355)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred ccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccc
Confidence 99999999999999999999999999999999888888777542211000000000000 00 011112
Q ss_pred CCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCCCC
Q 012191 148 DLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKPYA 186 (468)
Q Consensus 148 ~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p~~ 186 (468)
.+++++++||.+||.+||.+||||+|||+||||+....+
T Consensus 282 ~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~ 320 (355)
T d2b1pa1 282 LKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320 (355)
T ss_dssp HHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence 357789999999999999999999999999999976543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.6e-33 Score=270.50 Aligned_cols=154 Identities=22% Similarity=0.363 Sum_probs=121.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCC--CCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGA--TDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~--~~~s~~ 77 (468)
+.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ........||+.|+|||++.+. ..|+.+
T Consensus 110 ~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ 189 (276)
T d1uwha_ 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189 (276)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHH
T ss_pred HHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCch
Confidence 3699999999999999999999999999999999999999997665322 2234556889999999999643 357889
Q ss_pred cceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
+|||||||+||||++|..||.+.+....+..+......++. +......+++++.+||
T Consensus 190 sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-----------------------~~~~~~~~~~~l~~li 246 (276)
T d1uwha_ 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-----------------------LSKVRSNCPKAMKRLM 246 (276)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-----------------------GGGSCTTCCHHHHHHH
T ss_pred hhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-----------------------chhccccchHHHHHHH
Confidence 99999999999999999999988777666555443222211 1223356889999999
Q ss_pred HHhcCCCCCCCcCHHHHHhc
Q 012191 158 ETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~H 177 (468)
.+||..||.+|||+.+++++
T Consensus 247 ~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 247 AECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.6e-33 Score=277.11 Aligned_cols=160 Identities=26% Similarity=0.399 Sum_probs=129.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCC-CCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGAT-DYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~-~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+............|++.|++||.+.+.. .++.++|
T Consensus 135 ~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksD 214 (322)
T d1vzoa_ 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 214 (322)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHH
T ss_pred HHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhh
Confidence 479999999999999999999999999999999999999999876554444455678899999999997643 4688999
Q ss_pred eeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 80 IWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||+||+|++|..||.+.........+......... .....+++++.+||.+
T Consensus 215 IWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~ 269 (322)
T d1vzoa_ 215 WWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-------------------------PYPQEMSALAKDLIQR 269 (322)
T ss_dssp HHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-------------------------CCCTTSCHHHHHHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC-------------------------CCcccCCHHHHHHHHH
Confidence 999999999999999999887655544444432211110 0113578999999999
Q ss_pred hcCCCCCCCc-----CHHHHHhcccccCCCC
Q 012191 160 LLSVEPYKRA-----TASAALASEYFSTKPY 185 (468)
Q Consensus 160 mL~~DP~kRp-----Ta~e~L~Hp~F~~~p~ 185 (468)
||.+||.+|| |++|+|+||||+...|
T Consensus 270 ~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 270 LLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp HTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred HcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 9999999999 5999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-32 Score=267.54 Aligned_cols=153 Identities=22% Similarity=0.370 Sum_probs=126.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+||||+.++.+||+|||++...............+|+.|+|||++.+ ..|+.++||
T Consensus 115 ~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDv 193 (272)
T d1qpca_ 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDV 193 (272)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHH
T ss_pred HHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC-CCCCchhhh
Confidence 3699999999999999999999999999999999999999998776554444456678999999999976 458999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|||++ |.+||...+..+.+..+......+ ....+++++.+||.+
T Consensus 194 wS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV----------------------------RPDNCPEELYQLMRL 245 (272)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------------------CcccChHHHHHHHHH
Confidence 999999999999 566677777766666654321110 013578899999999
Q ss_pred hcCCCCCCCcCHHHHHh--cccccC
Q 012191 160 LLSVEPYKRATASAALA--SEYFST 182 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~--Hp~F~~ 182 (468)
||+.||.+|||+.++++ ++||+.
T Consensus 246 cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 246 CWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999998 899863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-32 Score=272.98 Aligned_cols=149 Identities=20% Similarity=0.248 Sum_probs=122.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+ ..|+.++|
T Consensus 170 ~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~D 248 (325)
T d1rjba_ 170 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSD 248 (325)
T ss_dssp HHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCccee
Confidence 369999999999999999999999999999999999999999765543222 2234567999999999876 46899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||+||||++ |.+||.+......+.++......++ ....+++++.+||.
T Consensus 249 iwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~ 301 (325)
T d1rjba_ 249 VWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQ 301 (325)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHH
T ss_pred ccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCCcCCHHHHHHHH
Confidence 9999999999997 8999998776666666654321111 01357899999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||++|+++|
T Consensus 302 ~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 302 SCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.7e-32 Score=266.47 Aligned_cols=149 Identities=23% Similarity=0.285 Sum_probs=115.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||++|||||||||+||||+.++.+||+|||++........ .......||+.|+|||++.+ ..|+.++|
T Consensus 140 ~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sD 218 (299)
T d1ywna1 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSD 218 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccc
Confidence 36999999999999999999999999999999999999999976544322 23345678999999999987 56899999
Q ss_pred eeeeehhhhhhhhc-CCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG-~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++| .+||.+....+.+..+......++ ....+++++.+||.
T Consensus 219 iwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~ 271 (299)
T d1ywna1 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTML 271 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHH
T ss_pred eeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHH
Confidence 99999999999986 578887665555554443221111 11357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||+.++|+|
T Consensus 272 ~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 272 DCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=260.29 Aligned_cols=148 Identities=22% Similarity=0.327 Sum_probs=112.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+++|+||||||+|||++.++.+||+|||++...............||+.|+|||++.+ ..|+.++||
T Consensus 107 ~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DV 185 (263)
T d1sm2a_ 107 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDV 185 (263)
T ss_dssp HHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTT-CCCCHHHHH
T ss_pred HHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC-CCCCchhhh
Confidence 3699999999999999999999999999999999999999998766544344445678999999999986 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|||++ |.+||.+.+..+.+..+......+. ...+++++.+||.+
T Consensus 186 wS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~----------------------------p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------------------------PRLASTHVYQIMNH 237 (263)
T ss_dssp HHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC----------------------------CTTSCHHHHHHHHH
T ss_pred cchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC----------------------------ccccCHHHHHHHHH
Confidence 999999999998 5777877777777776654211110 02467899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||++++|+|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=9.4e-32 Score=262.29 Aligned_cols=155 Identities=23% Similarity=0.422 Sum_probs=119.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC--CCCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH--RQPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
++||+.||+|||++||+||||||+|||++.++.++|+|||.+....... .......+||+.|+|||++.+ ..|+.++
T Consensus 117 ~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~ 195 (277)
T d1o6ya_ 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARS 195 (277)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHH
T ss_pred HHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcce
Confidence 4799999999999999999999999999999999999999986544322 123445689999999999976 4689999
Q ss_pred ceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 79 DLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 79 DIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||||+|+|++|.+||.+.+..+.+.++......++ ......+|+++.+||.
T Consensus 196 DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~s~~l~~li~ 250 (277)
T d1o6ya_ 196 DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-------------------------SARHEGLSADLDAVVL 250 (277)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG-------------------------GGTSSSCCHHHHHHHH
T ss_pred ecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC-------------------------chhccCCCHHHHHHHH
Confidence 999999999999999999999998888777765332222 1223578999999999
Q ss_pred HhcCCCCCCCcCHHHHHhccccc
Q 012191 159 TLLSVEPYKRATASAALASEYFS 181 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~Hp~F~ 181 (468)
+||+.||.+||+..+.|.|+|++
T Consensus 251 ~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 251 KALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999555555677653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8e-32 Score=262.40 Aligned_cols=148 Identities=23% Similarity=0.345 Sum_probs=113.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...........+...+|+.|+|||++.+ ..|+.++||
T Consensus 114 ~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~Di 192 (273)
T d1mp8a_ 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDV 192 (273)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHH
T ss_pred HHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc-CCCCCcccc
Confidence 3699999999999999999999999999999999999999998766544334455678999999999976 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|||++ |.+||.+.+..+.+..+.... .+ ...+.+++.+.+||.+
T Consensus 193 wSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~--~~--------------------------~~~~~~~~~~~~li~~ 244 (273)
T d1mp8a_ 193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--RL--------------------------PMPPNCPPTLYSLMTK 244 (273)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHHHH
T ss_pred ccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCCCCCHHHHHHHHH
Confidence 999999999987 899999988877777664321 10 0124678999999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||.+|||+.+++++
T Consensus 245 cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 245 CWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHH
Confidence 999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-31 Score=257.00 Aligned_cols=147 Identities=22% Similarity=0.353 Sum_probs=126.0
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCccee
Q 012191 2 NQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDLW 81 (468)
Q Consensus 2 ~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDIW 81 (468)
.||+.||.|||+.||+||||||+|||++.++.+||+|||++...............+|+.|+|||++.+ ..|+.++|||
T Consensus 107 ~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiw 185 (258)
T d1k2pa_ 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIW 185 (258)
T ss_dssp HHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred HHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-CCCCcceeec
Confidence 699999999999999999999999999999999999999998766554444556678999999999986 4589999999
Q ss_pred eeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHHh
Q 012191 82 SVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIETL 160 (468)
Q Consensus 82 SLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~m 160 (468)
||||++|||++ |..||.+.+..+....+......+. ...+++.+.+||.+|
T Consensus 186 S~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR----------------------------PHLASEKVYTIMYSC 237 (258)
T ss_dssp HHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHT
T ss_pred ccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----------------------------cccccHHHHHHHHHH
Confidence 99999999998 8999999998887777754221111 124678999999999
Q ss_pred cCCCCCCCcCHHHHHhc
Q 012191 161 LSVEPYKRATASAALAS 177 (468)
Q Consensus 161 L~~DP~kRpTa~e~L~H 177 (468)
|+.||.+|||+.++|+|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=262.53 Aligned_cols=152 Identities=20% Similarity=0.289 Sum_probs=122.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+ ..|+.++
T Consensus 113 ~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~s 191 (277)
T d1xbba_ 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKS 191 (277)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHH
T ss_pred HHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcC-CCCCchh
Confidence 369999999999999999999999999999999999999999866543221 2234568999999999976 4588999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|||++ |.+||.+.+..+....+... ..+ .....+|+++.+||
T Consensus 192 DiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~~--------------------------~~p~~~~~~~~~li 243 (277)
T d1xbba_ 192 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ERM--------------------------GCPAGCPREMYDLM 243 (277)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CCC--------------------------CCCTTCCHHHHHHH
T ss_pred hhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CCC--------------------------CCCcccCHHHHHHH
Confidence 99999999999997 89999998877766665431 110 01135789999999
Q ss_pred HHhcCCCCCCCcCHHHH---Hhccccc
Q 012191 158 ETLLSVEPYKRATASAA---LASEYFS 181 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~---L~Hp~F~ 181 (468)
.+||+.||.+|||++++ |+|+||.
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999998 4666653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1.8e-31 Score=262.43 Aligned_cols=147 Identities=19% Similarity=0.272 Sum_probs=117.2
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++...............+|+.|+|||++.+ ..|+.++||
T Consensus 121 ~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~Di 199 (287)
T d1opja_ 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDV 199 (287)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHH
T ss_pred HHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcC-CCCCchhhh
Confidence 3699999999999999999999999999999999999999998766544333444567899999999876 468999999
Q ss_pred eeeehhhhhhhhcCCC-CCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGKPI-LQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~~p-f~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|||++|..| |.+.+.......+... ..+ .....+++++.+||.+
T Consensus 200 wS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~---------------------------~~~~~~~~~l~~li~~ 251 (287)
T d1opja_ 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM---------------------------ERPEGCPEKVYELMRA 251 (287)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC---------------------------CCCccchHHHHHHHHH
Confidence 9999999999996655 4554444443333221 111 0113578999999999
Q ss_pred hcCCCCCCCcCHHHHHh
Q 012191 160 LLSVEPYKRATASAALA 176 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~ 176 (468)
||+.||.+|||+.++++
T Consensus 252 cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 252 CWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCCHhHCcCHHHHHH
Confidence 99999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=3.4e-31 Score=261.85 Aligned_cols=148 Identities=22% Similarity=0.359 Sum_probs=113.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC----CccccccCCcccChhhhcCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ----PLTSRVVTLWYRPPELLLGATDYGP 76 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~l~g~~~~s~ 76 (468)
+.||+.||.|||++||+||||||+||||+.++.+||+|||++......... ......+|+.|+|||++.+ ..|+.
T Consensus 134 ~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ 212 (299)
T d1jpaa_ 134 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTS 212 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHS-CCCCH
T ss_pred HHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCc
Confidence 479999999999999999999999999999999999999999876543221 1123456899999999976 46899
Q ss_pred Ccceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHH
Q 012191 77 SVDLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVN 155 (468)
Q Consensus 77 ~sDIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~d 155 (468)
++|||||||+||||++ |.+||.+.+..+.+..+......+. ...++..+.+
T Consensus 213 ~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~ 264 (299)
T d1jpaa_ 213 ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP----------------------------PMDCPSALHQ 264 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHH
T ss_pred ccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CccchHHHHH
Confidence 9999999999999997 8999999888877777654221110 1357889999
Q ss_pred HHHHhcCCCCCCCcCHHHHHhc
Q 012191 156 LIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 156 LL~~mL~~DP~kRpTa~e~L~H 177 (468)
||.+||+.||.+|||+.+++++
T Consensus 265 li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 265 LMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-31 Score=262.22 Aligned_cols=152 Identities=20% Similarity=0.271 Sum_probs=125.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC--CCccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR--QPLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+ ..|+.++
T Consensus 115 ~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ks 193 (285)
T d1u59a_ 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRS 193 (285)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHH
T ss_pred HHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhC-CCCCccc
Confidence 47999999999999999999999999999999999999999987654322 12234567899999999976 4689999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|||++ |.+||.+.+..+.+..+.... .+ +....+++++.+||
T Consensus 194 DVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--~~--------------------------~~p~~~~~~l~~li 245 (285)
T d1u59a_ 194 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--RM--------------------------ECPPECPPELYALM 245 (285)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHH
T ss_pred hhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCCcCCHHHHHHH
Confidence 99999999999998 999999888777766664321 10 01135789999999
Q ss_pred HHhcCCCCCCCcCHHHH---Hhccccc
Q 012191 158 ETLLSVEPYKRATASAA---LASEYFS 181 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~---L~Hp~F~ 181 (468)
.+||..||.+|||+.++ |+|.|++
T Consensus 246 ~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 246 SDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999888 6788875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.1e-31 Score=259.80 Aligned_cols=154 Identities=25% Similarity=0.376 Sum_probs=120.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++...............+|+.|+|||++.+ ..++.++||
T Consensus 119 ~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI 197 (285)
T d1fmka3 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 197 (285)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHH
T ss_pred HHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhh
Confidence 3699999999999999999999999999999999999999998765544444455678999999999976 468999999
Q ss_pred eeeehhhhhhhhc-CCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG-~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||||||++| .++|.+....+.+..+......+ ....+++++++||.+
T Consensus 198 ~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 198 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQ 249 (285)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTSCHHHHHHHHH
T ss_pred hcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------------------CCcccCHHHHHHHHH
Confidence 9999999999995 56667777777776665422111 113578999999999
Q ss_pred hcCCCCCCCcCHHHHHh--cccccCC
Q 012191 160 LLSVEPYKRATASAALA--SEYFSTK 183 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~--Hp~F~~~ 183 (468)
||+.||++|||+.+++. ++||+..
T Consensus 250 cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 250 CWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 99999999999999988 8898763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=4.8e-31 Score=265.37 Aligned_cols=179 Identities=29% Similarity=0.529 Sum_probs=133.2
Q ss_pred CHHHHHHHHHHHh-CCCeeccCCCCceEECCCC------cEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCC
Q 012191 1 MNQLLHGLEHCHS-RGVLHRDIKGSNLLVNNEG------VLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATD 73 (468)
Q Consensus 1 m~QLL~gL~yLHs-~gIvHrDIKp~NILld~~g------~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~ 73 (468)
++||+.||+|||+ .||+||||||+||||+.++ .++|+|||.+..... .....+||+.|+|||++.+ ..
T Consensus 131 ~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~ 205 (362)
T d1q8ya_ 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-AP 205 (362)
T ss_dssp HHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CC
T ss_pred HHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc----ccccccccccccChhhccc-cC
Confidence 4799999999998 8999999999999997665 399999999875543 3345689999999999986 56
Q ss_pred CCCCcceeeeehhhhhhhhcCCCCCCCc------hHHHHHHHHHHcCCCCchhhhccCCCccc-----cCC--CC---CC
Q 012191 74 YGPSVDLWSVGCVFAELLIGKPILQGRT------EVEQLHKIFKLCGSPPDDYWKKSKLPHAT-----LFK--PQ---QP 137 (468)
Q Consensus 74 ~s~~sDIWSLG~ILyeLltG~~pf~g~~------~~e~l~~i~~~~g~p~~~~~~~~~~~~~~-----~~~--~~---~~ 137 (468)
|+.++||||+||++++|++|+.||.+.. ....+..++..+|.++...+......... ... .. .+
T Consensus 206 ~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
T d1q8ya_ 206 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285 (362)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCc
Confidence 8999999999999999999999997543 35567777888888877665432221100 000 00 01
Q ss_pred CCchhhhh---cCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhcccccCCC
Q 012191 138 YDSSLRET---FKDLPTTAVNLIETLLSVEPYKRATASAALASEYFSTKP 184 (468)
Q Consensus 138 ~~~~l~~~---~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~Hp~F~~~p 184 (468)
....+... ....++.+++||.+||.+||.+||||.|||+||||+..+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 286 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 11111111 123567899999999999999999999999999999644
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-31 Score=262.13 Aligned_cols=148 Identities=21% Similarity=0.278 Sum_probs=120.1
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC-CccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ-PLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+ ..|+.++|
T Consensus 117 ~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sD 195 (317)
T d1xkka_ 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSD 195 (317)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhc-CCCChhhh
Confidence 369999999999999999999999999999999999999999876543322 2234568999999999987 46899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++ |.+||.+.+..+....+..... ++ ....+++.+.+||.
T Consensus 196 vwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~---------------------------~p~~~~~~~~~li~ 247 (317)
T d1xkka_ 196 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LP---------------------------QPPICTIDVYMIMV 247 (317)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-CC---------------------------CCTTBCHHHHHHHH
T ss_pred hhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC---------------------------CCcccCHHHHHHHH
Confidence 9999999999998 8999998877666555543211 11 01357889999999
Q ss_pred HhcCCCCCCCcCHHHHHhc
Q 012191 159 TLLSVEPYKRATASAALAS 177 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~H 177 (468)
+||+.||.+|||+.+++.|
T Consensus 248 ~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 248 KCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCChhhCcCHHHHHHH
Confidence 9999999999999999988
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-30 Score=253.80 Aligned_cols=147 Identities=21% Similarity=0.321 Sum_probs=111.0
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++........ ......||+.|+|||++.+ ..|+.++
T Consensus 116 ~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~s 194 (283)
T d1mqba_ 116 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSAS 194 (283)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHH
T ss_pred HHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcc
Confidence 369999999999999999999999999999999999999999876543221 2234567999999999976 4689999
Q ss_pred ceeeeehhhhhhhhc-CCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLltG-~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|||++| .++|.+....+.+..+..... ++ ....++..+.+||
T Consensus 195 DI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~---------------------------~~~~~~~~l~~li 246 (283)
T d1mqba_ 195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LP---------------------------TPMDCPSAIYQLM 246 (283)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC---------------------------CCTTCBHHHHHHH
T ss_pred cccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-CC---------------------------CchhhHHHHHHHH
Confidence 999999999999985 555666666655555433211 10 1135788999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||+.||.+|||+.++++
T Consensus 247 ~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 247 MQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=4.3e-30 Score=253.62 Aligned_cols=147 Identities=22% Similarity=0.301 Sum_probs=120.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCC-CCCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGH-RQPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ....+...+|+.|+|||.+.+ ..|+.++|
T Consensus 146 ~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksD 224 (301)
T d1lufa_ 146 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESD 224 (301)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhh
Confidence 3699999999999999999999999999999999999999997554332 223345678899999999986 56899999
Q ss_pred eeeeehhhhhhhhcC-CCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG~-~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||+|||++|. +||.+.+..+.+..+.... .+ .....+++++.+||.
T Consensus 225 VwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~--~~--------------------------~~p~~~~~~~~~li~ 276 (301)
T d1lufa_ 225 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN--IL--------------------------ACPENCPLELYNLMR 276 (301)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CC--------------------------CCCTTCCHHHHHHHH
T ss_pred hccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCccchHHHHHHHH
Confidence 999999999999984 7899988888877765421 11 111367889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.|+++
T Consensus 277 ~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 277 LCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhHCcCHHHHHH
Confidence 999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.2e-30 Score=250.78 Aligned_cols=148 Identities=26% Similarity=0.360 Sum_probs=121.3
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCC--CccccccCCcccChhhhcCCCCCCCCc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQ--PLTSRVVTLWYRPPELLLGATDYGPSV 78 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l~g~~~~s~~s 78 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......++..|+|||++.+ ..++.++
T Consensus 117 ~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~ 195 (273)
T d1u46a_ 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHAS 195 (273)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHH
T ss_pred HHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcch
Confidence 369999999999999999999999999999999999999999876543221 2233456889999999987 4689999
Q ss_pred ceeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHH
Q 012191 79 DLWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLI 157 (468)
Q Consensus 79 DIWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL 157 (468)
|||||||++|||++ |.+||.+.+..+.+..+.+....++ ....++..+.+||
T Consensus 196 Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~~l~~li 248 (273)
T d1u46a_ 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---------------------------RPEDCPQDIYNVM 248 (273)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHHH
T ss_pred hhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC---------------------------CcccccHHHHHHH
Confidence 99999999999998 8999999999888887755321111 1136789999999
Q ss_pred HHhcCCCCCCCcCHHHHHh
Q 012191 158 ETLLSVEPYKRATASAALA 176 (468)
Q Consensus 158 ~~mL~~DP~kRpTa~e~L~ 176 (468)
.+||..||.+|||+.++++
T Consensus 249 ~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 249 VQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-29 Score=249.48 Aligned_cols=147 Identities=23% Similarity=0.327 Sum_probs=121.4
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
++||+.||+|||++|||||||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+ ..|+.++|
T Consensus 141 ~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~D 219 (299)
T d1fgka_ 141 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSD 219 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhh
Confidence 47999999999999999999999999999999999999999986654322 22345678999999999976 56999999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
|||||||+|||++ |.+||.+.+....+..+... ..++ ....+++++.+||.
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~---------------------------~p~~~~~~l~~li~ 271 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMD---------------------------KPSNCTNELYMMMR 271 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCC---------------------------CCSSCCHHHHHHHH
T ss_pred hHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CCCC---------------------------CCccchHHHHHHHH
Confidence 9999999999997 79999888776665554321 1111 01357889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.|+|+
T Consensus 272 ~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 272 DCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHccCCHhHCcCHHHHHH
Confidence 999999999999999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=1.4e-29 Score=248.95 Aligned_cols=160 Identities=20% Similarity=0.266 Sum_probs=119.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC---CCcEEEEecCCccccCCCCCC------CccccccCCcccChhhhcCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN---EGVLKLADFGLANFSNTGHRQ------PLTSRVVTLWYRPPELLLGA 71 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~---~g~vKL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l~g~ 71 (468)
+.||+.||+|||++||+||||||+|||++. +..+||+|||++..+...... .....+||+.|+|||++.+
T Consensus 109 ~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 187 (299)
T d1ckia_ 109 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG- 187 (299)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-
T ss_pred HHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-
Confidence 369999999999999999999999999864 457999999999876543221 2235579999999999987
Q ss_pred CCCCCCcceeeeehhhhhhhhcCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcH
Q 012191 72 TDYGPSVDLWSVGCVFAELLIGKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPT 151 (468)
Q Consensus 72 ~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~ 151 (468)
..|+.++|||||||++|||++|..||.+.........+....... ...........+|+
T Consensus 188 ~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~p~ 246 (299)
T d1ckia_ 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---------------------MSTPIEVLCKGYPS 246 (299)
T ss_dssp BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH---------------------HHSCHHHHTTTSCH
T ss_pred CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc---------------------CCCChhHhccCCCH
Confidence 458999999999999999999999998765544433332211000 00011233467899
Q ss_pred HHHHHHHHhcCCCCCCCcCHH---HHHhcccccC
Q 012191 152 TAVNLIETLLSVEPYKRATAS---AALASEYFST 182 (468)
Q Consensus 152 ~l~dLL~~mL~~DP~kRpTa~---e~L~Hp~F~~ 182 (468)
++.+||..||..||.+||++. ++|+|+|.+.
T Consensus 247 ~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 247 EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 999999999999999999987 5577877654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.5e-29 Score=246.87 Aligned_cols=148 Identities=22% Similarity=0.339 Sum_probs=121.9
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||+|||++|||||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|
T Consensus 151 ~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 229 (311)
T d1t46a_ 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESD 229 (311)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCccc
Confidence 47999999999999999999999999999999999999999987654332 22344678999999999976 46899999
Q ss_pred eeeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++ |.+||.+....+.+.++......+.. ...+++.+.+||.
T Consensus 230 IwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~l~~Li~ 282 (311)
T d1t46a_ 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS---------------------------PEHAPAEMYDIMK 282 (311)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC---------------------------CTTSCHHHHHHHH
T ss_pred ccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---------------------------cccccHHHHHHHH
Confidence 9999999999998 77888887776666666543221110 1247889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.++|+
T Consensus 283 ~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 283 TCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhHCcCHHHHHH
Confidence 999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.8e-29 Score=246.02 Aligned_cols=147 Identities=18% Similarity=0.264 Sum_probs=121.8
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC-CCccccccCCcccChhhhcCCCCCCCCcc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR-QPLTSRVVTLWYRPPELLLGATDYGPSVD 79 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l~g~~~~s~~sD 79 (468)
+.||+.||.|||+++|+||||||+||||+.++.+||+|||++........ .......+|+.|+|||.+.+ ..++.++|
T Consensus 139 ~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~D 217 (308)
T d1p4oa_ 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSD 217 (308)
T ss_dssp HHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHH
T ss_pred HHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccc
Confidence 36899999999999999999999999999999999999999976543322 12234467999999999976 46888999
Q ss_pred eeeeehhhhhhhhc-CCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHH
Q 012191 80 LWSVGCVFAELLIG-KPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIE 158 (468)
Q Consensus 80 IWSLG~ILyeLltG-~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~ 158 (468)
||||||++|||++| .+||.+.+..+.+..+......+ ....+++.+.+||.
T Consensus 218 v~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~ 269 (308)
T d1p4oa_ 218 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD----------------------------KPDNCPDMLFELMR 269 (308)
T ss_dssp HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHH
T ss_pred cccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC----------------------------CcccchHHHHHHHH
Confidence 99999999999998 58899888888877765421110 11357889999999
Q ss_pred HhcCCCCCCCcCHHHHHh
Q 012191 159 TLLSVEPYKRATASAALA 176 (468)
Q Consensus 159 ~mL~~DP~kRpTa~e~L~ 176 (468)
+||+.||.+|||+.++|+
T Consensus 270 ~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 270 MCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhHCcCHHHHHH
Confidence 999999999999999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.2e-29 Score=247.54 Aligned_cols=146 Identities=23% Similarity=0.291 Sum_probs=118.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|..|+|||.+.+ ..|+.++||
T Consensus 133 ~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDv 209 (309)
T d1fvra_ 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDV 209 (309)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHH
T ss_pred HHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc--cccceecCCcccchHHhcc-CCCCcccee
Confidence 3699999999999999999999999999999999999999997554321 2234468999999999976 468999999
Q ss_pred eeeehhhhhhhhcC-CCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLIGK-PILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLltG~-~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
||||||+|||++|. +||.+.+..+.+..+.... .+ .....+++++.+||.+
T Consensus 210 wSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~--~~--------------------------~~~~~~~~~~~~li~~ 261 (309)
T d1fvra_ 210 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RL--------------------------EKPLNCDDEVYDLMRQ 261 (309)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC--CC--------------------------CCCTTBCHHHHHHHHH
T ss_pred ehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CC--------------------------CCCccCCHHHHHHHHH
Confidence 99999999999964 6788888777766653311 10 0113578999999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||+.||++|||+.++|++
T Consensus 262 cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 262 CWREKPYERPSFAQILVS 279 (309)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9e-29 Score=240.05 Aligned_cols=144 Identities=17% Similarity=0.297 Sum_probs=113.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++||
T Consensus 109 ~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~-~~~t~~sDI 183 (262)
T d1byga_ 109 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDV 183 (262)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHH-CCCCHHHHH
T ss_pred HHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----CccccccccCCChHHHhC-CCCChHHHH
Confidence 369999999999999999999999999999999999999999765432 233467889999999976 468999999
Q ss_pred eeeehhhhhhhh-cCCCCCCCchHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHHHHH
Q 012191 81 WSVGCVFAELLI-GKPILQGRTEVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNLIET 159 (468)
Q Consensus 81 WSLG~ILyeLlt-G~~pf~g~~~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dLL~~ 159 (468)
|||||++|||++ |.+||.+.+..+....+.... .+ +....+++++.+||.+
T Consensus 184 wSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--~~--------------------------~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 184 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KM--------------------------DAPDGCPPAVYEVMKN 235 (262)
T ss_dssp HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--CC--------------------------CCCTTCCHHHHHHHHH
T ss_pred HhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--CC--------------------------CCCccCCHHHHHHHHH
Confidence 999999999998 789998877766666653211 00 1113578899999999
Q ss_pred hcCCCCCCCcCHHHHHhc
Q 012191 160 LLSVEPYKRATASAALAS 177 (468)
Q Consensus 160 mL~~DP~kRpTa~e~L~H 177 (468)
||..||.+|||+.+++++
T Consensus 236 cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHH
Confidence 999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.2e-28 Score=242.86 Aligned_cols=148 Identities=18% Similarity=0.219 Sum_probs=114.7
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcCCCCCCCC
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLGATDYGPS 77 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g~~~~s~~ 77 (468)
+.||+.||.|||+.+|+||||||+||||+.++.+||+|||++........ .......||+.|+|||.+.+ ..++.+
T Consensus 136 ~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k 214 (311)
T d1r0pa_ 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTK 214 (311)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHH
T ss_pred HHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc-CCCCCh
Confidence 36999999999999999999999999999999999999999986654322 12234568999999999876 468999
Q ss_pred cceeeeehhhhhhhhcCCCCCCCc-hHHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhcCCCcHHHHHH
Q 012191 78 VDLWSVGCVFAELLIGKPILQGRT-EVEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETFKDLPTTAVNL 156 (468)
Q Consensus 78 sDIWSLG~ILyeLltG~~pf~g~~-~~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~s~~l~dL 156 (468)
+|||||||++|||++|..||.... ..+....+.. |..+. ....+++.+.+|
T Consensus 215 sDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~~~~--------------------------~p~~~~~~l~~l 266 (311)
T d1r0pa_ 215 SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRRLL--------------------------QPEYCPDPLYEV 266 (311)
T ss_dssp HHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TCCCC--------------------------CCTTCCHHHHHH
T ss_pred hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CCCCC--------------------------CcccCcHHHHHH
Confidence 999999999999999776665443 3333333322 11110 013467899999
Q ss_pred HHHhcCCCCCCCcCHHHHHhc
Q 012191 157 IETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 157 L~~mL~~DP~kRpTa~e~L~H 177 (468)
|.+||+.||.+|||+.|+++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.94 E-value=8.1e-28 Score=236.45 Aligned_cols=151 Identities=21% Similarity=0.261 Sum_probs=117.5
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECC-----CCcEEEEecCCccccCCCCC------CCccccccCCcccChhhhc
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNN-----EGVLKLADFGLANFSNTGHR------QPLTSRVVTLWYRPPELLL 69 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~-----~g~vKL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~l~ 69 (468)
+.||+.||+|||++||+||||||+|||++. .+.+||+|||++..+..... ......+||+.|+|||++.
T Consensus 107 ~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~ 186 (293)
T d1csna_ 107 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186 (293)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhc
Confidence 479999999999999999999999999964 57899999999987653221 1233557999999999998
Q ss_pred CCCCCCCCcceeeeehhhhhhhhcCCCCCCCch---HHHHHHHHHHcCCCCchhhhccCCCccccCCCCCCCCchhhhhc
Q 012191 70 GATDYGPSVDLWSVGCVFAELLIGKPILQGRTE---VEQLHKIFKLCGSPPDDYWKKSKLPHATLFKPQQPYDSSLRETF 146 (468)
Q Consensus 70 g~~~~s~~sDIWSLG~ILyeLltG~~pf~g~~~---~e~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (468)
+ ..++.++|||||||++|+|++|..||.+... ...+..+......+ ...+..
T Consensus 187 ~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~------------------------~~~~l~ 241 (293)
T d1csna_ 187 G-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST------------------------PLRELC 241 (293)
T ss_dssp T-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS------------------------CHHHHT
T ss_pred C-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC------------------------ChHHhc
Confidence 7 5689999999999999999999999986543 33333332211000 123445
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCcCHHHHHh
Q 012191 147 KDLPTTAVNLIETLLSVEPYKRATASAALA 176 (468)
Q Consensus 147 ~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~ 176 (468)
+.+|+++.+||..|+..+|.+||+.+.+.+
T Consensus 242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 678999999999999999999999776643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.8e-27 Score=233.88 Aligned_cols=155 Identities=25% Similarity=0.308 Sum_probs=109.2
Q ss_pred HHHHHHHHHHHh--------CCCeeccCCCCceEECCCCcEEEEecCCccccCCCCC---CCccccccCCcccChhhhcC
Q 012191 2 NQLLHGLEHCHS--------RGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHR---QPLTSRVVTLWYRPPELLLG 70 (468)
Q Consensus 2 ~QLL~gL~yLHs--------~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~~~gt~~Y~APE~l~g 70 (468)
.|++.||+|||+ +||+||||||+||||+.++.+||+|||++........ ......+||+.|+|||++.+
T Consensus 107 ~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp HHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccc
Confidence 689999999996 5999999999999999999999999999986654322 12345689999999999875
Q ss_pred CC-----CCCCCcceeeeehhhhhhhhcCCCCCCCch--------------HHHHHHHHHHcCCCCchhhhccCCCcccc
Q 012191 71 AT-----DYGPSVDLWSVGCVFAELLIGKPILQGRTE--------------VEQLHKIFKLCGSPPDDYWKKSKLPHATL 131 (468)
Q Consensus 71 ~~-----~~s~~sDIWSLG~ILyeLltG~~pf~g~~~--------------~e~l~~i~~~~g~p~~~~~~~~~~~~~~~ 131 (468)
.. .++.++|||||||+||||++|.+||..... ...+.......+
T Consensus 187 ~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 249 (303)
T d1vjya_ 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----------------- 249 (303)
T ss_dssp CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-----------------
T ss_pred cccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc-----------------
Confidence 32 246689999999999999999888743221 111111110000
Q ss_pred CCCCCCCCchhhhhcCCCcHHHHHHHHHhcCCCCCCCcCHHHHHhc
Q 012191 132 FKPQQPYDSSLRETFKDLPTTAVNLIETLLSVEPYKRATASAALAS 177 (468)
Q Consensus 132 ~~~~~~~~~~l~~~~~~~s~~l~dLL~~mL~~DP~kRpTa~e~L~H 177 (468)
+++..+ . ..........+.+||.+||+.||.+|||+.|++++
T Consensus 250 ~~p~~~--~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 250 LRPNIP--N--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCCCC--G--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cCCCCC--c--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 001000 0 00011234568999999999999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.18 E-value=4.8e-13 Score=121.54 Aligned_cols=79 Identities=20% Similarity=0.243 Sum_probs=53.6
Q ss_pred CHHHHHHHHHHHhCCCeeccCCCCceEECCCCcEEEEecCCccccCCCCCCCccccccCCcccChhhhcCCCCCCCCcce
Q 012191 1 MNQLLHGLEHCHSRGVLHRDIKGSNLLVNNEGVLKLADFGLANFSNTGHRQPLTSRVVTLWYRPPELLLGATDYGPSVDL 80 (468)
Q Consensus 1 m~QLL~gL~yLHs~gIvHrDIKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l~g~~~~s~~sDI 80 (468)
+.||+.||.|||++||+||||||+|||++++ .++|+|||++..........+.....+ .-.+.+. ..|+..+|+
T Consensus 109 ~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~---~~~~~f~--r~y~~~~d~ 182 (191)
T d1zara2 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR---NIITYFS--RTYRTEKDI 182 (191)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHH---HHHHHHH--HHHCCCCCH
T ss_pred HHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHH---HHHHHHc--CCCCCcccH
Confidence 3699999999999999999999999999865 589999999876543211100000000 0012222 357889999
Q ss_pred eeeeh
Q 012191 81 WSVGC 85 (468)
Q Consensus 81 WSLG~ 85 (468)
||+.-
T Consensus 183 ~s~~~ 187 (191)
T d1zara2 183 NSAID 187 (191)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.05 E-value=0.012 Score=54.93 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=26.8
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999774
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=90.08 E-value=0.05 Score=48.74 Aligned_cols=29 Identities=28% Similarity=0.409 Sum_probs=25.0
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceeecCCceEEEeechhcc
Confidence 38999999999999876666799999774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=89.61 E-value=0.053 Score=48.32 Aligned_cols=28 Identities=29% Similarity=0.305 Sum_probs=24.8
Q ss_pred CeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 16 VLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 16 IvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999887667899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=86.33 E-value=0.15 Score=49.26 Aligned_cols=28 Identities=18% Similarity=0.328 Sum_probs=24.6
Q ss_pred CCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 15 GVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 15 gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.++|+|+.+.|||++.++ ++|+||.++.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 699999999999998764 8999998774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=84.55 E-value=0.16 Score=47.47 Aligned_cols=28 Identities=29% Similarity=0.319 Sum_probs=22.7
Q ss_pred CCCeeccCCCCceEECCCCcEEEEecCCcc
Q 012191 14 RGVLHRDIKGSNLLVNNEGVLKLADFGLAN 43 (468)
Q Consensus 14 ~gIvHrDIKp~NILld~~g~vKL~DFGla~ 43 (468)
.++||+|+.+.|||+++ + ..++||+.+.
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 36899999999999974 3 4589999764
|